{
    "5e6157cb1af46fc13000000e_1": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.1328125,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.162109375,
            "end_logit": 8.1328125,
            "text": "syndrome",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.34375,
            "text": "Ret",
            "probability": 7.665157318115234e-05
        },
        {
            "start_logit": -6.6328125,
            "end_logit": 8.1328125,
            "text": "t syndrome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.00390625,
            "text": "Rett",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.234375,
            "text": "Rett syndrome.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 8.1328125,
            "text": "methyl-CpG-binding protein-2 gene (MECP2) are commonly associated with Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 8.1328125,
            "text": "MECP2) are commonly associated with Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 8.1328125,
            "text": "commonly associated with Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 8.1328125,
            "text": "CpG-binding protein-2 gene (MECP2) are commonly associated with Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0,
            "end_logit": 8.1328125,
            "text": "associated with Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 8.1328125,
            "text": "Mutations in the methyl-CpG-binding protein-2 gene (MECP2) are commonly associated with Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.162109375,
            "end_logit": -7.234375,
            "text": "syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": -1.34375,
            "text": "methyl-CpG-binding protein-2 gene (MECP2) are commonly associated with Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -1.34375,
            "text": "MECP2) are commonly associated with Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.95703125,
            "end_logit": -1.34375,
            "text": "commonly associated with Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.97265625,
            "end_logit": -1.34375,
            "text": "CpG-binding protein-2 gene (MECP2) are commonly associated with Ret",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -1.34375,
            "text": "associated with Ret",
            "probability": 0.0
        },
        {
            "start_logit": -8.0078125,
            "end_logit": -1.34375,
            "text": "Mutations in the methyl-CpG-binding protein-2 gene (MECP2) are commonly associated with Ret",
            "probability": 0.0
        },
        {
            "start_logit": -6.6328125,
            "end_logit": -7.00390625,
            "text": "t",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_2": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.1171875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.1953125,
            "end_logit": 8.1171875,
            "text": "syndrome",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.396484375,
            "text": "Ret",
            "probability": 7.426738739013672e-05
        },
        {
            "start_logit": -6.828125,
            "end_logit": 8.1171875,
            "text": "t syndrome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.93359375,
            "text": "Rett",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.34765625,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding the methyl-CpG-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.36328125,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding the methyl-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.3984375,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.41015625,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.42578125,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding the methyl-CpG-binding protein",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.453125,
            "text": "Rett syndrome (RS) is a debilitating neurological",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.45703125,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.4609375,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.4765625,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.4765625,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.4765625,
            "text": "Rett syndrome (RS) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.48046875,
            "text": "Rett syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.48046875,
            "text": "Rett syndrome (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.1953125,
            "end_logit": -7.34765625,
            "text": "syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding the methyl-CpG-",
            "probability": 0.0
        },
        {
            "start_logit": -1.1953125,
            "end_logit": -7.36328125,
            "text": "syndrome (RS) is a debilitating neurological disorder affecting mostly girls with heterozygous mutations in the gene encoding the methyl-",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_3": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.1171875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.236328125,
            "end_logit": 8.1171875,
            "text": "syndrome",
            "probability": 7.903575897216797e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.341796875,
            "text": "Ret",
            "probability": 7.784366607666016e-05
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 8.1171875,
            "text": "t syndrome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.01171875,
            "text": "Rett",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.16015625,
            "text": "Rett syndrome (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.16796875,
            "text": "Rett syndrome (RTT",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.34375,
            "text": "Rett syndrome (RTT).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.48828125,
            "text": "Rett syndrome (RTT)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.5,
            "text": "Rett syndrome (RT",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 8.1171875,
            "text": "neurodevelopmental disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 8.1171875,
            "text": "cause the neurodevelopmental disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 8.1171875,
            "text": "MECP2 gene cause the neurodevelopmental disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 8.1171875,
            "text": "disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0,
            "end_logit": 8.1171875,
            "text": "P2 gene cause the neurodevelopmental disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 8.1171875,
            "text": "Mutations in the MECP2 gene cause the neurodevelopmental disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 8.1171875,
            "text": "the neurodevelopmental disorder Rett syndrome",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.236328125,
            "end_logit": -7.16015625,
            "text": "syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": -1.236328125,
            "end_logit": -7.16796875,
            "text": "syndrome (RTT",
            "probability": 0.0
        },
        {
            "start_logit": -1.236328125,
            "end_logit": -7.34375,
            "text": "syndrome (RTT).",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_4": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.125,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.205078125,
            "end_logit": 8.125,
            "text": "syndrome",
            "probability": 8.094310760498047e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.3193359375,
            "text": "Ret",
            "probability": 7.903575897216797e-05
        },
        {
            "start_logit": -6.71875,
            "end_logit": 8.125,
            "text": "t syndrome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.90234375,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in the transcriptional regulator MeCP2.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.0078125,
            "text": "Rett",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3125,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.37109375,
            "text": "Rett syndrome is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.40625,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4375,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.453125,
            "text": "Rett syndrome is a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4609375,
            "text": "Rett syndrome is a severe neurodevelopmental disorder",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4921875,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.50390625,
            "text": "Rett syndrome is a severe neurodevelopmental",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.52734375,
            "text": "Rett syndrome is a severe",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.53515625,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in the transcriptional regulator",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.54296875,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in the transcriptional",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.55859375,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations in the transcriptional regulator MeCP2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.56640625,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused by mutations",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.609375,
            "text": "Rett syndrome is a severe neurodevelopmental disorder mainly caused",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e6157cb1af46fc13000000e_5": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.1171875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.2734375,
            "end_logit": 8.1171875,
            "text": "syndrome",
            "probability": 7.724761962890625e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.37890625,
            "text": "Ret",
            "probability": 7.605552673339844e-05
        },
        {
            "start_logit": -6.58984375,
            "end_logit": 8.1171875,
            "text": "t syndrome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.16796875,
            "text": "Rett",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.390625,
            "text": "Rett syndrome,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.39453125,
            "text": "Rett syndrome, a progressive neurodevelopmental disorder.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.44921875,
            "text": "Rett syndrome, a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.48828125,
            "text": "Rett syndrome, a progressive neurodevelopmental disorder",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.60546875,
            "text": "Rett syndrome, a progressive neurodevelopmental",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.73046875,
            "text": "Rett syndrome, a progressive",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 8.1171875,
            "text": "MeCP2 gene cause Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 8.1171875,
            "text": "cause Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 8.1171875,
            "text": "Mutations in the MeCP2 gene cause Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 8.1171875,
            "text": "P2 gene cause Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.390625,
            "text": "syndrome,",
            "probability": 0.0
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.39453125,
            "text": "syndrome, a progressive neurodevelopmental disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.44921875,
            "text": "syndrome, a",
            "probability": 0.0
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.48828125,
            "text": "syndrome, a progressive neurodevelopmental disorder",
            "probability": 0.0
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.60546875,
            "text": "syndrome, a progressive neurodevelopmental",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_6": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.1484375,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.0703125,
            "end_logit": 8.1484375,
            "text": "syndrome",
            "probability": 9.173154830932617e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.31640625,
            "text": "Ret",
            "probability": 7.724761962890625e-05
        },
        {
            "start_logit": -6.75,
            "end_logit": 8.1484375,
            "text": "t syndrome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.92578125,
            "text": "Rett",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.17578125,
            "text": "Rett syndrome (RTT",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.26171875,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the transcription factor Methyl CpG Binding Protein 2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3359375,
            "text": "Rett syndrome (RTT) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.35546875,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.37109375,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the transcription factor Methyl CpG Binding Protein 2 (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.37109375,
            "text": "Rett syndrome (RTT) is a debilitating neurological",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.41796875,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.43359375,
            "text": "Rett syndrome (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.43359375,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.43359375,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene encoding the transcription factor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4375,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4453125,
            "text": "Rett syndrome (RTT) is a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.44921875,
            "text": "Rett syndrome (RTT) is a debilitating neurological disorder caused by mutations in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.45703125,
            "text": "Rett syndrome (RT",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.0703125,
            "end_logit": -7.17578125,
            "text": "syndrome (RTT",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_7": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.140625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.12890625,
            "end_logit": 8.140625,
            "text": "syndrome",
            "probability": 8.887052536010742e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.3291015625,
            "text": "Ret",
            "probability": 7.784366607666016e-05
        },
        {
            "start_logit": -6.71875,
            "end_logit": 8.140625,
            "text": "t syndrome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.875,
            "text": "Rett syndrome (RTT) is",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.90234375,
            "text": "Rett syndrome (RTT",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.94140625,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional repressor gene MeCP2.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.984375,
            "text": "Rett",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.21875,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional repressor gene",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.234375,
            "text": "Rett syndrome (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.30859375,
            "text": "Rett syndrome (RTT) is associated with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.33984375,
            "text": "Rett syndrome (RTT) is associated with mutations in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.34375,
            "text": "Rett syndrome (RTT)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.37109375,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional repressor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.38671875,
            "text": "Rett syndrome (RT",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.39453125,
            "text": "Rett syndrome (RTT) is associated with mutations in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.3984375,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional repressor gene MeCP2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.44140625,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.47265625,
            "text": "Rett syndrome (RTT) is associated with mutations in the transcriptional repressor gene MeC",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.5,
            "text": "Rett syndrome (RTT) is associated",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5e6157cb1af46fc13000000e_8": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.1171875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.2734375,
            "end_logit": 8.1171875,
            "text": "syndrome",
            "probability": 7.724761962890625e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.37890625,
            "text": "Ret",
            "probability": 7.605552673339844e-05
        },
        {
            "start_logit": -6.58984375,
            "end_logit": 8.1171875,
            "text": "t syndrome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.16796875,
            "text": "Rett",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.390625,
            "text": "Rett syndrome,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.39453125,
            "text": "Rett syndrome, a progressive neurodevelopmental disorder.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.44921875,
            "text": "Rett syndrome, a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.48828125,
            "text": "Rett syndrome, a progressive neurodevelopmental disorder",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.60546875,
            "text": "Rett syndrome, a progressive neurodevelopmental",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.73046875,
            "text": "Rett syndrome, a progressive",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 8.1171875,
            "text": "MeCP2 gene cause Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 8.1171875,
            "text": "cause Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 8.1171875,
            "text": "Mutations in the MeCP2 gene cause Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 8.1171875,
            "text": "P2 gene cause Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.390625,
            "text": "syndrome,",
            "probability": 0.0
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.39453125,
            "text": "syndrome, a progressive neurodevelopmental disorder.",
            "probability": 0.0
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.44921875,
            "text": "syndrome, a",
            "probability": 0.0
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.48828125,
            "text": "syndrome, a progressive neurodevelopmental disorder",
            "probability": 0.0
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.60546875,
            "text": "syndrome, a progressive neurodevelopmental",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_9": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.1171875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.32421875,
            "text": "Ret",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": -1.23046875,
            "end_logit": 8.1171875,
            "text": "syndrome",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": -6.5859375,
            "end_logit": 8.1171875,
            "text": "t syndrome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.9921875,
            "text": "Rett",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 8.1171875,
            "text": "Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.73828125,
            "text": "Rett syndrome.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 8.1171875,
            "text": "MECP2) mutation type is associated with disease severity in Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 8.1171875,
            "text": "in Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 8.1171875,
            "text": "CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 8.1171875,
            "text": "(MECP2) mutation type is associated with disease severity in Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 8.1171875,
            "text": "P2) mutation type is associated with disease severity in Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 8.1171875,
            "text": "mutation type is associated with disease severity in Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96875,
            "end_logit": 8.1171875,
            "text": "disease severity in Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -1.32421875,
            "text": "Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Ret",
            "probability": 0.0
        },
        {
            "start_logit": -1.23046875,
            "end_logit": -7.73828125,
            "text": "syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -7.80859375,
            "end_logit": -1.32421875,
            "text": "MECP2) mutation type is associated with disease severity in Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.83984375,
            "end_logit": -1.32421875,
            "text": "in Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.92578125,
            "end_logit": -1.32421875,
            "text": "CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Ret",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -1.32421875,
            "text": "(MECP2) mutation type is associated with disease severity in Ret",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_10": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.140625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.123046875,
            "end_logit": 8.140625,
            "text": "syndrome",
            "probability": 8.887052536010742e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.3662109375,
            "text": "Ret",
            "probability": 7.426738739013672e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.87890625,
            "text": "Rett",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 8.140625,
            "text": "t syndrome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.15234375,
            "text": "Rett syndrome (RTT",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.35546875,
            "text": "Rett syndrome (RTT), the second most common cause of mental retardation in females,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.123046875,
            "end_logit": -7.15234375,
            "text": "syndrome (RTT",
            "probability": 0.0
        },
        {
            "start_logit": -1.123046875,
            "end_logit": -7.34375,
            "text": "syndrome (RTT), the second most common cause of mental retardation in females, has been associated with mutations in MeCP2, the archetypic",
            "probability": 0.0
        },
        {
            "start_logit": -1.123046875,
            "end_logit": -7.35546875,
            "text": "syndrome (RTT), the second most common cause of mental retardation in females,",
            "probability": 0.0
        },
        {
            "start_logit": -6.8203125,
            "end_logit": -6.87890625,
            "text": "t",
            "probability": 0.0
        },
        {
            "start_logit": -6.8203125,
            "end_logit": -7.15234375,
            "text": "t syndrome (RTT",
            "probability": 0.0
        },
        {
            "start_logit": -6.8203125,
            "end_logit": -7.35546875,
            "text": "t syndrome (RTT), the second most common cause of mental retardation in females,",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -7.2734375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.96875,
            "end_logit": -7.13671875,
            "text": ", has been associated with mutations in MeCP2, the archetypical member of the methyl-CpG binding domain (MBD",
            "probability": 0.0
        },
        {
            "start_logit": -7.96875,
            "end_logit": -7.15234375,
            "text": ", has been associated with mutations in MeCP2, the archetypical member of the methyl-CpG binding domain",
            "probability": 0.0
        },
        {
            "start_logit": -7.96875,
            "end_logit": -7.1953125,
            "text": ", has been associated with mutations in MeCP2, the archetypical member of the methyl-CpG binding domain (MBD) family",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -7.13671875,
            "text": "methyl-CpG binding domain (MBD",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -7.15234375,
            "text": "(RTT",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -7.15234375,
            "text": "methyl-CpG binding domain",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_11": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.140625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.130859375,
            "end_logit": 8.140625,
            "text": "syndrome",
            "probability": 8.821487426757812e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.3447265625,
            "text": "Ret",
            "probability": 7.665157318115234e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.8984375,
            "text": "Rett",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.828125,
            "end_logit": 8.140625,
            "text": "t syndrome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.203125,
            "text": "Rett syndrome (RTT",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.21875,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.234375,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-binding protein 2 (MECP2)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.2734375,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-binding protein 2 (MECP2),",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.28125,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-binding protein 2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.3046875,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.33203125,
            "text": "Rett syndrome (RTT) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.33984375,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.34375,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-binding protein 2 (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.359375,
            "text": "Rett syndrome (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.41796875,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-binding protein",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.41796875,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.41796875,
            "text": "Rett syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.130859375,
            "end_logit": -7.203125,
            "text": "syndrome (RTT",
            "probability": 0.0
        },
        {
            "start_logit": -1.130859375,
            "end_logit": -7.21875,
            "text": "syndrome (RTT) is a severe neurodevelopmental disease caused by mutations in methyl-CpG-",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_12": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.15625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.03125,
            "end_logit": 8.15625,
            "text": "syndrome",
            "probability": 9.608268737792969e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.3134765625,
            "text": "Ret",
            "probability": 7.724761962890625e-05
        },
        {
            "start_logit": -6.765625,
            "end_logit": 8.15625,
            "text": "t syndrome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.89453125,
            "text": "Rett",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.13671875,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2 (MECP2).",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.1484375,
            "text": "Rett syndrome (RTT) is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.15625,
            "text": "Rett syndrome (RTT",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.33984375,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.34375,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.359375,
            "text": "Rett syndrome (RTT) is caused by mutations in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3671875,
            "text": "Rett syndrome (RTT) is caused by",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4296875,
            "text": "Rett syndrome (RTT)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4375,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein 2 (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4375,
            "text": "Rett syndrome (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.44140625,
            "text": "Rett syndrome (RT",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4453125,
            "text": "Rett syndrome (RTT) is caused by mutations in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.44921875,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor methyl CpG-binding protein",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.44921875,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional repressor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4609375,
            "text": "Rett syndrome (RTT) is caused by mutations in the transcriptional",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5e6157cb1af46fc13000000e_13": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.1171875,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.2578125,
            "end_logit": 8.1171875,
            "text": "syndrome",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.380859375,
            "text": "Ret",
            "probability": 7.545948028564453e-05
        },
        {
            "start_logit": -6.67578125,
            "end_logit": 8.1171875,
            "text": "t syndrome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.05078125,
            "text": "Rett syndrome (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.14453125,
            "text": "Rett syndrome (RTT",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.1640625,
            "text": "Rett",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.3515625,
            "text": "Rett syndrome (RTT).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.4921875,
            "text": "Rett syndrome (RTT)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.51953125,
            "text": "Rett syndrome (RT",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 8.1171875,
            "text": "neurodevelopmental disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 8.1171875,
            "text": "cause the neurodevelopmental disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 8.1171875,
            "text": "disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 8.1171875,
            "text": "MECP2 cause the neurodevelopmental disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 8.1171875,
            "text": "Mutations in MECP2 cause the neurodevelopmental disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 8.1171875,
            "text": "the neurodevelopmental disorder Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.2578125,
            "end_logit": -7.05078125,
            "text": "syndrome (",
            "probability": 0.0
        },
        {
            "start_logit": -1.2578125,
            "end_logit": -7.14453125,
            "text": "syndrome (RTT",
            "probability": 0.0
        },
        {
            "start_logit": -1.2578125,
            "end_logit": -7.3515625,
            "text": "syndrome (RTT).",
            "probability": 0.0
        },
        {
            "start_logit": -1.2578125,
            "end_logit": -7.4921875,
            "text": "syndrome (RTT)",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_14": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.140625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.119140625,
            "end_logit": 8.140625,
            "text": "syndrome",
            "probability": 8.958578109741211e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.3564453125,
            "text": "Ret",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": -6.703125,
            "end_logit": 8.140625,
            "text": "t syndrome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.9921875,
            "text": "Rett",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.33984375,
            "text": "Rett syndrome , an autism spectrum disorder",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.38671875,
            "text": "Rett syndrome , an autism spectrum disorder mainly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.4140625,
            "text": "Rett syndrome ,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5234375,
            "text": "Rett syndrome , an autism spectrum disorder mainly affecting young females .",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5546875,
            "text": "Rett syndrome , an",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.609375,
            "text": "Rett syndrome , an autism spectrum disorder mainly affecting",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 8.140625,
            "text": "methyl-CpG-binding protein MECP2 are the major cause of Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 8.140625,
            "text": "major cause of Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 8.140625,
            "text": "MECP2 are the major cause of Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 8.140625,
            "text": "cause of Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 8.140625,
            "text": "Mutations in the gene encoding the methyl-CpG-binding protein MECP2 are the major cause of Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.119140625,
            "end_logit": -7.33984375,
            "text": "syndrome , an autism spectrum disorder",
            "probability": 0.0
        },
        {
            "start_logit": -1.119140625,
            "end_logit": -7.38671875,
            "text": "syndrome , an autism spectrum disorder mainly",
            "probability": 0.0
        },
        {
            "start_logit": -1.119140625,
            "end_logit": -7.4140625,
            "text": "syndrome ,",
            "probability": 0.0
        },
        {
            "start_logit": -1.119140625,
            "end_logit": -7.5234375,
            "text": "syndrome , an autism spectrum disorder mainly affecting young females .",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_15": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.140625,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.126953125,
            "end_logit": 8.140625,
            "text": "syndrome",
            "probability": 8.887052536010742e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.341796875,
            "text": "Ret",
            "probability": 7.665157318115234e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.8984375,
            "text": "Rett",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.84375,
            "end_logit": 8.140625,
            "text": "t syndrome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.296875,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that results from mutation of the gene encoding the transcriptional repressor methyl-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.33984375,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.33984375,
            "text": "Rett syndrome ( RTT",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.375,
            "text": "Rett syndrome ( RTT ) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.3984375,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that results from mutation of the gene encoding the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.40625,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that results from mutation of the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.40625,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that results from mutation of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.41796875,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that results from mutation of the gene encoding",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.4296875,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that results from mutation of the gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.4375,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.4453125,
            "text": "Rett syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.44921875,
            "text": "Rett syndrome (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.126953125,
            "end_logit": -7.296875,
            "text": "syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that results from mutation of the gene encoding the transcriptional repressor methyl-",
            "probability": 0.0
        },
        {
            "start_logit": -1.126953125,
            "end_logit": -7.3125,
            "text": "syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that results from mutation of the gene encoding the transcriptional repressor methyl-CpG binding protein",
            "probability": 0.0
        },
        {
            "start_logit": -1.126953125,
            "end_logit": -7.33984375,
            "text": "syndrome ( RTT ) is a severe neurodevelopmental disorder with features of autism that",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_16": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.1328125,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.1484375,
            "end_logit": 8.1328125,
            "text": "syndrome",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.3291015625,
            "text": "Ret",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": -6.8046875,
            "end_logit": 8.1328125,
            "text": "t syndrome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.94140625,
            "text": "Rett",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.9921875,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due to mutations affecting the neural transcription factor MeCP2.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.1015625,
            "text": "Rett syndrome (RTT) is an X",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.2578125,
            "text": "Rett syndrome (RTT",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.26171875,
            "text": "Rett syndrome (RTT) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3125,
            "text": "Rett syndrome (RTT) is an X-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.359375,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3984375,
            "text": "Rett syndrome (RTT) is an",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.421875,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.47265625,
            "text": "Rett syndrome (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.47265625,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due to mutations affecting the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4765625,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due to mutations affecting the neural transcription factor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.484375,
            "text": "Rett syndrome (RTT) is an X-linked",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.48828125,
            "text": "Rett syndrome (RTT)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.5078125,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.5390625,
            "text": "Rett syndrome (RTT) is an X-linked neurodevelopmental disorder due to mutations affecting the neural transcription factor MeCP2",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5e6157cb1af46fc13000000e_17": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.1328125,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.193359375,
            "end_logit": 8.1328125,
            "text": "syndrome",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.380859375,
            "text": "Ret",
            "probability": 7.31348991394043e-05
        },
        {
            "start_logit": -6.8125,
            "end_logit": 8.1328125,
            "text": "t syndrome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.890625,
            "text": "Rett syndrome (RTT).",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.03125,
            "text": "Rett syndrome (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.046875,
            "text": "Rett",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.26171875,
            "text": "Rett syndrome (RTT",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.37109375,
            "text": "Rett syndrome (RTT)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.48828125,
            "text": "Rett syndrome (RT",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 8.1328125,
            "text": "methyl-CpG-binding-protein 2 (MeCP2) cause a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 8.1328125,
            "text": "disorder known as Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 8.1328125,
            "text": "cause a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 8.1328125,
            "text": "onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 8.1328125,
            "text": "neurodevelopmental disorder known as Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 8.1328125,
            "text": "Mutations in the transcription factor methyl-CpG-binding-protein 2 (MeCP2) cause a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 8.1328125,
            "text": "delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 8.1328125,
            "text": "CpG-binding-protein 2 (MeCP2) cause a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 8.1328125,
            "text": "MeCP2) cause a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 8.1328125,
            "text": "a delayed-onset neurodevelopmental disorder known as Rett syndrome",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e6157cb1af46fc13000000e_18": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.1328125,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.134765625,
            "end_logit": 8.1328125,
            "text": "syndrome",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.3173828125,
            "text": "Ret",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 8.1328125,
            "text": "t syndrome",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.91796875,
            "text": "Rett",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.140625,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding the transcription factor methyl-CpG-binding protein 2 (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.171875,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding the transcription factor methyl-CpG-binding protein 2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.2109375,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding the transcription factor methyl-CpG-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.30078125,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding the transcription factor methyl-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.30859375,
            "text": "Rett syndrome is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.30859375,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3125,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.35546875,
            "text": "Rett syndrome is a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.35546875,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.359375,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.36328125,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3671875,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3671875,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3671875,
            "text": "Rett syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.134765625,
            "end_logit": -7.140625,
            "text": "syndrome is a neurodevelopmental disorder caused by loss-of-function mutations in the gene encoding the transcription factor methyl-CpG-binding protein 2 (",
            "probability": 0.0
        }
    ],
    "5e6157cb1af46fc13000000e_19": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.1328125,
            "text": "Rett syndrome",
            "probability": 1.0
        },
        {
            "start_logit": -1.138671875,
            "end_logit": 8.1328125,
            "text": "syndrome",
            "probability": 8.684396743774414e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.31640625,
            "text": "Ret",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": -6.7109375,
            "end_logit": 8.1328125,
            "text": "t syndrome",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.96484375,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either MECP2 or CDKL5 genes.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.0,
            "text": "Rett",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.28125,
            "text": "Rett syndrome is a monogenic disease due to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.30859375,
            "text": "Rett syndrome is a monogenic disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3125,
            "text": "Rett syndrome is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.32421875,
            "text": "Rett syndrome is a monogenic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.41015625,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either MECP2 or CDKL5 genes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.41015625,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4140625,
            "text": "Rett syndrome is a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.44140625,
            "text": "Rett syndrome is a monogenic disease due to de novo",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4453125,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.44921875,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either MECP2 or",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.51171875,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either MECP2 or CDKL5",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.53515625,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.5390625,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either MECP2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.5625,
            "text": "Rett syndrome is a monogenic disease due to de novo mutations in either MECP2 or CDK",
            "probability": 1.7881393432617188e-07
        }
    ],
    "58b6bd2622d300530900000c_1": [
        {
            "start_logit": 8.28125,
            "end_logit": 8.1875,
            "text": "apoE2 isoform",
            "probability": 1.0
        },
        {
            "start_logit": -0.299072265625,
            "end_logit": 8.1875,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 0.0001882314682006836
        },
        {
            "start_logit": 8.28125,
            "end_logit": -0.958984375,
            "text": "apoE",
            "probability": 0.00010639429092407227
        },
        {
            "start_logit": -0.89794921875,
            "end_logit": 8.1875,
            "text": "isoform",
            "probability": 0.00010311603546142578
        },
        {
            "start_logit": 8.28125,
            "end_logit": -5.46484375,
            "text": "apoE2",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.28125,
            "end_logit": -6.20703125,
            "text": "apoE2 isoform is encoded by the R158C allele.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -6.94921875,
            "text": "apoE2 isoform is encoded by the R158C allele",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 8.1875,
            "text": "2 isoform",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -7.21875,
            "text": "apoE2 isoform is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 8.1875,
            "text": ", and the common apoE2 isoform",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 8.1875,
            "text": "the common apoE2 isoform",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -7.38671875,
            "text": "apoE2 isoform is encoded by the R158C",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3125,
            "end_logit": 8.1875,
            "text": "and the common apoE2 isoform",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.1875,
            "text": "relationship to type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.1875,
            "text": "common apoE2 isoform",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 8.1875,
            "text": "type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 8.1875,
            "text": "well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 8.1875,
            "text": "hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.299072265625,
            "end_logit": -0.958984375,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE",
            "probability": 0.0
        },
        {
            "start_logit": -0.299072265625,
            "end_logit": -3.669921875,
            "text": "ApoE2",
            "probability": 0.0
        }
    ],
    "58b6bd2622d300530900000c_2": [
        {
            "start_logit": 8.28125,
            "end_logit": 8.1875,
            "text": "apoE2 isoform",
            "probability": 1.0
        },
        {
            "start_logit": -0.299072265625,
            "end_logit": 8.1875,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 0.0001882314682006836
        },
        {
            "start_logit": 8.28125,
            "end_logit": -0.958984375,
            "text": "apoE",
            "probability": 0.00010639429092407227
        },
        {
            "start_logit": -0.89794921875,
            "end_logit": 8.1875,
            "text": "isoform",
            "probability": 0.00010311603546142578
        },
        {
            "start_logit": 8.28125,
            "end_logit": -5.46484375,
            "text": "apoE2",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.28125,
            "end_logit": -6.20703125,
            "text": "apoE2 isoform is encoded by the R158C allele.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -6.94921875,
            "text": "apoE2 isoform is encoded by the R158C allele",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 8.1875,
            "text": "2 isoform",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -7.21875,
            "text": "apoE2 isoform is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 8.1875,
            "text": ", and the common apoE2 isoform",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 8.1875,
            "text": "the common apoE2 isoform",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -7.38671875,
            "text": "apoE2 isoform is encoded by the R158C",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3125,
            "end_logit": 8.1875,
            "text": "and the common apoE2 isoform",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.1875,
            "text": "relationship to type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.1875,
            "text": "common apoE2 isoform",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 8.1875,
            "text": "type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 8.1875,
            "text": "well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 8.1875,
            "text": "hyperlipoproteinemia, and the common apoE2 isoform",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.299072265625,
            "end_logit": -0.958984375,
            "text": "ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE",
            "probability": 0.0
        },
        {
            "start_logit": -0.299072265625,
            "end_logit": -3.669921875,
            "text": "ApoE2",
            "probability": 0.0
        }
    ],
    "54db62a3034aea571d000001_1": [
        {
            "start_logit": -0.210205078125,
            "end_logit": -0.012847900390625,
            "text": "SERCA",
            "probability": 0.994140625
        },
        {
            "start_logit": -0.210205078125,
            "end_logit": -5.63671875,
            "text": "SERCA)",
            "probability": 0.0035858154296875
        },
        {
            "start_logit": -6.58984375,
            "end_logit": -0.012847900390625,
            "text": "(SERCA",
            "probability": 0.0016870498657226562
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -0.012847900390625,
            "text": "sarcoplasmic reticulum (SR) calcium pump (SERCA",
            "probability": 0.0005970001220703125
        },
        {
            "start_logit": -6.58984375,
            "end_logit": -5.63671875,
            "text": "(SERCA)",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -5.63671875,
            "text": "sarcoplasmic reticulum (SR) calcium pump (SERCA)",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.78515625,
            "end_logit": -5.63671875,
            "text": ")",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -7.28125,
            "text": "sarcoplasmic reticulum (SR",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -7.390625,
            "text": "sarcoplasmic reticulum (SR) calcium pump",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -7.50390625,
            "text": "sarcoplasmic reticulum",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -7.5703125,
            "text": "sarcoplasmic reticulum (SR)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -7.5703125,
            "text": "sarcoplasmic reticulum (SR) calcium",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -7.5859375,
            "text": "sarcoplasmic reticulum (",
            "probability": 2.980232238769531e-07
        }
    ],
    "54db62a3034aea571d000001_2": [
        {
            "start_logit": -3.5546875,
            "end_logit": 5.4921875,
            "text": "sarco/endoplasmic reticulum Ca(2+)-ATPase",
            "probability": 0.64208984375
        },
        {
            "start_logit": -4.82421875,
            "end_logit": 5.4921875,
            "text": "ATPase",
            "probability": 0.180419921875
        },
        {
            "start_logit": -5.89453125,
            "end_logit": 5.4921875,
            "text": "Ca(2+)-ATPase",
            "probability": 0.06182861328125
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 5.4921875,
            "text": "+)-ATPase",
            "probability": 0.0255889892578125
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 5.4921875,
            "text": "the sarco/endoplasmic reticulum Ca(2+)-ATPase",
            "probability": 0.0157623291015625
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 5.4921875,
            "text": "2+)-ATPase",
            "probability": 0.0156402587890625
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 5.4921875,
            "text": ")-ATPase",
            "probability": 0.0153961181640625
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 5.4921875,
            "text": "-ATPase",
            "probability": 0.01358795166015625
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 5.4921875,
            "text": "(2+)-ATPase",
            "probability": 0.0131683349609375
        },
        {
            "start_logit": -7.90625,
            "end_logit": 5.4921875,
            "text": "o/endoplasmic reticulum Ca(2+)-ATPase",
            "probability": 0.008270263671875
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 5.4921875,
            "text": "reticulum Ca(2+)-ATPase",
            "probability": 0.00811004638671875
        },
        {
            "start_logit": -3.06640625,
            "end_logit": -3.6484375,
            "text": "SERCA",
            "probability": 0.00011175870895385742
        },
        {
            "start_logit": -3.5546875,
            "end_logit": -3.6484375,
            "text": "sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA",
            "probability": 6.884336471557617e-05
        },
        {
            "start_logit": -4.82421875,
            "end_logit": -3.6484375,
            "text": "ATPase (SERCA",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": -5.89453125,
            "end_logit": -3.6484375,
            "text": "Ca(2+)-ATPase (SERCA",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": -3.06640625,
            "end_logit": -6.78125,
            "text": "SERCA)",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -3.5546875,
            "end_logit": -6.78125,
            "text": "sarco/endoplasmic reticulum Ca(2+)-ATPase (SERCA)",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -6.77734375,
            "end_logit": -3.6484375,
            "text": "+)-ATPase (SERCA",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -6.953125,
            "end_logit": -3.6484375,
            "text": "(SERCA",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -3.5546875,
            "end_logit": -7.35546875,
            "text": "sarco/endoplasmic",
            "probability": 1.6689300537109375e-06
        }
    ],
    "54db62a3034aea571d000001_3": [
        {
            "start_logit": 3.05859375,
            "end_logit": 0.98779296875,
            "text": "SERCA",
            "probability": 0.8115234375
        },
        {
            "start_logit": 3.05859375,
            "end_logit": -0.587890625,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER lumen.",
            "probability": 0.1678466796875
        },
        {
            "start_logit": 3.05859375,
            "end_logit": -2.87109375,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER",
            "probability": 0.0171051025390625
        },
        {
            "start_logit": 3.05859375,
            "end_logit": -6.71875,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the",
            "probability": 0.0003647804260253906
        },
        {
            "start_logit": 3.05859375,
            "end_logit": -6.76171875,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for",
            "probability": 0.0003495216369628906
        },
        {
            "start_logit": 3.05859375,
            "end_logit": -6.77734375,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER lumen",
            "probability": 0.0003440380096435547
        },
        {
            "start_logit": 3.05859375,
            "end_logit": -7.0625,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump,",
            "probability": 0.0002598762512207031
        },
        {
            "start_logit": 3.05859375,
            "end_logit": -7.07421875,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible",
            "probability": 0.00025582313537597656
        },
        {
            "start_logit": 3.05859375,
            "end_logit": -7.19921875,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is",
            "probability": 0.00022554397583007812
        },
        {
            "start_logit": 3.05859375,
            "end_logit": -7.24609375,
            "text": "SERCA, an endoplasmic reticulum (ER",
            "probability": 0.00021529197692871094
        },
        {
            "start_logit": 3.05859375,
            "end_logit": -7.25390625,
            "text": "SERCA, an endoplasmic reticulum (ER)",
            "probability": 0.000213623046875
        },
        {
            "start_logit": 3.05859375,
            "end_logit": -7.28125,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump",
            "probability": 0.00020873546600341797
        },
        {
            "start_logit": 3.05859375,
            "end_logit": -7.30078125,
            "text": "SERCA, an endoplasmic reticulum (",
            "probability": 0.00020384788513183594
        },
        {
            "start_logit": 3.05859375,
            "end_logit": -7.3046875,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium",
            "probability": 0.00020229816436767578
        },
        {
            "start_logit": 3.05859375,
            "end_logit": -7.33984375,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic",
            "probability": 0.00019609928131103516
        },
        {
            "start_logit": 3.05859375,
            "end_logit": -7.33984375,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into",
            "probability": 0.00019609928131103516
        },
        {
            "start_logit": 3.05859375,
            "end_logit": -7.3515625,
            "text": "SERCA, an endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting",
            "probability": 0.00019299983978271484
        },
        {
            "start_logit": 3.05859375,
            "end_logit": -7.41015625,
            "text": "SERCA,",
            "probability": 0.00018274784088134766
        },
        {
            "start_logit": -5.4609375,
            "end_logit": -0.587890625,
            "text": ".",
            "probability": 3.355741500854492e-05
        },
        {
            "start_logit": -7.59375,
            "end_logit": -0.587890625,
            "text": "endoplasmic reticulum (ER) calcium pump, is solely responsible for transporting cytosolic calcium into the ER lumen.",
            "probability": 3.993511199951172e-06
        }
    ],
    "54db62a3034aea571d000001_4": [
        {
            "start_logit": 0.039794921875,
            "end_logit": 0.11083984375,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase",
            "probability": 0.8720703125
        },
        {
            "start_logit": 0.039794921875,
            "end_logit": -2.171875,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA)",
            "probability": 0.08892822265625
        },
        {
            "start_logit": 0.039794921875,
            "end_logit": -3.638671875,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA",
            "probability": 0.0205078125
        },
        {
            "start_logit": -4.90234375,
            "end_logit": 0.11083984375,
            "text": "Ca(2+)-ATPase",
            "probability": 0.0062103271484375
        },
        {
            "start_logit": -3.09375,
            "end_logit": -2.171875,
            "text": "SERCA)",
            "probability": 0.0038700103759765625
        },
        {
            "start_logit": 0.039794921875,
            "end_logit": -6.62890625,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is",
            "probability": 0.0010290145874023438
        },
        {
            "start_logit": -3.09375,
            "end_logit": -3.638671875,
            "text": "SERCA",
            "probability": 0.0008907318115234375
        },
        {
            "start_logit": 0.039794921875,
            "end_logit": -6.89453125,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and",
            "probability": 0.0007891654968261719
        },
        {
            "start_logit": -3.09375,
            "end_logit": -3.921875,
            "text": "SERCA) is the pump crucial for calcium homeostasis and its impairment results in pathologies such as myopathy, heart failure or diabetes.",
            "probability": 0.0006723403930664062
        },
        {
            "start_logit": -4.90234375,
            "end_logit": -2.171875,
            "text": "Ca(2+)-ATPase (SERCA)",
            "probability": 0.0006341934204101562
        },
        {
            "start_logit": 0.039794921875,
            "end_logit": -7.28515625,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the",
            "probability": 0.0005340576171875
        },
        {
            "start_logit": 0.039794921875,
            "end_logit": -7.30078125,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial",
            "probability": 0.0005259513854980469
        },
        {
            "start_logit": 0.039794921875,
            "end_logit": -7.30078125,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis and its",
            "probability": 0.0005259513854980469
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 0.11083984375,
            "text": "+)-ATPase",
            "probability": 0.0004935264587402344
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 0.11083984375,
            "text": "(2+)-ATPase",
            "probability": 0.00048041343688964844
        },
        {
            "start_logit": 0.039794921875,
            "end_logit": -7.48828125,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump",
            "probability": 0.00043582916259765625
        },
        {
            "start_logit": 0.039794921875,
            "end_logit": -7.5234375,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for calcium homeostasis",
            "probability": 0.0004208087921142578
        },
        {
            "start_logit": 0.039794921875,
            "end_logit": -7.58203125,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (SERCA) is the pump crucial for",
            "probability": 0.000396728515625
        },
        {
            "start_logit": 0.039794921875,
            "end_logit": -7.5859375,
            "text": "Sarcoplasmic reticulum Ca(2+)-ATPase (",
            "probability": 0.0003952980041503906
        },
        {
            "start_logit": 0.039794921875,
            "end_logit": -7.59375,
            "text": "Sarcoplasmic reticulum Ca(2+)-",
            "probability": 0.0003921985626220703
        }
    ],
    "54db62a3034aea571d000001_5": [
        {
            "start_logit": 0.89794921875,
            "end_logit": 3.248046875,
            "text": "SERCA enzymes).",
            "probability": 0.93701171875
        },
        {
            "start_logit": 0.89794921875,
            "end_logit": -0.208251953125,
            "text": "SERCA",
            "probability": 0.0295867919921875
        },
        {
            "start_logit": -2.564453125,
            "end_logit": 3.248046875,
            "text": ".",
            "probability": 0.0294189453125
        },
        {
            "start_logit": -5.4140625,
            "end_logit": 3.248046875,
            "text": "Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.0016994476318359375
        },
        {
            "start_logit": -6.6796875,
            "end_logit": 3.248046875,
            "text": "(SERCA enzymes).",
            "probability": 0.0004794597625732422
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 3.248046875,
            "text": "Calcium is actively accumulated in the endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.0004329681396484375
        },
        {
            "start_logit": -7.25,
            "end_logit": 3.248046875,
            "text": ").",
            "probability": 0.00027298927307128906
        },
        {
            "start_logit": 0.89794921875,
            "end_logit": -5.0390625,
            "text": "SERCA enzymes",
            "probability": 0.0002372264862060547
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 3.248046875,
            "text": "by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.00022983551025390625
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 3.248046875,
            "text": "o/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes).",
            "probability": 0.00019061565399169922
        },
        {
            "start_logit": -5.4140625,
            "end_logit": -0.208251953125,
            "text": "Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA",
            "probability": 5.3763389587402344e-05
        },
        {
            "start_logit": 0.89794921875,
            "end_logit": -6.8125,
            "text": "SERCA enzymes)",
            "probability": 3.999471664428711e-05
        },
        {
            "start_logit": -6.6796875,
            "end_logit": -0.208251953125,
            "text": "(SERCA",
            "probability": 1.519918441772461e-05
        },
        {
            "start_logit": -6.78515625,
            "end_logit": -0.208251953125,
            "text": "Calcium is actively accumulated in the endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA",
            "probability": 1.3589859008789062e-05
        },
        {
            "start_logit": -7.4140625,
            "end_logit": -0.208251953125,
            "text": "by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -0.208251953125,
            "text": "o/Endoplasmic Reticulum Calcium transport ATPases (SERCA",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": -5.4140625,
            "end_logit": -5.0390625,
            "text": "Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.4140625,
            "end_logit": -6.234375,
            "text": "Sarco/Endoplasmic Reticulum Calcium transport ATPases",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.6796875,
            "end_logit": -5.0390625,
            "text": "(SERCA enzymes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.78515625,
            "end_logit": -5.0390625,
            "text": "Calcium is actively accumulated in the endoplasmic reticulum by Sarco/Endoplasmic Reticulum Calcium transport ATPases (SERCA enzymes",
            "probability": 1.1920928955078125e-07
        }
    ],
    "54db62a3034aea571d000001_6": [
        {
            "start_logit": 0.267822265625,
            "end_logit": -0.63671875,
            "text": "SERCA",
            "probability": 0.990234375
        },
        {
            "start_logit": 0.267822265625,
            "end_logit": -5.7734375,
            "text": "SERCA)",
            "probability": 0.00582122802734375
        },
        {
            "start_logit": -5.671875,
            "end_logit": -0.63671875,
            "text": "sarco(endo)plasmic reticulum calcium pump (SERCA",
            "probability": 0.0026035308837890625
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -0.63671875,
            "text": "(SERCA",
            "probability": 0.0005855560302734375
        },
        {
            "start_logit": -7.625,
            "end_logit": -0.63671875,
            "text": "o(endo)plasmic reticulum calcium pump (SERCA",
            "probability": 0.0003676414489746094
        },
        {
            "start_logit": -7.890625,
            "end_logit": -0.63671875,
            "text": "plasmic reticulum calcium pump (SERCA",
            "probability": 0.0002818107604980469
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -0.63671875,
            "text": "endo)plasmic reticulum calcium pump (SERCA",
            "probability": 0.0002799034118652344
        },
        {
            "start_logit": -5.671875,
            "end_logit": -5.7734375,
            "text": "sarco(endo)plasmic reticulum calcium pump (SERCA)",
            "probability": 1.52587890625e-05
        },
        {
            "start_logit": -5.671875,
            "end_logit": -6.9609375,
            "text": "sarco(endo)plasmic reticulum calcium pump",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -5.7734375,
            "text": "(SERCA)",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": -5.671875,
            "end_logit": -7.2890625,
            "text": "sarco(endo)plasmic reticulum",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -5.671875,
            "end_logit": -7.51171875,
            "text": "sarco(endo)",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -5.671875,
            "end_logit": -7.6015625,
            "text": "sarco(endo)plasmic",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -5.671875,
            "end_logit": -7.6171875,
            "text": "sarco(endo)plasm",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -5.671875,
            "end_logit": -7.65625,
            "text": "sarco(",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -7.625,
            "end_logit": -5.7734375,
            "text": "o(endo)plasmic reticulum calcium pump (SERCA)",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -5.671875,
            "end_logit": -7.73046875,
            "text": "sarco(endo)plasmic reticulum calcium",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.6328125,
            "end_logit": -5.7734375,
            "text": ")",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.890625,
            "end_logit": -5.7734375,
            "text": "plasmic reticulum calcium pump (SERCA)",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -5.7734375,
            "text": "endo)plasmic reticulum calcium pump (SERCA)",
            "probability": 1.6689300537109375e-06
        }
    ],
    "54db62a3034aea571d000001_7": [
        {
            "start_logit": 5.53515625,
            "end_logit": 5.3671875,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases and pumps free cytosolic calcium into intracellular stores.",
            "probability": 0.990234375
        },
        {
            "start_logit": 5.53515625,
            "end_logit": 0.72021484375,
            "text": "SERCA",
            "probability": 0.0094451904296875
        },
        {
            "start_logit": -2.224609375,
            "end_logit": 5.3671875,
            "text": ".",
            "probability": 0.0004200935363769531
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -3.845703125,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases and",
            "probability": 9.822845458984375e-05
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -5.25390625,
            "text": "SERCA is",
            "probability": 2.4080276489257812e-05
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -6.1328125,
            "text": "SERCA is a membrane protein that belongs to the family of P",
            "probability": 1.0013580322265625e-05
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -6.36328125,
            "text": "SERCA is a membrane protein that belongs to the family of P-",
            "probability": 7.927417755126953e-06
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -6.453125,
            "text": "SERCA is a membrane protein that",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -6.5625,
            "text": "SERCA is a membrane protein that belongs to the family of",
            "probability": 6.496906280517578e-06
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -6.58984375,
            "text": "SERCA is a membrane protein that belongs to the",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -6.640625,
            "text": "SERCA is a",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -6.765625,
            "text": "SERCA is a membrane protein",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -6.984375,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -7.01953125,
            "text": "SERCA is a membrane protein that belongs to",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -7.05859375,
            "text": "SERCA is a membrane protein that belongs to the family",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -7.109375,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases and pumps free cytosolic calcium",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -7.16015625,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion transloc",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -7.203125,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -7.2421875,
            "text": "SERCA is a membrane protein that belongs to the family of P-type ion translocating ATPases and pumps",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 5.3671875,
            "text": "P-type ion translocating ATPases and pumps free cytosolic calcium into intracellular stores.",
            "probability": 2.384185791015625e-06
        }
    ],
    "54db62a3034aea571d000001_8": [
        {
            "start_logit": 8.25,
            "end_logit": 8.1796875,
            "text": "SERCA2a",
            "probability": 0.9990234375
        },
        {
            "start_logit": 0.86279296875,
            "end_logit": 8.1796875,
            "text": "SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 0.0006117820739746094
        },
        {
            "start_logit": 8.25,
            "end_logit": -0.9912109375,
            "text": "SERCA",
            "probability": 0.000102996826171875
        },
        {
            "start_logit": -1.021484375,
            "end_logit": 8.1796875,
            "text": "2a",
            "probability": 9.304285049438477e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -2.404296875,
            "text": "SERCA2a isoform in the heart.",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -3.58984375,
            "end_logit": 8.1796875,
            "text": "SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": -4.53125,
            "end_logit": 8.1796875,
            "text": "SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -5.1796875,
            "end_logit": 8.1796875,
            "text": "SERCA genes were identified-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.25,
            "end_logit": -5.95703125,
            "text": "SERCA2a isoform",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.3984375,
            "end_logit": 8.1796875,
            "text": ". SERCA is mainly represented by the SERCA2a",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.69921875,
            "text": "SERCA2a isoform in the heart",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.921875,
            "end_logit": 8.1796875,
            "text": "SERCA is mainly represented by the SERCA2a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 8.1796875,
            "text": "Three different SERCA genes were identified-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.1796875,
            "text": ", SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 8.1796875,
            "text": "different SERCA genes were identified-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.86279296875,
            "end_logit": -0.2445068359375,
            "text": "SERCA1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.1796875,
            "text": "and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 8.1796875,
            "text": ", and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 8.1796875,
            "text": "identified-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 8.1796875,
            "text": "-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 1.1920928955078125e-07
        }
    ],
    "54db62a3034aea571d000001_9": [
        {
            "start_logit": 8.25,
            "end_logit": 8.1796875,
            "text": "SERCA2a",
            "probability": 0.9990234375
        },
        {
            "start_logit": 0.86279296875,
            "end_logit": 8.1796875,
            "text": "SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 0.0006117820739746094
        },
        {
            "start_logit": 8.25,
            "end_logit": -0.9912109375,
            "text": "SERCA",
            "probability": 0.000102996826171875
        },
        {
            "start_logit": -1.021484375,
            "end_logit": 8.1796875,
            "text": "2a",
            "probability": 9.304285049438477e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -2.404296875,
            "text": "SERCA2a isoform in the heart.",
            "probability": 2.5093555450439453e-05
        },
        {
            "start_logit": -3.58984375,
            "end_logit": 8.1796875,
            "text": "SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 7.212162017822266e-06
        },
        {
            "start_logit": -4.53125,
            "end_logit": 8.1796875,
            "text": "SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -5.1796875,
            "end_logit": 8.1796875,
            "text": "SERCA genes were identified-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.25,
            "end_logit": -5.95703125,
            "text": "SERCA2a isoform",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.3984375,
            "end_logit": 8.1796875,
            "text": ". SERCA is mainly represented by the SERCA2a",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.69921875,
            "text": "SERCA2a isoform in the heart",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.921875,
            "end_logit": 8.1796875,
            "text": "SERCA is mainly represented by the SERCA2a",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 8.1796875,
            "text": "Three different SERCA genes were identified-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.1796875,
            "text": ", SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 8.1796875,
            "text": "different SERCA genes were identified-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.86279296875,
            "end_logit": -0.2445068359375,
            "text": "SERCA1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.1796875,
            "text": "and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 8.1796875,
            "text": ", and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 8.1796875,
            "text": "identified-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 8.1796875,
            "text": "-SERCA1, SERCA2, and SERCA3. SERCA is mainly represented by the SERCA2a",
            "probability": 1.1920928955078125e-07
        }
    ],
    "54db62a3034aea571d000001_10": [
        {
            "start_logit": -2.3984375,
            "end_logit": 4.25390625,
            "text": ".",
            "probability": 0.64111328125
        },
        {
            "start_logit": 4.6328125,
            "end_logit": -4.6796875,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase",
            "probability": 0.09564208984375
        },
        {
            "start_logit": 4.6328125,
            "end_logit": -4.95703125,
            "text": "The",
            "probability": 0.072509765625
        },
        {
            "start_logit": 4.6328125,
            "end_logit": -5.24609375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA",
            "probability": 0.0543212890625
        },
        {
            "start_logit": -5.9453125,
            "end_logit": 4.25390625,
            "text": "SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against the higher calcium concentration in the sarcoplasmic reticulum.",
            "probability": 0.0184783935546875
        },
        {
            "start_logit": 4.6328125,
            "end_logit": -6.9609375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from",
            "probability": 0.00977325439453125
        },
        {
            "start_logit": 4.6328125,
            "end_logit": -6.9921875,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to",
            "probability": 0.0094757080078125
        },
        {
            "start_logit": 4.6328125,
            "end_logit": -6.99609375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA)",
            "probability": 0.00943756103515625
        },
        {
            "start_logit": 4.6328125,
            "end_logit": -7.09375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (",
            "probability": 0.0085601806640625
        },
        {
            "start_logit": 4.6328125,
            "end_logit": -7.09375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is",
            "probability": 0.0085601806640625
        },
        {
            "start_logit": 4.6328125,
            "end_logit": -7.140625,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-",
            "probability": 0.0081634521484375
        },
        {
            "start_logit": 4.6328125,
            "end_logit": -7.1875,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound",
            "probability": 0.007793426513671875
        },
        {
            "start_logit": 4.6328125,
            "end_logit": -7.19140625,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against the higher",
            "probability": 0.007762908935546875
        },
        {
            "start_logit": 4.6328125,
            "end_logit": -7.2734375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that",
            "probability": 0.007152557373046875
        },
        {
            "start_logit": 4.6328125,
            "end_logit": -7.28125,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against the higher calcium",
            "probability": 0.007091522216796875
        },
        {
            "start_logit": 4.6328125,
            "end_logit": -7.2890625,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against",
            "probability": 0.007038116455078125
        },
        {
            "start_logit": 4.6328125,
            "end_logit": -7.30859375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive",
            "probability": 0.006900787353515625
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 4.25390625,
            "text": "membrane-bound pump that utilizes ATP to drive calcium ions from the myocyte cytosol against the higher calcium concentration in the sarcoplasmic reticulum.",
            "probability": 0.006771087646484375
        },
        {
            "start_logit": 4.6328125,
            "end_logit": -7.3359375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump",
            "probability": 0.006717681884765625
        },
        {
            "start_logit": 4.6328125,
            "end_logit": -7.33984375,
            "text": "The sarcoplasmic reticulum Ca\ufffdz ATPase (SERCA) is a membrane-bound pump that utilizes ATP to drive calcium ions from the",
            "probability": 0.00669097900390625
        }
    ],
    "550739cf3b8a5dc045000002_1": [
        {
            "start_logit": 8.0703125,
            "end_logit": 7.51171875,
            "text": "AAUAAA hexamer",
            "probability": 0.998046875
        },
        {
            "start_logit": 8.0703125,
            "end_logit": 0.91650390625,
            "text": "AAUAAA",
            "probability": 0.00136566162109375
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -1.8115234375,
            "text": "AA",
            "probability": 8.940696716308594e-05
        },
        {
            "start_logit": -2.826171875,
            "end_logit": 7.51171875,
            "text": "mer",
            "probability": 1.8596649169921875e-05
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -4.62109375,
            "text": "AAUAAA hexa",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": -6.234375,
            "end_logit": 7.51171875,
            "text": "UAAA hexamer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0703125,
            "end_logit": -7.125,
            "text": "AAUA",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.76953125,
            "end_logit": 7.51171875,
            "text": "hexamer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 7.51171875,
            "text": "The most canonical AAUAAA hexamer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 7.51171875,
            "text": "AA hexamer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 7.51171875,
            "text": "canonical AAUAAA hexamer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 7.51171875,
            "text": "most canonical AAUAAA hexamer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.234375,
            "end_logit": 0.91650390625,
            "text": "UAAA",
            "probability": 0.0
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 0.91650390625,
            "text": "The most canonical AAUAAA",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 0.91650390625,
            "text": "AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 0.91650390625,
            "text": "canonical AAUAAA",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 0.91650390625,
            "text": "most canonical AAUAAA",
            "probability": 0.0
        },
        {
            "start_logit": -7.14453125,
            "end_logit": -1.8115234375,
            "text": "The most canonical AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -1.8115234375,
            "text": "canonical AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -1.8115234375,
            "text": "most canonical AA",
            "probability": 0.0
        }
    ],
    "550739cf3b8a5dc045000002_2": [
        {
            "start_logit": 8.109375,
            "end_logit": 8.0,
            "text": "AAUAAA",
            "probability": 1.0
        },
        {
            "start_logit": 8.109375,
            "end_logit": -1.6787109375,
            "text": "AA",
            "probability": 6.252527236938477e-05
        },
        {
            "start_logit": -1.744140625,
            "end_logit": 8.0,
            "text": "AA",
            "probability": 5.269050598144531e-05
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 8.0,
            "text": "UAAA",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -6.921875,
            "text": "AAUA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 8.0,
            "text": "polyadenylation signal AAUAAA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 8.0,
            "text": "ylation signal AAUAAA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 8.0,
            "text": "signal AAUAAA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -1.6787109375,
            "text": "polyadenylation signal AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -1.6787109375,
            "text": "ylation signal AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -1.6787109375,
            "text": "signal AA",
            "probability": 0.0
        },
        {
            "start_logit": -6.42578125,
            "end_logit": -6.921875,
            "text": "UA",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -6.921875,
            "text": "polyadenylation signal AAUA",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -6.921875,
            "text": "ylation signal AAUA",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -6.921875,
            "text": "signal AAUA",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -7.7421875,
            "text": "polyadenylation signal",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -7.7421875,
            "text": "ylation signal",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -7.7421875,
            "text": "signal",
            "probability": 0.0
        }
    ],
    "550739cf3b8a5dc045000002_3": [
        {
            "start_logit": 8.109375,
            "end_logit": 8.0,
            "text": "AAUAAA",
            "probability": 1.0
        },
        {
            "start_logit": 8.109375,
            "end_logit": -1.6787109375,
            "text": "AA",
            "probability": 6.252527236938477e-05
        },
        {
            "start_logit": -1.744140625,
            "end_logit": 8.0,
            "text": "AA",
            "probability": 5.269050598144531e-05
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 8.0,
            "text": "UAAA",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -6.921875,
            "text": "AAUA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 8.0,
            "text": "polyadenylation signal AAUAAA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 8.0,
            "text": "ylation signal AAUAAA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 8.0,
            "text": "signal AAUAAA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -1.6787109375,
            "text": "polyadenylation signal AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -1.6787109375,
            "text": "ylation signal AA",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -1.6787109375,
            "text": "signal AA",
            "probability": 0.0
        },
        {
            "start_logit": -6.42578125,
            "end_logit": -6.921875,
            "text": "UA",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -6.921875,
            "text": "polyadenylation signal AAUA",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -6.921875,
            "text": "ylation signal AAUA",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -6.921875,
            "text": "signal AAUA",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -7.7421875,
            "text": "polyadenylation signal",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -7.7421875,
            "text": "ylation signal",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -7.7421875,
            "text": "signal",
            "probability": 0.0
        }
    ],
    "550739cf3b8a5dc045000002_4": [
        {
            "start_logit": 8.140625,
            "end_logit": 8.109375,
            "text": "AAUAAA",
            "probability": 1.0
        },
        {
            "start_logit": -1.404296875,
            "end_logit": 8.109375,
            "text": "AA",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": 8.140625,
            "end_logit": -1.5498046875,
            "text": "AA",
            "probability": 6.401538848876953e-05
        },
        {
            "start_logit": 8.140625,
            "end_logit": -6.14453125,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is required for poly(A) synthesis.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.4609375,
            "end_logit": 8.109375,
            "text": "UAAA",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -6.71875,
            "text": "AAUA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.09765625,
            "text": "AAUAAA) nearby the 3",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.1171875,
            "text": "AAUAAA)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.30078125,
            "text": "AAUAAA) nearby the 3'",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 8.109375,
            "text": "polyadenylation signal (AAUAAA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.109375,
            "text": "A polyadenylation signal (AAUAAA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.41015625,
            "text": "AAUAAA) nearby the 3' end",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.4140625,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.421875,
            "text": "AAUAAA) nearby the 3' end of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.50390625,
            "text": "AAUAAA) nearby the 3' end of pre-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.5546875,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.60546875,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is required for poly(A)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.68359375,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is required for poly(A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.71875,
            "text": "AAUAAA) nearby the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.72265625,
            "text": "AAUAAA) nearby the 3' end of pre-mRNA is required for poly(",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e764647c6a8763d23000016_1": [
        {
            "start_logit": -1.138671875,
            "end_logit": 6.453125,
            "text": "CVD 103-HgR",
            "probability": 0.90478515625
        },
        {
            "start_logit": -3.81640625,
            "end_logit": 6.453125,
            "text": "R",
            "probability": 0.062286376953125
        },
        {
            "start_logit": -5.13671875,
            "end_logit": 6.453125,
            "text": "HgR",
            "probability": 0.016632080078125
        },
        {
            "start_logit": -6.265625,
            "end_logit": 6.453125,
            "text": "cholera vaccine CVD 103-HgR",
            "probability": 0.00537872314453125
        },
        {
            "start_logit": -6.4140625,
            "end_logit": 6.453125,
            "text": "103-HgR",
            "probability": 0.004638671875
        },
        {
            "start_logit": -6.60546875,
            "end_logit": 6.453125,
            "text": "-HgR",
            "probability": 0.0038299560546875
        },
        {
            "start_logit": -6.9375,
            "end_logit": 6.453125,
            "text": "The oral live cholera vaccine CVD 103-HgR",
            "probability": 0.00274658203125
        },
        {
            "start_logit": -4.359375,
            "end_logit": -2.07421875,
            "text": "1993, Switzerland) the ideal cholera vaccine: single-dose, protective efficacy of 80-100% against moderate to severe cholera",
            "probability": 7.092952728271484e-06
        },
        {
            "start_logit": -4.3984375,
            "end_logit": -2.07421875,
            "text": "cholera",
            "probability": 6.9141387939453125e-06
        },
        {
            "start_logit": -4.6953125,
            "end_logit": -2.07421875,
            "text": "cholera vaccine: single-dose, protective efficacy of 80-100% against moderate to severe cholera",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": -1.138671875,
            "end_logit": -5.671875,
            "text": "CVD 103-HgR (Orochol, Mutachol)",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -1.138671875,
            "end_logit": -5.71484375,
            "text": "CVD 103-HgR (Orochol",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -1.138671875,
            "end_logit": -6.41796875,
            "text": "CVD 103-HgR (",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -1.138671875,
            "end_logit": -6.6484375,
            "text": "CVD 103-HgR (Orochol, Mutachol), the first genetically modified organism",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -3.81640625,
            "end_logit": -4.19140625,
            "text": "R (Orochol, Mutachol), the first genetically modified organism (GMO) used as vaccine, was in its time (launched 1993",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -4.359375,
            "end_logit": -3.802734375,
            "text": "1993, Switzerland) the ideal cholera",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -1.138671875,
            "end_logit": -7.04296875,
            "text": "CVD 103-HgR (Orochol, Mutachol",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -4.6953125,
            "end_logit": -3.802734375,
            "text": "cholera",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -4.359375,
            "end_logit": -4.19140625,
            "text": "1993",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -4.88671875,
            "end_logit": -3.802734375,
            "text": "Mutachol), the first genetically modified organism (GMO) used as vaccine, was in its time (launched 1993, Switzerland) the ideal cholera",
            "probability": 7.748603820800781e-07
        }
    ],
    "5319a7d2b166e2b806000029_1": [
        {
            "start_logit": 5.0390625,
            "end_logit": 3.9453125,
            "text": "hsc70-interacting protein (CHIP)",
            "probability": 0.9970703125
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -2.69140625,
            "text": "hsc70-interacting protein (",
            "probability": 0.0013074874877929688
        },
        {
            "start_logit": -2.029296875,
            "end_logit": 3.9453125,
            "text": "Carboxyl terminus of hsc70-interacting protein (CHIP)",
            "probability": 0.0008478164672851562
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -4.2734375,
            "text": "hsc70-interacting protein (CHIP) can",
            "probability": 0.0002689361572265625
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -4.74609375,
            "text": "hsc70-interacting protein",
            "probability": 0.00016820430755615234
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -4.8671875,
            "text": "hsc",
            "probability": 0.00014841556549072266
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -5.51171875,
            "text": "hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and mediate ubiquitination of both the AhR",
            "probability": 7.82012939453125e-05
        },
        {
            "start_logit": -4.84375,
            "end_logit": 3.9453125,
            "text": ")",
            "probability": 5.08427619934082e-05
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -6.04296875,
            "text": "hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and mediate ubiquitination of both the AhR and",
            "probability": 4.601478576660156e-05
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -6.27734375,
            "text": "hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and",
            "probability": 3.635883331298828e-05
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -6.296875,
            "text": "hsc70",
            "probability": 3.552436828613281e-05
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -6.3828125,
            "text": "hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and mediate ubiquitination of both the AhR and the 90",
            "probability": 3.260374069213867e-05
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -6.56640625,
            "text": "hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR)",
            "probability": 2.7060508728027344e-05
        },
        {
            "start_logit": 5.0390625,
            "end_logit": -6.8046875,
            "text": "hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and mediate ubiquitination",
            "probability": 2.1398067474365234e-05
        },
        {
            "start_logit": -6.3515625,
            "end_logit": 3.9453125,
            "text": "interacting protein (CHIP)",
            "probability": 1.1265277862548828e-05
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 3.9453125,
            "text": "of hsc70-interacting protein (CHIP)",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": -6.96875,
            "end_logit": 3.9453125,
            "text": "CHIP)",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 3.9453125,
            "text": "(CHIP)",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -2.029296875,
            "end_logit": -2.69140625,
            "text": "Carboxyl terminus of hsc70-interacting protein (",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -2.029296875,
            "end_logit": -4.2734375,
            "text": "Carboxyl terminus of hsc70-interacting protein (CHIP) can",
            "probability": 2.384185791015625e-07
        }
    ],
    "5313058de3eabad02100000e_1": [
        {
            "start_logit": 8.0859375,
            "end_logit": 7.58984375,
            "text": "lumbosacral transitional vertebrae",
            "probability": 1.0
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -1.123046875,
            "text": "lumbosacral",
            "probability": 0.0001647472381591797
        },
        {
            "start_logit": -2.57421875,
            "end_logit": 7.58984375,
            "text": "vertebrae",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": -5.44140625,
            "end_logit": 7.58984375,
            "text": "transitional vertebrae",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.09375,
            "text": "lumbosacral transitional vertebrae,",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.37109375,
            "text": "lumbosacral transitional vertebrae, is an important cause of low back",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.46875,
            "text": "lumbosacral transitional",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.53125,
            "text": "lumbosacral transitional vertebrae, is an important cause of low back pain",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.6015625,
            "text": "lumbosacral transitional vertebrae, is an important cause of low back pain in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.6171875,
            "text": "lumbosacral transitional vertebrae, is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.625,
            "text": "lumbosacral transitional vertebrae, is an important cause of low back pain in young patients",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.625,
            "text": "lumbosacral transitional vertebrae, is an important",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.6328125,
            "text": "lumbosacral transitional vertebrae, is an important cause of low back pain in young",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.66796875,
            "text": "lumbosacral transitional vertebrae, is an important cause of low back pain in young patients.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 7.58984375,
            "text": "lumbago in lumbosacral transitional vertebrae",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.58984375,
            "text": "in lumbosacral transitional vertebrae",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 7.58984375,
            "text": "form of lumbago in lumbosacral transitional vertebrae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 7.58984375,
            "text": "Bertolotti's syndrome (BS), a form of lumbago in lumbosacral transitional vertebrae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 7.58984375,
            "text": ", a form of lumbago in lumbosacral transitional vertebrae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 7.58984375,
            "text": "tolotti's syndrome (BS), a form of lumbago in lumbosacral transitional vertebrae",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5313058de3eabad02100000e_2": [
        {
            "start_logit": 6.078125,
            "end_logit": 6.64453125,
            "text": "lumbosacral",
            "probability": 1.0
        },
        {
            "start_logit": 6.078125,
            "end_logit": -7.26171875,
            "text": "lumbosacral anomalies and",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 6.64453125,
            "text": "characteristic lumbosacral",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.078125,
            "end_logit": -7.3671875,
            "text": "lumbosacral anomalies and often have severe sciatica.",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 6.64453125,
            "text": "Patients with Bertolotti's syndrome have characteristic lumbosacral",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.078125,
            "end_logit": -7.375,
            "text": "lumbosacral anomalies",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.078125,
            "end_logit": -7.39453125,
            "text": "lumbosacral anomalies and often",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.078125,
            "end_logit": -7.5625,
            "text": "lumbosacral anomalies and often have severe sciatica",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.078125,
            "end_logit": -7.6328125,
            "text": "lumbosacral anomalies and often have",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.078125,
            "end_logit": -7.6640625,
            "text": "lumbosacral anomalies and often have severe",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": -7.3671875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.26171875,
            "text": "characteristic lumbosacral anomalies and",
            "probability": 0.0
        },
        {
            "start_logit": -7.93359375,
            "end_logit": -7.26171875,
            "text": "Patients with Bertolotti's syndrome have characteristic lumbosacral anomalies and",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.3671875,
            "text": "characteristic lumbosacral anomalies and often have severe sciatica.",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.375,
            "text": "characteristic lumbosacral anomalies",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.39453125,
            "text": "characteristic lumbosacral anomalies and often",
            "probability": 0.0
        },
        {
            "start_logit": -7.921875,
            "end_logit": -7.3671875,
            "text": "sciatica.",
            "probability": 0.0
        },
        {
            "start_logit": -7.93359375,
            "end_logit": -7.3671875,
            "text": "Patients with Bertolotti's syndrome have characteristic lumbosacral anomalies and often have severe sciatica.",
            "probability": 0.0
        },
        {
            "start_logit": -7.93359375,
            "end_logit": -7.375,
            "text": "Patients with Bertolotti's syndrome have characteristic lumbosacral anomalies",
            "probability": 0.0
        },
        {
            "start_logit": -7.93359375,
            "end_logit": -7.39453125,
            "text": "Patients with Bertolotti's syndrome have characteristic lumbosacral anomalies and often",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_3": [
        {
            "start_logit": 8.171875,
            "end_logit": 8.2109375,
            "text": "lumbosacral junction",
            "probability": 1.0
        },
        {
            "start_logit": -0.904296875,
            "end_logit": 8.2109375,
            "text": "junction",
            "probability": 0.0001150369644165039
        },
        {
            "start_logit": 8.171875,
            "end_logit": -1.287109375,
            "text": "lumbosacral",
            "probability": 7.545948028564453e-05
        },
        {
            "start_logit": 8.171875,
            "end_logit": -6.8046875,
            "text": "lumbosacral junction pseudarticulation",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.2734375,
            "text": "lumbosacral junction pseud",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.4609375,
            "text": "lumbosacral junction pseudartic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.5546875,
            "text": "lumbosacral junction pseudarticulation (Bertolotti's syndrome)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.5625,
            "text": "lumbosacral junction pseudarticulation (Bertolotti's syndrome): a case report",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.5703125,
            "text": "lumbosacral junction pseudarticulation (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.2109375,
            "text": "Radiofrequency sensory ablation as a treatment for symptomatic unilateral lumbosacral junction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.6328125,
            "text": "lumbosacral junction pseudarticulation (Bertolotti's syndrome): a case",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.65234375,
            "text": "lumbosacral junction pseudarticulation (Bertolotti's syndrome): a case report.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.66015625,
            "text": "lumbosacral junction pseudarticulation (Bertolotti'",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 8.2109375,
            "text": "sensory ablation as a treatment for symptomatic unilateral lumbosacral junction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 8.2109375,
            "text": "unilateral lumbosacral junction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 8.2109375,
            "text": "symptomatic unilateral lumbosacral junction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.904296875,
            "end_logit": -6.8046875,
            "text": "junction pseudarticulation",
            "probability": 0.0
        },
        {
            "start_logit": -0.904296875,
            "end_logit": -7.2734375,
            "text": "junction pseud",
            "probability": 0.0
        },
        {
            "start_logit": -0.904296875,
            "end_logit": -7.4609375,
            "text": "junction pseudartic",
            "probability": 0.0
        },
        {
            "start_logit": -0.904296875,
            "end_logit": -7.5546875,
            "text": "junction pseudarticulation (Bertolotti's syndrome)",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_4": [
        {
            "start_logit": 3.40625,
            "end_logit": 7.9296875,
            "text": "spine",
            "probability": 0.99609375
        },
        {
            "start_logit": -2.689453125,
            "end_logit": 7.9296875,
            "text": "lumbar spine",
            "probability": 0.002246856689453125
        },
        {
            "start_logit": 3.966796875,
            "end_logit": 0.393798828125,
            "text": "Lumbosacral transitional vertebra",
            "probability": 0.0009298324584960938
        },
        {
            "start_logit": -4.53515625,
            "end_logit": 7.9296875,
            "text": "sacrum or ilium. The association of that variant with low back pain and the change in the biomechanical properties of the lumbar spine",
            "probability": 0.0003542900085449219
        },
        {
            "start_logit": 3.966796875,
            "end_logit": -0.6904296875,
            "text": "Lumbosacral transitional vertebra is an anatomical variation of the fifth lumbar vertebra",
            "probability": 0.0003139972686767578
        },
        {
            "start_logit": 3.33203125,
            "end_logit": -0.6904296875,
            "text": "fifth lumbar vertebra",
            "probability": 0.00016677379608154297
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 7.9296875,
            "text": ". The association of that variant with low back pain and the change in the biomechanical properties of the lumbar spine",
            "probability": 4.738569259643555e-05
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 7.9296875,
            "text": "the lumbar spine",
            "probability": 4.0531158447265625e-05
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.9296875,
            "text": "the sacrum or ilium. The association of that variant with low back pain and the change in the biomechanical properties of the lumbar spine",
            "probability": 1.71661376953125e-05
        },
        {
            "start_logit": 3.966796875,
            "end_logit": -5.25,
            "text": "Lumbosacral transitional vertebra is an anatomical variation of the fifth lumbar vertebra in which an enlarged transverse process can form a joint or fusion with the sacrum",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": 3.966796875,
            "end_logit": -5.34765625,
            "text": "Lumbosacral",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": 3.966796875,
            "end_logit": -5.4921875,
            "text": "Lumbosacral transitional vertebra is an anatomical variation of the fifth",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 3.40625,
            "end_logit": -5.2421875,
            "text": "spine is called Bertolotti's syndrome.",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 3.33203125,
            "end_logit": -5.2421875,
            "text": "fifth lumbar vertebra in which an enlarged transverse process can form a joint or fusion with the sacrum or ilium.",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 3.33203125,
            "end_logit": -5.25,
            "text": "fifth lumbar vertebra in which an enlarged transverse process can form a joint or fusion with the sacrum",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 3.33203125,
            "end_logit": -5.4921875,
            "text": "fifth",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 3.966796875,
            "end_logit": -6.2109375,
            "text": "Lumbosacral transitional vertebra is an anatomical variation of the fifth lumbar",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 3.966796875,
            "end_logit": -6.21875,
            "text": "Lumbosacral transitional vertebra is an anatomical variation of the fifth lumbar vertebra in which an enlarged transverse process can form a joint or fusion with the sacr",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 3.966796875,
            "end_logit": -6.35546875,
            "text": "Lumbosacral transitional vertebra is",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 3.966796875,
            "end_logit": -6.58984375,
            "text": "Lumbosacral transitional vertebra is an anatomical variation of the fifth lumbar vertebra in which an enlarged transverse process can",
            "probability": 8.940696716308594e-07
        }
    ],
    "5313058de3eabad02100000e_5": [
        {
            "start_logit": -1.455078125,
            "end_logit": 5.82421875,
            "text": "lumbosacral vertebrae",
            "probability": 0.8828125
        },
        {
            "start_logit": -3.7890625,
            "end_logit": 5.82421875,
            "text": "Transitional lumbosacral vertebrae",
            "probability": 0.085693359375
        },
        {
            "start_logit": -4.77734375,
            "end_logit": 5.82421875,
            "text": "vertebrae",
            "probability": 0.031890869140625
        },
        {
            "start_logit": -1.455078125,
            "end_logit": -7.48046875,
            "text": "lumbosacral vertebrae and",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -1.455078125,
            "end_logit": -7.5703125,
            "text": "lumbosacral vertebrae and low back",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -1.455078125,
            "end_logit": -7.71484375,
            "text": "lumbosacral vertebrae and low back pain: diagnostic pitfalls and management of Bertolotti'",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -1.455078125,
            "end_logit": -7.74609375,
            "text": "lumbosacral vertebrae and low back pain: diagnostic pitfalls and management of Bertolotti's syndrome.",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -3.7890625,
            "end_logit": -7.48046875,
            "text": "Transitional lumbosacral vertebrae and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.7890625,
            "end_logit": -7.5703125,
            "text": "Transitional lumbosacral vertebrae and low back",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.7890625,
            "end_logit": -7.71484375,
            "text": "Transitional lumbosacral vertebrae and low back pain: diagnostic pitfalls and management of Bertolotti'",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.7890625,
            "end_logit": -7.74609375,
            "text": "Transitional lumbosacral vertebrae and low back pain: diagnostic pitfalls and management of Bertolotti's syndrome.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.77734375,
            "end_logit": -7.48046875,
            "text": "vertebrae and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.77734375,
            "end_logit": -7.5703125,
            "text": "vertebrae and low back",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.77734375,
            "end_logit": -7.71484375,
            "text": "vertebrae and low back pain: diagnostic pitfalls and management of Bertolotti'",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.77734375,
            "end_logit": -7.74609375,
            "text": "vertebrae and low back pain: diagnostic pitfalls and management of Bertolotti's syndrome.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.72265625,
            "end_logit": -7.74609375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -7.5703125,
            "text": "low back",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -7.71484375,
            "text": "low back pain: diagnostic pitfalls and management of Bertolotti'",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -7.74609375,
            "text": "low back pain: diagnostic pitfalls and management of Bertolotti's syndrome.",
            "probability": 0.0
        },
        {
            "start_logit": -7.8125,
            "end_logit": -7.71484375,
            "text": ": diagnostic pitfalls and management of Bertolotti'",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_6": [
        {
            "start_logit": 6.3828125,
            "end_logit": 5.421875,
            "text": "lumbosacral",
            "probability": 0.6416015625
        },
        {
            "start_logit": 5.58984375,
            "end_logit": 5.421875,
            "text": "facet joint contralateral to a unilateral anomalous lumbosacral",
            "probability": 0.29150390625
        },
        {
            "start_logit": 5.58984375,
            "end_logit": 3.94921875,
            "text": "facet joint",
            "probability": 0.06658935546875
        },
        {
            "start_logit": 5.58984375,
            "end_logit": -4.08203125,
            "text": "facet",
            "probability": 2.1636486053466797e-05
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -6.55078125,
            "text": "lumbosacral articulation",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": -6.19140625,
            "end_logit": 5.421875,
            "text": "joint contralateral to a unilateral anomalous lumbosacral",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -7.265625,
            "text": "lumbosacral articulation (Bertolotti's syndrome).",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 5.58984375,
            "end_logit": -6.55078125,
            "text": "facet joint contralateral to a unilateral anomalous lumbosacral articulation",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -7.50390625,
            "text": "lumbosacral articulation (Bertolotti's syndrome)",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -7.51953125,
            "text": "lumbosacral articulation (",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -7.62109375,
            "text": "lumbosacral articulation (Bertolotti'",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 5.58984375,
            "end_logit": -7.265625,
            "text": "facet joint contralateral to a unilateral anomalous lumbosacral articulation (Bertolotti's syndrome).",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 5.58984375,
            "end_logit": -7.390625,
            "text": "facet joint contralateral",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 5.58984375,
            "end_logit": -7.50390625,
            "text": "facet joint contralateral to a unilateral anomalous lumbosacral articulation (Bertolotti's syndrome)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 5.58984375,
            "end_logit": -7.51953125,
            "text": "facet joint contralateral to a unilateral anomalous lumbosacral articulation (",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 5.58984375,
            "end_logit": -7.546875,
            "text": "facet joint contralateral to a unilateral",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 5.58984375,
            "end_logit": -7.59765625,
            "text": "facet joint contralateral to",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 5.58984375,
            "end_logit": -7.62109375,
            "text": "facet joint contralateral to a unilateral anomalous lumbosacral articulation (Bertolotti'",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 5.58984375,
            "end_logit": -7.64453125,
            "text": "facet joint contralateral to a unilateral anomalous",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 5.421875,
            "text": "anomalous lumbosacral",
            "probability": 5.960464477539062e-07
        }
    ],
    "5313058de3eabad02100000e_7": [
        {
            "start_logit": 7.9453125,
            "end_logit": 7.6171875,
            "text": "L6-S1 facet joint",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -0.65087890625,
            "text": "L6-S1",
            "probability": 0.0002570152282714844
        },
        {
            "start_logit": -0.78271484375,
            "end_logit": 7.6171875,
            "text": "facet joint",
            "probability": 0.0001621246337890625
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -2.09375,
            "text": "L6",
            "probability": 6.0558319091796875e-05
        },
        {
            "start_logit": -2.482421875,
            "end_logit": 7.6171875,
            "text": "joint",
            "probability": 2.956390380859375e-05
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -4.1640625,
            "text": "L6-S1 facet joint contralateral to an anomalous lumbosacral",
            "probability": 7.62939453125e-06
        },
        {
            "start_logit": -6.125,
            "end_logit": 7.6171875,
            "text": "-S1 facet joint",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.59765625,
            "text": "L6-S1 facet joint contralateral to an anomalous lumbosacral articulation.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.51171875,
            "end_logit": 7.6171875,
            "text": "S1 facet joint",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.90234375,
            "text": "L6-S1 facet joint contralateral to an anomalous lumbosacral articulation",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.16796875,
            "text": "L6-S1 facet",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.37109375,
            "text": "L6-S1 facet joint contralateral",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 7.6171875,
            "text": "symptomatic L6-S1 facet joint",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.28125,
            "end_logit": 7.6171875,
            "text": "Repeated fluoroscopically guided injections implicated a symptomatic L6-S1 facet joint",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.6171875,
            "text": "a symptomatic L6-S1 facet joint",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 7.6171875,
            "text": "implicated a symptomatic L6-S1 facet joint",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 7.6171875,
            "text": "fluoroscopically guided injections implicated a symptomatic L6-S1 facet joint",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 7.6171875,
            "text": "injections implicated a symptomatic L6-S1 facet joint",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.78271484375,
            "end_logit": -4.1640625,
            "text": "facet joint contralateral to an anomalous lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -2.482421875,
            "end_logit": -4.1640625,
            "text": "joint contralateral to an anomalous lumbosacral",
            "probability": 0.0
        }
    ],
    "5313058de3eabad02100000e_8": [
        {
            "start_logit": 8.0625,
            "end_logit": 7.33984375,
            "text": "lumbosacral transitional vertebrae",
            "probability": 1.0
        },
        {
            "start_logit": 8.0625,
            "end_logit": -1.080078125,
            "text": "lumbosacral",
            "probability": 0.0002200603485107422
        },
        {
            "start_logit": -3.142578125,
            "end_logit": 7.33984375,
            "text": "vertebrae",
            "probability": 1.3530254364013672e-05
        },
        {
            "start_logit": -5.38671875,
            "end_logit": 7.33984375,
            "text": "transitional vertebrae",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.0625,
            "end_logit": -6.77734375,
            "text": "lumbosacral transitional vertebrae.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 7.33984375,
            "text": "Bertolotti's syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 7.33984375,
            "text": "tolotti's syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 7.33984375,
            "text": "with lumbosacral transitional vertebrae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 7.33984375,
            "text": "back pain with lumbosacral transitional vertebrae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 7.33984375,
            "text": "lotti's syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 7.33984375,
            "text": "syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.828125,
            "end_logit": 7.33984375,
            "text": "association of back pain with lumbosacral transitional vertebrae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 7.33984375,
            "text": "the association of back pain with lumbosacral transitional vertebrae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 7.33984375,
            "text": "ti's syndrome refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 7.33984375,
            "text": "refers to the association of back pain with lumbosacral transitional vertebrae",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": -1.080078125,
            "text": "Bertolotti's syndrome refers to the association of back pain with lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -7.6484375,
            "end_logit": -1.080078125,
            "text": "tolotti's syndrome refers to the association of back pain with lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -1.080078125,
            "text": "with lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -7.74609375,
            "end_logit": -1.080078125,
            "text": "back pain with lumbosacral",
            "probability": 0.0
        },
        {
            "start_logit": -7.74609375,
            "end_logit": -1.080078125,
            "text": "lotti's syndrome refers to the association of back pain with lumbosacral",
            "probability": 0.0
        }
    ],
    "554140ad182542114d000003_1": [
        {
            "start_logit": 8.1953125,
            "end_logit": 8.1171875,
            "text": "mpMoRFsDB",
            "probability": 1.0
        },
        {
            "start_logit": -1.201171875,
            "end_logit": 8.1171875,
            "text": "DB",
            "probability": 8.285045623779297e-05
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -1.3994140625,
            "text": "mpM",
            "probability": 7.367134094238281e-05
        },
        {
            "start_logit": -5.96484375,
            "end_logit": 8.1171875,
            "text": "oRFsDB",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -6.11328125,
            "text": "mpMoRFs",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.0078125,
            "end_logit": 8.1171875,
            "text": "FsDB",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.22265625,
            "text": "mpMoR",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.46875,
            "text": "mpMoRFsDB: a database of molecular recognition features in membrane proteins",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.609375,
            "text": "mpMoRFsDB: a database",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.66015625,
            "text": "mpMoRFsDB: a database of molecular recognition features in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.67578125,
            "text": "mpMoRFsDB: a database of molecular recognition features in membrane",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.68359375,
            "text": "mpMoRFsDB: a database of molecular recognition features",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.69921875,
            "text": "mpMoRFsDB: a database of molecular recognition",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.75,
            "text": "mpMoRFsDB: a database of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.201171875,
            "end_logit": -7.46875,
            "text": "DB: a database of molecular recognition features in membrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": -1.201171875,
            "end_logit": -7.609375,
            "text": "DB: a database",
            "probability": 0.0
        },
        {
            "start_logit": -1.201171875,
            "end_logit": -7.66015625,
            "text": "DB: a database of molecular recognition features in",
            "probability": 0.0
        },
        {
            "start_logit": -1.201171875,
            "end_logit": -7.67578125,
            "text": "DB: a database of molecular recognition features in membrane",
            "probability": 0.0
        },
        {
            "start_logit": -1.201171875,
            "end_logit": -7.68359375,
            "text": "DB: a database of molecular recognition features",
            "probability": 0.0
        },
        {
            "start_logit": -1.201171875,
            "end_logit": -7.69921875,
            "text": "DB: a database of molecular recognition",
            "probability": 0.0
        }
    ],
    "554140ad182542114d000003_2": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.1328125,
            "text": "mpMoRFsDB",
            "probability": 1.0
        },
        {
            "start_logit": -1.0078125,
            "end_logit": 8.1328125,
            "text": "DB",
            "probability": 9.918212890625e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.310546875,
            "text": "mpM",
            "probability": 7.903575897216797e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -5.609375,
            "text": "mpMoRFs",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.08203125,
            "end_logit": 8.1328125,
            "text": "oRFsDB",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.0,
            "text": "mpMoR",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 8.1328125,
            "text": "FsDB",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.51953125,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-protein",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.5859375,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions in membrane proteins",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.6015625,
            "text": "mpMoRFsDB provides valuable information related to disorder-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.60546875,
            "text": "mpMoRFsDB provides valuable",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.61328125,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.62109375,
            "text": "mpMoRFsDB provides valuable information related to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.63671875,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.640625,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.65234375,
            "text": "mpMoRFsDB provides valuable information related to disorder-based protein-protein interactions in membrane",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.6640625,
            "text": "mpMoRFsDB provides valuable information related",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.6796875,
            "text": "mpMoRFsDB provides valuable information related to disorder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.6796875,
            "text": "mpMoRFsDB provides valuable information related to disorder-based",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.71484375,
            "text": "mpMoRFsDB provides valuable information",
            "probability": 1.1920928955078125e-07
        }
    ],
    "554140ad182542114d000003_3": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.125,
            "text": "mpMoRFsDB",
            "probability": 1.0
        },
        {
            "start_logit": -1.201171875,
            "end_logit": 8.125,
            "text": "DB",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.36328125,
            "text": "mpM",
            "probability": 7.605552673339844e-05
        },
        {
            "start_logit": -5.86328125,
            "end_logit": 8.125,
            "text": "oRFsDB",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.34375,
            "text": "mpMoRFs",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 8.125,
            "text": "FsDB",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.3203125,
            "text": "mpMoR",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5625,
            "text": "mpMoRFsDB: a database",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.60546875,
            "text": "mpMoRFsDB: a database of molecular recognition features in membrane proteins",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.71484375,
            "text": "mpMoRFsDB: a database of molecular recognition features in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.74609375,
            "text": "mpMoRFsDB: a database of molecular recognition",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.74609375,
            "text": "mpMoRFsDB: a database of molecular recognition features in membrane",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.765625,
            "text": "mpMoRFsDB: a database of molecular recognition features",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.201171875,
            "end_logit": -7.5625,
            "text": "DB: a database",
            "probability": 0.0
        },
        {
            "start_logit": -1.201171875,
            "end_logit": -7.60546875,
            "text": "DB: a database of molecular recognition features in membrane proteins",
            "probability": 0.0
        },
        {
            "start_logit": -1.201171875,
            "end_logit": -7.71484375,
            "text": "DB: a database of molecular recognition features in",
            "probability": 0.0
        },
        {
            "start_logit": -1.201171875,
            "end_logit": -7.74609375,
            "text": "DB: a database of molecular recognition",
            "probability": 0.0
        },
        {
            "start_logit": -1.201171875,
            "end_logit": -7.74609375,
            "text": "DB: a database of molecular recognition features in membrane",
            "probability": 0.0
        },
        {
            "start_logit": -1.201171875,
            "end_logit": -7.765625,
            "text": "DB: a database of molecular recognition features",
            "probability": 0.0
        },
        {
            "start_logit": -5.86328125,
            "end_logit": -6.34375,
            "text": "oRFs",
            "probability": 0.0
        }
    ],
    "5c632542e842deac6700000d_1": [
        {
            "start_logit": 7.890625,
            "end_logit": 8.203125,
            "text": "magnetic resonance imaging",
            "probability": 1.0
        },
        {
            "start_logit": -0.84814453125,
            "end_logit": 8.203125,
            "text": "imaging",
            "probability": 0.0001609325408935547
        },
        {
            "start_logit": 7.890625,
            "end_logit": -2.275390625,
            "text": "magnetic",
            "probability": 2.8192996978759766e-05
        },
        {
            "start_logit": 7.890625,
            "end_logit": -5.66796875,
            "text": "magnetic resonance",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.19140625,
            "end_logit": 8.203125,
            "text": ". Here, we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 8.203125,
            "text": "novel approach of magnetic resonance imaging",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.78125,
            "end_logit": 8.203125,
            "text": "of magnetic resonance imaging",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 8.203125,
            "text": "the novel approach of magnetic resonance imaging",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 8.203125,
            "text": "resonance imaging",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -6.66796875,
            "text": "magnetic resonance imaging and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 8.203125,
            "text": "using the novel approach of magnetic resonance imaging",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 8.203125,
            "text": ", we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 8.203125,
            "text": "Here, we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.890625,
            "end_logit": -7.2734375,
            "text": "magnetic resonance imaging and we conduct a systematic review of all patients reported in the last 60 years, discussing the core clinical features of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.84814453125,
            "end_logit": -6.66796875,
            "text": "imaging and",
            "probability": 0.0
        },
        {
            "start_logit": -0.84814453125,
            "end_logit": -7.2734375,
            "text": "imaging and we conduct a systematic review of all patients reported in the last 60 years, discussing the core clinical features of",
            "probability": 0.0
        },
        {
            "start_logit": -6.19140625,
            "end_logit": -2.275390625,
            "text": ". Here, we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic",
            "probability": 0.0
        },
        {
            "start_logit": -6.53515625,
            "end_logit": -2.275390625,
            "text": "novel approach of magnetic",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -2.275390625,
            "text": "of magnetic",
            "probability": 0.0
        },
        {
            "start_logit": -6.87109375,
            "end_logit": -2.275390625,
            "text": "the novel approach of magnetic",
            "probability": 0.0
        }
    ],
    "5c632542e842deac6700000d_2": [
        {
            "start_logit": 7.71484375,
            "end_logit": 8.1484375,
            "text": "magnetic resonance imaging",
            "probability": 1.0
        },
        {
            "start_logit": -1.212890625,
            "end_logit": 8.1484375,
            "text": "imaging",
            "probability": 0.00013339519500732422
        },
        {
            "start_logit": 7.71484375,
            "end_logit": -2.69921875,
            "text": "magnetic",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 7.71484375,
            "end_logit": -6.2109375,
            "text": "magnetic resonance",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 8.1484375,
            "text": "the novel approach of magnetic resonance imaging",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 8.1484375,
            "text": "resonance imaging",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 8.1484375,
            "text": "of magnetic resonance imaging",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 8.1484375,
            "text": ", we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 8.1484375,
            "text": "Here, we report a patient with CVG-ID that was diagnosed using the novel approach of magnetic resonance imaging",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 8.1484375,
            "text": "novel approach of magnetic resonance imaging",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 8.1484375,
            "text": "using the novel approach of magnetic resonance imaging",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.71484375,
            "end_logit": -7.41015625,
            "text": "magnetic resonance imaging and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.71484375,
            "end_logit": -7.6015625,
            "text": "magnetic resonance imaging and we conduct a systematic review of all patients reported in the last 60 years, discussing the core clinical features of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.71484375,
            "end_logit": -7.60546875,
            "text": "magnetic resonance imaging and we conduct a systematic review of all patients reported in the last 60 years",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.71484375,
            "end_logit": -7.6328125,
            "text": "magnetic resonance imaging and we conduct a systematic review of all patients reported in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.71484375,
            "end_logit": -7.63671875,
            "text": "magnetic resonance imaging and we conduct a systematic review of all patients reported in the last 60",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.212890625,
            "end_logit": -7.41015625,
            "text": "imaging and",
            "probability": 0.0
        },
        {
            "start_logit": -1.212890625,
            "end_logit": -7.6015625,
            "text": "imaging and we conduct a systematic review of all patients reported in the last 60 years, discussing the core clinical features of",
            "probability": 0.0
        },
        {
            "start_logit": -1.212890625,
            "end_logit": -7.60546875,
            "text": "imaging and we conduct a systematic review of all patients reported in the last 60 years",
            "probability": 0.0
        },
        {
            "start_logit": -1.212890625,
            "end_logit": -7.6328125,
            "text": "imaging and we conduct a systematic review of all patients reported in",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_1": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.15625,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": -0.98193359375,
            "end_logit": 8.15625,
            "text": "R",
            "probability": 9.918212890625e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.1962890625,
            "text": "tra",
            "probability": 8.684396743774414e-05
        },
        {
            "start_logit": -6.39453125,
            "end_logit": 8.15625,
            "text": "seR",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.99609375,
            "text": "trase",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.35546875,
            "text": "traseR: an R package",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.625,
            "text": "traseR: an R package for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.63671875,
            "text": "traseR: an R package for performing trait-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6484375,
            "text": "traseR: an R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6875,
            "text": "traseR:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.69921875,
            "text": "traseR: an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.71875,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.72265625,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.734375,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in genomic intervals",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.75390625,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in genomic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.765625,
            "text": "traseR: an R package for performing trait-associated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.765625,
            "text": "traseR: an R package for performing trait",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.7734375,
            "text": "traseR: an R package for performing trait-associated SNP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.98193359375,
            "end_logit": -7.35546875,
            "text": "R: an R package",
            "probability": 0.0
        },
        {
            "start_logit": -0.98193359375,
            "end_logit": -7.625,
            "text": "R: an R package for",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_2": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1484375,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": -1.0078125,
            "end_logit": 8.1484375,
            "text": "R",
            "probability": 9.763240814208984e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.2041015625,
            "text": "tra",
            "probability": 8.684396743774414e-05
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 8.1484375,
            "text": "seR",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.78125,
            "text": "trase",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 8.1484375,
            "text": "present traseR",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.40234375,
            "text": "traseR, an easy-to-use",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.43359375,
            "text": "traseR, an easy-to-use R",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 8.1484375,
            "text": "Here, we present traseR",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.625,
            "text": "traseR, an easy-to-use R Bioconductor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6484375,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6640625,
            "text": "traseR, an easy-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.67578125,
            "text": "traseR, an easy-to-use R Bioconductor package",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6875,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.70703125,
            "text": "traseR,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.70703125,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 8.1484375,
            "text": ", we present traseR",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.74609375,
            "text": "traseR, an easy-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.75,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.75,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals",
            "probability": 1.1920928955078125e-07
        }
    ],
    "587e3129c32c812009000002_3": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1484375,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": -1.013671875,
            "end_logit": 8.1484375,
            "text": "R",
            "probability": 9.685754776000977e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.20703125,
            "text": "tra",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": -6.484375,
            "end_logit": 8.1484375,
            "text": "seR",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.83984375,
            "text": "trase",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 8.1484375,
            "text": "present traseR",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.421875,
            "text": "traseR, an easy-to-use",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.48828125,
            "text": "traseR, an easy-to-use R",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.62109375,
            "text": "traseR, an easy-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.66015625,
            "text": "traseR, an easy-to-use R Bioconductor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.671875,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.71484375,
            "text": "traseR, an easy-to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.71875,
            "text": "traseR, an easy-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.72265625,
            "text": "traseR, an easy-to-use R Bioconductor package",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.73828125,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.7421875,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.75390625,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.7578125,
            "text": "traseR, an easy-to-use R Bioc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.76171875,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.7734375,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic",
            "probability": 1.1920928955078125e-07
        }
    ],
    "587e3129c32c812009000002_4": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1640625,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": -0.95751953125,
            "end_logit": 8.1640625,
            "text": "R",
            "probability": 0.00010228157043457031
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.171875,
            "text": "tra",
            "probability": 8.821487426757812e-05
        },
        {
            "start_logit": -6.40625,
            "end_logit": 8.1640625,
            "text": "seR",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.84375,
            "text": "trase",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 8.1640625,
            "text": "present traseR",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.25390625,
            "text": "traseR, an easy-to-use R",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.30078125,
            "text": "traseR, an easy-to-use",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.1640625,
            "text": "Here, we present traseR",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.55859375,
            "text": "traseR, an easy-to-use R Bioconductor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6015625,
            "text": "traseR, an easy-to-use R Bioconductor package",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.609375,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6171875,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 8.1640625,
            "text": ", we present traseR",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.65625,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.67578125,
            "text": "traseR, an easy-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6953125,
            "text": "traseR,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.7109375,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.71484375,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.73046875,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic",
            "probability": 1.1920928955078125e-07
        }
    ],
    "587e3129c32c812009000002_5": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.171875,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": -0.95166015625,
            "end_logit": 8.171875,
            "text": "R",
            "probability": 0.00010228157043457031
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.17578125,
            "text": "tra",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": -6.26171875,
            "end_logit": 8.171875,
            "text": "seR",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.10546875,
            "text": "trase",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.39453125,
            "text": "traseR: an R package",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.57421875,
            "text": "traseR: an R package for performing trait-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.640625,
            "text": "traseR: an R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.64453125,
            "text": "traseR:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.65234375,
            "text": "traseR: an R package for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6796875,
            "text": "traseR: an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.68359375,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in genomic intervals.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.7421875,
            "text": "traseR: an R package for performing trait",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.75,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.75390625,
            "text": "traseR: an R package for performing trait-associated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.765625,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.95166015625,
            "end_logit": -7.39453125,
            "text": "R: an R package",
            "probability": 0.0
        },
        {
            "start_logit": -0.95166015625,
            "end_logit": -7.57421875,
            "text": "R: an R package for performing trait-",
            "probability": 0.0
        },
        {
            "start_logit": -0.95166015625,
            "end_logit": -7.640625,
            "text": "R: an R",
            "probability": 0.0
        },
        {
            "start_logit": -0.95166015625,
            "end_logit": -7.64453125,
            "text": "R:",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_6": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.171875,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": -0.95166015625,
            "end_logit": 8.171875,
            "text": "R",
            "probability": 0.00010228157043457031
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.17578125,
            "text": "tra",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": -6.26171875,
            "end_logit": 8.171875,
            "text": "seR",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.10546875,
            "text": "trase",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.39453125,
            "text": "traseR: an R package",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.57421875,
            "text": "traseR: an R package for performing trait-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.640625,
            "text": "traseR: an R",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.64453125,
            "text": "traseR:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.65234375,
            "text": "traseR: an R package for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6796875,
            "text": "traseR: an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.68359375,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in genomic intervals.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.7421875,
            "text": "traseR: an R package for performing trait",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.75,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.75390625,
            "text": "traseR: an R package for performing trait-associated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.765625,
            "text": "traseR: an R package for performing trait-associated SNP enrichment analysis in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.95166015625,
            "end_logit": -7.39453125,
            "text": "R: an R package",
            "probability": 0.0
        },
        {
            "start_logit": -0.95166015625,
            "end_logit": -7.57421875,
            "text": "R: an R package for performing trait-",
            "probability": 0.0
        },
        {
            "start_logit": -0.95166015625,
            "end_logit": -7.640625,
            "text": "R: an R",
            "probability": 0.0
        },
        {
            "start_logit": -0.95166015625,
            "end_logit": -7.64453125,
            "text": "R:",
            "probability": 0.0
        }
    ],
    "587e3129c32c812009000002_7": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1640625,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": -0.95751953125,
            "end_logit": 8.1640625,
            "text": "R",
            "probability": 0.00010228157043457031
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.171875,
            "text": "tra",
            "probability": 8.821487426757812e-05
        },
        {
            "start_logit": -6.40625,
            "end_logit": 8.1640625,
            "text": "seR",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.84375,
            "text": "trase",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 8.1640625,
            "text": "present traseR",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.25390625,
            "text": "traseR, an easy-to-use R",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.30078125,
            "text": "traseR, an easy-to-use",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.1640625,
            "text": "Here, we present traseR",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.55859375,
            "text": "traseR, an easy-to-use R Bioconductor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6015625,
            "text": "traseR, an easy-to-use R Bioconductor package",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.609375,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6171875,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 8.1640625,
            "text": ", we present traseR",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.65625,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.67578125,
            "text": "traseR, an easy-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6953125,
            "text": "traseR,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.7109375,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic intervals with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.71484375,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.73046875,
            "text": "traseR, an easy-to-use R Bioconductor package that performs enrichment analyses of trait-associated SNPs in arbitrary genomic",
            "probability": 1.1920928955078125e-07
        }
    ],
    "587e3129c32c812009000002_8": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1484375,
            "text": "traseR",
            "probability": 1.0
        },
        {
            "start_logit": -0.94189453125,
            "end_logit": 8.1484375,
            "text": "R",
            "probability": 0.00010395050048828125
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.2080078125,
            "text": "tra",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.65234375,
            "text": "trase",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.62890625,
            "end_logit": 8.1484375,
            "text": "seR",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.9609375,
            "text": "traseR R package preloaded with up-to-date collection of trait-associated SNPs are freely available in Bioconductor zhaohui",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.23828125,
            "text": "traseR R",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.453125,
            "text": "traseR R package",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.546875,
            "text": "traseR R package preload",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.55859375,
            "text": "traseR R package preloaded with up-to-date collection of trait-associated SNPs are freely available in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.58984375,
            "text": "traseR R package preloaded with up-to-date collection of trait-associated SNPs are freely available in Bioconductor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.59375,
            "text": "traseR R package preloaded with up-to-date collection of trait-associated SNPs are freely available in Bioconductor zhaohu",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.61328125,
            "text": "traseR R package preloaded with up-to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.625,
            "text": "traseR R package preloaded with up-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.640625,
            "text": "traseR R package preloaded",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.65625,
            "text": "traseR R package preloaded with up-to-date collection of trait-associated SNPs are freely available",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6640625,
            "text": "traseR R package preloaded with up-to-date collection of trait-associated SNPs are",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.67578125,
            "text": "traseR R package preloaded with up-to-date collection of trait-associated SNPs are freely available in Bioconductor zh",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6796875,
            "text": "traseR R package preloaded with up-to-date collection of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6953125,
            "text": "traseR R package preloaded with up-to-date collection of trait-",
            "probability": 1.1920928955078125e-07
        }
    ],
    "587e1bfdfc7e8dd84f000002_1": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.15625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -0.98193359375,
            "end_logit": 8.15625,
            "text": "e",
            "probability": 0.00010073184967041016
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.30078125,
            "text": "GBs",
            "probability": 7.724761962890625e-05
        },
        {
            "start_logit": -6.40234375,
            "end_logit": 8.15625,
            "text": "hape",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.9296875,
            "text": "GBshap",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.46875,
            "text": "GBshape: a genome browser",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.5390625,
            "text": "GBshape: a genome browser database",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.625,
            "text": "GBshape: a genome browser database for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.625,
            "text": "GBshape: a genome browser database for DNA shape annotations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.63671875,
            "text": "GBshape: a genome browse",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.65234375,
            "text": "GBshape: a genome browser database for DNA shape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.671875,
            "text": "GBshape: a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.98193359375,
            "end_logit": -7.46875,
            "text": "e: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -0.98193359375,
            "end_logit": -7.5390625,
            "text": "e: a genome browser database",
            "probability": 0.0
        },
        {
            "start_logit": -0.98193359375,
            "end_logit": -7.625,
            "text": "e: a genome browser database for",
            "probability": 0.0
        },
        {
            "start_logit": -0.98193359375,
            "end_logit": -7.625,
            "text": "e: a genome browser database for DNA shape annotations",
            "probability": 0.0
        },
        {
            "start_logit": -0.98193359375,
            "end_logit": -7.63671875,
            "text": "e: a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": -0.98193359375,
            "end_logit": -7.65234375,
            "text": "e: a genome browser database for DNA shape",
            "probability": 0.0
        },
        {
            "start_logit": -0.98193359375,
            "end_logit": -7.671875,
            "text": "e: a",
            "probability": 0.0
        },
        {
            "start_logit": -6.40234375,
            "end_logit": -6.9296875,
            "text": "hap",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_2": [
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2109375,
            "text": "GBshape framework. GBshape",
            "probability": 0.16845703125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2109375,
            "text": "GBshape",
            "probability": 0.16845703125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.203125,
            "text": "GBshape",
            "probability": 0.165771484375
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.1953125,
            "text": "GBshape",
            "probability": 0.165771484375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.2109375,
            "text": "GBshape",
            "probability": 0.165771484375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.203125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.165771484375
        },
        {
            "start_logit": -0.254638671875,
            "end_logit": 8.2109375,
            "text": "e framework. GBshape",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": -0.26220703125,
            "end_logit": 8.2109375,
            "text": "e",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": -0.254638671875,
            "end_logit": 8.1953125,
            "text": "e",
            "probability": 3.272294998168945e-05
        },
        {
            "start_logit": -0.2978515625,
            "end_logit": 8.203125,
            "text": "e",
            "probability": 3.170967102050781e-05
        },
        {
            "start_logit": -0.312255859375,
            "end_logit": 8.2109375,
            "text": "e",
            "probability": 3.141164779663086e-05
        },
        {
            "start_logit": -0.312255859375,
            "end_logit": 8.203125,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.83837890625,
            "text": "GBshape framework. GBs",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.83837890625,
            "text": "GBs",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.84228515625,
            "text": "GBs",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.849609375,
            "text": "GBs",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.849609375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.86669921875,
            "text": "GBs",
            "probability": 1.9073486328125e-05
        },
        {
            "start_logit": -4.796875,
            "end_logit": 8.2109375,
            "text": ". GBshape",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -4.796875,
            "end_logit": 8.2109375,
            "text": ". Additional genomes can easily be added using the GBshape framework. GBshape",
            "probability": 3.5762786865234375e-07
        }
    ],
    "587e1bfdfc7e8dd84f000002_3": [
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2109375,
            "text": "GBshape framework. GBshape",
            "probability": 0.16845703125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2109375,
            "text": "GBshape",
            "probability": 0.16845703125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.203125,
            "text": "GBshape",
            "probability": 0.165771484375
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.1953125,
            "text": "GBshape",
            "probability": 0.165771484375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.2109375,
            "text": "GBshape",
            "probability": 0.165771484375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.203125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.165771484375
        },
        {
            "start_logit": -0.254638671875,
            "end_logit": 8.2109375,
            "text": "e framework. GBshape",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": -0.26220703125,
            "end_logit": 8.2109375,
            "text": "e",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": -0.254638671875,
            "end_logit": 8.1953125,
            "text": "e",
            "probability": 3.272294998168945e-05
        },
        {
            "start_logit": -0.2978515625,
            "end_logit": 8.203125,
            "text": "e",
            "probability": 3.170967102050781e-05
        },
        {
            "start_logit": -0.312255859375,
            "end_logit": 8.2109375,
            "text": "e",
            "probability": 3.141164779663086e-05
        },
        {
            "start_logit": -0.312255859375,
            "end_logit": 8.203125,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.83837890625,
            "text": "GBshape framework. GBs",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.83837890625,
            "text": "GBs",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.84228515625,
            "text": "GBs",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.849609375,
            "text": "GBs",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.849609375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.86669921875,
            "text": "GBs",
            "probability": 1.9073486328125e-05
        },
        {
            "start_logit": -4.796875,
            "end_logit": 8.2109375,
            "text": ". GBshape",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -4.796875,
            "end_logit": 8.2109375,
            "text": ". Additional genomes can easily be added using the GBshape framework. GBshape",
            "probability": 3.5762786865234375e-07
        }
    ],
    "587e1bfdfc7e8dd84f000002_4": [
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2109375,
            "text": "GBshape framework. GBshape",
            "probability": 0.16845703125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2109375,
            "text": "GBshape",
            "probability": 0.16845703125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.203125,
            "text": "GBshape",
            "probability": 0.165771484375
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.1953125,
            "text": "GBshape",
            "probability": 0.165771484375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.2109375,
            "text": "GBshape",
            "probability": 0.165771484375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.203125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.165771484375
        },
        {
            "start_logit": -0.254638671875,
            "end_logit": 8.2109375,
            "text": "e framework. GBshape",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": -0.26220703125,
            "end_logit": 8.2109375,
            "text": "e",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": -0.254638671875,
            "end_logit": 8.1953125,
            "text": "e",
            "probability": 3.272294998168945e-05
        },
        {
            "start_logit": -0.2978515625,
            "end_logit": 8.203125,
            "text": "e",
            "probability": 3.170967102050781e-05
        },
        {
            "start_logit": -0.312255859375,
            "end_logit": 8.2109375,
            "text": "e",
            "probability": 3.141164779663086e-05
        },
        {
            "start_logit": -0.312255859375,
            "end_logit": 8.203125,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.83837890625,
            "text": "GBshape framework. GBs",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.83837890625,
            "text": "GBs",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.84228515625,
            "text": "GBs",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.849609375,
            "text": "GBs",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.849609375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.86669921875,
            "text": "GBs",
            "probability": 1.9073486328125e-05
        },
        {
            "start_logit": -4.796875,
            "end_logit": 8.2109375,
            "text": ". GBshape",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -4.796875,
            "end_logit": 8.2109375,
            "text": ". Additional genomes can easily be added using the GBshape framework. GBshape",
            "probability": 3.5762786865234375e-07
        }
    ],
    "587e1bfdfc7e8dd84f000002_5": [
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2109375,
            "text": "GBshape framework. GBshape",
            "probability": 0.16845703125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2109375,
            "text": "GBshape",
            "probability": 0.16845703125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.203125,
            "text": "GBshape",
            "probability": 0.165771484375
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.1953125,
            "text": "GBshape",
            "probability": 0.165771484375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.2109375,
            "text": "GBshape",
            "probability": 0.165771484375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.203125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.165771484375
        },
        {
            "start_logit": -0.254638671875,
            "end_logit": 8.2109375,
            "text": "e framework. GBshape",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": -0.26220703125,
            "end_logit": 8.2109375,
            "text": "e",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": -0.254638671875,
            "end_logit": 8.1953125,
            "text": "e",
            "probability": 3.272294998168945e-05
        },
        {
            "start_logit": -0.2978515625,
            "end_logit": 8.203125,
            "text": "e",
            "probability": 3.170967102050781e-05
        },
        {
            "start_logit": -0.312255859375,
            "end_logit": 8.2109375,
            "text": "e",
            "probability": 3.141164779663086e-05
        },
        {
            "start_logit": -0.312255859375,
            "end_logit": 8.203125,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.83837890625,
            "text": "GBshape framework. GBs",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.83837890625,
            "text": "GBs",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.84228515625,
            "text": "GBs",
            "probability": 1.9669532775878906e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.849609375,
            "text": "GBs",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.849609375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.86669921875,
            "text": "GBs",
            "probability": 1.9073486328125e-05
        },
        {
            "start_logit": -4.796875,
            "end_logit": 8.2109375,
            "text": ". GBshape",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -4.796875,
            "end_logit": 8.2109375,
            "text": ". Additional genomes can easily be added using the GBshape framework. GBshape",
            "probability": 3.5762786865234375e-07
        }
    ],
    "587e1bfdfc7e8dd84f000002_6": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.1640625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": 8.1640625,
            "text": "e",
            "probability": 0.00010228157043457031
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.2783203125,
            "text": "GBs",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": -6.3046875,
            "end_logit": 8.1640625,
            "text": "hape",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.01953125,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.515625,
            "text": "GBshape: a genome browser",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.58203125,
            "text": "GBshape: a genome browser database",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.59375,
            "text": "GBshape: a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.65234375,
            "text": "GBshape: a genome browser database for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.671875,
            "text": "GBshape: a genome browse",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.6953125,
            "text": "GBshape: a genome browser database for DNA shape annotations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": -7.515625,
            "text": "e: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": -7.58203125,
            "text": "e: a genome browser database",
            "probability": 0.0
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": -7.59375,
            "text": "e: a",
            "probability": 0.0
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": -7.65234375,
            "text": "e: a genome browser database for",
            "probability": 0.0
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": -7.671875,
            "text": "e: a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": -7.6953125,
            "text": "e: a genome browser database for DNA shape annotations",
            "probability": 0.0
        },
        {
            "start_logit": -6.3046875,
            "end_logit": -7.01953125,
            "text": "hap",
            "probability": 0.0
        },
        {
            "start_logit": -6.3046875,
            "end_logit": -7.515625,
            "text": "hape: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -6.3046875,
            "end_logit": -7.58203125,
            "text": "hape: a genome browser database",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_7": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.1796875,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": 8.1796875,
            "text": "e",
            "probability": 0.00011777877807617188
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.1865234375,
            "text": "GBs",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.51171875,
            "text": "GBshap",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.67578125,
            "end_logit": 8.1796875,
            "text": "hape",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.30078125,
            "text": "GBshape can",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.33203125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.35546875,
            "text": "GBshape can be",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.43359375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4765625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4921875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.51953125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.53515625,
            "text": "GBshape can be used to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.5625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6328125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": -7.30078125,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": -7.33203125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": -7.35546875,
            "text": "e can be",
            "probability": 0.0
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": -7.43359375,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 0.0
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": -7.4765625,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_8": [
        {
            "start_logit": 8.25,
            "end_logit": 8.1875,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.1875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.1875,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": -0.484130859375,
            "end_logit": 8.1875,
            "text": "e",
            "probability": 5.364418029785156e-05
        },
        {
            "start_logit": -0.5888671875,
            "end_logit": 8.1875,
            "text": "e",
            "probability": 4.8100948333740234e-05
        },
        {
            "start_logit": -0.5888671875,
            "end_logit": 8.1875,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 4.8100948333740234e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -0.99072265625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 3.439188003540039e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -0.99072265625,
            "text": "GBs",
            "probability": 3.439188003540039e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.0283203125,
            "text": "GBs",
            "probability": 3.30805778503418e-05
        },
        {
            "start_logit": -5.69140625,
            "end_logit": 8.1875,
            "text": "hape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.69140625,
            "end_logit": 8.1875,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -5.98828125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -5.98828125,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.078125,
            "end_logit": 8.1875,
            "text": "hape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.3203125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.3203125,
            "text": "GBshape/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.34375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.4765625,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.51171875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.58203125,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        }
    ],
    "587e1bfdfc7e8dd84f000002_9": [
        {
            "start_logit": 8.25,
            "end_logit": 8.1875,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.1875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.1875,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": -0.484130859375,
            "end_logit": 8.1875,
            "text": "e",
            "probability": 5.364418029785156e-05
        },
        {
            "start_logit": -0.5888671875,
            "end_logit": 8.1875,
            "text": "e",
            "probability": 4.8100948333740234e-05
        },
        {
            "start_logit": -0.5888671875,
            "end_logit": 8.1875,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 4.8100948333740234e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -0.99072265625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 3.439188003540039e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -0.99072265625,
            "text": "GBs",
            "probability": 3.439188003540039e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.0283203125,
            "text": "GBs",
            "probability": 3.30805778503418e-05
        },
        {
            "start_logit": -5.69140625,
            "end_logit": 8.1875,
            "text": "hape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.69140625,
            "end_logit": 8.1875,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -5.98828125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -5.98828125,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.078125,
            "end_logit": 8.1875,
            "text": "hape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.3203125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.3203125,
            "text": "GBshape/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.34375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.4765625,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.51171875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.58203125,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        }
    ],
    "587e1bfdfc7e8dd84f000002_10": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.1796875,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": 8.1796875,
            "text": "e",
            "probability": 0.00011777877807617188
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.1865234375,
            "text": "GBs",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.51171875,
            "text": "GBshap",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.67578125,
            "end_logit": 8.1796875,
            "text": "hape",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.30078125,
            "text": "GBshape can",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.33203125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.35546875,
            "text": "GBshape can be",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.43359375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4765625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4921875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.51953125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.53515625,
            "text": "GBshape can be used to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.5625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6328125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": -7.30078125,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": -7.33203125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": -7.35546875,
            "text": "e can be",
            "probability": 0.0
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": -7.43359375,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 0.0
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": -7.4765625,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_11": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.1796875,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": 8.1796875,
            "text": "e",
            "probability": 0.00011777877807617188
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.1865234375,
            "text": "GBs",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.51171875,
            "text": "GBshap",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.67578125,
            "end_logit": 8.1796875,
            "text": "hape",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.30078125,
            "text": "GBshape can",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.33203125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.35546875,
            "text": "GBshape can be",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.43359375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4765625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4921875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.51953125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.53515625,
            "text": "GBshape can be used to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.5625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6328125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": -7.30078125,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": -7.33203125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": -7.35546875,
            "text": "e can be",
            "probability": 0.0
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": -7.43359375,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 0.0
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": -7.4765625,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_12": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.1640625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": 8.1640625,
            "text": "e",
            "probability": 0.00010228157043457031
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.2783203125,
            "text": "GBs",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": -6.3046875,
            "end_logit": 8.1640625,
            "text": "hape",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.01953125,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.515625,
            "text": "GBshape: a genome browser",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.58203125,
            "text": "GBshape: a genome browser database",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.59375,
            "text": "GBshape: a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.65234375,
            "text": "GBshape: a genome browser database for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.671875,
            "text": "GBshape: a genome browse",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.6953125,
            "text": "GBshape: a genome browser database for DNA shape annotations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": -7.515625,
            "text": "e: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": -7.58203125,
            "text": "e: a genome browser database",
            "probability": 0.0
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": -7.59375,
            "text": "e: a",
            "probability": 0.0
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": -7.65234375,
            "text": "e: a genome browser database for",
            "probability": 0.0
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": -7.671875,
            "text": "e: a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": -7.6953125,
            "text": "e: a genome browser database for DNA shape annotations",
            "probability": 0.0
        },
        {
            "start_logit": -6.3046875,
            "end_logit": -7.01953125,
            "text": "hap",
            "probability": 0.0
        },
        {
            "start_logit": -6.3046875,
            "end_logit": -7.515625,
            "text": "hape: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -6.3046875,
            "end_logit": -7.58203125,
            "text": "hape: a genome browser database",
            "probability": 0.0
        }
    ],
    "587e1bfdfc7e8dd84f000002_13": [
        {
            "start_logit": 8.25,
            "end_logit": 8.1875,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.1875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.1875,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": -0.484130859375,
            "end_logit": 8.1875,
            "text": "e",
            "probability": 5.364418029785156e-05
        },
        {
            "start_logit": -0.5888671875,
            "end_logit": 8.1875,
            "text": "e",
            "probability": 4.8100948333740234e-05
        },
        {
            "start_logit": -0.5888671875,
            "end_logit": 8.1875,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 4.8100948333740234e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -0.99072265625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 3.439188003540039e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -0.99072265625,
            "text": "GBs",
            "probability": 3.439188003540039e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.0283203125,
            "text": "GBs",
            "probability": 3.30805778503418e-05
        },
        {
            "start_logit": -5.69140625,
            "end_logit": 8.1875,
            "text": "hape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.69140625,
            "end_logit": 8.1875,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -5.98828125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -5.98828125,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.078125,
            "end_logit": 8.1875,
            "text": "hape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.3203125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.3203125,
            "text": "GBshape/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.34375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.4765625,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.51171875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.58203125,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        }
    ],
    "587e1bfdfc7e8dd84f000002_14": [
        {
            "start_logit": 8.25,
            "end_logit": 8.1875,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.1875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.1875,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": -0.484130859375,
            "end_logit": 8.1875,
            "text": "e",
            "probability": 5.364418029785156e-05
        },
        {
            "start_logit": -0.5888671875,
            "end_logit": 8.1875,
            "text": "e",
            "probability": 4.8100948333740234e-05
        },
        {
            "start_logit": -0.5888671875,
            "end_logit": 8.1875,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 4.8100948333740234e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -0.99072265625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 3.439188003540039e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -0.99072265625,
            "text": "GBs",
            "probability": 3.439188003540039e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.0283203125,
            "text": "GBs",
            "probability": 3.30805778503418e-05
        },
        {
            "start_logit": -5.69140625,
            "end_logit": 8.1875,
            "text": "hape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.69140625,
            "end_logit": 8.1875,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -5.98828125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -5.98828125,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.078125,
            "end_logit": 8.1875,
            "text": "hape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.3203125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.3203125,
            "text": "GBshape/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.34375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.4765625,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.51171875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.58203125,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        }
    ],
    "53262cdcd6d3ac6a34000003_1": [
        {
            "start_logit": 7.0546875,
            "end_logit": 5.5,
            "text": "epidural blood patch",
            "probability": 0.958984375
        },
        {
            "start_logit": 7.0546875,
            "end_logit": 2.33203125,
            "text": "epidural blood patch.",
            "probability": 0.04052734375
        },
        {
            "start_logit": -0.22216796875,
            "end_logit": 5.5,
            "text": "CSF leak using an epidural blood patch",
            "probability": 0.0006623268127441406
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -3.544921875,
            "text": "epidural",
            "probability": 0.00011295080184936523
        },
        {
            "start_logit": -0.22216796875,
            "end_logit": 2.33203125,
            "text": "CSF leak using an epidural blood patch.",
            "probability": 2.7894973754882812e-05
        },
        {
            "start_logit": 7.0546875,
            "end_logit": -6.5,
            "text": "epidural blood",
            "probability": 5.900859832763672e-06
        },
        {
            "start_logit": -5.51171875,
            "end_logit": 5.5,
            "text": "patch",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": -6.90625,
            "end_logit": 5.5,
            "text": "blood patch",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 5.5,
            "text": "she was treated for CSF leak using an epidural blood patch",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 5.5,
            "text": "treated for CSF leak using an epidural blood patch",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 5.5,
            "text": "for CSF leak using an epidural blood patch",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 5.5,
            "text": "was treated for CSF leak using an epidural blood patch",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 5.5,
            "text": "an epidural blood patch",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.51171875,
            "end_logit": 2.33203125,
            "text": "patch.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.69140625,
            "end_logit": 2.33203125,
            "text": ".",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.22216796875,
            "end_logit": -3.544921875,
            "text": "CSF leak using an epidural",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.22216796875,
            "end_logit": -4.1875,
            "text": "CSF leak",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.90625,
            "end_logit": 2.33203125,
            "text": "blood patch.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 2.33203125,
            "text": "she was treated for CSF leak using an epidural blood patch.",
            "probability": 0.0
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 2.33203125,
            "text": "treated for CSF leak using an epidural blood patch.",
            "probability": 0.0
        }
    ],
    "53262cdcd6d3ac6a34000003_2": [
        {
            "start_logit": 8.1796875,
            "end_logit": 7.9375,
            "text": "epidural blood patch",
            "probability": 1.0
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -1.3740234375,
            "text": "epidural",
            "probability": 8.958578109741211e-05
        },
        {
            "start_logit": -1.716796875,
            "end_logit": 7.9375,
            "text": "patch",
            "probability": 4.988908767700195e-05
        },
        {
            "start_logit": -5.80859375,
            "end_logit": 7.9375,
            "text": "blood patch",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.015625,
            "text": "epidural blood patch providing",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 7.9375,
            "text": "invasive measures with epidural blood patch",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.1953125,
            "text": "epidural blood patch providing the cornerstone of the invasive measures",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.59375,
            "text": "epidural blood",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.7265625,
            "text": "epidural blood patch providing the cornerstone",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.73828125,
            "text": "epidural blood patch providing the cornerstone of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.75390625,
            "text": "epidural blood patch providing the cornerstone of the invasive",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 7.9375,
            "text": "with epidural blood patch",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 7.9375,
            "text": "measures with epidural blood patch",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.81640625,
            "end_logit": -1.3740234375,
            "text": "invasive measures with epidural",
            "probability": 0.0
        },
        {
            "start_logit": -1.716796875,
            "end_logit": -7.015625,
            "text": "patch providing",
            "probability": 0.0
        },
        {
            "start_logit": -1.716796875,
            "end_logit": -7.1953125,
            "text": "patch providing the cornerstone of the invasive measures",
            "probability": 0.0
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -1.3740234375,
            "text": "with epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.79296875,
            "end_logit": -1.3740234375,
            "text": "measures with epidural",
            "probability": 0.0
        },
        {
            "start_logit": -1.716796875,
            "end_logit": -7.7265625,
            "text": "patch providing the cornerstone",
            "probability": 0.0
        },
        {
            "start_logit": -1.716796875,
            "end_logit": -7.73828125,
            "text": "patch providing the cornerstone of",
            "probability": 0.0
        }
    ],
    "53262cdcd6d3ac6a34000003_3": [
        {
            "start_logit": 7.80859375,
            "end_logit": 6.73046875,
            "text": "epidural blood patch",
            "probability": 1.0
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -2.064453125,
            "text": "epidural",
            "probability": 0.00015115737915039062
        },
        {
            "start_logit": -3.87109375,
            "end_logit": 6.73046875,
            "text": "patch",
            "probability": 8.463859558105469e-06
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -5.84765625,
            "text": "epidural blood",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -6.93359375,
            "text": "epidural blood patch should",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -7.3984375,
            "text": "epidural blood patch should be",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.84375,
            "end_logit": 6.73046875,
            "text": ", epidural blood patch",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 6.73046875,
            "text": "needle puncture, epidural blood patch",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 6.73046875,
            "text": "blood patch",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 6.73046875,
            "text": "In high-risk patients , for example, age < 50 years, postpartum, large-gauge needle puncture, epidural blood patch",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 6.73046875,
            "text": "large-gauge needle puncture, epidural blood patch",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 6.73046875,
            "text": ", age < 50 years, postpartum, large-gauge needle puncture, epidural blood patch",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 6.73046875,
            "text": ", large-gauge needle puncture, epidural blood patch",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 6.73046875,
            "text": "age < 50 years, postpartum, large-gauge needle puncture, epidural blood patch",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 6.73046875,
            "text": "puncture, epidural blood patch",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 6.73046875,
            "text": "gauge needle puncture, epidural blood patch",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.73046875,
            "text": ", postpartum, large-gauge needle puncture, epidural blood patch",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 6.73046875,
            "text": "< 50 years, postpartum, large-gauge needle puncture, epidural blood patch",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 6.73046875,
            "text": "high-risk patients , for example, age < 50 years, postpartum, large-gauge needle puncture, epidural blood patch",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 6.73046875,
            "text": "for example, age < 50 years, postpartum, large-gauge needle puncture, epidural blood patch",
            "probability": 1.7881393432617188e-07
        }
    ],
    "53262cdcd6d3ac6a34000003_4": [
        {
            "start_logit": 6.640625,
            "end_logit": 6.29296875,
            "text": "acupuncture",
            "probability": 1.0
        },
        {
            "start_logit": 6.640625,
            "end_logit": -6.1953125,
            "text": "acupuncture rather than an epidural blood patch.",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 6.640625,
            "end_logit": -7.13671875,
            "text": "acupuncture rather than an epidural blood",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.640625,
            "end_logit": -7.19921875,
            "text": "acupuncture rather",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.640625,
            "end_logit": -7.21484375,
            "text": "acupuncture rather than an epidural blood patch",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.640625,
            "end_logit": -7.37109375,
            "text": "acupuncture rather than an",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.640625,
            "end_logit": -7.43359375,
            "text": "acupuncture rather than",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.640625,
            "end_logit": -7.7265625,
            "text": "acupuncture rather than an epidural",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 6.29296875,
            "text": "using acupuncture",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 6.29296875,
            "text": "parturients were successfully managed using acupuncture",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 6.29296875,
            "text": "Both parturients were successfully managed using acupuncture",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 6.29296875,
            "text": "urients were successfully managed using acupuncture",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 6.29296875,
            "text": "successfully managed using acupuncture",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.29296875,
            "text": "managed using acupuncture",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -6.1953125,
            "text": "blood patch.",
            "probability": 0.0
        },
        {
            "start_logit": -7.2265625,
            "end_logit": -6.1953125,
            "text": "epidural blood patch.",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -6.1953125,
            "text": "using acupuncture rather than an epidural blood patch.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6484375,
            "end_logit": -6.1953125,
            "text": "parturients were successfully managed using acupuncture rather than an epidural blood patch.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -6.1953125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -6.1953125,
            "text": "Both parturients were successfully managed using acupuncture rather than an epidural blood patch.",
            "probability": 0.0
        }
    ],
    "53262cdcd6d3ac6a34000003_5": [
        {
            "start_logit": -2.38671875,
            "end_logit": 7.4375,
            "text": "LP shunt placement",
            "probability": 0.36474609375
        },
        {
            "start_logit": -2.388671875,
            "end_logit": 7.4375,
            "text": "shunt placement",
            "probability": 0.36328125
        },
        {
            "start_logit": -2.7890625,
            "end_logit": 7.4375,
            "text": "placement",
            "probability": 0.243896484375
        },
        {
            "start_logit": -5.78125,
            "end_logit": 7.4375,
            "text": "after LP shunt placement",
            "probability": 0.01224517822265625
        },
        {
            "start_logit": -7.34375,
            "end_logit": 7.4375,
            "text": "In this case, a 17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement",
            "probability": 0.0025653839111328125
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 7.4375,
            "text": ", a 17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement",
            "probability": 0.0024662017822265625
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.4375,
            "text": "a 17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement",
            "probability": 0.0020542144775390625
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.4375,
            "text": "this case, a 17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement",
            "probability": 0.0019664764404296875
        },
        {
            "start_logit": -7.6875,
            "end_logit": 7.4375,
            "text": "low-pressure headache after LP shunt placement",
            "probability": 0.0018186569213867188
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 7.4375,
            "text": "a low-pressure headache after LP shunt placement",
            "probability": 0.0017557144165039062
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 7.4375,
            "text": "girl had symptoms of a low-pressure headache after LP shunt placement",
            "probability": 0.0017290115356445312
        },
        {
            "start_logit": -7.75,
            "end_logit": 7.4375,
            "text": "case, a 17-yr-old girl had symptoms of a low-pressure headache after LP shunt placement",
            "probability": 0.0017080307006835938
        },
        {
            "start_logit": -2.38671875,
            "end_logit": -3.46484375,
            "text": "LP shunt placement alleviated by an epidural blood patch.",
            "probability": 6.67572021484375e-06
        },
        {
            "start_logit": -2.388671875,
            "end_logit": -3.46484375,
            "text": "shunt placement alleviated by an epidural blood patch.",
            "probability": 6.67572021484375e-06
        },
        {
            "start_logit": -2.7890625,
            "end_logit": -3.46484375,
            "text": "placement alleviated by an epidural blood patch.",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -2.38671875,
            "end_logit": -6.12890625,
            "text": "LP shunt placement alleviated by an epidural blood patch",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -2.388671875,
            "end_logit": -6.12890625,
            "text": "shunt placement alleviated by an epidural blood patch",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.4453125,
            "end_logit": -3.46484375,
            "text": "epidural blood patch.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -2.7890625,
            "end_logit": -6.12890625,
            "text": "placement alleviated by an epidural blood patch",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.78125,
            "end_logit": -3.46484375,
            "text": "after LP shunt placement alleviated by an epidural blood patch.",
            "probability": 2.384185791015625e-07
        }
    ],
    "53262cdcd6d3ac6a34000003_6": [
        {
            "start_logit": 8.1484375,
            "end_logit": 7.9921875,
            "text": "epidural blood patch",
            "probability": 1.0
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -1.494140625,
            "text": "epidural",
            "probability": 7.605552673339844e-05
        },
        {
            "start_logit": -1.439453125,
            "end_logit": 7.9921875,
            "text": "patch",
            "probability": 6.866455078125e-05
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -6.55859375,
            "text": "epidural blood",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.80859375,
            "end_logit": 7.9921875,
            "text": "blood patch",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 7.9921875,
            "text": ", large-gauge-needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural blood patch",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 7.9921875,
            "text": "), patients should be offered early (within 24-48 h of dural puncture) epidural blood patch",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.9921875,
            "text": "large-gauge-needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural blood patch",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.9921875,
            "text": "dural puncture) epidural blood patch",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 7.9921875,
            "text": "needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural blood patch",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 7.9921875,
            "text": "partum, large-gauge-needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural blood patch",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 7.9921875,
            "text": "post-partum, large-gauge-needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural blood patch",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": -1.494140625,
            "text": ", large-gauge-needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -1.494140625,
            "text": "), patients should be offered early (within 24-48 h of dural puncture) epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -1.494140625,
            "text": "large-gauge-needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -1.494140625,
            "text": "dural puncture) epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.703125,
            "end_logit": -1.494140625,
            "text": "needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.71484375,
            "end_logit": -1.494140625,
            "text": ", post-partum, large-gauge-needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -1.494140625,
            "text": "partum, large-gauge-needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural",
            "probability": 0.0
        },
        {
            "start_logit": -7.75,
            "end_logit": -1.494140625,
            "text": "post-partum, large-gauge-needle puncture), patients should be offered early (within 24-48 h of dural puncture) epidural",
            "probability": 0.0
        }
    ],
    "5c5b268986df2b9174000019_1": [
        {
            "start_logit": 8.1875,
            "end_logit": 8.109375,
            "text": "DSMNC",
            "probability": 1.0
        },
        {
            "start_logit": 8.1875,
            "end_logit": -1.322265625,
            "text": "DSM",
            "probability": 8.028745651245117e-05
        },
        {
            "start_logit": -1.2734375,
            "end_logit": 8.109375,
            "text": "NC",
            "probability": 7.784366607666016e-05
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.55078125,
            "text": "DSMNC: a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.5859375,
            "text": "DSMNC: a database of somatic mutations in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.58984375,
            "text": "DSMNC: a database",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.6796875,
            "text": "DSMNC: a database of somatic mutations in normal cells",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.70703125,
            "text": "DSMNC: a database of somatic mutations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.71484375,
            "text": "DSMNC: a database of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.73046875,
            "text": "DSMNC: a database of somatic mutations in normal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.55078125,
            "text": "NC: a",
            "probability": 0.0
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.5859375,
            "text": "NC: a database of somatic mutations in",
            "probability": 0.0
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.58984375,
            "text": "NC: a database",
            "probability": 0.0
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.6796875,
            "text": "NC: a database of somatic mutations in normal cells",
            "probability": 0.0
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.70703125,
            "text": "NC: a database of somatic mutations",
            "probability": 0.0
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.71484375,
            "text": "NC: a database of",
            "probability": 0.0
        },
        {
            "start_logit": -1.2734375,
            "end_logit": -7.73046875,
            "text": "NC: a database of somatic mutations in normal",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -7.55078125,
            "text": ": a",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -7.5859375,
            "text": ": a database of somatic mutations in",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -7.58984375,
            "text": ": a database",
            "probability": 0.0
        }
    ],
    "5c5b268986df2b9174000019_2": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.125,
            "text": "DSMNC",
            "probability": 0.20361328125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.109375,
            "text": "DSMNC",
            "probability": 0.200439453125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1171875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 0.200439453125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 8.109375,
            "text": "DSMNC",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1171875,
            "text": "dsmnc",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.25,
            "end_logit": -0.70068359375,
            "text": "DSM",
            "probability": 2.9861927032470703e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -0.7353515625,
            "text": "DSM",
            "probability": 2.866983413696289e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -0.73291015625,
            "text": "DSM",
            "probability": 2.866983413696289e-05
        },
        {
            "start_logit": -0.64111328125,
            "end_logit": 8.1171875,
            "text": "nc",
            "probability": 2.7835369110107422e-05
        },
        {
            "start_logit": -0.69287109375,
            "end_logit": 8.125,
            "text": "NC",
            "probability": 2.676248550415039e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -0.81103515625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsm",
            "probability": 2.6524066925048828e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -0.81103515625,
            "text": "dsm",
            "probability": 2.6106834411621094e-05
        },
        {
            "start_logit": -0.72119140625,
            "end_logit": 8.109375,
            "text": "NC",
            "probability": 2.5510787963867188e-05
        },
        {
            "start_logit": -0.7529296875,
            "end_logit": 8.1171875,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 2.473592758178711e-05
        },
        {
            "start_logit": -0.7529296875,
            "end_logit": 8.109375,
            "text": "NC",
            "probability": 2.473592758178711e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -3.95703125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -3.95703125,
            "text": "dsmnc.big.ac.cn",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -5.1953125,
            "end_logit": 8.125,
            "text": ". DSMNC",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.19921875,
            "end_logit": 8.125,
            "text": ". The database interface supports the user-friendly capability of browsing and searching the SNVs and their annotation information. DSMNC",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.19921875,
            "end_logit": 8.1171875,
            "text": ". Here, we established DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 2.980232238769531e-07
        }
    ],
    "5c5b268986df2b9174000019_3": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.125,
            "text": "DSMNC",
            "probability": 0.20361328125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.109375,
            "text": "DSMNC",
            "probability": 0.200439453125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1171875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 0.200439453125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 8.109375,
            "text": "DSMNC",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1171875,
            "text": "dsmnc",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.25,
            "end_logit": -0.70068359375,
            "text": "DSM",
            "probability": 2.9861927032470703e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -0.7353515625,
            "text": "DSM",
            "probability": 2.866983413696289e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -0.73291015625,
            "text": "DSM",
            "probability": 2.866983413696289e-05
        },
        {
            "start_logit": -0.64111328125,
            "end_logit": 8.1171875,
            "text": "nc",
            "probability": 2.7835369110107422e-05
        },
        {
            "start_logit": -0.69287109375,
            "end_logit": 8.125,
            "text": "NC",
            "probability": 2.676248550415039e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -0.81103515625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsm",
            "probability": 2.6524066925048828e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -0.81103515625,
            "text": "dsm",
            "probability": 2.6106834411621094e-05
        },
        {
            "start_logit": -0.72119140625,
            "end_logit": 8.109375,
            "text": "NC",
            "probability": 2.5510787963867188e-05
        },
        {
            "start_logit": -0.7529296875,
            "end_logit": 8.1171875,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 2.473592758178711e-05
        },
        {
            "start_logit": -0.7529296875,
            "end_logit": 8.109375,
            "text": "NC",
            "probability": 2.473592758178711e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -3.95703125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -3.95703125,
            "text": "dsmnc.big.ac.cn",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -5.1953125,
            "end_logit": 8.125,
            "text": ". DSMNC",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.19921875,
            "end_logit": 8.125,
            "text": ". The database interface supports the user-friendly capability of browsing and searching the SNVs and their annotation information. DSMNC",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.19921875,
            "end_logit": 8.1171875,
            "text": ". Here, we established DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 2.980232238769531e-07
        }
    ],
    "5c5b268986df2b9174000019_4": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.125,
            "text": "DSMNC",
            "probability": 0.20361328125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.109375,
            "text": "DSMNC",
            "probability": 0.200439453125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1171875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 0.200439453125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 8.109375,
            "text": "DSMNC",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1171875,
            "text": "dsmnc",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.25,
            "end_logit": -0.70068359375,
            "text": "DSM",
            "probability": 2.9861927032470703e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -0.7353515625,
            "text": "DSM",
            "probability": 2.866983413696289e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -0.73291015625,
            "text": "DSM",
            "probability": 2.866983413696289e-05
        },
        {
            "start_logit": -0.64111328125,
            "end_logit": 8.1171875,
            "text": "nc",
            "probability": 2.7835369110107422e-05
        },
        {
            "start_logit": -0.69287109375,
            "end_logit": 8.125,
            "text": "NC",
            "probability": 2.676248550415039e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -0.81103515625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsm",
            "probability": 2.6524066925048828e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -0.81103515625,
            "text": "dsm",
            "probability": 2.6106834411621094e-05
        },
        {
            "start_logit": -0.72119140625,
            "end_logit": 8.109375,
            "text": "NC",
            "probability": 2.5510787963867188e-05
        },
        {
            "start_logit": -0.7529296875,
            "end_logit": 8.1171875,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 2.473592758178711e-05
        },
        {
            "start_logit": -0.7529296875,
            "end_logit": 8.109375,
            "text": "NC",
            "probability": 2.473592758178711e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -3.95703125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -3.95703125,
            "text": "dsmnc.big.ac.cn",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -5.1953125,
            "end_logit": 8.125,
            "text": ". DSMNC",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.19921875,
            "end_logit": 8.125,
            "text": ". The database interface supports the user-friendly capability of browsing and searching the SNVs and their annotation information. DSMNC",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.19921875,
            "end_logit": 8.1171875,
            "text": ". Here, we established DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 2.980232238769531e-07
        }
    ],
    "5c5b268986df2b9174000019_5": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.125,
            "text": "DSMNC",
            "probability": 0.20361328125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.109375,
            "text": "DSMNC",
            "probability": 0.200439453125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1171875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 0.200439453125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 8.109375,
            "text": "DSMNC",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1171875,
            "text": "dsmnc",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.25,
            "end_logit": -0.70068359375,
            "text": "DSM",
            "probability": 2.9861927032470703e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -0.7353515625,
            "text": "DSM",
            "probability": 2.866983413696289e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -0.73291015625,
            "text": "DSM",
            "probability": 2.866983413696289e-05
        },
        {
            "start_logit": -0.64111328125,
            "end_logit": 8.1171875,
            "text": "nc",
            "probability": 2.7835369110107422e-05
        },
        {
            "start_logit": -0.69287109375,
            "end_logit": 8.125,
            "text": "NC",
            "probability": 2.676248550415039e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -0.81103515625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsm",
            "probability": 2.6524066925048828e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -0.81103515625,
            "text": "dsm",
            "probability": 2.6106834411621094e-05
        },
        {
            "start_logit": -0.72119140625,
            "end_logit": 8.109375,
            "text": "NC",
            "probability": 2.5510787963867188e-05
        },
        {
            "start_logit": -0.7529296875,
            "end_logit": 8.1171875,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 2.473592758178711e-05
        },
        {
            "start_logit": -0.7529296875,
            "end_logit": 8.109375,
            "text": "NC",
            "probability": 2.473592758178711e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -3.95703125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -3.95703125,
            "text": "dsmnc.big.ac.cn",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -5.1953125,
            "end_logit": 8.125,
            "text": ". DSMNC",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.19921875,
            "end_logit": 8.125,
            "text": ". The database interface supports the user-friendly capability of browsing and searching the SNVs and their annotation information. DSMNC",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.19921875,
            "end_logit": 8.1171875,
            "text": ". Here, we established DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 2.980232238769531e-07
        }
    ],
    "5c5b268986df2b9174000019_6": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.125,
            "text": "dsmnc",
            "probability": 0.336669921875
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 8.125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 0.336669921875
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 8.109375,
            "text": "DSMNC",
            "probability": 0.326171875
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.0224609375,
            "text": "dsm",
            "probability": 3.5822391510009766e-05
        },
        {
            "start_logit": -0.92822265625,
            "end_logit": 8.125,
            "text": "nc",
            "probability": 3.5822391510009766e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.0224609375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsm",
            "probability": 3.552436828613281e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.09765625,
            "text": "DSM",
            "probability": 3.2842159271240234e-05
        },
        {
            "start_logit": -1.09375,
            "end_logit": 8.125,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 3.039836883544922e-05
        },
        {
            "start_logit": -1.09375,
            "end_logit": 8.109375,
            "text": "NC",
            "probability": 2.9921531677246094e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -4.38671875,
            "text": "dsmnc.big.ac.cn",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -4.38671875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.6015625,
            "text": "dsmnc.big",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.6015625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.94921875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http:/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.19921875,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells from various normal tissues",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3125,
            "text": "dsmnc.big.ac.cn/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.3125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.32421875,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3984375,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4296875,
            "text": "dsmnc.big.ac.",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c5b268986df2b9174000019_7": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.125,
            "text": "dsmnc",
            "probability": 0.336669921875
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 8.125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 0.336669921875
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 8.109375,
            "text": "DSMNC",
            "probability": 0.326171875
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.0224609375,
            "text": "dsm",
            "probability": 3.5822391510009766e-05
        },
        {
            "start_logit": -0.92822265625,
            "end_logit": 8.125,
            "text": "nc",
            "probability": 3.5822391510009766e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.0224609375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsm",
            "probability": 3.552436828613281e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.09765625,
            "text": "DSM",
            "probability": 3.2842159271240234e-05
        },
        {
            "start_logit": -1.09375,
            "end_logit": 8.125,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 3.039836883544922e-05
        },
        {
            "start_logit": -1.09375,
            "end_logit": 8.109375,
            "text": "NC",
            "probability": 2.9921531677246094e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -4.38671875,
            "text": "dsmnc.big.ac.cn",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -4.38671875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.6015625,
            "text": "dsmnc.big",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.6015625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.94921875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http:/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.19921875,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells from various normal tissues",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3125,
            "text": "dsmnc.big.ac.cn/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.3125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.32421875,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3984375,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4296875,
            "text": "dsmnc.big.ac.",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c5b268986df2b9174000019_8": [
        {
            "start_logit": 8.1875,
            "end_logit": 8.125,
            "text": "DSMNC",
            "probability": 1.0
        },
        {
            "start_logit": -1.208984375,
            "end_logit": 8.125,
            "text": "NC",
            "probability": 8.285045623779297e-05
        },
        {
            "start_logit": 8.1875,
            "end_logit": -1.3125,
            "text": "DSM",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": 8.1875,
            "end_logit": -6.9140625,
            "text": "DSMNC: a database of somatic mutations in normal cells.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.4375,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.4375,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line origin,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.46484375,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line origin, occur",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.47265625,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.5078125,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.53515625,
            "text": "DSMNC: a database of somatic mutations in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.57421875,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line origin, occur in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.59375,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.60546875,
            "text": "DSMNC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line origin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.61328125,
            "text": "DSMNC: a database",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.208984375,
            "end_logit": -6.9140625,
            "text": "NC: a database of somatic mutations in normal cells.",
            "probability": 0.0
        },
        {
            "start_logit": -1.208984375,
            "end_logit": -7.4375,
            "text": "NC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those",
            "probability": 0.0
        },
        {
            "start_logit": -1.208984375,
            "end_logit": -7.4375,
            "text": "NC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line origin,",
            "probability": 0.0
        },
        {
            "start_logit": -1.208984375,
            "end_logit": -7.46484375,
            "text": "NC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line origin, occur",
            "probability": 0.0
        },
        {
            "start_logit": -1.208984375,
            "end_logit": -7.47265625,
            "text": "NC: a database of somatic mutations in normal cells.Numerous non-",
            "probability": 0.0
        },
        {
            "start_logit": -1.208984375,
            "end_logit": -7.5078125,
            "text": "NC: a database of somatic mutations in normal cells.Numerous non-inherited somatic mutations, distinct from those of germ-line",
            "probability": 0.0
        }
    ],
    "5c5b268986df2b9174000019_9": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.125,
            "text": "dsmnc",
            "probability": 0.336669921875
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 8.125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 0.336669921875
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 8.109375,
            "text": "DSMNC",
            "probability": 0.326171875
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.0224609375,
            "text": "dsm",
            "probability": 3.5822391510009766e-05
        },
        {
            "start_logit": -0.92822265625,
            "end_logit": 8.125,
            "text": "nc",
            "probability": 3.5822391510009766e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.0224609375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsm",
            "probability": 3.552436828613281e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.09765625,
            "text": "DSM",
            "probability": 3.2842159271240234e-05
        },
        {
            "start_logit": -1.09375,
            "end_logit": 8.125,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 3.039836883544922e-05
        },
        {
            "start_logit": -1.09375,
            "end_logit": 8.109375,
            "text": "NC",
            "probability": 2.9921531677246094e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -4.38671875,
            "text": "dsmnc.big.ac.cn",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -4.38671875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.6015625,
            "text": "dsmnc.big",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.6015625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.94921875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http:/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.19921875,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells from various normal tissues",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3125,
            "text": "dsmnc.big.ac.cn/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.3125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.32421875,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3984375,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4296875,
            "text": "dsmnc.big.ac.",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c5b268986df2b9174000019_10": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.125,
            "text": "dsmnc",
            "probability": 0.336669921875
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 8.125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 0.336669921875
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 8.109375,
            "text": "DSMNC",
            "probability": 0.326171875
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.0224609375,
            "text": "dsm",
            "probability": 3.5822391510009766e-05
        },
        {
            "start_logit": -0.92822265625,
            "end_logit": 8.125,
            "text": "nc",
            "probability": 3.5822391510009766e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.0224609375,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsm",
            "probability": 3.552436828613281e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.09765625,
            "text": "DSM",
            "probability": 3.2842159271240234e-05
        },
        {
            "start_logit": -1.09375,
            "end_logit": 8.125,
            "text": "NC: a database of somatic mutations in normal cells (http://dsmnc",
            "probability": 3.039836883544922e-05
        },
        {
            "start_logit": -1.09375,
            "end_logit": 8.109375,
            "text": "NC",
            "probability": 2.9921531677246094e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -4.38671875,
            "text": "dsmnc.big.ac.cn",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -4.38671875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.6015625,
            "text": "dsmnc.big",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.6015625,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.94921875,
            "text": "DSMNC: a database of somatic mutations in normal cells (http:/",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.19921875,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells from various normal tissues",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3125,
            "text": "dsmnc.big.ac.cn/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.3125,
            "text": "DSMNC: a database of somatic mutations in normal cells (http://dsmnc.big.ac.cn/",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.32421875,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3984375,
            "text": "dsmnc.big.ac.cn/), which provides most comprehensive catalogue of somatic SNVs in single cells",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4296875,
            "text": "dsmnc.big.ac.",
            "probability": 5.960464477539063e-08
        }
    ],
    "5a690487b750ff445500001f_1": [
        {
            "start_logit": 8.0625,
            "end_logit": 6.8046875,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": 8.0625,
            "end_logit": -1.533203125,
            "text": "Epstein-Barr virus (EBV",
            "probability": 0.0002397298812866211
        },
        {
            "start_logit": 8.0625,
            "end_logit": -1.8359375,
            "text": "Epstein",
            "probability": 0.0001767873764038086
        },
        {
            "start_logit": 1.791015625,
            "end_logit": 2.08203125,
            "text": "EBV",
            "probability": 1.6808509826660156e-05
        },
        {
            "start_logit": -3.865234375,
            "end_logit": 6.8046875,
            "text": "virus",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": 8.0625,
            "end_logit": -6.1328125,
            "text": "Epstein-Barr",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 8.0625,
            "end_logit": -6.35546875,
            "text": "Epstein-Barr virus (EBV)",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -6.484375,
            "end_logit": 6.8046875,
            "text": "-Barr virus",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 6.8046875,
            "text": "Barr virus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 1.791015625,
            "end_logit": -4.97265625,
            "text": "EBV infection.",
            "probability": 0.0
        },
        {
            "start_logit": 1.791015625,
            "end_logit": -5.390625,
            "text": "EBV infection",
            "probability": 0.0
        },
        {
            "start_logit": -5.9921875,
            "end_logit": 2.08203125,
            "text": "during EBV",
            "probability": 0.0
        },
        {
            "start_logit": -2.828125,
            "end_logit": -1.533203125,
            "text": "EBV",
            "probability": 0.0
        },
        {
            "start_logit": -3.865234375,
            "end_logit": -1.533203125,
            "text": "virus (EBV",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 2.08203125,
            "text": "detect antired cell antibodies produced as part of a polyclonal antibody response occurring during EBV",
            "probability": 0.0
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 2.08203125,
            "text": ", are red cell or latex agglutination assays, which detect antired cell antibodies produced as part of a polyclonal antibody response occurring during EBV",
            "probability": 0.0
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 2.08203125,
            "text": ", which detect antired cell antibodies produced as part of a polyclonal antibody response occurring during EBV",
            "probability": 0.0
        },
        {
            "start_logit": -2.828125,
            "end_logit": -4.97265625,
            "text": "EBV) is a highly prevalent virus, transmitted via saliva, which often causes asymptomatic infection in children but frequently results in infectious mononucleosis in adolescents.",
            "probability": 0.0
        },
        {
            "start_logit": -6.484375,
            "end_logit": -1.533203125,
            "text": "-Barr virus (EBV",
            "probability": 0.0
        },
        {
            "start_logit": -6.55859375,
            "end_logit": -1.533203125,
            "text": "(EBV",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_2": [
        {
            "start_logit": 7.71875,
            "end_logit": 7.453125,
            "text": "Epstein-Barr virus",
            "probability": 0.5712890625
        },
        {
            "start_logit": 7.71875,
            "end_logit": 6.8515625,
            "text": "Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus",
            "probability": 0.31298828125
        },
        {
            "start_logit": 7.71875,
            "end_logit": 5.16796875,
            "text": "Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 0.058380126953125
        },
        {
            "start_logit": 5.421875,
            "end_logit": 6.8515625,
            "text": "Epstein-Barr virus",
            "probability": 0.031494140625
        },
        {
            "start_logit": 6.6484375,
            "end_logit": 5.16796875,
            "text": "cytomegalovirus",
            "probability": 0.019866943359375
        },
        {
            "start_logit": 5.421875,
            "end_logit": 5.16796875,
            "text": "Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 0.005870819091796875
        },
        {
            "start_logit": 7.71875,
            "end_logit": -2.330078125,
            "text": "Epstein",
            "probability": 3.230571746826172e-05
        },
        {
            "start_logit": -2.37109375,
            "end_logit": 7.453125,
            "text": "virus",
            "probability": 2.3663043975830078e-05
        },
        {
            "start_logit": -2.37109375,
            "end_logit": 6.8515625,
            "text": "virus viral capsid antibody IgM/IgG and Epstein-Barr virus",
            "probability": 1.3053417205810547e-05
        },
        {
            "start_logit": -2.771484375,
            "end_logit": 6.8515625,
            "text": "virus",
            "probability": 8.702278137207031e-06
        },
        {
            "start_logit": 6.6484375,
            "end_logit": -3.658203125,
            "text": "cytomegalovirus (CMV)",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 6.6484375,
            "end_logit": -3.6875,
            "text": "cytomegalovirus (CMV) IgM and IgG were positive, suggesting that her mononucleosis-like syndrome was due to acute CMV infection",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 7.71875,
            "end_logit": -4.90625,
            "text": "Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -2.37109375,
            "end_logit": 5.16796875,
            "text": "virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -4.80078125,
            "end_logit": 7.453125,
            "text": "positive monospot test result. Further investigation showed the Epstein-Barr virus",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -2.771484375,
            "end_logit": 5.16796875,
            "text": "virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 6.6484375,
            "end_logit": -4.31640625,
            "text": "cytomegalovirus (CMV",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -4.80078125,
            "end_logit": 6.8515625,
            "text": "positive monospot test result. Further investigation showed the Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.71875,
            "end_logit": -5.75,
            "text": "Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 5.421875,
            "end_logit": -3.658203125,
            "text": "Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus (CMV)",
            "probability": 8.344650268554688e-07
        }
    ],
    "5a690487b750ff445500001f_3": [
        {
            "start_logit": 7.71875,
            "end_logit": 7.453125,
            "text": "Epstein-Barr virus",
            "probability": 0.5712890625
        },
        {
            "start_logit": 7.71875,
            "end_logit": 6.8515625,
            "text": "Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus",
            "probability": 0.31298828125
        },
        {
            "start_logit": 7.71875,
            "end_logit": 5.16796875,
            "text": "Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 0.058380126953125
        },
        {
            "start_logit": 5.421875,
            "end_logit": 6.8515625,
            "text": "Epstein-Barr virus",
            "probability": 0.031494140625
        },
        {
            "start_logit": 6.6484375,
            "end_logit": 5.16796875,
            "text": "cytomegalovirus",
            "probability": 0.019866943359375
        },
        {
            "start_logit": 5.421875,
            "end_logit": 5.16796875,
            "text": "Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 0.005870819091796875
        },
        {
            "start_logit": 7.71875,
            "end_logit": -2.330078125,
            "text": "Epstein",
            "probability": 3.230571746826172e-05
        },
        {
            "start_logit": -2.37109375,
            "end_logit": 7.453125,
            "text": "virus",
            "probability": 2.3663043975830078e-05
        },
        {
            "start_logit": -2.37109375,
            "end_logit": 6.8515625,
            "text": "virus viral capsid antibody IgM/IgG and Epstein-Barr virus",
            "probability": 1.3053417205810547e-05
        },
        {
            "start_logit": -2.771484375,
            "end_logit": 6.8515625,
            "text": "virus",
            "probability": 8.702278137207031e-06
        },
        {
            "start_logit": 6.6484375,
            "end_logit": -3.658203125,
            "text": "cytomegalovirus (CMV)",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 6.6484375,
            "end_logit": -3.6875,
            "text": "cytomegalovirus (CMV) IgM and IgG were positive, suggesting that her mononucleosis-like syndrome was due to acute CMV infection",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 7.71875,
            "end_logit": -4.90625,
            "text": "Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -2.37109375,
            "end_logit": 5.16796875,
            "text": "virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -4.80078125,
            "end_logit": 7.453125,
            "text": "positive monospot test result. Further investigation showed the Epstein-Barr virus",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -2.771484375,
            "end_logit": 5.16796875,
            "text": "virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 6.6484375,
            "end_logit": -4.31640625,
            "text": "cytomegalovirus (CMV",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -4.80078125,
            "end_logit": 6.8515625,
            "text": "positive monospot test result. Further investigation showed the Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.71875,
            "end_logit": -5.75,
            "text": "Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 5.421875,
            "end_logit": -3.658203125,
            "text": "Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus (CMV)",
            "probability": 8.344650268554688e-07
        }
    ],
    "5a690487b750ff445500001f_4": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.1484375,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": -1.173828125,
            "end_logit": 8.1484375,
            "text": "virus",
            "probability": 8.547306060791016e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.2919921875,
            "text": "Epstein",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -4.32421875,
            "text": "Epstein-Barr virus infection",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -5.99609375,
            "end_logit": 8.1484375,
            "text": "-Barr virus",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.22265625,
            "end_logit": 8.1484375,
            "text": ". The unifying diagnosis was infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 8.1484375,
            "text": "Barr virus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.55859375,
            "text": "Epstein-Barr",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.6953125,
            "text": "Epstein-Barr virus infection.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.0703125,
            "end_logit": 8.1484375,
            "text": "to Epstein-Barr virus",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 8.1484375,
            "text": "infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.1484375,
            "text": "secondary to Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.173828125,
            "end_logit": -4.32421875,
            "text": "virus infection",
            "probability": 0.0
        },
        {
            "start_logit": -6.22265625,
            "end_logit": -1.2919921875,
            "text": ". The unifying diagnosis was infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein",
            "probability": 0.0
        },
        {
            "start_logit": -6.2265625,
            "end_logit": -1.2919921875,
            "text": ". He was taken to theatre for urgent splenectomy. The unifying diagnosis was infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein",
            "probability": 0.0
        },
        {
            "start_logit": -1.173828125,
            "end_logit": -6.6953125,
            "text": "virus infection.",
            "probability": 0.0
        },
        {
            "start_logit": -7.0703125,
            "end_logit": -1.2919921875,
            "text": "to Epstein",
            "probability": 0.0
        },
        {
            "start_logit": -7.44921875,
            "end_logit": -1.2919921875,
            "text": "infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -1.2919921875,
            "text": "secondary to Epstein",
            "probability": 0.0
        },
        {
            "start_logit": -5.890625,
            "end_logit": -4.32421875,
            "text": "infection",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_5": [
        {
            "start_logit": 8.15625,
            "end_logit": 8.015625,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": 8.15625,
            "end_logit": -1.4921875,
            "text": "Epstein",
            "probability": 7.426738739013672e-05
        },
        {
            "start_logit": -1.712890625,
            "end_logit": 8.015625,
            "text": "virus",
            "probability": 5.1856040954589844e-05
        },
        {
            "start_logit": 8.15625,
            "end_logit": -2.986328125,
            "text": "Epstein-Barr virus (EBV",
            "probability": 1.6689300537109375e-05
        },
        {
            "start_logit": 8.15625,
            "end_logit": -5.90625,
            "text": "Epstein-Barr virus (EBV)",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.1640625,
            "end_logit": 8.015625,
            "text": "-Barr virus",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -6.3984375,
            "text": "Epstein-Barr",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 8.015625,
            "text": "Barr virus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.38671875,
            "text": "Epstein-Barr virus (EBV) is almost ubiquitous in humans and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.390625,
            "text": "Epstein-Barr virus (EBV) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 8.015625,
            "text": "Infection with Epstein-Barr virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.712890625,
            "end_logit": -2.986328125,
            "text": "virus (EBV",
            "probability": 0.0
        },
        {
            "start_logit": -2.646484375,
            "end_logit": -2.986328125,
            "text": "EBV",
            "probability": 0.0
        },
        {
            "start_logit": -1.712890625,
            "end_logit": -5.90625,
            "text": "virus (EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -2.646484375,
            "end_logit": -5.90625,
            "text": "EBV)",
            "probability": 0.0
        },
        {
            "start_logit": -7.33984375,
            "end_logit": -1.4921875,
            "text": "Infection with Epstein",
            "probability": 0.0
        },
        {
            "start_logit": -1.712890625,
            "end_logit": -7.38671875,
            "text": "virus (EBV) is almost ubiquitous in humans and",
            "probability": 0.0
        },
        {
            "start_logit": -1.712890625,
            "end_logit": -7.390625,
            "text": "virus (EBV) is",
            "probability": 0.0
        },
        {
            "start_logit": -6.1640625,
            "end_logit": -2.986328125,
            "text": "-Barr virus (EBV",
            "probability": 0.0
        },
        {
            "start_logit": -6.7734375,
            "end_logit": -2.986328125,
            "text": "Barr virus (EBV",
            "probability": 0.0
        }
    ],
    "5a690487b750ff445500001f_6": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.1796875,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": -0.94921875,
            "end_logit": 8.1796875,
            "text": "virus",
            "probability": 0.0001055598258972168
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.310546875,
            "text": "Epstein",
            "probability": 7.545948028564453e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -5.07421875,
            "text": "Epstein-Barr virus viral load (EBV",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -5.45703125,
            "end_logit": 8.1796875,
            "text": "-Barr virus",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.01953125,
            "text": "Epstein-Barr",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.6015625,
            "end_logit": 8.1796875,
            "text": "Barr virus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.16015625,
            "text": "Epstein-Barr virus viral load (EBV-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.3125,
            "text": "Epstein-Barr virus viral",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 8.1796875,
            "text": "real-time PCR (RT-PCR), IgM/IgG antibodies measured with different assays [measurement of Epstein-Barr virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.50390625,
            "text": "Epstein-Barr virus viral load (EBV-VL) in peripheral blood",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.51171875,
            "text": "Epstein-Barr virus viral load",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.1796875,
            "text": "measurement of Epstein-Barr virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 8.1796875,
            "text": "(RT-PCR), IgM/IgG antibodies measured with different assays [measurement of Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.55859375,
            "text": "Epstein-Barr virus viral load (EBV-VL",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 8.1796875,
            "text": "The evaluated diagnostic methods were real-time PCR (RT-PCR), IgM/IgG antibodies measured with different assays [measurement of Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 8.1796875,
            "text": "time PCR (RT-PCR), IgM/IgG antibodies measured with different assays [measurement of Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 8.1796875,
            "text": "of Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.703125,
            "text": "Epstein-Barr virus viral load (EBV-VL) in peripheral",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.73046875,
            "text": "Epstein-Barr virus viral load (EBV-VL) in peripheral blood, neutrophil/lymphocyte",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5a690487b750ff445500001f_7": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.1640625,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": -1.02734375,
            "end_logit": 8.1640625,
            "text": "virus",
            "probability": 9.763240814208984e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.3427734375,
            "text": "Epstein",
            "probability": 7.367134094238281e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -5.04296875,
            "text": "Epstein-Barr virus-related infectious mononucleosis",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -5.953125,
            "end_logit": 8.1640625,
            "text": "-Barr virus",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.078125,
            "text": "Epstein-Barr",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.6171875,
            "end_logit": 8.1640625,
            "text": "Barr virus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 8.1640625,
            "text": ". Epstein-Barr virus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 8.1640625,
            "text": ". The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.80078125,
            "text": "Epstein-Barr virus-related infectious mononucle",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.9609375,
            "text": "Epstein-Barr virus-related infectious mononucleosis was considered the most likely diagnosis for our patient.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.26953125,
            "text": "Epstein-Barr virus-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.359375,
            "text": "Epstein-Barr virus-related infectious mononucleosis was",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 8.1640625,
            "text": "and positive monospot test. The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.1640625,
            "text": ", and positive monospot test. The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.55859375,
            "text": "Epstein-Barr virus-related infectious mononucleosis was considered the most likely diagnosis for our patient",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.1640625,
            "text": "monospot test. The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.625,
            "text": "Epstein-Barr virus-related",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 8.1640625,
            "text": "positive monospot test. The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 8.1640625,
            "text": "smear, and positive monospot test. The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5a690487b750ff445500001f_8": [
        {
            "start_logit": 7.6796875,
            "end_logit": 7.36328125,
            "text": "Epstein-Barr virus",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -0.391845703125,
            "text": "Epstein-Barr virus (EBV",
            "probability": 0.00042700767517089844
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -2.505859375,
            "text": "Epstein",
            "probability": 5.137920379638672e-05
        },
        {
            "start_logit": -2.916015625,
            "end_logit": 7.36328125,
            "text": "virus",
            "probability": 2.485513687133789e-05
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -5.87109375,
            "text": "Epstein-Barr",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -5.9765625,
            "text": "Epstein-Barr virus (EBV)",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -6.4140625,
            "text": "Epstein-Barr virus (EBV) by the Monospot slide test to diagnose acute infectious mononucleosis",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -6.4296875,
            "text": "Epstein-Barr virus (EBV) by",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.25,
            "end_logit": 7.36328125,
            "text": "-Barr virus",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -6.58203125,
            "text": "Epstein-Barr virus (",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -6.890625,
            "text": "Epstein-Barr virus (EBV) by the Monospot slide test to diagnose acute infectious mononucleosis and",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -6.953125,
            "text": "Epstein-Barr virus (EBV) by the Monospot slide test to diagnose acute infectious mononucle",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 7.36328125,
            "text": "against Epstein-Barr virus",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.6796875,
            "end_logit": -7.09375,
            "text": "Epstein-Barr virus (EBV) by the Monospot slide test",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 7.36328125,
            "text": "Barr virus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 7.36328125,
            "text": "both viruses: Hepatitis A (HAV) and Hepatitis B (HBV) were subsequently tested for IGM Heterophil antibodies against Epstein-Barr virus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.25,
            "end_logit": 7.36328125,
            "text": "(HBV) were subsequently tested for IGM Heterophil antibodies against Epstein-Barr virus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 7.36328125,
            "text": "viruses: Hepatitis A (HAV) and Hepatitis B (HBV) were subsequently tested for IGM Heterophil antibodies against Epstein-Barr virus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 7.36328125,
            "text": "HBV) were subsequently tested for IGM Heterophil antibodies against Epstein-Barr virus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.36328125,
            "text": "tested for IGM Heterophil antibodies against Epstein-Barr virus",
            "probability": 2.384185791015625e-07
        }
    ],
    "5a690487b750ff445500001f_9": [
        {
            "start_logit": 8.1875,
            "end_logit": 8.0703125,
            "text": "Epstein-Barr virus",
            "probability": 1.0
        },
        {
            "start_logit": 8.1875,
            "end_logit": -1.416015625,
            "text": "Epstein",
            "probability": 7.665157318115234e-05
        },
        {
            "start_logit": -1.50390625,
            "end_logit": 8.0703125,
            "text": "virus",
            "probability": 6.204843521118164e-05
        },
        {
            "start_logit": -6.03515625,
            "end_logit": 8.0703125,
            "text": "-Barr virus",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.5703125,
            "end_logit": 8.0703125,
            "text": "Barr virus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -6.73828125,
            "text": "Epstein-Barr",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.16015625,
            "text": "Epstein-Barr virus.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 8.0703125,
            "text": "for Epstein-Barr virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 8.0703125,
            "text": ", but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.0703125,
            "text": "positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.0703125,
            "text": "Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 8.0703125,
            "text": "a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 8.0703125,
            "text": "His septic screen was negative, but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 8.0703125,
            "text": "negative, but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 8.0703125,
            "text": "he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 8.0703125,
            "text": "had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 8.0703125,
            "text": "septic screen was negative, but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 8.0703125,
            "text": "pot test and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.828125,
            "end_logit": 8.0703125,
            "text": "and immunoglobulin G for Epstein-Barr virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.50390625,
            "end_logit": -7.16015625,
            "text": "virus.",
            "probability": 0.0
        }
    ],
    "5c89623bf9c2ba6b28000004_1": [
        {
            "start_logit": -1.990234375,
            "end_logit": -1.6396484375,
            "text": "a novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.71484375
        },
        {
            "start_logit": -3.888671875,
            "end_logit": -1.6396484375,
            "text": "(c.19G>A, p.Val7Met",
            "probability": 0.10711669921875
        },
        {
            "start_logit": -1.990234375,
            "end_logit": -4.96875,
            "text": "a novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7",
            "probability": 0.0255279541015625
        },
        {
            "start_logit": -5.43359375,
            "end_logit": -1.6396484375,
            "text": "Val7Met",
            "probability": 0.0228118896484375
        },
        {
            "start_logit": -1.990234375,
            "end_logit": -5.3828125,
            "text": "a novel homozygous missense mutation in exon 2",
            "probability": 0.016876220703125
        },
        {
            "start_logit": -5.859375,
            "end_logit": -1.6396484375,
            "text": "c.19G>A, p.Val7Met",
            "probability": 0.014892578125
        },
        {
            "start_logit": -6.015625,
            "end_logit": -1.6396484375,
            "text": "novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.0127410888671875
        },
        {
            "start_logit": -1.990234375,
            "end_logit": -5.72265625,
            "text": "a novel homozygous missense mutation",
            "probability": 0.0120697021484375
        },
        {
            "start_logit": -1.990234375,
            "end_logit": -5.96875,
            "text": "a novel homozygous missense mutation in exon 2 (c.19",
            "probability": 0.00939178466796875
        },
        {
            "start_logit": -1.990234375,
            "end_logit": -6.2265625,
            "text": "a novel homozygous missense",
            "probability": 0.00726318359375
        },
        {
            "start_logit": -1.990234375,
            "end_logit": -6.26171875,
            "text": "a novel homozygous missense mutation in exon 2 (c.19G>A",
            "probability": 0.007038116455078125
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -1.6396484375,
            "text": "missense mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.006984710693359375
        },
        {
            "start_logit": -6.73046875,
            "end_logit": -1.6396484375,
            "text": "p.Val7Met",
            "probability": 0.006256103515625
        },
        {
            "start_logit": -1.990234375,
            "end_logit": -6.44140625,
            "text": "a novel homozygous missense mutation in exon 2 (c",
            "probability": 0.00588226318359375
        },
        {
            "start_logit": -6.8125,
            "end_logit": -1.6396484375,
            "text": "mutation in exon 2 (c.19G>A, p.Val7Met",
            "probability": 0.00574493408203125
        },
        {
            "start_logit": -6.83984375,
            "end_logit": -1.6396484375,
            "text": ", p.Val7Met",
            "probability": 0.00560760498046875
        },
        {
            "start_logit": -1.990234375,
            "end_logit": -6.5703125,
            "text": "a novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7Met)",
            "probability": 0.00514984130859375
        },
        {
            "start_logit": -1.990234375,
            "end_logit": -6.578125,
            "text": "a novel homozygous missense mutation in exon 2 (c.19G",
            "probability": 0.005107879638671875
        },
        {
            "start_logit": -1.990234375,
            "end_logit": -6.73828125,
            "text": "a novel homozygous missense mutation in exon 2 (c.",
            "probability": 0.00437164306640625
        },
        {
            "start_logit": -1.990234375,
            "end_logit": -6.80859375,
            "text": "a novel homozygous missense mutation in exon 2 (c.19G>A, p.Val7Met) of CFL2",
            "probability": 0.0040740966796875
        }
    ],
    "56c85ed65795f9a73e000012_1": [
        {
            "start_logit": -3.70703125,
            "end_logit": -3.59765625,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell responses.",
            "probability": 0.2587890625
        },
        {
            "start_logit": -3.771484375,
            "end_logit": -3.59765625,
            "text": ".",
            "probability": 0.2431640625
        },
        {
            "start_logit": -3.70703125,
            "end_logit": -3.71875,
            "text": "inhibits",
            "probability": 0.229248046875
        },
        {
            "start_logit": -5.9453125,
            "end_logit": -3.59765625,
            "text": "show that dasatinib inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell responses.",
            "probability": 0.027496337890625
        },
        {
            "start_logit": -5.94921875,
            "end_logit": -3.59765625,
            "text": "dasatinib inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell responses.",
            "probability": 0.027496337890625
        },
        {
            "start_logit": -5.9921875,
            "end_logit": -3.59765625,
            "text": "Herein, we show that dasatinib inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell responses.",
            "probability": 0.0262451171875
        },
        {
            "start_logit": -5.9453125,
            "end_logit": -3.71875,
            "text": "show that dasatinib inhibits",
            "probability": 0.0244598388671875
        },
        {
            "start_logit": -5.94921875,
            "end_logit": -3.71875,
            "text": "dasatinib inhibits",
            "probability": 0.024261474609375
        },
        {
            "start_logit": -5.9921875,
            "end_logit": -3.71875,
            "text": "Herein, we show that dasatinib inhibits",
            "probability": 0.0233306884765625
        },
        {
            "start_logit": -6.171875,
            "end_logit": -3.59765625,
            "text": ", we show that dasatinib inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell responses.",
            "probability": 0.0220794677734375
        },
        {
            "start_logit": -6.171875,
            "end_logit": -3.71875,
            "text": ", we show that dasatinib inhibits",
            "probability": 0.019500732421875
        },
        {
            "start_logit": -6.953125,
            "end_logit": -3.59765625,
            "text": "we show that dasatinib inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell responses.",
            "probability": 0.0101165771484375
        },
        {
            "start_logit": -6.953125,
            "end_logit": -3.59765625,
            "text": "that dasatinib inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell responses.",
            "probability": 0.0101165771484375
        },
        {
            "start_logit": -6.953125,
            "end_logit": -3.71875,
            "text": "we show that dasatinib inhibits",
            "probability": 0.0089263916015625
        },
        {
            "start_logit": -6.953125,
            "end_logit": -3.71875,
            "text": "that dasatinib inhibits",
            "probability": 0.0089263916015625
        },
        {
            "start_logit": -3.70703125,
            "end_logit": -7.08203125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and",
            "probability": 0.00794219970703125
        },
        {
            "start_logit": -3.70703125,
            "end_logit": -7.1484375,
            "text": "inhibits TCR-",
            "probability": 0.0074005126953125
        },
        {
            "start_logit": -3.70703125,
            "end_logit": -7.2109375,
            "text": "inhibits TCR-mediated signal transduction",
            "probability": 0.00695037841796875
        },
        {
            "start_logit": -3.70703125,
            "end_logit": -7.2421875,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production",
            "probability": 0.00673675537109375
        },
        {
            "start_logit": -3.70703125,
            "end_logit": -7.28125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation",
            "probability": 0.006534576416015625
        }
    ],
    "56c85ed65795f9a73e000012_2": [
        {
            "start_logit": -4.125,
            "end_logit": -2.796875,
            "text": "inhibits",
            "probability": 0.60107421875
        },
        {
            "start_logit": -6.28515625,
            "end_logit": -2.796875,
            "text": "show that dasatinib inhibits",
            "probability": 0.06964111328125
        },
        {
            "start_logit": -6.33203125,
            "end_logit": -2.796875,
            "text": ", we show that dasatinib inhibits",
            "probability": 0.06640625
        },
        {
            "start_logit": -6.3984375,
            "end_logit": -2.796875,
            "text": "Herein, we show that dasatinib inhibits",
            "probability": 0.061920166015625
        },
        {
            "start_logit": -6.56640625,
            "end_logit": -2.796875,
            "text": "dasatinib inhibits",
            "probability": 0.05255126953125
        },
        {
            "start_logit": -6.984375,
            "end_logit": -2.796875,
            "text": "that dasatinib inhibits",
            "probability": 0.034454345703125
        },
        {
            "start_logit": -7.171875,
            "end_logit": -2.796875,
            "text": "we show that dasatinib inhibits",
            "probability": 0.028564453125
        },
        {
            "start_logit": -4.125,
            "end_logit": -7.15625,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production",
            "probability": 0.0076904296875
        },
        {
            "start_logit": -4.125,
            "end_logit": -7.17578125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and",
            "probability": 0.007568359375
        },
        {
            "start_logit": -4.125,
            "end_logit": -7.23828125,
            "text": "inhibits TCR-mediated signal transduction",
            "probability": 0.007110595703125
        },
        {
            "start_logit": -4.125,
            "end_logit": -7.265625,
            "text": "inhibits TCR-",
            "probability": 0.00688934326171875
        },
        {
            "start_logit": -4.125,
            "end_logit": -7.29296875,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in",
            "probability": 0.006679534912109375
        },
        {
            "start_logit": -4.125,
            "end_logit": -7.3125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo",
            "probability": 0.006580352783203125
        },
        {
            "start_logit": -4.125,
            "end_logit": -7.34375,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine",
            "probability": 0.00637054443359375
        },
        {
            "start_logit": -4.125,
            "end_logit": -7.34375,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation",
            "probability": 0.00637054443359375
        },
        {
            "start_logit": -4.125,
            "end_logit": -7.3671875,
            "text": "inhibits TCR-mediated",
            "probability": 0.0062255859375
        },
        {
            "start_logit": -4.125,
            "end_logit": -7.3671875,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell responses",
            "probability": 0.0062255859375
        },
        {
            "start_logit": -4.125,
            "end_logit": -7.421875,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production, and in vivo T-cell",
            "probability": 0.005893707275390625
        },
        {
            "start_logit": -4.125,
            "end_logit": -7.42578125,
            "text": "inhibits TCR",
            "probability": 0.005893707275390625
        },
        {
            "start_logit": -4.125,
            "end_logit": -7.42578125,
            "text": "inhibits TCR-mediated signal transduction, cellular proliferation, cytokine production,",
            "probability": 0.005893707275390625
        }
    ],
    "56c85ed65795f9a73e000012_3": [
        {
            "start_logit": -5.06640625,
            "end_logit": -5.59375,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor",
            "probability": 0.1959228515625
        },
        {
            "start_logit": -5.06640625,
            "end_logit": -6.2265625,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase",
            "probability": 0.10321044921875
        },
        {
            "start_logit": -5.06640625,
            "end_logit": -6.35546875,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits",
            "probability": 0.09112548828125
        },
        {
            "start_logit": -6.1171875,
            "end_logit": -5.59375,
            "text": "protein tyrosine kinase inhibitor",
            "probability": 0.0682373046875
        },
        {
            "start_logit": -5.06640625,
            "end_logit": -6.72265625,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation",
            "probability": 0.06304931640625
        },
        {
            "start_logit": -6.25390625,
            "end_logit": -5.59375,
            "text": "small-molecule protein tyrosine kinase inhibitor",
            "probability": 0.059722900390625
        },
        {
            "start_logit": -5.06640625,
            "end_logit": -6.8828125,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and",
            "probability": 0.053558349609375
        },
        {
            "start_logit": -6.1171875,
            "end_logit": -6.2265625,
            "text": "protein tyrosine kinase",
            "probability": 0.036224365234375
        },
        {
            "start_logit": -6.828125,
            "end_logit": -5.59375,
            "text": "molecule protein tyrosine kinase inhibitor",
            "probability": 0.03350830078125
        },
        {
            "start_logit": -5.06640625,
            "end_logit": -7.37890625,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell",
            "probability": 0.032745361328125
        },
        {
            "start_logit": -6.1171875,
            "end_logit": -6.35546875,
            "text": "protein tyrosine kinase inhibitor, inhibits",
            "probability": 0.031982421875
        },
        {
            "start_logit": -6.25390625,
            "end_logit": -6.2265625,
            "text": "small-molecule protein tyrosine kinase",
            "probability": 0.031494140625
        },
        {
            "start_logit": -5.06640625,
            "end_logit": -7.4609375,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor,",
            "probability": 0.030029296875
        },
        {
            "start_logit": -5.06640625,
            "end_logit": -7.515625,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-",
            "probability": 0.0286712646484375
        },
        {
            "start_logit": -6.25390625,
            "end_logit": -6.35546875,
            "text": "small-molecule protein tyrosine kinase inhibitor, inhibits",
            "probability": 0.0277862548828125
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -5.59375,
            "text": "tyrosine kinase inhibitor",
            "probability": 0.0277862548828125
        },
        {
            "start_logit": -5.06640625,
            "end_logit": -7.63671875,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T",
            "probability": 0.025299072265625
        },
        {
            "start_logit": -6.1171875,
            "end_logit": -6.72265625,
            "text": "protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation",
            "probability": 0.02197265625
        },
        {
            "start_logit": -6.25390625,
            "end_logit": -6.72265625,
            "text": "small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation",
            "probability": 0.0192413330078125
        },
        {
            "start_logit": -6.1171875,
            "end_logit": -6.8828125,
            "text": "protein tyrosine kinase inhibitor, inhibits T-cell activation and",
            "probability": 0.018798828125
        }
    ],
    "56c85ed65795f9a73e000012_4": [
        {
            "start_logit": -0.05157470703125,
            "end_logit": -0.818359375,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.",
            "probability": 0.94970703125
        },
        {
            "start_logit": -0.05157470703125,
            "end_logit": -5.484375,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor",
            "probability": 0.0089569091796875
        },
        {
            "start_logit": -4.78515625,
            "end_logit": -0.818359375,
            "text": "inhibits T-cell activation and proliferation.",
            "probability": 0.0083770751953125
        },
        {
            "start_logit": -4.83203125,
            "end_logit": -0.818359375,
            "text": ".",
            "probability": 0.00799560546875
        },
        {
            "start_logit": -0.05157470703125,
            "end_logit": -6.07421875,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase",
            "probability": 0.004962921142578125
        },
        {
            "start_logit": -5.98046875,
            "end_logit": -0.818359375,
            "text": "small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.",
            "probability": 0.002536773681640625
        },
        {
            "start_logit": -0.05157470703125,
            "end_logit": -6.83203125,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and",
            "probability": 0.00232696533203125
        },
        {
            "start_logit": -6.10546875,
            "end_logit": -0.818359375,
            "text": "protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.",
            "probability": 0.0022373199462890625
        },
        {
            "start_logit": -0.05157470703125,
            "end_logit": -6.91015625,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits",
            "probability": 0.0021514892578125
        },
        {
            "start_logit": -0.05157470703125,
            "end_logit": -7.109375,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation",
            "probability": 0.0017633438110351562
        },
        {
            "start_logit": -0.05157470703125,
            "end_logit": -7.453125,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor,",
            "probability": 0.0012502670288085938
        },
        {
            "start_logit": -0.05157470703125,
            "end_logit": -7.46484375,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell",
            "probability": 0.0012359619140625
        },
        {
            "start_logit": -0.05157470703125,
            "end_logit": -7.5390625,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-",
            "probability": 0.001148223876953125
        },
        {
            "start_logit": -6.86328125,
            "end_logit": -0.818359375,
            "text": "molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.",
            "probability": 0.001049041748046875
        },
        {
            "start_logit": -0.05157470703125,
            "end_logit": -7.765625,
            "text": "Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation",
            "probability": 0.0009150505065917969
        },
        {
            "start_logit": -7.03125,
            "end_logit": -0.818359375,
            "text": "tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.",
            "probability": 0.0008831024169921875
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -0.818359375,
            "text": "inhibitor, inhibits T-cell activation and proliferation.",
            "probability": 0.000720977783203125
        },
        {
            "start_logit": -7.34765625,
            "end_logit": -0.818359375,
            "text": "atinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.",
            "probability": 0.0006465911865234375
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -0.818359375,
            "text": "a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.",
            "probability": 0.0005745887756347656
        },
        {
            "start_logit": -7.5546875,
            "end_logit": -0.818359375,
            "text": ", a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation.",
            "probability": 0.0005230903625488281
        }
    ],
    "56c85ed65795f9a73e000012_5": [
        {
            "start_logit": 1.91796875,
            "end_logit": 0.89599609375,
            "text": "inhibits the proliferation and function of CD4+CD25+ regulatory T cells.",
            "probability": 0.7177734375
        },
        {
            "start_logit": 0.59814453125,
            "end_logit": 0.89599609375,
            "text": "Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells.",
            "probability": 0.191650390625
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -1.5361328125,
            "text": "inhibits",
            "probability": 0.06292724609375
        },
        {
            "start_logit": 0.59814453125,
            "end_logit": -1.5361328125,
            "text": "Dasatinib inhibits",
            "probability": 0.016845703125
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -4.5,
            "text": "inhibits the proliferation and function of CD4+CD25+ regulatory T cells",
            "probability": 0.003246307373046875
        },
        {
            "start_logit": -3.748046875,
            "end_logit": 0.89599609375,
            "text": ".",
            "probability": 0.0024890899658203125
        },
        {
            "start_logit": 0.59814453125,
            "end_logit": -4.5,
            "text": "Dasatinib inhibits the proliferation and function of CD4+CD25+ regulatory T cells",
            "probability": 0.0008668899536132812
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -5.921875,
            "text": "inhibits the proliferation and function of CD4+CD25",
            "probability": 0.0007829666137695312
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -6.3671875,
            "text": "inhibits the",
            "probability": 0.0005016326904296875
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -6.54296875,
            "text": "inhibits the proliferation and function of CD4",
            "probability": 0.00042247772216796875
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -6.5859375,
            "text": "inhibits the proliferation and",
            "probability": 0.0004031658172607422
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -6.6328125,
            "text": "inhibits the proliferation",
            "probability": 0.0003845691680908203
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -6.828125,
            "text": "inhibits the proliferation and function of",
            "probability": 0.000316619873046875
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -7.0,
            "text": "inhibits the proliferation and function of CD4+CD25+",
            "probability": 0.0002663135528564453
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -7.109375,
            "text": "inhibits the proliferation and function of CD4+CD25+ regulatory T",
            "probability": 0.00023889541625976562
        },
        {
            "start_logit": 0.59814453125,
            "end_logit": -5.921875,
            "text": "Dasatinib inhibits the proliferation and function of CD4+CD25",
            "probability": 0.0002090930938720703
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -7.2734375,
            "text": "inhibits the proliferation and function of CD4+CD25+ regulatory",
            "probability": 0.0002027750015258789
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -7.3515625,
            "text": "inhibits the proliferation and function of CD4+",
            "probability": 0.0001875162124633789
        },
        {
            "start_logit": 1.91796875,
            "end_logit": -7.40234375,
            "text": "inhibits the proliferation and function",
            "probability": 0.00017893314361572266
        },
        {
            "start_logit": 0.59814453125,
            "end_logit": -6.3671875,
            "text": "Dasatinib inhibits the",
            "probability": 0.00013399124145507812
        }
    ],
    "58f4b25e70f9fc6f0f000011_1": [
        {
            "start_logit": 6.34375,
            "end_logit": 6.5625,
            "text": "Liver",
            "probability": 1.0
        },
        {
            "start_logit": -1.380859375,
            "end_logit": 6.5625,
            "text": "transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 0.0004410743713378906
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.12890625,
            "text": "Liver Injury",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 6.5625,
            "text": "10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.34765625,
            "text": "Liver Injury Network",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 6.5625,
            "text": "higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 6.5625,
            "text": "need for transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 6.5625,
            "text": "for transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 6.5625,
            "text": ", including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 6.5625,
            "text": "prospective U.S. Drug-Induced Liver",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 6.5625,
            "text": "of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -1.380859375,
            "end_logit": -2.779296875,
            "text": "transplant",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.380859375,
            "end_logit": -6.94921875,
            "text": "transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S",
            "probability": 0.0
        },
        {
            "start_logit": -1.380859375,
            "end_logit": -7.08984375,
            "text": "transplant of 10%",
            "probability": 0.0
        },
        {
            "start_logit": -1.380859375,
            "end_logit": -7.12890625,
            "text": "transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-Induced Liver Injury",
            "probability": 0.0
        },
        {
            "start_logit": -1.380859375,
            "end_logit": -7.19921875,
            "text": "transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U",
            "probability": 0.0
        },
        {
            "start_logit": -1.380859375,
            "end_logit": -7.21875,
            "text": "transplant of 10% or higher",
            "probability": 0.0
        },
        {
            "start_logit": -1.380859375,
            "end_logit": -7.24609375,
            "text": "transplant of",
            "probability": 0.0
        },
        {
            "start_logit": -1.380859375,
            "end_logit": -7.29296875,
            "text": "transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.S. Drug-",
            "probability": 0.0
        },
        {
            "start_logit": -1.380859375,
            "end_logit": -7.296875,
            "text": "transplant of 10% or higher has been validated in several large national registries, including the ongoing, prospective U.",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_2": [
        {
            "start_logit": 6.31640625,
            "end_logit": 6.69140625,
            "text": "liver",
            "probability": 1.0
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.01171875,
            "text": "liver injury",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.3046875,
            "text": "liver injury patterns were found to affect potential severity as",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 6.69140625,
            "text": "with liver",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 6.69140625,
            "text": "No additional alleles outside those associated with liver",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 6.69140625,
            "text": "associated with liver",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 6.69140625,
            "text": "additional alleles outside those associated with liver",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.51953125,
            "text": "liver injury patterns",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 6.69140625,
            "text": "those associated with liver",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.578125,
            "text": "liver injury patterns were found to affect potential severity as measured by Hy's",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 6.69140625,
            "text": "alleles outside those associated with liver",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.59375,
            "text": "liver injury patterns were found to affect potential severity as measured by Hy'",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": -7.01171875,
            "text": "with liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -7.01171875,
            "text": "No additional alleles outside those associated with liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.80078125,
            "end_logit": -7.01171875,
            "text": "associated with liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.83984375,
            "end_logit": -7.01171875,
            "text": "additional alleles outside those associated with liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.9453125,
            "end_logit": -7.01171875,
            "text": "those associated with liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -7.01171875,
            "text": "alleles outside those associated with liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.75390625,
            "end_logit": -7.3046875,
            "text": "with liver injury patterns were found to affect potential severity as",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -7.3046875,
            "text": "No additional alleles outside those associated with liver injury patterns were found to affect potential severity as",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_3": [
        {
            "start_logit": 6.3671875,
            "end_logit": 6.546875,
            "text": "liver",
            "probability": 0.3359375
        },
        {
            "start_logit": 6.37109375,
            "end_logit": 6.53125,
            "text": "liver",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.3671875,
            "end_logit": 6.53125,
            "text": "liver aminotransferase levels above the upper limit of normal, and no pre-existing liver",
            "probability": 0.330810546875
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 6.546875,
            "text": ".We conducted a retrospective cohort study of 15,353 Kaiser Permanente Northern California members diagnosed with DILI from 2004 through 2010, liver",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.8359375,
            "text": "liver disease",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -6.8359375,
            "text": "liver aminotransferase levels above the upper limit of normal, and no pre-existing liver disease",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.10546875,
            "text": "liver aminotransferase",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.1328125,
            "text": "liver disease.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.1328125,
            "text": "liver aminotransferase levels above the upper limit of normal, and no pre-existing liver disease.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.22265625,
            "text": "liver aminotransferase levels above the upper limit of",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.546875,
            "text": ", liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.53125,
            "text": ", liver aminotransferase levels above the upper limit of normal, and no pre-existing liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 6.53125,
            "text": "existing liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 6.53125,
            "text": ", and no pre-existing liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 6.546875,
            "text": ",353 Kaiser Permanente Northern California members diagnosed with DILI from 2004 through 2010, liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -7.0625,
            "text": ".We conducted a retrospective cohort study of 15",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -7.10546875,
            "text": ".We conducted a retrospective cohort study of 15,353 Kaiser Permanente Northern California members diagnosed with DILI from 2004 through 2010, liver aminotransferase",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -7.1328125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -7.1328125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -7.203125,
            "text": ".We conducted a retrospective cohort study of 15,353 Kaiser Permanente Northern California members diagnosed with DILI",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_4": [
        {
            "start_logit": 6.3671875,
            "end_logit": 6.546875,
            "text": "liver",
            "probability": 0.3359375
        },
        {
            "start_logit": 6.37109375,
            "end_logit": 6.53125,
            "text": "liver",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.3671875,
            "end_logit": 6.53125,
            "text": "liver aminotransferase levels above the upper limit of normal, and no pre-existing liver",
            "probability": 0.330810546875
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 6.546875,
            "text": ".We conducted a retrospective cohort study of 15,353 Kaiser Permanente Northern California members diagnosed with DILI from 2004 through 2010, liver",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.8359375,
            "text": "liver disease",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -6.8359375,
            "text": "liver aminotransferase levels above the upper limit of normal, and no pre-existing liver disease",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.10546875,
            "text": "liver aminotransferase",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.1328125,
            "text": "liver disease.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.1328125,
            "text": "liver aminotransferase levels above the upper limit of normal, and no pre-existing liver disease.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.22265625,
            "text": "liver aminotransferase levels above the upper limit of",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.546875,
            "text": ", liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.53125,
            "text": ", liver aminotransferase levels above the upper limit of normal, and no pre-existing liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 6.53125,
            "text": "existing liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 6.53125,
            "text": ", and no pre-existing liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 6.546875,
            "text": ",353 Kaiser Permanente Northern California members diagnosed with DILI from 2004 through 2010, liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -7.0625,
            "text": ".We conducted a retrospective cohort study of 15",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -7.10546875,
            "text": ".We conducted a retrospective cohort study of 15,353 Kaiser Permanente Northern California members diagnosed with DILI from 2004 through 2010, liver aminotransferase",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -7.1328125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -7.1328125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.62109375,
            "end_logit": -7.203125,
            "text": ".We conducted a retrospective cohort study of 15,353 Kaiser Permanente Northern California members diagnosed with DILI",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_5": [
        {
            "start_logit": 6.328125,
            "end_logit": 6.6171875,
            "text": "Liver",
            "probability": 0.33837890625
        },
        {
            "start_logit": 6.328125,
            "end_logit": 6.59375,
            "text": "Liver",
            "probability": 0.33056640625
        },
        {
            "start_logit": 6.328125,
            "end_logit": 6.59375,
            "text": "Liver Failure in Patients With Drug-Induced Liver",
            "probability": 0.33056640625
        },
        {
            "start_logit": 6.328125,
            "end_logit": -6.6875,
            "text": "Liver Failure",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.34375,
            "text": "Liver Injury",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.34375,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 6.6171875,
            "text": "Acute Liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 6.59375,
            "text": "Acute Liver Failure in Patients With Drug-Induced Liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 6.6171875,
            "text": "Risk of Acute Liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.5390625,
            "text": "Liver Failure in Patients With Drug-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 6.59375,
            "text": "Risk of Acute Liver Failure in Patients With Drug-Induced Liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.546875,
            "text": "Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.546875,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.56640625,
            "text": "Liver Injury: Evaluation of Hy'",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.56640625,
            "text": "Liver Injury: Evaluation of Hy's",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.56640625,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy'",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.56640625,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.59375,
            "text": "Liver Failure in Patients With Drug",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 6.59375,
            "text": "Induced Liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.640625,
            "text": "Liver Failure in",
            "probability": 2.384185791015625e-07
        }
    ],
    "58f4b25e70f9fc6f0f000011_6": [
        {
            "start_logit": 6.328125,
            "end_logit": 6.6171875,
            "text": "Liver",
            "probability": 0.33837890625
        },
        {
            "start_logit": 6.328125,
            "end_logit": 6.59375,
            "text": "Liver",
            "probability": 0.33056640625
        },
        {
            "start_logit": 6.328125,
            "end_logit": 6.59375,
            "text": "Liver Failure in Patients With Drug-Induced Liver",
            "probability": 0.33056640625
        },
        {
            "start_logit": 6.328125,
            "end_logit": -6.6875,
            "text": "Liver Failure",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.34375,
            "text": "Liver Injury",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.34375,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 6.6171875,
            "text": "Acute Liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 6.59375,
            "text": "Acute Liver Failure in Patients With Drug-Induced Liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 6.6171875,
            "text": "Risk of Acute Liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.5390625,
            "text": "Liver Failure in Patients With Drug-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 6.59375,
            "text": "Risk of Acute Liver Failure in Patients With Drug-Induced Liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.546875,
            "text": "Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.546875,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.56640625,
            "text": "Liver Injury: Evaluation of Hy'",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.56640625,
            "text": "Liver Injury: Evaluation of Hy's",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.56640625,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy'",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.56640625,
            "text": "Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.59375,
            "text": "Liver Failure in Patients With Drug",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 6.59375,
            "text": "Induced Liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.640625,
            "text": "Liver Failure in",
            "probability": 2.384185791015625e-07
        }
    ],
    "58f4b25e70f9fc6f0f000011_7": [
        {
            "start_logit": 6.34375,
            "end_logit": 6.5703125,
            "text": "liver",
            "probability": 0.337646484375
        },
        {
            "start_logit": 6.31640625,
            "end_logit": 6.58203125,
            "text": "liver",
            "probability": 0.33251953125
        },
        {
            "start_logit": 6.31640625,
            "end_logit": 6.5703125,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver",
            "probability": 0.330078125
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.0859375,
            "text": "liver failure",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.0859375,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.16015625,
            "text": "liver failure (ALF",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.16015625,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure (ALF",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 6.58203125,
            "text": "states that hepatocellular drug-induced liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.35546875,
            "text": "liver injury",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 6.5703125,
            "text": "states that hepatocellular drug-induced liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 6.5703125,
            "text": "acute liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.4140625,
            "text": "liver failure (ALF).",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.4140625,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure (ALF).",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.4609375,
            "text": "liver failure (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.4609375,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.48046875,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.48828125,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 6.58203125,
            "text": "which states that hepatocellular drug-induced liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 6.5703125,
            "text": "which states that hepatocellular drug-induced liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 6.58203125,
            "text": "Hy's Law, which states that hepatocellular drug-induced liver",
            "probability": 2.384185791015625e-07
        }
    ],
    "58f4b25e70f9fc6f0f000011_8": [
        {
            "start_logit": 6.34375,
            "end_logit": 6.5703125,
            "text": "liver",
            "probability": 0.337646484375
        },
        {
            "start_logit": 6.31640625,
            "end_logit": 6.58203125,
            "text": "liver",
            "probability": 0.33251953125
        },
        {
            "start_logit": 6.31640625,
            "end_logit": 6.5703125,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver",
            "probability": 0.330078125
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.0859375,
            "text": "liver failure",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.0859375,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.16015625,
            "text": "liver failure (ALF",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.16015625,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure (ALF",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 6.58203125,
            "text": "states that hepatocellular drug-induced liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.35546875,
            "text": "liver injury",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 6.5703125,
            "text": "states that hepatocellular drug-induced liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 6.5703125,
            "text": "acute liver",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.4140625,
            "text": "liver failure (ALF).",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.4140625,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure (ALF).",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.4609375,
            "text": "liver failure (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.4609375,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver failure (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.48046875,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.48828125,
            "text": "liver injury (DILI) with jaundice indicates a serious reaction, is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 6.58203125,
            "text": "which states that hepatocellular drug-induced liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 6.5703125,
            "text": "which states that hepatocellular drug-induced liver injury (DILI) with jaundice indicates a serious reaction, is used widely to determine risk for acute liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 6.58203125,
            "text": "Hy's Law, which states that hepatocellular drug-induced liver",
            "probability": 2.384185791015625e-07
        }
    ],
    "58f4b25e70f9fc6f0f000011_9": [
        {
            "start_logit": 6.34375,
            "end_logit": 6.6484375,
            "text": "liver",
            "probability": 1.0
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.09765625,
            "text": "liver injury",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 6.6484375,
            "text": "Hy's law is a method used to identify drug-induced liver",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 6.6484375,
            "text": "drug-induced liver",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 6.6484375,
            "text": "identify drug-induced liver",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.6484375,
            "text": "method used to identify drug-induced liver",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.609375,
            "text": "liver injury (DILI)",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 6.6484375,
            "text": "to identify drug-induced liver",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 6.6484375,
            "text": "used to identify drug-induced liver",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.0390625,
            "end_logit": 6.6484375,
            "text": "induced liver",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.078125,
            "end_logit": 6.6484375,
            "text": "'s law is a method used to identify drug-induced liver",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": -7.09765625,
            "text": "Hy's law is a method used to identify drug-induced liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.890625,
            "end_logit": -7.09765625,
            "text": "drug-induced liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.8984375,
            "end_logit": -7.09765625,
            "text": "identify drug-induced liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -7.09765625,
            "text": "method used to identify drug-induced liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": -7.09765625,
            "text": "to identify drug-induced liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -7.09765625,
            "text": "used to identify drug-induced liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -7.78515625,
            "end_logit": -7.35546875,
            "text": "Hy's law is a method used to identify drug-",
            "probability": 0.0
        },
        {
            "start_logit": -8.0390625,
            "end_logit": -7.09765625,
            "text": "induced liver injury",
            "probability": 0.0
        },
        {
            "start_logit": -8.078125,
            "end_logit": -7.09765625,
            "text": "'s law is a method used to identify drug-induced liver injury",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_10": [
        {
            "start_logit": 6.37890625,
            "end_logit": 6.640625,
            "text": "liver",
            "probability": 1.0
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.234375,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN) and total bilirubin",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.3671875,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN) and total bilirubin>2 \u00d7 ULN, and",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.37890625,
            "text": "liver injury",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.45703125,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.48046875,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN) and total bilirubin>",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.484375,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal (ULN) and total bilirubin>2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.5078125,
            "text": "liver injury is identified in clinical trials by ALT>3 \u00d7 upper limits of normal",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.515625,
            "text": "liver injury is",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 6.640625,
            "text": "severe liver",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 6.640625,
            "text": "Potential severe liver",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": -7.00390625,
            "text": ", and termed 'Hy's Law' by the US FDA",
            "probability": 0.0
        },
        {
            "start_logit": -7.80859375,
            "end_logit": -7.00390625,
            "text": "'Hy's Law' by the US FDA",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": -7.00390625,
            "text": ") and total bilirubin>2 \u00d7 ULN, and termed 'Hy's Law' by the US FDA",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -7.3203125,
            "text": ", and termed 'Hy'",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -7.34765625,
            "text": ", and termed 'Hy's Law",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -7.35546875,
            "text": ", and termed 'Hy's",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -7.3671875,
            "text": ", and",
            "probability": 0.0
        },
        {
            "start_logit": -7.9921875,
            "end_logit": -7.00390625,
            "text": "(ULN) and total bilirubin>2 \u00d7 ULN, and termed 'Hy's Law' by the US FDA",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -7.00390625,
            "text": "the US FDA",
            "probability": 0.0
        }
    ],
    "58f4b25e70f9fc6f0f000011_11": [
        {
            "start_logit": 6.3515625,
            "end_logit": 6.63671875,
            "text": "liver",
            "probability": 0.3359375
        },
        {
            "start_logit": 6.32421875,
            "end_logit": 6.65625,
            "text": "liver",
            "probability": 0.3359375
        },
        {
            "start_logit": 6.32421875,
            "end_logit": 6.63671875,
            "text": "liver injury is identified by the liver",
            "probability": 0.328369140625
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.19140625,
            "text": "liver chemistry threshold of alanine aminotransferase",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.19140625,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.24609375,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.24609375,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.2890625,
            "text": "liver injury",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.36328125,
            "text": "liver chemistry",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.36328125,
            "text": "liver injury is identified by the liver chemistry",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.39453125,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN) and bilirubin>2\u00d7 UL",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.3984375,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN) and bilirubin>2",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.40234375,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.40625,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN) and bilirubin>2\u00d7 ULN",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.40625,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)>",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 6.65625,
            "text": "Severe liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.421875,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.42578125,
            "text": "liver chemistry threshold of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.3984375,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN) and bilirubin>2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.40234375,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal",
            "probability": 2.384185791015625e-07
        }
    ],
    "58f4b25e70f9fc6f0f000011_12": [
        {
            "start_logit": 6.3515625,
            "end_logit": 6.63671875,
            "text": "liver",
            "probability": 0.3359375
        },
        {
            "start_logit": 6.32421875,
            "end_logit": 6.65625,
            "text": "liver",
            "probability": 0.3359375
        },
        {
            "start_logit": 6.32421875,
            "end_logit": 6.63671875,
            "text": "liver injury is identified by the liver",
            "probability": 0.328369140625
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.19140625,
            "text": "liver chemistry threshold of alanine aminotransferase",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.19140625,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.24609375,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.24609375,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.2890625,
            "text": "liver injury",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.36328125,
            "text": "liver chemistry",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.36328125,
            "text": "liver injury is identified by the liver chemistry",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.39453125,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN) and bilirubin>2\u00d7 UL",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.3984375,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN) and bilirubin>2",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.40234375,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.40625,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN) and bilirubin>2\u00d7 ULN",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.40625,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)>",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 6.65625,
            "text": "Severe liver",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.421875,
            "text": "liver chemistry threshold of alanine aminotransferase (ALT)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.42578125,
            "text": "liver chemistry threshold of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.3984375,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal (ULN) and bilirubin>2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.40234375,
            "text": "liver injury is identified by the liver chemistry threshold of alanine aminotransferase (ALT)>3\u00d7 upper limit of normal",
            "probability": 2.384185791015625e-07
        }
    ],
    "5a7237672dc08e987e000008_1": [
        {
            "start_logit": 6.328125,
            "end_logit": 6.6796875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -2.376953125,
            "end_logit": 6.6796875,
            "text": "DOACs i.e., dabigatran",
            "probability": 0.00016605854034423828
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 6.6796875,
            "text": "ACs i.e., dabigatran",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 6.6796875,
            "text": ", dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 6.6796875,
            "text": "idarucizumab for one of the DOACs i.e., dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 6.6796875,
            "text": "reversal agent has been approved by the Food and Drug Administration (FDA), idarucizumab for one of the DOACs i.e., dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 6.6796875,
            "text": "of the DOACs i.e., dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 6.6796875,
            "text": "the DOACs i.e., dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 6.6796875,
            "text": "FDA), idarucizumab for one of the DOACs i.e., dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 6.6796875,
            "text": "for one of the DOACs i.e., dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 6.6796875,
            "text": "izumab for one of the DOACs i.e., dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.625,
            "text": "dabigatran.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -2.376953125,
            "end_logit": -3.24609375,
            "text": "DOACs",
            "probability": 0.0
        },
        {
            "start_logit": -2.376953125,
            "end_logit": -6.8671875,
            "text": "DOACs i",
            "probability": 0.0
        },
        {
            "start_logit": -2.376953125,
            "end_logit": -6.94140625,
            "text": "DOACs i.e",
            "probability": 0.0
        },
        {
            "start_logit": -2.376953125,
            "end_logit": -7.35546875,
            "text": "DOACs i.e.",
            "probability": 0.0
        },
        {
            "start_logit": -2.376953125,
            "end_logit": -7.48828125,
            "text": "DOACs i.",
            "probability": 0.0
        },
        {
            "start_logit": -2.376953125,
            "end_logit": -7.5078125,
            "text": "DOACs i.e.,",
            "probability": 0.0
        },
        {
            "start_logit": -2.376953125,
            "end_logit": -7.625,
            "text": "DOACs i.e., dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.28515625,
            "end_logit": -3.24609375,
            "text": "ACs",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_2": [
        {
            "start_logit": 6.76171875,
            "end_logit": 6.67578125,
            "text": "vitamin K antagonists",
            "probability": 0.50537109375
        },
        {
            "start_logit": 6.44140625,
            "end_logit": 6.67578125,
            "text": "anticoagulants such as apixaban, rivaroxaban, or dabigatran may be preferred to vitamin K antagonists",
            "probability": 0.36669921875
        },
        {
            "start_logit": 6.44140625,
            "end_logit": 5.625,
            "text": "anticoagulants",
            "probability": 0.1278076171875
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -2.384765625,
            "text": "anticoagulants such as apixaban, rivaroxaban",
            "probability": 4.2498111724853516e-05
        },
        {
            "start_logit": 6.76171875,
            "end_logit": -3.7109375,
            "text": "vitamin",
            "probability": 1.5497207641601562e-05
        },
        {
            "start_logit": -3.720703125,
            "end_logit": 6.67578125,
            "text": "rivaroxaban, or dabigatran may be preferred to vitamin K antagonists",
            "probability": 1.4126300811767578e-05
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -3.7109375,
            "text": "anticoagulants such as apixaban, rivaroxaban, or dabigatran may be preferred to vitamin",
            "probability": 1.1324882507324219e-05
        },
        {
            "start_logit": -4.0859375,
            "end_logit": 6.67578125,
            "text": "antagonists",
            "probability": 9.894371032714844e-06
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -4.171875,
            "text": "anticoagulants such as apixaban, rivaroxaban, or dabigatran",
            "probability": 7.092952728271484e-06
        },
        {
            "start_logit": -5.078125,
            "end_logit": 6.67578125,
            "text": "dabigatran may be preferred to vitamin K antagonists",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -5.125,
            "end_logit": 6.67578125,
            "text": "apixaban, rivaroxaban, or dabigatran may be preferred to vitamin K antagonists",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -5.1015625,
            "text": "anticoagulants such as apixaban",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 6.76171875,
            "end_logit": -5.99609375,
            "text": "vitamin K",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -5.99609375,
            "text": "anticoagulants such as apixaban, rivaroxaban, or dabigatran may be preferred to vitamin K",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -6.16796875,
            "text": "anticoagulants such as apixaban, rivaroxaban, or dabigatran may",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.76171875,
            "end_logit": -6.703125,
            "text": "vitamin K antagonists in patients without cancer or renal failure, more so after the development of reversal agents such as idarucizumab and andexanet",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.76171875,
            "end_logit": -6.86328125,
            "text": "vitamin K antagonists in patients without cancer or renal failure, more so after the development of reversal agents such as idarucizumab and andexanet alfa",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.76171875,
            "end_logit": -6.9765625,
            "text": "vitamin K antagonists in",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.76171875,
            "end_logit": -7.16796875,
            "text": "vitamin K antagonists in patients without cancer or renal failure, more so after the development of reversal agents such as idarucizumab and and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 6.67578125,
            "text": ", rivaroxaban, or dabigatran may be preferred to vitamin K antagonists",
            "probability": 4.76837158203125e-07
        }
    ],
    "5a7237672dc08e987e000008_3": [
        {
            "start_logit": 6.32421875,
            "end_logit": 6.7421875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -6.9453125,
            "text": "dabigatran anticoagulant",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 6.7421875,
            "text": "complete and sustained reversal of dabigatran",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 6.7421875,
            "text": "immediate, complete and sustained reversal of dabigatran",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 6.7421875,
            "text": ", complete and sustained reversal of dabigatran",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.7421875,
            "text": "Idarucizumab resulted in immediate, complete and sustained reversal of dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 6.7421875,
            "text": "sustained reversal of dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 6.7421875,
            "text": "and sustained reversal of dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 6.7421875,
            "text": "reversal of dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.44140625,
            "text": "dabigatran anticoagulant activity",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 6.7421875,
            "text": "of dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.56640625,
            "text": "dabigatran anticoagulant activity, and was safe and well tolerated in middle-aged, elderly and renally impaired volunteers.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.72265625,
            "text": "dabigatran anticoagulant activity, and was safe and well tolerated in middle-aged, elderly and renal",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.74609375,
            "text": "dabigatran anticoagulant activity, and was safe and well tolerated in middle-aged, elderly and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.76953125,
            "text": "dabigatran anticoagulant activity,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.7734375,
            "text": "dabigatran anticoagulant activity, and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": -6.9453125,
            "text": "complete and sustained reversal of dabigatran anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -6.9453125,
            "text": "immediate, complete and sustained reversal of dabigatran anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -6.98828125,
            "end_logit": -7.56640625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -6.9453125,
            "text": ", complete and sustained reversal of dabigatran anticoagulant",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_4": [
        {
            "start_logit": 6.33984375,
            "end_logit": 6.73046875,
            "text": "Dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.33984375,
            "end_logit": -6.9609375,
            "text": "Dabigatran Anticoagulant",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 6.73046875,
            "text": "Idarucizumab-Mediated Reversal of Dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 6.73046875,
            "text": "Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 6.73046875,
            "text": "of Dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 6.73046875,
            "text": "Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 6.73046875,
            "text": "izumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 6.73046875,
            "text": "Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 6.73046875,
            "text": "Mediated Reversal of Dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 6.73046875,
            "text": "Reversal of Dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.33984375,
            "end_logit": -7.55859375,
            "text": "Dabigatran Anticoagulant Activity",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.33984375,
            "end_logit": -7.5703125,
            "text": "Dabigatran Anticoagulant Activity in",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.33984375,
            "end_logit": -7.609375,
            "text": "Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.33984375,
            "end_logit": -7.73046875,
            "text": "Dabigatran Anticoagulant Activity in a Randomized, Double-Blind",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.33984375,
            "end_logit": -7.7890625,
            "text": "Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -6.9609375,
            "text": "Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.74609375,
            "end_logit": -6.9609375,
            "text": "Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.76171875,
            "end_logit": -6.9609375,
            "text": "of Dabigatran Anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.76171875,
            "end_logit": -6.9609375,
            "text": "Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -6.9609375,
            "text": "izumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_5": [
        {
            "start_logit": 6.33203125,
            "end_logit": 6.67578125,
            "text": "dabigatran",
            "probability": 0.9990234375
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -0.50146484375,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently under development for the reversal of rivaroxaban",
            "probability": 0.0007638931274414062
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -6.06640625,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently under development for the reversal of rivaroxaban, apixaban",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -6.796875,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently under development for the reversal of rivaroxaban, apixa",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.375,
            "end_logit": 6.67578125,
            "text": "reversal of dabigatran",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 6.67578125,
            "text": "the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.5,
            "end_logit": 6.67578125,
            "text": "the reversal of dabigatran",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 6.67578125,
            "text": "We also discuss reversal strategies, both specific and nonspecific, for each drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 6.67578125,
            "text": "discuss reversal strategies, both specific and nonspecific, for each drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 6.67578125,
            "text": ", for each drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -0.370849609375,
            "end_logit": -0.50146484375,
            "text": "rivaroxaban",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.2265625,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently under",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 6.67578125,
            "text": "each drug, including the preferential use of idarucizumab for the reversal of dabigatran",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.67578125,
            "text": "of dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.37890625,
            "text": "dabigatran and two agents, andexanet and ciraparantag",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.41796875,
            "text": "dabigatran and",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.453125,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently under development for the reversal of rivaroxaban, api",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.45703125,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently under development for the reversal",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.4765625,
            "text": "dabigatran and two agents, andexanet",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.48046875,
            "text": "dabigatran and two agents, andexanet and ciraparantag, currently under development",
            "probability": 7.152557373046875e-07
        }
    ],
    "5a7237672dc08e987e000008_6": [
        {
            "start_logit": 6.36328125,
            "end_logit": 6.6796875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 6.6796875,
            "text": "anticoagulant effects of dabigatran",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.41015625,
            "text": "dabigatran.",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.6796875,
            "text": "urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 6.6796875,
            "text": "Idarucizumab is a targeted reversal agent that is approved for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 6.6796875,
            "text": "reversal of the anticoagulant effects of dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 6.6796875,
            "text": "the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.6796875,
            "text": "is approved for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 6.6796875,
            "text": "the anticoagulant effects of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 6.6796875,
            "text": "targeted reversal agent that is approved for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 6.6796875,
            "text": "for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.0,
            "end_logit": 6.6796875,
            "text": "of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 6.6796875,
            "text": "a targeted reversal agent that is approved for the urgent reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.96484375,
            "end_logit": -7.11328125,
            "text": "anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -6.96484375,
            "end_logit": -7.32421875,
            "text": "anticoagulant effects of",
            "probability": 0.0
        },
        {
            "start_logit": -6.96484375,
            "end_logit": -7.41015625,
            "text": "anticoagulant effects of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -6.96484375,
            "end_logit": -7.5,
            "text": "anticoagulant effects",
            "probability": 0.0
        },
        {
            "start_logit": -7.15234375,
            "end_logit": -7.41015625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -7.11328125,
            "text": "urgent reversal of the anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.765625,
            "end_logit": -7.11328125,
            "text": "Idarucizumab is a targeted reversal agent that is approved for the urgent reversal of the anticoagulant",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_7": [
        {
            "start_logit": 6.3515625,
            "end_logit": 6.71484375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 6.71484375,
            "text": ": The initial data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 6.71484375,
            "text": "CONCLUSIONS: The initial data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 6.71484375,
            "text": "initial data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.38671875,
            "text": "dabigatran.",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 6.71484375,
            "text": "with dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 6.71484375,
            "text": "The initial data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 6.71484375,
            "text": "data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.71484375,
            "text": "idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 6.71484375,
            "text": "bleeding associated with dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 6.71484375,
            "text": "treatment of bleeding associated with dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 6.71484375,
            "text": "definite role for idarucizumab in treatment of bleeding associated with dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": -7.38671875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.38671875,
            "text": ": The initial data suggest a definite role for idarucizumab in treatment of bleeding associated with dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.45703125,
            "text": ": The initial data suggest a definite role for idarucizumab in treatment of bleeding associated",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.5078125,
            "text": ": The initial data suggest a definite role for idarucizumab in",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.515625,
            "text": ": The initial data suggest a definite role for idarucizumab in treatment of bleeding",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.51953125,
            "text": ": The initial data suggest",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.5234375,
            "text": ": The initial data suggest a definite role for",
            "probability": 0.0
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.53125,
            "text": ": The initial data suggest a definite role for idarucizumab in treatment of",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_8": [
        {
            "start_logit": 6.37109375,
            "end_logit": 6.68359375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.5078125,
            "end_logit": 6.68359375,
            "text": "anticoagulant activity of dabigatran",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -7.28125,
            "end_logit": 6.68359375,
            "text": "5 g of intravenous idarucizumab promptly and completely reversed the anticoagulant activity of dabigatran",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 6.68359375,
            "text": "intravenous idarucizumab promptly and completely reversed the anticoagulant activity of dabigatran",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 6.68359375,
            "text": "The administration of 5 g of intravenous idarucizumab promptly and completely reversed the anticoagulant activity of dabigatran",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 6.68359375,
            "text": "administration of 5 g of intravenous idarucizumab promptly and completely reversed the anticoagulant activity of dabigatran",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 6.68359375,
            "text": "reversed the anticoagulant activity of dabigatran",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.34375,
            "text": "dabigatran as",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 6.68359375,
            "text": "idarucizumab promptly and completely reversed the anticoagulant activity of dabigatran",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 6.68359375,
            "text": "completely reversed the anticoagulant activity of dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 6.68359375,
            "text": "the anticoagulant activity of dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.515625,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.5234375,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.5390625,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from 26 to 11 s and diluted thrombin time from 92",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.5625,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from 26",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.578125,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from 26 to 11 s and diluted thrombin",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.6171875,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.63671875,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.640625,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.65234375,
            "text": "dabigatran as assessed by routine and specific coagulation assays (aPTT from to 75 to 26 s, PT from 26 to 11",
            "probability": 5.960464477539062e-07
        }
    ],
    "5a7237672dc08e987e000008_9": [
        {
            "start_logit": 6.328125,
            "end_logit": 6.703125,
            "text": "dabigatran",
            "probability": 0.3359375
        },
        {
            "start_logit": 6.31640625,
            "end_logit": 6.70703125,
            "text": "dabigatran",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.31640625,
            "end_logit": 6.703125,
            "text": "dabigatran with high affinity, is in development as a specific antidote for dabigatran",
            "probability": 0.330810546875
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 6.703125,
            "text": "antidote for dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 6.703125,
            "text": ", is in development as a specific antidote for dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.26953125,
            "text": "dabigatran.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.26953125,
            "text": "dabigatran with high affinity, is in development as a specific antidote for dabigatran.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 6.703125,
            "text": "for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.70703125,
            "text": "Idarucizumab, a monoclonal antibody fragment that binds dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.35546875,
            "text": "dabigatran with high affinity, is in development as a specific antidote",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.703125,
            "text": "Idarucizumab, a monoclonal antibody fragment that binds dabigatran with high affinity, is in development as a specific antidote for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.375,
            "text": "dabigatran with",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.4375,
            "text": "dabigatran with high affinity,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 6.70703125,
            "text": "binds dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 6.703125,
            "text": "binds dabigatran with high affinity, is in development as a specific antidote for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 6.70703125,
            "text": "that binds dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 6.703125,
            "text": "that binds dabigatran with high affinity, is in development as a specific antidote for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 6.703125,
            "text": "specific antidote for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 6.703125,
            "text": "development as a specific antidote for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 6.70703125,
            "text": "monoclonal antibody fragment that binds dabigatran",
            "probability": 2.384185791015625e-07
        }
    ],
    "5a7237672dc08e987e000008_10": [
        {
            "start_logit": 6.328125,
            "end_logit": 6.703125,
            "text": "dabigatran",
            "probability": 0.3359375
        },
        {
            "start_logit": 6.31640625,
            "end_logit": 6.70703125,
            "text": "dabigatran",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.31640625,
            "end_logit": 6.703125,
            "text": "dabigatran with high affinity, is in development as a specific antidote for dabigatran",
            "probability": 0.330810546875
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 6.703125,
            "text": "antidote for dabigatran",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 6.703125,
            "text": ", is in development as a specific antidote for dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.26953125,
            "text": "dabigatran.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.26953125,
            "text": "dabigatran with high affinity, is in development as a specific antidote for dabigatran.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 6.703125,
            "text": "for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.70703125,
            "text": "Idarucizumab, a monoclonal antibody fragment that binds dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.35546875,
            "text": "dabigatran with high affinity, is in development as a specific antidote",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.703125,
            "text": "Idarucizumab, a monoclonal antibody fragment that binds dabigatran with high affinity, is in development as a specific antidote for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.375,
            "text": "dabigatran with",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.4375,
            "text": "dabigatran with high affinity,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 6.70703125,
            "text": "binds dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 6.703125,
            "text": "binds dabigatran with high affinity, is in development as a specific antidote for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 6.70703125,
            "text": "that binds dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 6.703125,
            "text": "that binds dabigatran with high affinity, is in development as a specific antidote for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 6.703125,
            "text": "specific antidote for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 6.703125,
            "text": "development as a specific antidote for dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 6.70703125,
            "text": "monoclonal antibody fragment that binds dabigatran",
            "probability": 2.384185791015625e-07
        }
    ],
    "5a7237672dc08e987e000008_11": [
        {
            "start_logit": 6.29296875,
            "end_logit": 6.75,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 6.75,
            "text": "A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.40625,
            "end_logit": 6.75,
            "text": "antidote to dabigatran",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 6.75,
            "text": "study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 6.75,
            "text": "investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 6.75,
            "text": "randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 6.75,
            "text": "specific antidote to dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 6.75,
            "text": "to dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 6.75,
            "text": "healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 6.75,
            "text": "idarucizumab, a specific antidote to dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 6.75,
            "text": "safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 6.75,
            "text": "a specific antidote to dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 6.75,
            "text": "in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 6.75,
            "text": "volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.75,
            "text": ", a specific antidote to dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.29296875,
            "end_logit": -7.703125,
            "text": "dabigatran.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.91796875,
            "end_logit": -7.703125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": -7.55859375,
            "text": "A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote",
            "probability": 0.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": -7.6015625,
            "text": "A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of",
            "probability": 0.0
        },
        {
            "start_logit": -7.35546875,
            "end_logit": -7.60546875,
            "text": "A randomised study in healthy volunteers to investigate the safety, tolerability and",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_12": [
        {
            "start_logit": 6.25,
            "end_logit": 6.796875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.24609375,
            "end_logit": 6.796875,
            "text": "anticoagulant activity of dabigatran",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 6.796875,
            "text": "To evaluate the role of idarucizumab, a humanized monoclonal antibody fragment, as a specific reversal agent for the anticoagulant activity of dabigatran",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 6.796875,
            "text": "evaluate the role of idarucizumab, a humanized monoclonal antibody fragment, as a specific reversal agent for the anticoagulant activity of dabigatran",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 6.796875,
            "text": ", as a specific reversal agent for the anticoagulant activity of dabigatran",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 6.796875,
            "text": "reversal agent for the anticoagulant activity of dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.796875,
            "text": "the anticoagulant activity of dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 6.796875,
            "text": "humanized monoclonal antibody fragment, as a specific reversal agent for the anticoagulant activity of dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.25,
            "end_logit": -7.66015625,
            "text": "dabigatran and to review the pharmacology, pharmacokinetic",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.25,
            "end_logit": -7.70703125,
            "text": "dabigatran and to review the pharmacology, pharmacokinetic properties",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.25,
            "end_logit": -7.72265625,
            "text": "dabigatran and to review the pharmacology",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.25,
            "end_logit": -7.76171875,
            "text": "dabigatran and to review the pharmacology, pharmacokinetic properties, efficacy, and safety of this agent",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.24609375,
            "end_logit": -6.59375,
            "text": "anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -6.24609375,
            "end_logit": -7.43359375,
            "text": "anticoagulant activity of",
            "probability": 0.0
        },
        {
            "start_logit": -6.24609375,
            "end_logit": -7.49609375,
            "text": "anticoagulant activity",
            "probability": 0.0
        },
        {
            "start_logit": -6.24609375,
            "end_logit": -7.66015625,
            "text": "anticoagulant activity of dabigatran and to review the pharmacology, pharmacokinetic",
            "probability": 0.0
        },
        {
            "start_logit": -6.24609375,
            "end_logit": -7.70703125,
            "text": "anticoagulant activity of dabigatran and to review the pharmacology, pharmacokinetic properties",
            "probability": 0.0
        },
        {
            "start_logit": -6.24609375,
            "end_logit": -7.72265625,
            "text": "anticoagulant activity of dabigatran and to review the pharmacology",
            "probability": 0.0
        },
        {
            "start_logit": -6.24609375,
            "end_logit": -7.76171875,
            "text": "anticoagulant activity of dabigatran and to review the pharmacology, pharmacokinetic properties, efficacy, and safety of this agent",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -6.59375,
            "text": "To evaluate the role of idarucizumab, a humanized monoclonal antibody fragment, as a specific reversal agent for the anticoagulant",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_13": [
        {
            "start_logit": 7.1015625,
            "end_logit": 5.453125,
            "text": "Dabigatran",
            "probability": 0.8896484375
        },
        {
            "start_logit": 7.1015625,
            "end_logit": 3.369140625,
            "text": "Dabigatran etexilate",
            "probability": 0.1104736328125
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -5.21484375,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by idarucizumab.",
            "probability": 2.0623207092285156e-05
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -6.62890625,
            "text": "Dabigatran etexila",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.0078125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.015625,
            "text": "Dabigatran etexilate is an oral thrombin",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.08984375,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.24609375,
            "text": "Dabigatran etexilate is",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.2578125,
            "text": "Dabigatran etexilate is an",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.28515625,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.2890625,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.4375,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.46484375,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.54296875,
            "text": "Dabigatran etexilate is an oral",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.54296875,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by idarucizumab",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.58203125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by idaruc",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.6640625,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by ida",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.7109375,
            "text": "Dabigatran et",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 3.369140625,
            "text": "exilate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.15625,
            "end_logit": 3.369140625,
            "text": "etexilate",
            "probability": 5.960464477539063e-08
        }
    ],
    "5a7237672dc08e987e000008_14": [
        {
            "start_logit": 6.375,
            "end_logit": 6.67578125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.0859375,
            "text": "dabigatran, anticoagulation",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.67578125,
            "text": "In ICH related to dabigatran",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.32421875,
            "text": "dabigatran, anticoagulation can be rapidly reversed with idarucizumab.",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.37890625,
            "text": "dabigatran, anticoagulation can",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 6.67578125,
            "text": "ICH related to dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.390625,
            "text": "dabigatran, anticoagulation can be",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.45703125,
            "text": "dabigatran, anticoagulation can be rapidly",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 6.67578125,
            "text": "to dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.5703125,
            "text": "dabigatran, anticoagulation can be rapidly reversed with",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.67578125,
            "text": "related to dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.625,
            "text": "dabigatran, anticoagulation can be rapidly reversed",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.67578125,
            "text": "dabigatran, anticoagulation can be rapidly reversed with idarucizumab",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.69140625,
            "text": "dabigatran, anticoagulation can be rapidly reversed with idaruc",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.6953125,
            "text": "dabigatran,",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -7.32421875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -7.0859375,
            "text": "In ICH related to dabigatran, anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -7.0859375,
            "text": "ICH related to dabigatran, anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.0859375,
            "text": "anticoagulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -7.0859375,
            "text": ", anticoagulation",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_15": [
        {
            "start_logit": 7.02734375,
            "end_logit": 5.7890625,
            "text": "dabigatran",
            "probability": 0.91943359375
        },
        {
            "start_logit": 7.02734375,
            "end_logit": 3.35546875,
            "text": "dabigatran etexilate",
            "probability": 0.0809326171875
        },
        {
            "start_logit": 7.02734375,
            "end_logit": -7.09765625,
            "text": "dabigatran etexila",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 7.02734375,
            "end_logit": -7.4375,
            "text": "dabigatran etexilate.",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 5.7890625,
            "text": "Idarucizumab is a reversal agent for dabigatran",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 5.7890625,
            "text": "rucizumab is a reversal agent for dabigatran",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.0546875,
            "end_logit": 3.35546875,
            "text": "etexilate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.33203125,
            "end_logit": 3.35546875,
            "text": "exilate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 3.35546875,
            "text": "ilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.171875,
            "end_logit": 3.35546875,
            "text": "te",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 3.35546875,
            "text": "Idarucizumab is a reversal agent for dabigatran etexilate",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 3.35546875,
            "text": "rucizumab is a reversal agent for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -6.0546875,
            "end_logit": -7.09765625,
            "text": "etexila",
            "probability": 0.0
        },
        {
            "start_logit": -6.33203125,
            "end_logit": -7.09765625,
            "text": "exila",
            "probability": 0.0
        },
        {
            "start_logit": -6.0546875,
            "end_logit": -7.4375,
            "text": "etexilate.",
            "probability": 0.0
        },
        {
            "start_logit": -6.33203125,
            "end_logit": -7.4375,
            "text": "exilate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.06640625,
            "end_logit": -7.09765625,
            "text": "ila",
            "probability": 0.0
        },
        {
            "start_logit": -7.06640625,
            "end_logit": -7.4375,
            "text": "ilate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.140625,
            "end_logit": -7.4375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.171875,
            "end_logit": -7.4375,
            "text": "te.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_16": [
        {
            "start_logit": 6.3671875,
            "end_logit": 6.6953125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 6.6953125,
            "text": "anticoagulant effect of dabigatran",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.05859375,
            "text": "dabigatran within minutes.",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.1640625,
            "text": "dabigatran within",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 6.6953125,
            "text": "Idarucizumab completely reversed the anticoagulant effect of dabigatran",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.4140625,
            "text": "dabigatran within minutes",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 6.6953125,
            "text": "reversed the anticoagulant effect of dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 6.6953125,
            "text": "completely reversed the anticoagulant effect of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 6.6953125,
            "text": "rucizumab completely reversed the anticoagulant effect of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 6.6953125,
            "text": "izumab completely reversed the anticoagulant effect of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 6.6953125,
            "text": "the anticoagulant effect of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.046875,
            "end_logit": -7.05859375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -7.05859375,
            "text": "anticoagulant effect of dabigatran within minutes.",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -7.12890625,
            "text": "anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -7.1640625,
            "text": "anticoagulant effect of dabigatran within",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -7.20703125,
            "text": "anticoagulant effect of",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -7.05859375,
            "text": "Idarucizumab completely reversed the anticoagulant effect of dabigatran within minutes.",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -7.12890625,
            "text": "Idarucizumab completely reversed the anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -7.4140625,
            "text": "anticoagulant effect of dabigatran within minutes",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -7.1640625,
            "text": "Idarucizumab completely reversed the anticoagulant effect of dabigatran within",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_17": [
        {
            "start_logit": 7.1015625,
            "end_logit": 5.453125,
            "text": "Dabigatran",
            "probability": 0.8896484375
        },
        {
            "start_logit": 7.1015625,
            "end_logit": 3.369140625,
            "text": "Dabigatran etexilate",
            "probability": 0.1104736328125
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -5.21484375,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by idarucizumab.",
            "probability": 2.0623207092285156e-05
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -6.62890625,
            "text": "Dabigatran etexila",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.0078125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.015625,
            "text": "Dabigatran etexilate is an oral thrombin",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.08984375,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.24609375,
            "text": "Dabigatran etexilate is",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.2578125,
            "text": "Dabigatran etexilate is an",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.28515625,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.2890625,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.4375,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.46484375,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.54296875,
            "text": "Dabigatran etexilate is an oral",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.54296875,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by idarucizumab",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.58203125,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by idaruc",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.6640625,
            "text": "Dabigatran etexilate is an oral thrombin inhibitor that can be reversed by ida",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -7.7109375,
            "text": "Dabigatran et",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 3.369140625,
            "text": "exilate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.15625,
            "end_logit": 3.369140625,
            "text": "etexilate",
            "probability": 5.960464477539063e-08
        }
    ],
    "5a7237672dc08e987e000008_18": [
        {
            "start_logit": 6.6171875,
            "end_logit": 6.36328125,
            "text": "dabigatran",
            "probability": 0.998046875
        },
        {
            "start_logit": 6.6171875,
            "end_logit": 0.152587890625,
            "text": "dabigatran etexilate",
            "probability": 0.001995086669921875
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -7.015625,
            "text": "dabigatran etexila",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.6171875,
            "end_logit": -7.54296875,
            "text": "dabigatran etexilate.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 6.36328125,
            "text": "INTRODUCTION Idarucizumab is a reversal agent for dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 6.36328125,
            "text": "Idarucizumab is a reversal agent for dabigatran",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.796875,
            "end_logit": 0.152587890625,
            "text": "etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -6.8125,
            "end_logit": 0.152587890625,
            "text": "exilate",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 0.152587890625,
            "text": "ilate",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": 0.152587890625,
            "text": "INTRODUCTION Idarucizumab is a reversal agent for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 0.152587890625,
            "text": "Idarucizumab is a reversal agent for dabigatran etexilate",
            "probability": 0.0
        },
        {
            "start_logit": -6.796875,
            "end_logit": -7.015625,
            "text": "etexila",
            "probability": 0.0
        },
        {
            "start_logit": -6.8125,
            "end_logit": -7.015625,
            "text": "exila",
            "probability": 0.0
        },
        {
            "start_logit": -6.796875,
            "end_logit": -7.54296875,
            "text": "etexilate.",
            "probability": 0.0
        },
        {
            "start_logit": -6.8125,
            "end_logit": -7.54296875,
            "text": "exilate.",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -7.015625,
            "text": "ila",
            "probability": 0.0
        },
        {
            "start_logit": -7.078125,
            "end_logit": -7.54296875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -7.015625,
            "text": "INTRODUCTION Idarucizumab is a reversal agent for dabigatran etexila",
            "probability": 0.0
        },
        {
            "start_logit": -7.8515625,
            "end_logit": -7.015625,
            "text": "Idarucizumab is a reversal agent for dabigatran etexila",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -7.54296875,
            "text": "ilate.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_19": [
        {
            "start_logit": 6.3515625,
            "end_logit": 6.6875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 6.6875,
            "text": "anticoagulant effects of dabigatran",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -7.6875,
            "end_logit": 6.6875,
            "text": "Idarucizumab is a humanized monoclonal antibody fragment for reversal of the anticoagulant effects of dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.4140625,
            "text": "dabigatran.",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 6.6875,
            "text": "reversal of the anticoagulant effects of dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 6.6875,
            "text": "the anticoagulant effects of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 6.6875,
            "text": "for reversal of the anticoagulant effects of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 6.6875,
            "text": "rucizumab is a humanized monoclonal antibody fragment for reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 6.6875,
            "text": "of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.96875,
            "end_logit": 6.6875,
            "text": "humanized monoclonal antibody fragment for reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 6.6875,
            "text": "izumab is a humanized monoclonal antibody fragment for reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 6.6875,
            "text": "fragment for reversal of the anticoagulant effects of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.63671875,
            "end_logit": -6.96484375,
            "text": "anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -6.63671875,
            "end_logit": -7.2890625,
            "text": "anticoagulant effects",
            "probability": 0.0
        },
        {
            "start_logit": -6.63671875,
            "end_logit": -7.3046875,
            "text": "anticoagulant effects of",
            "probability": 0.0
        },
        {
            "start_logit": -6.63671875,
            "end_logit": -7.4140625,
            "text": "anticoagulant effects of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": -7.4140625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.6875,
            "end_logit": -6.96484375,
            "text": "Idarucizumab is a humanized monoclonal antibody fragment for reversal of the anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -6.96484375,
            "text": "reversal of the anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.91015625,
            "end_logit": -6.96484375,
            "text": "the anticoagulant",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_20": [
        {
            "start_logit": 6.32421875,
            "end_logit": 6.71875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": 6.71875,
            "text": "to dabigatran",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 6.71875,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.42578125,
            "text": "dabigatran.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 6.71875,
            "text": "targeted to dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 6.71875,
            "text": "monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 6.71875,
            "text": "specifically targeted to dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 6.71875,
            "text": "rucizumab is a monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -7.42578125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -7.42578125,
            "text": "to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -7.42578125,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically targeted to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -7.51953125,
            "text": "Idarucizumab is a",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -7.52734375,
            "text": "Idarucizumab is",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -7.66796875,
            "text": "to",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": -7.42578125,
            "text": "targeted to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -7.6484375,
            "text": "Idarucizumab is a monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -7.6640625,
            "text": "Idarucizumab is a monoclonal antibody fragment",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -7.66796875,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically targeted to",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -7.69921875,
            "text": "Idarucizumab",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -7.7109375,
            "text": "Idaruc",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_21": [
        {
            "start_logit": 6.32421875,
            "end_logit": 6.71875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": 6.71875,
            "text": "to dabigatran",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 6.71875,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.42578125,
            "text": "dabigatran.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 6.71875,
            "text": "targeted to dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 6.71875,
            "text": "monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 6.71875,
            "text": "specifically targeted to dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 6.71875,
            "text": "rucizumab is a monoclonal antibody fragment specifically targeted to dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": -7.42578125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -7.42578125,
            "text": "to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -7.42578125,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically targeted to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -7.51953125,
            "text": "Idarucizumab is a",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -7.52734375,
            "text": "Idarucizumab is",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -7.66796875,
            "text": "to",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": -7.42578125,
            "text": "targeted to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -7.6484375,
            "text": "Idarucizumab is a monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -7.6640625,
            "text": "Idarucizumab is a monoclonal antibody fragment",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -7.66796875,
            "text": "Idarucizumab is a monoclonal antibody fragment specifically targeted to",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -7.69921875,
            "text": "Idarucizumab",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -7.7109375,
            "text": "Idaruc",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_22": [
        {
            "start_logit": 7.25,
            "end_logit": 5.7265625,
            "text": "dabigatran etexilate",
            "probability": 0.5810546875
        },
        {
            "start_logit": 7.25,
            "end_logit": 5.3984375,
            "text": "dabigatran",
            "probability": 0.41845703125
        },
        {
            "start_logit": -5.1484375,
            "end_logit": 5.7265625,
            "text": "te",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 7.25,
            "end_logit": -7.15625,
            "text": "dabigatran etexilate and neutralizes its activity.",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -5.6640625,
            "end_logit": 5.7265625,
            "text": "etexilate",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -5.84375,
            "end_logit": 5.7265625,
            "text": "exilate",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.25,
            "end_logit": -7.41796875,
            "text": "dabigatran etexila",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.25,
            "end_logit": -7.66796875,
            "text": "dabigatran etexilate and",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.25,
            "end_logit": -7.71484375,
            "text": "dabigatran etexilate and neutralizes its",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.25,
            "end_logit": -7.78125,
            "text": "dabigatran etexilate and neutralizes its activity",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.25,
            "end_logit": -7.80078125,
            "text": "dabigatran etexilate and neutralizes",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 5.7265625,
            "text": "ilate",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 5.7265625,
            "text": ", directly binds dabigatran etexilate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 5.7265625,
            "text": "Idarucizumab, a monoclonal antibody fragment, directly binds dabigatran etexilate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 5.7265625,
            "text": "binds dabigatran etexilate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 5.7265625,
            "text": "directly binds dabigatran etexilate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 5.7265625,
            "text": ", a monoclonal antibody fragment, directly binds dabigatran etexilate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 5.7265625,
            "text": "monoclonal antibody fragment, directly binds dabigatran etexilate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 5.3984375,
            "text": ", directly binds dabigatran",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 5.3984375,
            "text": "Idarucizumab, a monoclonal antibody fragment, directly binds dabigatran",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5a7237672dc08e987e000008_23": [
        {
            "start_logit": 6.41015625,
            "end_logit": 6.6171875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.10546875,
            "text": "dabigatran with high affinity.",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.37109375,
            "text": "dabigatran with",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.46875,
            "text": "dabigatran with high",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 6.6171875,
            "text": "Idarucizumab is an antibody fragment that binds dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.57421875,
            "text": "dabigatran with high affinity",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 6.6171875,
            "text": "binds dabigatran",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 6.6171875,
            "text": "antibody fragment that binds dabigatran",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": -7.10546875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.10546875,
            "text": "Idarucizumab is an antibody fragment that binds dabigatran with high affinity.",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -7.10546875,
            "text": "binds dabigatran with high affinity.",
            "probability": 0.0
        },
        {
            "start_logit": -7.99609375,
            "end_logit": -7.10546875,
            "text": "antibody fragment that binds dabigatran with high affinity.",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.37109375,
            "text": "Idarucizumab is an antibody fragment that binds dabigatran with",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.46875,
            "text": "Idarucizumab is an antibody fragment that binds dabigatran with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.53125,
            "text": "Idarucizumab is an antibody fragment that",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.5390625,
            "text": "Idarucizumab is an",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.5703125,
            "text": "Idarucizumab is",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.57421875,
            "text": "Idarucizumab is an antibody fragment that binds dabigatran with high affinity",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.59765625,
            "text": "Idarucizumab is an antibody fragment",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -7.37109375,
            "text": "binds dabigatran with",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_24": [
        {
            "start_logit": 6.640625,
            "end_logit": 7.0234375,
            "text": "dabigatran etexilate",
            "probability": 0.66357421875
        },
        {
            "start_logit": 6.640625,
            "end_logit": 6.34375,
            "text": "dabigatran",
            "probability": 0.33642578125
        },
        {
            "start_logit": -3.658203125,
            "end_logit": 7.0234375,
            "text": "te",
            "probability": 2.2411346435546875e-05
        },
        {
            "start_logit": -5.9140625,
            "end_logit": 7.0234375,
            "text": "etexilate",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -6.1171875,
            "end_logit": 7.0234375,
            "text": "exilate",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -6.55859375,
            "end_logit": 7.0234375,
            "text": "ilate",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.0234375,
            "text": "CONCLUSION Reversal of dabigatran etexilate",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.640625,
            "end_logit": -7.37109375,
            "text": "dabigatran etexilate using idarucizumab was safe and successful with no recombinant tissue plasminogen activator",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 7.0234375,
            "text": "Reversal of dabigatran etexilate",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.640625,
            "end_logit": -7.48046875,
            "text": "dabigatran etexilate using idarucizumab was safe and successful with no recombinant tissue plasminogen activator interactions.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.640625,
            "end_logit": -7.64453125,
            "text": "dabigatran etexilate using idarucizumab was safe and successful with no recombinant tissue plasminogen",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.640625,
            "end_logit": -7.6796875,
            "text": "dabigatran etexilate using idarucizumab was",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.640625,
            "end_logit": -7.7109375,
            "text": "dabigatran etexilate using idarucizumab was safe and successful with no recombinant tissue plasminogen activator interactions",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.640625,
            "end_logit": -7.71875,
            "text": "dabigatran etexilate using idarucizumab",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.640625,
            "end_logit": -7.734375,
            "text": "dabigatran etexilate using idarucizumab was safe and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.640625,
            "end_logit": -7.7578125,
            "text": "dabigatran etexilate using idarucizumab was safe and successful",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.640625,
            "end_logit": -7.7734375,
            "text": "dabigatran etexilate using idaruc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.640625,
            "end_logit": -7.7734375,
            "text": "dabigatran etexilate using",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 6.34375,
            "text": "CONCLUSION Reversal of dabigatran",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 6.34375,
            "text": "Reversal of dabigatran",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5a7237672dc08e987e000008_25": [
        {
            "start_logit": 6.375,
            "end_logit": 6.65234375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": 6.65234375,
            "text": "RESULTS Idarucizumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.3359375,
            "text": "dabigatran.",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.65234375,
            "text": "Idarucizumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 6.65234375,
            "text": "to dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 6.65234375,
            "text": "novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 6.65234375,
            "text": ", monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 6.65234375,
            "text": "that specifically binds to dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 6.65234375,
            "text": "treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 6.65234375,
            "text": "specifically binds to dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 6.65234375,
            "text": "it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 6.65234375,
            "text": "humanized, monoclonal antibody fragment that specifically binds to dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -7.3359375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -7.3359375,
            "text": "RESULTS Idarucizumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.71875,
            "end_logit": -7.3359375,
            "text": "Idarucizumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -7.58984375,
            "text": "RESULTS Idarucizumab represents a novel treatment option",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -7.6171875,
            "text": "RESULTS Idarucizumab represents a novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -7.62109375,
            "text": "RESULTS Idarucizumab represents a novel treatment option as",
            "probability": 0.0
        },
        {
            "start_logit": -7.84765625,
            "end_logit": -7.3359375,
            "text": "to dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.3359375,
            "text": "novel treatment option as it is the only humanized, monoclonal antibody fragment that specifically binds to dabigatran.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_26": [
        {
            "start_logit": 6.34375,
            "end_logit": 6.7109375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 6.7109375,
            "text": "anticoagulant effects of dabigatran",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 6.7109375,
            "text": "In 2015, the humanized monoclonal antibody fragment idarucizumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 6.7109375,
            "text": "rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 6.7109375,
            "text": ", the humanized monoclonal antibody fragment idarucizumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 6.7109375,
            "text": "reversal of anticoagulant effects of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.54296875,
            "text": "dabigatran.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 6.7109375,
            "text": "2015, the humanized monoclonal antibody fragment idarucizumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 6.7109375,
            "text": "minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 6.7109375,
            "text": "idarucizumab was approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 6.7109375,
            "text": "(minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 6.7109375,
            "text": "approved for rapid (minutes) reversal of anticoagulant effects of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 6.7109375,
            "text": "of anticoagulant effects of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.94921875,
            "end_logit": -7.1484375,
            "text": "anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -6.94921875,
            "end_logit": -7.4140625,
            "text": "anticoagulant effects of",
            "probability": 0.0
        },
        {
            "start_logit": -6.94921875,
            "end_logit": -7.43359375,
            "text": "anticoagulant effects",
            "probability": 0.0
        },
        {
            "start_logit": -6.94921875,
            "end_logit": -7.54296875,
            "text": "anticoagulant effects of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.140625,
            "end_logit": -7.54296875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.69140625,
            "end_logit": -7.1484375,
            "text": "In 2015, the humanized monoclonal antibody fragment idarucizumab was approved for rapid (minutes) reversal of anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.78515625,
            "end_logit": -7.1484375,
            "text": "rapid (minutes) reversal of anticoagulant",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_27": [
        {
            "start_logit": 6.390625,
            "end_logit": 6.59375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.1875,
            "end_logit": 6.59375,
            "text": "thrombin inhibitor, dabigatran",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.359375,
            "end_logit": 6.59375,
            "text": "direct thrombin inhibitor, dabigatran",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 6.59375,
            "text": "Idarucizumab is a specific antidote targeted to reverse the direct thrombin inhibitor, dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.390625,
            "end_logit": -7.55078125,
            "text": "dabigatran, which was recently approved for use in the USA.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 6.59375,
            "text": "antidote targeted to reverse the direct thrombin inhibitor, dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.390625,
            "end_logit": -7.5703125,
            "text": "dabigatran, which was recently approved for use in the USA",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 6.59375,
            "text": "reverse the direct thrombin inhibitor, dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.390625,
            "end_logit": -7.625,
            "text": "dabigatran, which was recently approved for",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.390625,
            "end_logit": -7.62890625,
            "text": "dabigatran, which was recently approved for use in",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.390625,
            "end_logit": -7.66796875,
            "text": "dabigatran, which was recently approved for use in the",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.390625,
            "end_logit": -7.69140625,
            "text": "dabigatran, which",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 6.59375,
            "text": "the direct thrombin inhibitor, dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.390625,
            "end_logit": -7.71875,
            "text": "dabigatran, which was recently approved",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.390625,
            "end_logit": -7.7265625,
            "text": "dabigatran, which was",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 6.59375,
            "text": ", dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.390625,
            "end_logit": -7.75,
            "text": "dabigatran,",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 6.59375,
            "text": "rucizumab is a specific antidote targeted to reverse the direct thrombin inhibitor, dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.1875,
            "end_logit": -6.9453125,
            "text": "thrombin inhibitor",
            "probability": 0.0
        },
        {
            "start_logit": -7.359375,
            "end_logit": -6.9453125,
            "text": "direct thrombin inhibitor",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_28": [
        {
            "start_logit": 6.4140625,
            "end_logit": 6.609375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -5.8046875,
            "text": "dabigatran, is the first specific antidote for a NOAC",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -6.76953125,
            "text": "dabigatran, is the first specific antidote for a NOAC to",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.265625,
            "text": "dabigatran, is the first specific antidote for a NOAC to be",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.48046875,
            "text": "dabigatran,",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.51171875,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved, but real-world experience is limited.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.5234375,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.53125,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved,",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.546875,
            "text": "dabigatran, is the first specific antidote",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.5625,
            "text": "dabigatran, is the first specific antidote for",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 6.609375,
            "text": "targeting dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 6.609375,
            "text": "Idarucizumab, an antibody fragment targeting dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.62109375,
            "text": "dabigatran, is the first specific antidote for a NO",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.62109375,
            "text": "dabigatran, is the first",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.625,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved, but real-world",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.625,
            "text": "dabigatran, is the first specific antidote for a NOAC to be approved, but real-world experience is limited",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.6328125,
            "text": "dabigatran, is the first specific antidote for a",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.63671875,
            "text": "dabigatran, is the first specific antid",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.64453125,
            "text": "dabigatran, is the",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 6.609375,
            "text": "antibody fragment targeting dabigatran",
            "probability": 5.960464477539062e-07
        }
    ],
    "5a7237672dc08e987e000008_29": [
        {
            "start_logit": 6.375,
            "end_logit": 6.64453125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.015625,
            "text": "dabigatran, and reversed the effects of the drug on coagulation variables.",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.24609375,
            "text": "dabigatran, and reversed the effects of the drug",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 6.64453125,
            "text": "neutralised plasma concentrations of dabigatran",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 6.64453125,
            "text": "Idarucizumab neutralised plasma concentrations of dabigatran",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.5546875,
            "text": "dabigatran, and reversed the effects of the drug on",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.57421875,
            "text": "dabigatran, and reversed the effects of the drug on coagulation",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.609375,
            "text": "dabigatran, and reversed the effects of",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.61328125,
            "text": "dabigatran, and reversed the effects of the",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 6.64453125,
            "text": "plasma concentrations of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 6.64453125,
            "text": "rucizumab neutralised plasma concentrations of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.67578125,
            "text": "dabigatran, and reversed the effects of the drug on coagulation variables",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.7890625,
            "text": "dabigatran, and reversed the",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.796875,
            "text": "dabigatran,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": -7.015625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -7.015625,
            "text": "neutralised plasma concentrations of dabigatran, and reversed the effects of the drug on coagulation variables.",
            "probability": 0.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -7.015625,
            "text": "and reversed the effects of the drug on coagulation variables.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6640625,
            "end_logit": -7.015625,
            "text": "Idarucizumab neutralised plasma concentrations of dabigatran, and reversed the effects of the drug on coagulation variables.",
            "probability": 0.0
        },
        {
            "start_logit": -7.66796875,
            "end_logit": -7.015625,
            "text": "reversed the effects of the drug on coagulation variables.",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": -7.015625,
            "text": ", and reversed the effects of the drug on coagulation variables.",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_30": [
        {
            "start_logit": 6.390625,
            "end_logit": 6.6484375,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -6.671875,
            "end_logit": 6.6484375,
            "text": "anticoagulant effects of dabigatran",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 6.390625,
            "end_logit": -7.22265625,
            "text": "dabigatran.",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 6.6484375,
            "text": ", was developed to reverse the anticoagulant effects of dabigatran",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.6484375,
            "text": "reverse the anticoagulant effects of dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.6484375,
            "text": "Idarucizumab, an antibody fragment, was developed to reverse the anticoagulant effects of dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 6.6484375,
            "text": "to reverse the anticoagulant effects of dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 6.6484375,
            "text": "developed to reverse the anticoagulant effects of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 6.6484375,
            "text": "the anticoagulant effects of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 6.6484375,
            "text": "was developed to reverse the anticoagulant effects of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 6.6484375,
            "text": ", an antibody fragment, was developed to reverse the anticoagulant effects of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 6.6484375,
            "text": "antibody fragment, was developed to reverse the anticoagulant effects of dabigatran",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.671875,
            "end_logit": -7.06640625,
            "text": "anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -6.671875,
            "end_logit": -7.1328125,
            "text": "anticoagulant effects of",
            "probability": 0.0
        },
        {
            "start_logit": -6.671875,
            "end_logit": -7.19921875,
            "text": "anticoagulant effects",
            "probability": 0.0
        },
        {
            "start_logit": -6.671875,
            "end_logit": -7.22265625,
            "text": "anticoagulant effects of dabigatran.",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": -7.22265625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": -7.06640625,
            "text": ", was developed to reverse the anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -7.06640625,
            "text": "reverse the anticoagulant",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": -7.1328125,
            "text": ", was developed to reverse the anticoagulant effects of",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_31": [
        {
            "start_logit": 6.34375,
            "end_logit": 6.6953125,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": 6.34375,
            "end_logit": -6.765625,
            "text": "dabigatran and, unlike PCCs, was not associated with over-correction of thrombin generation.",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.1328125,
            "text": "dabigatran and, unlike PCCs, was not associated with over-correction of thrombin",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.15234375,
            "text": "dabigatran and, unlike PCCs, was not associated with over-correction of thrombin generation",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.17578125,
            "text": "dabigatran and",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.36328125,
            "text": "dabigatran and, unlike PCCs, was not associated with over-",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 6.6953125,
            "text": "Idarucizumab also reversed the effects of dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 6.6953125,
            "text": "reversed the effects of dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 6.6953125,
            "text": "effects of dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.4140625,
            "text": "dabigatran and, unlike PCCs, was not associated with",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.55078125,
            "text": "dabigatran and, unlike PCC",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.56640625,
            "text": "dabigatran and, unlike PCCs, was not associated with over-correction",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 6.6953125,
            "text": "the effects of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.625,
            "text": "dabigatran and, unlike PCCs",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.6328125,
            "text": "dabigatran and, unlike PCCs, was not associated with over",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.64453125,
            "text": "dabigatran and, unlike",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.6484375,
            "text": "dabigatran and, unlike PCCs, was not associated with over-correction of",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.68359375,
            "text": "dabigatran and, unlike PCCs, was not",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.734375,
            "text": "dabigatran and, unlike PCCs, was",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.7421875,
            "text": "dabigatran and, unlike PCCs,",
            "probability": 5.364418029785156e-07
        }
    ],
    "5a7237672dc08e987e000008_32": [
        {
            "start_logit": 6.8515625,
            "end_logit": 6.03125,
            "text": "Dabigatran",
            "probability": 0.76171875
        },
        {
            "start_logit": 6.8515625,
            "end_logit": 4.87109375,
            "text": "Dabigatran etexilate",
            "probability": 0.2379150390625
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -6.1328125,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding time, which were reversed by idarucizumab.",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -6.65625,
            "text": "Dabigatran etexila",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.05859375,
            "text": "Dabigatran etexilate (",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.1328125,
            "text": "Dabigatran etexilate (DE) dose-dependently",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.1640625,
            "text": "Dabigatran etexilate (DE) dose-",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.23828125,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.29296875,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.40625,
            "text": "Dabigatran etexilate (DE",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.41015625,
            "text": "Dabigatran etexilate (DE)",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.47265625,
            "text": "Dabigatran etexilate (DE) dose",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.56640625,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding time, which were",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.58203125,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.58203125,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding time, which",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.5859375,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.61328125,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding time",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.8515625,
            "end_logit": -7.65625,
            "text": "Dabigatran etexilate (DE) dose-dependently prolonged diluted thrombin time and tail-vein bleeding time, which were reversed",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.05859375,
            "end_logit": 4.87109375,
            "text": "te",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.2265625,
            "end_logit": 4.87109375,
            "text": "exilate",
            "probability": 4.76837158203125e-07
        }
    ],
    "5a7237672dc08e987e000008_33": [
        {
            "start_logit": 6.30859375,
            "end_logit": 6.76171875,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 6.76171875,
            "text": "In this article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 6.76171875,
            "text": "this article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.703125,
            "end_logit": 6.76171875,
            "text": "article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 6.76171875,
            "text": ", we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 6.76171875,
            "text": "discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 6.76171875,
            "text": "we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 6.76171875,
            "text": "the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 6.76171875,
            "text": "efficacy for reversing effect of dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 6.76171875,
            "text": "effect of dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 6.76171875,
            "text": "evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 6.76171875,
            "text": "idarucizumab safety, tolerability and its efficacy for reversing effect of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 6.76171875,
            "text": "reversing effect of dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": -7.53515625,
            "text": "In this article",
            "probability": 0.0
        },
        {
            "start_logit": -7.39453125,
            "end_logit": -7.5703125,
            "text": "In this article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -7.53515625,
            "text": "this article",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -7.5703125,
            "text": "this article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for reversing effect of",
            "probability": 0.0
        },
        {
            "start_logit": -7.39453125,
            "end_logit": -7.6953125,
            "text": "In this article, we discuss the evidence addressing idarucizumab safety, tolerability and",
            "probability": 0.0
        },
        {
            "start_logit": -7.39453125,
            "end_logit": -7.703125,
            "text": "In this article, we discuss the evidence addressing idarucizumab safety,",
            "probability": 0.0
        },
        {
            "start_logit": -7.39453125,
            "end_logit": -7.71484375,
            "text": "In this article, we discuss the evidence addressing idarucizumab safety, tolerability and its efficacy for",
            "probability": 0.0
        }
    ],
    "5a7237672dc08e987e000008_34": [
        {
            "start_logit": 6.31640625,
            "end_logit": 6.75390625,
            "text": "dabigatran",
            "probability": 1.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 6.75390625,
            "text": "potential reversal agent for dabigatran",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.828125,
            "end_logit": 6.75390625,
            "text": "reversal agent for dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.828125,
            "end_logit": 6.75390625,
            "text": "a potential reversal agent for dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 6.75390625,
            "text": "Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 6.75390625,
            "text": "for dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 6.75390625,
            "text": "recent The Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 6.75390625,
            "text": ", a potential reversal agent for dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 6.75390625,
            "text": "idarucizumab, a potential reversal agent for dabigatran",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 6.75390625,
            "text": "This was until the recent The Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 6.75390625,
            "text": "approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 6.75390625,
            "text": "was until the recent The Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 6.75390625,
            "text": "The Food and Drug Administration approval of idarucizumab, a potential reversal agent for dabigatran",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -7.6484375,
            "text": "potential reversal agent",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": -7.484375,
            "text": "Food and Drug Administration",
            "probability": 0.0
        },
        {
            "start_logit": -7.84765625,
            "end_logit": -7.484375,
            "text": "recent The Food and Drug Administration",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": -7.58984375,
            "text": "Food and Drug Administration approval of",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": -7.59375,
            "text": "Food and Drug",
            "probability": 0.0
        },
        {
            "start_logit": -7.94140625,
            "end_logit": -7.484375,
            "text": "This was until the recent The Food and Drug Administration",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": -7.60546875,
            "text": "Food and",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_1": [
        {
            "start_logit": 8.2578125,
            "end_logit": 8.046875,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -0.89306640625,
            "text": "lectin",
            "probability": 0.00012934207916259766
        },
        {
            "start_logit": -1.474609375,
            "end_logit": 8.046875,
            "text": "pathway",
            "probability": 5.8770179748535156e-05
        },
        {
            "start_logit": -5.6796875,
            "end_logit": 8.046875,
            "text": "complement pathway",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.28125,
            "text": "lectin complement pathway and SLE.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.0703125,
            "end_logit": 8.046875,
            "text": "This study aims to investigate whether an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.3671875,
            "text": "lectin complement",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.41796875,
            "text": "lectin complement pathway and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 8.046875,
            "text": "investigate whether an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 8.046875,
            "text": "ficolins that are part of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 8.046875,
            "text": "part of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 8.046875,
            "text": "aims to investigate whether an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 8.046875,
            "text": "study aims to investigate whether an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 8.046875,
            "text": "the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 8.046875,
            "text": "whether an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 8.046875,
            "text": "olins that are part of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.828125,
            "end_logit": 8.046875,
            "text": "association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 8.046875,
            "text": "to investigate whether an association exists between the ficolins that are part of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 8.046875,
            "text": "between the ficolins that are part of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 8.046875,
            "text": "of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56c1d856ef6e394741000032_2": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.09375,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.0869140625,
            "text": "lectin",
            "probability": 0.00010395050048828125
        },
        {
            "start_logit": -1.283203125,
            "end_logit": 8.09375,
            "text": "pathway",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": -5.8046875,
            "end_logit": 8.09375,
            "text": "complement pathway",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.53125,
            "text": "lectin complement",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.55078125,
            "text": "lectin complement pathway (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.09375,
            "text": "To assess the involvement of ficolin-3, the main initiator of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6875,
            "text": "lectin complement pathway (LCP), in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 8.09375,
            "text": "OBJECTIVES: To assess the involvement of ficolin-3, the main initiator of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.09375,
            "text": "assess the involvement of ficolin-3, the main initiator of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.09375,
            "text": ": To assess the involvement of ficolin-3, the main initiator of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.78125,
            "text": "lectin complement pathway (LCP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.7890625,
            "text": "lectin complement pathway (LCP), in subarachnoid hemorrhage (SAH) pathology",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.8125,
            "text": "lectin complement pathway (LCP), in subarachnoid hemorrhage (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.81640625,
            "text": "lectin complement pathway (LCP)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.81640625,
            "text": "lectin complement pathway (LCP),",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 8.09375,
            "text": "ficolin-3, the main initiator of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 8.09375,
            "text": ", the main initiator of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 8.09375,
            "text": "olin-3, the main initiator of the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 8.09375,
            "text": "the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56c1d856ef6e394741000032_3": [
        {
            "start_logit": 8.1953125,
            "end_logit": 8.046875,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -1.1806640625,
            "text": "lectin",
            "probability": 9.763240814208984e-05
        },
        {
            "start_logit": -1.45703125,
            "end_logit": 8.046875,
            "text": "pathway",
            "probability": 6.401538848876953e-05
        },
        {
            "start_logit": -6.0390625,
            "end_logit": 8.046875,
            "text": "complement pathway",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -6.35546875,
            "text": "lectin complement pathway activation in",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -6.734375,
            "text": "lectin complement",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.1875,
            "text": "lectin complement pathway activation",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.34765625,
            "text": "lectin complement pathway activation in patients with subarachnoid hemorrhage.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 8.046875,
            "text": "mediated lectin complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 8.046875,
            "text": "Ficolin-3-mediated lectin complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.6171875,
            "text": "lectin complement pathway activation in patients with subarachnoid hemorrhage",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.6171875,
            "text": "lectin complement pathway activation in patients with subarachnoid",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.68359375,
            "text": "lectin complement pathway activation in patients",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.69921875,
            "text": "lectin complement pathway activation in patients with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 8.046875,
            "text": "olin-3-mediated lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 8.046875,
            "text": "-3-mediated lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.45703125,
            "end_logit": -6.35546875,
            "text": "pathway activation in",
            "probability": 0.0
        },
        {
            "start_logit": -7.41796875,
            "end_logit": -1.1806640625,
            "text": "mediated lectin",
            "probability": 0.0
        },
        {
            "start_logit": -7.44140625,
            "end_logit": -1.1806640625,
            "text": "Ficolin-3-mediated lectin",
            "probability": 0.0
        },
        {
            "start_logit": -1.45703125,
            "end_logit": -7.1875,
            "text": "pathway activation",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_4": [
        {
            "start_logit": 8.2890625,
            "end_logit": 7.9921875,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.560546875,
            "text": "lectin",
            "probability": 0.0001926422119140625
        },
        {
            "start_logit": -1.404296875,
            "end_logit": 7.9921875,
            "text": "pathway",
            "probability": 6.157159805297852e-05
        },
        {
            "start_logit": -5.98828125,
            "end_logit": 7.9921875,
            "text": "complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.30078125,
            "text": "lectin complement",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.0234375,
            "end_logit": 7.9921875,
            "text": "complement pathway",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 7.9921875,
            "text": "the lectin complement pathway",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.95703125,
            "end_logit": 7.9921875,
            "text": "among the lectin complement pathway",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -7.375,
            "text": "lectin complement pathway initiators.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -7.5625,
            "text": "lectin complement pathway initiator",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 7.9921875,
            "text": ", Ficolin-3 has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -7.68359375,
            "text": "lectin complement pathway initiators",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.9921875,
            "text": "Ficolin-3 has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 7.9921875,
            "text": "Moreover, Ficolin-3 has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 7.9921875,
            "text": "molecule among the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 7.9921875,
            "text": "high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 7.9921875,
            "text": "a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 7.9921875,
            "text": "olin-3 has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 7.9921875,
            "text": "collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 7.9921875,
            "text": "potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56c1d856ef6e394741000032_5": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.0078125,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.060546875,
            "text": "lectin",
            "probability": 0.0001150369644165039
        },
        {
            "start_logit": -1.537109375,
            "end_logit": 8.0078125,
            "text": "pathway",
            "probability": 5.829334259033203e-05
        },
        {
            "start_logit": -5.14453125,
            "end_logit": 8.0078125,
            "text": "complement pathway",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.21875,
            "text": "lectin complement",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.0078125,
            "text": "the lectin complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.66015625,
            "text": "lectin complement pathway.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 8.0078125,
            "text": "in the lectin complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.0078125,
            "text": "Ficolin-3 (Hakata antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.0078125,
            "text": "molecule in the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.0078125,
            "text": "Hakata antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 8.0078125,
            "text": "ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 8.0078125,
            "text": ") is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 8.0078125,
            "text": "kata antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 8.0078125,
            "text": "olin-3 (Hakata antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 8.0078125,
            "text": "pattern recognition molecule in the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 8.0078125,
            "text": "or H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 8.0078125,
            "text": "a antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 8.0078125,
            "text": "H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": -1.060546875,
            "text": "the lectin",
            "probability": 0.0
        }
    ],
    "56c1d856ef6e394741000032_6": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.1171875,
            "text": "lectin complement pathway",
            "probability": 1.0
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.001953125,
            "text": "lectin",
            "probability": 0.00010889768600463867
        },
        {
            "start_logit": -1.095703125,
            "end_logit": 8.1171875,
            "text": "pathway",
            "probability": 8.958578109741211e-05
        },
        {
            "start_logit": 2.6640625,
            "end_logit": 3.103515625,
            "text": "lectin pathway",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": -4.41796875,
            "end_logit": 8.1171875,
            "text": "complement pathway",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.7109375,
            "text": "lectin complement pathway and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.16796875,
            "text": "lectin complement",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 8.1171875,
            "text": "the lectin complement pathway",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.296875,
            "end_logit": 8.1171875,
            "text": "in the lectin complement pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4609375,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1, -2 and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.53125,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.5390625,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1, -2 and -",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.58203125,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1, -",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.59375,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.62109375,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1, -2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.62890625,
            "text": "lectin complement pathway and form",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.64453125,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.6484375,
            "text": "lectin complement pathway and form complexes with serine proteases named MASP-1, -2 and -3 and two nonenzymatic proteins. MASP",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 8.1171875,
            "text": "Ficolin-1, -2 and -3 are recognition molecules in the lectin complement pathway",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.6640625,
            "end_logit": -3.01953125,
            "text": "lectin",
            "probability": 5.960464477539063e-08
        }
    ],
    "5a7639419e632bc066000005_1": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1796875,
            "text": "DeepLoc",
            "probability": 1.0
        },
        {
            "start_logit": -0.919921875,
            "end_logit": 8.1796875,
            "text": "c",
            "probability": 0.00010639429092407227
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.1982421875,
            "text": "Deep",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": -6.375,
            "end_logit": 8.1796875,
            "text": "Loc",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.875,
            "text": "DeepLo",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.46484375,
            "text": "DeepLoc: prediction of protein subcellular localization using",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.515625,
            "text": "DeepLoc: prediction of protein subcellular localization",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.578125,
            "text": "DeepLoc: prediction of protein subcellular localization using deep learning",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.58984375,
            "text": "DeepLoc: prediction of protein subcellular",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.59375,
            "text": "DeepLoc: prediction of protein",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6328125,
            "text": "DeepLoc: prediction of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.65625,
            "text": "DeepLoc: prediction of protein subcellular localization using deep",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6875,
            "text": "DeepLoc: prediction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.919921875,
            "end_logit": -7.46484375,
            "text": "c: prediction of protein subcellular localization using",
            "probability": 0.0
        },
        {
            "start_logit": -0.919921875,
            "end_logit": -7.515625,
            "text": "c: prediction of protein subcellular localization",
            "probability": 0.0
        },
        {
            "start_logit": -0.919921875,
            "end_logit": -7.578125,
            "text": "c: prediction of protein subcellular localization using deep learning",
            "probability": 0.0
        },
        {
            "start_logit": -0.919921875,
            "end_logit": -7.58984375,
            "text": "c: prediction of protein subcellular",
            "probability": 0.0
        },
        {
            "start_logit": -0.919921875,
            "end_logit": -7.59375,
            "text": "c: prediction of protein",
            "probability": 0.0
        },
        {
            "start_logit": -0.919921875,
            "end_logit": -7.6328125,
            "text": "c: prediction of",
            "probability": 0.0
        },
        {
            "start_logit": -0.919921875,
            "end_logit": -7.65625,
            "text": "c: prediction of protein subcellular localization using deep",
            "probability": 0.0
        }
    ],
    "5a7639419e632bc066000005_2": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1796875,
            "text": "DeepLoc",
            "probability": 1.0
        },
        {
            "start_logit": -0.919921875,
            "end_logit": 8.1796875,
            "text": "c",
            "probability": 0.00010639429092407227
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.1982421875,
            "text": "Deep",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": -6.375,
            "end_logit": 8.1796875,
            "text": "Loc",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.875,
            "text": "DeepLo",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.46484375,
            "text": "DeepLoc: prediction of protein subcellular localization using",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.515625,
            "text": "DeepLoc: prediction of protein subcellular localization",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.578125,
            "text": "DeepLoc: prediction of protein subcellular localization using deep learning",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.58984375,
            "text": "DeepLoc: prediction of protein subcellular",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.59375,
            "text": "DeepLoc: prediction of protein",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6328125,
            "text": "DeepLoc: prediction of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.65625,
            "text": "DeepLoc: prediction of protein subcellular localization using deep",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6875,
            "text": "DeepLoc: prediction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.919921875,
            "end_logit": -7.46484375,
            "text": "c: prediction of protein subcellular localization using",
            "probability": 0.0
        },
        {
            "start_logit": -0.919921875,
            "end_logit": -7.515625,
            "text": "c: prediction of protein subcellular localization",
            "probability": 0.0
        },
        {
            "start_logit": -0.919921875,
            "end_logit": -7.578125,
            "text": "c: prediction of protein subcellular localization using deep learning",
            "probability": 0.0
        },
        {
            "start_logit": -0.919921875,
            "end_logit": -7.58984375,
            "text": "c: prediction of protein subcellular",
            "probability": 0.0
        },
        {
            "start_logit": -0.919921875,
            "end_logit": -7.59375,
            "text": "c: prediction of protein",
            "probability": 0.0
        },
        {
            "start_logit": -0.919921875,
            "end_logit": -7.6328125,
            "text": "c: prediction of",
            "probability": 0.0
        },
        {
            "start_logit": -0.919921875,
            "end_logit": -7.65625,
            "text": "c: prediction of protein subcellular localization using deep",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_1": [
        {
            "start_logit": 8.1953125,
            "end_logit": 8.140625,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.23046875,
            "end_logit": 8.140625,
            "text": "17A",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -1.39453125,
            "text": "interleukin",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": -6.6953125,
            "end_logit": 8.140625,
            "text": "-17A",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.43359375,
            "text": "interleukin-17A monoclonal antibody.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.515625,
            "text": "interleukin-17A monoclonal antibody",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.5703125,
            "text": "interleukin-17A monoclonal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.140625,
            "text": "anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.6171875,
            "text": "interleukin-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 8.140625,
            "text": "fully human anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 8.140625,
            "text": "Secukinumab is a fully human anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 8.140625,
            "text": "human anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 8.140625,
            "text": "inumab is a fully human anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 8.140625,
            "text": "ukinumab is a fully human anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 8.140625,
            "text": ": Secukinumab is a fully human anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.23046875,
            "end_logit": -7.43359375,
            "text": "17A monoclonal antibody.",
            "probability": 0.0
        },
        {
            "start_logit": -1.23046875,
            "end_logit": -7.515625,
            "text": "17A monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -1.23046875,
            "end_logit": -7.5703125,
            "text": "17A monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -1.39453125,
            "text": "anti-interleukin",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -1.39453125,
            "text": "fully human anti-interleukin",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_2": [
        {
            "start_logit": 8.1875,
            "end_logit": 8.1875,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.021484375,
            "end_logit": 8.1875,
            "text": "17A",
            "probability": 9.995698928833008e-05
        },
        {
            "start_logit": 8.1875,
            "end_logit": -1.4296875,
            "text": "interleukin",
            "probability": 6.657838821411133e-05
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 8.1875,
            "text": "-17A",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.2109375,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.35546875,
            "text": "interleukin-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.390625,
            "text": "interleukin-17A monoclonal antibody,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.44921875,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.4609375,
            "text": "interleukin-17A monoclonal antibody",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.515625,
            "text": "interleukin-17A monoclonal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.55078125,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.5546875,
            "text": "interleukin-17A monoclonal antibody, demonstrated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.56640625,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.1875,
            "text": "anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.57421875,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when administered via subcutaneous injection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.6015625,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when administered",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.609375,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when administered via",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.61328125,
            "text": "interleukin-17A monoclonal antibody, demonstrated efficacy and safety in moderate-to-severe plaque psoriasis when administered via subcutaneous injection.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.1875,
            "text": "fully human anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 8.1875,
            "text": "human anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        }
    ],
    "54e0d7471388e8454a000015_3": [
        {
            "start_logit": 8.1875,
            "end_logit": 8.171875,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.064453125,
            "end_logit": 8.171875,
            "text": "17A",
            "probability": 9.608268737792969e-05
        },
        {
            "start_logit": 8.1875,
            "end_logit": -1.427734375,
            "text": "interleukin",
            "probability": 6.765127182006836e-05
        },
        {
            "start_logit": -6.703125,
            "end_logit": 8.171875,
            "text": "-17A",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.06640625,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe plaque psoriasis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.3828125,
            "text": "interleukin-17A monoclonal antibody,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.43359375,
            "text": "interleukin-17A monoclonal antibody",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.4609375,
            "text": "interleukin-17A monoclonal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.4609375,
            "text": "interleukin-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.4609375,
            "text": "interleukin-17A monoclonal antibody, in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.5078125,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.54296875,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe plaque psoriasis.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 8.171875,
            "text": "anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.5703125,
            "text": "interleukin-17A monoclonal antibody, in patients with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 8.171875,
            "text": "fully human anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.61328125,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.64453125,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 8.171875,
            "text": "human anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 8.171875,
            "text": "secukinumab, a fully human anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 8.171875,
            "text": "evaluated secukinumab, a fully human anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        }
    ],
    "54e0d7471388e8454a000015_4": [
        {
            "start_logit": 8.1484375,
            "end_logit": 8.1171875,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.337890625,
            "end_logit": 8.1171875,
            "text": "17A",
            "probability": 7.605552673339844e-05
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -1.587890625,
            "text": "interleukin",
            "probability": 6.109476089477539e-05
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 8.1171875,
            "text": "-17A",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.2890625,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.5234375,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.55078125,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis:",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.56640625,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.58203125,
            "text": "interleukin-17A monoclonal antibody secukinumab in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.60546875,
            "text": "interleukin-17A monoclonal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.60546875,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.609375,
            "text": "interleukin-17A monoclonal antibody secukinumab",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.62109375,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.6328125,
            "text": "interleukin-17A monoclonal antibody",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.6484375,
            "text": "interleukin-17A monoclonal antibody secukinum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.6484375,
            "text": "interleukin-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.6484375,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.703125,
            "text": "interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.71875,
            "text": "interleukin-17A monoclonal antibody secuk",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 8.1171875,
            "text": "Anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        }
    ],
    "54e0d7471388e8454a000015_5": [
        {
            "start_logit": 8.1875,
            "end_logit": 8.1796875,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.0390625,
            "end_logit": 8.1796875,
            "text": "17A",
            "probability": 9.763240814208984e-05
        },
        {
            "start_logit": 8.1875,
            "end_logit": -1.4365234375,
            "text": "interleukin",
            "probability": 6.604194641113281e-05
        },
        {
            "start_logit": -6.75,
            "end_logit": 8.1796875,
            "text": "-17A",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.38671875,
            "text": "interleukin-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.390625,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.4921875,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.5546875,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.1796875,
            "text": "anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.578125,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.58984375,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.59375,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 8.1796875,
            "text": "fully human anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.62109375,
            "text": "interleukin-17A monoclonal antibody",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.63671875,
            "text": "interleukin-17A monoclonal antibody, in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.6484375,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.66015625,
            "text": "interleukin-17A monoclonal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.66796875,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.6796875,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.68359375,
            "text": "interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind,",
            "probability": 1.1920928955078125e-07
        }
    ],
    "54e0d7471388e8454a000015_6": [
        {
            "start_logit": 8.15625,
            "end_logit": 8.1640625,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.15625,
            "end_logit": 8.1640625,
            "text": "17A",
            "probability": 9.101629257202148e-05
        },
        {
            "start_logit": 8.15625,
            "end_logit": -1.5654296875,
            "text": "interleukin",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": -6.67578125,
            "end_logit": 8.1640625,
            "text": "-17A",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 8.1640625,
            "text": "targeted interleukin-17A",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.5234375,
            "text": "interleukin-17A blockade, in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.59375,
            "text": "interleukin-17A blockade",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.62890625,
            "text": "interleukin-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 8.1640625,
            "text": "fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.69921875,
            "text": "interleukin-17A blockade,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.71875,
            "text": "interleukin-17A blockade, in patients with noninfectious uveitis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 8.1640625,
            "text": "To determine the efficacy and safety of different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 8.1640625,
            "text": "determine the efficacy and safety of different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 8.1640625,
            "text": "PURPOSE: To determine the efficacy and safety of different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.7421875,
            "text": "interleukin-17A blockade, in patients with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 8.1640625,
            "text": "secukinumab, a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 8.1640625,
            "text": ", a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 8.1640625,
            "text": "monoclonal antibody for targeted interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 8.1640625,
            "text": "efficacy and safety of different doses of secukinumab, a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 8.1640625,
            "text": "inumab, a fully human monoclonal antibody for targeted interleukin-17A",
            "probability": 1.1920928955078125e-07
        }
    ],
    "54e0d7471388e8454a000015_7": [
        {
            "start_logit": 8.1328125,
            "end_logit": 8.1328125,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.255859375,
            "end_logit": 8.1328125,
            "text": "17A",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -1.66015625,
            "text": "interleukin",
            "probability": 5.561113357543945e-05
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.12109375,
            "text": "interleukin-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.1328125,
            "end_logit": 8.1328125,
            "text": "-17A",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.60546875,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.6484375,
            "text": "interleukin-17A-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.6796875,
            "text": "interleukin-17A-blocking antibody secukinumab",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.68359375,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.7109375,
            "text": "interleukin-17A-blocking antibody",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.73046875,
            "text": "interleukin-17A-blocking antibody secukinumab does",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.73046875,
            "text": "interleukin-17A-blocking",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.73828125,
            "text": "interleukin-17A-blocking antibody secukinum",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.74609375,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.74609375,
            "text": "interleukin-17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.7578125,
            "text": "interleukin-17A-blocking antibody secuk",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.255859375,
            "end_logit": -7.5703125,
            "text": "17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open-label",
            "probability": 0.0
        },
        {
            "start_logit": -1.255859375,
            "end_logit": -7.60546875,
            "text": "17A-blocking antibody secukinumab does not interfere with the efficacy of influenza and meningococcal vaccinations in healthy subjects: results of an open",
            "probability": 0.0
        },
        {
            "start_logit": -1.255859375,
            "end_logit": -7.6484375,
            "text": "17A-",
            "probability": 0.0
        },
        {
            "start_logit": -1.255859375,
            "end_logit": -7.6796875,
            "text": "17A-blocking antibody secukinumab",
            "probability": 0.0
        }
    ],
    "54e0d7471388e8454a000015_8": [
        {
            "start_logit": 8.171875,
            "end_logit": 8.1640625,
            "text": "interleukin-17A",
            "probability": 1.0
        },
        {
            "start_logit": -1.076171875,
            "end_logit": 8.1640625,
            "text": "17A",
            "probability": 9.5367431640625e-05
        },
        {
            "start_logit": 8.171875,
            "end_logit": -1.4404296875,
            "text": "interleukin",
            "probability": 6.711483001708984e-05
        },
        {
            "start_logit": 8.171875,
            "end_logit": -6.8203125,
            "text": "interleukin-17A (IL-17A",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 8.1640625,
            "text": "-17A",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.23828125,
            "text": "interleukin-17A (IL-17A) monoclonal antibody (MAb",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.2578125,
            "text": "interleukin-17A (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.28515625,
            "text": "interleukin-17A (IL",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.3359375,
            "text": "interleukin-17A (IL-17A)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.37890625,
            "text": "interleukin-17A (IL-17A) monoclonal antibody",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.41015625,
            "text": "interleukin-17A (IL-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.4375,
            "text": "interleukin-17A (IL-17A) monoclonal antibody (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.50390625,
            "text": "interleukin-17A (IL-17A) monoclonal antibody (MAb)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.5390625,
            "text": "interleukin-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.6171875,
            "text": "interleukin-17A (IL-17A) monoclonal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.64453125,
            "text": "interleukin-17A (IL-17A) monoclonal antibody (MAb) secukinumab.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.66796875,
            "text": "interleukin-17A (IL-17A) monoclonal antibody (MAb) secukinumab",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 8.1640625,
            "text": "Our objective was to evaluate the efficacy of influenza and meningococcal vaccinations in healthy subjects exposed to the anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 8.1640625,
            "text": "evaluate the efficacy of influenza and meningococcal vaccinations in healthy subjects exposed to the anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 8.1640625,
            "text": "influenza and meningococcal vaccinations in healthy subjects exposed to the anti-interleukin-17A",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58b6978822d300530900000a_1": [
        {
            "start_logit": 8.25,
            "end_logit": 8.140625,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.158203125,
            "text": "Alzheimer",
            "probability": 9.173154830932617e-05
        },
        {
            "start_logit": -1.23046875,
            "end_logit": 8.140625,
            "text": "disease",
            "probability": 7.605552673339844e-05
        },
        {
            "start_logit": -6.2109375,
            "end_logit": 8.140625,
            "text": "'s disease",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.4765625,
            "end_logit": 8.140625,
            "text": "s disease",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 8.140625,
            "text": "this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.078125,
            "end_logit": 8.140625,
            "text": "study the transgenic mice cognitive abilities presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.20703125,
            "text": "Alzheimer's",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.1171875,
            "end_logit": 8.140625,
            "text": "The novel approach to study the transgenic mice cognitive abilities presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.4765625,
            "text": "Alzheimer'",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 8.140625,
            "text": "novel approach to study the transgenic mice cognitive abilities presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 8.140625,
            "text": "the Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 8.140625,
            "text": "the transgenic mice cognitive abilities presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.6484375,
            "text": "Alzheimer's disease mouse",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.6484375,
            "text": "Alzheimer's disease mouse model.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 8.140625,
            "text": "in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.140625,
            "text": "presented in this paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.140625,
            "text": "insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.69140625,
            "text": "Alzheimer's disease mouse model",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 8.140625,
            "text": "paper offers new insight into cognitive dysfunctions of the Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58b6978822d300530900000a_2": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.1484375,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.2138671875,
            "text": "Alzheimer",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": -1.154296875,
            "end_logit": 8.1484375,
            "text": "disease",
            "probability": 8.416175842285156e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -5.29296875,
            "text": "Alzheimer's disease (AD",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.04296875,
            "text": "Alzheimer's disease (AD) is the massive loss of synapses that occurs at an early clinical stage of the disease",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.18359375,
            "text": "Alzheimer's disease (AD)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.1015625,
            "end_logit": 8.1484375,
            "text": "'s disease",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.375,
            "end_logit": 8.1484375,
            "text": "s disease",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.90625,
            "text": "Alzheimer's disease (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.9140625,
            "text": "Alzheimer's disease (AD) is the massive loss of synapses that occurs at an early clinical stage of the disease.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -0.6689453125,
            "end_logit": -1.072265625,
            "text": "Swedish mutation",
            "probability": 0.0
        },
        {
            "start_logit": -2.072265625,
            "end_logit": -1.072265625,
            "text": "the Swedish mutation",
            "probability": 0.0
        },
        {
            "start_logit": -0.6689453125,
            "end_logit": -2.76953125,
            "text": "Swedish",
            "probability": 0.0
        },
        {
            "start_logit": -3.203125,
            "end_logit": -1.072265625,
            "text": "carrying the Swedish mutation",
            "probability": 0.0
        },
        {
            "start_logit": -2.072265625,
            "end_logit": -2.76953125,
            "text": "the Swedish",
            "probability": 0.0
        },
        {
            "start_logit": -2.06640625,
            "end_logit": -3.5234375,
            "text": "carrying the London mutation",
            "probability": 0.0
        },
        {
            "start_logit": -3.203125,
            "end_logit": -2.76953125,
            "text": "carrying the Swedish",
            "probability": 0.0
        },
        {
            "start_logit": -5.0859375,
            "end_logit": -1.072265625,
            "text": "mutation",
            "probability": 0.0
        },
        {
            "start_logit": -0.6689453125,
            "end_logit": -5.60546875,
            "text": "Swedish mutation, compared with wild-type littermates. A similar reduction of 42",
            "probability": 0.0
        },
        {
            "start_logit": -0.6689453125,
            "end_logit": -5.703125,
            "text": "Swedish mutation, compared with wild-type littermates. A similar reduction of 42%",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_3": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.1015625,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.2822265625,
            "text": "Alzheimer",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": -1.384765625,
            "end_logit": 8.1015625,
            "text": "disease",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": -5.95703125,
            "end_logit": 8.1015625,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.09375,
            "end_logit": 8.1015625,
            "text": "'s disease",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.37890625,
            "end_logit": 8.1015625,
            "text": "s disease",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.90625,
            "end_logit": 8.1015625,
            "text": "The London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.0703125,
            "text": "Alzheimer's disease.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.5,
            "text": "Alzheimer's",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.1015625,
            "text": "APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 8.1015625,
            "text": "with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 8.1015625,
            "text": "(Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.72265625,
            "text": "Alzheimer'",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.1015625,
            "text": "onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 8.1015625,
            "text": "early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 8.1015625,
            "text": "London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 8.1015625,
            "text": "two Italian families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 8.1015625,
            "text": "717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 8.1015625,
            "text": "families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 8.1015625,
            "text": "mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58b6978822d300530900000a_4": [
        {
            "start_logit": 6.3203125,
            "end_logit": 6.82421875,
            "text": "AD",
            "probability": 0.5
        },
        {
            "start_logit": 6.30859375,
            "end_logit": 6.83203125,
            "text": "AD",
            "probability": 0.5
        },
        {
            "start_logit": -6.484375,
            "end_logit": 6.83203125,
            "text": ". Two subjects of the other family with AD",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 6.82421875,
            "text": ", this mutation was responsible for AD",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 6.83203125,
            "text": "with AD",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -6.6953125,
            "text": "AD in",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.21875,
            "end_logit": 6.82421875,
            "text": "mutation was responsible for AD",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 6.82421875,
            "text": "In 1 family, this mutation was responsible for AD",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -6.859375,
            "text": "AD diagnosis were carriers of the same mutation",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 6.82421875,
            "text": "this mutation was responsible for AD",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 6.82421875,
            "text": "family, this mutation was responsible for AD",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 6.82421875,
            "text": "1 family, this mutation was responsible for AD",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 6.83203125,
            "text": "present in a fourth sibling who has only shown signs of executive dysfunction so far. Two subjects of the other family with AD",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.171875,
            "text": "AD diagnosis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.35546875,
            "text": "AD in 3 out",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.421875,
            "text": "AD in 3 out of 7 siblings and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.44921875,
            "text": "AD in 3 out of 7 siblings and it is also present in a fourth sibling who has only shown signs of executive dysfunction so",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.4453125,
            "text": "AD diagnosis were carriers",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.46484375,
            "text": "AD in 3 out of 7 siblings and it is also present in a fourth sibling who has only shown signs of executive dysfunction so far.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.46484375,
            "text": "AD diagnosis were carriers of the same mutation.",
            "probability": 2.980232238769531e-07
        }
    ],
    "58b6978822d300530900000a_5": [
        {
            "start_logit": 6.3203125,
            "end_logit": 6.82421875,
            "text": "AD",
            "probability": 0.5
        },
        {
            "start_logit": 6.30859375,
            "end_logit": 6.83203125,
            "text": "AD",
            "probability": 0.5
        },
        {
            "start_logit": -6.484375,
            "end_logit": 6.83203125,
            "text": ". Two subjects of the other family with AD",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 6.82421875,
            "text": ", this mutation was responsible for AD",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 6.83203125,
            "text": "with AD",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -6.6953125,
            "text": "AD in",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.21875,
            "end_logit": 6.82421875,
            "text": "mutation was responsible for AD",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 6.82421875,
            "text": "In 1 family, this mutation was responsible for AD",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -6.859375,
            "text": "AD diagnosis were carriers of the same mutation",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 6.82421875,
            "text": "this mutation was responsible for AD",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 6.82421875,
            "text": "family, this mutation was responsible for AD",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 6.82421875,
            "text": "1 family, this mutation was responsible for AD",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 6.83203125,
            "text": "present in a fourth sibling who has only shown signs of executive dysfunction so far. Two subjects of the other family with AD",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.171875,
            "text": "AD diagnosis",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.35546875,
            "text": "AD in 3 out",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.421875,
            "text": "AD in 3 out of 7 siblings and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.44921875,
            "text": "AD in 3 out of 7 siblings and it is also present in a fourth sibling who has only shown signs of executive dysfunction so",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.4453125,
            "text": "AD diagnosis were carriers",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.46484375,
            "text": "AD in 3 out of 7 siblings and it is also present in a fourth sibling who has only shown signs of executive dysfunction so far.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.46484375,
            "text": "AD diagnosis were carriers of the same mutation.",
            "probability": 2.980232238769531e-07
        }
    ],
    "58b6978822d300530900000a_6": [
        {
            "start_logit": 6.09765625,
            "end_logit": 6.703125,
            "text": "AD",
            "probability": 0.26953125
        },
        {
            "start_logit": 6.0,
            "end_logit": 6.703125,
            "text": "AD",
            "probability": 0.245361328125
        },
        {
            "start_logit": 6.0,
            "end_logit": 6.703125,
            "text": "AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD",
            "probability": 0.245361328125
        },
        {
            "start_logit": 6.046875,
            "end_logit": 6.6328125,
            "text": "AD",
            "probability": 0.23974609375
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -1.1083984375,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP",
            "probability": 0.00010949373245239258
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -1.8447265625,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(LON",
            "probability": 5.233287811279297e-05
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -3.3515625,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": 6.046875,
            "end_logit": -3.41796875,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": -4.23828125,
            "end_logit": 6.703125,
            "text": ". For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": -4.23828125,
            "end_logit": 6.703125,
            "text": ". Studies have revealed a strong genetic linkage in the early-onset familial form (<60 years old) of AD",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -4.3203125,
            "text": "AD.",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -4.37109375,
            "text": "AD. These mutants facilitate Abeta",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 6.046875,
            "end_logit": -4.3203125,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta), a metabolic product of amyloid precursor protein (APP).",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 6.0,
            "end_logit": -4.3203125,
            "text": "AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD.",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 6.0,
            "end_logit": -4.32421875,
            "text": "AD.",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 6.0,
            "end_logit": -4.37109375,
            "text": "AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD. These mutants facilitate Abeta",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -4.5078125,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(LON)",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 6.046875,
            "end_logit": -4.52734375,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta), a metabolic product of amyloid precursor protein (APP",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -5.046875,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -5.71875,
            "end_logit": 6.703125,
            "text": "of AD",
            "probability": 1.9669532775878906e-06
        }
    ],
    "58b6978822d300530900000a_7": [
        {
            "start_logit": 6.09765625,
            "end_logit": 6.703125,
            "text": "AD",
            "probability": 0.26953125
        },
        {
            "start_logit": 6.0,
            "end_logit": 6.703125,
            "text": "AD",
            "probability": 0.245361328125
        },
        {
            "start_logit": 6.0,
            "end_logit": 6.703125,
            "text": "AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD",
            "probability": 0.245361328125
        },
        {
            "start_logit": 6.046875,
            "end_logit": 6.6328125,
            "text": "AD",
            "probability": 0.23974609375
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -1.1083984375,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP",
            "probability": 0.00010949373245239258
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -1.8447265625,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(LON",
            "probability": 5.233287811279297e-05
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -3.3515625,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": 6.046875,
            "end_logit": -3.41796875,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": -4.23828125,
            "end_logit": 6.703125,
            "text": ". For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": -4.23828125,
            "end_logit": 6.703125,
            "text": ". Studies have revealed a strong genetic linkage in the early-onset familial form (<60 years old) of AD",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -4.3203125,
            "text": "AD.",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -4.37109375,
            "text": "AD. These mutants facilitate Abeta",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 6.046875,
            "end_logit": -4.3203125,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta), a metabolic product of amyloid precursor protein (APP).",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 6.0,
            "end_logit": -4.3203125,
            "text": "AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD.",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 6.0,
            "end_logit": -4.32421875,
            "text": "AD.",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 6.0,
            "end_logit": -4.37109375,
            "text": "AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD. These mutants facilitate Abeta",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -4.5078125,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(LON)",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 6.046875,
            "end_logit": -4.52734375,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta), a metabolic product of amyloid precursor protein (APP",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -5.046875,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -5.71875,
            "end_logit": 6.703125,
            "text": "of AD",
            "probability": 1.9669532775878906e-06
        }
    ],
    "58b6978822d300530900000a_8": [
        {
            "start_logit": 6.09765625,
            "end_logit": 6.703125,
            "text": "AD",
            "probability": 0.26953125
        },
        {
            "start_logit": 6.0,
            "end_logit": 6.703125,
            "text": "AD",
            "probability": 0.245361328125
        },
        {
            "start_logit": 6.0,
            "end_logit": 6.703125,
            "text": "AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD",
            "probability": 0.245361328125
        },
        {
            "start_logit": 6.046875,
            "end_logit": 6.6328125,
            "text": "AD",
            "probability": 0.23974609375
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -1.1083984375,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP",
            "probability": 0.00010949373245239258
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -1.8447265625,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(LON",
            "probability": 5.233287811279297e-05
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -3.3515625,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": 6.046875,
            "end_logit": -3.41796875,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": -4.23828125,
            "end_logit": 6.703125,
            "text": ". For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": -4.23828125,
            "end_logit": 6.703125,
            "text": ". Studies have revealed a strong genetic linkage in the early-onset familial form (<60 years old) of AD",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -4.3203125,
            "text": "AD.",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -4.37109375,
            "text": "AD. These mutants facilitate Abeta",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 6.046875,
            "end_logit": -4.3203125,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta), a metabolic product of amyloid precursor protein (APP).",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 6.0,
            "end_logit": -4.3203125,
            "text": "AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD.",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 6.0,
            "end_logit": -4.32421875,
            "text": "AD.",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 6.0,
            "end_logit": -4.37109375,
            "text": "AD. For example, some mutant APPs are transmitted dominantly and are segregated with inheritance of early onset AD. These mutants facilitate Abeta",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -4.5078125,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(LON)",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 6.046875,
            "end_logit": -4.52734375,
            "text": "AD patient is extracellular amyloid plaques formed by accumulated beta-amyloid protein (Abeta), a metabolic product of amyloid precursor protein (APP",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -5.046875,
            "text": "AD. These mutants facilitate Abeta production. The \"Swedish\" mutations (APP(SW)) and the \"London\" mutation (APP(",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -5.71875,
            "end_logit": 6.703125,
            "text": "of AD",
            "probability": 1.9669532775878906e-06
        }
    ],
    "58b6978822d300530900000a_9": [
        {
            "start_logit": 6.32421875,
            "end_logit": 6.75,
            "text": "AD",
            "probability": 1.0
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -5.109375,
            "text": "AD development.",
            "probability": 7.092952728271484e-06
        },
        {
            "start_logit": -5.546875,
            "end_logit": 6.75,
            "text": "APP(SW) and APP(LON) in AD",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": -6.17578125,
            "end_logit": 6.75,
            "text": "of APP(SW) and APP(LON) in AD",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 6.75,
            "text": "investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -6.6875,
            "end_logit": 6.75,
            "text": "the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -6.984375,
            "end_logit": 6.75,
            "text": "studies to investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -7.046875,
            "end_logit": 6.75,
            "text": "to investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 6.75,
            "text": "study may be useful in both in vivo and in vitro studies to investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 6.75,
            "text": "this study may be useful in both in vivo and in vitro studies to investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 6.75,
            "text": "in AD",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -6.7578125,
            "text": "AD development",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.46875,
            "end_logit": 6.75,
            "text": "in vitro studies to investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 6.75,
            "text": "vitro studies to investigate the pathophysiological role of APP(SW) and APP(LON) in AD",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -2.904296875,
            "end_logit": -3.650390625,
            "text": "APP(SW)",
            "probability": 0.0
        },
        {
            "start_logit": -2.904296875,
            "end_logit": -5.58984375,
            "text": "APP(SW) and APP",
            "probability": 0.0
        },
        {
            "start_logit": -2.904296875,
            "end_logit": -5.640625,
            "text": "APP",
            "probability": 0.0
        },
        {
            "start_logit": -2.904296875,
            "end_logit": -5.7578125,
            "text": "APP(SW) and APP(LON) as identified in this study may",
            "probability": 0.0
        },
        {
            "start_logit": -2.904296875,
            "end_logit": -6.0,
            "text": "APP(SW) and",
            "probability": 0.0
        },
        {
            "start_logit": -2.904296875,
            "end_logit": -6.32421875,
            "text": "APP(SW",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_10": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.140625,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.20703125,
            "end_logit": 8.140625,
            "text": "disease",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.3408203125,
            "text": "Alzheimer",
            "probability": 7.724761962890625e-05
        },
        {
            "start_logit": -6.21484375,
            "end_logit": 8.140625,
            "text": "'s disease",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 8.140625,
            "text": "s disease",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 8.140625,
            "text": "familial Alzheimer's disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.1171875,
            "text": "Alzheimer's",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 8.140625,
            "text": "Here, we show ASP-RNAi against the Swedish- and London-type amyloid precursor protein (APP) variants related to familial Alzheimer's disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.37109375,
            "text": "Alzheimer's disease using",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 8.140625,
            "text": "amyloid precursor protein (APP) variants related to familial Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.359375,
            "end_logit": 8.140625,
            "text": ", we show ASP-RNAi against the Swedish- and London-type amyloid precursor protein (APP) variants related to familial Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.49609375,
            "text": "Alzheimer's disease using two reporter alleles encoding the Photinus and Renilla luciferase genes and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.140625,
            "text": "and London-type amyloid precursor protein (APP) variants related to familial Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.53125,
            "text": "Alzheimer'",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.140625,
            "text": "show ASP-RNAi against the Swedish- and London-type amyloid precursor protein (APP) variants related to familial Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.5859375,
            "text": "Alzheimer's disease using two reporter alleles encoding the Photinus and Renilla luciferase genes and carrying mutant and wild-type",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.58984375,
            "text": "Alzheimer's disease using two reporter alleles encoding the Photinus and Renilla luciferase genes and carrying mutant and wild-type allelic sequences in their 3'",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 8.140625,
            "text": "Swedish- and London-type amyloid precursor protein (APP) variants related to familial Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.140625,
            "text": "to familial Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.140625,
            "text": "type amyloid precursor protein (APP) variants related to familial Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58b6978822d300530900000a_11": [
        {
            "start_logit": 8.1796875,
            "end_logit": 8.1328125,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.232421875,
            "end_logit": 8.1328125,
            "text": "disease",
            "probability": 8.153915405273438e-05
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -1.453125,
            "text": "Alzheimer",
            "probability": 6.866455078125e-05
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -4.828125,
            "text": "Alzheimer's disease (V642I",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -6.15625,
            "text": "Alzheimer's disease (V642",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.12109375,
            "end_logit": 8.1328125,
            "text": "'s disease",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -6.265625,
            "text": "Alzheimer's disease (V64",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -6.65234375,
            "text": "Alzheimer's disease (V",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.61328125,
            "end_logit": 8.1328125,
            "text": "s disease",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -6.7578125,
            "text": "Alzheimer's disease (V642I, so-called",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.109375,
            "text": "Alzheimer's disease (V642I, so-called London mutation, hereafter APPLd2)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.22265625,
            "text": "Alzheimer's",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.234375,
            "text": "Alzheimer's disease (V642I, so",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.28515625,
            "text": "Alzheimer's disease (V642I, so-called London mutation, hereafter APPLd2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.3046875,
            "text": "Alzheimer's disease (V642I, so-called London mutation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.3125,
            "text": "Alzheimer's disease (V642I, so-called London mutation, hereafter APPLd2) and wild-type controls were",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.3359375,
            "text": "Alzheimer's disease (V642I, so-called London mutation, hereafter",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.3984375,
            "text": "Alzheimer's disease (V642I, so-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.4140625,
            "text": "Alzheimer's disease (V642I, so-called London mutation,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 8.1328125,
            "text": "695 isoform) bearing a mutation associated with Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        }
    ],
    "58b6978822d300530900000a_12": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.1640625,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.2158203125,
            "text": "Alzheimer",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": -1.146484375,
            "end_logit": 8.1640625,
            "text": "disease",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -5.703125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.00390625,
            "end_logit": 8.1640625,
            "text": "'s disease",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.1484375,
            "end_logit": 8.1640625,
            "text": "s disease",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.0390625,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 8.1640625,
            "text": "Allele-specific silencing of Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 8.1640625,
            "text": "of Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 8.1640625,
            "text": "specific silencing of Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.62109375,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.1640625,
            "text": "silencing of Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6640625,
            "text": "Alzheimer's disease genes: the amyloid precursor protein",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.72265625,
            "text": "Alzheimer's disease genes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.78515625,
            "text": "Alzheimer's",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.146484375,
            "end_logit": -5.703125,
            "text": "disease genes: the amyloid precursor protein genes with Swedish",
            "probability": 0.0
        },
        {
            "start_logit": -1.146484375,
            "end_logit": -7.0390625,
            "text": "disease genes: the amyloid precursor protein genes with Swedish or London mutations.",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -1.2158203125,
            "text": "Allele-specific silencing of Alzheimer",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -1.2158203125,
            "text": "of Alzheimer",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -1.2158203125,
            "text": "specific silencing of Alzheimer",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_13": [
        {
            "start_logit": 8.1171875,
            "end_logit": 7.9453125,
            "text": "Alzheimers disease",
            "probability": 1.0
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -1.484375,
            "text": "Alzheimer",
            "probability": 8.028745651245117e-05
        },
        {
            "start_logit": -1.900390625,
            "end_logit": 7.9453125,
            "text": "disease",
            "probability": 4.470348358154297e-05
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -4.83984375,
            "text": "Alzheimers disease (AD",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -5.01171875,
            "text": "Alzheimers disease (AD)",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.53515625,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense mutation in exon 17",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.5390625,
            "text": "Alzheimers disease (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.59375,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.69921875,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense mutation",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.8515625,
            "text": "Alzheimers",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.0,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21 (Val",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.125,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.1875,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.02734375,
            "end_logit": 7.9453125,
            "text": "s disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.9453125,
            "text": "Mutations in the amyloid precursor protein gene were the first to be recognized as a cause of Alzheimers disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.900390625,
            "end_logit": -4.83984375,
            "text": "disease (AD",
            "probability": 0.0
        },
        {
            "start_logit": -1.900390625,
            "end_logit": -5.01171875,
            "text": "disease (AD)",
            "probability": 0.0
        },
        {
            "start_logit": -1.900390625,
            "end_logit": -5.41796875,
            "text": "disease (AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21 (Val717",
            "probability": 0.0
        },
        {
            "start_logit": -1.900390625,
            "end_logit": -5.89453125,
            "text": "disease (AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21 (Val71",
            "probability": 0.0
        },
        {
            "start_logit": -1.900390625,
            "end_logit": -6.53515625,
            "text": "disease (AD).We describe 2 Italian families showing the missense mutation in exon 17",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_14": [
        {
            "start_logit": 8.1171875,
            "end_logit": 7.9453125,
            "text": "Alzheimers disease",
            "probability": 1.0
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -1.484375,
            "text": "Alzheimer",
            "probability": 8.028745651245117e-05
        },
        {
            "start_logit": -1.900390625,
            "end_logit": 7.9453125,
            "text": "disease",
            "probability": 4.470348358154297e-05
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -4.83984375,
            "text": "Alzheimers disease (AD",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -5.01171875,
            "text": "Alzheimers disease (AD)",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.53515625,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense mutation in exon 17",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.5390625,
            "text": "Alzheimers disease (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.59375,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.69921875,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense mutation",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.8515625,
            "text": "Alzheimers",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.0,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21 (Val",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.125,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.1875,
            "text": "Alzheimers disease (AD).We describe 2 Italian families showing the missense",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.02734375,
            "end_logit": 7.9453125,
            "text": "s disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 7.9453125,
            "text": "Mutations in the amyloid precursor protein gene were the first to be recognized as a cause of Alzheimers disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.900390625,
            "end_logit": -4.83984375,
            "text": "disease (AD",
            "probability": 0.0
        },
        {
            "start_logit": -1.900390625,
            "end_logit": -5.01171875,
            "text": "disease (AD)",
            "probability": 0.0
        },
        {
            "start_logit": -1.900390625,
            "end_logit": -5.41796875,
            "text": "disease (AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21 (Val717",
            "probability": 0.0
        },
        {
            "start_logit": -1.900390625,
            "end_logit": -5.89453125,
            "text": "disease (AD).We describe 2 Italian families showing the missense mutation in exon 17 of the amyloid precursor protein gene on chromosome 21 (Val71",
            "probability": 0.0
        },
        {
            "start_logit": -1.900390625,
            "end_logit": -6.53515625,
            "text": "disease (AD).We describe 2 Italian families showing the missense mutation in exon 17",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_15": [
        {
            "start_logit": 8.1875,
            "end_logit": 8.03125,
            "text": "Alzheimers disease",
            "probability": 1.0
        },
        {
            "start_logit": 8.1875,
            "end_logit": -1.4033203125,
            "text": "Alzheimer",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": -1.53515625,
            "end_logit": 8.03125,
            "text": "disease",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": 8.1875,
            "end_logit": -6.62890625,
            "text": "Alzheimers",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.52734375,
            "end_logit": 8.03125,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.8828125,
            "end_logit": 8.03125,
            "text": "s disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 8.03125,
            "text": "The London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 8.03125,
            "text": "with early-onset Alzheimers disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 8.03125,
            "text": "APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 8.03125,
            "text": "onset Alzheimers disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 8.03125,
            "text": "early-onset Alzheimers disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 8.03125,
            "text": "London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 8.03125,
            "text": "two Italian families with early-onset Alzheimers disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 8.03125,
            "text": "(Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimers disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 8.03125,
            "text": "families with early-onset Alzheimers disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.52734375,
            "end_logit": -1.4033203125,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -1.4033203125,
            "text": "The London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -1.4033203125,
            "text": "with early-onset Alzheimer",
            "probability": 0.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -1.4033203125,
            "text": "APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer",
            "probability": 0.0
        },
        {
            "start_logit": -7.76953125,
            "end_logit": -1.4033203125,
            "text": "onset Alzheimer",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_16": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.1640625,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.2158203125,
            "text": "Alzheimer",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": -1.146484375,
            "end_logit": 8.1640625,
            "text": "disease",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -5.703125,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.00390625,
            "end_logit": 8.1640625,
            "text": "'s disease",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.1484375,
            "end_logit": 8.1640625,
            "text": "s disease",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.0390625,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 8.1640625,
            "text": "Allele-specific silencing of Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 8.1640625,
            "text": "of Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 8.1640625,
            "text": "specific silencing of Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.62109375,
            "text": "Alzheimer's disease genes: the amyloid precursor protein genes with Swedish or London mutations",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.1640625,
            "text": "silencing of Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6640625,
            "text": "Alzheimer's disease genes: the amyloid precursor protein",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.72265625,
            "text": "Alzheimer's disease genes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.78515625,
            "text": "Alzheimer's",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.146484375,
            "end_logit": -5.703125,
            "text": "disease genes: the amyloid precursor protein genes with Swedish",
            "probability": 0.0
        },
        {
            "start_logit": -1.146484375,
            "end_logit": -7.0390625,
            "text": "disease genes: the amyloid precursor protein genes with Swedish or London mutations.",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -1.2158203125,
            "text": "Allele-specific silencing of Alzheimer",
            "probability": 0.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": -1.2158203125,
            "text": "of Alzheimer",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -1.2158203125,
            "text": "specific silencing of Alzheimer",
            "probability": 0.0
        }
    ],
    "58b6978822d300530900000a_17": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.1015625,
            "text": "Alzheimer's disease",
            "probability": 1.0
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.2822265625,
            "text": "Alzheimer",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": -1.384765625,
            "end_logit": 8.1015625,
            "text": "disease",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": -5.95703125,
            "end_logit": 8.1015625,
            "text": "Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.09375,
            "end_logit": 8.1015625,
            "text": "'s disease",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.37890625,
            "end_logit": 8.1015625,
            "text": "s disease",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.90625,
            "end_logit": 8.1015625,
            "text": "The London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.0703125,
            "text": "Alzheimer's disease.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.5,
            "text": "Alzheimer's",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 8.1015625,
            "text": "APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 8.1015625,
            "text": "with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 8.1015625,
            "text": "(Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.72265625,
            "text": "Alzheimer'",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.1015625,
            "text": "onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 8.1015625,
            "text": "early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 8.1015625,
            "text": "London APP mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 8.1015625,
            "text": "two Italian families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 8.1015625,
            "text": "717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 8.1015625,
            "text": "families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 8.1015625,
            "text": "mutation (Val717Ile) associated with early shifting abilities and behavioral changes in two Italian families with early-onset Alzheimer's disease",
            "probability": 1.1920928955078125e-07
        }
    ],
    "52fe58f82059c6d71c00007a_1": [
        {
            "start_logit": 7.5703125,
            "end_logit": 4.00390625,
            "text": "multiple",
            "probability": 0.986328125
        },
        {
            "start_logit": 3.072265625,
            "end_logit": 4.00390625,
            "text": "single origins, whereas most archaea and all eukaryotes replicate using multiple",
            "probability": 0.010955810546875
        },
        {
            "start_logit": 7.5703125,
            "end_logit": -2.021484375,
            "text": "multiple origins.",
            "probability": 0.0023708343505859375
        },
        {
            "start_logit": 3.072265625,
            "end_logit": 0.716796875,
            "text": "single",
            "probability": 0.0004086494445800781
        },
        {
            "start_logit": 7.5703125,
            "end_logit": -4.66015625,
            "text": "multiple origins",
            "probability": 0.0001690387725830078
        },
        {
            "start_logit": 3.072265625,
            "end_logit": -2.021484375,
            "text": "single origins, whereas most archaea and all eukaryotes replicate using multiple origins.",
            "probability": 2.6345252990722656e-05
        },
        {
            "start_logit": 3.072265625,
            "end_logit": -4.66015625,
            "text": "single origins, whereas most archaea and all eukaryotes replicate using multiple origins",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -5.671875,
            "end_logit": 4.00390625,
            "text": "Bacteria and some archaea replicate from single origins, whereas most archaea and all eukaryotes replicate using multiple",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.48828125,
            "end_logit": 4.00390625,
            "text": "using multiple",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 3.072265625,
            "end_logit": -5.98828125,
            "text": "single origins",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 4.00390625,
            "text": "from single origins, whereas most archaea and all eukaryotes replicate using multiple",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.234375,
            "end_logit": 4.00390625,
            "text": ", whereas most archaea and all eukaryotes replicate using multiple",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 4.00390625,
            "text": "replicate from single origins, whereas most archaea and all eukaryotes replicate using multiple",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 4.00390625,
            "text": "replicate using multiple",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 4.00390625,
            "text": "most archaea and all eukaryotes replicate using multiple",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 4.00390625,
            "text": "eukaryotes replicate using multiple",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 4.00390625,
            "text": "whereas most archaea and all eukaryotes replicate using multiple",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 4.00390625,
            "text": "archaea replicate from single origins, whereas most archaea and all eukaryotes replicate using multiple",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 4.00390625,
            "text": "all eukaryotes replicate using multiple",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 4.00390625,
            "text": "and all eukaryotes replicate using multiple",
            "probability": 1.7881393432617188e-07
        }
    ],
    "52fe58f82059c6d71c00007a_2": [
        {
            "start_logit": 7.3046875,
            "end_logit": 4.80078125,
            "text": "multiple",
            "probability": 1.0
        },
        {
            "start_logit": 7.3046875,
            "end_logit": -5.59765625,
            "text": "multiple DNA replication origins are",
            "probability": 3.0219554901123047e-05
        },
        {
            "start_logit": 7.3046875,
            "end_logit": -6.64453125,
            "text": "multiple DNA replication origins",
            "probability": 1.0609626770019531e-05
        },
        {
            "start_logit": 7.3046875,
            "end_logit": -6.93359375,
            "text": "multiple DNA replication origins are a hallmark of Eukaryotes and",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": 7.3046875,
            "end_logit": -7.26171875,
            "text": "multiple DNA replication origins are a",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": 7.3046875,
            "end_logit": -7.34765625,
            "text": "multiple DNA replication",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": 7.3046875,
            "end_logit": -7.37890625,
            "text": "multiple DNA replication origins are a hallmark of Eukaryotes and some",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": 7.3046875,
            "end_logit": -7.47265625,
            "text": "multiple DNA replication origins are a hallmark of Eukaryotes",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 7.3046875,
            "end_logit": -7.57421875,
            "text": "multiple DNA replication origins are a hallmark of Eukaryotes and some Archaea",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": 7.3046875,
            "end_logit": -7.671875,
            "text": "multiple DNA replication origins are a hallmark",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -7.53125,
            "end_logit": -5.59765625,
            "text": "DNA replication origins are",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -6.64453125,
            "text": "DNA replication origins",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -6.93359375,
            "text": "DNA replication origins are a hallmark of Eukaryotes and",
            "probability": 0.0
        },
        {
            "start_logit": -7.76171875,
            "end_logit": -6.93359375,
            "text": "of Eukaryotes and",
            "probability": 0.0
        },
        {
            "start_logit": -7.8359375,
            "end_logit": -6.93359375,
            "text": "a hallmark of Eukaryotes and",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -6.93359375,
            "text": "Eukaryotes and",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -7.26171875,
            "text": "DNA replication origins are a",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -6.93359375,
            "text": "hallmark of Eukaryotes and",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -7.34765625,
            "text": "DNA replication",
            "probability": 0.0
        },
        {
            "start_logit": -7.53125,
            "end_logit": -7.37890625,
            "text": "DNA replication origins are a hallmark of Eukaryotes and some",
            "probability": 0.0
        }
    ],
    "52fe58f82059c6d71c00007a_3": [
        {
            "start_logit": 7.3203125,
            "end_logit": 0.67919921875,
            "text": "Multiple",
            "probability": 0.9873046875
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -4.46484375,
            "text": "Multiple orc/cdc6-associated replication origins were",
            "probability": 0.00576019287109375
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -6.54296875,
            "text": "Multiple orc/cdc6-associated replication origins",
            "probability": 0.000720977783203125
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -6.6171875,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed haloarchaeal genome",
            "probability": 0.0006690025329589844
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -6.66796875,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all",
            "probability": 0.0006361007690429688
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -6.77734375,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in",
            "probability": 0.0005702972412109375
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -6.9375,
            "text": "Multiple orc/cdc6",
            "probability": 0.0004858970642089844
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -7.0625,
            "text": "Multiple orc/cdc6-associated replication origins were predicted",
            "probability": 0.0004286766052246094
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -7.07421875,
            "text": "Multiple orc/cdc6-",
            "probability": 0.00042366981506347656
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -7.0859375,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed haloarchaeal",
            "probability": 0.0004189014434814453
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -7.23046875,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed haloarch",
            "probability": 0.000362396240234375
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -7.2578125,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed haloarchaea",
            "probability": 0.00035262107849121094
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -7.26953125,
            "text": "Multiple orc/",
            "probability": 0.0003483295440673828
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -7.2890625,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the",
            "probability": 0.0003418922424316406
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -7.30078125,
            "text": "Multiple orc",
            "probability": 0.00033783912658691406
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -7.4140625,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of the analyzed",
            "probability": 0.00030159950256347656
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -7.421875,
            "text": "Multiple orc/cdc6-associated replication origins were predicted in all of",
            "probability": 0.00029921531677246094
        },
        {
            "start_logit": 7.3203125,
            "end_logit": -7.484375,
            "text": "Multiple orc/cdc",
            "probability": 0.0002810955047607422
        },
        {
            "start_logit": -6.98046875,
            "end_logit": -4.46484375,
            "text": "orc/cdc6-associated replication origins were",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": -4.46484375,
            "text": "replication origins were",
            "probability": 0.0
        }
    ],
    "52fe58f82059c6d71c00007a_4": [
        {
            "start_logit": 7.23046875,
            "end_logit": 2.76171875,
            "text": "multiple",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.23046875,
            "end_logit": -5.95703125,
            "text": "multiple replication origins",
            "probability": 0.0001633167266845703
        },
        {
            "start_logit": 7.23046875,
            "end_logit": -6.21484375,
            "text": "multiple replication",
            "probability": 0.00012624263763427734
        },
        {
            "start_logit": 7.23046875,
            "end_logit": -6.28515625,
            "text": "multiple replication origins serve purposes other than simply shortening the time required for replication",
            "probability": 0.0001176595687866211
        },
        {
            "start_logit": 7.23046875,
            "end_logit": -6.71484375,
            "text": "multiple replication origins serve",
            "probability": 7.659196853637695e-05
        },
        {
            "start_logit": 7.23046875,
            "end_logit": -6.73046875,
            "text": "multiple replication origins serve purposes other than simply shortening the time required",
            "probability": 7.539987564086914e-05
        },
        {
            "start_logit": 7.23046875,
            "end_logit": -6.796875,
            "text": "multiple replication origins serve purposes other",
            "probability": 7.027387619018555e-05
        },
        {
            "start_logit": 7.23046875,
            "end_logit": -6.828125,
            "text": "multiple replication origins serve purposes other than",
            "probability": 6.80685043334961e-05
        },
        {
            "start_logit": 7.23046875,
            "end_logit": -6.85546875,
            "text": "multiple replication origins serve purposes other than simply",
            "probability": 6.651878356933594e-05
        },
        {
            "start_logit": 7.23046875,
            "end_logit": -6.8984375,
            "text": "multiple replication origins serve purposes other than simply shortening the time required for",
            "probability": 6.395578384399414e-05
        },
        {
            "start_logit": -2.546875,
            "end_logit": 2.76171875,
            "text": "Sulfolobus chromosome implies that the multiple",
            "probability": 5.644559860229492e-05
        },
        {
            "start_logit": 7.23046875,
            "end_logit": -7.08203125,
            "text": "multiple replication origins serve purposes",
            "probability": 5.2988529205322266e-05
        },
        {
            "start_logit": -3.72265625,
            "end_logit": 2.76171875,
            "text": "The strong replication-biased structuring of the Sulfolobus chromosome implies that the multiple",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 2.76171875,
            "text": "the Sulfolobus chromosome implies that the multiple",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 2.76171875,
            "text": "the multiple",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 2.76171875,
            "text": "strong replication-biased structuring of the Sulfolobus chromosome implies that the multiple",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 2.76171875,
            "text": "implies that the multiple",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 2.76171875,
            "text": "of the Sulfolobus chromosome implies that the multiple",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 2.76171875,
            "text": "lobus chromosome implies that the multiple",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 2.76171875,
            "text": "bus chromosome implies that the multiple",
            "probability": 4.172325134277344e-07
        }
    ],
    "52fe58f82059c6d71c00007a_5": [
        {
            "start_logit": 4.72265625,
            "end_logit": -1.9921875,
            "text": "multiple",
            "probability": 0.84423828125
        },
        {
            "start_logit": 4.72265625,
            "end_logit": -4.26953125,
            "text": "multiple replication origin",
            "probability": 0.0865478515625
        },
        {
            "start_logit": 4.72265625,
            "end_logit": -5.890625,
            "text": "multiple replication origin paradigm has also been demonstrated within the archaeal domain of life",
            "probability": 0.017120361328125
        },
        {
            "start_logit": 4.72265625,
            "end_logit": -6.08984375,
            "text": "multiple replication",
            "probability": 0.01403045654296875
        },
        {
            "start_logit": 4.72265625,
            "end_logit": -6.421875,
            "text": "multiple replication origin paradigm",
            "probability": 0.01006317138671875
        },
        {
            "start_logit": 4.72265625,
            "end_logit": -7.19921875,
            "text": "multiple replication origin paradigm has also been demonstrated within the archaeal domain of",
            "probability": 0.0046234130859375
        },
        {
            "start_logit": 4.72265625,
            "end_logit": -7.3046875,
            "text": "multiple replication origin paradigm has also been demonstrated within the",
            "probability": 0.004161834716796875
        },
        {
            "start_logit": 4.72265625,
            "end_logit": -7.3046875,
            "text": "multiple replication origin paradigm has",
            "probability": 0.004161834716796875
        },
        {
            "start_logit": 4.72265625,
            "end_logit": -7.328125,
            "text": "multiple replication origin paradigm has also been demonstrated within the archaeal domain",
            "probability": 0.004062652587890625
        },
        {
            "start_logit": 4.72265625,
            "end_logit": -7.37109375,
            "text": "multiple replication origin paradigm has also been demonstrated within",
            "probability": 0.0038928985595703125
        },
        {
            "start_logit": 4.72265625,
            "end_logit": -7.46875,
            "text": "multiple replication origin paradigm has also been",
            "probability": 0.00353240966796875
        },
        {
            "start_logit": 4.72265625,
            "end_logit": -7.5390625,
            "text": "multiple replication origin paradigm has also been demonstrated within the archaeal",
            "probability": 0.003292083740234375
        },
        {
            "start_logit": -5.43359375,
            "end_logit": -1.9921875,
            "text": "the multiple",
            "probability": 3.2782554626464844e-05
        },
        {
            "start_logit": -5.43359375,
            "end_logit": -4.26953125,
            "text": "the multiple replication origin",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": -5.43359375,
            "end_logit": -5.890625,
            "text": "the multiple replication origin paradigm has also been demonstrated within the archaeal domain of life",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.43359375,
            "end_logit": -6.08984375,
            "text": "the multiple replication",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.43359375,
            "end_logit": -6.421875,
            "text": "the multiple replication origin paradigm",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.43359375,
            "end_logit": -7.19921875,
            "text": "the multiple replication origin paradigm has also been demonstrated within the archaeal domain of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.43359375,
            "end_logit": -7.3046875,
            "text": "the multiple replication origin paradigm has also been demonstrated within the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.43359375,
            "end_logit": -7.3046875,
            "text": "the multiple replication origin paradigm has",
            "probability": 1.7881393432617188e-07
        }
    ],
    "52fe58f82059c6d71c00007a_6": [
        {
            "start_logit": 7.04296875,
            "end_logit": 5.34765625,
            "text": "multiple",
            "probability": 1.0
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -6.18359375,
            "text": "multiple chromosome replication origins in Sulfolobus",
            "probability": 9.834766387939453e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -6.72265625,
            "text": "multiple chromosome replication origins in",
            "probability": 5.7220458984375e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -6.75,
            "text": "multiple chromosome replication",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -6.80078125,
            "text": "multiple chromosome replication origins in Sulfolobus species has",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -6.93359375,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet another eukaryotic trait to the archaea",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -6.9453125,
            "text": "multiple chromosome replication origins",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -7.15234375,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet another",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -7.2890625,
            "text": "multiple chromosome",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -7.31640625,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet another eukaryotic",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -7.33203125,
            "text": "multiple chromosome replication origins in Sulfolobus species has added",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -7.38671875,
            "text": "multiple chromosome replication origins in Sulfolobus species",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -7.390625,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -7.46875,
            "text": "multiple chromosome replication origins in Sulfolobu",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 7.04296875,
            "end_logit": -7.50390625,
            "text": "multiple chromosome replication origins in Sulfolobus species has added yet another eukaryotic trait",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -6.18359375,
            "text": "Sulfolobus",
            "probability": 0.0
        },
        {
            "start_logit": -7.40234375,
            "end_logit": -6.18359375,
            "text": "lobus",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -6.18359375,
            "text": "bus",
            "probability": 0.0
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -6.80078125,
            "text": "Sulfolobus species has",
            "probability": 0.0
        },
        {
            "start_logit": -7.01171875,
            "end_logit": -6.93359375,
            "text": "Sulfolobus species has added yet another eukaryotic trait to the archaea",
            "probability": 0.0
        }
    ],
    "52fe58f82059c6d71c00007a_7": [
        {
            "start_logit": 5.921875,
            "end_logit": 0.051544189453125,
            "text": "multiple",
            "probability": 0.91748046875
        },
        {
            "start_logit": 5.921875,
            "end_logit": -2.56640625,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus",
            "probability": 0.06695556640625
        },
        {
            "start_logit": 5.921875,
            "end_logit": -4.95703125,
            "text": "multiple replication origins",
            "probability": 0.006134033203125
        },
        {
            "start_logit": 5.921875,
            "end_logit": -6.37109375,
            "text": "multiple replication",
            "probability": 0.001491546630859375
        },
        {
            "start_logit": 5.921875,
            "end_logit": -6.609375,
            "text": "multiple replication origins of",
            "probability": 0.0011749267578125
        },
        {
            "start_logit": 5.921875,
            "end_logit": -6.79296875,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus are",
            "probability": 0.0009784698486328125
        },
        {
            "start_logit": 5.921875,
            "end_logit": -6.8125,
            "text": "multiple replication origins of the archaeon Sulfolobus",
            "probability": 0.0009589195251464844
        },
        {
            "start_logit": 5.921875,
            "end_logit": -6.859375,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus are suggested by the analysis based on the Z curve method",
            "probability": 0.00091552734375
        },
        {
            "start_logit": 5.921875,
            "end_logit": -7.265625,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataricus are suggested by the analysis based on the Z curve",
            "probability": 0.0006098747253417969
        },
        {
            "start_logit": 5.921875,
            "end_logit": -7.27734375,
            "text": "multiple replication origins of the archaeon Sulfolobu",
            "probability": 0.0006022453308105469
        },
        {
            "start_logit": 5.921875,
            "end_logit": -7.34375,
            "text": "multiple replication origins of the archaeon Sulfolobus solfataric",
            "probability": 0.0005640983581542969
        },
        {
            "start_logit": 5.921875,
            "end_logit": -7.38671875,
            "text": "multiple replication origins of the",
            "probability": 0.0005402565002441406
        },
        {
            "start_logit": 5.921875,
            "end_logit": -7.5078125,
            "text": "multiple replication origins of the archaeon Sulfolobus sol",
            "probability": 0.0004787445068359375
        },
        {
            "start_logit": 5.921875,
            "end_logit": -7.51953125,
            "text": "multiple replication origins of the archaeon Sulfolobus solfata",
            "probability": 0.0004730224609375
        },
        {
            "start_logit": 5.921875,
            "end_logit": -7.546875,
            "text": "multiple replication origins of the archae",
            "probability": 0.0004603862762451172
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 0.051544189453125,
            "text": "potential multiple",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 0.051544189453125,
            "text": ", the potential multiple",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 0.051544189453125,
            "text": "the potential multiple",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -7.53125,
            "end_logit": 0.051544189453125,
            "text": "In addition, the potential multiple",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 0.051544189453125,
            "text": "addition, the potential multiple",
            "probability": 1.0132789611816406e-06
        }
    ],
    "52fe58f82059c6d71c00007a_8": [
        {
            "start_logit": 7.6328125,
            "end_logit": 2.650390625,
            "text": "multiple",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -5.40234375,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about their evolutionary processes.",
            "probability": 0.0003199577331542969
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -5.421875,
            "text": "multiple replication origins",
            "probability": 0.0003123283386230469
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -6.7890625,
            "text": "multiple replication origins have been observed",
            "probability": 7.963180541992188e-05
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -6.953125,
            "text": "multiple replication origins have been observed in archaea, considerably less is known",
            "probability": 6.759166717529297e-05
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -7.04296875,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about their",
            "probability": 6.198883056640625e-05
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -7.046875,
            "text": "multiple replication origins have",
            "probability": 6.151199340820312e-05
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -7.11328125,
            "text": "multiple replication origins have been",
            "probability": 5.733966827392578e-05
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -7.25390625,
            "text": "multiple replication origins have been observed in",
            "probability": 4.982948303222656e-05
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -7.328125,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about",
            "probability": 4.64320182800293e-05
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -7.3515625,
            "text": "multiple replication",
            "probability": 4.5359134674072266e-05
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -7.37890625,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about their evolutionary",
            "probability": 4.392862319946289e-05
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -7.49609375,
            "text": "multiple replication origins have been observed in archaea, considerably less is known about their evolutionary processes",
            "probability": 3.93986701965332e-05
        },
        {
            "start_logit": 7.6328125,
            "end_logit": -7.5078125,
            "text": "multiple replication origins have been observed in archaea",
            "probability": 3.88026237487793e-05
        },
        {
            "start_logit": -6.4765625,
            "end_logit": 2.650390625,
            "text": "While multiple",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.4765625,
            "end_logit": -5.40234375,
            "text": "While multiple replication origins have been observed in archaea, considerably less is known about their evolutionary processes.",
            "probability": 0.0
        },
        {
            "start_logit": -6.4765625,
            "end_logit": -5.421875,
            "text": "While multiple replication origins",
            "probability": 0.0
        },
        {
            "start_logit": -6.90234375,
            "end_logit": -5.40234375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.12890625,
            "end_logit": -5.40234375,
            "text": "less is known about their evolutionary processes.",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -5.40234375,
            "text": "is known about their evolutionary processes.",
            "probability": 0.0
        }
    ],
    "52fe58f82059c6d71c00007a_9": [
        {
            "start_logit": 7.03515625,
            "end_logit": 3.2578125,
            "text": "multiple",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -5.32421875,
            "text": "multiple orc/cdc6-associated replication origins",
            "probability": 0.00018644332885742188
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -6.0234375,
            "text": "multiple orc/cdc6-associated replication origins in",
            "probability": 9.304285049438477e-05
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -6.47265625,
            "text": "multiple orc/cdc6-associated replication origins in haloarchaeal genomes",
            "probability": 5.91278076171875e-05
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -6.8125,
            "text": "multiple orc/cdc6-",
            "probability": 4.190206527709961e-05
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -6.92578125,
            "text": "multiple orc/cdc6-associated replication origins in haloarchaea",
            "probability": 3.7550926208496094e-05
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -6.9453125,
            "text": "multiple orc/cdc6-associated replication origins in haloarchaeal",
            "probability": 3.701448440551758e-05
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -6.96484375,
            "text": "multiple orc/cdc6-associated replication",
            "probability": 3.612041473388672e-05
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -7.0078125,
            "text": "multiple orc/cdc6-associated replication origins in haloarch",
            "probability": 3.4749507904052734e-05
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -7.10546875,
            "text": "multiple orc/",
            "probability": 3.141164779663086e-05
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -7.12890625,
            "text": "multiple orc/cdc6",
            "probability": 3.063678741455078e-05
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -7.390625,
            "text": "multiple orc/cdc6-associated replication origins in halo",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -7.4453125,
            "text": "multiple orc/cdc6-associated",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": 7.03515625,
            "end_logit": -7.54296875,
            "text": "multiple orc",
            "probability": 2.0325183868408203e-05
        },
        {
            "start_logit": -7.1484375,
            "end_logit": -5.32421875,
            "text": "orc/cdc6-associated replication origins",
            "probability": 0.0
        },
        {
            "start_logit": -7.79296875,
            "end_logit": -5.32421875,
            "text": "cdc6-associated replication origins",
            "probability": 0.0
        },
        {
            "start_logit": -7.1484375,
            "end_logit": -6.0234375,
            "text": "orc/cdc6-associated replication origins in",
            "probability": 0.0
        },
        {
            "start_logit": -8.0,
            "end_logit": -5.32421875,
            "text": "c/cdc6-associated replication origins",
            "probability": 0.0
        },
        {
            "start_logit": -8.015625,
            "end_logit": -5.32421875,
            "text": "associated replication origins",
            "probability": 0.0
        },
        {
            "start_logit": -7.1484375,
            "end_logit": -6.47265625,
            "text": "orc/cdc6-associated replication origins in haloarchaeal genomes",
            "probability": 0.0
        }
    ],
    "5fe31317a43ad31278000044_1": [
        {
            "start_logit": 3.619140625,
            "end_logit": 3.712890625,
            "text": "cytokines",
            "probability": 0.9970703125
        },
        {
            "start_logit": -3.13671875,
            "end_logit": 3.712890625,
            "text": "pro-inflammatory cytokines",
            "probability": 0.0011577606201171875
        },
        {
            "start_logit": 3.619140625,
            "end_logit": -3.111328125,
            "text": "cytokines (IL-1\u03b2, IL-6 and IL-8",
            "probability": 0.0010843276977539062
        },
        {
            "start_logit": 3.619140625,
            "end_logit": -4.96484375,
            "text": "cytokines (IL-1\u03b2, IL-6 and IL-8).",
            "probability": 0.00016951560974121094
        },
        {
            "start_logit": 3.619140625,
            "end_logit": -5.0234375,
            "text": "cytokines (IL-1\u03b2",
            "probability": 0.00016045570373535156
        },
        {
            "start_logit": -6.3671875,
            "end_logit": 3.712890625,
            "text": "adipose tissue biopsies to study the relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines",
            "probability": 4.601478576660156e-05
        },
        {
            "start_logit": 3.619140625,
            "end_logit": -7.0,
            "text": "cytokines (IL-1\u03b2, IL-6 and IL-",
            "probability": 2.2232532501220703e-05
        },
        {
            "start_logit": 3.619140625,
            "end_logit": -7.08203125,
            "text": "cytokines (",
            "probability": 2.0384788513183594e-05
        },
        {
            "start_logit": 3.619140625,
            "end_logit": -7.08984375,
            "text": "cytokines (IL-1\u03b2, IL-",
            "probability": 2.0265579223632812e-05
        },
        {
            "start_logit": 3.619140625,
            "end_logit": -7.12109375,
            "text": "cytokines (IL-1\u03b2, IL-6",
            "probability": 1.9609928131103516e-05
        },
        {
            "start_logit": -7.3125,
            "end_logit": 3.712890625,
            "text": "inflammatory cytokines",
            "probability": 1.7881393432617188e-05
        },
        {
            "start_logit": 3.619140625,
            "end_logit": -7.26171875,
            "text": "cytokines (IL-",
            "probability": 1.704692840576172e-05
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 3.712890625,
            "text": "human adipose tissue biopsies to study the relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines",
            "probability": 1.5616416931152344e-05
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 3.712890625,
            "text": "obesity and expression of pro-inflammatory cytokines",
            "probability": 1.5497207641601562e-05
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 3.712890625,
            "text": "study the relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines",
            "probability": 1.5497207641601562e-05
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 3.712890625,
            "text": "MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines",
            "probability": 1.5139579772949219e-05
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 3.712890625,
            "text": "of pro-inflammatory cytokines",
            "probability": 1.4007091522216797e-05
        },
        {
            "start_logit": -7.671875,
            "end_logit": 3.712890625,
            "text": "We used human adipose tissue biopsies to study the relationship of MAP3K8 expression with markers of obesity and expression of pro-inflammatory cytokines",
            "probability": 1.245737075805664e-05
        },
        {
            "start_logit": -3.13671875,
            "end_logit": -3.111328125,
            "text": "pro-inflammatory cytokines (IL-1\u03b2, IL-6 and IL-8",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -3.13671875,
            "end_logit": -4.96484375,
            "text": "pro-inflammatory cytokines (IL-1\u03b2, IL-6 and IL-8).",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5fe31317a43ad31278000044_2": [
        {
            "start_logit": 8.265625,
            "end_logit": 7.9765625,
            "text": "IL-1\u03b2",
            "probability": 1.0
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.8896484375,
            "text": "IL",
            "probability": 0.0001398324966430664
        },
        {
            "start_logit": -0.69384765625,
            "end_logit": 7.9765625,
            "text": "adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 0.00012731552124023438
        },
        {
            "start_logit": -1.65234375,
            "end_logit": 7.9765625,
            "text": "1\u03b2",
            "probability": 4.9114227294921875e-05
        },
        {
            "start_logit": -0.69384765625,
            "end_logit": 4.48828125,
            "text": "adipose tissue",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 8.265625,
            "end_logit": -5.94140625,
            "text": "IL-1\u03b2 and its responsive cytokines IL-6 and IL-8, but does not seem to have systemic effects on insulin resistance.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -5.67578125,
            "end_logit": 7.9765625,
            "text": "tissue inflammation, specifically for IL-1\u03b2",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -5.97265625,
            "text": "IL-1\u03b2 and its responsive cytokines IL-6 and IL-8",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -6.390625,
            "text": "IL-1\u03b2 and its responsive cytokines",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.140625,
            "end_logit": 7.9765625,
            "text": "inflammation, specifically for IL-1\u03b2",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.265625,
            "end_logit": 7.9765625,
            "text": "the data in both human and mouse show that MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -6.671875,
            "text": "IL-1\u03b2 and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.56640625,
            "end_logit": 7.9765625,
            "text": ", the data in both human and mouse show that MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -6.87890625,
            "text": "IL-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.6015625,
            "end_logit": 7.9765625,
            "text": "Together, the data in both human and mouse show that MAP3K8 is involved in local adipose tissue inflammation, specifically for IL-1\u03b2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -6.9765625,
            "text": "IL-1\u03b2 and its responsive cytokines IL-6 and IL-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -6.9921875,
            "text": "IL-1\u03b2 and its responsive cytokines IL-6",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.1015625,
            "text": "IL-1\u03b2 and its responsive cytokines IL-6 and IL",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.1640625,
            "text": "IL-1\u03b2 and its responsive cytokines IL-6 and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.21875,
            "text": "IL-1\u03b2 and its responsive cytokines IL-",
            "probability": 2.384185791015625e-07
        }
    ],
    "5fe31317a43ad31278000044_3": [
        {
            "start_logit": 3.55078125,
            "end_logit": 4.046875,
            "text": "TNF\u03b1",
            "probability": 0.53662109375
        },
        {
            "start_logit": 3.40234375,
            "end_logit": 4.046875,
            "text": "tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 0.462646484375
        },
        {
            "start_logit": 3.40234375,
            "end_logit": -3.525390625,
            "text": "tumor progression locus 2",
            "probability": 0.00023853778839111328
        },
        {
            "start_logit": 3.55078125,
            "end_logit": -3.880859375,
            "text": "TNF\u03b1, IL-1\u03b2",
            "probability": 0.0001932382583618164
        },
        {
            "start_logit": 3.55078125,
            "end_logit": -4.70703125,
            "text": "TNF\u03b1, IL-1\u03b2, and IFN\u03b3.",
            "probability": 8.505582809448242e-05
        },
        {
            "start_logit": 3.40234375,
            "end_logit": -5.42578125,
            "text": "tumor",
            "probability": 3.546476364135742e-05
        },
        {
            "start_logit": 3.40234375,
            "end_logit": -5.890625,
            "text": "tumor progression locus 2 (",
            "probability": 2.2351741790771484e-05
        },
        {
            "start_logit": -6.68359375,
            "end_logit": 4.046875,
            "text": "also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 1.9311904907226562e-05
        },
        {
            "start_logit": -7.1328125,
            "end_logit": 4.046875,
            "text": "of TNF\u03b1",
            "probability": 1.2278556823730469e-05
        },
        {
            "start_logit": 3.40234375,
            "end_logit": -6.55859375,
            "text": "tumor progression locus 2 (Tpl2, also known",
            "probability": 1.150369644165039e-05
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 4.046875,
            "text": "production of TNF\u03b1",
            "probability": 9.655952453613281e-06
        },
        {
            "start_logit": 3.40234375,
            "end_logit": -6.7421875,
            "text": "tumor progression",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": 3.55078125,
            "end_logit": -6.9765625,
            "text": "TNF\u03b1, IL-",
            "probability": 8.761882781982422e-06
        },
        {
            "start_logit": 3.40234375,
            "end_logit": -6.828125,
            "text": "tumor progression locus",
            "probability": 8.761882781982422e-06
        },
        {
            "start_logit": 3.55078125,
            "end_logit": -6.99609375,
            "text": "TNF\u03b1, IL",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 4.046875,
            "text": "drives the production of TNF\u03b1",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": 3.40234375,
            "end_logit": -6.99609375,
            "text": "tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1, IL",
            "probability": 7.450580596923828e-06
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 4.046875,
            "text": "known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": -7.75,
            "end_logit": 4.046875,
            "text": "Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 6.67572021484375e-06
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 4.046875,
            "text": "potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 6.198883056640625e-06
        }
    ],
    "5fe31317a43ad31278000044_4": [
        {
            "start_logit": 3.5859375,
            "end_logit": 3.951171875,
            "text": "tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 0.62353515625
        },
        {
            "start_logit": 3.078125,
            "end_logit": 3.951171875,
            "text": "TNF\u03b1",
            "probability": 0.37548828125
        },
        {
            "start_logit": 3.5859375,
            "end_logit": -3.552734375,
            "text": "tumor progression locus 2",
            "probability": 0.00034236907958984375
        },
        {
            "start_logit": 3.078125,
            "end_logit": -3.72265625,
            "text": "TNF\u03b1, IL-1\u03b2, and IFN\u03b3.",
            "probability": 0.00017333030700683594
        },
        {
            "start_logit": 3.078125,
            "end_logit": -3.798828125,
            "text": "TNF\u03b1, IL-1\u03b2",
            "probability": 0.00016164779663085938
        },
        {
            "start_logit": 3.5859375,
            "end_logit": -5.30078125,
            "text": "tumor",
            "probability": 5.990266799926758e-05
        },
        {
            "start_logit": 3.5859375,
            "end_logit": -5.63671875,
            "text": "tumor progression locus 2 (",
            "probability": 4.2498111724853516e-05
        },
        {
            "start_logit": -6.6171875,
            "end_logit": 3.951171875,
            "text": "also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 2.3126602172851562e-05
        },
        {
            "start_logit": 3.5859375,
            "end_logit": -6.390625,
            "text": "tumor progression locus 2 (Tpl2, also known",
            "probability": 2.008676528930664e-05
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 3.951171875,
            "text": "of TNF\u03b1",
            "probability": 1.3887882232666016e-05
        },
        {
            "start_logit": 3.5859375,
            "end_logit": -6.83984375,
            "text": "tumor progression",
            "probability": 1.2755393981933594e-05
        },
        {
            "start_logit": 3.5859375,
            "end_logit": -6.87890625,
            "text": "tumor progression locus",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": 3.5859375,
            "end_logit": -6.9609375,
            "text": "tumor progression locus 2 (Tpl2, also known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1, IL",
            "probability": 1.1324882507324219e-05
        },
        {
            "start_logit": -7.359375,
            "end_logit": 3.951171875,
            "text": "production of TNF\u03b1",
            "probability": 1.1026859283447266e-05
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 3.951171875,
            "text": "drives the production of TNF\u03b1",
            "probability": 9.059906005859375e-06
        },
        {
            "start_logit": 3.5859375,
            "end_logit": -7.2734375,
            "text": "tumor progression locus 2 (Tpl2,",
            "probability": 8.285045623779297e-06
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 3.951171875,
            "text": "known as Map3k8/Cot) is a potent inflammatory mediator that drives the production of TNF\u03b1",
            "probability": 8.225440979003906e-06
        },
        {
            "start_logit": 3.5859375,
            "end_logit": -7.296875,
            "text": "tumor progression locus 2 (Tpl2, also known as Map3k8",
            "probability": 8.106231689453125e-06
        },
        {
            "start_logit": 3.5859375,
            "end_logit": -7.30859375,
            "text": "tumor progression locus 2 (Tpl2, also known as Map3k8/Cot",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": 3.5859375,
            "end_logit": -7.31640625,
            "text": "tumor progression locus 2 (Tpl2, also known as",
            "probability": 7.987022399902344e-06
        }
    ],
    "5fe31317a43ad31278000044_5": [
        {
            "start_logit": 8.265625,
            "end_logit": 8.1484375,
            "text": "IL-1\u03b2",
            "probability": 1.0
        },
        {
            "start_logit": 8.265625,
            "end_logit": -1.072265625,
            "text": "IL",
            "probability": 9.995698928833008e-05
        },
        {
            "start_logit": -1.06640625,
            "end_logit": 8.1484375,
            "text": "1\u03b2",
            "probability": 8.887052536010742e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -6.671875,
            "text": "IL-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 8.1484375,
            "text": "found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL-1\u03b2",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 8.1484375,
            "text": "-1\u03b2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 8.1484375,
            "text": "EPAC and TPL2 reduced AR agonist-induced IL-1\u03b2",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.3359375,
            "text": "IL-1\u03b2 reporter",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 8.1484375,
            "text": "tumor progression locus 2, MAP3K8) and found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL-1\u03b2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 8.1484375,
            "text": ") and found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL-1\u03b2",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.50390625,
            "text": "IL-1\u03b2 reporter activity",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.1484375,
            "text": "induced IL-1\u03b2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 8.1484375,
            "text": ", MAP3K8) and found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL-1\u03b2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.1484375,
            "text": "that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL-1\u03b2",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.79296875,
            "end_logit": -1.072265625,
            "text": "found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL",
            "probability": 0.0
        },
        {
            "start_logit": -7.05078125,
            "end_logit": -1.072265625,
            "text": "EPAC and TPL2 reduced AR agonist-induced IL",
            "probability": 0.0
        },
        {
            "start_logit": -7.265625,
            "end_logit": -1.072265625,
            "text": "tumor progression locus 2, MAP3K8) and found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL",
            "probability": 0.0
        },
        {
            "start_logit": -7.26953125,
            "end_logit": -1.072265625,
            "text": ") and found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL",
            "probability": 0.0
        },
        {
            "start_logit": -1.06640625,
            "end_logit": -7.3359375,
            "text": "1\u03b2 reporter",
            "probability": 0.0
        },
        {
            "start_logit": -7.4375,
            "end_logit": -1.072265625,
            "text": ") and TPL2 (tumor progression locus 2, MAP3K8) and found that inhibitors for EPAC and TPL2 reduced AR agonist-induced IL",
            "probability": 0.0
        }
    ],
    "5fe31317a43ad31278000044_6": [
        {
            "start_logit": 3.65625,
            "end_logit": 5.8828125,
            "text": "IL-1\u03b2, IL-6 and IL-8",
            "probability": 0.537109375
        },
        {
            "start_logit": 3.47265625,
            "end_logit": 5.8828125,
            "text": "IL-8",
            "probability": 0.44873046875
        },
        {
            "start_logit": 3.65625,
            "end_logit": 2.09375,
            "text": "IL-1\u03b2",
            "probability": 0.01214599609375
        },
        {
            "start_logit": 3.65625,
            "end_logit": -0.63427734375,
            "text": "IL-1\u03b2, IL-6 and IL-8, but not TNF -\u03b1",
            "probability": 0.0007948875427246094
        },
        {
            "start_logit": 3.47265625,
            "end_logit": -0.63427734375,
            "text": "IL-8, but not TNF -\u03b1",
            "probability": 0.0006589889526367188
        },
        {
            "start_logit": -4.0,
            "end_logit": 5.8828125,
            "text": "8",
            "probability": 0.00025391578674316406
        },
        {
            "start_logit": 3.47265625,
            "end_logit": -2.724609375,
            "text": "IL-8, but not TNF -\u03b1, in human adipose tissue were associated with higher expression of MAP3K8.",
            "probability": 8.177757263183594e-05
        },
        {
            "start_logit": 1.25,
            "end_logit": -0.63427734375,
            "text": "TNF -\u03b1",
            "probability": 7.164478302001953e-05
        },
        {
            "start_logit": 3.65625,
            "end_logit": -4.01171875,
            "text": "IL-1\u03b2, IL-6 and IL-8, but not TNF",
            "probability": 2.7179718017578125e-05
        },
        {
            "start_logit": 3.47265625,
            "end_logit": -4.01171875,
            "text": "IL-8, but not TNF",
            "probability": 2.2530555725097656e-05
        },
        {
            "start_logit": 3.65625,
            "end_logit": -4.40234375,
            "text": "IL",
            "probability": 1.8417835235595703e-05
        },
        {
            "start_logit": -6.83203125,
            "end_logit": 5.8828125,
            "text": "and IL-8",
            "probability": 1.5020370483398438e-05
        },
        {
            "start_logit": -6.8359375,
            "end_logit": 5.8828125,
            "text": ", high mRNA expression levels of IL-1\u03b2, IL-6 and IL-8",
            "probability": 1.4901161193847656e-05
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 5.8828125,
            "text": "of IL-1\u03b2, IL-6 and IL-8",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 5.8828125,
            "text": "1\u03b2, IL-6 and IL-8",
            "probability": 1.055002212524414e-05
        },
        {
            "start_logit": 1.25,
            "end_logit": -2.724609375,
            "text": "TNF -\u03b1, in human adipose tissue were associated with higher expression of MAP3K8.",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 5.8828125,
            "text": "IL-6 and IL-8",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 5.8828125,
            "text": "high mRNA expression levels of IL-1\u03b2, IL-6 and IL-8",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": 3.65625,
            "end_logit": -5.2734375,
            "text": "IL-1\u03b2, IL-6 and IL-8, but not TNF -\u03b1, in human adipose tissue",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": -7.5625,
            "end_logit": 5.8828125,
            "text": "Additionally, high mRNA expression levels of IL-1\u03b2, IL-6 and IL-8",
            "probability": 7.212162017822266e-06
        }
    ],
    "5fe31317a43ad31278000044_7": [
        {
            "start_logit": 8.1328125,
            "end_logit": 7.90234375,
            "text": "IL-1\u03b2",
            "probability": 0.9970703125
        },
        {
            "start_logit": 8.1328125,
            "end_logit": 1.8623046875,
            "text": "IL-1\u03b2, IL-6 and CXCL1",
            "probability": 0.002376556396484375
        },
        {
            "start_logit": 8.1328125,
            "end_logit": 0.1080322265625,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue",
            "probability": 0.00041294097900390625
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -1.29296875,
            "text": "IL",
            "probability": 0.00010198354721069336
        },
        {
            "start_logit": 4.66796875,
            "end_logit": 1.8623046875,
            "text": "CXCL1",
            "probability": 7.462501525878906e-05
        },
        {
            "start_logit": -1.74609375,
            "end_logit": 7.90234375,
            "text": "1\u03b2",
            "probability": 5.125999450683594e-05
        },
        {
            "start_logit": 4.66796875,
            "end_logit": 0.1080322265625,
            "text": "CXCL1 in adipose tissue",
            "probability": 1.2934207916259766e-05
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -3.54296875,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in response to the HFD as compared to WT animals.",
            "probability": 1.0728836059570312e-05
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -3.736328125,
            "text": "IL-1\u03b2, IL-6 and CXCL",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -5.95703125,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in response to the HFD",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.4375,
            "end_logit": 7.90234375,
            "text": "of IL-1\u03b2",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -6.8359375,
            "text": "IL-1\u03b2,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -6.859375,
            "text": "IL-1\u03b2, IL-",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -6.98828125,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 4.66796875,
            "end_logit": -3.54296875,
            "text": "CXCL1 in adipose tissue in response to the HFD as compared to WT animals.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.01171875,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in response to the HFD as",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.04296875,
            "text": "IL-1\u03b2, IL-6",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.10546875,
            "text": "IL-1\u03b2, IL-6 and CXCL1 in adipose tissue in response to the HFD as compared to",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.1953125,
            "text": "IL-1\u03b2, IL",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 4.66796875,
            "end_logit": -3.736328125,
            "text": "CXCL",
            "probability": 2.980232238769531e-07
        }
    ],
    "621ebb733a8413c65300005c_1": [
        {
            "start_logit": 4.80859375,
            "end_logit": 1.912109375,
            "text": "SARS-CoV-2.",
            "probability": 0.8505859375
        },
        {
            "start_logit": 4.80859375,
            "end_logit": -0.21435546875,
            "text": "SARS-CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antiviral",
            "probability": 0.1015625
        },
        {
            "start_logit": 4.80859375,
            "end_logit": -1.5703125,
            "text": "SARS-CoV",
            "probability": 0.02618408203125
        },
        {
            "start_logit": 2.501953125,
            "end_logit": -0.21435546875,
            "text": "antiviral",
            "probability": 0.0101318359375
        },
        {
            "start_logit": 4.80859375,
            "end_logit": -3.08203125,
            "text": "SARS",
            "probability": 0.00577545166015625
        },
        {
            "start_logit": 4.80859375,
            "end_logit": -3.6015625,
            "text": "SARS-CoV-2",
            "probability": 0.0034351348876953125
        },
        {
            "start_logit": 4.80859375,
            "end_logit": -5.171875,
            "text": "SARS-CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antivirals",
            "probability": 0.0007147789001464844
        },
        {
            "start_logit": 4.80859375,
            "end_logit": -5.5,
            "text": "SARS-CoV-",
            "probability": 0.0005145072937011719
        },
        {
            "start_logit": 4.80859375,
            "end_logit": -6.41796875,
            "text": "SARS-CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antivirals against virus",
            "probability": 0.00020551681518554688
        },
        {
            "start_logit": 4.80859375,
            "end_logit": -6.79296875,
            "text": "SARS-",
            "probability": 0.00014126300811767578
        },
        {
            "start_logit": 4.80859375,
            "end_logit": -6.83984375,
            "text": "SARS-CoV-2. There are reports about the uses of Remdesivir and Favipiravir as existing antivirals against",
            "probability": 0.0001347064971923828
        },
        {
            "start_logit": 4.80859375,
            "end_logit": -6.984375,
            "text": "SARS-CoV-2. There are reports about the uses of Remdesivir",
            "probability": 0.00011712312698364258
        },
        {
            "start_logit": 4.80859375,
            "end_logit": -7.125,
            "text": "SARS-CoV-2. There are reports about the uses of Remdesivir and",
            "probability": 0.0001017451286315918
        },
        {
            "start_logit": 4.80859375,
            "end_logit": -7.1328125,
            "text": "SARS-CoV-2. There are",
            "probability": 0.00010019540786743164
        },
        {
            "start_logit": 4.80859375,
            "end_logit": -7.1875,
            "text": "SARS-CoV-2. There are reports about the uses of",
            "probability": 9.554624557495117e-05
        },
        {
            "start_logit": -4.3125,
            "end_logit": 1.912109375,
            "text": ".",
            "probability": 9.340047836303711e-05
        },
        {
            "start_logit": 2.501953125,
            "end_logit": -5.171875,
            "text": "antivirals",
            "probability": 7.104873657226562e-05
        },
        {
            "start_logit": -4.8125,
            "end_logit": 1.912109375,
            "text": "In the COVID-19 era, there has been a race for drugs to be effective against SARS-CoV-2.",
            "probability": 5.6624412536621094e-05
        },
        {
            "start_logit": 2.501953125,
            "end_logit": -6.41796875,
            "text": "antivirals against virus",
            "probability": 2.0503997802734375e-05
        },
        {
            "start_logit": -5.9296875,
            "end_logit": 1.912109375,
            "text": ". In the COVID-19 era, there has been a race for drugs to be effective against SARS-CoV-2.",
            "probability": 1.8477439880371094e-05
        }
    ],
    "621ebb733a8413c65300005c_2": [
        {
            "start_logit": 6.94140625,
            "end_logit": 3.919921875,
            "text": "COVID-19",
            "probability": 0.9990234375
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -2.978515625,
            "text": "COV",
            "probability": 0.0010080337524414062
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -5.66015625,
            "text": "COVID-",
            "probability": 6.914138793945312e-05
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -5.8671875,
            "text": "COVID-19 (",
            "probability": 5.644559860229492e-05
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.05859375,
            "text": "COVID",
            "probability": 4.64320182800293e-05
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.60546875,
            "text": "COVID-19 (lopinavir, ritonavir",
            "probability": 2.6881694793701172e-05
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.796875,
            "text": "COVID-19 (lopinavir, ritonavir, ivermectin",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.87890625,
            "text": "COVID-19 (lopinavir, ritonavir, ivermectin, remdesivir and favipiravir)",
            "probability": 2.0444393157958984e-05
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -6.9609375,
            "text": "COVID-19 (lopinavir",
            "probability": 1.895427703857422e-05
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -7.2578125,
            "text": "COVID-19 (lopin",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -7.26171875,
            "text": "COVID-19 (lopinavir,",
            "probability": 1.3947486877441406e-05
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -7.44921875,
            "text": "COVID-19 (lopinavir, ritonavir,",
            "probability": 1.1563301086425781e-05
        },
        {
            "start_logit": 6.94140625,
            "end_logit": -7.46875,
            "text": "COVID-19 (lopinavir, ritonavir, ivermectin, remdesivir and favipiravir),",
            "probability": 1.1324882507324219e-05
        },
        {
            "start_logit": -6.6171875,
            "end_logit": 3.919921875,
            "text": "19",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 3.919921875,
            "text": "repurposed drugs advocated to treat COVID-19",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.109375,
            "end_logit": 3.919921875,
            "text": "key repurposed drugs advocated to treat COVID-19",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 3.919921875,
            "text": "to treat COVID-19",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 3.919921875,
            "text": "treat COVID-19",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 3.919921875,
            "text": "urposed drugs advocated to treat COVID-19",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 3.919921875,
            "text": "ID-19",
            "probability": 4.76837158203125e-07
        }
    ],
    "621ebb733a8413c65300005c_3": [
        {
            "start_logit": 8.2109375,
            "end_logit": 7.2890625,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.1591796875,
            "text": "COV",
            "probability": 0.00021326541900634766
        },
        {
            "start_logit": -3.13671875,
            "end_logit": 7.2890625,
            "text": "19",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -5.04296875,
            "text": "COVID-",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.0859375,
            "text": "COVID-19 patients",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.765625,
            "text": "COVID",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.015625,
            "end_logit": 7.2890625,
            "text": ": To compare the efficacy and safety of favipiravir and umifenovir (Arbidol) to treat COVID-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.109375,
            "end_logit": 7.2890625,
            "text": "treat COVID-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 7.2890625,
            "text": "To compare the efficacy and safety of favipiravir and umifenovir (Arbidol) to treat COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 7.2890625,
            "text": "ID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 7.2890625,
            "text": "compare the efficacy and safety of favipiravir and umifenovir (Arbidol) to treat COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 7.2890625,
            "text": ") to treat COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.2890625,
            "text": "(Arbidol) to treat COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.2890625,
            "text": "Arbidol) to treat COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 7.2890625,
            "text": "favipiravir and umifenovir (Arbidol) to treat COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 7.2890625,
            "text": "to treat COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 7.2890625,
            "text": "efficacy and safety of favipiravir and umifenovir (Arbidol) to treat COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 7.2890625,
            "text": "ipiravir and umifenovir (Arbidol) to treat COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 7.2890625,
            "text": "ifenovir (Arbidol) to treat COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 7.2890625,
            "text": "umifenovir (Arbidol) to treat COVID-19",
            "probability": 1.1920928955078125e-07
        }
    ],
    "621ebb733a8413c65300005c_4": [
        {
            "start_logit": 4.90234375,
            "end_logit": 1.1669921875,
            "text": "COVID-19",
            "probability": 0.994140625
        },
        {
            "start_logit": 4.90234375,
            "end_logit": -4.39453125,
            "text": "COV",
            "probability": 0.0038166046142578125
        },
        {
            "start_logit": 4.90234375,
            "end_logit": -5.92578125,
            "text": "COVID-",
            "probability": 0.0008254051208496094
        },
        {
            "start_logit": 4.90234375,
            "end_logit": -6.40234375,
            "text": "COVID",
            "probability": 0.0005125999450683594
        },
        {
            "start_logit": 4.90234375,
            "end_logit": -6.44140625,
            "text": "COVID-19 treatments",
            "probability": 0.0004930496215820312
        },
        {
            "start_logit": -6.5,
            "end_logit": 1.1669921875,
            "text": "hydroxychloroquine (HCQ) are considered possible COVID-19",
            "probability": 1.1086463928222656e-05
        },
        {
            "start_logit": -6.5234375,
            "end_logit": 1.1669921875,
            "text": "Favipiravir (FPV) and hydroxychloroquine (HCQ) are considered possible COVID-19",
            "probability": 1.0907649993896484e-05
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 1.1669921875,
            "text": ") and hydroxychloroquine (HCQ) are considered possible COVID-19",
            "probability": 6.198883056640625e-06
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 1.1669921875,
            "text": "possible COVID-19",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 1.1669921875,
            "text": ") are considered possible COVID-19",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 1.1669921875,
            "text": "considered possible COVID-19",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 1.1669921875,
            "text": "loroquine (HCQ) are considered possible COVID-19",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 1.1669921875,
            "text": "ipiravir (FPV) and hydroxychloroquine (HCQ) are considered possible COVID-19",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 1.1669921875,
            "text": "ID-19",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -7.71875,
            "end_logit": 1.1669921875,
            "text": "FPV) and hydroxychloroquine (HCQ) are considered possible COVID-19",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 1.1669921875,
            "text": "19",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 1.1669921875,
            "text": "iravir (FPV) and hydroxychloroquine (HCQ) are considered possible COVID-19",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 1.1669921875,
            "text": "V) and hydroxychloroquine (HCQ) are considered possible COVID-19",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 1.1669921875,
            "text": "HCQ) are considered possible COVID-19",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -6.5,
            "end_logit": -4.39453125,
            "text": "hydroxychloroquine (HCQ) are considered possible COV",
            "probability": 5.960464477539063e-08
        }
    ],
    "621ebb733a8413c65300005c_5": [
        {
            "start_logit": 6.67578125,
            "end_logit": 5.14453125,
            "text": "COVID-19",
            "probability": 0.9912109375
        },
        {
            "start_logit": 6.67578125,
            "end_logit": 0.446044921875,
            "text": "COVID-19 in many countries.",
            "probability": 0.00902557373046875
        },
        {
            "start_logit": 6.67578125,
            "end_logit": -3.88671875,
            "text": "COV",
            "probability": 0.00011861324310302734
        },
        {
            "start_logit": 6.67578125,
            "end_logit": -6.44140625,
            "text": "COVID-19 in",
            "probability": 9.238719940185547e-06
        },
        {
            "start_logit": -5.45703125,
            "end_logit": 5.14453125,
            "text": "Favipiravir (FVP) has been used for treatment of COVID-19",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": 6.67578125,
            "end_logit": -7.08203125,
            "text": "COVID-",
            "probability": 4.827976226806641e-06
        },
        {
            "start_logit": -5.62109375,
            "end_logit": 5.14453125,
            "text": "19",
            "probability": 4.5299530029296875e-06
        },
        {
            "start_logit": 6.67578125,
            "end_logit": -7.40625,
            "text": "COVID-19 in many",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 6.67578125,
            "end_logit": -7.41015625,
            "text": "COVID-19 in many countries",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -6.5390625,
            "end_logit": 5.14453125,
            "text": "ID-19",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.9609375,
            "end_logit": 5.14453125,
            "text": "treatment of COVID-19",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 5.14453125,
            "text": "FVP) has been used for treatment of COVID-19",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 5.14453125,
            "text": "ipiravir (FVP) has been used for treatment of COVID-19",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 5.14453125,
            "text": "-19",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 5.14453125,
            "text": ") has been used for treatment of COVID-19",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 5.14453125,
            "text": "iravir (FVP) has been used for treatment of COVID-19",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 5.14453125,
            "text": "P) has been used for treatment of COVID-19",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 5.14453125,
            "text": "of COVID-19",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 5.14453125,
            "text": "vir (FVP) has been used for treatment of COVID-19",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -5.45703125,
            "end_logit": 0.446044921875,
            "text": "Favipiravir (FVP) has been used for treatment of COVID-19 in many countries.",
            "probability": 5.960464477539063e-08
        }
    ],
    "621ebb733a8413c65300005c_6": [
        {
            "start_logit": 8.3046875,
            "end_logit": 8.2109375,
            "text": "COVID-19 infection",
            "probability": 1.0
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -0.8857421875,
            "text": "COV",
            "probability": 0.00011235475540161133
        },
        {
            "start_logit": -1.017578125,
            "end_logit": 8.2109375,
            "text": "infection",
            "probability": 8.958578109741211e-05
        },
        {
            "start_logit": -4.421875,
            "end_logit": 8.2109375,
            "text": "severe COVID-19 infection",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -5.609375,
            "text": "COVID-19 infection.",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -5.66796875,
            "end_logit": 8.2109375,
            "text": "ID-19 infection",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -6.5234375,
            "text": "COVID-19",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 8.2109375,
            "text": "-19 infection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.1328125,
            "end_logit": 8.2109375,
            "text": "To assess the efficacy of Favipiravir compared to the standard therapy in treating patients with severe COVID-19 infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 8.2109375,
            "text": "19 infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.2109375,
            "text": "assess the efficacy of Favipiravir compared to the standard therapy in treating patients with severe COVID-19 infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 8.2109375,
            "text": "treating patients with severe COVID-19 infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.7265625,
            "text": "COVID-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 8.2109375,
            "text": "standard therapy in treating patients with severe COVID-19 infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 8.2109375,
            "text": "Favipiravir compared to the standard therapy in treating patients with severe COVID-19 infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 8.2109375,
            "text": "therapy in treating patients with severe COVID-19 infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 8.2109375,
            "text": "patients with severe COVID-19 infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 8.2109375,
            "text": "the standard therapy in treating patients with severe COVID-19 infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.421875,
            "end_logit": -0.8857421875,
            "text": "severe COV",
            "probability": 0.0
        },
        {
            "start_logit": -1.017578125,
            "end_logit": -5.609375,
            "text": "infection.",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_7": [
        {
            "start_logit": -2.037109375,
            "end_logit": 7.3203125,
            "text": "COVID-19 infections",
            "probability": 0.455810546875
        },
        {
            "start_logit": -2.28515625,
            "end_logit": 7.3203125,
            "text": "severe COVID-19 infections",
            "probability": 0.3564453125
        },
        {
            "start_logit": -3.08984375,
            "end_logit": 7.3203125,
            "text": "infections",
            "probability": 0.159423828125
        },
        {
            "start_logit": -6.55078125,
            "end_logit": 7.3203125,
            "text": "ID-19 infections",
            "probability": 0.0050048828125
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 7.3203125,
            "text": "Favipiravir versus standard of care in patients with severe COVID-19 infections",
            "probability": 0.0029888153076171875
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 7.3203125,
            "text": "in patients with severe COVID-19 infections",
            "probability": 0.0026378631591796875
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 7.3203125,
            "text": "-19 infections",
            "probability": 0.00258636474609375
        },
        {
            "start_logit": -7.234375,
            "end_logit": 7.3203125,
            "text": "with severe COVID-19 infections",
            "probability": 0.0025272369384765625
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 7.3203125,
            "text": "19 infections",
            "probability": 0.0023822784423828125
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 7.3203125,
            "text": "patients with severe COVID-19 infections",
            "probability": 0.002185821533203125
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.3203125,
            "text": "ipiravir versus standard of care in patients with severe COVID-19 infections",
            "probability": 0.0018787384033203125
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.3203125,
            "text": "standard of care in patients with severe COVID-19 infections",
            "probability": 0.0018491744995117188
        },
        {
            "start_logit": -7.734375,
            "end_logit": 7.3203125,
            "text": "iravir versus standard of care in patients with severe COVID-19 infections",
            "probability": 0.0015325546264648438
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 7.3203125,
            "text": "versus standard of care in patients with severe COVID-19 infections",
            "probability": 0.0014009475708007812
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 7.3203125,
            "text": "care in patients with severe COVID-19 infections",
            "probability": 0.0013370513916015625
        },
        {
            "start_logit": -2.037109375,
            "end_logit": -7.27734375,
            "text": "COVID-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.28515625,
            "end_logit": -7.27734375,
            "text": "severe COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.037109375,
            "end_logit": -7.765625,
            "text": "COVID-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.28515625,
            "end_logit": -7.765625,
            "text": "severe COVID-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.55078125,
            "end_logit": -7.27734375,
            "text": "ID-19",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_8": [
        {
            "start_logit": 6.09765625,
            "end_logit": 5.48828125,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -4.5859375,
            "text": "COV",
            "probability": 4.1961669921875e-05
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -4.8828125,
            "text": "COVID-19.",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": -5.43359375,
            "end_logit": 5.48828125,
            "text": "19",
            "probability": 9.834766387939453e-06
        },
        {
            "start_logit": 6.09765625,
            "end_logit": -6.6640625,
            "text": "COVID-",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -6.6875,
            "end_logit": 5.48828125,
            "text": "ID-19",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -7.09375,
            "end_logit": 5.48828125,
            "text": "treatment of COVID-19",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 5.48828125,
            "text": "of COVID-19",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 5.48828125,
            "text": "Molnupiravir/Favipiravir in the treatment of COVID-19",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.546875,
            "end_logit": 5.48828125,
            "text": "in the treatment of COVID-19",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 5.48828125,
            "text": "the treatment of COVID-19",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 5.48828125,
            "text": "iravir in the treatment of COVID-19",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 5.48828125,
            "text": "nupiravir/Favipiravir in the treatment of COVID-19",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 5.48828125,
            "text": "Favipiravir in the treatment of COVID-19",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 5.48828125,
            "text": "ipiravir in the treatment of COVID-19",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 5.48828125,
            "text": "vir in the treatment of COVID-19",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -5.43359375,
            "end_logit": -4.8828125,
            "text": "19.",
            "probability": 0.0
        },
        {
            "start_logit": -6.6875,
            "end_logit": -4.8828125,
            "text": "ID-19.",
            "probability": 0.0
        },
        {
            "start_logit": -7.09375,
            "end_logit": -4.5859375,
            "text": "treatment of COV",
            "probability": 0.0
        },
        {
            "start_logit": -7.12109375,
            "end_logit": -4.5859375,
            "text": "of COV",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_9": [
        {
            "start_logit": 8.40625,
            "end_logit": 7.3359375,
            "text": "influenza infections",
            "probability": 0.9990234375
        },
        {
            "start_logit": 8.40625,
            "end_logit": 0.62548828125,
            "text": "influenza",
            "probability": 0.001216888427734375
        },
        {
            "start_logit": 8.40625,
            "end_logit": -2.28515625,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2, although this is not yet fully validated.",
            "probability": 6.598234176635742e-05
        },
        {
            "start_logit": -2.919921875,
            "end_logit": 7.3359375,
            "text": "infections",
            "probability": 1.2040138244628906e-05
        },
        {
            "start_logit": 8.40625,
            "end_logit": -6.5859375,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.40625,
            "end_logit": -6.77734375,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.40625,
            "end_logit": -6.8515625,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.03125,
            "text": "influenza infections,",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.18359375,
            "text": "influenza infections, has been suggested to be",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.1953125,
            "text": "influenza infections, has been suggested to",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.22265625,
            "text": "influenza infections, has been suggested to be effective against SARS",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.23046875,
            "text": "influenza infections, has been suggested to be effective against SARS-",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.234375,
            "text": "influenza infections, has been suggested to be effective against SARS-CoV-2,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.34765625,
            "text": "influenza infections, has been suggested",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.40625,
            "end_logit": -7.39453125,
            "text": "influenza infections, has been",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 7.3359375,
            "text": "treatment of new and re-emerging influenza infections",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 7.3359375,
            "text": "Favipiravir, indicated for the treatment of new and re-emerging influenza infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.3359375,
            "text": "new and re-emerging influenza infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 7.3359375,
            "text": "emerging influenza infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 7.3359375,
            "text": "ipiravir, indicated for the treatment of new and re-emerging influenza infections",
            "probability": 1.1920928955078125e-07
        }
    ],
    "621ebb733a8413c65300005c_10": [
        {
            "start_logit": 6.1015625,
            "end_logit": 3.75390625,
            "text": "COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir.",
            "probability": 0.96044921875
        },
        {
            "start_logit": 6.1015625,
            "end_logit": 0.478271484375,
            "text": "COVID-19",
            "probability": 0.03607177734375
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -2.099609375,
            "text": "COVID-19 patients",
            "probability": 0.0027408599853515625
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -3.767578125,
            "text": "COV",
            "probability": 0.000518798828125
        },
        {
            "start_logit": -3.7109375,
            "end_logit": 3.75390625,
            "text": ".",
            "probability": 5.263090133666992e-05
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -6.2578125,
            "text": "COVID-19 patients treated with hydroxychloroquine",
            "probability": 4.291534423828125e-05
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -6.73046875,
            "text": "COVID-",
            "probability": 2.6881694793701172e-05
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -6.8671875,
            "text": "COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -7.14453125,
            "text": "COVID-19 patients treated",
            "probability": 1.7642974853515625e-05
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -7.15234375,
            "text": "COVID",
            "probability": 1.7642974853515625e-05
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -7.2421875,
            "text": "COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychlor",
            "probability": 1.6033649444580078e-05
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -7.2890625,
            "text": "COVID-19 patients treated with hydroxychloroquine,",
            "probability": 1.52587890625e-05
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -7.30078125,
            "text": "COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus",
            "probability": 1.5079975128173828e-05
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -7.41796875,
            "text": "COVID-19 patients treated with hydroxychloroquine, favipiravir, and",
            "probability": 1.3530254364013672e-05
        },
        {
            "start_logit": -5.90234375,
            "end_logit": 3.75390625,
            "text": "mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir.",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 3.75390625,
            "text": "hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir.",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 3.75390625,
            "text": "hydroxychloroquine plus favipiravir.",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 3.75390625,
            "text": "ID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir.",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 3.75390625,
            "text": "favipiravir.",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.484375,
            "end_logit": 3.75390625,
            "text": "moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir.",
            "probability": 1.1920928955078125e-06
        }
    ],
    "621ebb733a8413c65300005c_11": [
        {
            "start_logit": 8.1171875,
            "end_logit": 1.9453125,
            "text": "influenza A/California/04/2009 (H1N1) virus infections",
            "probability": 0.93701171875
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -1.279296875,
            "text": "influenza",
            "probability": 0.037200927734375
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -2.017578125,
            "text": "influenza A/California/04/2009 (H1N1) virus infections in mice.",
            "probability": 0.0178375244140625
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -3.43359375,
            "text": "influenza A/California/04/2009 (H1N1",
            "probability": 0.004322052001953125
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -4.09765625,
            "text": "influenza A",
            "probability": 0.002223968505859375
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -5.09765625,
            "text": "influenza A/California/04/2009 (H1N1) virus infections in",
            "probability": 0.0008182525634765625
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.015625,
            "text": "influenza A/",
            "probability": 0.0003268718719482422
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.55859375,
            "text": "influenza A/California/04/2009 (H1N1) virus",
            "probability": 0.00019061565399169922
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.06640625,
            "text": "influenza A/California",
            "probability": 0.0001137852668762207
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.140625,
            "text": "influenza A/California/04/",
            "probability": 0.00010609626770019531
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.16796875,
            "text": "influenza A/California/04",
            "probability": 0.0001036524772644043
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.16796875,
            "text": "influenza A/California/",
            "probability": 0.0001036524772644043
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.3203125,
            "text": "influenza A/California/04/2009",
            "probability": 8.863210678100586e-05
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.48046875,
            "text": "influenza A/California/04/2009 (",
            "probability": 7.581710815429688e-05
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.515625,
            "text": "influenza A/California/04/2009 (H1N1)",
            "probability": 7.295608520507812e-05
        },
        {
            "start_logit": -6.46875,
            "end_logit": 1.9453125,
            "text": "pandemic influenza A/California/04/2009 (H1N1) virus infections",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 1.9453125,
            "text": ") virus infections",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 1.9453125,
            "text": "peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 1.9453125,
            "text": "H1N1) virus infections",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 1.9453125,
            "text": "treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections",
            "probability": 1.7881393432617188e-07
        }
    ],
    "621ebb733a8413c65300005c_12": [
        {
            "start_logit": 6.19921875,
            "end_logit": 2.587890625,
            "text": "COVID-19.",
            "probability": 0.5634765625
        },
        {
            "start_logit": 6.19921875,
            "end_logit": 2.328125,
            "text": "COVID-19",
            "probability": 0.435546875
        },
        {
            "start_logit": 6.19921875,
            "end_logit": -4.30078125,
            "text": "COV",
            "probability": 0.0005736351013183594
        },
        {
            "start_logit": 6.19921875,
            "end_logit": -6.765625,
            "text": "COVID-",
            "probability": 4.851818084716797e-05
        },
        {
            "start_logit": 6.19921875,
            "end_logit": -7.74609375,
            "text": "COVID",
            "probability": 1.8298625946044922e-05
        },
        {
            "start_logit": -5.39453125,
            "end_logit": 2.587890625,
            "text": ".",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 2.587890625,
            "text": "ID-19.",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 2.587890625,
            "text": "with COVID-19.",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 2.328125,
            "text": "ID-19",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 2.328125,
            "text": "with COVID-19",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.046875,
            "end_logit": 2.587890625,
            "text": "Favipiravir possesses high utility for treating patients with COVID-19.",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 2.587890625,
            "text": "patients with COVID-19.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 2.587890625,
            "text": "BACKGROUND: Favipiravir possesses high utility for treating patients with COVID-19.",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.046875,
            "end_logit": 2.328125,
            "text": "Favipiravir possesses high utility for treating patients with COVID-19",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 2.587890625,
            "text": "high utility for treating patients with COVID-19.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 2.587890625,
            "text": "treating patients with COVID-19.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 2.587890625,
            "text": ": Favipiravir possesses high utility for treating patients with COVID-19.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 2.328125,
            "text": "patients with COVID-19",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 2.587890625,
            "text": "19.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 2.328125,
            "text": "BACKGROUND: Favipiravir possesses high utility for treating patients with COVID-19",
            "probability": 5.960464477539062e-07
        }
    ],
    "621ebb733a8413c65300005c_13": [
        {
            "start_logit": 5.3046875,
            "end_logit": 5.05859375,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and the recently emerged A(H7N9) avian virus.",
            "probability": 0.98291015625
        },
        {
            "start_logit": 5.3046875,
            "end_logit": 0.98291015625,
            "text": "influenza",
            "probability": 0.01678466796875
        },
        {
            "start_logit": -2.556640625,
            "end_logit": 5.05859375,
            "text": ".",
            "probability": 0.00037932395935058594
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -3.630859375,
            "text": "influenza viruses, including A(H1N1)pdm09",
            "probability": 0.00016582012176513672
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -4.0546875,
            "text": "influenza viruses",
            "probability": 0.0001087188720703125
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -5.0859375,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1",
            "probability": 3.88026237487793e-05
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -5.1328125,
            "text": "influenza viruses, including A(H1N1)pdm09, A",
            "probability": 3.695487976074219e-05
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -5.1328125,
            "text": "influenza viruses, including A(H1N1",
            "probability": 3.695487976074219e-05
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -5.71484375,
            "text": "influenza viruses, including A",
            "probability": 2.0742416381835938e-05
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -5.97265625,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and the recently emerged A",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -6.046875,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1)",
            "probability": 1.4841556549072266e-05
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -6.0859375,
            "text": "influenza viruses,",
            "probability": 1.424551010131836e-05
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -6.33203125,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and the recently emerged A(H7",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -6.5078125,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and the recently emerged A(H7N9",
            "probability": 9.357929229736328e-06
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -6.5234375,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and",
            "probability": 9.179115295410156e-06
        },
        {
            "start_logit": -6.31640625,
            "end_logit": 5.05859375,
            "text": "A(H1N1)pdm09, A(H5N1) and the recently emerged A(H7N9) avian virus.",
            "probability": 8.821487426757812e-06
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -6.5859375,
            "text": "influenza viruses, including A(H1N1)pdm09, A(",
            "probability": 8.64267349243164e-06
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -6.83203125,
            "text": "influenza viruses, including A(H1N1)pdm09, A(H5N1) and the recently emerged A(H7N9)",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": 5.3046875,
            "end_logit": -6.87890625,
            "text": "influenza viruses, including",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 5.05859375,
            "text": "emerged A(H7N9) avian virus.",
            "probability": 4.351139068603516e-06
        }
    ],
    "621ebb733a8413c65300005c_14": [
        {
            "start_logit": 8.21875,
            "end_logit": 7.984375,
            "text": "influenza virus infections",
            "probability": 1.0
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.259765625,
            "text": "influenza",
            "probability": 9.685754776000977e-05
        },
        {
            "start_logit": -1.685546875,
            "end_logit": 7.984375,
            "text": "infections",
            "probability": 4.988908767700195e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.1953125,
            "text": "influenza virus",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.46875,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with demonstrated efficacy in the type I interferon deficient mouse model.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.84765625,
            "text": "influenza virus infections and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 7.984375,
            "text": "Favipiravir is approved in Japan for the treatment of influenza virus infections",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.48046875,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with demonstrated efficacy in the type I interferon",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.49609375,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 7.984375,
            "text": "treatment of influenza virus infections",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.5546875,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 7.984375,
            "text": "virus infections",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.59375,
            "text": "influenza virus infections and has shown",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.6171875,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with demonstrated efficacy in the type I",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.62109375,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.6484375,
            "text": "influenza virus infections and has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.671875,
            "text": "influenza virus infections and has shown promise against other highly pathogenic RNA viruses including CCHFV with demonstrated efficacy in the type I interferon deficient",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 7.984375,
            "text": "ipiravir is approved in Japan for the treatment of influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 7.984375,
            "text": "of influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 7.984375,
            "text": "iravir is approved in Japan for the treatment of influenza virus infections",
            "probability": 1.1920928955078125e-07
        }
    ],
    "621ebb733a8413c65300005c_15": [
        {
            "start_logit": 6.1875,
            "end_logit": 3.10546875,
            "text": "COVID-19 treatment, and we currently have limited information regarding its efficacy and safety.",
            "probability": 0.9951171875
        },
        {
            "start_logit": 6.1875,
            "end_logit": -2.8203125,
            "text": "COVID-19",
            "probability": 0.0026454925537109375
        },
        {
            "start_logit": 6.1875,
            "end_logit": -3.376953125,
            "text": "COV",
            "probability": 0.0015192031860351562
        },
        {
            "start_logit": 6.1875,
            "end_logit": -6.26171875,
            "text": "COVID-19 treatment",
            "probability": 8.440017700195312e-05
        },
        {
            "start_logit": 6.1875,
            "end_logit": -6.34765625,
            "text": "COVID-19 treatment,",
            "probability": 7.808208465576172e-05
        },
        {
            "start_logit": 6.1875,
            "end_logit": -6.83984375,
            "text": "COVID-",
            "probability": 4.7326087951660156e-05
        },
        {
            "start_logit": 6.1875,
            "end_logit": -7.12109375,
            "text": "COVID-19 treatment, and",
            "probability": 3.5762786865234375e-05
        },
        {
            "start_logit": 6.1875,
            "end_logit": -7.37890625,
            "text": "COVID-19 treatment, and we currently have limited information regarding its efficacy and",
            "probability": 2.7835369110107422e-05
        },
        {
            "start_logit": 6.1875,
            "end_logit": -7.48828125,
            "text": "COVID-19 treatment, and we currently have limited information regarding its",
            "probability": 2.4974346160888672e-05
        },
        {
            "start_logit": 6.1875,
            "end_logit": -7.5,
            "text": "COVID",
            "probability": 2.4557113647460938e-05
        },
        {
            "start_logit": 6.1875,
            "end_logit": -7.51171875,
            "text": "COVID-19 treatment, and we currently have limited",
            "probability": 2.4199485778808594e-05
        },
        {
            "start_logit": 6.1875,
            "end_logit": -7.6015625,
            "text": "COVID-19 treatment, and we",
            "probability": 2.2172927856445312e-05
        },
        {
            "start_logit": -4.8046875,
            "end_logit": 3.10546875,
            "text": ".",
            "probability": 1.6629695892333984e-05
        },
        {
            "start_logit": -6.08203125,
            "end_logit": 3.10546875,
            "text": "antiviral drug, is being used for COVID-19 treatment, and we currently have limited information regarding its efficacy and safety.",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -7.1015625,
            "end_logit": 3.10546875,
            "text": "ID-19 treatment, and we currently have limited information regarding its efficacy and safety.",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 3.10546875,
            "text": "ipiravir, an antiviral drug, is being used for COVID-19 treatment, and we currently have limited information regarding its efficacy and safety.",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 3.10546875,
            "text": ", is being used for COVID-19 treatment, and we currently have limited information regarding its efficacy and safety.",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.546875,
            "end_logit": 3.10546875,
            "text": "iravir, an antiviral drug, is being used for COVID-19 treatment, and we currently have limited information regarding its efficacy and safety.",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 3.10546875,
            "text": "vir, an antiviral drug, is being used for COVID-19 treatment, and we currently have limited information regarding its efficacy and safety.",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 3.10546875,
            "text": "for COVID-19 treatment, and we currently have limited information regarding its efficacy and safety.",
            "probability": 9.5367431640625e-07
        }
    ],
    "621ebb733a8413c65300005c_16": [
        {
            "start_logit": 6.58984375,
            "end_logit": 6.3046875,
            "text": "influenza",
            "probability": 1.0
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -3.92578125,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome coronavirus-2.",
            "probability": 3.618001937866211e-05
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -5.9609375,
            "text": "influenza in",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -6.3203125,
            "text": "influenza in Japan",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -6.62890625,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome coronavirus-2",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -6.671875,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome coronavirus",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -6.703125,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome coronavirus-",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -6.79296875,
            "text": "influenza in Japan in 2014",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -6.87890625,
            "text": "influenza in Japan in 2014 and",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -6.91015625,
            "text": "influenza in Japan in",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -7.0703125,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -7.18359375,
            "text": "influenza in Japan in 2014 and has shown potent in vitro activity against severe acute respiratory syndrome",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -7.3828125,
            "text": "influenza in Japan in 2014 and has shown",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.58984375,
            "end_logit": -7.484375,
            "text": "influenza in Japan in 2014 and has",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.296875,
            "end_logit": 6.3046875,
            "text": "Favipiravir is one such oral drug that was approved for new and reemerging pandemic influenza",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 6.3046875,
            "text": "new and reemerging pandemic influenza",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.3125,
            "end_logit": 6.3046875,
            "text": "pandemic influenza",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 6.3046875,
            "text": "oral drug that was approved for new and reemerging pandemic influenza",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 6.3046875,
            "text": "drug that was approved for new and reemerging pandemic influenza",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.3046875,
            "text": "was approved for new and reemerging pandemic influenza",
            "probability": 6.556510925292969e-07
        }
    ],
    "621ebb733a8413c65300005c_17": [
        {
            "start_logit": 6.72265625,
            "end_logit": 3.435546875,
            "text": "influenza",
            "probability": 0.5693359375
        },
        {
            "start_logit": 6.72265625,
            "end_logit": 3.154296875,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment of COVID-19.",
            "probability": 0.429931640625
        },
        {
            "start_logit": 6.72265625,
            "end_logit": -4.28125,
            "text": "influenza and",
            "probability": 0.0002541542053222656
        },
        {
            "start_logit": 6.72265625,
            "end_logit": -5.6484375,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment of COVID-19",
            "probability": 6.502866744995117e-05
        },
        {
            "start_logit": 6.72265625,
            "end_logit": -6.16796875,
            "text": "influenza and Ebola,",
            "probability": 3.8504600524902344e-05
        },
        {
            "start_logit": 6.72265625,
            "end_logit": -6.1953125,
            "text": "influenza and Ebola",
            "probability": 3.7610530853271484e-05
        },
        {
            "start_logit": 6.72265625,
            "end_logit": -6.40234375,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment of COV",
            "probability": 3.045797348022461e-05
        },
        {
            "start_logit": 6.72265625,
            "end_logit": -6.48046875,
            "text": "influenza and Ebola, which has shown some",
            "probability": 2.8192996978759766e-05
        },
        {
            "start_logit": 6.72265625,
            "end_logit": -6.58203125,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment of COVID-",
            "probability": 2.5451183319091797e-05
        },
        {
            "start_logit": 6.72265625,
            "end_logit": -6.7890625,
            "text": "influenza and Ebola, which has",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": 6.72265625,
            "end_logit": -6.79296875,
            "text": "influenza and Ebola, which",
            "probability": 2.0623207092285156e-05
        },
        {
            "start_logit": 6.72265625,
            "end_logit": -7.12890625,
            "text": "influenza and Ebola, which has shown",
            "probability": 1.4722347259521484e-05
        },
        {
            "start_logit": 6.72265625,
            "end_logit": -7.25,
            "text": "influenza and Ebola, which has shown some promise in early trials for treatment of",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": 6.72265625,
            "end_logit": -7.2734375,
            "text": "influenza and Ebola, which has shown some promise",
            "probability": 1.2814998626708984e-05
        },
        {
            "start_logit": -4.12890625,
            "end_logit": 3.154296875,
            "text": "COVID-19.",
            "probability": 8.344650268554688e-06
        },
        {
            "start_logit": -4.43359375,
            "end_logit": 3.435546875,
            "text": "Favipiravir is an antiviral previously indicated for influenza",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": -4.43359375,
            "end_logit": 3.154296875,
            "text": "Favipiravir is an antiviral previously indicated for influenza and Ebola, which has shown some promise in early trials for treatment of COVID-19.",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": -4.75390625,
            "end_logit": 3.154296875,
            "text": ".",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -6.57421875,
            "end_logit": 3.154296875,
            "text": "treatment of COVID-19.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 3.435546875,
            "text": "ipiravir is an antiviral previously indicated for influenza",
            "probability": 4.76837158203125e-07
        }
    ],
    "621ebb733a8413c65300005c_18": [
        {
            "start_logit": 8.1484375,
            "end_logit": 8.109375,
            "text": "Ebola virus infection",
            "probability": 0.98828125
        },
        {
            "start_logit": 3.658203125,
            "end_logit": 8.109375,
            "text": "influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 0.0111541748046875
        },
        {
            "start_logit": 3.658203125,
            "end_logit": 3.65625,
            "text": "influenza",
            "probability": 0.00012981891632080078
        },
        {
            "start_logit": -1.224609375,
            "end_logit": 8.109375,
            "text": "infection",
            "probability": 8.445978164672852e-05
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -1.3193359375,
            "text": "Ebola",
            "probability": 7.998943328857422e-05
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -2.54296875,
            "text": "Ebola virus infection.",
            "probability": 2.3603439331054688e-05
        },
        {
            "start_logit": 3.658203125,
            "end_logit": -1.3193359375,
            "text": "influenza, now has been demonstrated to have a curative effect in treating Ebola",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 8.109375,
            "text": "virus infection",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.75390625,
            "end_logit": 8.109375,
            "text": "treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 8.109375,
            "text": "treating Ebola virus infection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 3.658203125,
            "end_logit": -2.54296875,
            "text": "influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.3359375,
            "text": "Ebola virus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 8.109375,
            "text": ", a novel antiviral drug which was mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 8.109375,
            "text": "has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 8.109375,
            "text": "demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.109375,
            "text": "now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.109375,
            "text": "been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 8.109375,
            "text": "antiviral drug which was mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 8.109375,
            "text": "drug which was mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 8.109375,
            "text": "was mainly used for the treatment of influenza, now has been demonstrated to have a curative effect in treating Ebola virus infection",
            "probability": 1.1920928955078125e-07
        }
    ],
    "621ebb733a8413c65300005c_19": [
        {
            "start_logit": 8.296875,
            "end_logit": 7.4375,
            "text": "influenza virus",
            "probability": 0.9990234375
        },
        {
            "start_logit": 8.296875,
            "end_logit": -0.108642578125,
            "text": "influenza",
            "probability": 0.0005273818969726562
        },
        {
            "start_logit": -2.630859375,
            "end_logit": 7.4375,
            "text": "virus",
            "probability": 1.7940998077392578e-05
        },
        {
            "start_logit": -4.6640625,
            "end_logit": 7.4375,
            "text": "infections with the influenza virus",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 8.296875,
            "end_logit": -5.63671875,
            "text": "influenza virus] inhibits in vitro murine norovirus replication.",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -5.4765625,
            "end_logit": 7.4375,
            "text": "treatment of infections with the influenza virus",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.296875,
            "end_logit": -6.7265625,
            "text": "influenza virus]",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.2421875,
            "text": "influenza virus] inhibits in vitro murine norovirus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.4921875,
            "text": "influenza virus] inhibits in vitro murine nor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.60546875,
            "text": "influenza virus] inhibits in vitro murine norovirus replication",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.6328125,
            "text": "influenza virus] inhibits",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 7.4375,
            "text": "demonstrate that Favipiravir [T-705, a drug in advanced clinical development for the treatment of infections with the influenza virus",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 7.4375,
            "text": "the treatment of infections with the influenza virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.4375,
            "text": "for the treatment of infections with the influenza virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.4375,
            "text": "with the influenza virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.4375,
            "text": "Favipiravir [T-705, a drug in advanced clinical development for the treatment of infections with the influenza virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 7.4375,
            "text": ", a drug in advanced clinical development for the treatment of infections with the influenza virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 7.4375,
            "text": "T-705, a drug in advanced clinical development for the treatment of infections with the influenza virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 7.4375,
            "text": "of infections with the influenza virus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.6640625,
            "end_logit": -0.108642578125,
            "text": "infections with the influenza",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_20": [
        {
            "start_logit": 8.09375,
            "end_logit": 7.34375,
            "text": "COVID-19",
            "probability": 1.0
        },
        {
            "start_logit": 8.09375,
            "end_logit": -1.373046875,
            "text": "COV",
            "probability": 0.0001634359359741211
        },
        {
            "start_logit": -3.125,
            "end_logit": 7.34375,
            "text": "19",
            "probability": 1.341104507446289e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -6.71875,
            "text": "COVID-",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -6.99609375,
            "text": "COVID",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 7.34375,
            "text": "Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID-19",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 7.34375,
            "text": "ID-19",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 7.34375,
            "text": "patients with COVID-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 7.34375,
            "text": "with COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.34375,
            "text": "pinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.34375,
            "text": "Favipiravir might be a treatment option for patients with COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 7.34375,
            "text": "The combination therapy of Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 7.34375,
            "text": "-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 7.34375,
            "text": "ipiravir might be a treatment option for patients with COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 7.34375,
            "text": "avir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 7.34375,
            "text": "iravir might be a treatment option for patients with COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 7.34375,
            "text": "combination therapy of Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 7.34375,
            "text": "for patients with COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 7.34375,
            "text": "vir might be a treatment option for patients with COVID-19",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.80078125,
            "end_logit": -1.373046875,
            "text": "Lopinavir/Ritonavir plus Favipiravir might be a treatment option for patients with COV",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_21": [
        {
            "start_logit": 7.98046875,
            "end_logit": 3.390625,
            "text": "COVID-19.",
            "probability": 0.556640625
        },
        {
            "start_logit": 7.98046875,
            "end_logit": 3.150390625,
            "text": "COVID-19",
            "probability": 0.436767578125
        },
        {
            "start_logit": 7.98046875,
            "end_logit": -1.02734375,
            "text": "COV",
            "probability": 0.006683349609375
        },
        {
            "start_logit": 7.98046875,
            "end_logit": -6.734375,
            "text": "COVID-",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": 7.98046875,
            "end_logit": -7.5234375,
            "text": "COVID",
            "probability": 1.0073184967041016e-05
        },
        {
            "start_logit": 7.98046875,
            "end_logit": -7.765625,
            "text": "COVID-19. Recent",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": -4.13671875,
            "end_logit": 3.390625,
            "text": ".",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -5.76171875,
            "end_logit": 3.390625,
            "text": "vir, Favipiravir and Ribavirin might be a safer therapeutic option for COVID-19.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.76171875,
            "end_logit": 3.150390625,
            "text": "vir, Favipiravir and Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.3125,
            "end_logit": 3.390625,
            "text": "Ribavirin might be a safer therapeutic option for COVID-19.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.3125,
            "end_logit": 3.150390625,
            "text": "Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 3.390625,
            "text": "19.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.6875,
            "end_logit": 3.390625,
            "text": "Favipiravir and Ribavirin might be a safer therapeutic option for COVID-19.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 3.390625,
            "text": "ID-19.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 3.150390625,
            "text": "19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.6875,
            "end_logit": 3.150390625,
            "text": "Favipiravir and Ribavirin might be a safer therapeutic option for COVID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 3.150390625,
            "text": "ID-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.953125,
            "end_logit": 3.390625,
            "text": "for COVID-19.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.1328125,
            "end_logit": 3.390625,
            "text": "ipiravir and Ribavirin might be a safer therapeutic option for COVID-19.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 3.390625,
            "text": "iravir and Ribavirin might be a safer therapeutic option for COVID-19.",
            "probability": 1.1920928955078125e-07
        }
    ],
    "621ebb733a8413c65300005c_22": [
        {
            "start_logit": 7.87890625,
            "end_logit": 6.5,
            "text": "Covid-19",
            "probability": 1.0
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -2.02734375,
            "text": "Cov",
            "probability": 0.00019872188568115234
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -5.25,
            "text": "Covid-19: A Retrospective Study.",
            "probability": 7.867813110351562e-06
        },
        {
            "start_logit": -4.39453125,
            "end_logit": 6.5,
            "text": "19",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -6.66015625,
            "text": "Covid-",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.58984375,
            "text": "Covid-19:",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.75390625,
            "text": "Covid",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.87890625,
            "end_logit": -7.82421875,
            "text": "Covid-19: A Retrospective",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.5390625,
            "end_logit": 6.5,
            "text": "id-19",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.65625,
            "end_logit": 6.5,
            "text": "Management of Covid-19",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 6.5,
            "text": "Hydroxychloroquine for Management of Covid-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 6.5,
            "text": "Effectiveness and Safety of Favipiravir Compared to Hydroxychloroquine for Management of Covid-19",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.5,
            "text": "of Covid-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 6.5,
            "text": "-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 6.5,
            "text": "loroquine for Management of Covid-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 6.5,
            "text": "Favipiravir Compared to Hydroxychloroquine for Management of Covid-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 6.5,
            "text": "Safety of Favipiravir Compared to Hydroxychloroquine for Management of Covid-19",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.65625,
            "end_logit": -2.02734375,
            "text": "Management of Cov",
            "probability": 0.0
        },
        {
            "start_logit": -7.2890625,
            "end_logit": -2.02734375,
            "text": "Hydroxychloroquine for Management of Cov",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -2.02734375,
            "text": "Effectiveness and Safety of Favipiravir Compared to Hydroxychloroquine for Management of Cov",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_23": [
        {
            "start_logit": 6.6640625,
            "end_logit": 6.28125,
            "text": "influenza",
            "probability": 1.0
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -6.83984375,
            "text": "influenza infec",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 6.6640625,
            "end_logit": -7.21875,
            "text": "influenza inf",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 6.28125,
            "text": "AIM: Favipiravir and oseltamivir are antiviral compounds used for the treatment of influenza",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 6.28125,
            "text": ": Favipiravir and oseltamivir are antiviral compounds used for the treatment of influenza",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 6.28125,
            "text": "Favipiravir and oseltamivir are antiviral compounds used for the treatment of influenza",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 6.28125,
            "text": "treatment of influenza",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 6.28125,
            "text": "eltamivir are antiviral compounds used for the treatment of influenza",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 6.28125,
            "text": "of influenza",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 6.28125,
            "text": "ipiravir and oseltamivir are antiviral compounds used for the treatment of influenza",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 6.28125,
            "text": "used for the treatment of influenza",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 6.28125,
            "text": "antiviral compounds used for the treatment of influenza",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.28125,
            "text": "oseltamivir are antiviral compounds used for the treatment of influenza",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 6.28125,
            "text": "compounds used for the treatment of influenza",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 6.28125,
            "text": "are antiviral compounds used for the treatment of influenza",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": -6.83984375,
            "text": "AIM: Favipiravir and oseltamivir are antiviral compounds used for the treatment of influenza infec",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": -6.83984375,
            "text": ": Favipiravir and oseltamivir are antiviral compounds used for the treatment of influenza infec",
            "probability": 0.0
        },
        {
            "start_logit": -7.765625,
            "end_logit": -6.83984375,
            "text": "Favipiravir and oseltamivir are antiviral compounds used for the treatment of influenza infec",
            "probability": 0.0
        },
        {
            "start_logit": -7.7734375,
            "end_logit": -6.83984375,
            "text": "treatment of influenza infec",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -6.83984375,
            "text": "eltamivir are antiviral compounds used for the treatment of influenza infec",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_24": [
        {
            "start_logit": 7.77734375,
            "end_logit": 6.47265625,
            "text": "coronavirus disease",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -0.3212890625,
            "text": "coronavirus disease 2019",
            "probability": 0.0011205673217773438
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -2.11328125,
            "text": "coronavirus",
            "probability": 0.00018644332885742188
        },
        {
            "start_logit": -4.265625,
            "end_logit": 6.47265625,
            "text": "disease",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -7.26171875,
            "text": "coronavirus disease 2019 (COVID-19)",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -7.3359375,
            "text": "coronavirus disease 2019 (COVID-",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -7.375,
            "text": "coronavirus disease 2019 (COVID",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -7.4453125,
            "text": "coronavirus disease 2019 (COV",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.14453125,
            "end_logit": 6.47265625,
            "text": "managing coronavirus disease",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -7.4609375,
            "text": "coronavirus disease 2019 (COVID-19",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.77734375,
            "end_logit": -7.46484375,
            "text": "coronavirus disease 2019 (",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 6.47265625,
            "text": ": Favipiravir is a promising treatment candidate for managing coronavirus disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 6.47265625,
            "text": "Favipiravir is a promising treatment candidate for managing coronavirus disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 6.47265625,
            "text": "OBJECTIVE: Favipiravir is a promising treatment candidate for managing coronavirus disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 6.47265625,
            "text": "WHAT IS KNOWN AND OBJECTIVE: Favipiravir is a promising treatment candidate for managing coronavirus disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 6.47265625,
            "text": "IS KNOWN AND OBJECTIVE: Favipiravir is a promising treatment candidate for managing coronavirus disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.47265625,
            "text": "ipiravir is a promising treatment candidate for managing coronavirus disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 6.47265625,
            "text": "iravir is a promising treatment candidate for managing coronavirus disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.265625,
            "end_logit": -0.3212890625,
            "text": "disease 2019",
            "probability": 0.0
        },
        {
            "start_logit": -6.14453125,
            "end_logit": -0.3212890625,
            "text": "managing coronavirus disease 2019",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_25": [
        {
            "start_logit": 6.3984375,
            "end_logit": 5.7109375,
            "text": "influenza",
            "probability": 0.986328125
        },
        {
            "start_logit": 6.3984375,
            "end_logit": 1.3583984375,
            "text": "influenza, the next pandemic influenza",
            "probability": 0.0127105712890625
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -2.65234375,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are not available.",
            "probability": 0.00023102760314941406
        },
        {
            "start_logit": 1.0078125,
            "end_logit": 1.3583984375,
            "text": "influenza",
            "probability": 5.799531936645508e-05
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -6.16015625,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections",
            "probability": 6.854534149169922e-06
        },
        {
            "start_logit": -5.984375,
            "end_logit": 5.7109375,
            "text": "Favipiravir is expected to be an important therapeutic agent for severe influenza",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -6.6875,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -6.703125,
            "text": "influenza,",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -6.72265625,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -6.93359375,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are not available",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -6.9453125,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -7.05078125,
            "text": "influenza, the next pandemic influenza strain",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -6.44140625,
            "end_logit": 5.7109375,
            "text": "severe influenza",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -7.13671875,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are not",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -7.1796875,
            "text": "influenza, the next pandemic influenza strain, and",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -7.1953125,
            "text": "influenza, the",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -7.265625,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -7.29296875,
            "text": "influenza, the next pandemic influenza strain, and other severe",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -7.3984375,
            "text": "influenza, the next pandemic influenza strain, and other",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 1.0078125,
            "end_logit": -2.65234375,
            "text": "influenza strain, and other severe RNA virus infections for which standard treatments are not available.",
            "probability": 1.0728836059570312e-06
        }
    ],
    "621ebb733a8413c65300005c_26": [
        {
            "start_logit": 6.3984375,
            "end_logit": 5.7109375,
            "text": "influenza",
            "probability": 0.986328125
        },
        {
            "start_logit": 6.3984375,
            "end_logit": 1.3583984375,
            "text": "influenza, the next pandemic influenza",
            "probability": 0.0127105712890625
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -2.65234375,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are not available.",
            "probability": 0.00023102760314941406
        },
        {
            "start_logit": 1.0078125,
            "end_logit": 1.3583984375,
            "text": "influenza",
            "probability": 5.799531936645508e-05
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -6.16015625,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections",
            "probability": 6.854534149169922e-06
        },
        {
            "start_logit": -5.984375,
            "end_logit": 5.7109375,
            "text": "Favipiravir is expected to be an important therapeutic agent for severe influenza",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -6.6875,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -6.703125,
            "text": "influenza,",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -6.72265625,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -6.93359375,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are not available",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -6.9453125,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -7.05078125,
            "text": "influenza, the next pandemic influenza strain",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -6.44140625,
            "end_logit": 5.7109375,
            "text": "severe influenza",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -7.13671875,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments are not",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -7.1796875,
            "text": "influenza, the next pandemic influenza strain, and",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -7.1953125,
            "text": "influenza, the",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -7.265625,
            "text": "influenza, the next pandemic influenza strain, and other severe RNA virus infections for which standard treatments",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -7.29296875,
            "text": "influenza, the next pandemic influenza strain, and other severe",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 6.3984375,
            "end_logit": -7.3984375,
            "text": "influenza, the next pandemic influenza strain, and other",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 1.0078125,
            "end_logit": -2.65234375,
            "text": "influenza strain, and other severe RNA virus infections for which standard treatments are not available.",
            "probability": 1.0728836059570312e-06
        }
    ],
    "621ebb733a8413c65300005c_27": [
        {
            "start_logit": 8.1328125,
            "end_logit": 7.3359375,
            "text": "influenza virus infections",
            "probability": 1.0
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -1.4716796875,
            "text": "influenza",
            "probability": 0.00014889240264892578
        },
        {
            "start_logit": -3.078125,
            "end_logit": 7.3359375,
            "text": "infections",
            "probability": 1.3530254364013672e-05
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -4.49609375,
            "text": "influenza virus infections.",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": -4.30078125,
            "end_logit": 7.3359375,
            "text": "treat pandemic influenza virus infections",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -5.73046875,
            "text": "influenza virus",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -5.14453125,
            "end_logit": 7.3359375,
            "text": "pandemic influenza virus infections",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 7.3359375,
            "text": "virus infections",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 7.3359375,
            "text": "also known as T-705, is an antiviral drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 7.3359375,
            "text": "known as T-705, is an antiviral drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 7.3359375,
            "text": "Japan to treat pandemic influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 7.3359375,
            "text": "to treat pandemic influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 7.3359375,
            "text": "ipiravir, also known as T-705, is an antiviral drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 7.3359375,
            "text": "drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 7.3359375,
            "text": "has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 7.3359375,
            "text": ", is an antiviral drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 7.3359375,
            "text": "iravir, also known as T-705, is an antiviral drug that has been approved in 2014 in Japan to treat pandemic influenza virus infections",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.30078125,
            "end_logit": -1.4716796875,
            "text": "treat pandemic influenza",
            "probability": 0.0
        },
        {
            "start_logit": -5.14453125,
            "end_logit": -1.4716796875,
            "text": "pandemic influenza",
            "probability": 0.0
        },
        {
            "start_logit": -3.078125,
            "end_logit": -4.49609375,
            "text": "infections.",
            "probability": 0.0
        }
    ],
    "621ebb733a8413c65300005c_28": [
        {
            "start_logit": 6.47265625,
            "end_logit": 6.3046875,
            "text": "influenza",
            "probability": 1.0
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -5.984375,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are ongoing in the United States and Europe.",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -7.11328125,
            "text": "influenza strains;",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -7.22265625,
            "text": "influenza strains",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -7.328125,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are ongoing in the United States",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -7.375,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are ongoing",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -7.390625,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -7.46484375,
            "text": "influenza strains; and",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -7.48046875,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are ongoing in the United",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -7.4921875,
            "text": "influenza strains; and several phase 2 and 3 clinical trials are ongoing in the United States and",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -7.53125,
            "text": "influenza strains; and several phase 2 and",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 6.3046875,
            "text": "emerging influenza",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 6.3046875,
            "text": "Favipiravir (T-705) is a purine analogue antiviral approved for use in Japan against emerging influenza",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 6.3046875,
            "text": "use in Japan against emerging influenza",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 6.3046875,
            "text": "purine analogue antiviral approved for use in Japan against emerging influenza",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 6.3046875,
            "text": "Japan against emerging influenza",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 6.3046875,
            "text": "analogue antiviral approved for use in Japan against emerging influenza",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 6.3046875,
            "text": "ipiravir (T-705) is a purine analogue antiviral approved for use in Japan against emerging influenza",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.3046875,
            "text": ") is a purine analogue antiviral approved for use in Japan against emerging influenza",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.3046875,
            "text": "against emerging influenza",
            "probability": 5.960464477539062e-07
        }
    ],
    "621ebb733a8413c65300005c_29": [
        {
            "start_logit": 6.52734375,
            "end_logit": 6.125,
            "text": "influenza",
            "probability": 1.0
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -5.37890625,
            "text": "influenza and many other RNA viral diseases for which there are no approved therapies.",
            "probability": 1.0073184967041016e-05
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -6.921875,
            "text": "influenza and",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.046875,
            "text": "influenza and many other RNA viral diseases",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.07421875,
            "text": "influenza and many other RNA viral diseases for which there are no",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.0859375,
            "text": "influenza and many other RNA viral",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.1875,
            "text": "influenza and many other RNA viral diseases for which there are no approved",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.23046875,
            "text": "influenza and many other RNA viral diseases for which there are",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.39453125,
            "text": "influenza and many other RNA viral diseases for",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.46875,
            "text": "influenza and many",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.5078125,
            "text": "influenza and many other RNA viral diseases for which",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 6.125,
            "text": "antiviral activity, favipiravir is a promising drug candidate for influenza",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 6.125,
            "text": ", favipiravir is a promising drug candidate for influenza",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 6.125,
            "text": "With its unique mechanism of action and broad range of antiviral activity, favipiravir is a promising drug candidate for influenza",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 6.125,
            "text": "favipiravir is a promising drug candidate for influenza",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 6.125,
            "text": "range of antiviral activity, favipiravir is a promising drug candidate for influenza",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 6.125,
            "text": "broad range of antiviral activity, favipiravir is a promising drug candidate for influenza",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 6.125,
            "text": "mechanism of action and broad range of antiviral activity, favipiravir is a promising drug candidate for influenza",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 6.125,
            "text": "action and broad range of antiviral activity, favipiravir is a promising drug candidate for influenza",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -5.37890625,
            "text": "antiviral activity, favipiravir is a promising drug candidate for influenza and many other RNA viral diseases for which there are no approved therapies.",
            "probability": 0.0
        }
    ],
    "5e48bf5ed14c9f295d000019_1": [
        {
            "start_logit": 6.3046875,
            "end_logit": 8.0390625,
            "text": "Status Epilepticus",
            "probability": 0.9677734375
        },
        {
            "start_logit": 2.888671875,
            "end_logit": 8.0390625,
            "text": "Nonconvulsive Status Epilepticus",
            "probability": 0.031829833984375
        },
        {
            "start_logit": -1.7109375,
            "end_logit": 8.0390625,
            "text": "Epilepticus",
            "probability": 0.00031948089599609375
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -4.578125,
            "text": "Status",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 8.0390625,
            "text": "ulsive Status Epilepticus",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 8.0390625,
            "text": "Reevaluation of the Critically Ill Patients With Nonconvulsive Status Epilepticus",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 8.0390625,
            "text": "With Nonconvulsive Status Epilepticus",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 8.0390625,
            "text": "Critically Ill Patients With Nonconvulsive Status Epilepticus",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 8.0390625,
            "text": "vulsive Status Epilepticus",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 8.0390625,
            "text": "Patients With Nonconvulsive Status Epilepticus",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 8.0390625,
            "text": "ation of the Critically Ill Patients With Nonconvulsive Status Epilepticus",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -6.94921875,
            "text": "Status Epilepticus by",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -7.4921875,
            "text": "Status Epilepticus by Using Salzburg Consensus Criteria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -7.57421875,
            "text": "Status Epilepticus by Using Salzburg Consensus Criteria.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.3046875,
            "end_logit": -7.671875,
            "text": "Status Epilepticus by Using Salzburg Consensus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 2.888671875,
            "end_logit": -4.578125,
            "text": "Nonconvulsive Status",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.888671875,
            "end_logit": -6.8515625,
            "text": "Noncon",
            "probability": 0.0
        },
        {
            "start_logit": 2.888671875,
            "end_logit": -6.94921875,
            "text": "Nonconvulsive Status Epilepticus by",
            "probability": 0.0
        },
        {
            "start_logit": 2.888671875,
            "end_logit": -7.4921875,
            "text": "Nonconvulsive Status Epilepticus by Using Salzburg Consensus Criteria",
            "probability": 0.0
        },
        {
            "start_logit": 2.888671875,
            "end_logit": -7.57421875,
            "text": "Nonconvulsive Status Epilepticus by Using Salzburg Consensus Criteria.",
            "probability": 0.0
        }
    ],
    "5e48bf5ed14c9f295d000019_2": [
        {
            "start_logit": 0.79931640625,
            "end_logit": 7.9375,
            "text": "nonconvulsive status epilepticus",
            "probability": 0.90625
        },
        {
            "start_logit": -1.548828125,
            "end_logit": 7.9375,
            "text": "epilepticus",
            "probability": 0.08697509765625
        },
        {
            "start_logit": -4.5546875,
            "end_logit": 7.9375,
            "text": "status epilepticus",
            "probability": 0.00429534912109375
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 7.9375,
            "text": "with nonconvulsive status epilepticus",
            "probability": 0.0004012584686279297
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 7.9375,
            "text": "the Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 0.00024437904357910156
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.9375,
            "text": "aimed to assess the usefulness of the Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 0.00022232532501220703
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 7.9375,
            "text": "Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 0.0002155303955078125
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 7.9375,
            "text": "ulsive status epilepticus",
            "probability": 0.00020253658294677734
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.9375,
            "text": "We aimed to assess the usefulness of the Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 0.00019633769989013672
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 7.9375,
            "text": "vulsive status epilepticus",
            "probability": 0.0001932382583618164
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.9375,
            "text": "assess the usefulness of the Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 0.0001844167709350586
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 7.9375,
            "text": "Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 0.00017595291137695312
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 7.9375,
            "text": "the usefulness of the Salzburg Consensus Criteria (SCC) for determining the prognosis of critically ill patients with nonconvulsive status epilepticus",
            "probability": 0.00017595291137695312
        },
        {
            "start_logit": 0.79931640625,
            "end_logit": -7.01953125,
            "text": "nonconvulsive status epilepticus (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 0.79931640625,
            "end_logit": -7.4140625,
            "text": "nonconvulsive status epilepticus (NCSE",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 0.79931640625,
            "end_logit": -7.58203125,
            "text": "nonconvulsive status epilepticus (NCS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 0.79931640625,
            "end_logit": -7.671875,
            "text": "nonconv",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 0.79931640625,
            "end_logit": -7.68359375,
            "text": "nonconvulsive status epilepticus (NCSE)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 0.79931640625,
            "end_logit": -7.6875,
            "text": "nonconvulsive",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 0.79931640625,
            "end_logit": -7.69921875,
            "text": "noncon",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5e48bf5ed14c9f295d000019_3": [
        {
            "start_logit": 8.125,
            "end_logit": 8.0703125,
            "text": "Nonconvulsive Status Epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": 8.125,
            "end_logit": -1.6259765625,
            "text": "Noncon",
            "probability": 6.204843521118164e-05
        },
        {
            "start_logit": -1.58984375,
            "end_logit": 8.0703125,
            "text": "Epilepticus",
            "probability": 6.109476089477539e-05
        },
        {
            "start_logit": -6.39453125,
            "end_logit": 8.0703125,
            "text": "ulsive Status Epilepticus",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.48828125,
            "end_logit": 8.0703125,
            "text": "Status Epilepticus",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.44921875,
            "text": "Nonconvulsive Status",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.48828125,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an Expert EEG",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.58203125,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an Expert EEG Examiner.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.0703125,
            "text": "vulsive Status Epilepticus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.73828125,
            "text": "Nonconvulsive Status Epilepticus:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.7421875,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.7421875,
            "text": "Nonconvulsive Status Epilepticus: Validating the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.75390625,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.76953125,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.78125,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.796875,
            "text": "Nonconvulsive Status Epilepticus: Validating the Salzburg Criteria Against an Expert EEG Examiner",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.58984375,
            "end_logit": -7.48828125,
            "text": "Epilepticus: Validating the Salzburg Criteria Against an Expert EEG",
            "probability": 0.0
        },
        {
            "start_logit": -1.58984375,
            "end_logit": -7.58203125,
            "text": "Epilepticus: Validating the Salzburg Criteria Against an Expert EEG Examiner.",
            "probability": 0.0
        },
        {
            "start_logit": -1.58984375,
            "end_logit": -7.73828125,
            "text": "Epilepticus:",
            "probability": 0.0
        },
        {
            "start_logit": -1.58984375,
            "end_logit": -7.7421875,
            "text": "Epilepticus: Validating the Salzburg",
            "probability": 0.0
        }
    ],
    "5e48bf5ed14c9f295d000019_4": [
        {
            "start_logit": 7.13671875,
            "end_logit": 8.1640625,
            "text": "nonconvulsive status epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": -1.0859375,
            "end_logit": 8.1640625,
            "text": "epilepticus",
            "probability": 0.0002696514129638672
        },
        {
            "start_logit": 7.13671875,
            "end_logit": -3.130859375,
            "text": "noncon",
            "probability": 1.2516975402832031e-05
        },
        {
            "start_logit": -4.1796875,
            "end_logit": 8.1640625,
            "text": "status epilepticus",
            "probability": 1.2218952178955078e-05
        },
        {
            "start_logit": -6.5625,
            "end_logit": 8.1640625,
            "text": "ulsive status epilepticus",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.57421875,
            "end_logit": 8.1640625,
            "text": "vulsive status epilepticus",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.4375,
            "end_logit": 8.1640625,
            "text": "improve the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.1640625,
            "text": "To improve the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.1640625,
            "text": "(EEG) criteria for nonconvulsive status epilepticus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.1640625,
            "text": "the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 8.1640625,
            "text": ") criteria for nonconvulsive status epilepticus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.13671875,
            "end_logit": -6.8515625,
            "text": "nonconvulsive status epilepticus (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.13671875,
            "end_logit": -7.5546875,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.13671875,
            "end_logit": -7.57421875,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.13671875,
            "end_logit": -7.6015625,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.13671875,
            "end_logit": -7.6328125,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.13671875,
            "end_logit": -7.69140625,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salz",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.13671875,
            "end_logit": -7.6953125,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is paramount",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.0859375,
            "end_logit": -6.8515625,
            "text": "epilepticus (",
            "probability": 0.0
        },
        {
            "start_logit": -1.0859375,
            "end_logit": -7.5546875,
            "text": "epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is",
            "probability": 0.0
        }
    ],
    "5e48bf5ed14c9f295d000019_5": [
        {
            "start_logit": 7.13671875,
            "end_logit": 8.1640625,
            "text": "nonconvulsive status epilepticus",
            "probability": 1.0
        },
        {
            "start_logit": -1.0859375,
            "end_logit": 8.1640625,
            "text": "epilepticus",
            "probability": 0.0002696514129638672
        },
        {
            "start_logit": 7.13671875,
            "end_logit": -3.130859375,
            "text": "noncon",
            "probability": 1.2516975402832031e-05
        },
        {
            "start_logit": -4.1796875,
            "end_logit": 8.1640625,
            "text": "status epilepticus",
            "probability": 1.2218952178955078e-05
        },
        {
            "start_logit": -6.5625,
            "end_logit": 8.1640625,
            "text": "ulsive status epilepticus",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.57421875,
            "end_logit": 8.1640625,
            "text": "vulsive status epilepticus",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.4375,
            "end_logit": 8.1640625,
            "text": "improve the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.1640625,
            "text": "To improve the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.1640625,
            "text": "(EEG) criteria for nonconvulsive status epilepticus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.1640625,
            "text": "the diagnostic accuracy of electroencephalography (EEG) criteria for nonconvulsive status epilepticus",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 8.1640625,
            "text": ") criteria for nonconvulsive status epilepticus",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.13671875,
            "end_logit": -6.8515625,
            "text": "nonconvulsive status epilepticus (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.13671875,
            "end_logit": -7.5546875,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.13671875,
            "end_logit": -7.57421875,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.13671875,
            "end_logit": -7.6015625,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.13671875,
            "end_logit": -7.6328125,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.13671875,
            "end_logit": -7.69140625,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salz",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.13671875,
            "end_logit": -7.6953125,
            "text": "nonconvulsive status epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is paramount",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.0859375,
            "end_logit": -6.8515625,
            "text": "epilepticus (",
            "probability": 0.0
        },
        {
            "start_logit": -1.0859375,
            "end_logit": -7.5546875,
            "text": "epilepticus (NCSE), external validation of the recently proposed Salzburg criteria is",
            "probability": 0.0
        }
    ],
    "623e02e0f0baec9a1b000005_1": [
        {
            "start_logit": -0.2254638671875,
            "end_logit": -2.314453125,
            "text": "ER retention sequence (KDEL)",
            "probability": 0.837890625
        },
        {
            "start_logit": -0.2254638671875,
            "end_logit": -4.32421875,
            "text": "ER retention sequence (",
            "probability": 0.11212158203125
        },
        {
            "start_logit": -0.2254638671875,
            "end_logit": -5.4765625,
            "text": "ER retention sequence",
            "probability": 0.035430908203125
        },
        {
            "start_logit": -0.2254638671875,
            "end_logit": -7.140625,
            "text": "ER",
            "probability": 0.00670623779296875
        },
        {
            "start_logit": -0.2254638671875,
            "end_logit": -7.546875,
            "text": "ER retention sequence (KDEL",
            "probability": 0.004467010498046875
        },
        {
            "start_logit": -6.09375,
            "end_logit": -2.314453125,
            "text": "KDEL)",
            "probability": 0.00237274169921875
        },
        {
            "start_logit": -6.8359375,
            "end_logit": -2.314453125,
            "text": "retention sequence (KDEL)",
            "probability": 0.001129150390625
        },
        {
            "start_logit": -6.8359375,
            "end_logit": -4.32421875,
            "text": "retention sequence (",
            "probability": 0.00015163421630859375
        },
        {
            "start_logit": -6.8359375,
            "end_logit": -5.4765625,
            "text": "retention sequence",
            "probability": 4.76837158203125e-05
        },
        {
            "start_logit": -6.09375,
            "end_logit": -7.546875,
            "text": "KDEL",
            "probability": 1.2636184692382812e-05
        },
        {
            "start_logit": -6.8359375,
            "end_logit": -7.546875,
            "text": "retention sequence (KDEL",
            "probability": 6.020069122314453e-06
        }
    ],
    "53617eeb7d100faa0900000a_1": [
        {
            "start_logit": 5.2890625,
            "end_logit": 3.41796875,
            "text": "Anorexia Athletica.",
            "probability": 0.93017578125
        },
        {
            "start_logit": 5.2890625,
            "end_logit": 0.81298828125,
            "text": "Anorexia Athletica",
            "probability": 0.0689697265625
        },
        {
            "start_logit": 5.2890625,
            "end_logit": -4.578125,
            "text": "Anorexia",
            "probability": 0.00031447410583496094
        },
        {
            "start_logit": -3.259765625,
            "end_logit": 3.41796875,
            "text": ".",
            "probability": 0.0001806020736694336
        },
        {
            "start_logit": -3.90234375,
            "end_logit": 3.41796875,
            "text": "Elite Rhythmic Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica.",
            "probability": 9.512901306152344e-05
        },
        {
            "start_logit": 5.2890625,
            "end_logit": -6.91796875,
            "text": "Anorexia Athletic",
            "probability": 3.045797348022461e-05
        },
        {
            "start_logit": -5.95703125,
            "end_logit": 3.41796875,
            "text": "Athletica.",
            "probability": 1.2218952178955078e-05
        },
        {
            "start_logit": -6.453125,
            "end_logit": 3.41796875,
            "text": "developing Anorexia Athletica.",
            "probability": 7.450580596923828e-06
        },
        {
            "start_logit": -3.90234375,
            "end_logit": 0.81298828125,
            "text": "Elite Rhythmic Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": -6.83984375,
            "end_logit": 3.41796875,
            "text": "Rhythmic Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica.",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 3.41796875,
            "text": "unique metabolic model and they are prone to developing Anorexia Athletica.",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 3.41796875,
            "text": ") constitute a unique metabolic model and they are prone to developing Anorexia Athletica.",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 3.41796875,
            "text": "metabolic model and they are prone to developing Anorexia Athletica.",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -7.5,
            "end_logit": 3.41796875,
            "text": "to developing Anorexia Athletica.",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 3.41796875,
            "text": "are prone to developing Anorexia Athletica.",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 3.41796875,
            "text": "prone to developing Anorexia Athletica.",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 3.41796875,
            "text": "Gymnasts (RGs) constitute a unique metabolic model and they are prone to developing Anorexia Athletica.",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 3.41796875,
            "text": "a.",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 3.41796875,
            "text": "they are prone to developing Anorexia Athletica.",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 3.41796875,
            "text": "and they are prone to developing Anorexia Athletica.",
            "probability": 2.3245811462402344e-06
        }
    ],
    "53617eeb7d100faa0900000a_2": [
        {
            "start_logit": 0.869140625,
            "end_logit": 4.2109375,
            "text": "anorexia athletica (AA",
            "probability": 0.9912109375
        },
        {
            "start_logit": -4.07421875,
            "end_logit": 4.2109375,
            "text": "athletica (AA",
            "probability": 0.007083892822265625
        },
        {
            "start_logit": -6.68359375,
            "end_logit": 4.2109375,
            "text": "AA",
            "probability": 0.0005207061767578125
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 4.2109375,
            "text": "with anorexia athletica (AA",
            "probability": 0.0002713203430175781
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 4.2109375,
            "text": "a (AA",
            "probability": 0.00023221969604492188
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 4.2109375,
            "text": "We studied 13 female juvenile elite gymnasts with anorexia athletica (AA",
            "probability": 0.0001672506332397461
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 4.2109375,
            "text": "gymnasts with anorexia athletica (AA",
            "probability": 0.00016200542449951172
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 4.2109375,
            "text": "studied 13 female juvenile elite gymnasts with anorexia athletica (AA",
            "probability": 0.0001595020294189453
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 4.2109375,
            "text": "elite gymnasts with anorexia athletica (AA",
            "probability": 0.0001569986343383789
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 4.2109375,
            "text": "female juvenile elite gymnasts with anorexia athletica (AA",
            "probability": 0.0001569986343383789
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 4.2109375,
            "text": "nasts with anorexia athletica (AA",
            "probability": 0.00014984607696533203
        },
        {
            "start_logit": 0.869140625,
            "end_logit": -5.23828125,
            "text": "anorexia athletica (",
            "probability": 7.832050323486328e-05
        },
        {
            "start_logit": 0.869140625,
            "end_logit": -6.765625,
            "text": "anorexia athletica",
            "probability": 1.6927719116210938e-05
        },
        {
            "start_logit": -4.07421875,
            "end_logit": -5.23828125,
            "text": "athletica (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -4.07421875,
            "end_logit": -6.765625,
            "text": "athletica",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": -5.23828125,
            "text": "with anorexia athletica (",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -5.23828125,
            "text": "a (",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -5.23828125,
            "text": "We studied 13 female juvenile elite gymnasts with anorexia athletica (",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -5.23828125,
            "text": "gymnasts with anorexia athletica (",
            "probability": 0.0
        },
        {
            "start_logit": -7.86328125,
            "end_logit": -5.23828125,
            "text": "studied 13 female juvenile elite gymnasts with anorexia athletica (",
            "probability": 0.0
        }
    ],
    "5c900b9eecadf2e73f000004_1": [
        {
            "start_logit": 8.125,
            "end_logit": 8.1875,
            "text": "Alnylam Pharmaceuticals",
            "probability": 1.0
        },
        {
            "start_logit": -1.01171875,
            "end_logit": 8.1875,
            "text": "Pharmaceuticals",
            "probability": 0.00010722875595092773
        },
        {
            "start_logit": 8.125,
            "end_logit": -1.57421875,
            "text": "Al",
            "probability": 5.739927291870117e-05
        },
        {
            "start_logit": 8.125,
            "end_logit": -6.32421875,
            "text": "Alnylam",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.703125,
            "end_logit": 8.1875,
            "text": "nylam Pharmaceuticals",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.80859375,
            "end_logit": 8.1875,
            "text": "ylam Pharmaceuticals",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -6.88671875,
            "text": "Alnylam Pharmaceuticals; it was recently approved in the USA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.0859375,
            "text": "Alnyl",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.21875,
            "end_logit": 8.1875,
            "text": "am Pharmaceuticals",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.3125,
            "text": "Alnylam Pharmaceuticals;",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.32421875,
            "text": "Alnylam Pharmaceuticals; it was recently approved in the USA for the treatment of the polyneuropathy of hereditary TTR-mediated amyloidosis (hATTR",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.38671875,
            "text": "Alnylam Pharmaceuticals; it was recently approved in the USA for the treatment of the polyneuropathy of hereditary TTR-mediated amyloidosis (hATTR)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.38671875,
            "text": "Alnylam Pharmaceuticals; it was recently approved in the USA for the treatment of the polyneuropathy of hereditary TTR-mediated amyloidosis (hATTR) in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.1875,
            "text": "Patisiran has been developed by Alnylam Pharmaceuticals",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 8.1875,
            "text": "siran has been developed by Alnylam Pharmaceuticals",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.01171875,
            "end_logit": -6.88671875,
            "text": "Pharmaceuticals; it was recently approved in the USA",
            "probability": 0.0
        },
        {
            "start_logit": -1.01171875,
            "end_logit": -7.12109375,
            "text": "Pharmaceuticals; it was recently approved in the USA for the treatment of the polyneuropathy of hereditary TTR-mediated amyloidosis (hATTR) in adults and",
            "probability": 0.0
        },
        {
            "start_logit": -1.01171875,
            "end_logit": -7.3125,
            "text": "Pharmaceuticals;",
            "probability": 0.0
        },
        {
            "start_logit": -1.01171875,
            "end_logit": -7.32421875,
            "text": "Pharmaceuticals; it was recently approved in the USA for the treatment of the polyneuropathy of hereditary TTR-mediated amyloidosis (hATTR",
            "probability": 0.0
        },
        {
            "start_logit": -1.01171875,
            "end_logit": -7.38671875,
            "text": "Pharmaceuticals; it was recently approved in the USA for the treatment of the polyneuropathy of hereditary TTR-mediated amyloidosis (hATTR)",
            "probability": 0.0
        }
    ],
    "58c27b7102b8c60953000021_1": [
        {
            "start_logit": 8.171875,
            "end_logit": 8.109375,
            "text": "Enhancer Sharing",
            "probability": 1.0
        },
        {
            "start_logit": 8.171875,
            "end_logit": -1.443359375,
            "text": "Enhancer",
            "probability": 7.086992263793945e-05
        },
        {
            "start_logit": -1.42578125,
            "end_logit": 8.109375,
            "text": "Sharing",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.296875,
            "text": "Enhancer Sharing Promotes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.671875,
            "text": "Enhancer Sharing Promotes Neighborhoods of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.6875,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.7109375,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.7265625,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.42578125,
            "end_logit": -7.296875,
            "text": "Sharing Promotes",
            "probability": 0.0
        },
        {
            "start_logit": -1.42578125,
            "end_logit": -7.671875,
            "text": "Sharing Promotes Neighborhoods of",
            "probability": 0.0
        },
        {
            "start_logit": -1.42578125,
            "end_logit": -7.6875,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation",
            "probability": 0.0
        },
        {
            "start_logit": -1.42578125,
            "end_logit": -7.7109375,
            "text": "Sharing Promotes Neighborhoods of Transcriptional",
            "probability": 0.0
        },
        {
            "start_logit": -1.42578125,
            "end_logit": -7.7265625,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -7.296875,
            "text": "Promotes",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -7.671875,
            "text": "Promotes Neighborhoods of",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -7.6875,
            "text": "Promotes Neighborhoods of Transcriptional Regulation",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -7.7109375,
            "text": "Promotes Neighborhoods of Transcriptional",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -7.7265625,
            "text": "Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": -7.8828125,
            "end_logit": -7.671875,
            "text": "Neighborhoods of",
            "probability": 0.0
        },
        {
            "start_logit": -7.8828125,
            "end_logit": -7.6875,
            "text": "Neighborhoods of Transcriptional Regulation",
            "probability": 0.0
        }
    ],
    "58c27b7102b8c60953000021_2": [
        {
            "start_logit": 8.1953125,
            "end_logit": 8.0625,
            "text": "enhancer sharing",
            "probability": 1.0
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -1.2255859375,
            "text": "enhancer",
            "probability": 9.316205978393555e-05
        },
        {
            "start_logit": -1.556640625,
            "end_logit": 8.0625,
            "text": "sharing",
            "probability": 5.8770179748535156e-05
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -2.1875,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance",
            "probability": 3.5643577575683594e-05
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -5.1171875,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -6.16015625,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer of information in gene regulation.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.01171875,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.10546875,
            "text": "enhancer sharing is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 8.0625,
            "text": "We propose that enhancer sharing",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 8.0625,
            "text": "propose that enhancer sharing",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.3125,
            "text": "enhancer sharing is commonplace among eukaryotes, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.390625,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 8.0625,
            "text": "that enhancer sharing",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.4609375,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.51953125,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer of information in gene",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.546875,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.578125,
            "text": "enhancer sharing is commonplace",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.6171875,
            "text": "enhancer sharing is commonplace among eukaryotes,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.69921875,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer of information",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.71484375,
            "text": "enhancer sharing is commonplace among eukaryotes, and that EP distance is an important layer of information in gene regulation",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58c27b7102b8c60953000021_3": [
        {
            "start_logit": 8.171875,
            "end_logit": 8.1171875,
            "text": "Enhancer Sharing",
            "probability": 1.0
        },
        {
            "start_logit": 8.171875,
            "end_logit": -1.4443359375,
            "text": "Enhancer",
            "probability": 7.086992263793945e-05
        },
        {
            "start_logit": -1.435546875,
            "end_logit": 8.1171875,
            "text": "Sharing",
            "probability": 6.765127182006836e-05
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.1640625,
            "text": "Enhancer Sharing Promotes",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.50390625,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation Across Eukaryotes.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.61328125,
            "text": "Enhancer Sharing Promotes Neighborhoods of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.6171875,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.703125,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.70703125,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional Regulation Across Eukaryotes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.7109375,
            "text": "Enhancer Sharing Promotes Neighborhoods of Transcriptional",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -7.1640625,
            "text": "Sharing Promotes",
            "probability": 0.0
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -7.50390625,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation Across Eukaryotes.",
            "probability": 0.0
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -7.61328125,
            "text": "Sharing Promotes Neighborhoods of",
            "probability": 0.0
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -7.6171875,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation Across",
            "probability": 0.0
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -7.703125,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation",
            "probability": 0.0
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -7.70703125,
            "text": "Sharing Promotes Neighborhoods of Transcriptional Regulation Across Eukaryotes",
            "probability": 0.0
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -7.7109375,
            "text": "Sharing Promotes Neighborhoods of Transcriptional",
            "probability": 0.0
        },
        {
            "start_logit": -7.1328125,
            "end_logit": -7.50390625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.76953125,
            "end_logit": -7.1640625,
            "text": "Promotes",
            "probability": 0.0
        },
        {
            "start_logit": -7.76953125,
            "end_logit": -7.50390625,
            "text": "Promotes Neighborhoods of Transcriptional Regulation Across Eukaryotes.",
            "probability": 0.0
        }
    ],
    "5c8973f3d558e5f232000007_1": [
        {
            "start_logit": 7.99609375,
            "end_logit": 7.921875,
            "text": "Alipogene tiparvovec",
            "probability": 1.0
        },
        {
            "start_logit": -1.853515625,
            "end_logit": 7.921875,
            "text": "c",
            "probability": 5.269050598144531e-05
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -1.9501953125,
            "text": "Ali",
            "probability": 5.143880844116211e-05
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -3.20703125,
            "text": "Alipogene tiparvovec (Glybera",
            "probability": 1.4603137969970703e-05
        },
        {
            "start_logit": -5.97265625,
            "end_logit": 7.921875,
            "text": "tiparvovec",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -6.07421875,
            "text": "Alipogene tiparvovec (Glybera\u00ae",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -6.34765625,
            "text": "Alipogene tiparvovec (Glyber",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -6.50390625,
            "text": "Alipogene tiparvovec (Glybera\u00ae)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 7.921875,
            "text": "vovec",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -6.66796875,
            "text": "Alipogene",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.65625,
            "end_logit": 7.921875,
            "text": "vec",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -6.7421875,
            "text": "Alipogene tiparvove",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -6.83203125,
            "text": "Alipogene tiparvovec (Glybera\u00ae) is",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.828125,
            "end_logit": 7.921875,
            "text": "arvovec",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -6.9765625,
            "text": "Alipo",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.99609375,
            "end_logit": -7.00390625,
            "text": "Alipogene tiparvovec (Glybera\u00ae) is the first gene therapy",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.109375,
            "end_logit": 7.921875,
            "text": "pogene tiparvovec",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.921875,
            "text": "gene tiparvovec",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.5,
            "end_logit": 0.249267578125,
            "text": "GENIALL (GENetherapy In the MAnagement of Lipoprotein Lipase Deficiency",
            "probability": 0.0
        },
        {
            "start_logit": -1.853515625,
            "end_logit": -3.20703125,
            "text": "c (Glybera",
            "probability": 0.0
        }
    ],
    "5c929094ecadf2e73f000019_1": [
        {
            "start_logit": 4.75,
            "end_logit": 4.59375,
            "text": "Senescent cells undergo dramatic alterations to their chromatin landscape that affect genome accessibility and their transcriptional program.",
            "probability": 0.94921875
        },
        {
            "start_logit": 1.537109375,
            "end_logit": 4.59375,
            "text": "activation of retrotransposons.",
            "probability": 0.03826904296875
        },
        {
            "start_logit": -0.3046875,
            "end_logit": 4.59375,
            "text": ".",
            "probability": 0.006053924560546875
        },
        {
            "start_logit": -0.3046875,
            "end_logit": 4.59375,
            "text": ".",
            "probability": 0.006053924560546875
        },
        {
            "start_logit": 4.75,
            "end_logit": -3.2421875,
            "text": "Senescent",
            "probability": 0.0003750324249267578
        },
        {
            "start_logit": 1.537109375,
            "end_logit": -0.603515625,
            "text": "activation",
            "probability": 0.00021207332611083984
        },
        {
            "start_logit": -4.8984375,
            "end_logit": 4.59375,
            "text": "the activation of retrotransposons.",
            "probability": 6.127357482910156e-05
        },
        {
            "start_logit": -5.1875,
            "end_logit": 4.59375,
            "text": "changes in chromatin composition that can lead to the activation of retrotransposons.",
            "probability": 4.589557647705078e-05
        },
        {
            "start_logit": -0.3046875,
            "end_logit": -0.603515625,
            "text": ". These include the loss of DNA-nuclear lamina interactions, the distension of centromeres, and changes in chromatin composition that can lead to the activation",
            "probability": 3.355741500854492e-05
        },
        {
            "start_logit": -5.8125,
            "end_logit": 4.59375,
            "text": "dramatic alterations to their chromatin landscape that affect genome accessibility and their transcriptional program.",
            "probability": 2.4557113647460938e-05
        },
        {
            "start_logit": -6.09375,
            "end_logit": 4.59375,
            "text": "can lead to the activation of retrotransposons.",
            "probability": 1.8537044525146484e-05
        },
        {
            "start_logit": 4.75,
            "end_logit": -6.35546875,
            "text": "Senescent cells",
            "probability": 1.6629695892333984e-05
        },
        {
            "start_logit": -6.203125,
            "end_logit": 4.59375,
            "text": "lead to the activation of retrotransposons.",
            "probability": 1.6629695892333984e-05
        },
        {
            "start_logit": 4.75,
            "end_logit": -6.3828125,
            "text": "Senescent cells undergo dramatic alterations to their chromatin landscape that",
            "probability": 1.621246337890625e-05
        },
        {
            "start_logit": -6.40234375,
            "end_logit": 4.59375,
            "text": "centromeres, and changes in chromatin composition that can lead to the activation of retrotransposons.",
            "probability": 1.3589859008789062e-05
        },
        {
            "start_logit": -6.41015625,
            "end_logit": 4.59375,
            "text": ", and changes in chromatin composition that can lead to the activation of retrotransposons.",
            "probability": 1.3589859008789062e-05
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 4.59375,
            "text": "retrotransposons.",
            "probability": 1.2934207916259766e-05
        },
        {
            "start_logit": 4.75,
            "end_logit": -6.7734375,
            "text": "Senescent cells undergo",
            "probability": 1.0967254638671875e-05
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 4.59375,
            "text": "that can lead to the activation of retrotransposons.",
            "probability": 1.0728836059570312e-05
        },
        {
            "start_logit": 4.75,
            "end_logit": -6.796875,
            "text": "Senescent cells undergo dramatic alterations to their chromatin landscape that affect genome accessibility and",
            "probability": 1.0728836059570312e-05
        }
    ],
    "5fe3130da43ad3127800003f_1": [
        {
            "start_logit": -2.908203125,
            "end_logit": 5.6328125,
            "text": "joints",
            "probability": 0.845703125
        },
        {
            "start_logit": -4.76171875,
            "end_logit": 5.6328125,
            "text": "28 joints",
            "probability": 0.132568359375
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 5.6328125,
            "text": "Disease activity score in 28 joints",
            "probability": 0.01548004150390625
        },
        {
            "start_logit": -7.796875,
            "end_logit": 5.6328125,
            "text": "in 28 joints",
            "probability": 0.00635528564453125
        },
        {
            "start_logit": -2.908203125,
            "end_logit": -5.47265625,
            "text": "joints (",
            "probability": 1.2636184692382812e-05
        },
        {
            "start_logit": -2.908203125,
            "end_logit": -7.0859375,
            "text": "joints (DAS28)",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": -4.76171875,
            "end_logit": -5.47265625,
            "text": "28 joints (",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -2.908203125,
            "end_logit": -7.36328125,
            "text": "joints (DAS28",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -2.908203125,
            "end_logit": -7.52734375,
            "text": "joints (DAS",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -4.76171875,
            "end_logit": -7.0859375,
            "text": "28 joints (DAS28)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -4.76171875,
            "end_logit": -7.36328125,
            "text": "28 joints (DAS28",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -4.76171875,
            "end_logit": -7.52734375,
            "text": "28 joints (DAS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.91015625,
            "end_logit": -5.47265625,
            "text": "Disease activity score in 28 joints (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": -5.47265625,
            "text": "in 28 joints (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.91015625,
            "end_logit": -7.0859375,
            "text": "Disease activity score in 28 joints (DAS28)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.91015625,
            "end_logit": -7.36328125,
            "text": "Disease activity score in 28 joints (DAS28",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.91015625,
            "end_logit": -7.39453125,
            "text": "Disease activity score",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.91015625,
            "end_logit": -7.49609375,
            "text": "Disease activity",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.91015625,
            "end_logit": -7.52734375,
            "text": "Disease activity score in 28 joints (DAS",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.91015625,
            "end_logit": -7.54296875,
            "text": "Disease activity score in",
            "probability": 5.960464477539063e-08
        }
    ],
    "5fe3130da43ad3127800003f_2": [
        {
            "start_logit": -2.078125,
            "end_logit": 6.2578125,
            "text": "joints",
            "probability": 0.83984375
        },
        {
            "start_logit": -3.95703125,
            "end_logit": 6.2578125,
            "text": "28 joints",
            "probability": 0.1282958984375
        },
        {
            "start_logit": -7.0859375,
            "end_logit": 6.2578125,
            "text": "in 28 joints",
            "probability": 0.005619049072265625
        },
        {
            "start_logit": -7.28125,
            "end_logit": 6.2578125,
            "text": "(Disease Activity Score in 28 joints",
            "probability": 0.004619598388671875
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 6.2578125,
            "text": "evaluate the current therapy with infliximab, the level of disease activity (Disease Activity Score in 28 joints",
            "probability": 0.0040283203125
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 6.2578125,
            "text": "study to evaluate the current therapy with infliximab, the level of disease activity (Disease Activity Score in 28 joints",
            "probability": 0.003627777099609375
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 6.2578125,
            "text": "the present study to evaluate the current therapy with infliximab, the level of disease activity (Disease Activity Score in 28 joints",
            "probability": 0.0036106109619140625
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 6.2578125,
            "text": "to evaluate the current therapy with infliximab, the level of disease activity (Disease Activity Score in 28 joints",
            "probability": 0.003299713134765625
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 6.2578125,
            "text": "present study to evaluate the current therapy with infliximab, the level of disease activity (Disease Activity Score in 28 joints",
            "probability": 0.003299713134765625
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 6.2578125,
            "text": "level of disease activity (Disease Activity Score in 28 joints",
            "probability": 0.0032634735107421875
        },
        {
            "start_logit": -2.078125,
            "end_logit": -4.17578125,
            "text": "joints [",
            "probability": 2.4616718292236328e-05
        },
        {
            "start_logit": -3.95703125,
            "end_logit": -4.17578125,
            "text": "28 joints [",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -2.078125,
            "end_logit": -6.40625,
            "text": "joints [DAS28",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -2.078125,
            "end_logit": -7.08984375,
            "text": "joints [DAS28]",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -2.078125,
            "end_logit": -7.16796875,
            "text": "joints [DAS",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -2.078125,
            "end_logit": -7.39453125,
            "text": "joints [DAS28]) and the reasons for infliximab",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -2.078125,
            "end_logit": -7.43359375,
            "text": "joints [DAS28]) and the reasons for infliximab discontinuation.",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -2.078125,
            "end_logit": -7.453125,
            "text": "joints [DAS28]) and",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -2.078125,
            "end_logit": -7.4609375,
            "text": "joints [DAS28])",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -2.078125,
            "end_logit": -7.640625,
            "text": "joints [DAS28]) and the reasons for infliximab discontinuation",
            "probability": 7.748603820800781e-07
        }
    ],
    "5fe3130da43ad3127800003f_3": [
        {
            "start_logit": -1.162109375,
            "end_logit": 7.31640625,
            "text": "Joints",
            "probability": 0.87841796875
        },
        {
            "start_logit": -3.443359375,
            "end_logit": 7.31640625,
            "text": "28 Joints",
            "probability": 0.08953857421875
        },
        {
            "start_logit": -4.6953125,
            "end_logit": 7.31640625,
            "text": "Disease Activity Score in 28 Joints",
            "probability": 0.025604248046875
        },
        {
            "start_logit": -7.20703125,
            "end_logit": 7.31640625,
            "text": "in 28 Joints",
            "probability": 0.0020771026611328125
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.31640625,
            "text": "BACKGROUND: Disease Activity Score in 28 Joints",
            "probability": 0.0015993118286132812
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.31640625,
            "text": ": Disease Activity Score in 28 Joints",
            "probability": 0.0015316009521484375
        },
        {
            "start_logit": -7.84375,
            "end_logit": 7.31640625,
            "text": "Score in 28 Joints",
            "probability": 0.0010986328125
        },
        {
            "start_logit": -1.162109375,
            "end_logit": -2.8359375,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arthritis (RA).",
            "probability": 3.415346145629883e-05
        },
        {
            "start_logit": -1.162109375,
            "end_logit": -3.74609375,
            "text": "Joints (",
            "probability": 1.3768672943115234e-05
        },
        {
            "start_logit": -3.443359375,
            "end_logit": -2.8359375,
            "text": "28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arthritis (RA).",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -3.443359375,
            "end_logit": -3.74609375,
            "text": "28 Joints (",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -4.6953125,
            "end_logit": -2.8359375,
            "text": "Disease Activity Score in 28 Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arthritis (RA).",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -1.162109375,
            "end_logit": -6.59765625,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arthritis",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -1.162109375,
            "end_logit": -6.91015625,
            "text": "Joints (DAS28) is",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -1.162109375,
            "end_logit": -7.0390625,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -1.162109375,
            "end_logit": -7.0625,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.3984375,
            "end_logit": -2.8359375,
            "text": ".",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -1.162109375,
            "end_logit": -7.078125,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arthritis (RA",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -1.162109375,
            "end_logit": -7.13671875,
            "text": "Joints (DAS28) is a",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -1.162109375,
            "end_logit": -7.1484375,
            "text": "Joints (DAS28",
            "probability": 4.76837158203125e-07
        }
    ],
    "5fe3130da43ad3127800003f_4": [
        {
            "start_logit": -0.85205078125,
            "end_logit": 7.41796875,
            "text": "joints",
            "probability": 0.9482421875
        },
        {
            "start_logit": -4.32421875,
            "end_logit": 7.41796875,
            "text": "28 joints",
            "probability": 0.0294342041015625
        },
        {
            "start_logit": -5.19921875,
            "end_logit": 7.41796875,
            "text": "a Disease Activity Score in 28 joints",
            "probability": 0.01226806640625
        },
        {
            "start_logit": -6.546875,
            "end_logit": 7.41796875,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.0031871795654296875
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 7.41796875,
            "text": "rheumatoid arthritis (RA) as defined by a Disease Activity Score in 28 joints",
            "probability": 0.001739501953125
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 7.41796875,
            "text": "in 28 joints",
            "probability": 0.0014476776123046875
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.41796875,
            "text": "by a Disease Activity Score in 28 joints",
            "probability": 0.001338958740234375
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.41796875,
            "text": ", in patients with active rheumatoid arthritis (RA) as defined by a Disease Activity Score in 28 joints",
            "probability": 0.001068115234375
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 7.41796875,
            "text": "defined by a Disease Activity Score in 28 joints",
            "probability": 0.000995635986328125
        },
        {
            "start_logit": -0.85205078125,
            "end_logit": -4.65234375,
            "text": "joints (",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": -0.85205078125,
            "end_logit": -5.66796875,
            "text": "joints (DAS28) score greater",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -0.85205078125,
            "end_logit": -6.05859375,
            "text": "joints (DAS28) score greater tha",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -0.85205078125,
            "end_logit": -6.82421875,
            "text": "joints (DAS28",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -0.85205078125,
            "end_logit": -6.96875,
            "text": "joints (DAS28)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -0.85205078125,
            "end_logit": -7.16796875,
            "text": "joints (DAS",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -4.32421875,
            "end_logit": -4.65234375,
            "text": "28 joints (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.19921875,
            "end_logit": -4.65234375,
            "text": "a Disease Activity Score in 28 joints (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.32421875,
            "end_logit": -5.66796875,
            "text": "28 joints (DAS28) score greater",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.4375,
            "end_logit": -5.66796875,
            "text": "greater",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.32421875,
            "end_logit": -6.05859375,
            "text": "28 joints (DAS28) score greater tha",
            "probability": 5.960464477539063e-08
        }
    ],
    "5fe3130da43ad3127800003f_5": [
        {
            "start_logit": -1.02734375,
            "end_logit": 7.578125,
            "text": "28 joints",
            "probability": 0.56982421875
        },
        {
            "start_logit": -1.322265625,
            "end_logit": 7.578125,
            "text": "joints",
            "probability": 0.425048828125
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 7.578125,
            "text": "on 28 joints",
            "probability": 0.0011348724365234375
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 7.578125,
            "text": "based on 28 joints",
            "probability": 0.0009484291076660156
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 7.578125,
            "text": "OBJECTIVE: The Disease Activity Score based on 28 joints",
            "probability": 0.00084686279296875
        },
        {
            "start_logit": -7.65625,
            "end_logit": 7.578125,
            "text": "Disease Activity Score based on 28 joints",
            "probability": 0.0007534027099609375
        },
        {
            "start_logit": -7.6875,
            "end_logit": 7.578125,
            "text": ": The Disease Activity Score based on 28 joints",
            "probability": 0.0007300376892089844
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 7.578125,
            "text": "The Disease Activity Score based on 28 joints",
            "probability": 0.0006699562072753906
        },
        {
            "start_logit": -1.02734375,
            "end_logit": -6.0234375,
            "text": "28 joints (",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -1.322265625,
            "end_logit": -6.0234375,
            "text": "joints (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -1.02734375,
            "end_logit": -6.89453125,
            "text": "28 joints (DAS28) has",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.02734375,
            "end_logit": -6.91796875,
            "text": "28 joints (DAS28) has been increasingly",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.02734375,
            "end_logit": -7.01953125,
            "text": "28 joints (DAS28) has been",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.322265625,
            "end_logit": -6.89453125,
            "text": "joints (DAS28) has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.322265625,
            "end_logit": -6.91796875,
            "text": "joints (DAS28) has been increasingly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.02734375,
            "end_logit": -7.21875,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.02734375,
            "end_logit": -7.2734375,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.02734375,
            "end_logit": -7.3046875,
            "text": "28 joints (DAS28) has been increasingly used",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.322265625,
            "end_logit": -7.01953125,
            "text": "joints (DAS28) has been",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.02734375,
            "end_logit": -7.37109375,
            "text": "28 joints (DAS28) has been increasingly used in",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5fe3130da43ad3127800003f_6": [
        {
            "start_logit": -0.947265625,
            "end_logit": 7.59375,
            "text": "28 joints",
            "probability": 0.5947265625
        },
        {
            "start_logit": -1.33984375,
            "end_logit": 7.59375,
            "text": "joints",
            "probability": 0.400634765625
        },
        {
            "start_logit": -7.234375,
            "end_logit": 7.59375,
            "text": "on 28 joints",
            "probability": 0.0011043548583984375
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 7.59375,
            "text": "based on 28 joints",
            "probability": 0.000911712646484375
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 7.59375,
            "text": "OBJECTIVE: The Disease Activity Score based on 28 joints",
            "probability": 0.0008015632629394531
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 7.59375,
            "text": "Disease Activity Score based on 28 joints",
            "probability": 0.0006880760192871094
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 7.59375,
            "text": ": The Disease Activity Score based on 28 joints",
            "probability": 0.000682830810546875
        },
        {
            "start_logit": -7.75,
            "end_logit": 7.59375,
            "text": "The Disease Activity Score based on 28 joints",
            "probability": 0.0006589889526367188
        },
        {
            "start_logit": -0.947265625,
            "end_logit": -6.01171875,
            "text": "28 joints (",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -1.33984375,
            "end_logit": -6.01171875,
            "text": "joints (",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -0.947265625,
            "end_logit": -6.82421875,
            "text": "28 joints (DAS28) has",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -0.947265625,
            "end_logit": -6.875,
            "text": "28 joints (DAS28) has been widely",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -0.947265625,
            "end_logit": -7.1015625,
            "text": "28 joints (DAS28) has been",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -0.947265625,
            "end_logit": -7.21484375,
            "text": "28 joints (DAS28) has been widely used in clinical practice",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -1.33984375,
            "end_logit": -6.82421875,
            "text": "joints (DAS28) has",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -0.947265625,
            "end_logit": -7.2421875,
            "text": "28 joints (DAS28) has been widely used in clinical practice and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -0.947265625,
            "end_logit": -7.26171875,
            "text": "28 joints (DAS28) has been widely used",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -1.33984375,
            "end_logit": -6.875,
            "text": "joints (DAS28) has been widely",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -0.947265625,
            "end_logit": -7.359375,
            "text": "28 joints (DAS28) has been widely used in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.947265625,
            "end_logit": -7.375,
            "text": "28 joints (DAS28) has been widely used in clinical practice and research studies of rheumatoid arthr",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5fe3130da43ad3127800003f_7": [
        {
            "start_logit": -2.03125,
            "end_logit": 6.9375,
            "text": "joints",
            "probability": 0.8720703125
        },
        {
            "start_logit": -4.47265625,
            "end_logit": 6.9375,
            "text": "28 joints",
            "probability": 0.075927734375
        },
        {
            "start_logit": -5.2265625,
            "end_logit": 6.9375,
            "text": "The Disease Activity Score in 28 joints",
            "probability": 0.035736083984375
        },
        {
            "start_logit": -7.171875,
            "end_logit": 6.9375,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.005107879638671875
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 6.9375,
            "text": "in 28 joints",
            "probability": 0.004055023193359375
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 6.9375,
            "text": "OBJECTIVE: The Disease Activity Score in 28 joints",
            "probability": 0.0035800933837890625
        },
        {
            "start_logit": -7.671875,
            "end_logit": 6.9375,
            "text": ": The Disease Activity Score in 28 joints",
            "probability": 0.0030975341796875
        },
        {
            "start_logit": -2.03125,
            "end_logit": -5.05078125,
            "text": "joints (",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": -2.03125,
            "end_logit": -6.33203125,
            "text": "joints (DAS28), used to assess disease activity in rheumatoid arthritis",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -2.03125,
            "end_logit": -6.890625,
            "text": "joints (DAS28),",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -2.03125,
            "end_logit": -7.0546875,
            "text": "joints (DAS28), used to assess disease activity in rheumatoid arthritis (RA), is",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -2.03125,
            "end_logit": -7.0703125,
            "text": "joints (DAS28), used to assess disease activity",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -2.03125,
            "end_logit": -7.08984375,
            "text": "joints (DAS28), used to assess disease activity in rheumatoid arthritis (RA),",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -2.03125,
            "end_logit": -7.15625,
            "text": "joints (DAS28), used to assess disease activity in rheumatoid arthritis (RA",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -2.03125,
            "end_logit": -7.1796875,
            "text": "joints (DAS28), used to assess disease activity in rheumatoid arthritis (",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -2.03125,
            "end_logit": -7.296875,
            "text": "joints (DAS28), used to assess disease activity in",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -2.03125,
            "end_logit": -7.296875,
            "text": "joints (DAS28",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -2.03125,
            "end_logit": -7.3359375,
            "text": "joints (DAS28), used to",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -2.03125,
            "end_logit": -7.3671875,
            "text": "joints (DAS28), used to assess disease activity in rheumatoid arthritis (RA), is a",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -2.03125,
            "end_logit": -7.42578125,
            "text": "joints (DAS28), used to assess disease",
            "probability": 5.364418029785156e-07
        }
    ],
    "5fe3130da43ad3127800003f_8": [
        {
            "start_logit": -3.4921875,
            "end_logit": 5.0,
            "text": "joints",
            "probability": 0.44677734375
        },
        {
            "start_logit": -3.9765625,
            "end_logit": 5.0,
            "text": "28 joints",
            "probability": 0.275390625
        },
        {
            "start_logit": -5.48046875,
            "end_logit": 5.0,
            "text": "component Disease Activity Score in 28 joints",
            "probability": 0.061187744140625
        },
        {
            "start_logit": -5.796875,
            "end_logit": 5.0,
            "text": "the 2-component Disease Activity Score in 28 joints",
            "probability": 0.044586181640625
        },
        {
            "start_logit": -5.8515625,
            "end_logit": 5.0,
            "text": "better reflects joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints",
            "probability": 0.042205810546875
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 5.0,
            "text": ", the 2-component Disease Activity Score in 28 joints",
            "probability": 0.0237579345703125
        },
        {
            "start_logit": -6.44140625,
            "end_logit": 5.0,
            "text": "reweighted disease activity score that better reflects joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints",
            "probability": 0.0233917236328125
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 5.0,
            "text": "joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints",
            "probability": 0.017669677734375
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 5.0,
            "text": "reflects joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints",
            "probability": 0.01528167724609375
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 5.0,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.0149993896484375
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 5.0,
            "text": "in 28 joints",
            "probability": 0.01354217529296875
        },
        {
            "start_logit": -7.234375,
            "end_logit": 5.0,
            "text": "eighted disease activity score that better reflects joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints",
            "probability": 0.010589599609375
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 5.0,
            "text": "2-component Disease Activity Score in 28 joints",
            "probability": 0.0105438232421875
        },
        {
            "start_logit": -3.4921875,
            "end_logit": -4.64453125,
            "text": "joints (",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": -3.9765625,
            "end_logit": -4.64453125,
            "text": "28 joints (",
            "probability": 1.7762184143066406e-05
        },
        {
            "start_logit": -5.48046875,
            "end_logit": -4.64453125,
            "text": "component Disease Activity Score in 28 joints (",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": -3.4921875,
            "end_logit": -6.828125,
            "text": "joints (DAS28) (based on swollen joint count and C-reactive protein",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": -5.796875,
            "end_logit": -4.64453125,
            "text": "the 2-component Disease Activity Score in 28 joints (",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -5.8515625,
            "end_logit": -4.64453125,
            "text": "better reflects joint synovitis, i.e., the 2-component Disease Activity Score in 28 joints (",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -3.4921875,
            "end_logit": -7.05859375,
            "text": "joints (DAS28",
            "probability": 2.6226043701171875e-06
        }
    ],
    "5fe3130da43ad3127800003f_9": [
        {
            "start_logit": -2.140625,
            "end_logit": 6.58984375,
            "text": "joints",
            "probability": 0.8212890625
        },
        {
            "start_logit": -3.765625,
            "end_logit": 6.58984375,
            "text": "28 joints",
            "probability": 0.1617431640625
        },
        {
            "start_logit": -7.5,
            "end_logit": 6.58984375,
            "text": "OBJECTIVE: The Disease Activity Score in 28 joints",
            "probability": 0.0038623809814453125
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 6.58984375,
            "text": ": The Disease Activity Score in 28 joints",
            "probability": 0.003726959228515625
        },
        {
            "start_logit": -7.640625,
            "end_logit": 6.58984375,
            "text": "The Disease Activity Score in 28 joints",
            "probability": 0.0033550262451171875
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 6.58984375,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.0033168792724609375
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.58984375,
            "text": "in 28 joints",
            "probability": 0.003177642822265625
        },
        {
            "start_logit": -2.140625,
            "end_logit": -5.68359375,
            "text": "joints (",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -2.140625,
            "end_logit": -7.03125,
            "text": "joints (DAS28) is",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -3.765625,
            "end_logit": -5.68359375,
            "text": "28 joints (",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -2.140625,
            "end_logit": -7.3515625,
            "text": "joints (DAS28) is a key measure in clinical practice",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -2.140625,
            "end_logit": -7.37890625,
            "text": "joints (DAS28",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -2.140625,
            "end_logit": -7.4296875,
            "text": "joints (DAS28) is a",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -2.140625,
            "end_logit": -7.5,
            "text": "joints (DAS28) is a key",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -2.140625,
            "end_logit": -7.5625,
            "text": "joints (DAS",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -2.140625,
            "end_logit": -7.5703125,
            "text": "joints (DAS28) is a key measure in clinical practice and",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -2.140625,
            "end_logit": -7.5859375,
            "text": "joints (DAS28) is a key measure in",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -2.140625,
            "end_logit": -7.58984375,
            "text": "joints (DAS28) is a key measure",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -2.140625,
            "end_logit": -7.6328125,
            "text": "joints (DAS28) is a key measure in clinical practice and clinic",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -2.140625,
            "end_logit": -7.6640625,
            "text": "joints (DAS28) is a key measure in clinical",
            "probability": 5.364418029785156e-07
        }
    ],
    "5fe3130da43ad3127800003f_10": [
        {
            "start_logit": -1.646484375,
            "end_logit": 6.921875,
            "text": "Joints",
            "probability": 0.91162109375
        },
        {
            "start_logit": -4.14453125,
            "end_logit": 6.921875,
            "text": "28 Joints",
            "probability": 0.07513427734375
        },
        {
            "start_logit": -6.921875,
            "end_logit": 6.921875,
            "text": "Disease Activity Score in 28 Joints",
            "probability": 0.00467681884765625
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 6.921875,
            "text": "in 28 Joints",
            "probability": 0.0031757354736328125
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 6.921875,
            "text": "BACKGROUND: Disease Activity Score in 28 Joints",
            "probability": 0.0028018951416015625
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 6.921875,
            "text": ": Disease Activity Score in 28 Joints",
            "probability": 0.002323150634765625
        },
        {
            "start_logit": -1.646484375,
            "end_logit": -4.71484375,
            "text": "Joints (",
            "probability": 8.106231689453125e-06
        },
        {
            "start_logit": -1.646484375,
            "end_logit": -5.92578125,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid arth",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -1.646484375,
            "end_logit": -6.64453125,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -1.646484375,
            "end_logit": -6.90625,
            "text": "Joints (DAS28) is",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -1.646484375,
            "end_logit": -7.13671875,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -1.646484375,
            "end_logit": -7.1875,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -4.14453125,
            "end_logit": -4.71484375,
            "text": "28 Joints (",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -1.646484375,
            "end_logit": -7.23046875,
            "text": "Joints (DAS28",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -1.646484375,
            "end_logit": -7.24609375,
            "text": "Joints (DAS28) is a scoring system",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -1.646484375,
            "end_logit": -7.24609375,
            "text": "Joints (DAS28) is a",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -1.646484375,
            "end_logit": -7.2578125,
            "text": "Joints (DAS28) is a scoring system to",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -1.646484375,
            "end_logit": -7.26953125,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity and treatment response",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -1.646484375,
            "end_logit": -7.3203125,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity and treatment",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -1.646484375,
            "end_logit": -7.3671875,
            "text": "Joints (DAS28) is a scoring system to evaluate disease",
            "probability": 5.364418029785156e-07
        }
    ],
    "5fe3130da43ad3127800003f_11": [
        {
            "start_logit": 1.068359375,
            "end_logit": 5.01171875,
            "text": "28 joints",
            "probability": 0.9697265625
        },
        {
            "start_logit": -2.42578125,
            "end_logit": 5.01171875,
            "text": "joints",
            "probability": 0.0295257568359375
        },
        {
            "start_logit": -6.78125,
            "end_logit": 5.01171875,
            "text": "Comparison of Disease Activity Score in 28 joints",
            "probability": 0.0003788471221923828
        },
        {
            "start_logit": -7.09375,
            "end_logit": 5.01171875,
            "text": "in 28 joints",
            "probability": 0.00027823448181152344
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 5.01171875,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.00018966197967529297
        },
        {
            "start_logit": 1.068359375,
            "end_logit": -4.89453125,
            "text": "28 joints with ESR",
            "probability": 4.839897155761719e-05
        },
        {
            "start_logit": 1.068359375,
            "end_logit": -5.08203125,
            "text": "28",
            "probability": 4.011392593383789e-05
        },
        {
            "start_logit": 1.068359375,
            "end_logit": -6.09765625,
            "text": "28 joints with ESR (",
            "probability": 1.4483928680419922e-05
        },
        {
            "start_logit": 1.068359375,
            "end_logit": -6.87109375,
            "text": "28 joints with ESR (DAS28",
            "probability": 6.67572021484375e-06
        },
        {
            "start_logit": 1.068359375,
            "end_logit": -6.875,
            "text": "28 joints with",
            "probability": 6.67572021484375e-06
        },
        {
            "start_logit": 1.068359375,
            "end_logit": -7.09765625,
            "text": "28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": 1.068359375,
            "end_logit": -7.1015625,
            "text": "28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": 1.068359375,
            "end_logit": -7.15625,
            "text": "28 joints with ESR (DAS28), Clinical Disease Activity",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": 1.068359375,
            "end_logit": -7.30859375,
            "text": "28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI)",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": 1.068359375,
            "end_logit": -7.30859375,
            "text": "28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI)",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -2.42578125,
            "end_logit": -4.89453125,
            "text": "joints with ESR",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -2.42578125,
            "end_logit": -6.09765625,
            "text": "joints with ESR (",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.87890625,
            "end_logit": -2.30859375,
            "text": "rheumatoid arthritis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.42578125,
            "end_logit": -6.87109375,
            "text": "joints with ESR (DAS28",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.42578125,
            "end_logit": -6.875,
            "text": "joints with",
            "probability": 2.384185791015625e-07
        }
    ],
    "5fe3130da43ad3127800003f_12": [
        {
            "start_logit": -1.85546875,
            "end_logit": 6.6171875,
            "text": "joints",
            "probability": 0.5498046875
        },
        {
            "start_logit": -2.67578125,
            "end_logit": 6.6171875,
            "text": "28 joints",
            "probability": 0.241943359375
        },
        {
            "start_logit": -3.02734375,
            "end_logit": 6.6171875,
            "text": "the Disease Activity Score in 28 joints",
            "probability": 0.1702880859375
        },
        {
            "start_logit": -5.71875,
            "end_logit": 6.6171875,
            "text": "and the Disease Activity Score in 28 joints",
            "probability": 0.01154327392578125
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 6.6171875,
            "text": ", and the Disease Activity Score in 28 joints",
            "probability": 0.0031681060791015625
        },
        {
            "start_logit": -7.0625,
            "end_logit": 6.6171875,
            "text": "CDAI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.0030117034912109375
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 6.6171875,
            "text": "Simplified Disease Activity Index (SDAI) scores, Clinical Disease Activity Index (CDAI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.002468109130859375
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 6.6171875,
            "text": ", Clinical Disease Activity Index (CDAI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.002437591552734375
        },
        {
            "start_logit": -7.390625,
            "end_logit": 6.6171875,
            "text": "in 28 joints",
            "probability": 0.0021686553955078125
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 6.6171875,
            "text": "SDAI) scores, Clinical Disease Activity Index (CDAI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.002094268798828125
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 6.6171875,
            "text": "Clinical Disease Activity Index (CDAI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.0020294189453125
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 6.6171875,
            "text": "METHODS: Simplified Disease Activity Index (SDAI) scores, Clinical Disease Activity Index (CDAI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.0019359588623046875
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 6.6171875,
            "text": "AI) scores, Clinical Disease Activity Index (CDAI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.0019063949584960938
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 6.6171875,
            "text": "scores, and the Disease Activity Score in 28 joints",
            "probability": 0.0018911361694335938
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 6.6171875,
            "text": "AI) scores, and the Disease Activity Score in 28 joints",
            "probability": 0.0018339157104492188
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.6171875,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.0017766952514648438
        },
        {
            "start_logit": -1.85546875,
            "end_logit": -4.14453125,
            "text": "joints (",
            "probability": 1.1622905731201172e-05
        },
        {
            "start_logit": -1.85546875,
            "end_logit": -4.890625,
            "text": "joints (DAS28) were calculated using data from tocilizumab trials in patients with RA",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": -2.67578125,
            "end_logit": -4.14453125,
            "text": "28 joints (",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": -3.02734375,
            "end_logit": -4.14453125,
            "text": "the Disease Activity Score in 28 joints (",
            "probability": 3.5762786865234375e-06
        }
    ],
    "5fe3130da43ad3127800003f_13": [
        {
            "start_logit": -1.328125,
            "end_logit": 6.6953125,
            "text": "joints",
            "probability": 0.9248046875
        },
        {
            "start_logit": -4.12890625,
            "end_logit": 6.6953125,
            "text": "Disease activity score in 28 joints",
            "probability": 0.05621337890625
        },
        {
            "start_logit": -5.4140625,
            "end_logit": 6.6953125,
            "text": "28 joints",
            "probability": 0.01554107666015625
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 6.6953125,
            "text": "in 28 joints",
            "probability": 0.002285003662109375
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 6.6953125,
            "text": "score in 28 joints",
            "probability": 0.0012807846069335938
        },
        {
            "start_logit": -1.328125,
            "end_logit": -4.703125,
            "text": "joints (",
            "probability": 1.0371208190917969e-05
        },
        {
            "start_logit": -1.328125,
            "end_logit": -5.40625,
            "text": "joints (DAS28)-remission has not been included among American College of Rheumatology/European League Against Rheumatism",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": -1.328125,
            "end_logit": -6.55078125,
            "text": "joints (DAS28)-remission has not been included among American College of Rheumatology",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -1.328125,
            "end_logit": -6.859375,
            "text": "joints (DAS28)-remission",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -1.328125,
            "end_logit": -6.98046875,
            "text": "joints (DAS28)",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -1.328125,
            "end_logit": -7.00390625,
            "text": "joints (DAS28",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -1.328125,
            "end_logit": -7.05078125,
            "text": "joints (DAS28)-remission has not been",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -1.328125,
            "end_logit": -7.09375,
            "text": "joints (DAS28)-remission has not been included among American College of Rheumatology/European League Against Rheumat",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -1.328125,
            "end_logit": -7.234375,
            "text": "joints (DAS28)-remission has",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -1.328125,
            "end_logit": -7.23828125,
            "text": "joints (DAS28)-",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -1.328125,
            "end_logit": -7.29296875,
            "text": "joints (DAS28)-remission has not been included among American College of Rheumatology/European League Against Rheumatism definitions",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -1.328125,
            "end_logit": -7.3515625,
            "text": "joints (DAS28)-remission has not been included among American College of Rheumatology/European League Against Rheumatism definitions, because of",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -1.328125,
            "end_logit": -7.36328125,
            "text": "joints (DAS28)-remission has not been included among",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -4.12890625,
            "end_logit": -4.703125,
            "text": "Disease activity score in 28 joints (",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -4.12890625,
            "end_logit": -5.40625,
            "text": "Disease activity score in 28 joints (DAS28)-remission has not been included among American College of Rheumatology/European League Against Rheumatism",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5fe3130da43ad3127800003f_14": [
        {
            "start_logit": 1.6484375,
            "end_logit": -1.2138671875,
            "text": "28 joints",
            "probability": 0.6513671875
        },
        {
            "start_logit": 1.6484375,
            "end_logit": -2.25390625,
            "text": "28 joints with C-reactive protein",
            "probability": 0.230224609375
        },
        {
            "start_logit": 1.6484375,
            "end_logit": -3.78125,
            "text": "28 joints with C-reactive protein (DAS)28",
            "probability": 0.050018310546875
        },
        {
            "start_logit": 1.6484375,
            "end_logit": -4.69140625,
            "text": "28",
            "probability": 0.0201416015625
        },
        {
            "start_logit": 1.6484375,
            "end_logit": -5.3515625,
            "text": "28 joints with C-reactive protein (",
            "probability": 0.010406494140625
        },
        {
            "start_logit": -2.72265625,
            "end_logit": -1.2138671875,
            "text": "joints",
            "probability": 0.00823211669921875
        },
        {
            "start_logit": 1.6484375,
            "end_logit": -5.671875,
            "text": "28 joints with C-reactive protein (DAS)28-CRP",
            "probability": 0.0075531005859375
        },
        {
            "start_logit": 1.6484375,
            "end_logit": -6.32421875,
            "text": "28 joints with C-reactive",
            "probability": 0.003932952880859375
        },
        {
            "start_logit": 1.6484375,
            "end_logit": -6.40625,
            "text": "28 joints with C-reactive protein (DAS",
            "probability": 0.0036258697509765625
        },
        {
            "start_logit": 1.6484375,
            "end_logit": -6.53125,
            "text": "28 joints with C-reactive protein (DAS)28-CRP).",
            "probability": 0.0031986236572265625
        },
        {
            "start_logit": -2.72265625,
            "end_logit": -2.25390625,
            "text": "joints with C-reactive protein",
            "probability": 0.0029125213623046875
        },
        {
            "start_logit": 1.6484375,
            "end_logit": -6.8125,
            "text": "28 joints with C-reactive protein (DAS)",
            "probability": 0.002414703369140625
        },
        {
            "start_logit": 1.6484375,
            "end_logit": -7.1875,
            "text": "28 joints with C-reactive protein (DAS)28-",
            "probability": 0.0016603469848632812
        },
        {
            "start_logit": 1.6484375,
            "end_logit": -7.19140625,
            "text": "28 joints with C-",
            "probability": 0.0016527175903320312
        },
        {
            "start_logit": 1.6484375,
            "end_logit": -7.26953125,
            "text": "28 joints with C-reactive protein (DAS)28-CRP)",
            "probability": 0.0015277862548828125
        },
        {
            "start_logit": -2.72265625,
            "end_logit": -3.78125,
            "text": "joints with C-reactive protein (DAS)28",
            "probability": 0.0006322860717773438
        },
        {
            "start_logit": -2.72265625,
            "end_logit": -5.3515625,
            "text": "joints with C-reactive protein (",
            "probability": 0.0001304149627685547
        },
        {
            "start_logit": -7.0546875,
            "end_logit": -1.2138671875,
            "text": "of 28 joints",
            "probability": 0.00010818243026733398
        },
        {
            "start_logit": -6.0234375,
            "end_logit": -2.25390625,
            "text": "with C-reactive protein",
            "probability": 0.00010645389556884766
        },
        {
            "start_logit": -2.72265625,
            "end_logit": -5.671875,
            "text": "joints with C-reactive protein (DAS)28-CRP",
            "probability": 9.542703628540039e-05
        }
    ],
    "5fe3130da43ad3127800003f_15": [
        {
            "start_logit": -1.3203125,
            "end_logit": 7.06640625,
            "text": "Joints",
            "probability": 0.93115234375
        },
        {
            "start_logit": -4.05859375,
            "end_logit": 7.06640625,
            "text": "28 Joints",
            "probability": 0.06024169921875
        },
        {
            "start_logit": -6.9375,
            "end_logit": 7.06640625,
            "text": "Disease Activity Score in 28 Joints",
            "probability": 0.003383636474609375
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 7.06640625,
            "text": "in 28 Joints",
            "probability": 0.0022106170654296875
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 7.06640625,
            "text": "BACKGROUND: Disease Activity Score in 28 Joints",
            "probability": 0.0020046234130859375
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 7.06640625,
            "text": ": Disease Activity Score in 28 Joints",
            "probability": 0.0016889572143554688
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -4.86328125,
            "text": "Joints (",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -6.03125,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid art",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -6.9609375,
            "text": "Joints (DAS28) is",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.17578125,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.2109375,
            "text": "Joints (DAS28) is a scoring system",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.22265625,
            "text": "Joints (DAS28",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.234375,
            "text": "Joints (DAS28) is a scoring system to",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.23828125,
            "text": "Joints (DAS28) is a",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.24609375,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.2578125,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity and treatment response",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.30859375,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity and treatment response in rheumatoid",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.359375,
            "text": "Joints (DAS28) is a scoring system to evaluate disease activity and treatment",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.390625,
            "text": "Joints (DAS28) is a scoring system to evaluate disease",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.5234375,
            "text": "Joints (DAS",
            "probability": 4.172325134277344e-07
        }
    ],
    "5fe3130da43ad3127800003f_16": [
        {
            "start_logit": -2.056640625,
            "end_logit": 6.609375,
            "text": "joints",
            "probability": 0.88671875
        },
        {
            "start_logit": -4.28125,
            "end_logit": 6.609375,
            "text": "28 joints",
            "probability": 0.09564208984375
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 6.609375,
            "text": ": The Disease Activity Score in 28 joints",
            "probability": 0.0038547515869140625
        },
        {
            "start_logit": -7.5,
            "end_logit": 6.609375,
            "text": "OBJECTIVE: The Disease Activity Score in 28 joints",
            "probability": 0.0038280487060546875
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 6.609375,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.0035114288330078125
        },
        {
            "start_logit": -7.6875,
            "end_logit": 6.609375,
            "text": "The Disease Activity Score in 28 joints",
            "probability": 0.0031719207763671875
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 6.609375,
            "text": "in 28 joints",
            "probability": 0.003063201904296875
        },
        {
            "start_logit": -2.056640625,
            "end_logit": -5.515625,
            "text": "joints (",
            "probability": 4.827976226806641e-06
        },
        {
            "start_logit": -2.056640625,
            "end_logit": -6.99609375,
            "text": "joints (DAS28) is",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -2.056640625,
            "end_logit": -7.26953125,
            "text": "joints (DAS28) is a key measure in clinical practice",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -2.056640625,
            "end_logit": -7.3515625,
            "text": "joints (DAS28",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -2.056640625,
            "end_logit": -7.40625,
            "text": "joints (DAS28) is a",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -2.056640625,
            "end_logit": -7.4453125,
            "text": "joints (DAS28) is a key measure in clinical practice and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -2.056640625,
            "end_logit": -7.4765625,
            "text": "joints (DAS28) is a key",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -2.056640625,
            "end_logit": -7.55859375,
            "text": "joints (DAS",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -2.056640625,
            "end_logit": -7.58984375,
            "text": "joints (DAS28) is a key measure in",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -2.056640625,
            "end_logit": -7.58984375,
            "text": "joints (DAS28) is a key measure",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -2.056640625,
            "end_logit": -7.62890625,
            "text": "joints (DAS28)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -2.056640625,
            "end_logit": -7.671875,
            "text": "joints (DAS28) is a key measure in clinical",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -2.056640625,
            "end_logit": -7.70703125,
            "text": "joints (DAS28) is a key measure in clinical practice and clini",
            "probability": 5.364418029785156e-07
        }
    ],
    "5fe3130da43ad3127800003f_17": [
        {
            "start_logit": -1.0078125,
            "end_logit": 7.4921875,
            "text": "joints",
            "probability": 0.86767578125
        },
        {
            "start_logit": -2.96875,
            "end_logit": 7.4921875,
            "text": "28 joints",
            "probability": 0.12213134765625
        },
        {
            "start_logit": -6.578125,
            "end_logit": 7.4921875,
            "text": "including 28 joints",
            "probability": 0.0033054351806640625
        },
        {
            "start_logit": -6.875,
            "end_logit": 7.4921875,
            "text": "The Disease Activity Score including 28 joints",
            "probability": 0.0024566650390625
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 7.4921875,
            "text": "Disease Activity Score including 28 joints",
            "probability": 0.0018768310546875
        },
        {
            "start_logit": -7.53125,
            "end_logit": 7.4921875,
            "text": "OBJECTIVE: The Disease Activity Score including 28 joints",
            "probability": 0.00127410888671875
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.4921875,
            "text": ": The Disease Activity Score including 28 joints",
            "probability": 0.0012111663818359375
        },
        {
            "start_logit": -1.0078125,
            "end_logit": -5.4609375,
            "text": "joints (",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -1.0078125,
            "end_logit": -5.85546875,
            "text": "joints (DAS28) and the Clinical Disease Activity Index (CDAI) were developed in order to provide a quantifiable measure of rheumatoid arthritis",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -1.0078125,
            "end_logit": -6.54296875,
            "text": "joints (DAS28) and the Clinical Disease Activity Index (CDAI) were developed in order to provide a quantifiable measure of rheumatoid arthritis (RA",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -1.0078125,
            "end_logit": -6.6796875,
            "text": "joints (DAS28) and the Clinical Disease Activity Index (CDAI) were",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -1.0078125,
            "end_logit": -6.93359375,
            "text": "joints (DAS28) and the Clinical Disease Activity Index (CDAI",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -1.0078125,
            "end_logit": -6.95703125,
            "text": "joints (DAS28) and the Clinical Disease Activity",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -1.0078125,
            "end_logit": -7.00390625,
            "text": "joints (DAS28) and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -1.0078125,
            "end_logit": -7.19140625,
            "text": "joints (DAS28) and the Clinical Disease Activity Index",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.0078125,
            "end_logit": -7.25,
            "text": "joints (DAS28) and the Clinical Disease Activity Index (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.0078125,
            "end_logit": -7.296875,
            "text": "joints (DAS28) and the Clinical Disease Activity Index (CDAI) were developed in order to",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.0078125,
            "end_logit": -7.359375,
            "text": "joints (DAS28) and the Clinical Disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.0078125,
            "end_logit": -7.390625,
            "text": "joints (DAS28) and the Clinical Disease Activity Index (CDAI) were developed in order to provide a quantifiable",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.0078125,
            "end_logit": -7.41796875,
            "text": "joints (DAS28) and the Clinical Disease Activity Index (CDAI) were developed in order to provide a quantifiable measure of rheumatoid arthritis (",
            "probability": 2.980232238769531e-07
        }
    ],
    "5fe3130da43ad3127800003f_18": [
        {
            "start_logit": -1.1171875,
            "end_logit": 7.52734375,
            "text": "28 joints",
            "probability": 0.56591796875
        },
        {
            "start_logit": -1.392578125,
            "end_logit": 7.52734375,
            "text": "joints",
            "probability": 0.4287109375
        },
        {
            "start_logit": -7.1953125,
            "end_logit": 7.52734375,
            "text": "on 28 joints",
            "probability": 0.0012969970703125
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 7.52734375,
            "text": "based on 28 joints",
            "probability": 0.0010709762573242188
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 7.52734375,
            "text": "OBJECTIVE: The Disease Activity Score based on 28 joints",
            "probability": 0.0009198188781738281
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 7.52734375,
            "text": ": The Disease Activity Score based on 28 joints",
            "probability": 0.0008082389831542969
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 7.52734375,
            "text": "Disease Activity Score based on 28 joints",
            "probability": 0.0008025169372558594
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 7.52734375,
            "text": "The Disease Activity Score based on 28 joints",
            "probability": 0.0007867813110351562
        },
        {
            "start_logit": -1.1171875,
            "end_logit": -6.01171875,
            "text": "28 joints (",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -1.1171875,
            "end_logit": -6.0859375,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice and research studies of rheumatoid arth",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -1.392578125,
            "end_logit": -6.01171875,
            "text": "joints (",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -1.392578125,
            "end_logit": -6.0859375,
            "text": "joints (DAS28) has been increasingly used in clinical practice and research studies of rheumatoid arth",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -1.1171875,
            "end_logit": -6.73046875,
            "text": "28 joints (DAS28) has",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.1171875,
            "end_logit": -6.84765625,
            "text": "28 joints (DAS28) has been increasingly",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -1.1171875,
            "end_logit": -6.921875,
            "text": "28 joints (DAS28) has been",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.392578125,
            "end_logit": -6.73046875,
            "text": "joints (DAS28) has",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.392578125,
            "end_logit": -6.84765625,
            "text": "joints (DAS28) has been increasingly",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -1.1171875,
            "end_logit": -7.14453125,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice and research studies of rheumatoid",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -1.1171875,
            "end_logit": -7.1640625,
            "text": "28 joints (DAS28) has been increasingly used in clinical practice",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -1.392578125,
            "end_logit": -6.921875,
            "text": "joints (DAS28) has been",
            "probability": 2.384185791015625e-07
        }
    ],
    "5fe3130da43ad3127800003f_19": [
        {
            "start_logit": -0.88623046875,
            "end_logit": 7.3984375,
            "text": "joints",
            "probability": 0.5146484375
        },
        {
            "start_logit": -1.154296875,
            "end_logit": 7.3984375,
            "text": "28 joints",
            "probability": 0.39306640625
        },
        {
            "start_logit": -2.677734375,
            "end_logit": 7.3984375,
            "text": "including 28 joints",
            "probability": 0.085693359375
        },
        {
            "start_logit": -6.5546875,
            "end_logit": 7.3984375,
            "text": "rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints",
            "probability": 0.00177764892578125
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 7.3984375,
            "text": "the Disease Activity Score including 28 joints",
            "probability": 0.0014905929565429688
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 7.3984375,
            "text": "of the Disease Activity Score including 28 joints",
            "probability": 0.0008831024169921875
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 7.3984375,
            "text": "ency of the Disease Activity Score including 28 joints",
            "probability": 0.0006880760192871094
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.3984375,
            "text": "Disease Activity Score including 28 joints",
            "probability": 0.0006566047668457031
        },
        {
            "start_logit": -7.65625,
            "end_logit": 7.3984375,
            "text": "congruency of the Disease Activity Score including 28 joints",
            "probability": 0.0005908012390136719
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 7.3984375,
            "text": "Disease activity assessment of rheumatoid arthritis in daily practice: validity, internal consistency, reliability and congruency of the Disease Activity Score including 28 joints",
            "probability": 0.0005254745483398438
        },
        {
            "start_logit": -0.88623046875,
            "end_logit": -3.875,
            "text": "joints (",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": -1.154296875,
            "end_logit": -3.875,
            "text": "28 joints (",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -2.677734375,
            "end_logit": -3.875,
            "text": "including 28 joints (",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -0.88623046875,
            "end_logit": -6.0703125,
            "text": "joints (DAS28) compared with the Clinical Disease Activity Index (CDAI",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -1.154296875,
            "end_logit": -6.0703125,
            "text": "28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -0.88623046875,
            "end_logit": -6.4921875,
            "text": "joints (DAS28) compared with the Clinical Disease Activity Index (CDAI).",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -1.154296875,
            "end_logit": -6.4921875,
            "text": "28 joints (DAS28) compared with the Clinical Disease Activity Index (CDAI).",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -0.88623046875,
            "end_logit": -6.82421875,
            "text": "joints (DAS28) compared with the Clinical Disease Activity Index (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -0.88623046875,
            "end_logit": -7.06640625,
            "text": "joints (DAS28) compared with the Clinical Disease Activity",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -0.88623046875,
            "end_logit": -7.08984375,
            "text": "joints (DAS28) compared with the Clinical Disease Activity Index",
            "probability": 2.980232238769531e-07
        }
    ],
    "5fe3130da43ad3127800003f_20": [
        {
            "start_logit": -3.009765625,
            "end_logit": 3.8203125,
            "text": "joints",
            "probability": 0.876953125
        },
        {
            "start_logit": -5.4765625,
            "end_logit": 3.8203125,
            "text": "28 joints",
            "probability": 0.07440185546875
        },
        {
            "start_logit": -6.875,
            "end_logit": 3.8203125,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.0183868408203125
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 3.8203125,
            "text": "in 28 joints",
            "probability": 0.00901031494140625
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 3.8203125,
            "text": "OBJECTIVES: Disease Activity Score in 28 joints",
            "probability": 0.00872802734375
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 3.8203125,
            "text": ": Disease Activity Score in 28 joints",
            "probability": 0.008331298828125
        },
        {
            "start_logit": -3.009765625,
            "end_logit": -1.7822265625,
            "text": "joints calculated with C-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 0.0032367706298828125
        },
        {
            "start_logit": -5.32421875,
            "end_logit": -1.7822265625,
            "text": "DAS28-CRP) is used instead of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 0.0003204345703125
        },
        {
            "start_logit": -5.66015625,
            "end_logit": -1.7822265625,
            "text": "DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 0.00022912025451660156
        },
        {
            "start_logit": -3.009765625,
            "end_logit": -4.64453125,
            "text": "joints calculated with C-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate (DAS28",
            "probability": 0.00018405914306640625
        },
        {
            "start_logit": -6.19921875,
            "end_logit": -1.7822265625,
            "text": "rheumatoid arthritis",
            "probability": 0.000133514404296875
        },
        {
            "start_logit": -6.89453125,
            "end_logit": -1.7822265625,
            "text": "C-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 6.61611557006836e-05
        },
        {
            "start_logit": -3.009765625,
            "end_logit": -5.75,
            "text": "joints calculated with C-reactive protein (DAS28",
            "probability": 6.121397018432617e-05
        },
        {
            "start_logit": -7.1796875,
            "end_logit": -1.7822265625,
            "text": ") is used instead of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 4.988908767700195e-05
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -1.7822265625,
            "text": "assess rheumatoid arthritis",
            "probability": 4.4405460357666016e-05
        },
        {
            "start_logit": -7.359375,
            "end_logit": -1.7822265625,
            "text": "erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 4.172325134277344e-05
        },
        {
            "start_logit": -3.009765625,
            "end_logit": -6.2265625,
            "text": "joints calculated with C-reactive protein (DAS28-CRP) is used instead of erythrocyte sedimentation rate",
            "probability": 3.796815872192383e-05
        },
        {
            "start_logit": -7.515625,
            "end_logit": -1.7822265625,
            "text": "(DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 3.5703182220458984e-05
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -1.7822265625,
            "text": ") to assess rheumatoid arthritis",
            "probability": 3.4332275390625e-05
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -1.7822265625,
            "text": "instead of erythrocyte sedimentation rate (DAS28-ESR) to assess rheumatoid arthritis",
            "probability": 3.2007694244384766e-05
        }
    ],
    "5fe3130da43ad3127800003f_21": [
        {
            "start_logit": -1.763671875,
            "end_logit": 6.765625,
            "text": "joints",
            "probability": 0.6572265625
        },
        {
            "start_logit": -2.513671875,
            "end_logit": 6.765625,
            "text": "28 joints",
            "probability": 0.310546875
        },
        {
            "start_logit": -6.19140625,
            "end_logit": 6.765625,
            "text": "Disease Activity Score in 28 joints",
            "probability": 0.00786590576171875
        },
        {
            "start_logit": -6.30859375,
            "end_logit": 6.765625,
            "text": "in 28 joints",
            "probability": 0.00699615478515625
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 6.765625,
            "text": "To optimize use of the Disease Activity Score in 28 joints",
            "probability": 0.0032024383544921875
        },
        {
            "start_logit": -7.15625,
            "end_logit": 6.765625,
            "text": "the Disease Activity Score in 28 joints",
            "probability": 0.0029964447021484375
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 6.765625,
            "text": "use of the Disease Activity Score in 28 joints",
            "probability": 0.002635955810546875
        },
        {
            "start_logit": -7.453125,
            "end_logit": 6.765625,
            "text": "OBJECTIVE: To optimize use of the Disease Activity Score in 28 joints",
            "probability": 0.0022258758544921875
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 6.765625,
            "text": "optimize use of the Disease Activity Score in 28 joints",
            "probability": 0.0021419525146484375
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 6.765625,
            "text": ": To optimize use of the Disease Activity Score in 28 joints",
            "probability": 0.001987457275390625
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 6.765625,
            "text": "of the Disease Activity Score in 28 joints",
            "probability": 0.0018825531005859375
        },
        {
            "start_logit": -1.763671875,
            "end_logit": -2.16015625,
            "text": "joints (",
            "probability": 8.767843246459961e-05
        },
        {
            "start_logit": -2.513671875,
            "end_logit": -2.16015625,
            "text": "28 joints (",
            "probability": 4.1425228118896484e-05
        },
        {
            "start_logit": -6.19140625,
            "end_logit": -2.16015625,
            "text": "Disease Activity Score in 28 joints (",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.30859375,
            "end_logit": -2.16015625,
            "text": "in 28 joints (",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -1.763671875,
            "end_logit": -6.87890625,
            "text": "joints (DAS28) in early rheumatoid arthritis",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -1.763671875,
            "end_logit": -6.921875,
            "text": "joints (DAS28",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -1.763671875,
            "end_logit": -7.015625,
            "text": "joints (DAS28) in",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -1.763671875,
            "end_logit": -7.12109375,
            "text": "joints (DAS",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -1.763671875,
            "end_logit": -7.27734375,
            "text": "joints (DAS28) in early rheumatoid arthritis (RA) by",
            "probability": 5.364418029785156e-07
        }
    ],
    "5710a592cf1c32585100002a_1": [
        {
            "start_logit": 4.03515625,
            "end_logit": 3.97265625,
            "text": "CO2",
            "probability": 0.82177734375
        },
        {
            "start_logit": 4.03515625,
            "end_logit": 2.0390625,
            "text": "CO2 concentrations, with increased expression of virulence factors that include the anthrax toxins and extracellular capsular layer.",
            "probability": 0.118896484375
        },
        {
            "start_logit": 3.296875,
            "end_logit": 2.0390625,
            "text": "anthrax toxins and extracellular capsular layer.",
            "probability": 0.05682373046875
        },
        {
            "start_logit": 4.03515625,
            "end_logit": -3.328125,
            "text": "CO2 concentrations, with increased expression of virulence factors that include the anthr",
            "probability": 0.0005550384521484375
        },
        {
            "start_logit": -1.517578125,
            "end_logit": 2.0390625,
            "text": ".",
            "probability": 0.000461578369140625
        },
        {
            "start_logit": 4.03515625,
            "end_logit": -3.626953125,
            "text": "CO2 concentrations, with increased expression of virulence factors that include the anthrax",
            "probability": 0.0004107952117919922
        },
        {
            "start_logit": 3.296875,
            "end_logit": -3.328125,
            "text": "anthr",
            "probability": 0.0002651214599609375
        },
        {
            "start_logit": 3.296875,
            "end_logit": -3.626953125,
            "text": "anthrax",
            "probability": 0.0001970529556274414
        },
        {
            "start_logit": 4.03515625,
            "end_logit": -4.5625,
            "text": "CO2 concentrations, with increased expression of virulence factors that include the anthrax toxins",
            "probability": 0.00016200542449951172
        },
        {
            "start_logit": 3.296875,
            "end_logit": -4.5625,
            "text": "anthrax toxins",
            "probability": 7.712841033935547e-05
        },
        {
            "start_logit": 4.03515625,
            "end_logit": -6.44140625,
            "text": "CO2 concentrations, with increased",
            "probability": 2.4616718292236328e-05
        },
        {
            "start_logit": 4.03515625,
            "end_logit": -6.4453125,
            "text": "CO2 concentrations, with increased expression of virulence factors that include the anthrax toxins and",
            "probability": 2.4497509002685547e-05
        },
        {
            "start_logit": 4.03515625,
            "end_logit": -6.6875,
            "text": "CO2 concentrations, with increased expression of virulence factors that",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": 4.03515625,
            "end_logit": -6.89453125,
            "text": "CO2 concentrations, with increased expression of",
            "probability": 1.5676021575927734e-05
        },
        {
            "start_logit": 4.03515625,
            "end_logit": -6.8984375,
            "text": "CO2 concentrations, with increased expression of virulence factors",
            "probability": 1.5556812286376953e-05
        },
        {
            "start_logit": 4.03515625,
            "end_logit": -6.9296875,
            "text": "CO2 concentrations, with increased expression",
            "probability": 1.5079975128173828e-05
        },
        {
            "start_logit": -6.90625,
            "end_logit": 3.97265625,
            "text": ", Bacillus anthracis responds to host cues, and particularly to elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 1.4603137969970703e-05
        },
        {
            "start_logit": 4.03515625,
            "end_logit": -6.984375,
            "text": "CO2 concentrations",
            "probability": 1.4424324035644531e-05
        },
        {
            "start_logit": 4.03515625,
            "end_logit": -7.07421875,
            "text": "CO2 concentrations, with",
            "probability": 1.3053417205810547e-05
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 3.97265625,
            "text": "elevated temperature (37\u00b0C) and bicarbonate/CO2",
            "probability": 1.2755393981933594e-05
        }
    ],
    "5710a592cf1c32585100002a_2": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.2109375,
            "text": "CO(2) /bicarbonate",
            "probability": 0.4990234375
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 8.2265625,
            "text": "CO(2) /bicarbonate",
            "probability": 0.4990234375
        },
        {
            "start_logit": 1.6171875,
            "end_logit": 8.2265625,
            "text": "bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(2) /bicarbonate",
            "probability": 0.000682830810546875
        },
        {
            "start_logit": 1.6171875,
            "end_logit": 8.2109375,
            "text": "bicarbonate",
            "probability": 0.0006723403930664062
        },
        {
            "start_logit": 1.3359375,
            "end_logit": 8.2265625,
            "text": "bicarbonate",
            "probability": 0.0005154609680175781
        },
        {
            "start_logit": 8.21875,
            "end_logit": -0.293212890625,
            "text": "CO(2)",
            "probability": 9.995698928833008e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -0.61279296875,
            "text": "CO(2) /bicarbonate, suggesting that this host-associated signal enhances AtxA function by shifting the dimer/monomer equilibrium towards the dimeric state.",
            "probability": 7.200241088867188e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.0009765625,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO",
            "probability": 4.947185516357422e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.0009765625,
            "text": "CO",
            "probability": 4.9114227294921875e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.0576171875,
            "text": "CO",
            "probability": 4.649162292480469e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.447265625,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(2)",
            "probability": 3.170967102050781e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.447265625,
            "text": "CO(2)",
            "probability": 3.141164779663086e-05
        },
        {
            "start_logit": -5.734375,
            "end_logit": 8.2265625,
            "text": "/bicarbonate",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.8671875,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.91796875,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -5.91796875,
            "text": "CO(2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.0078125,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.0078125,
            "text": "CO(",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.13671875,
            "end_logit": 8.2265625,
            "text": "/bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(2) /bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.13671875,
            "end_logit": 8.2109375,
            "text": "/bicarbonate",
            "probability": 2.980232238769531e-07
        }
    ],
    "5710a592cf1c32585100002a_3": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.2109375,
            "text": "CO(2) /bicarbonate",
            "probability": 0.4990234375
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 8.2265625,
            "text": "CO(2) /bicarbonate",
            "probability": 0.4990234375
        },
        {
            "start_logit": 1.6171875,
            "end_logit": 8.2265625,
            "text": "bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(2) /bicarbonate",
            "probability": 0.000682830810546875
        },
        {
            "start_logit": 1.6171875,
            "end_logit": 8.2109375,
            "text": "bicarbonate",
            "probability": 0.0006723403930664062
        },
        {
            "start_logit": 1.3359375,
            "end_logit": 8.2265625,
            "text": "bicarbonate",
            "probability": 0.0005154609680175781
        },
        {
            "start_logit": 8.21875,
            "end_logit": -0.293212890625,
            "text": "CO(2)",
            "probability": 9.995698928833008e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -0.61279296875,
            "text": "CO(2) /bicarbonate, suggesting that this host-associated signal enhances AtxA function by shifting the dimer/monomer equilibrium towards the dimeric state.",
            "probability": 7.200241088867188e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.0009765625,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO",
            "probability": 4.947185516357422e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.0009765625,
            "text": "CO",
            "probability": 4.9114227294921875e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.0576171875,
            "text": "CO",
            "probability": 4.649162292480469e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.447265625,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(2)",
            "probability": 3.170967102050781e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.447265625,
            "text": "CO(2)",
            "probability": 3.141164779663086e-05
        },
        {
            "start_logit": -5.734375,
            "end_logit": 8.2265625,
            "text": "/bicarbonate",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.8671875,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.91796875,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -5.91796875,
            "text": "CO(2",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.0078125,
            "text": "CO(2) /bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.0078125,
            "text": "CO(",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.13671875,
            "end_logit": 8.2265625,
            "text": "/bicarbonate exhibited increased AtxA dimer/monomer ratios and increased AtxA activity, relative to cultures grown without added CO(2) /bicarbonate",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.13671875,
            "end_logit": 8.2109375,
            "text": "/bicarbonate",
            "probability": 2.980232238769531e-07
        }
    ],
    "5710a592cf1c32585100002a_4": [
        {
            "start_logit": 6.37890625,
            "end_logit": 6.69140625,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": 6.69140625,
            "text": "by CO2",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.23828125,
            "text": "CO2, a signal mimicking the host environment.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 6.69140625,
            "text": "virulence genes is triggered by CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 6.69140625,
            "text": "anthracis virulence genes is triggered by CO2",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.5390625,
            "text": "CO2,",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.59765625,
            "text": "CO2, a",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.6328125,
            "text": "CO2, a signal mimicking the host environment",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.69921875,
            "text": "CO2, a signal mimicking the host",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.74609375,
            "text": "CO2, a signal mimicking the",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.02734375,
            "end_logit": -7.23828125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -7.23828125,
            "text": "by CO2, a signal mimicking the host environment.",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -7.5390625,
            "text": "by CO2,",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -7.59765625,
            "text": "by CO2, a",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -7.6328125,
            "text": "by CO2, a signal mimicking the host environment",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -7.69921875,
            "text": "by CO2, a signal mimicking the host",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -7.74609375,
            "text": "by CO2, a signal mimicking the",
            "probability": 0.0
        },
        {
            "start_logit": -7.76171875,
            "end_logit": -7.23828125,
            "text": "signal mimicking the host environment.",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -7.23828125,
            "text": "virulence genes is triggered by CO2, a signal mimicking the host environment.",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": -7.23828125,
            "text": "anthracis virulence genes is triggered by CO2, a signal mimicking the host environment.",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_5": [
        {
            "start_logit": 6.296875,
            "end_logit": 6.7578125,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": 6.296875,
            "end_logit": -6.5,
            "text": "CO2 and in vivo, AtxA is part of the sap and eag",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 6.7578125,
            "text": "presence of CO2",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 6.7578125,
            "text": "in presence of CO2",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 6.7578125,
            "text": "of CO2",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 6.7578125,
            "text": ", in vitro in presence of CO2",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 6.7578125,
            "text": "in vitro in presence of CO2",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 6.7578125,
            "text": "vitro in presence of CO2",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.7578125,
            "text": "Furthermore, in vitro in presence of CO2",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.296875,
            "end_logit": -7.33984375,
            "text": "CO2 and in vivo, AtxA is part of the sap and eag regulatory network.",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.296875,
            "end_logit": -7.4921875,
            "text": "CO2 and in vivo, AtxA is part of the sap and ea",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.296875,
            "end_logit": -7.5546875,
            "text": "CO2 and in vivo, AtxA is part of the sap and eag regulatory",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.296875,
            "end_logit": -7.59765625,
            "text": "CO2 and in vivo, AtxA is part of the sap and eag regulatory network",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.296875,
            "end_logit": -7.62109375,
            "text": "CO2 and in vivo, AtxA is part",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.296875,
            "end_logit": -7.640625,
            "text": "CO2 and in vivo, AtxA is part of",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.296875,
            "end_logit": -7.65234375,
            "text": "CO2 and in vivo, AtxA is",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.296875,
            "end_logit": -7.71484375,
            "text": "CO2 and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.296875,
            "end_logit": -7.71484375,
            "text": "CO2 and in vivo, AtxA is part of the sap",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.296875,
            "end_logit": -7.71875,
            "text": "CO2 and in vivo, AtxA is part of the sap and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.296875,
            "end_logit": -7.765625,
            "text": "CO2 and in vivo, AtxA is part of the",
            "probability": 4.76837158203125e-07
        }
    ],
    "5710a592cf1c32585100002a_6": [
        {
            "start_logit": 8.1015625,
            "end_logit": 7.55859375,
            "text": "CO2/bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -1.263671875,
            "text": "CO2",
            "probability": 0.00014770030975341797
        },
        {
            "start_logit": -2.509765625,
            "end_logit": 7.55859375,
            "text": "bicarbonate",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.01171875,
            "text": "CO2/bicarbonate, affects AtxA synthesis.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.33203125,
            "text": "CO2/bicarbonate, affects AtxA synthesis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.359375,
            "text": "CO2/bicarbonate,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.421875,
            "text": "CO2/bicarbonate, affects AtxA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.6640625,
            "text": "CO2/bicarbonate, affects",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 7.55859375,
            "text": "temperature, not CO2/bicarbonate",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 7.55859375,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 7.55859375,
            "text": "/bicarbonate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.55859375,
            "text": "not CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 7.55859375,
            "text": "Regulation of anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 7.55859375,
            "text": "xA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -1.263671875,
            "text": "temperature, not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -1.263671875,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -1.263671875,
            "text": "not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -1.263671875,
            "text": "Regulation of anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -1.263671875,
            "text": "xA) expression in Bacillus anthracis: temperature, not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -2.509765625,
            "end_logit": -7.01171875,
            "text": "bicarbonate, affects AtxA synthesis.",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_7": [
        {
            "start_logit": 6.68359375,
            "end_logit": 2.2109375,
            "text": "CO2/bicarbonate",
            "probability": 0.599609375
        },
        {
            "start_logit": 6.68359375,
            "end_logit": 1.771484375,
            "text": "CO2/bicarbonate and temperature.",
            "probability": 0.386962890625
        },
        {
            "start_logit": 6.68359375,
            "end_logit": -1.61328125,
            "text": "CO2",
            "probability": 0.01314544677734375
        },
        {
            "start_logit": 6.68359375,
            "end_logit": -5.98046875,
            "text": "CO2/bicarbonate and temperature",
            "probability": 0.0001666545867919922
        },
        {
            "start_logit": 6.68359375,
            "end_logit": -6.73828125,
            "text": "CO2/bicarbonate and",
            "probability": 7.814168930053711e-05
        },
        {
            "start_logit": -2.888671875,
            "end_logit": 1.771484375,
            "text": ".",
            "probability": 2.7000904083251953e-05
        },
        {
            "start_logit": -6.06640625,
            "end_logit": 2.2109375,
            "text": "elevated CO2/bicarbonate",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -6.06640625,
            "end_logit": 1.771484375,
            "text": "elevated CO2/bicarbonate and temperature.",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -6.6953125,
            "end_logit": 2.2109375,
            "text": "lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 2.2109375,
            "text": "expression of the toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.6953125,
            "end_logit": 1.771484375,
            "text": "lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate and temperature.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.15234375,
            "end_logit": 2.2109375,
            "text": "bicarbonate",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 2.2109375,
            "text": ", expression of the toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 2.2109375,
            "text": "toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 2.2109375,
            "text": "pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 2.2109375,
            "text": "f, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 2.2109375,
            "text": ", and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 2.2109375,
            "text": ", lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.046875,
            "end_logit": 1.771484375,
            "text": "temperature.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 1.771484375,
            "text": "expression of the toxin genes (pag, lef, and cya) is enhanced by two physiologically significant signals: elevated CO2/bicarbonate and temperature.",
            "probability": 4.172325134277344e-07
        }
    ],
    "5710a592cf1c32585100002a_8": [
        {
            "start_logit": 8.3359375,
            "end_logit": 8.25,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 0.336669921875
        },
        {
            "start_logit": 8.3359375,
            "end_logit": 8.25,
            "text": "CO2/bicarbonate",
            "probability": 0.336669921875
        },
        {
            "start_logit": 8.3359375,
            "end_logit": 8.234375,
            "text": "CO2/bicarbonate",
            "probability": 0.326171875
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -0.072509765625,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2",
            "probability": 8.13603401184082e-05
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -0.072509765625,
            "text": "CO2",
            "probability": 8.13603401184082e-05
        },
        {
            "start_logit": -0.23828125,
            "end_logit": 8.25,
            "text": "bicarbonate",
            "probability": 6.335973739624023e-05
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -0.455322265625,
            "text": "CO2",
            "probability": 5.501508712768555e-05
        },
        {
            "start_logit": -0.491943359375,
            "end_logit": 8.25,
            "text": "bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 4.89354133605957e-05
        },
        {
            "start_logit": -0.491943359375,
            "end_logit": 8.234375,
            "text": "bicarbonate",
            "probability": 4.8220157623291016e-05
        },
        {
            "start_logit": -5.21484375,
            "end_logit": 8.25,
            "text": ". However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.3671875,
            "text": "CO2/bicarbonate levels.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.3671875,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher than that observed in cells grown in the same conditions at 28 degrees C.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.69921875,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.98828125,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.98828125,
            "text": "CO2/bicarbonate at",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.52734375,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at 37 degrees C is five",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.52734375,
            "text": "CO2/bicarbonate at 37 degrees C is five",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 8.25,
            "text": "/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.5703125,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 8.234375,
            "text": "/bicarbonate",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5710a592cf1c32585100002a_9": [
        {
            "start_logit": 8.3359375,
            "end_logit": 8.25,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 0.336669921875
        },
        {
            "start_logit": 8.3359375,
            "end_logit": 8.25,
            "text": "CO2/bicarbonate",
            "probability": 0.336669921875
        },
        {
            "start_logit": 8.3359375,
            "end_logit": 8.234375,
            "text": "CO2/bicarbonate",
            "probability": 0.326171875
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -0.072509765625,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2",
            "probability": 8.13603401184082e-05
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -0.072509765625,
            "text": "CO2",
            "probability": 8.13603401184082e-05
        },
        {
            "start_logit": -0.23828125,
            "end_logit": 8.25,
            "text": "bicarbonate",
            "probability": 6.335973739624023e-05
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -0.455322265625,
            "text": "CO2",
            "probability": 5.501508712768555e-05
        },
        {
            "start_logit": -0.491943359375,
            "end_logit": 8.25,
            "text": "bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 4.89354133605957e-05
        },
        {
            "start_logit": -0.491943359375,
            "end_logit": 8.234375,
            "text": "bicarbonate",
            "probability": 4.8220157623291016e-05
        },
        {
            "start_logit": -5.21484375,
            "end_logit": 8.25,
            "text": ". However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.3671875,
            "text": "CO2/bicarbonate levels.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.3671875,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher than that observed in cells grown in the same conditions at 28 degrees C.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.69921875,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.98828125,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.98828125,
            "text": "CO2/bicarbonate at",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.52734375,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at 37 degrees C is five",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.52734375,
            "text": "CO2/bicarbonate at 37 degrees C is five",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 8.25,
            "text": "/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.5703125,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 8.234375,
            "text": "/bicarbonate",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5710a592cf1c32585100002a_10": [
        {
            "start_logit": 8.3359375,
            "end_logit": 8.25,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 0.336669921875
        },
        {
            "start_logit": 8.3359375,
            "end_logit": 8.25,
            "text": "CO2/bicarbonate",
            "probability": 0.336669921875
        },
        {
            "start_logit": 8.3359375,
            "end_logit": 8.234375,
            "text": "CO2/bicarbonate",
            "probability": 0.326171875
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -0.072509765625,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2",
            "probability": 8.13603401184082e-05
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -0.072509765625,
            "text": "CO2",
            "probability": 8.13603401184082e-05
        },
        {
            "start_logit": -0.23828125,
            "end_logit": 8.25,
            "text": "bicarbonate",
            "probability": 6.335973739624023e-05
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -0.455322265625,
            "text": "CO2",
            "probability": 5.501508712768555e-05
        },
        {
            "start_logit": -0.491943359375,
            "end_logit": 8.25,
            "text": "bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 4.89354133605957e-05
        },
        {
            "start_logit": -0.491943359375,
            "end_logit": 8.234375,
            "text": "bicarbonate",
            "probability": 4.8220157623291016e-05
        },
        {
            "start_logit": -5.21484375,
            "end_logit": 8.25,
            "text": ". However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.3671875,
            "text": "CO2/bicarbonate levels.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.3671875,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher than that observed in cells grown in the same conditions at 28 degrees C.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.69921875,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.98828125,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.98828125,
            "text": "CO2/bicarbonate at",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.52734375,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at 37 degrees C is five",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.52734375,
            "text": "CO2/bicarbonate at 37 degrees C is five",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 8.25,
            "text": "/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.5703125,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 8.234375,
            "text": "/bicarbonate",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5710a592cf1c32585100002a_11": [
        {
            "start_logit": 8.3359375,
            "end_logit": 8.25,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 0.336669921875
        },
        {
            "start_logit": 8.3359375,
            "end_logit": 8.25,
            "text": "CO2/bicarbonate",
            "probability": 0.336669921875
        },
        {
            "start_logit": 8.3359375,
            "end_logit": 8.234375,
            "text": "CO2/bicarbonate",
            "probability": 0.326171875
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -0.072509765625,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2",
            "probability": 8.13603401184082e-05
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -0.072509765625,
            "text": "CO2",
            "probability": 8.13603401184082e-05
        },
        {
            "start_logit": -0.23828125,
            "end_logit": 8.25,
            "text": "bicarbonate",
            "probability": 6.335973739624023e-05
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -0.455322265625,
            "text": "CO2",
            "probability": 5.501508712768555e-05
        },
        {
            "start_logit": -0.491943359375,
            "end_logit": 8.25,
            "text": "bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 4.89354133605957e-05
        },
        {
            "start_logit": -0.491943359375,
            "end_logit": 8.234375,
            "text": "bicarbonate",
            "probability": 4.8220157623291016e-05
        },
        {
            "start_logit": -5.21484375,
            "end_logit": 8.25,
            "text": ". However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.3671875,
            "text": "CO2/bicarbonate levels.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.3671875,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher than that observed in cells grown in the same conditions at 28 degrees C.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.69921875,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold higher",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.98828125,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -5.98828125,
            "text": "CO2/bicarbonate at",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.52734375,
            "text": "CO2/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate at 37 degrees C is five",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.52734375,
            "text": "CO2/bicarbonate at 37 degrees C is five",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 8.25,
            "text": "/bicarbonate levels. However, the steady-state level of atxA mRNA in cells grown in elevated CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3359375,
            "end_logit": -6.5703125,
            "text": "CO2/bicarbonate at 37 degrees C is five- to sixfold",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 8.234375,
            "text": "/bicarbonate",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5710a592cf1c32585100002a_12": [
        {
            "start_logit": 0.814453125,
            "end_logit": 7.2578125,
            "text": "CO2",
            "probability": 0.9970703125
        },
        {
            "start_logit": -6.76953125,
            "end_logit": 7.2578125,
            "text": ", in response to the same signal, CO2",
            "probability": 0.0005083084106445312
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 7.2578125,
            "text": "which transcription of all three genes is activated in trans by the same regulatory gene, atxA, in response to the same signal, CO2",
            "probability": 0.00048470497131347656
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 7.2578125,
            "text": "the same regulatory gene, atxA, in response to the same signal, CO2",
            "probability": 0.0002903938293457031
        },
        {
            "start_logit": -7.359375,
            "end_logit": 7.2578125,
            "text": "in response to the same signal, CO2",
            "probability": 0.0002818107604980469
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 7.2578125,
            "text": "in which transcription of all three genes is activated in trans by the same regulatory gene, atxA, in response to the same signal, CO2",
            "probability": 0.0002689361572265625
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 7.2578125,
            "text": "response to the same signal, CO2",
            "probability": 0.0002605915069580078
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 7.2578125,
            "text": ", in which transcription of all three genes is activated in trans by the same regulatory gene, atxA, in response to the same signal, CO2",
            "probability": 0.0002505779266357422
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.2578125,
            "text": "the same signal, CO2",
            "probability": 0.0002409219741821289
        },
        {
            "start_logit": -7.640625,
            "end_logit": 7.2578125,
            "text": ", atxA, in response to the same signal, CO2",
            "probability": 0.00021266937255859375
        },
        {
            "start_logit": -6.81640625,
            "end_logit": -6.421875,
            "text": "which transcription of all three genes is activated in trans by the same regulatory gene",
            "probability": 0.0
        },
        {
            "start_logit": -6.81640625,
            "end_logit": -6.46875,
            "text": "which transcription of all three genes",
            "probability": 0.0
        },
        {
            "start_logit": -6.76953125,
            "end_logit": -6.75390625,
            "text": ", in response to the same signal",
            "probability": 0.0
        },
        {
            "start_logit": -6.81640625,
            "end_logit": -6.75390625,
            "text": "which transcription of all three genes is activated in trans by the same regulatory gene, atxA, in response to the same signal",
            "probability": 0.0
        },
        {
            "start_logit": -7.1796875,
            "end_logit": -6.421875,
            "text": ", can be viewed as a regulon, in which transcription of all three genes is activated in trans by the same regulatory gene",
            "probability": 0.0
        },
        {
            "start_logit": -7.1796875,
            "end_logit": -6.46875,
            "text": ", can be viewed as a regulon, in which transcription of all three genes",
            "probability": 0.0
        },
        {
            "start_logit": -6.81640625,
            "end_logit": -6.88671875,
            "text": "which transcription of all three",
            "probability": 0.0
        },
        {
            "start_logit": -7.32421875,
            "end_logit": -6.421875,
            "text": "the same regulatory gene",
            "probability": 0.0
        },
        {
            "start_logit": -6.81640625,
            "end_logit": -6.98828125,
            "text": "which transcription of all three genes is activated in trans by the same regulatory",
            "probability": 0.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": -6.421875,
            "text": "in which transcription of all three genes is activated in trans by the same regulatory gene",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_13": [
        {
            "start_logit": 6.203125,
            "end_logit": 6.8203125,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": -4.36328125,
            "end_logit": 6.8203125,
            "text": "elevated CO2",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": 6.203125,
            "end_logit": -4.41796875,
            "text": "CO2 and the toxin gene regulator, atxA.",
            "probability": 1.3232231140136719e-05
        },
        {
            "start_logit": 6.203125,
            "end_logit": -5.703125,
            "text": "CO2 and the toxin",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -6.45703125,
            "end_logit": 6.8203125,
            "text": "Comparison of the resulting protein patterns indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 6.8203125,
            "text": "indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 6.203125,
            "end_logit": -6.54296875,
            "text": "CO2 and the toxin gene regulator,",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 6.8203125,
            "text": "in elevated CO2",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 6.8203125,
            "text": "toxin proteins is influenced by growth in elevated CO2",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.5,
            "end_logit": 6.8203125,
            "text": "the resulting protein patterns indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 6.8203125,
            "text": "resulting protein patterns indicated that synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.546875,
            "end_logit": 6.8203125,
            "text": "synthesis of non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 6.8203125,
            "text": "non-toxin proteins is influenced by growth in elevated CO2",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.203125,
            "end_logit": -6.9765625,
            "text": "CO2 and the toxin gene",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.8203125,
            "text": "growth in elevated CO2",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.203125,
            "end_logit": -7.20703125,
            "text": "CO2 and the toxin gene regulator",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.203125,
            "end_logit": -7.625,
            "text": "CO2 and the",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.203125,
            "end_logit": -7.734375,
            "text": "CO2 and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -4.36328125,
            "end_logit": -4.41796875,
            "text": "elevated CO2 and the toxin gene regulator, atxA.",
            "probability": 0.0
        },
        {
            "start_logit": -5.5859375,
            "end_logit": -4.41796875,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_14": [
        {
            "start_logit": 6.4375,
            "end_logit": 6.578125,
            "text": "bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": 6.4375,
            "end_logit": -4.40234375,
            "text": "bicarbonate.",
            "probability": 1.6987323760986328e-05
        },
        {
            "start_logit": -5.29296875,
            "end_logit": 6.578125,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": -6.859375,
            "end_logit": 6.578125,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 6.578125,
            "text": "by bicarbonate",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.359375,
            "end_logit": 6.578125,
            "text": "A, and activation appeared to be stimulated by bicarbonate",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 6.578125,
            "text": "appeared to be stimulated by bicarbonate",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 6.578125,
            "text": "xA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 6.578125,
            "text": "atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 6.578125,
            "text": "P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.578125,
            "text": ", and activation appeared to be stimulated by bicarbonate",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.578125,
            "text": "activation appeared to be stimulated by bicarbonate",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 6.578125,
            "text": "by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.578125,
            "text": "both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 6.578125,
            "text": "stimulated by bicarbonate",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.04296875,
            "end_logit": -4.40234375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.29296875,
            "end_logit": -4.40234375,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -5.29296875,
            "end_logit": -5.82421875,
            "text": "acpA",
            "probability": 0.0
        },
        {
            "start_logit": -6.859375,
            "end_logit": -4.40234375,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -4.40234375,
            "text": "by bicarbonate.",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_15": [
        {
            "start_logit": 6.30859375,
            "end_logit": 6.7734375,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 6.7734375,
            "text": "to CO2",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.32421875,
            "text": "CO2 through an AtxA",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 6.7734375,
            "text": "respond to CO2",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.34765625,
            "text": "CO2 through an AtxA-dependent",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 6.7734375,
            "text": "anthracis genes that respond to CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 6.7734375,
            "text": "Transcriptome analysis identifies Bacillus anthracis genes that respond to CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 6.7734375,
            "text": "analysis identifies Bacillus anthracis genes that respond to CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 6.7734375,
            "text": "Bacillus anthracis genes that respond to CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 6.7734375,
            "text": "identifies Bacillus anthracis genes that respond to CO2",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.453125,
            "text": "CO2 through an AtxA-dependent mechanism",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.546875,
            "text": "CO2 through an AtxA-",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.7109375,
            "text": "CO2 through an",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.75390625,
            "text": "CO2 through",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -7.32421875,
            "text": "to CO2 through an AtxA",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -7.34765625,
            "text": "to CO2 through an AtxA-dependent",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -7.453125,
            "text": "to CO2 through an AtxA-dependent mechanism",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -7.546875,
            "text": "to CO2 through an AtxA-",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -7.7109375,
            "text": "to CO2 through an",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -7.75390625,
            "text": "to CO2 through",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_16": [
        {
            "start_logit": 6.4375,
            "end_logit": 6.578125,
            "text": "bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": 6.4375,
            "end_logit": -4.40234375,
            "text": "bicarbonate.",
            "probability": 1.6987323760986328e-05
        },
        {
            "start_logit": -5.29296875,
            "end_logit": 6.578125,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": -6.859375,
            "end_logit": 6.578125,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 6.578125,
            "text": "by bicarbonate",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.359375,
            "end_logit": 6.578125,
            "text": "A, and activation appeared to be stimulated by bicarbonate",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 6.578125,
            "text": "appeared to be stimulated by bicarbonate",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 6.578125,
            "text": "xA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 6.578125,
            "text": "atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 6.578125,
            "text": "P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.578125,
            "text": ", and activation appeared to be stimulated by bicarbonate",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.578125,
            "text": "activation appeared to be stimulated by bicarbonate",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 6.578125,
            "text": "by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.578125,
            "text": "both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 6.578125,
            "text": "stimulated by bicarbonate",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.04296875,
            "end_logit": -4.40234375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.29296875,
            "end_logit": -4.40234375,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -5.29296875,
            "end_logit": -5.82421875,
            "text": "acpA",
            "probability": 0.0
        },
        {
            "start_logit": -6.859375,
            "end_logit": -4.40234375,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -4.40234375,
            "text": "by bicarbonate.",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_17": [
        {
            "start_logit": 6.34765625,
            "end_logit": 6.71484375,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -6.578125,
            "text": "CO2 through an AtxA-dependent mechanism.",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -7.296875,
            "end_logit": 6.71484375,
            "text": "to CO2",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.24609375,
            "text": "CO2 through an AtxA",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 6.71484375,
            "text": "respond to CO2",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.28125,
            "text": "CO2 through an AtxA-dependent",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 6.71484375,
            "text": "anthracis genes that respond to CO2",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 6.71484375,
            "text": "analysis identifies Bacillus anthracis genes that respond to CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 6.71484375,
            "text": "Transcriptome analysis identifies Bacillus anthracis genes that respond to CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 6.71484375,
            "text": "genes that respond to CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.45703125,
            "text": "CO2 through an AtxA-",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 6.71484375,
            "text": "Bacillus anthracis genes that respond to CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 6.71484375,
            "text": "identifies Bacillus anthracis genes that respond to CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.6015625,
            "text": "CO2 through an",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.71875,
            "text": "CO2 through",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.7578125,
            "text": "CO2 through an AtxA-dependent mechanism",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -6.578125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.296875,
            "end_logit": -6.578125,
            "text": "to CO2 through an AtxA-dependent mechanism.",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": -6.578125,
            "text": "respond to CO2 through an AtxA-dependent mechanism.",
            "probability": 0.0
        },
        {
            "start_logit": -7.73828125,
            "end_logit": -6.578125,
            "text": "AtxA-dependent mechanism.",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_18": [
        {
            "start_logit": 6.3828125,
            "end_logit": 6.63671875,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": 6.3828125,
            "end_logit": -5.94140625,
            "text": "CO2.",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 6.63671875,
            "text": "toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 6.63671875,
            "text": "Expression of the toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 6.63671875,
            "text": "anthracis is enhanced during growth under elevated levels of CO2",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 6.63671875,
            "text": "of CO2",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.9453125,
            "end_logit": -5.94140625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.2109375,
            "end_logit": -5.94140625,
            "text": "toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2.",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -5.94140625,
            "text": "Expression of the toxin genes by B. anthracis is enhanced during growth under elevated levels of CO2.",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -5.94140625,
            "text": "anthracis is enhanced during growth under elevated levels of CO2.",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -5.94140625,
            "text": "of CO2.",
            "probability": 0.0
        },
        {
            "start_logit": -7.2109375,
            "end_logit": -6.42578125,
            "text": "toxin genes by",
            "probability": 0.0
        },
        {
            "start_logit": -7.2109375,
            "end_logit": -6.625,
            "text": "toxin genes by B. anthracis",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -6.42578125,
            "text": "Expression of the toxin genes by",
            "probability": 0.0
        },
        {
            "start_logit": -7.2109375,
            "end_logit": -6.703125,
            "text": "toxin genes by B. anthracis is",
            "probability": 0.0
        },
        {
            "start_logit": -7.2109375,
            "end_logit": -6.765625,
            "text": "toxin",
            "probability": 0.0
        },
        {
            "start_logit": -7.2109375,
            "end_logit": -6.81640625,
            "text": "toxin genes by B. anthrac",
            "probability": 0.0
        },
        {
            "start_logit": -7.2109375,
            "end_logit": -6.82421875,
            "text": "toxin genes by B",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -6.625,
            "text": "Expression of the toxin genes by B. anthracis",
            "probability": 0.0
        },
        {
            "start_logit": -7.4921875,
            "end_logit": -6.625,
            "text": "anthracis",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_19": [
        {
            "start_logit": 6.52734375,
            "end_logit": 6.37109375,
            "text": "CO2",
            "probability": 1.0
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -3.775390625,
            "text": "CO2 effect is observed only in the presence of another pXO1",
            "probability": 3.916025161743164e-05
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -4.9453125,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator of anthrax toxin synthesis.",
            "probability": 1.2218952178955078e-05
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -5.11328125,
            "text": "CO2 effect is observed only in the presence of another pX",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -6.83203125,
            "text": "CO2 effect",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -6.859375,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator of anthrax toxin",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.015625,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene,",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.1796875,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator of anthrax",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.1953125,
            "text": "CO2 effect is",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.19921875,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.234375,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator of anthr",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.25390625,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA,",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.3359375,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.37890625,
            "text": "CO2 effect is observed only",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.41015625,
            "text": "CO2 effect is observed only in the presence of",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.42578125,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a transactivator of",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.44140625,
            "text": "CO2 effect is observed only in the presence of another pXO1 gene, atxA, which encodes a trans",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.49609375,
            "text": "CO2 effect is observed only in the",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": 6.37109375,
            "text": "This CO2",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -3.279296875,
            "end_logit": -3.775390625,
            "text": "pXO1",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_20": [
        {
            "start_logit": 6.32421875,
            "end_logit": 6.73828125,
            "text": "CO2",
            "probability": 0.9990234375
        },
        {
            "start_logit": -1.224609375,
            "end_logit": 6.73828125,
            "text": "5% CO2",
            "probability": 0.0005273818969726562
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -5.6640625,
            "text": "CO2 compared with cells grown in air.",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -6.2265625,
            "text": "CO2 compared with cells grown in air",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 6.73828125,
            "text": "Here we show that transcription of atxA does not appear to differ in cells grown in 5% CO2",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -6.94921875,
            "text": "CO2 compared",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.484375,
            "end_logit": 6.73828125,
            "text": "show that transcription of atxA does not appear to differ in cells grown in 5% CO2",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.09765625,
            "text": "CO2 compared with cells",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.32421875,
            "end_logit": -7.11328125,
            "text": "CO2 compared with",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 6.73828125,
            "text": "we show that transcription of atxA does not appear to differ in cells grown in 5% CO2",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -1.224609375,
            "end_logit": -5.6640625,
            "text": "5% CO2 compared with cells grown in air.",
            "probability": 0.0
        },
        {
            "start_logit": -1.224609375,
            "end_logit": -6.1953125,
            "text": "5",
            "probability": 0.0
        },
        {
            "start_logit": -1.224609375,
            "end_logit": -6.2265625,
            "text": "5% CO2 compared with cells grown in air",
            "probability": 0.0
        },
        {
            "start_logit": -1.224609375,
            "end_logit": -6.76953125,
            "text": "5%",
            "probability": 0.0
        },
        {
            "start_logit": -1.224609375,
            "end_logit": -6.94921875,
            "text": "5% CO2 compared",
            "probability": 0.0
        },
        {
            "start_logit": -1.224609375,
            "end_logit": -7.09765625,
            "text": "5% CO2 compared with cells",
            "probability": 0.0
        },
        {
            "start_logit": -1.224609375,
            "end_logit": -7.11328125,
            "text": "5% CO2 compared with",
            "probability": 0.0
        },
        {
            "start_logit": -6.69140625,
            "end_logit": -5.6640625,
            "text": "Here we show that transcription of atxA does not appear to differ in cells grown in 5% CO2 compared with cells grown in air.",
            "probability": 0.0
        },
        {
            "start_logit": -7.14453125,
            "end_logit": -5.6640625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -6.69140625,
            "end_logit": -6.1953125,
            "text": "Here we show that transcription of atxA does not appear to differ in cells grown in 5",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_21": [
        {
            "start_logit": 6.84765625,
            "end_logit": 6.94921875,
            "text": "acpA",
            "probability": 0.56982421875
        },
        {
            "start_logit": 6.38671875,
            "end_logit": 5.96484375,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA and acpA",
            "probability": 0.13427734375
        },
        {
            "start_logit": 6.84765625,
            "end_logit": 5.44140625,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 0.126220703125
        },
        {
            "start_logit": 5.9765625,
            "end_logit": 5.96484375,
            "text": "acpA",
            "probability": 0.0887451171875
        },
        {
            "start_logit": 6.38671875,
            "end_logit": 5.44140625,
            "text": "bicarbonate",
            "probability": 0.07958984375
        },
        {
            "start_logit": 6.84765625,
            "end_logit": -0.4619140625,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0003447532653808594
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -0.4619140625,
            "text": "bicarbonate.",
            "probability": 0.00021755695343017578
        },
        {
            "start_logit": -0.235595703125,
            "end_logit": 5.96484375,
            "text": ". Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA and acpA",
            "probability": 0.00017964839935302734
        },
        {
            "start_logit": 5.9765625,
            "end_logit": -0.462646484375,
            "text": "acpA required a DNA segment of 70 bp extending upstream of the P1 site.",
            "probability": 0.0001442432403564453
        },
        {
            "start_logit": -0.94384765625,
            "end_logit": 5.96484375,
            "text": "revealed that activation by both atxA and acpA",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": -1.58984375,
            "end_logit": 5.96484375,
            "text": "and acpA",
            "probability": 4.6133995056152344e-05
        },
        {
            "start_logit": 6.84765625,
            "end_logit": -2.765625,
            "text": "acp",
            "probability": 3.427267074584961e-05
        },
        {
            "start_logit": 5.9765625,
            "end_logit": -2.248046875,
            "text": "acpA required a DNA segment of 70 bp extending upstream of the P1",
            "probability": 2.4139881134033203e-05
        },
        {
            "start_logit": -3.2421875,
            "end_logit": 6.94921875,
            "text": "A",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": 6.84765625,
            "end_logit": -3.7890625,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -3.33984375,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed that activation by both atxA and acp",
            "probability": 1.2218952178955078e-05
        },
        {
            "start_logit": -2.970703125,
            "end_logit": 5.96484375,
            "text": "both atxA and acpA",
            "probability": 1.1563301086425781e-05
        },
        {
            "start_logit": 5.9765625,
            "end_logit": -3.33984375,
            "text": "acp",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -3.7890625,
            "text": "bicarbonate. Deletion analysis of the upstream region of the cap promoter revealed",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": -3.2421875,
            "end_logit": 5.44140625,
            "text": "A, and activation appeared to be stimulated by bicarbonate",
            "probability": 5.245208740234375e-06
        }
    ],
    "5710a592cf1c32585100002a_22": [
        {
            "start_logit": 6.14453125,
            "end_logit": 6.02734375,
            "text": "bicarbonate",
            "probability": 0.9931640625
        },
        {
            "start_logit": 1.109375,
            "end_logit": 6.02734375,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 0.006458282470703125
        },
        {
            "start_logit": -2.4765625,
            "end_logit": 6.02734375,
            "text": ". Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 0.00017833709716796875
        },
        {
            "start_logit": 6.14453125,
            "end_logit": -3.498046875,
            "text": "bicarbonate.",
            "probability": 7.265806198120117e-05
        },
        {
            "start_logit": -4.59765625,
            "end_logit": 6.02734375,
            "text": "both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 2.1517276763916016e-05
        },
        {
            "start_logit": 1.109375,
            "end_logit": -0.91796875,
            "text": "acpA",
            "probability": 6.198883056640625e-06
        },
        {
            "start_logit": -6.01953125,
            "end_logit": 6.02734375,
            "text": "atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": -6.07421875,
            "end_logit": 6.02734375,
            "text": "appeared to be stimulated by bicarbonate",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -6.421875,
            "end_logit": 6.02734375,
            "text": ", and activation appeared to be stimulated by bicarbonate",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -6.6953125,
            "end_logit": 6.02734375,
            "text": "xA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 6.02734375,
            "text": "by bicarbonate",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 6.02734375,
            "text": "capB. Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -6.8828125,
            "end_logit": 6.02734375,
            "text": "and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 6.02734375,
            "text": "and activation appeared to be stimulated by bicarbonate",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 1.109375,
            "end_logit": -3.498046875,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -2.4765625,
            "end_logit": -0.91796875,
            "text": ". Transcription initiated from P1 and P2 was activated by both atxA and acpA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 1.109375,
            "end_logit": -5.8515625,
            "text": "acp",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.59765625,
            "end_logit": -0.91796875,
            "text": "both atxA and acpA",
            "probability": 0.0
        },
        {
            "start_logit": 1.109375,
            "end_logit": -6.73046875,
            "text": "acpA, and activation appeared to",
            "probability": 0.0
        },
        {
            "start_logit": 1.109375,
            "end_logit": -6.76171875,
            "text": "acpA, and activation appeared",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_23": [
        {
            "start_logit": 6.4375,
            "end_logit": 6.578125,
            "text": "bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": 6.4375,
            "end_logit": -4.40234375,
            "text": "bicarbonate.",
            "probability": 1.6987323760986328e-05
        },
        {
            "start_logit": -5.29296875,
            "end_logit": 6.578125,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": -6.859375,
            "end_logit": 6.578125,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 6.578125,
            "text": "by bicarbonate",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.359375,
            "end_logit": 6.578125,
            "text": "A, and activation appeared to be stimulated by bicarbonate",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 6.578125,
            "text": "appeared to be stimulated by bicarbonate",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 6.578125,
            "text": "xA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 6.578125,
            "text": "atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 6.578125,
            "text": "P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.578125,
            "text": ", and activation appeared to be stimulated by bicarbonate",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.578125,
            "text": "activation appeared to be stimulated by bicarbonate",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 6.578125,
            "text": "by both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.578125,
            "text": "both atxA and acpA, and activation appeared to be stimulated by bicarbonate",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 6.578125,
            "text": "stimulated by bicarbonate",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.04296875,
            "end_logit": -4.40234375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -5.29296875,
            "end_logit": -4.40234375,
            "text": "acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -5.29296875,
            "end_logit": -5.82421875,
            "text": "acpA",
            "probability": 0.0
        },
        {
            "start_logit": -6.859375,
            "end_logit": -4.40234375,
            "text": "Transcription initiated from P1 and P2 was activated by both atxA and acpA, and activation appeared to be stimulated by bicarbonate.",
            "probability": 0.0
        },
        {
            "start_logit": -6.88671875,
            "end_logit": -4.40234375,
            "text": "by bicarbonate.",
            "probability": 0.0
        }
    ],
    "5710a592cf1c32585100002a_24": [
        {
            "start_logit": 8.1015625,
            "end_logit": 7.55859375,
            "text": "CO2/bicarbonate",
            "probability": 1.0
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -1.263671875,
            "text": "CO2",
            "probability": 0.00014770030975341797
        },
        {
            "start_logit": -2.509765625,
            "end_logit": 7.55859375,
            "text": "bicarbonate",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.01171875,
            "text": "CO2/bicarbonate, affects AtxA synthesis.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.33203125,
            "text": "CO2/bicarbonate, affects AtxA synthesis",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.359375,
            "text": "CO2/bicarbonate,",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.421875,
            "text": "CO2/bicarbonate, affects AtxA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.6640625,
            "text": "CO2/bicarbonate, affects",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 7.55859375,
            "text": "temperature, not CO2/bicarbonate",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 7.55859375,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 7.55859375,
            "text": "/bicarbonate",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.55859375,
            "text": "not CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 7.55859375,
            "text": "Regulation of anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 7.55859375,
            "text": "xA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -1.263671875,
            "text": "temperature, not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -7.2578125,
            "end_logit": -1.263671875,
            "text": "anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -1.263671875,
            "text": "not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -1.263671875,
            "text": "Regulation of anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -1.263671875,
            "text": "xA) expression in Bacillus anthracis: temperature, not CO2",
            "probability": 0.0
        },
        {
            "start_logit": -2.509765625,
            "end_logit": -7.01171875,
            "text": "bicarbonate, affects AtxA synthesis.",
            "probability": 0.0
        }
    ],
    "5a87ea1861bb38fb2400000d_1": [
        {
            "start_logit": 8.125,
            "end_logit": 7.65625,
            "text": "circularized oligodeoxynucleotides",
            "probability": 0.9990234375
        },
        {
            "start_logit": 8.125,
            "end_logit": 0.1651611328125,
            "text": "circularized oligodeoxynucleotides (",
            "probability": 0.00055694580078125
        },
        {
            "start_logit": 8.125,
            "end_logit": -1.52734375,
            "text": "circular",
            "probability": 0.00010216236114501953
        },
        {
            "start_logit": -2.53125,
            "end_logit": 7.65625,
            "text": "otides",
            "probability": 2.3543834686279297e-05
        },
        {
            "start_logit": 8.125,
            "end_logit": -6.453125,
            "text": "circularized oligodeoxynucleotides (coligos)",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -6.90234375,
            "text": "circularized oligodeoxynucle",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.46875,
            "end_logit": 7.65625,
            "text": "oligodeoxynucleotides",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.640625,
            "end_logit": 7.65625,
            "text": "ized oligodeoxynucleotides",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.0,
            "end_logit": 7.65625,
            "text": "ynucleotides",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.484375,
            "text": "circularized oligodeox",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.53125,
            "end_logit": 0.1651611328125,
            "text": "otides (",
            "probability": 0.0
        },
        {
            "start_logit": -6.46875,
            "end_logit": 0.1651611328125,
            "text": "oligodeoxynucleotides (",
            "probability": 0.0
        },
        {
            "start_logit": -6.640625,
            "end_logit": 0.1651611328125,
            "text": "ized oligodeoxynucleotides (",
            "probability": 0.0
        },
        {
            "start_logit": -7.0,
            "end_logit": 0.1651611328125,
            "text": "ynucleotides (",
            "probability": 0.0
        },
        {
            "start_logit": -2.53125,
            "end_logit": -6.453125,
            "text": "otides (coligos)",
            "probability": 0.0
        },
        {
            "start_logit": -6.46875,
            "end_logit": -6.453125,
            "text": "oligodeoxynucleotides (coligos)",
            "probability": 0.0
        },
        {
            "start_logit": -6.640625,
            "end_logit": -6.453125,
            "text": "ized oligodeoxynucleotides (coligos)",
            "probability": 0.0
        },
        {
            "start_logit": -6.46875,
            "end_logit": -6.90234375,
            "text": "oligodeoxynucle",
            "probability": 0.0
        },
        {
            "start_logit": -7.0,
            "end_logit": -6.453125,
            "text": "ynucleotides (coligos)",
            "probability": 0.0
        },
        {
            "start_logit": -6.640625,
            "end_logit": -6.90234375,
            "text": "ized oligodeoxynucle",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_1": [
        {
            "start_logit": 8.1484375,
            "end_logit": 8.1171875,
            "text": "hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": -1.36328125,
            "end_logit": 8.1171875,
            "text": "cardiomyopathy",
            "probability": 7.367134094238281e-05
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -1.5078125,
            "text": "hypertrophic",
            "probability": 6.604194641113281e-05
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.22265625,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9 %",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.359375,
            "text": "hypertrophic cardiomyopathy (30 %",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.37109375,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.375,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9 %)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.42578125,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.4296875,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.44921875,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9 %).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.4765625,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.5234375,
            "text": "hypertrophic cardiomyopathy (30",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 8.1171875,
            "text": "The most common cause of death was hypertrophic cardiomyopathy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.609375,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.6171875,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.6328125,
            "text": "hypertrophic cardiomyopathy (30 %), followed by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.63671875,
            "text": "hypertrophic cardiomyopathy (30 %), followed by coronary artery anomalies",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1484375,
            "end_logit": -7.66796875,
            "text": "hypertrophic cardiomyopathy (30 %)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 8.1171875,
            "text": "most common cause of death was hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.36328125,
            "end_logit": -7.22265625,
            "text": "cardiomyopathy (30 %), followed by coronary artery anomalies (9 %), and myocarditis (9 %",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_2": [
        {
            "start_logit": 8.1796875,
            "end_logit": 8.1015625,
            "text": "hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -1.4033203125,
            "text": "hypertrophic",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": -1.451171875,
            "end_logit": 8.1015625,
            "text": "cardiomyopathy",
            "probability": 6.556510925292969e-05
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -6.7421875,
            "text": "hypertrophic cardiomyopathy (HCM",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.30859375,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.3359375,
            "text": "hypertrophic cardiomyopathy (HCM)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.37109375,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a third",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.4140625,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.46875,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.47265625,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a third of cases and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.48046875,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a third of cases and is manageable.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.5,
            "text": "hypertrophic cardiomyopathy (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.53125,
            "text": "hypertrophic cardiomyopathy (HCM),",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.53125,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.53125,
            "text": "hypertrophic cardiomyopathy (HCM), is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.59765625,
            "text": "hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a third of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.6484375,
            "text": "hypertrophic cardiomyopathy (HCM), is a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 8.1015625,
            "text": "The most common cause of this, hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 8.1015625,
            "text": "most common cause of this, hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 8.1015625,
            "text": ", hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        }
    ],
    "530cf4e0c8a0b4a00c000006_3": [
        {
            "start_logit": 8.09375,
            "end_logit": 8.109375,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": -1.515625,
            "end_logit": 8.109375,
            "text": "cardiomyopathy",
            "probability": 6.711483001708984e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -1.75,
            "text": "Hypertrophic",
            "probability": 5.227327346801758e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -6.6640625,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -6.86328125,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.3046875,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.42578125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.45703125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.46875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in young people",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.46875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.515625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.55859375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.56640625,
            "text": "Hypertrophic cardiomyopathy (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.58984375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in young",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.6015625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.62890625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in young people,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.640625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.64453125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death (SCD) in young people, including trained athletes.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.6484375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.515625,
            "end_logit": -6.6640625,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_4": [
        {
            "start_logit": 8.109375,
            "end_logit": 8.109375,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": -1.51171875,
            "end_logit": 8.109375,
            "text": "cardiomyopathy",
            "probability": 6.604194641113281e-05
        },
        {
            "start_logit": 8.109375,
            "end_logit": -1.7080078125,
            "text": "Hypertrophic",
            "probability": 5.4776668548583984e-05
        },
        {
            "start_logit": 8.109375,
            "end_logit": -6.5703125,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -6.8125,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.1328125,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.3125,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young people",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.3125,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.34375,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young people (including trained athletes)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.38671875,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.39453125,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young people (including trained athletes).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.42578125,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.453125,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.4609375,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young people (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.51171875,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.51953125,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.52734375,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death in young",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.55859375,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac death",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.5703125,
            "text": "Hypertrophic cardiomyopathy (HCM) is regarded as the most common cause of sudden cardiac",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.51171875,
            "end_logit": -6.5703125,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_5": [
        {
            "start_logit": 8.1171875,
            "end_logit": 8.109375,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": -1.5234375,
            "end_logit": 8.109375,
            "text": "cardiomyopathy",
            "probability": 6.556510925292969e-05
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -1.6826171875,
            "text": "Hypertrophic",
            "probability": 5.650520324707031e-05
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.46875,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -6.86328125,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.2890625,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.35546875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young people",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.3984375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.4375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.51171875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.5625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.5625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young people, including trained athletes.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.57421875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.58984375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young people,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.58984375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.58984375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young people, including trained athletes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.59375,
            "text": "Hypertrophic cardiomyopathy (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.62109375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -7.6328125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of sudden cardiac death in young people, including",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.5234375,
            "end_logit": -6.46875,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_6": [
        {
            "start_logit": 8.1640625,
            "end_logit": 8.1171875,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": -1.392578125,
            "end_logit": 8.1171875,
            "text": "cardiomyopathy",
            "probability": 7.086992263793945e-05
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -1.4453125,
            "text": "Hypertrophic",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.3125,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people (including trained athletes)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.39453125,
            "text": "Hypertrophic cardiomyopathy is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.43359375,
            "text": "Hypertrophic cardiomyopathy is regarded as",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.44140625,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.4453125,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.453125,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.53125,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.54296875,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.55859375,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.56640625,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people (including trained athletes).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.578125,
            "text": "Hypertrophic cardiomyopathy is regarded as the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.59765625,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.6015625,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people (including trained athletes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.6171875,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.640625,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.6640625,
            "text": "Hypertrophic cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people (including",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.392578125,
            "end_logit": -7.3125,
            "text": "cardiomyopathy is regarded as the most common cause of sudden cardiac death in young people (including trained athletes)",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_7": [
        {
            "start_logit": 8.1796875,
            "end_logit": 8.078125,
            "text": "hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -1.365234375,
            "text": "hypertrophic",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": -1.537109375,
            "end_logit": 8.078125,
            "text": "cardiomyopathy",
            "probability": 6.0617923736572266e-05
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.078125,
            "text": "The most common cause of sudden cardiac death in athletes is hypertrophic cardiomyopathy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 8.078125,
            "text": "most common cause of sudden cardiac death in athletes is hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -1.365234375,
            "text": "The most common cause of sudden cardiac death in athletes is hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -1.365234375,
            "text": "most common cause of sudden cardiac death in athletes is hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -7.40625,
            "text": "The most common cause of sudden cardiac death in athletes is",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -7.55078125,
            "text": "The most common cause of",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -7.6484375,
            "text": "The most common cause of sudden cardiac death in",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -7.6484375,
            "text": "The most common cause",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -7.65234375,
            "text": "The most common",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.40625,
            "text": "most common cause of sudden cardiac death in athletes is",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -7.71484375,
            "text": "The most common cause of sudden cardiac",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -7.7421875,
            "text": "The most common cause of sudden cardiac death",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -7.7421875,
            "text": "The most common cause of sudden cardiac death in athletes",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -7.76953125,
            "text": "The most common cause of sudden",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.55078125,
            "text": "most common cause of",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.6484375,
            "text": "most common cause of sudden cardiac death in",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.6484375,
            "text": "most common cause",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_8": [
        {
            "start_logit": 8.0859375,
            "end_logit": 8.0546875,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": -1.703125,
            "end_logit": 8.0546875,
            "text": "cardiomyopathy",
            "probability": 5.608797073364258e-05
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -1.787109375,
            "text": "Hypertrophic",
            "probability": 5.3048133850097656e-05
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -5.7734375,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.80078125,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.10546875,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.37109375,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.421875,
            "text": "Hypertrophic cardiomyopathy (HCM) is one",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.51953125,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.53515625,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the most common cause of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.56640625,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.56640625,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the most common cause of sudden cardiac death in young athletes.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.5859375,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the most common cause of sudden cardiac death in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.58984375,
            "text": "Hypertrophic cardiomyopathy (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.59765625,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.59765625,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.6328125,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the most common cause",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.6328125,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders and the most common",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.6328125,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common inherited primary cardiac disorders",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.63671875,
            "text": "Hypertrophic cardiomyopathy (HCM) is one of the most common",
            "probability": 1.7881393432617188e-07
        }
    ],
    "530cf4e0c8a0b4a00c000006_9": [
        {
            "start_logit": 8.125,
            "end_logit": 8.1015625,
            "text": "hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": -1.48046875,
            "end_logit": 8.1015625,
            "text": "cardiomyopathy",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": 8.125,
            "end_logit": -1.625,
            "text": "hypertrophic",
            "probability": 6.014108657836914e-05
        },
        {
            "start_logit": 8.125,
            "end_logit": -6.31640625,
            "text": "hypertrophic cardiomyopathy (HCM",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -6.45703125,
            "text": "hypertrophic cardiomyopathy (HCM)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.125,
            "end_logit": -7.359375,
            "text": "hypertrophic cardiomyopathy (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 8.1015625,
            "text": "The most common cause of sudden cardiac death in individuals aged less than 35 years, including competitive athletes, is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 8.1015625,
            "text": ", is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 8.1015625,
            "text": "inherited disorder hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 8.1015625,
            "text": "most common cause of sudden cardiac death in individuals aged less than 35 years, including competitive athletes, is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 8.1015625,
            "text": "competitive athletes, is the inherited disorder hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 8.1015625,
            "text": "the inherited disorder hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 8.1015625,
            "text": "disorder hypertrophic cardiomyopathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.48046875,
            "end_logit": -6.31640625,
            "text": "cardiomyopathy (HCM",
            "probability": 0.0
        },
        {
            "start_logit": -1.48046875,
            "end_logit": -6.45703125,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        },
        {
            "start_logit": -1.48046875,
            "end_logit": -7.359375,
            "text": "cardiomyopathy (",
            "probability": 0.0
        },
        {
            "start_logit": -7.6953125,
            "end_logit": -1.625,
            "text": "The most common cause of sudden cardiac death in individuals aged less than 35 years, including competitive athletes, is the inherited disorder hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -7.72265625,
            "end_logit": -1.625,
            "text": ", is the inherited disorder hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -7.8359375,
            "end_logit": -1.625,
            "text": "inherited disorder hypertrophic",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -1.625,
            "text": "most common cause of sudden cardiac death in individuals aged less than 35 years, including competitive athletes, is the inherited disorder hypertrophic",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_10": [
        {
            "start_logit": 8.140625,
            "end_logit": 8.1171875,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": -1.466796875,
            "end_logit": 8.1171875,
            "text": "cardiomyopathy",
            "probability": 6.765127182006836e-05
        },
        {
            "start_logit": 8.140625,
            "end_logit": -1.5869140625,
            "text": "Hypertrophic",
            "probability": 6.157159805297852e-05
        },
        {
            "start_logit": 8.140625,
            "end_logit": -6.6796875,
            "text": "Hypertrophic cardiomyopathy (HCM)",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -6.91015625,
            "text": "Hypertrophic cardiomyopathy (HCM",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.32421875,
            "text": "Hypertrophic cardiomyopathy (HCM) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.5,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.5078125,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.54296875,
            "text": "Hypertrophic cardiomyopathy (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.5546875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.60546875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.609375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.62109375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the young, particularly in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the young",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.65234375,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the young,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.671875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the young, particularly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.671875,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the young, particularly in young competitive athletes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.69140625,
            "text": "Hypertrophic cardiomyopathy (HCM) is the most common cause of death in the young, particularly in young competitive athletes.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.466796875,
            "end_logit": -6.6796875,
            "text": "cardiomyopathy (HCM)",
            "probability": 0.0
        }
    ],
    "530cf4e0c8a0b4a00c000006_11": [
        {
            "start_logit": 8.1796875,
            "end_logit": 8.125,
            "text": "Hypertrophic cardiomyopathy",
            "probability": 1.0
        },
        {
            "start_logit": -1.353515625,
            "end_logit": 8.125,
            "text": "cardiomyopathy",
            "probability": 7.200241088867188e-05
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -1.4091796875,
            "text": "Hypertrophic",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.49609375,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.51953125,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.53125,
            "text": "Hypertrophic cardiomyopathy (HC) is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.57421875,
            "text": "Hypertrophic cardiomyopathy (HC)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.58984375,
            "text": "Hypertrophic cardiomyopathy (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.58984375,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.609375,
            "text": "Hypertrophic cardiomyopathy (HC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.62890625,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.66015625,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.6640625,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.66796875,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.67578125,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes, and this diagnosis has represented a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.68359375,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes, and this diagnosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.68359375,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes, and this diagnosis has represented a contraindication to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.68359375,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.6875,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden cardiac death in youthful athletes, and this diagnosis has represented a contraindication to continued participation",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.703125,
            "text": "Hypertrophic cardiomyopathy (HC) is probably the most common cause of sudden",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e4601293f54159529000002_1": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1171875,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.1376953125,
            "text": "multiple",
            "probability": 9.608268737792969e-05
        },
        {
            "start_logit": -1.1640625,
            "end_logit": 8.1171875,
            "text": "sclerosis",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.3984375,
            "text": "multiple sclerosis with a simplified three",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.44140625,
            "text": "multiple sclerosis with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.65234375,
            "text": "multiple sclerosis with a simplified three-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.68359375,
            "text": "multiple sclerosis with a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.71484375,
            "text": "multiple sclerosis with a simplified three-lesion",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.71484375,
            "text": "multiple sclerosis with a simplified three-lesion algorithm.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 8.1171875,
            "text": "Diagnostic performance of central vein sign for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 8.1171875,
            "text": "performance of central vein sign for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 8.1171875,
            "text": "for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 8.1171875,
            "text": "central vein sign for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 8.1171875,
            "text": "vein sign for multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -7.3984375,
            "text": "sclerosis with a simplified three",
            "probability": 0.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -7.44140625,
            "text": "sclerosis with",
            "probability": 0.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -7.65234375,
            "text": "sclerosis with a simplified three-",
            "probability": 0.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -7.68359375,
            "text": "sclerosis with a",
            "probability": 0.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -7.71484375,
            "text": "sclerosis with a simplified three-lesion",
            "probability": 0.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -7.71484375,
            "text": "sclerosis with a simplified three-lesion algorithm.",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_2": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.125,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.2109375,
            "end_logit": 8.125,
            "text": "sclerosis",
            "probability": 8.028745651245117e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.3203125,
            "text": "multiple",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.1875,
            "text": "multiple sclerosis (MS",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.02734375,
            "text": "multiple sclerosis (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.43359375,
            "text": "multiple sclerosis (MS)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 8.125,
            "text": ": Detection of a \"central vein sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 8.125,
            "text": "CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 8.125,
            "text": "Detection of a \"central vein sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.828125,
            "end_logit": 8.125,
            "text": "FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 8.125,
            "text": "for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 8.125,
            "text": "magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 8.125,
            "text": "MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 8.125,
            "text": "central vein sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 8.125,
            "text": "\"central vein sign\" (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 8.125,
            "text": "AIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 8.125,
            "text": "imaging (MRI) is highly specific and sensitive for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.2109375,
            "end_logit": -6.1875,
            "text": "sclerosis (MS",
            "probability": 0.0
        },
        {
            "start_logit": -1.2109375,
            "end_logit": -7.02734375,
            "text": "sclerosis (",
            "probability": 0.0
        },
        {
            "start_logit": -1.2109375,
            "end_logit": -7.43359375,
            "text": "sclerosis (MS)",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_3": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.1015625,
            "text": "Multiple Sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.203125,
            "text": "Multiple",
            "probability": 9.03010368347168e-05
        },
        {
            "start_logit": -1.314453125,
            "end_logit": 8.1015625,
            "text": "Sclerosis",
            "probability": 7.086992263793945e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.3046875,
            "text": "Multiple Sclerosis from central nervous system inflammatory vascul",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.04296875,
            "text": "Multiple Sclerosis from central nervous system inflammatory vasculopathies",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.08984375,
            "text": "Multiple Sclerosis from central nervous system inflammatory",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.140625,
            "text": "Multiple Sclerosis from central nervous system inflammatory vasculopathies.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.26953125,
            "text": "Multiple Sclerosis from central nervous system",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.484375,
            "text": "Multiple Sclerosis from central nervous",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.66015625,
            "text": "Multiple Sclerosis from central",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.68359375,
            "text": "Multiple Sclerosis from",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 8.1015625,
            "text": "Central vein sign differentiates Multiple Sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 8.1015625,
            "text": "differentiates Multiple Sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 8.1015625,
            "text": "vein sign differentiates Multiple Sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 8.1015625,
            "text": "s Multiple Sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.314453125,
            "end_logit": -6.3046875,
            "text": "Sclerosis from central nervous system inflammatory vascul",
            "probability": 0.0
        },
        {
            "start_logit": -1.314453125,
            "end_logit": -7.04296875,
            "text": "Sclerosis from central nervous system inflammatory vasculopathies",
            "probability": 0.0
        },
        {
            "start_logit": -1.314453125,
            "end_logit": -7.08984375,
            "text": "Sclerosis from central nervous system inflammatory",
            "probability": 0.0
        },
        {
            "start_logit": -1.314453125,
            "end_logit": -7.140625,
            "text": "Sclerosis from central nervous system inflammatory vasculopathies.",
            "probability": 0.0
        },
        {
            "start_logit": -1.314453125,
            "end_logit": -7.26953125,
            "text": "Sclerosis from central nervous system",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_4": [
        {
            "start_logit": 8.1953125,
            "end_logit": 8.15625,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.09375,
            "end_logit": 8.15625,
            "text": "sclerosis",
            "probability": 9.316205978393555e-05
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -1.39453125,
            "text": "multiple",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -6.44921875,
            "text": "multiple sclerosis (MS) and neuromyelitis optica spectrum disorder",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -6.91015625,
            "text": "multiple sclerosis (MS) and neuromyelitis optic",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -6.91796875,
            "text": "multiple sclerosis (MS) and neuromyelitis optica",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.2890625,
            "text": "multiple sclerosis (MS) and neuromyel",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.37890625,
            "text": "multiple sclerosis (MS) and neuromyelitis optica spectrum",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.39453125,
            "text": "multiple sclerosis (MS) and neuromyelitis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.421875,
            "text": "multiple sclerosis (MS",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.15625,
            "text": ": To assess the value of the central vein sign (CVS) on a clinical 3T scanner to distinguish between multiple sclerosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.48046875,
            "text": "multiple sclerosis (MS) and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.484375,
            "text": "multiple sclerosis (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.5390625,
            "text": "multiple sclerosis (MS) and neurom",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.54296875,
            "text": "multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.15625,
            "text": "To assess the value of the central vein sign (CVS) on a clinical 3T scanner to distinguish between multiple sclerosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 8.15625,
            "text": "central vein sign (CVS) on a clinical 3T scanner to distinguish between multiple sclerosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.5859375,
            "text": "multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.15625,
            "text": "OBJECTIVE: To assess the value of the central vein sign (CVS) on a clinical 3T scanner to distinguish between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 8.15625,
            "text": "between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e4601293f54159529000002_5": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.1015625,
            "text": "Multiple Sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.1982421875,
            "text": "Multiple",
            "probability": 9.03010368347168e-05
        },
        {
            "start_logit": -1.32421875,
            "end_logit": 8.1015625,
            "text": "Sclerosis",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": -7.6875,
            "end_logit": 8.1015625,
            "text": "Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 8.1015625,
            "text": "in Multiple Sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 8.1015625,
            "text": "Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.1015625,
            "text": "Imaging Biomarker in Multiple Sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 8.1015625,
            "text": "Biomarker in Multiple Sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 8.1015625,
            "text": "Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 8.1015625,
            "text": "of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 8.1015625,
            "text": "the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.0,
            "end_logit": 8.1015625,
            "text": "Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6875,
            "end_logit": -1.1982421875,
            "text": "Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -1.1982421875,
            "text": "in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -1.1982421875,
            "text": "Diagnostic Imaging Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.859375,
            "end_logit": -1.1982421875,
            "text": "Imaging Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.890625,
            "end_logit": -1.1982421875,
            "text": "Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.95703125,
            "end_logit": -1.1982421875,
            "text": "Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -1.1982421875,
            "text": "of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.96484375,
            "end_logit": -1.1982421875,
            "text": "the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_6": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1328125,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.2705078125,
            "text": "multiple",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": -1.1796875,
            "end_logit": 8.1328125,
            "text": "sclerosis",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.1640625,
            "text": "multiple sclerosis (MS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.1796875,
            "text": "multiple sclerosis (MS) and not MS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.39453125,
            "text": "multiple sclerosis (MS) and not MS, mainly based on findings from ultrahigh-field magnetic resonance imaging (MRI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.453125,
            "text": "multiple sclerosis (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.51953125,
            "text": "multiple sclerosis (MS) and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.53125,
            "text": "multiple sclerosis (MS) and not MS, mainly based on findings from ultrahigh-field magnetic resonance imaging (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.55078125,
            "text": "multiple sclerosis (MS)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.609375,
            "text": "multiple sclerosis (MS) and not",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.62890625,
            "text": "multiple sclerosis (MS) and not MS, mainly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6328125,
            "text": "multiple sclerosis (MS) and not MS, mainly based on findings from ultrahigh-field magnetic resonance imaging (MRI) studies.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.63671875,
            "text": "multiple sclerosis (MS) and not MS,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.640625,
            "text": "multiple sclerosis (MS) and not MS, mainly based on findings from ultrahigh-field magnetic resonance",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 8.1328125,
            "text": "Importance  The central vein sign has been proposed as a specific imaging biomarker for distinguishing between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 8.1328125,
            "text": "distinguishing between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.828125,
            "end_logit": 8.1328125,
            "text": "proposed as a specific imaging biomarker for distinguishing between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.1328125,
            "text": "imaging biomarker for distinguishing between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 8.1328125,
            "text": "central vein sign has been proposed as a specific imaging biomarker for distinguishing between multiple sclerosis",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e4601293f54159529000002_7": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1171875,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.1396484375,
            "text": "multiple",
            "probability": 9.5367431640625e-05
        },
        {
            "start_logit": -1.228515625,
            "end_logit": 8.1171875,
            "text": "sclerosis",
            "probability": 7.724761962890625e-05
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 8.1171875,
            "text": "PURPOSE  The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 8.1171875,
            "text": "BACKGROUND AND PURPOSE  The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 8.1171875,
            "text": "for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 8.1171875,
            "text": "MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 8.1171875,
            "text": "AND PURPOSE  The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 8.1171875,
            "text": "imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 8.1171875,
            "text": "biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 8.1171875,
            "text": "diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 8.1171875,
            "text": "promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 8.1171875,
            "text": "The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 8.1171875,
            "text": "central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -1.1396484375,
            "text": "PURPOSE  The central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -1.1396484375,
            "text": "BACKGROUND AND PURPOSE  The central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -1.1396484375,
            "text": "for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": -1.1396484375,
            "text": "MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": -1.1396484375,
            "text": "AND PURPOSE  The central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.8515625,
            "end_logit": -1.1396484375,
            "text": "imaging diagnostic biomarker for multiple",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_8": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1171875,
            "text": "multiple sclerosis",
            "probability": 1.0
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.1396484375,
            "text": "multiple",
            "probability": 9.5367431640625e-05
        },
        {
            "start_logit": -1.228515625,
            "end_logit": 8.1171875,
            "text": "sclerosis",
            "probability": 7.724761962890625e-05
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 8.1171875,
            "text": "PURPOSE The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 8.1171875,
            "text": "BACKGROUND AND PURPOSE The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 8.1171875,
            "text": "for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 8.1171875,
            "text": "MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 8.1171875,
            "text": "AND PURPOSE The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 8.1171875,
            "text": "imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 8.1171875,
            "text": "biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 8.1171875,
            "text": "diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 8.1171875,
            "text": "promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 8.1171875,
            "text": "The central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 8.1171875,
            "text": "central vein sign is a promising MR imaging diagnostic biomarker for multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -1.1396484375,
            "text": "PURPOSE The central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -1.1396484375,
            "text": "BACKGROUND AND PURPOSE The central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -1.1396484375,
            "text": "for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": -1.1396484375,
            "text": "MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.83203125,
            "end_logit": -1.1396484375,
            "text": "AND PURPOSE The central vein sign is a promising MR imaging diagnostic biomarker for multiple",
            "probability": 0.0
        },
        {
            "start_logit": -7.8515625,
            "end_logit": -1.1396484375,
            "text": "imaging diagnostic biomarker for multiple",
            "probability": 0.0
        }
    ],
    "5e4601293f54159529000002_9": [
        {
            "start_logit": 8.2578125,
            "end_logit": 8.140625,
            "text": "Multiple Sclerosis",
            "probability": 0.5078125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.1328125,
            "text": "multiple sclerosis",
            "probability": 0.4921875
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -1.083984375,
            "text": "Multiple",
            "probability": 4.9591064453125e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.1162109375,
            "text": "multiple",
            "probability": 4.76837158203125e-05
        },
        {
            "start_logit": -1.01953125,
            "end_logit": 8.140625,
            "text": "Sclerosis",
            "probability": 4.7326087951660156e-05
        },
        {
            "start_logit": -1.05078125,
            "end_logit": 8.1328125,
            "text": "sclerosis",
            "probability": 4.51207160949707e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.4296875,
            "text": "multiple sclerosis (MS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.07421875,
            "text": "multiple sclerosis (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.140625,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T. BACKGROUND AND PURPOSE Previous T2*-weighted magnetic resonance imaging (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.28125,
            "text": "Multiple Sclerosis Lesions",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.3125,
            "text": "multiple sclerosis (MS)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.41796875,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T. BACKGROUND AND PURPOSE Previous T2*",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.46484375,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T. BACKGROUND AND PURPOSE Previous T2*-weighted magnetic resonance imaging (MRI",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.45703125,
            "text": "multiple sclerosis (MS) from",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 8.1328125,
            "text": "PURPOSE Previous T2*-weighted magnetic resonance imaging (MRI) studies have used white matter lesion (WML) central veins to distinguish multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 8.1328125,
            "text": "distinguish multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 8.1328125,
            "text": "WML) central veins to distinguish multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 8.1328125,
            "text": "magnetic resonance imaging (MRI) studies have used white matter lesion (WML) central veins to distinguish multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 8.1328125,
            "text": "BACKGROUND AND PURPOSE Previous T2*-weighted magnetic resonance imaging (MRI) studies have used white matter lesion (WML) central veins to distinguish multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 8.140625,
            "text": "in Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e4601293f54159529000002_10": [
        {
            "start_logit": 8.2578125,
            "end_logit": 8.140625,
            "text": "Multiple Sclerosis",
            "probability": 0.5078125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.1328125,
            "text": "multiple sclerosis",
            "probability": 0.4921875
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -1.083984375,
            "text": "Multiple",
            "probability": 4.9591064453125e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.1162109375,
            "text": "multiple",
            "probability": 4.76837158203125e-05
        },
        {
            "start_logit": -1.01953125,
            "end_logit": 8.140625,
            "text": "Sclerosis",
            "probability": 4.7326087951660156e-05
        },
        {
            "start_logit": -1.05078125,
            "end_logit": 8.1328125,
            "text": "sclerosis",
            "probability": 4.51207160949707e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.4296875,
            "text": "multiple sclerosis (MS",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.07421875,
            "text": "multiple sclerosis (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.140625,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T. BACKGROUND AND PURPOSE Previous T2*-weighted magnetic resonance imaging (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.28125,
            "text": "Multiple Sclerosis Lesions",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.3125,
            "text": "multiple sclerosis (MS)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.41796875,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T. BACKGROUND AND PURPOSE Previous T2*",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.46484375,
            "text": "Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T. BACKGROUND AND PURPOSE Previous T2*-weighted magnetic resonance imaging (MRI",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.45703125,
            "text": "multiple sclerosis (MS) from",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 8.1328125,
            "text": "PURPOSE Previous T2*-weighted magnetic resonance imaging (MRI) studies have used white matter lesion (WML) central veins to distinguish multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 8.1328125,
            "text": "distinguish multiple sclerosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 8.1328125,
            "text": "WML) central veins to distinguish multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 8.1328125,
            "text": "magnetic resonance imaging (MRI) studies have used white matter lesion (WML) central veins to distinguish multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 8.1328125,
            "text": "BACKGROUND AND PURPOSE Previous T2*-weighted magnetic resonance imaging (MRI) studies have used white matter lesion (WML) central veins to distinguish multiple sclerosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 8.140625,
            "text": "in Multiple Sclerosis",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c8fe7cb0101eac87000000c_1": [
        {
            "start_logit": 7.90234375,
            "end_logit": 4.296875,
            "text": "Runt related factor-2 (",
            "probability": 0.97314453125
        },
        {
            "start_logit": 7.90234375,
            "end_logit": 0.64013671875,
            "text": "Runt related factor-2",
            "probability": 0.0249481201171875
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -2.2109375,
            "text": "Run",
            "probability": 0.0014467239379882812
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -6.21875,
            "text": "Runt related factor",
            "probability": 2.6404857635498047e-05
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -6.52734375,
            "text": "Runt",
            "probability": 1.9311904907226562e-05
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -6.875,
            "text": "Runt related",
            "probability": 1.3709068298339844e-05
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.06640625,
            "text": "Runt related factor-",
            "probability": 1.1265277862548828e-05
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.22265625,
            "text": "Runt related factor-2 (Runx2)",
            "probability": 9.655952453613281e-06
        },
        {
            "start_logit": 7.90234375,
            "end_logit": -7.54296875,
            "text": "Runt related factor-2 (Runx2",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": -5.828125,
            "end_logit": 4.296875,
            "text": "(",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 4.296875,
            "text": "t related factor-2 (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 4.296875,
            "text": "related factor-2 (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 0.64013671875,
            "text": "t related factor-2",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 0.64013671875,
            "text": "related factor-2",
            "probability": 0.0
        },
        {
            "start_logit": -5.828125,
            "end_logit": -7.22265625,
            "text": "(Runx2)",
            "probability": 0.0
        },
        {
            "start_logit": -5.828125,
            "end_logit": -7.54296875,
            "text": "(Runx2",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -6.21875,
            "text": "t related factor",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -6.21875,
            "text": "related factor",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -6.52734375,
            "text": "t",
            "probability": 0.0
        },
        {
            "start_logit": -7.5390625,
            "end_logit": -6.875,
            "text": "t related",
            "probability": 0.0
        }
    ],
    "55032efde9bde69634000035_1": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.1484375,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": -1.1484375,
            "end_logit": 8.1484375,
            "text": "receptor",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.4384765625,
            "text": "calcitonin",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -5.17578125,
            "text": "calcitonin gene-related peptide",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -6.453125,
            "end_logit": 8.1484375,
            "text": "gene-related peptide receptor",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.6796875,
            "end_logit": 8.1484375,
            "text": "related peptide receptor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.7421875,
            "end_logit": 8.1484375,
            "text": "-related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.046875,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.125,
            "text": "calcitonin gene-related peptide receptor occupancy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.19921875,
            "text": "calcitonin gene",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.20703125,
            "text": "calcitonin gene-related peptide receptor occupancy by",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.3046875,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.4609375,
            "text": "calcitonin gene-related",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.51953125,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.54296875,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.55859375,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5703125,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.1484375,
            "text": "peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.59375,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]MK-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.6015625,
            "text": "calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_2": [
        {
            "start_logit": 2.51953125,
            "end_logit": 4.52734375,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.529296875
        },
        {
            "start_logit": 2.3984375,
            "end_logit": 4.52734375,
            "text": "CGRP) receptor",
            "probability": 0.46875
        },
        {
            "start_logit": -4.17578125,
            "end_logit": 4.52734375,
            "text": ") receptor",
            "probability": 0.0006546974182128906
        },
        {
            "start_logit": 2.51953125,
            "end_logit": -2.443359375,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 0.0004978179931640625
        },
        {
            "start_logit": 2.3984375,
            "end_logit": -2.443359375,
            "text": "CGRP",
            "probability": 0.0004394054412841797
        },
        {
            "start_logit": -6.03125,
            "end_logit": 4.52734375,
            "text": "novel calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.00010275840759277344
        },
        {
            "start_logit": -6.1328125,
            "end_logit": 4.52734375,
            "text": "receptor",
            "probability": 9.208917617797852e-05
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 4.52734375,
            "text": "related peptide (CGRP) receptor",
            "probability": 3.1828880310058594e-05
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 4.52734375,
            "text": "gene-related peptide (CGRP) receptor",
            "probability": 3.1828880310058594e-05
        },
        {
            "start_logit": 2.51953125,
            "end_logit": -5.2265625,
            "text": "calcitonin gene-related peptide",
            "probability": 3.0875205993652344e-05
        },
        {
            "start_logit": -7.421875,
            "end_logit": 4.52734375,
            "text": "-related peptide (CGRP) receptor",
            "probability": 2.5570392608642578e-05
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 4.52734375,
            "text": ") is a novel calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.7344951629638672e-05
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 4.52734375,
            "text": "Telcagepant (MK-0974) is a novel calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.704692840576172e-05
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 4.52734375,
            "text": "cagepant (MK-0974) is a novel calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.609325408935547e-05
        },
        {
            "start_logit": 2.51953125,
            "end_logit": -6.73828125,
            "text": "calcitonin gene-related peptide (",
            "probability": 6.794929504394531e-06
        },
        {
            "start_logit": 2.51953125,
            "end_logit": -6.859375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine (http:/",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 2.51953125,
            "end_logit": -6.890625,
            "text": "calcitonin",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": 2.51953125,
            "end_logit": -6.95703125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine (http://www.merck",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 2.3984375,
            "end_logit": -6.859375,
            "text": "CGRP) receptor antagonist currently undergoing clinical trials for migraine (http:/",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": 2.51953125,
            "end_logit": -7.03125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist currently undergoing clinical trials for migraine (http://www.merck.com/research",
            "probability": 5.066394805908203e-06
        }
    ],
    "55032efde9bde69634000035_3": [
        {
            "start_logit": 5.7109375,
            "end_logit": 7.29296875,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.96875
        },
        {
            "start_logit": 2.259765625,
            "end_logit": 7.29296875,
            "text": "CGRP) receptor",
            "probability": 0.0308990478515625
        },
        {
            "start_logit": -3.142578125,
            "end_logit": 7.29296875,
            "text": "receptor",
            "probability": 0.00013875961303710938
        },
        {
            "start_logit": -4.17578125,
            "end_logit": 7.29296875,
            "text": ") receptor",
            "probability": 4.941225051879883e-05
        },
        {
            "start_logit": 5.7109375,
            "end_logit": -4.78125,
            "text": "calcitonin",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": 5.7109375,
            "end_logit": -4.8125,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": 5.7109375,
            "end_logit": -5.1875,
            "text": "calcitonin gene-related peptide",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -6.87109375,
            "end_logit": 7.29296875,
            "text": "gene-related peptide (CGRP) receptor",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 7.29296875,
            "text": "related peptide (CGRP) receptor",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 7.29296875,
            "text": "-related peptide (CGRP) receptor",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 5.7109375,
            "end_logit": -6.1328125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being evaluated for acute migraine treatment.",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.84375,
            "end_logit": 7.29296875,
            "text": "peptide (CGRP) receptor",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 7.29296875,
            "text": "Telcagepant is a calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 7.29296875,
            "text": "cagepant is a calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.953125,
            "end_logit": 7.29296875,
            "text": "gepant is a calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 5.7109375,
            "end_logit": -7.02734375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 5.7109375,
            "end_logit": -7.125,
            "text": "calcitonin gene-related peptide (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.7109375,
            "end_logit": -7.3359375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being evaluated for acute migraine",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.7109375,
            "end_logit": -7.35546875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being evaluated",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.7109375,
            "end_logit": -7.4453125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 4.172325134277344e-07
        }
    ],
    "55032efde9bde69634000035_4": [
        {
            "start_logit": 8.1953125,
            "end_logit": 8.1015625,
            "text": "Calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": -1.3203125,
            "end_logit": 8.1015625,
            "text": "receptor",
            "probability": 7.367134094238281e-05
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -1.4599609375,
            "text": "Calcitonin",
            "probability": 7.033348083496094e-05
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -5.62109375,
            "text": "Calcitonin gene-related peptide",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.6328125,
            "end_logit": 8.1015625,
            "text": "related peptide receptor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.6875,
            "end_logit": 8.1015625,
            "text": "-related peptide receptor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 8.1015625,
            "text": "gene-related peptide receptor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -6.84375,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.171875,
            "text": "Calcitonin gene",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.41796875,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.453125,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.4609375,
            "text": "Calcitonin gene-related peptide receptor antagonists",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.48046875,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.484375,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.50390625,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients with cardiovascular disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.5234375,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.5390625,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients with cardiovascular disease, a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.546875,
            "text": "Calcitonin gene-related",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.5546875,
            "text": "Calcitonin gene-related peptide receptor antagonists, such as telcagepant, may be useful for acute migraine treatment in patients with cardiovascular disease,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.1015625,
            "text": "peptide receptor",
            "probability": 1.7881393432617188e-07
        }
    ],
    "55032efde9bde69634000035_5": [
        {
            "start_logit": 3.8125,
            "end_logit": 1.4453125,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.9541015625
        },
        {
            "start_logit": 3.8125,
            "end_logit": -2.07421875,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 0.02825927734375
        },
        {
            "start_logit": -0.7470703125,
            "end_logit": 1.4453125,
            "text": "CGRP) receptor",
            "probability": 0.0099945068359375
        },
        {
            "start_logit": 3.8125,
            "end_logit": -3.83203125,
            "text": "calcitonin gene-related peptide",
            "probability": 0.00487518310546875
        },
        {
            "start_logit": 3.8125,
            "end_logit": -6.22265625,
            "text": "calcitonin",
            "probability": 0.00044608116149902344
        },
        {
            "start_logit": -0.7470703125,
            "end_logit": -2.07421875,
            "text": "CGRP",
            "probability": 0.0002961158752441406
        },
        {
            "start_logit": -4.54296875,
            "end_logit": 1.4453125,
            "text": ") receptor",
            "probability": 0.00022351741790771484
        },
        {
            "start_logit": 3.8125,
            "end_logit": -6.94140625,
            "text": "calcitonin gene",
            "probability": 0.00021660327911376953
        },
        {
            "start_logit": 3.8125,
            "end_logit": -7.01953125,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 0.00020039081573486328
        },
        {
            "start_logit": 3.8125,
            "end_logit": -7.04296875,
            "text": "calcitonin gene-related peptide (",
            "probability": 0.00019729137420654297
        },
        {
            "start_logit": 3.8125,
            "end_logit": -7.19921875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists (gepants)-olcegepant",
            "probability": 0.00016868114471435547
        },
        {
            "start_logit": 3.8125,
            "end_logit": -7.203125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists",
            "probability": 0.00016736984252929688
        },
        {
            "start_logit": 3.8125,
            "end_logit": -7.2890625,
            "text": "calcitonin gene-related",
            "probability": 0.00015354156494140625
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 1.4453125,
            "text": "gene-related peptide (CGRP) receptor",
            "probability": 1.2218952178955078e-05
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 1.4453125,
            "text": "related peptide (CGRP) receptor",
            "probability": 1.055002212524414e-05
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 1.4453125,
            "text": "-related peptide (CGRP) receptor",
            "probability": 9.59634780883789e-06
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 1.4453125,
            "text": "receptor",
            "probability": 8.940696716308594e-06
        },
        {
            "start_logit": -0.7470703125,
            "end_logit": -7.01953125,
            "text": "CGRP)",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -0.7470703125,
            "end_logit": -7.19140625,
            "text": "CGRP) receptor antagonists (gepants)-olcegepant (BIBN 4096 BS), telcagepant (MK",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -0.7470703125,
            "end_logit": -7.19921875,
            "text": "CGRP) receptor antagonists (gepants)-olcegepant",
            "probability": 1.7881393432617188e-06
        }
    ],
    "55032efde9bde69634000035_6": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.078125,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.4228515625,
            "text": "calcitonin",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": -1.44921875,
            "end_logit": 8.078125,
            "text": "receptor",
            "probability": 6.401538848876953e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -5.75390625,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.5546875,
            "end_logit": 8.078125,
            "text": "gene-related peptide receptor",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 8.078125,
            "text": "related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.90234375,
            "end_logit": 8.078125,
            "text": "-related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.23828125,
            "text": "calcitonin gene",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.34375,
            "text": "calcitonin gene-related peptide receptor antagonist,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.41015625,
            "text": "calcitonin gene-related",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.41015625,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed for the acute treatment of migraine.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 8.078125,
            "text": "peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.48046875,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed for the acute treatment of migraine",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.484375,
            "text": "calcitonin gene-related peptide receptor antagonist, is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.53515625,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5859375,
            "text": "calcitonin gene-related peptide receptor antagonist, is being",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.58984375,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.59375,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed for the acute treatment of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.61328125,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed for the acute",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.67578125,
            "text": "calcitonin gene-related peptide receptor antagonist, is being developed for",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_7": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.109375,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.3974609375,
            "text": "calcitonin",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": -1.32421875,
            "end_logit": 8.109375,
            "text": "receptor",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.078125,
            "text": "calcitonin gene-related peptide",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.640625,
            "end_logit": 8.109375,
            "text": "related peptide receptor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 8.109375,
            "text": "-related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 8.109375,
            "text": "gene-related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.16015625,
            "text": "calcitonin gene",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 8.109375,
            "text": "peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.5625,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.56640625,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.6015625,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.65625,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant, does",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.65625,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.66796875,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepan",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.671875,
            "text": "calcitonin gene-related",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.68359375,
            "text": "calcitonin gene-related peptide receptor antagonist, tel",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.68359375,
            "text": "calcitonin gene-related peptide receptor antagonist, telca",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.6875,
            "text": "calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.69140625,
            "text": "calcitonin gene-related peptide receptor antagonist, telcage",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_8": [
        {
            "start_logit": 4.47265625,
            "end_logit": 2.220703125,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.97607421875
        },
        {
            "start_logit": 0.191162109375,
            "end_logit": 2.220703125,
            "text": "CGRP) receptor",
            "probability": 0.01349639892578125
        },
        {
            "start_logit": 4.47265625,
            "end_logit": -2.828125,
            "text": "calcitonin gene-related peptide",
            "probability": 0.006252288818359375
        },
        {
            "start_logit": 4.47265625,
            "end_logit": -3.75390625,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 0.002475738525390625
        },
        {
            "start_logit": 4.47265625,
            "end_logit": -5.828125,
            "text": "calcitonin",
            "probability": 0.00031256675720214844
        },
        {
            "start_logit": -3.990234375,
            "end_logit": 2.220703125,
            "text": ") receptor",
            "probability": 0.00020492076873779297
        },
        {
            "start_logit": 4.47265625,
            "end_logit": -6.83203125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the haemodynamic response to sublingual nitroglycerin (NTG).",
            "probability": 0.00011402368545532227
        },
        {
            "start_logit": 4.47265625,
            "end_logit": -7.09765625,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 8.744001388549805e-05
        },
        {
            "start_logit": 4.47265625,
            "end_logit": -7.4765625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 5.9664249420166016e-05
        },
        {
            "start_logit": 4.47265625,
            "end_logit": -7.55078125,
            "text": "calcitonin gene",
            "probability": 5.555152893066406e-05
        },
        {
            "start_logit": 4.47265625,
            "end_logit": -7.57421875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the haemodynamic response to",
            "probability": 5.429983139038086e-05
        },
        {
            "start_logit": 4.47265625,
            "end_logit": -7.58203125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the haemodynamic response to sublingual nitroglycerin (",
            "probability": 5.3882598876953125e-05
        },
        {
            "start_logit": 4.47265625,
            "end_logit": -7.58984375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the haemodynamic",
            "probability": 5.346536636352539e-05
        },
        {
            "start_logit": 4.47265625,
            "end_logit": -7.625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the haemodynamic response to sublingual nitroglycerin (NTG",
            "probability": 5.179643630981445e-05
        },
        {
            "start_logit": 4.47265625,
            "end_logit": -7.62890625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on",
            "probability": 5.143880844116211e-05
        },
        {
            "start_logit": 4.47265625,
            "end_logit": -7.6328125,
            "text": "calcitonin gene-related",
            "probability": 5.1021575927734375e-05
        },
        {
            "start_logit": 4.47265625,
            "end_logit": -7.63671875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant",
            "probability": 5.1021575927734375e-05
        },
        {
            "start_logit": 4.47265625,
            "end_logit": -7.6484375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the haemodynamic response",
            "probability": 5.0187110900878906e-05
        },
        {
            "start_logit": 4.47265625,
            "end_logit": -7.69921875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, on the haemodynamic response to sublingual",
            "probability": 4.792213439941406e-05
        },
        {
            "start_logit": 0.191162109375,
            "end_logit": -3.75390625,
            "text": "CGRP",
            "probability": 3.427267074584961e-05
        }
    ],
    "55032efde9bde69634000035_9": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.109375,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.2958984375,
            "text": "calcitonin",
            "probability": 8.153915405273438e-05
        },
        {
            "start_logit": -1.34765625,
            "end_logit": 8.109375,
            "text": "receptor",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 8.109375,
            "text": "related peptide receptor",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.7578125,
            "text": "calcitonin gene-related peptide",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.75390625,
            "end_logit": 8.109375,
            "text": "gene-related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.796875,
            "end_logit": 8.109375,
            "text": "peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 8.109375,
            "text": "-related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.00390625,
            "text": "calcitonin gene",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.33203125,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated for the acute treatment of migraine.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.546875,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.609375,
            "text": "calcitonin gene-related peptide receptor antagonist which is being",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6171875,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated for the acute treatment of migraine",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6171875,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated for the acute treatment of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6328125,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated for the acute",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.65625,
            "text": "calcitonin gene-related peptide receptor antagonist which",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.66015625,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.66796875,
            "text": "calcitonin gene-related peptide receptor antagonist which is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.68359375,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.69140625,
            "text": "calcitonin gene-related peptide receptor antagonist which is being evaluated for the",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_10": [
        {
            "start_logit": 4.57421875,
            "end_logit": 6.90625,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.98193359375
        },
        {
            "start_logit": 0.55322265625,
            "end_logit": 6.90625,
            "text": "CGRP) receptor",
            "probability": 0.017578125
        },
        {
            "start_logit": -3.400390625,
            "end_logit": 6.90625,
            "text": ") receptor",
            "probability": 0.0003371238708496094
        },
        {
            "start_logit": -3.697265625,
            "end_logit": 6.90625,
            "text": "receptor",
            "probability": 0.0002505779266357422
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 6.90625,
            "text": "gene-related peptide (CGRP) receptor",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": -7.0625,
            "end_logit": 6.90625,
            "text": "related peptide (CGRP) receptor",
            "probability": 8.64267349243164e-06
        },
        {
            "start_logit": 4.57421875,
            "end_logit": -4.84375,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 7.748603820800781e-06
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 6.90625,
            "text": "-related peptide (CGRP) receptor",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 6.90625,
            "text": ": The calcitonin gene-related peptide (CGRP) receptor",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -7.75,
            "end_logit": 6.90625,
            "text": "(CGRP) receptor",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 6.90625,
            "text": "peptide (CGRP) receptor",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 6.90625,
            "text": "BACKGROUND: The calcitonin gene-related peptide (CGRP) receptor",
            "probability": 4.0531158447265625e-06
        },
        {
            "start_logit": 4.57421875,
            "end_logit": -5.6484375,
            "text": "calcitonin gene-related peptide",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 4.57421875,
            "end_logit": -5.8203125,
            "text": "calcitonin",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": 4.57421875,
            "end_logit": -6.4296875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant and telcagepant are very potent drugs.",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 4.57421875,
            "end_logit": -7.32421875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 4.57421875,
            "end_logit": -7.40625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 4.57421875,
            "end_logit": -7.47265625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant and",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 4.57421875,
            "end_logit": -7.515625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists olcegepant and telcagepant",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 4.57421875,
            "end_logit": -7.55078125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonists ol",
            "probability": 5.364418029785156e-07
        }
    ],
    "55032efde9bde69634000035_11": [
        {
            "start_logit": 7.0,
            "end_logit": 2.072265625,
            "text": "Calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.96875
        },
        {
            "start_logit": 7.0,
            "end_logit": -1.9775390625,
            "text": "Calcitonin gene-related peptide (CGRP",
            "probability": 0.0169219970703125
        },
        {
            "start_logit": 7.0,
            "end_logit": -2.537109375,
            "text": "Calcitonin gene-related peptide",
            "probability": 0.0096435546875
        },
        {
            "start_logit": 7.0,
            "end_logit": -3.556640625,
            "text": "Calcitonin",
            "probability": 0.0034942626953125
        },
        {
            "start_logit": -0.90234375,
            "end_logit": 2.072265625,
            "text": "CGRP) receptor",
            "probability": 0.00035953521728515625
        },
        {
            "start_logit": 7.0,
            "end_logit": -6.6640625,
            "text": "Calcitonin gene",
            "probability": 0.00015592575073242188
        },
        {
            "start_logit": 7.0,
            "end_logit": -6.71875,
            "text": "Calcitonin gene-related peptide (CGRP) receptor antagonists are another promising nonvasoconstrictor approach to treating acute migraine.",
            "probability": 0.0001475811004638672
        },
        {
            "start_logit": 7.0,
            "end_logit": -6.8671875,
            "text": "Calcitonin gene-related peptide (CGRP) receptor antagonists are another promising nonvasoconstrictor approach to treating acute migraine. Olcegepant",
            "probability": 0.00012731552124023438
        },
        {
            "start_logit": 7.0,
            "end_logit": -7.01171875,
            "text": "Calcitonin gene-related peptide (CGRP)",
            "probability": 0.00011056661605834961
        },
        {
            "start_logit": 7.0,
            "end_logit": -7.08203125,
            "text": "Calcitonin gene-related peptide (CGRP) receptor antagonists",
            "probability": 0.00010228157043457031
        },
        {
            "start_logit": 7.0,
            "end_logit": -7.125,
            "text": "Calcitonin gene-related peptide (CGRP) receptor antagonists are another promising nonvasoconstrictor approach to treating acute migraine. Olcegepant (BIB",
            "probability": 9.834766387939453e-05
        },
        {
            "start_logit": -4.90625,
            "end_logit": 2.072265625,
            "text": ") receptor",
            "probability": 6.496906280517578e-06
        },
        {
            "start_logit": -0.90234375,
            "end_logit": -1.9775390625,
            "text": "CGRP",
            "probability": 6.258487701416016e-06
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 2.072265625,
            "text": "(CGRP) receptor",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 2.072265625,
            "text": "receptor",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 2.072265625,
            "text": "gene-related peptide (CGRP) receptor",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 2.072265625,
            "text": "-related peptide (CGRP) receptor",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 2.072265625,
            "text": "related peptide (CGRP) receptor",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -0.90234375,
            "end_logit": -6.71875,
            "text": "CGRP) receptor antagonists are another promising nonvasoconstrictor approach to treating acute migraine.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.90234375,
            "end_logit": -6.8671875,
            "text": "CGRP) receptor antagonists are another promising nonvasoconstrictor approach to treating acute migraine. Olcegepant",
            "probability": 5.960464477539063e-08
        }
    ],
    "55032efde9bde69634000035_12": [
        {
            "start_logit": 6.0390625,
            "end_logit": 7.0,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.9462890625
        },
        {
            "start_logit": 3.158203125,
            "end_logit": 7.0,
            "text": "CGRP) receptor",
            "probability": 0.052978515625
        },
        {
            "start_logit": -3.52734375,
            "end_logit": 7.0,
            "text": "receptor",
            "probability": 6.657838821411133e-05
        },
        {
            "start_logit": -3.84765625,
            "end_logit": 7.0,
            "text": ") receptor",
            "probability": 4.792213439941406e-05
        },
        {
            "start_logit": 6.0390625,
            "end_logit": -3.0859375,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 3.9458274841308594e-05
        },
        {
            "start_logit": 6.0390625,
            "end_logit": -4.328125,
            "text": "calcitonin",
            "probability": 1.138448715209961e-05
        },
        {
            "start_logit": 6.0390625,
            "end_logit": -5.34765625,
            "text": "calcitonin gene-related peptide",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 3.158203125,
            "end_logit": -3.0859375,
            "text": "CGRP",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -7.171875,
            "end_logit": 7.0,
            "text": "related peptide (CGRP) receptor",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 6.0390625,
            "end_logit": -6.27734375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute treatment of migraine.",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 7.0,
            "text": "gene-related peptide (CGRP) receptor",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 7.0,
            "text": "-related peptide (CGRP) receptor",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 7.0,
            "text": "(CGRP) receptor",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 7.0,
            "text": "- Telcagepant is a calcitonin gene-related peptide (CGRP) receptor",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 7.0,
            "text": "peptide (CGRP) receptor",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.0390625,
            "end_logit": -7.0078125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.96875,
            "end_logit": 7.0,
            "text": ".- Telcagepant is a calcitonin gene-related peptide (CGRP) receptor",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.0390625,
            "end_logit": -7.25390625,
            "text": "calcitonin gene",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.0390625,
            "end_logit": -7.421875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.0390625,
            "end_logit": -7.4296875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist being investigated for the acute",
            "probability": 5.364418029785156e-07
        }
    ],
    "55032efde9bde69634000035_13": [
        {
            "start_logit": 8.0859375,
            "end_logit": 7.85546875,
            "text": "calcitonin gene-related peptide",
            "probability": 1.0
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -1.8095703125,
            "text": "calcitonin",
            "probability": 6.401538848876953e-05
        },
        {
            "start_logit": -2.07421875,
            "end_logit": 7.85546875,
            "text": "peptide",
            "probability": 3.886222839355469e-05
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.8984375,
            "text": "calcitonin gene-related",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.078125,
            "text": "calcitonin gene",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.90625,
            "end_logit": 7.85546875,
            "text": "gene-related peptide",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.1953125,
            "text": "calcitonin gene-related peptide antagonist",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.390625,
            "text": "calcitonin gene-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.42578125,
            "text": "calcitonin gene-related peptide antagonist telcagepant 300 mg orally had an",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 7.85546875,
            "text": "-related peptide",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.51171875,
            "text": "calcitonin gene-related peptide antagonist telcagepant 300 mg orally had",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.55078125,
            "text": "calcitonin gene-related peptide antagonist telcagepant 300 mg",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.5546875,
            "text": "calcitonin gene-related peptide antagonist telcagepant 300 mg orally had an incidence of adverse events similar to placebo when",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.5703125,
            "text": "calcitonin gene-related peptide antagonist telcagepant 300",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.58203125,
            "text": "calcitonin gene-related peptide antagonist telcagepant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.609375,
            "text": "calcitonin gene-related peptide antagonist telcagepant 300 mg orally",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.61328125,
            "text": "calcitonin gene-related peptide antagonist telcagepant 300 mg orally had an incidence of adverse events similar to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 7.85546875,
            "text": "related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.85546875,
            "text": ") the calcitonin gene-related peptide",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 7.85546875,
            "text": "3 randomized clinical trials (n = 1585) the calcitonin gene-related peptide",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_14": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.09375,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.376953125,
            "text": "calcitonin",
            "probability": 7.665157318115234e-05
        },
        {
            "start_logit": -1.373046875,
            "end_logit": 8.09375,
            "text": "receptor",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.3515625,
            "text": "calcitonin gene-related peptide",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.84765625,
            "text": "calcitonin gene",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 8.09375,
            "text": "related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 8.09375,
            "text": "-related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0,
            "end_logit": 8.09375,
            "text": "gene-related peptide receptor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 8.09375,
            "text": "peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.5234375,
            "text": "calcitonin gene-related",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.56640625,
            "text": "calcitonin gene-related peptide receptor antagonist with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.6328125,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine efficacy comparable to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.6328125,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.66015625,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine efficacy comparable",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.66796875,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine efficacy comparable to oral",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.67578125,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine efficacy comparable to oral triptan",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.6796875,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine efficacy comparable to oral triptans",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.68359375,
            "text": "calcitonin gene-related peptide receptor antagonist with acute",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.73046875,
            "text": "calcitonin gene-related peptide receptor antagonist with acute antimigraine efficacy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 8.09375,
            "text": "oral calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_15": [
        {
            "start_logit": 2.83203125,
            "end_logit": 6.15625,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.82763671875
        },
        {
            "start_logit": 1.24609375,
            "end_logit": 6.15625,
            "text": "CGRP) receptor",
            "probability": 0.170166015625
        },
        {
            "start_logit": -3.4453125,
            "end_logit": 6.15625,
            "text": ") receptor",
            "probability": 0.0015611648559570312
        },
        {
            "start_logit": -4.69140625,
            "end_logit": 6.15625,
            "text": "receptor",
            "probability": 0.0004487037658691406
        },
        {
            "start_logit": -6.80859375,
            "end_logit": 6.15625,
            "text": "gene-related peptide (CGRP) receptor",
            "probability": 5.3822994232177734e-05
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 6.15625,
            "text": "related peptide (CGRP) receptor",
            "probability": 4.13060188293457e-05
        },
        {
            "start_logit": -7.16796875,
            "end_logit": 6.15625,
            "text": "-related peptide (CGRP) receptor",
            "probability": 3.7610530853271484e-05
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 6.15625,
            "text": ": This study evaluated the calcitonin gene-related peptide (CGRP) receptor",
            "probability": 2.5212764739990234e-05
        },
        {
            "start_logit": -7.609375,
            "end_logit": 6.15625,
            "text": "METHODS: This study evaluated the calcitonin gene-related peptide (CGRP) receptor",
            "probability": 2.4259090423583984e-05
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 6.15625,
            "text": "This study evaluated the calcitonin gene-related peptide (CGRP) receptor",
            "probability": 2.3126602172851562e-05
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 6.15625,
            "text": "study evaluated the calcitonin gene-related peptide (CGRP) receptor",
            "probability": 1.9490718841552734e-05
        },
        {
            "start_logit": 2.83203125,
            "end_logit": -4.65625,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 1.6689300537109375e-05
        },
        {
            "start_logit": 2.83203125,
            "end_logit": -5.21484375,
            "text": "calcitonin gene-related peptide",
            "probability": 9.59634780883789e-06
        },
        {
            "start_logit": 1.24609375,
            "end_logit": -4.65625,
            "text": "CGRP",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 2.83203125,
            "end_logit": -6.6015625,
            "text": "calcitonin gene-related peptide (",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 2.83203125,
            "end_logit": -6.671875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 2.83203125,
            "end_logit": -7.0078125,
            "text": "calcitonin",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 2.83203125,
            "end_logit": -7.140625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation) for treatment of a migraine attack and across four attacks.",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 2.83203125,
            "end_logit": -7.41015625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 2.83203125,
            "end_logit": -7.43359375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant (tablet formulation",
            "probability": 1.0132789611816406e-06
        }
    ],
    "55032efde9bde69634000035_16": [
        {
            "start_logit": 4.171875,
            "end_logit": -0.1295166015625,
            "text": "calcitonin gene-related peptide",
            "probability": 0.71923828125
        },
        {
            "start_logit": 4.171875,
            "end_logit": -1.17578125,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.25244140625
        },
        {
            "start_logit": 4.171875,
            "end_logit": -3.775390625,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 0.0187530517578125
        },
        {
            "start_logit": 4.171875,
            "end_logit": -5.9453125,
            "text": "calcitonin",
            "probability": 0.0021419525146484375
        },
        {
            "start_logit": 4.171875,
            "end_logit": -6.69921875,
            "text": "calcitonin gene-related",
            "probability": 0.001007080078125
        },
        {
            "start_logit": 4.171875,
            "end_logit": -6.8125,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 0.0008997917175292969
        },
        {
            "start_logit": 4.171875,
            "end_logit": -6.8828125,
            "text": "calcitonin gene-related peptide (",
            "probability": 0.0008387565612792969
        },
        {
            "start_logit": 4.171875,
            "end_logit": -7.13671875,
            "text": "calcitonin gene",
            "probability": 0.0006504058837890625
        },
        {
            "start_logit": 4.171875,
            "end_logit": -7.140625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, and zolmitriptan",
            "probability": 0.0006480216979980469
        },
        {
            "start_logit": 4.171875,
            "end_logit": -7.32421875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, and zolmitript",
            "probability": 0.0005393028259277344
        },
        {
            "start_logit": 4.171875,
            "end_logit": -7.3671875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 0.0005168914794921875
        },
        {
            "start_logit": 4.171875,
            "end_logit": -7.37109375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, and zolmitriptan in the acute treatment of migraine",
            "probability": 0.0005145072937011719
        },
        {
            "start_logit": 4.171875,
            "end_logit": -7.52734375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant",
            "probability": 0.00044035911560058594
        },
        {
            "start_logit": 4.171875,
            "end_logit": -7.58984375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, and zolmitriptan in",
            "probability": 0.0004134178161621094
        },
        {
            "start_logit": 4.171875,
            "end_logit": -7.62109375,
            "text": "calcitonin gene-",
            "probability": 0.00040078163146972656
        },
        {
            "start_logit": 4.171875,
            "end_logit": -7.63671875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist, telcagepant, and zolmitriptan in the acute treatment of migraine.",
            "probability": 0.00039458274841308594
        },
        {
            "start_logit": -3.466796875,
            "end_logit": -1.17578125,
            "text": "CGRP) receptor",
            "probability": 0.00012129545211791992
        },
        {
            "start_logit": -4.2265625,
            "end_logit": -1.17578125,
            "text": ") receptor",
            "probability": 5.6862831115722656e-05
        },
        {
            "start_logit": -6.69140625,
            "end_logit": -0.1295166015625,
            "text": "the calcitonin gene-related peptide",
            "probability": 1.3828277587890625e-05
        },
        {
            "start_logit": -3.466796875,
            "end_logit": -3.775390625,
            "text": "CGRP",
            "probability": 9.059906005859375e-06
        }
    ],
    "55032efde9bde69634000035_17": [
        {
            "start_logit": 1.53125,
            "end_logit": 2.763671875,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.7763671875
        },
        {
            "start_logit": 0.237060546875,
            "end_logit": 2.763671875,
            "text": "CGRP) receptor",
            "probability": 0.2122802734375
        },
        {
            "start_logit": -3.29296875,
            "end_logit": 2.763671875,
            "text": ") receptor",
            "probability": 0.006214141845703125
        },
        {
            "start_logit": 1.53125,
            "end_logit": -2.841796875,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 0.0028438568115234375
        },
        {
            "start_logit": 0.237060546875,
            "end_logit": -2.841796875,
            "text": "CGRP",
            "probability": 0.0007805824279785156
        },
        {
            "start_logit": -6.8828125,
            "end_logit": 2.763671875,
            "text": "gene-related peptide (CGRP) receptor",
            "probability": 0.00017213821411132812
        },
        {
            "start_logit": 1.53125,
            "end_logit": -5.80078125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries.",
            "probability": 0.00014829635620117188
        },
        {
            "start_logit": 1.53125,
            "end_logit": -5.82421875,
            "text": "calcitonin gene-related peptide",
            "probability": 0.0001437664031982422
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 2.763671875,
            "text": "related peptide (CGRP) receptor",
            "probability": 0.00012683868408203125
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 2.763671875,
            "text": "-related peptide (CGRP) receptor",
            "probability": 0.00011116266250610352
        },
        {
            "start_logit": -7.390625,
            "end_logit": 2.763671875,
            "text": "receptor",
            "probability": 0.00010353326797485352
        },
        {
            "start_logit": -7.6875,
            "end_logit": 2.763671875,
            "text": "Effect of the calcitonin gene-related peptide (CGRP) receptor",
            "probability": 7.700920104980469e-05
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 2.763671875,
            "text": "the calcitonin gene-related peptide (CGRP) receptor",
            "probability": 6.955862045288086e-05
        },
        {
            "start_logit": -7.890625,
            "end_logit": 2.763671875,
            "text": "peptide (CGRP) receptor",
            "probability": 6.282329559326172e-05
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 2.763671875,
            "text": "of the calcitonin gene-related peptide (CGRP) receptor",
            "probability": 5.996227264404297e-05
        },
        {
            "start_logit": 1.53125,
            "end_logit": -7.05859375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 4.190206527709961e-05
        },
        {
            "start_logit": 0.237060546875,
            "end_logit": -5.80078125,
            "text": "CGRP) receptor antagonist telcagepant in human cranial arteries.",
            "probability": 4.0590763092041016e-05
        },
        {
            "start_logit": 1.53125,
            "end_logit": -7.1328125,
            "text": "calcitonin gene-related peptide (",
            "probability": 3.898143768310547e-05
        },
        {
            "start_logit": 1.53125,
            "end_logit": -7.44921875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in",
            "probability": 2.8312206268310547e-05
        },
        {
            "start_logit": 1.53125,
            "end_logit": -7.52734375,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 2.6166439056396484e-05
        }
    ],
    "55032efde9bde69634000035_18": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.109375,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.375,
            "text": "calcitonin",
            "probability": 7.605552673339844e-05
        },
        {
            "start_logit": -1.322265625,
            "end_logit": 8.109375,
            "text": "receptor",
            "probability": 7.200241088867188e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.35546875,
            "text": "calcitonin gene-related peptide",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.76953125,
            "end_logit": 8.109375,
            "text": "gene-related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.80859375,
            "end_logit": 8.109375,
            "text": "related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.81640625,
            "end_logit": 8.109375,
            "text": "-related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.1875,
            "text": "calcitonin gene",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 8.109375,
            "text": "peptide receptor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4921875,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (MK-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.52734375,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.53125,
            "text": "calcitonin gene-related",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.5390625,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.54296875,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.5546875,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.6015625,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.62890625,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.6484375,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepan",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.65234375,
            "text": "calcitonin gene-related peptide receptor antagonist tel",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.66015625,
            "text": "calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_19": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.09375,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.4091796875,
            "text": "calcitonin",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": -1.37890625,
            "end_logit": 8.09375,
            "text": "receptor",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -5.19921875,
            "text": "calcitonin gene-related peptide",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -6.59765625,
            "end_logit": 8.09375,
            "text": "gene-related peptide receptor",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 8.09375,
            "text": "related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 8.09375,
            "text": "-related peptide receptor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.078125,
            "text": "calcitonin gene",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.125,
            "text": "calcitonin gene-related",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.390625,
            "text": "calcitonin gene-related peptide receptor blockers.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.625,
            "text": "calcitonin gene-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 8.09375,
            "text": "peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.6875,
            "text": "calcitonin gene-related peptide receptor blockers",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 8.09375,
            "text": "the calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 8.09375,
            "text": "antimigraine drug-the calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.09375,
            "text": "drug-the calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 8.09375,
            "text": "Telcagepant represents a new class of antimigraine drug-the calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 8.09375,
            "text": "cagepant represents a new class of antimigraine drug-the calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 8.09375,
            "text": "igraine drug-the calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 8.09375,
            "text": "aine drug-the calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_20": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.09375,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.3740234375,
            "text": "calcitonin",
            "probability": 7.665157318115234e-05
        },
        {
            "start_logit": -1.349609375,
            "end_logit": 8.09375,
            "text": "receptor",
            "probability": 6.979703903198242e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -5.73828125,
            "text": "calcitonin gene-related peptide",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.6484375,
            "text": "calcitonin gene",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.859375,
            "end_logit": 8.09375,
            "text": "related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 8.09375,
            "text": "gene-related peptide receptor",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 8.09375,
            "text": "-related peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 8.09375,
            "text": "peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.43359375,
            "text": "calcitonin gene-related",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.4765625,
            "text": "calcitonin gene-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.62890625,
            "text": "calcitonin gene-related peptide receptor antagonist, in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 8.09375,
            "text": "oral calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.70703125,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 8.09375,
            "text": "telcagepant, an oral calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 8.09375,
            "text": "an oral calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 8.09375,
            "text": "cagepant, an oral calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 8.09375,
            "text": "gepant, an oral calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 8.09375,
            "text": ", an oral calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 8.09375,
            "text": "Single- and multiple-dose pharmacokinetics and tolerability of telcagepant, an oral calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_21": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.125,
            "text": "calcitonin gene-related peptide receptor",
            "probability": 1.0
        },
        {
            "start_logit": -1.236328125,
            "end_logit": 8.125,
            "text": "receptor",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.3515625,
            "text": "calcitonin",
            "probability": 7.665157318115234e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.5234375,
            "text": "calcitonin gene-related peptide",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -6.71875,
            "end_logit": 8.125,
            "text": "gene-related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 8.125,
            "text": "related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.85546875,
            "end_logit": 8.125,
            "text": "-related peptide receptor",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.0859375,
            "text": "calcitonin gene",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.25,
            "text": "calcitonin gene-related",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.39453125,
            "text": "calcitonin gene-related peptide receptor antagonist being",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.49609375,
            "text": "calcitonin gene-related peptide receptor antagonist",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 8.125,
            "text": "peptide receptor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.51171875,
            "text": "calcitonin gene-related peptide receptor antagonist being developed for acute treatment of migraine with and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.51171875,
            "text": "calcitonin gene-related peptide receptor antagonist being developed for acute treatment of migraine with and without",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.57421875,
            "text": "calcitonin gene-related peptide receptor antagonist being developed for acute treatment of migraine with and without aura.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.5859375,
            "text": "calcitonin gene-related peptide receptor antagonist being developed for",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.63671875,
            "text": "calcitonin gene-related peptide receptor antagonist being developed",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.63671875,
            "text": "calcitonin gene-related peptide receptor antagonist being developed for acute",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.63671875,
            "text": "calcitonin gene-related peptide receptor antagonist being developed for acute treatment of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 8.125,
            "text": "selective calcitonin gene-related peptide receptor",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55032efde9bde69634000035_22": [
        {
            "start_logit": 5.29296875,
            "end_logit": 1.015625,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.84912109375
        },
        {
            "start_logit": 5.29296875,
            "end_logit": -1.078125,
            "text": "calcitonin gene-related peptide",
            "probability": 0.1046142578125
        },
        {
            "start_logit": 5.29296875,
            "end_logit": -2.08984375,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 0.03802490234375
        },
        {
            "start_logit": -0.151611328125,
            "end_logit": 1.015625,
            "text": "CGRP) receptor",
            "probability": 0.003665924072265625
        },
        {
            "start_logit": 5.29296875,
            "end_logit": -5.15625,
            "text": "calcitonin",
            "probability": 0.0017719268798828125
        },
        {
            "start_logit": 5.29296875,
            "end_logit": -6.1015625,
            "text": "calcitonin gene-related peptide (CGRP)",
            "probability": 0.0006885528564453125
        },
        {
            "start_logit": 5.29296875,
            "end_logit": -6.49609375,
            "text": "calcitonin gene-related peptide (",
            "probability": 0.0004639625549316406
        },
        {
            "start_logit": 5.29296875,
            "end_logit": -7.15234375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant and",
            "probability": 0.00023984909057617188
        },
        {
            "start_logit": 5.29296875,
            "end_logit": -7.3203125,
            "text": "calcitonin gene",
            "probability": 0.00020360946655273438
        },
        {
            "start_logit": 5.29296875,
            "end_logit": -7.33984375,
            "text": "calcitonin gene-related",
            "probability": 0.00019884109497070312
        },
        {
            "start_logit": 5.29296875,
            "end_logit": -7.42578125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 0.00018393993377685547
        },
        {
            "start_logit": 5.29296875,
            "end_logit": -7.49609375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant and to compare its coronary vasoconstrictive",
            "probability": 0.00016999244689941406
        },
        {
            "start_logit": 5.29296875,
            "end_logit": -7.5,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant and to compare its coronary vasoconstrictive potential to that of zolmitri",
            "probability": 0.00016999244689941406
        },
        {
            "start_logit": 5.29296875,
            "end_logit": -7.51953125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant and to compare its coronary vasoconstrictive potential to that of zolmit",
            "probability": 0.00016736984252929688
        },
        {
            "start_logit": -0.151611328125,
            "end_logit": -2.08984375,
            "text": "CGRP",
            "probability": 0.00016486644744873047
        },
        {
            "start_logit": -5.58984375,
            "end_logit": 1.015625,
            "text": ") receptor",
            "probability": 1.5914440155029297e-05
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 1.015625,
            "text": "gene-related peptide (CGRP) receptor",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -0.151611328125,
            "end_logit": -6.1015625,
            "text": "CGRP)",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 1.015625,
            "text": "Studies were conducted in human isolated coronary arteries to explore the vascular effects of the calcitonin gene-related peptide (CGRP) receptor",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 1.015625,
            "text": "-related peptide (CGRP) receptor",
            "probability": 2.7418136596679688e-06
        }
    ],
    "55032efde9bde69634000035_23": [
        {
            "start_logit": 4.48046875,
            "end_logit": 2.90234375,
            "text": "calcitonin gene-related peptide (CGRP) receptor",
            "probability": 0.91748046875
        },
        {
            "start_logit": 1.919921875,
            "end_logit": 2.90234375,
            "text": "CGRP) receptor",
            "probability": 0.07073974609375
        },
        {
            "start_logit": 4.48046875,
            "end_logit": -1.654296875,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 0.00965118408203125
        },
        {
            "start_logit": 1.919921875,
            "end_logit": -1.654296875,
            "text": "CGRP",
            "probability": 0.0007443428039550781
        },
        {
            "start_logit": 4.48046875,
            "end_logit": -4.47265625,
            "text": "calcitonin gene-related peptide",
            "probability": 0.0005750656127929688
        },
        {
            "start_logit": 4.48046875,
            "end_logit": -5.11328125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and is currently under clinical development.",
            "probability": 0.00030303001403808594
        },
        {
            "start_logit": 4.48046875,
            "end_logit": -5.58203125,
            "text": "calcitonin",
            "probability": 0.00018966197967529297
        },
        {
            "start_logit": 4.48046875,
            "end_logit": -6.26953125,
            "text": "calcitonin gene-related peptide (",
            "probability": 9.5367431640625e-05
        },
        {
            "start_logit": -5.1875,
            "end_logit": 2.90234375,
            "text": ") receptor",
            "probability": 5.7816505432128906e-05
        },
        {
            "start_logit": 4.48046875,
            "end_logit": -6.8359375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and",
            "probability": 5.429983139038086e-05
        },
        {
            "start_logit": 4.48046875,
            "end_logit": -7.18359375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and is currently under clinical",
            "probability": 3.820657730102539e-05
        },
        {
            "start_logit": 4.48046875,
            "end_logit": -7.23828125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and is currently under",
            "probability": 3.618001937866211e-05
        },
        {
            "start_logit": 4.48046875,
            "end_logit": -7.26953125,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and is currently",
            "probability": 3.504753112792969e-05
        },
        {
            "start_logit": 4.48046875,
            "end_logit": -7.32421875,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and is currently under clinical development",
            "probability": 3.319978713989258e-05
        },
        {
            "start_logit": 4.48046875,
            "end_logit": -7.34765625,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist and is",
            "probability": 3.24249267578125e-05
        },
        {
            "start_logit": 4.48046875,
            "end_logit": -7.48046875,
            "text": "calcitonin gene",
            "probability": 2.8371810913085938e-05
        },
        {
            "start_logit": 4.48046875,
            "end_logit": -7.5234375,
            "text": "calcitonin gene-related peptide (CGRP) receptor antagonist",
            "probability": 2.7358531951904297e-05
        },
        {
            "start_logit": 1.919921875,
            "end_logit": -5.11328125,
            "text": "CGRP) receptor antagonist and is currently under clinical development.",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": -7.015625,
            "end_logit": 2.90234375,
            "text": "oral calcitonin gene-related peptide (CGRP) receptor",
            "probability": 9.298324584960938e-06
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 2.90234375,
            "text": "receptor",
            "probability": 7.748603820800781e-06
        }
    ],
    "5c6ab4c17c78d6947100001d_1": [
        {
            "start_logit": 7.9375,
            "end_logit": 8.1796875,
            "text": "MATLAB environment",
            "probability": 1.0
        },
        {
            "start_logit": -0.67236328125,
            "end_logit": 8.1796875,
            "text": "environment",
            "probability": 0.00018095970153808594
        },
        {
            "start_logit": 7.9375,
            "end_logit": -2.017578125,
            "text": "MAT",
            "probability": 3.707408905029297e-05
        },
        {
            "start_logit": 7.9375,
            "end_logit": -3.12890625,
            "text": "MATLAB",
            "probability": 1.2218952178955078e-05
        },
        {
            "start_logit": -3.708984375,
            "end_logit": 8.1796875,
            "text": "under the MATLAB environment",
            "probability": 8.64267349243164e-06
        },
        {
            "start_logit": -4.3828125,
            "end_logit": 8.1796875,
            "text": ".Availability and implementation: SELANSI runs under the MATLAB environment",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": -5.00390625,
            "end_logit": 8.1796875,
            "text": "the MATLAB environment",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 7.9375,
            "end_logit": -5.44140625,
            "text": "MATLAB environment,",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.9375,
            "end_logit": -6.16015625,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -6.1640625,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view/selansi",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -6.36328125,
            "text": "MATLAB environment, and",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -6.609375,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.9375,
            "end_logit": -6.65625,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.98046875,
            "end_logit": 8.1796875,
            "text": "LAB environment",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 8.1796875,
            "text": ": SELANSI runs under the MATLAB environment",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -3.708984375,
            "end_logit": -2.017578125,
            "text": "under the MAT",
            "probability": 0.0
        },
        {
            "start_logit": -0.67236328125,
            "end_logit": -5.44140625,
            "text": "environment,",
            "probability": 0.0
        },
        {
            "start_logit": -4.3828125,
            "end_logit": -2.017578125,
            "text": ".Availability and implementation: SELANSI runs under the MAT",
            "probability": 0.0
        },
        {
            "start_logit": -0.67236328125,
            "end_logit": -6.16015625,
            "text": "environment, and is available under GPLv3 license at https://sites.google.com",
            "probability": 0.0
        },
        {
            "start_logit": -0.67236328125,
            "end_logit": -6.1640625,
            "text": "environment, and is available under GPLv3 license at https://sites.google.com/view/selansi",
            "probability": 0.0
        }
    ],
    "5c6ab4c17c78d6947100001d_2": [
        {
            "start_logit": 7.96484375,
            "end_logit": 8.1484375,
            "text": "MATLAB environment",
            "probability": 1.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": 8.1484375,
            "text": "environment",
            "probability": 0.00010889768600463867
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -2.08203125,
            "text": "MAT",
            "probability": 3.618001937866211e-05
        },
        {
            "start_logit": -6.328125,
            "end_logit": 8.1484375,
            "text": "under the MATLAB environment",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -6.18359375,
            "text": "MATLAB",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.39453125,
            "end_logit": 8.1484375,
            "text": "the MATLAB environment",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.859375,
            "end_logit": 8.1484375,
            "text": "LAB environment",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -6.80078125,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.0,
            "text": "MATLAB environment,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.09765625,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.15234375,
            "text": "MATLAB environment, and is available under GPLv3",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.15234375,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.23828125,
            "text": "MATLAB environment, and is available under GPLv3 licens",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.25390625,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.265625,
            "text": "MATLAB environment, and is available under GPLv3 license at https:/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.28125,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.296875,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.1484375,
            "text": "implementation SELANSI runs under the MATLAB environment",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.30859375,
            "text": "MATLAB environment, and is available under GPLv3 license",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.41796875,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view/selansi.",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5c6ab4c17c78d6947100001d_3": [
        {
            "start_logit": 7.4609375,
            "end_logit": 8.140625,
            "text": "MATLAB environment",
            "probability": 0.9990234375
        },
        {
            "start_logit": 0.1806640625,
            "end_logit": 8.140625,
            "text": "the MATLAB environment",
            "probability": 0.0006880760192871094
        },
        {
            "start_logit": -1.091796875,
            "end_logit": 8.140625,
            "text": "environment",
            "probability": 0.00019240379333496094
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -3.162109375,
            "text": "MAT",
            "probability": 1.233816146850586e-05
        },
        {
            "start_logit": -5.07421875,
            "end_logit": 8.140625,
            "text": "under the MATLAB environment",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -5.5234375,
            "end_logit": 8.140625,
            "text": ".<br><b>Availability and implementation</b>: SELANSI runs under the MATLAB environment",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -5.0390625,
            "text": "MATLAB",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 8.140625,
            "text": "LAB environment",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 8.140625,
            "text": ": SELANSI runs under the MATLAB environment",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 8.140625,
            "text": "simulation options.<br><b>Availability and implementation</b>: SELANSI runs under the MATLAB environment",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -6.7734375,
            "text": "MATLAB environment, and is available under GPLv3 licens",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 8.140625,
            "text": ", as well as simulation options.<br><b>Availability and implementation</b>: SELANSI runs under the MATLAB environment",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -6.82421875,
            "text": "MATLAB environment, and is available under GPLv3 license",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.140625,
            "text": "<br><b>Availability and implementation</b>: SELANSI runs under the MATLAB environment",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 8.140625,
            "text": "as simulation options.<br><b>Availability and implementation</b>: SELANSI runs under the MATLAB environment",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -7.109375,
            "text": "MATLAB environment, and is available under GPLv3",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -7.1171875,
            "text": "MATLAB environment,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -7.37109375,
            "text": "MATLAB environment, and is available under GPLv3 license at https:/",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -7.3984375,
            "text": "MATLAB environment, and is available under GPLv3 license at https",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.4609375,
            "end_logit": -7.41015625,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5c6ab4c17c78d6947100001d_4": [
        {
            "start_logit": 8.09375,
            "end_logit": 8.1484375,
            "text": "MATLAB environment",
            "probability": 1.0
        },
        {
            "start_logit": -1.123046875,
            "end_logit": 8.1484375,
            "text": "environment",
            "probability": 9.840726852416992e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -1.7021484375,
            "text": "MAT",
            "probability": 5.227327346801758e-05
        },
        {
            "start_logit": 8.09375,
            "end_logit": -6.546875,
            "text": "MATLAB",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 8.1484375,
            "text": "LAB environment",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -6.80078125,
            "text": "MATLAB environment,",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -6.890625,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -6.95703125,
            "text": "MATLAB environment, and is available under GPLv3 license",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -6.9609375,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 8.1484375,
            "text": "under the MATLAB environment",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.0078125,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.09765625,
            "text": "MATLAB environment, and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.12109375,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.23046875,
            "end_logit": 8.1484375,
            "text": "the MATLAB environment",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.20703125,
            "text": "MATLAB environment, and is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.2109375,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.google.com/view/selansi",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.2265625,
            "text": "MATLAB environment, and is available under GPLv3",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.265625,
            "text": "MATLAB environment, and is available under GPLv3 license at",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.26953125,
            "text": "MATLAB environment, and is available under GPLv3 licens",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.09375,
            "end_logit": -7.28515625,
            "text": "MATLAB environment, and is available under GPLv3 license at https://sites.",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5a992b371d1251d03b00000a_1": [
        {
            "start_logit": 8.0078125,
            "end_logit": 8.0390625,
            "text": "Metagenomics of the Human Intestinal Tract",
            "probability": 1.0
        },
        {
            "start_logit": -0.9951171875,
            "end_logit": 8.0390625,
            "text": "Tract",
            "probability": 0.0001233816146850586
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -1.92578125,
            "text": "Metagen",
            "probability": 4.684925079345703e-05
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -4.09375,
            "text": "Metagenomics of the Human Intestinal Tract (MetaHIT) project are focusing mainly on the human microbiome",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -4.30859375,
            "text": "Metagenomics of the Human Intestinal Tract (MetaHIT) project are focusing mainly on the human microbiome.",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -4.34375,
            "end_logit": 8.0390625,
            "text": "and Metagenomics of the Human Intestinal Tract",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -4.5234375,
            "text": "Metagenomics",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -5.89453125,
            "text": "Metagenomics of the Human Intestinal Tract (MetaHIT) project",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.078125,
            "end_logit": 8.0390625,
            "text": "Human Intestinal Tract",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.29296875,
            "end_logit": 8.0390625,
            "text": "the Human Intestinal Tract",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -6.33203125,
            "text": "Metagenomics of the Human Intestinal Tract (",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.4765625,
            "end_logit": 8.0390625,
            "text": "of the Human Intestinal Tract",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -6.515625,
            "text": "Metagenomics of the Human Intestinal Tract (MetaHIT) project are",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -6.7265625,
            "text": "Metagenomics of the Human Intestinal",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 8.0390625,
            "text": ") and Metagenomics of the Human Intestinal Tract",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.83203125,
            "end_logit": 8.0390625,
            "text": "Human Microbiome project (HMP) and Metagenomics of the Human Intestinal Tract",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.84765625,
            "end_logit": 8.0390625,
            "text": "The importance of microbiome constituency is so relevant that several consortia like the Human Microbiome project (HMP) and Metagenomics of the Human Intestinal Tract",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 8.0390625,
            "text": "Microbiome project (HMP) and Metagenomics of the Human Intestinal Tract",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 8.0390625,
            "text": "consortia like the Human Microbiome project (HMP) and Metagenomics of the Human Intestinal Tract",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0078125,
            "end_logit": -7.07421875,
            "text": "Metagenomics of the Human Intestinal Tract (MetaHIT) project are focusing mainly on the human",
            "probability": 2.980232238769531e-07
        }
    ],
    "530c7f52970c65fa6b000010_1": [
        {
            "start_logit": -0.533203125,
            "end_logit": 5.40625,
            "text": "biofilm development",
            "probability": 0.8857421875
        },
        {
            "start_logit": -3.42578125,
            "end_logit": 5.40625,
            "text": "polymicrobial biofilm development",
            "probability": 0.04901123046875
        },
        {
            "start_logit": -0.533203125,
            "end_logit": 2.291015625,
            "text": "biofilm development of periodontal pathogens",
            "probability": 0.039215087890625
        },
        {
            "start_logit": -5.37109375,
            "end_logit": 5.40625,
            "text": "disrupts polymicrobial biofilm development",
            "probability": 0.007007598876953125
        },
        {
            "start_logit": -5.5390625,
            "end_logit": 5.40625,
            "text": "development",
            "probability": 0.005924224853515625
        },
        {
            "start_logit": -6.1015625,
            "end_logit": 5.40625,
            "text": "Oxantel disrupts polymicrobial biofilm development",
            "probability": 0.0033740997314453125
        },
        {
            "start_logit": -3.42578125,
            "end_logit": 2.291015625,
            "text": "polymicrobial biofilm development of periodontal pathogens",
            "probability": 0.002178192138671875
        },
        {
            "start_logit": -6.90625,
            "end_logit": 5.40625,
            "text": "robial biofilm development",
            "probability": 0.0015087127685546875
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 5.40625,
            "text": "icrobial biofilm development",
            "probability": 0.001468658447265625
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 5.40625,
            "text": "ntel disrupts polymicrobial biofilm development",
            "probability": 0.001316070556640625
        },
        {
            "start_logit": -7.13671875,
            "end_logit": 5.40625,
            "text": "ial biofilm development",
            "probability": 0.0011987686157226562
        },
        {
            "start_logit": -7.171875,
            "end_logit": 5.40625,
            "text": "el disrupts polymicrobial biofilm development",
            "probability": 0.0011577606201171875
        },
        {
            "start_logit": -5.37109375,
            "end_logit": 2.291015625,
            "text": "disrupts polymicrobial biofilm development of periodontal pathogens",
            "probability": 0.0003116130828857422
        },
        {
            "start_logit": -5.5390625,
            "end_logit": 2.291015625,
            "text": "development of periodontal pathogens",
            "probability": 0.00026226043701171875
        },
        {
            "start_logit": -6.1015625,
            "end_logit": 2.291015625,
            "text": "Oxantel disrupts polymicrobial biofilm development of periodontal pathogens",
            "probability": 0.0001493692398071289
        },
        {
            "start_logit": -6.25,
            "end_logit": 2.291015625,
            "text": "periodontal pathogens",
            "probability": 0.00012886524200439453
        },
        {
            "start_logit": -6.90625,
            "end_logit": 2.291015625,
            "text": "robial biofilm development of periodontal pathogens",
            "probability": 6.681680679321289e-05
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 2.291015625,
            "text": "of periodontal pathogens",
            "probability": 6.681680679321289e-05
        },
        {
            "start_logit": -6.93359375,
            "end_logit": 2.291015625,
            "text": "icrobial biofilm development of periodontal pathogens",
            "probability": 6.526708602905273e-05
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 2.291015625,
            "text": "ntel disrupts polymicrobial biofilm development of periodontal pathogens",
            "probability": 5.84721565246582e-05
        }
    ],
    "5540fbce234c5a7c75000001_1": [
        {
            "start_logit": 8.0625,
            "end_logit": 6.875,
            "text": "Chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": 8.0625,
            "end_logit": -1.8095703125,
            "text": "Chaperone",
            "probability": 0.00016868114471435547
        },
        {
            "start_logit": 8.0625,
            "end_logit": -3.849609375,
            "text": "Chaperone-mediated autophagy (",
            "probability": 2.193450927734375e-05
        },
        {
            "start_logit": -3.814453125,
            "end_logit": 6.875,
            "text": "autophagy",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": 8.0625,
            "end_logit": -5.4296875,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 4.5299530029296875e-06
        },
        {
            "start_logit": 8.0625,
            "end_logit": -5.87890625,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 8.0625,
            "end_logit": -6.51171875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the KFERQ motif.",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.0625,
            "end_logit": -6.85546875,
            "text": "Chaperone-mediated",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.0625,
            "end_logit": -6.96484375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.078125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.12890625,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.27734375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.3359375,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.34375,
            "text": "Chaperone-",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.37890625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.4453125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.46875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.47265625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.546875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.546875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the KFERQ",
            "probability": 5.364418029785156e-07
        }
    ],
    "5540fbce234c5a7c75000001_2": [
        {
            "start_logit": 8.0625,
            "end_logit": 6.875,
            "text": "Chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": 8.0625,
            "end_logit": -1.8095703125,
            "text": "Chaperone",
            "probability": 0.00016868114471435547
        },
        {
            "start_logit": 8.0625,
            "end_logit": -3.849609375,
            "text": "Chaperone-mediated autophagy (",
            "probability": 2.193450927734375e-05
        },
        {
            "start_logit": -3.814453125,
            "end_logit": 6.875,
            "text": "autophagy",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": 8.0625,
            "end_logit": -5.4296875,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 4.5299530029296875e-06
        },
        {
            "start_logit": 8.0625,
            "end_logit": -5.87890625,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 8.0625,
            "end_logit": -6.51171875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the KFERQ motif.",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.0625,
            "end_logit": -6.85546875,
            "text": "Chaperone-mediated",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.0625,
            "end_logit": -6.96484375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.078125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.12890625,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.27734375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.3359375,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.34375,
            "text": "Chaperone-",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.37890625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.4453125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.46875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.47265625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.546875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.0625,
            "end_logit": -7.546875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective form of lysosomal degradation targeting proteins carrying the KFERQ",
            "probability": 5.364418029785156e-07
        }
    ],
    "5540fbce234c5a7c75000001_3": [
        {
            "start_logit": 8.0390625,
            "end_logit": 6.73046875,
            "text": "Chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -1.9033203125,
            "text": "Chaperone",
            "probability": 0.00017952919006347656
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -2.970703125,
            "text": "Chaperone-mediated autophagy (",
            "probability": 6.157159805297852e-05
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -5.05859375,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 7.62939453125e-06
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -5.30078125,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": -4.0,
            "end_logit": 6.73046875,
            "text": "autophagy",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -6.859375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFERQ.",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -6.92578125,
            "text": "Chaperone-mediated",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.3125,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.37109375,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.39453125,
            "text": "Chaperone-",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.45703125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.546875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.55078125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.5625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.5625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.56640625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.578125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFERQ",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.609375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for",
            "probability": 5.960464477539062e-07
        }
    ],
    "5540fbce234c5a7c75000001_4": [
        {
            "start_logit": 8.0234375,
            "end_logit": 8.0859375,
            "text": "chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": -1.478515625,
            "end_logit": 8.0859375,
            "text": "autophagy",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -1.8115234375,
            "text": "chaperone",
            "probability": 5.02467155456543e-05
        },
        {
            "start_logit": -3.041015625,
            "end_logit": 8.0859375,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy",
            "probability": 1.5676021575927734e-05
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -5.75,
            "text": "chaperone-mediated autophagy (CMA)",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.140625,
            "text": "chaperone-mediated autophagy (",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.74609375,
            "text": "chaperone-mediated autophagy (CMA),",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.83984375,
            "end_logit": 8.0859375,
            "text": "autophagy is followed by chaperone-mediated autophagy",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 8.0859375,
            "text": "-mediated autophagy",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.8828125,
            "text": "chaperone-mediated",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.0859375,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc70 (Heat shock cognate 70) selectively binds proteins with exposed KFERQ motifs and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 8.0859375,
            "text": "mediated autophagy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 8.0859375,
            "text": "ophagy is followed by chaperone-mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 8.0859375,
            "text": "followed by chaperone-mediated autophagy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.041015625,
            "end_logit": -1.8115234375,
            "text": "Macroautophagy is followed by chaperone",
            "probability": 0.0
        },
        {
            "start_logit": -1.478515625,
            "end_logit": -5.75,
            "text": "autophagy (CMA)",
            "probability": 0.0
        },
        {
            "start_logit": -1.478515625,
            "end_logit": -6.140625,
            "text": "autophagy (",
            "probability": 0.0
        },
        {
            "start_logit": -3.041015625,
            "end_logit": -4.57421875,
            "text": "Macroautophagy",
            "probability": 0.0
        },
        {
            "start_logit": -1.478515625,
            "end_logit": -6.21484375,
            "text": "autophagy (CMA), in which Hsc70 (Heat shock cognate 70) selectively binds proteins with exposed KFERQ motifs and pushes them inside lysosomes",
            "probability": 0.0
        },
        {
            "start_logit": -1.478515625,
            "end_logit": -6.74609375,
            "text": "autophagy (CMA),",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_5": [
        {
            "start_logit": 8.0234375,
            "end_logit": 8.0859375,
            "text": "chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": -1.478515625,
            "end_logit": 8.0859375,
            "text": "autophagy",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -1.8115234375,
            "text": "chaperone",
            "probability": 5.02467155456543e-05
        },
        {
            "start_logit": -3.041015625,
            "end_logit": 8.0859375,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy",
            "probability": 1.5676021575927734e-05
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -5.75,
            "text": "chaperone-mediated autophagy (CMA)",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.140625,
            "text": "chaperone-mediated autophagy (",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.74609375,
            "text": "chaperone-mediated autophagy (CMA),",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.83984375,
            "end_logit": 8.0859375,
            "text": "autophagy is followed by chaperone-mediated autophagy",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 8.0859375,
            "text": "-mediated autophagy",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.8828125,
            "text": "chaperone-mediated",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.0859375,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc70 (Heat shock cognate 70) selectively binds proteins with exposed KFERQ motifs and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 8.0859375,
            "text": "mediated autophagy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 8.0859375,
            "text": "ophagy is followed by chaperone-mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 8.0859375,
            "text": "followed by chaperone-mediated autophagy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.041015625,
            "end_logit": -1.8115234375,
            "text": "Macroautophagy is followed by chaperone",
            "probability": 0.0
        },
        {
            "start_logit": -1.478515625,
            "end_logit": -5.75,
            "text": "autophagy (CMA)",
            "probability": 0.0
        },
        {
            "start_logit": -1.478515625,
            "end_logit": -6.140625,
            "text": "autophagy (",
            "probability": 0.0
        },
        {
            "start_logit": -3.041015625,
            "end_logit": -4.57421875,
            "text": "Macroautophagy",
            "probability": 0.0
        },
        {
            "start_logit": -1.478515625,
            "end_logit": -6.21484375,
            "text": "autophagy (CMA), in which Hsc70 (Heat shock cognate 70) selectively binds proteins with exposed KFERQ motifs and pushes them inside lysosomes",
            "probability": 0.0
        },
        {
            "start_logit": -1.478515625,
            "end_logit": -6.74609375,
            "text": "autophagy (CMA),",
            "probability": 0.0
        }
    ],
    "5540fbce234c5a7c75000001_6": [
        {
            "start_logit": 8.1015625,
            "end_logit": 7.8125,
            "text": "Chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -1.7177734375,
            "text": "Chaperone",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": -2.32421875,
            "end_logit": 7.8125,
            "text": "autophagy",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -5.23046875,
            "text": "Chaperone-mediated autophagy (",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -6.46484375,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -6.74609375,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.03125,
            "text": "Chaperone-mediated",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.90625,
            "end_logit": 7.8125,
            "text": "-mediated autophagy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.19921875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFERQ.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 7.8125,
            "text": "mediated autophagy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.58203125,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.58984375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.63671875,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.63671875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.64453125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.671875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.69140625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFERQ",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.6953125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.69921875,
            "text": "Chaperone-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -7.703125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5540fbce234c5a7c75000001_7": [
        {
            "start_logit": 7.9453125,
            "end_logit": 6.76171875,
            "text": "Chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -2.138671875,
            "text": "Chaperone",
            "probability": 0.0001366138458251953
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -4.0390625,
            "text": "Chaperone-mediated autophagy (",
            "probability": 2.0444393157958984e-05
        },
        {
            "start_logit": -4.04296875,
            "end_logit": 6.76171875,
            "text": "autophagy",
            "probability": 6.258487701416016e-06
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -5.40625,
            "text": "Chaperone-mediated autophagy (CMA)",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.13671875,
            "text": "Chaperone-mediated autophagy (CMA) is",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -6.9453125,
            "text": "Chaperone-mediated",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.1796875,
            "text": "Chaperone-mediated autophagy (CMA",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.3515625,
            "text": "Chaperone-",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.48046875,
            "text": "Chaperone-mediated autophagy (CMA) is a",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.5,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.5234375,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.5390625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.54296875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.546875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.55078125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFERQ",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.57421875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.63671875,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the degradation of soluble cytosolic proteins bearing the sequence KFER",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.66015625,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 7.9453125,
            "end_logit": -7.67578125,
            "text": "Chaperone-mediated autophagy (CMA) is a selective mechanism for the",
            "probability": 5.364418029785156e-07
        }
    ],
    "5540fbce234c5a7c75000001_8": [
        {
            "start_logit": 7.921875,
            "end_logit": 7.9765625,
            "text": "chaperone-mediated autophagy",
            "probability": 1.0
        },
        {
            "start_logit": -1.82421875,
            "end_logit": 7.9765625,
            "text": "autophagy",
            "probability": 5.829334259033203e-05
        },
        {
            "start_logit": 7.921875,
            "end_logit": -2.056640625,
            "text": "chaperone",
            "probability": 4.398822784423828e-05
        },
        {
            "start_logit": -3.8046875,
            "end_logit": 7.9765625,
            "text": "Macroautophagy is followed by chaperone-mediated autophagy",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": 7.921875,
            "end_logit": -6.1015625,
            "text": "chaperone-mediated autophagy (CMA)",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -6.56640625,
            "text": "chaperone-mediated autophagy (",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -6.91015625,
            "text": "chaperone-mediated",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.96875,
            "end_logit": 7.9765625,
            "text": "-mediated autophagy",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -6.98046875,
            "text": "chaperone-mediated autophagy (CMA),",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.09375,
            "end_logit": 7.9765625,
            "text": "autophagy is followed by chaperone-mediated autophagy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.921875,
            "end_logit": -7.22265625,
            "text": "chaperone-mediated autophagy (CMA), in which Hsc70 (Heat shock cognate 70) selectively binds proteins with exposed KFERQ motifs and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 7.9765625,
            "text": "mediated autophagy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.9765625,
            "text": "ophagy is followed by chaperone-mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 7.9765625,
            "text": "followed by chaperone-mediated autophagy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.8046875,
            "end_logit": -2.056640625,
            "text": "Macroautophagy is followed by chaperone",
            "probability": 0.0
        },
        {
            "start_logit": -1.82421875,
            "end_logit": -6.1015625,
            "text": "autophagy (CMA)",
            "probability": 0.0
        },
        {
            "start_logit": -1.82421875,
            "end_logit": -6.56640625,
            "text": "autophagy (",
            "probability": 0.0
        },
        {
            "start_logit": -1.82421875,
            "end_logit": -6.8984375,
            "text": "autophagy (CMA), in which Hsc70 (Heat shock cognate 70) selectively binds proteins with exposed KFERQ motifs and pushes them inside lysosomes",
            "probability": 0.0
        },
        {
            "start_logit": -3.8046875,
            "end_logit": -4.92578125,
            "text": "Macroautophagy",
            "probability": 0.0
        },
        {
            "start_logit": -1.82421875,
            "end_logit": -6.98046875,
            "text": "autophagy (CMA),",
            "probability": 0.0
        }
    ],
    "5ac138aa95d0062724000001_1": [
        {
            "start_logit": 5.76953125,
            "end_logit": 6.984375,
            "text": "N-arginine dibasic convertase",
            "probability": 0.9990234375
        },
        {
            "start_logit": -1.080078125,
            "end_logit": 6.984375,
            "text": "Nardilysin (N-arginine dibasic convertase",
            "probability": 0.0010652542114257812
        },
        {
            "start_logit": 5.76953125,
            "end_logit": -1.646484375,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase",
            "probability": 0.00017940998077392578
        },
        {
            "start_logit": -3.515625,
            "end_logit": 6.984375,
            "text": "ase",
            "probability": 9.304285049438477e-05
        },
        {
            "start_logit": 5.76953125,
            "end_logit": -4.140625,
            "text": "N-arginine dibasic convertase;",
            "probability": 1.4722347259521484e-05
        },
        {
            "start_logit": -2.384765625,
            "end_logit": 3.767578125,
            "text": ".",
            "probability": 1.1563301086425781e-05
        },
        {
            "start_logit": -6.30859375,
            "end_logit": 6.984375,
            "text": "arginine dibasic convertase",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": -6.3359375,
            "end_logit": 6.984375,
            "text": "dibasic convertase",
            "probability": 5.543231964111328e-06
        },
        {
            "start_logit": 5.76953125,
            "end_logit": -5.125,
            "text": "N",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": -6.40234375,
            "end_logit": 6.984375,
            "text": "convertase",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -6.578125,
            "end_logit": 6.984375,
            "text": "-arginine dibasic convertase",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -6.7578125,
            "end_logit": 6.984375,
            "text": "asic convertase",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": 1.767578125,
            "end_logit": -1.646484375,
            "text": "metalloendopeptidase",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 5.76953125,
            "end_logit": -6.39453125,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the M16 family that promotes ectodomain shedding",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 5.76953125,
            "end_logit": -6.859375,
            "text": "N-arginine dibasic convert",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 5.76953125,
            "end_logit": -7.00390625,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the M16 family that promotes ectodomain",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 5.76953125,
            "end_logit": -7.0625,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the M16",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 5.76953125,
            "end_logit": -7.06640625,
            "text": "N-arginine dibasic convertase; Nrdc) is a metallo",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 5.76953125,
            "end_logit": -7.109375,
            "text": "N-arginine dibasic convertase; Nr",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 5.76953125,
            "end_logit": -7.1171875,
            "text": "N-arginine dibasic convertase; Nrdc) is a metalloendopeptidase of the M16 family that",
            "probability": 7.748603820800781e-07
        }
    ],
    "5708a845cf1c32585100000f_1": [
        {
            "start_logit": 6.546875,
            "end_logit": 6.33984375,
            "text": "Wnt",
            "probability": 0.62548828125
        },
        {
            "start_logit": 6.12890625,
            "end_logit": 6.24609375,
            "text": "Wnt",
            "probability": 0.37353515625
        },
        {
            "start_logit": 6.546875,
            "end_logit": -0.52294921875,
            "text": "Wnt signaling",
            "probability": 0.0006513595581054688
        },
        {
            "start_logit": -5.5859375,
            "end_logit": 6.24609375,
            "text": ". Although Dishevelled is activated by Wnt",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -6.30078125,
            "end_logit": 6.24609375,
            "text": "by Wnt",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.546875,
            "end_logit": -6.921875,
            "text": "Wnt signaling is known to be important for diverse embryonic and post-natal cellular events and be regulated by the proteins Dishevelled and Axin.",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.328125,
            "text": "Wnt signaling is known to be important for diverse embryonic and post-natal cellular events and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.12890625,
            "end_logit": -6.9140625,
            "text": "Wnt and",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.12890625,
            "end_logit": -6.921875,
            "text": "Wnt and involved in signal transduction, it is not clear how Dishevelled-mediated signaling is turned off.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.375,
            "text": "Wnt signaling is known to",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.47265625,
            "text": "Wnt signaling is",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.4765625,
            "text": "Wnt signaling is known",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.546875,
            "end_logit": -7.48828125,
            "text": "Wnt signaling is known to be important for diverse embryonic and post-natal cellular events and be",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.12890625,
            "end_logit": -7.1015625,
            "text": "Wnt and involved in signal transduction, it is not clear how Dishevelled",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.12890625,
            "end_logit": -7.15234375,
            "text": "Wnt and involved in signal transduction, it is not clear",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.12890625,
            "end_logit": -7.3203125,
            "text": "Wnt and involved in signal transduction",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.12890625,
            "end_logit": -7.3359375,
            "text": "Wnt and involved in signal transduction, it is not clear how Dishevelled-mediated signaling",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.12890625,
            "end_logit": -7.45703125,
            "text": "Wnt and involved in signal transduction, it is not clear how Dishevelled-",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.12890625,
            "end_logit": -7.4921875,
            "text": "Wnt and involved in signal transduction, it is not clear how Dishevelled-mediated signaling is turned off",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.12890625,
            "end_logit": -7.50390625,
            "text": "Wnt and involved in signal transduction, it is not clear how Dishevelled-mediated",
            "probability": 4.172325134277344e-07
        }
    ],
    "5708a845cf1c32585100000f_2": [
        {
            "start_logit": 7.56640625,
            "end_logit": 4.2734375,
            "text": "Wnt signaling",
            "probability": 0.55810546875
        },
        {
            "start_logit": 7.56640625,
            "end_logit": 4.046875,
            "text": "Wnt",
            "probability": 0.441650390625
        },
        {
            "start_logit": 7.56640625,
            "end_logit": -7.61328125,
            "text": "Wnt signaling,",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -4.9609375,
            "end_logit": 4.2734375,
            "text": "canonical Wnt signaling",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -4.9609375,
            "end_logit": 4.046875,
            "text": "canonical Wnt",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.078125,
            "end_logit": 4.2734375,
            "text": ". Intriguingly, within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt signaling",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.203125,
            "end_logit": 4.2734375,
            "text": "signaling",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.078125,
            "end_logit": 4.046875,
            "text": ". Intriguingly, within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 4.2734375,
            "text": "via canonical Wnt signaling",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 4.2734375,
            "text": "diverse biological processes. Intriguingly, within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt signaling",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 4.2734375,
            "text": "biological processes. Intriguingly, within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt signaling",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 4.046875,
            "text": "via canonical Wnt",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 4.2734375,
            "text": "several diverse biological processes. Intriguingly, within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt signaling",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 4.2734375,
            "text": ", within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt signaling",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 4.2734375,
            "text": "within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt signaling",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 4.2734375,
            "text": "Dishevelled (Xdsh) controls cell fate via canonical Wnt signaling",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 4.046875,
            "text": "diverse biological processes. Intriguingly, within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 4.046875,
            "text": "biological processes. Intriguingly, within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 4.046875,
            "text": "several diverse biological processes. Intriguingly, within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 4.046875,
            "text": ", within the same tissues where Xenopus Dishevelled (Xdsh) controls cell fate via canonical Wnt",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5708a845cf1c32585100000f_3": [
        {
            "start_logit": 6.609375,
            "end_logit": 6.08984375,
            "text": "Wnt",
            "probability": 1.0
        },
        {
            "start_logit": 6.609375,
            "end_logit": -6.14453125,
            "text": "Wnt signaling",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": 6.609375,
            "end_logit": -6.75390625,
            "text": "Wnt signaling pathways",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 6.609375,
            "end_logit": -7.5234375,
            "text": "Wnt signaling pathways.",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 6.08984375,
            "text": "canonical and noncanonical Wnt",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 6.08984375,
            "text": ", are highly conserved components of canonical and noncanonical Wnt",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 6.08984375,
            "text": "nical Wnt",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 6.08984375,
            "text": "al Wnt",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 6.08984375,
            "text": "noncanonical Wnt",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 6.08984375,
            "text": "anonical Wnt",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 6.08984375,
            "text": "which have been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.08984375,
            "text": "Dishevelled (DVL) proteins, three of which have been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 6.08984375,
            "text": "of canonical and noncanonical Wnt",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 6.08984375,
            "text": "components of canonical and noncanonical Wnt",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 6.08984375,
            "text": "three of which have been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 6.08984375,
            "text": "have been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 6.08984375,
            "text": "and noncanonical Wnt",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 6.08984375,
            "text": "DVL) proteins, three of which have been identified in humans, are highly conserved components of canonical and noncanonical Wnt",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.21484375,
            "end_logit": -6.14453125,
            "text": "canonical and noncanonical Wnt signaling",
            "probability": 0.0
        },
        {
            "start_logit": -7.34765625,
            "end_logit": -6.14453125,
            "text": ", are highly conserved components of canonical and noncanonical Wnt signaling",
            "probability": 0.0
        }
    ],
    "5acf74460340b9f058000013_1": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.1328125,
            "text": "ABCC11",
            "probability": 1.0
        },
        {
            "start_logit": -1.134765625,
            "end_logit": 8.1328125,
            "text": "1",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.353515625,
            "text": "ABC",
            "probability": 7.545948028564453e-05
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 8.1328125,
            "text": "C11",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.796875,
            "text": "ABCC1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.140625,
            "end_logit": 8.1328125,
            "text": "in ABCC11",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 8.1328125,
            "text": "A single nucleotide polymorphism (SNP) in ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.4609375,
            "text": "ABCC11 affects the cerumen VOC profiles of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.1328125,
            "text": "single nucleotide polymorphism (SNP) in ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5859375,
            "text": "ABCC11 affects the cerumen VOC profiles",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.58984375,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African, Caucasian, and Asian",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.59375,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.625,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.65234375,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.65234375,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African, Caucasian",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.6953125,
            "text": "ABCC11 affects the cerumen VOC profiles of individuals from African, Caucasian, and Asian descent",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.7265625,
            "text": "ABCC11 affects the cerumen VOC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.7265625,
            "text": "ABCC11 affects",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.73828125,
            "text": "ABCC11 affects the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 8.1328125,
            "text": "SNP) in ABCC11",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5acf74460340b9f058000013_2": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.1640625,
            "text": "ABCC11",
            "probability": 1.0
        },
        {
            "start_logit": -1.05078125,
            "end_logit": 8.1640625,
            "text": "1",
            "probability": 9.459257125854492e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.333984375,
            "text": "ABC",
            "probability": 7.426738739013672e-05
        },
        {
            "start_logit": -6.1484375,
            "end_logit": 8.1640625,
            "text": "C11",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.921875,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found in human cerumen, and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.96875,
            "text": "ABCC1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.296875,
            "text": "ABCC11 genotype",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 8.1640625,
            "text": "that ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.41796875,
            "text": "ABCC11 genotype alone does",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.44921875,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found in human cerumen,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.4921875,
            "text": "ABCC11 genotype alone does not predict the type and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.51171875,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.53125,
            "text": "ABCC11 genotype alone",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.54296875,
            "text": "ABCC11 genotype alone does not",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 8.1640625,
            "text": "reveal that ABCC11",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.62109375,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.62890625,
            "text": "ABCC11 genotype alone does not predict the type and relative levels",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.64453125,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found in human cerumen, and suggest that other biochemical pathways must",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 8.1640625,
            "text": "findings also reveal that ABCC11",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.65625,
            "text": "ABCC11 genotype alone does not predict the type and relative levels of volatiles found in human cerumen, and suggest that other biochemical pathways",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5acf74460340b9f058000013_3": [
        {
            "start_logit": 8.1953125,
            "end_logit": 8.1328125,
            "text": "ABCC11",
            "probability": 1.0
        },
        {
            "start_logit": -1.2265625,
            "end_logit": 8.1328125,
            "text": "1",
            "probability": 8.094310760498047e-05
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -1.365234375,
            "text": "ABC",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": -6.37890625,
            "end_logit": 8.1328125,
            "text": "C11",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -6.94140625,
            "text": "ABCC1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.1640625,
            "text": "ABCC11 encodes an",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.328125,
            "text": "ABCC11 encodes an ATP-driven efflux pump",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.3671875,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.3984375,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an important",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.4140625,
            "text": "ABCC11 encodes an ATP-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.42578125,
            "text": "ABCC11 encodes",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.4375,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an important function in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.45703125,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an important function in ceruminous apocrine glands of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.4609375,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.48046875,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.484375,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.51171875,
            "text": "ABCC11 encodes an ATP-driven efflux pump protein that plays an important function in ceruminous",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.51953125,
            "text": "ABCC11 encodes an ATP-driven",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.2265625,
            "end_logit": -7.1640625,
            "text": "1 encodes an",
            "probability": 0.0
        },
        {
            "start_logit": -1.2265625,
            "end_logit": -7.328125,
            "text": "1 encodes an ATP-driven efflux pump",
            "probability": 0.0
        }
    ],
    "5acf74460340b9f058000013_4": [
        {
            "start_logit": 8.1328125,
            "end_logit": 8.109375,
            "text": "ABCC11",
            "probability": 1.0
        },
        {
            "start_logit": -1.28125,
            "end_logit": 8.109375,
            "text": "1",
            "probability": 8.094310760498047e-05
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -1.5400390625,
            "text": "ABC",
            "probability": 6.401538848876953e-05
        },
        {
            "start_logit": -5.29296875,
            "end_logit": 8.109375,
            "text": "the adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -5.890625,
            "text": "ABCC1",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -6.640625,
            "text": "ABCC11) to the production of different types of axillary odorants",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 8.109375,
            "text": "(ABCC11",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 8.109375,
            "text": "a single nucleotide polymorphism (SNP) in the adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 8.109375,
            "text": "adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 8.109375,
            "text": "C11",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.203125,
            "end_logit": 8.109375,
            "text": "single nucleotide polymorphism (SNP) in the adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.296875,
            "text": "ABCC11) to the production of different types of axillary odorants and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.3359375,
            "text": "ABCC11)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.4296875,
            "text": "ABCC11) to the production of different types",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.4375,
            "text": "ABCC11) to the production",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.453125,
            "text": "ABCC11) to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 8.109375,
            "text": "in the adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.109375,
            "text": "link a single nucleotide polymorphism (SNP) in the adenosine triphosphate (ATP) binding cassette, sub-family C, member 11 gene (ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.109375,
            "text": "member 11 gene (ABCC11",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.109375,
            "text": ", member 11 gene (ABCC11",
            "probability": 1.1920928955078125e-07
        }
    ],
    "62265b4a3a8413c653000083_1": [
        {
            "start_logit": 8.0234375,
            "end_logit": 5.61328125,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms are involved in adipogenesis.",
            "probability": 0.9970703125
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -1.2734375,
            "text": "Runt-related transcription factor 1",
            "probability": 0.00101470947265625
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -1.359375,
            "text": "Runt-related transcription factor 1 (",
            "probability": 0.0009307861328125
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -1.8564453125,
            "text": "Run",
            "probability": 0.0005669593811035156
        },
        {
            "start_logit": -2.94140625,
            "end_logit": 5.61328125,
            "text": ".",
            "probability": 1.71661376953125e-05
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.5,
            "text": "Runt-related transcription factor",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -6.70703125,
            "text": "Runt",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.16015625,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.16796875,
            "text": "Runt-related transcription",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.23046875,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms are",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.3125,
            "text": "Runt-related",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.34375,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms are involved in",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.390625,
            "text": "Runt-related transcription factor 1 (RUNX1T1) isoforms are involved in adipogenesis",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.44140625,
            "text": "Runt-",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 8.0234375,
            "end_logit": -7.59765625,
            "text": "Runt-related transcription factor 1 (RUNX1T1)",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.3984375,
            "end_logit": 5.61328125,
            "text": ") isoforms are involved in adipogenesis.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.46484375,
            "end_logit": 5.61328125,
            "text": "RUNX1T1) isoforms are involved in adipogenesis.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 5.61328125,
            "text": "isoforms are involved in adipogenesis.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 5.61328125,
            "text": "involved in adipogenesis.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 5.61328125,
            "text": "X1T1) isoforms are involved in adipogenesis.",
            "probability": 2.384185791015625e-07
        }
    ],
    "54e8c7220fc566b149000002_1": [
        {
            "start_logit": -2.73046875,
            "end_logit": 6.87890625,
            "text": "nucleus",
            "probability": 0.9541015625
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 6.87890625,
            "text": "the nucleus",
            "probability": 0.0111083984375
        },
        {
            "start_logit": -7.328125,
            "end_logit": 6.87890625,
            "text": "S100A4 interacts with p53 in the nucleus",
            "probability": 0.00962066650390625
        },
        {
            "start_logit": -7.328125,
            "end_logit": 6.87890625,
            "text": "in the nucleus",
            "probability": 0.00962066650390625
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 6.87890625,
            "text": "4 interacts with p53 in the nucleus",
            "probability": 0.005458831787109375
        },
        {
            "start_logit": -7.9375,
            "end_logit": 6.87890625,
            "text": "interacts with p53 in the nucleus",
            "probability": 0.00522613525390625
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 6.87890625,
            "text": "p53 in the nucleus",
            "probability": 0.00502777099609375
        },
        {
            "start_logit": -7.328125,
            "end_logit": -7.59765625,
            "text": "S100A4 interacts with",
            "probability": 0.0
        },
        {
            "start_logit": -7.328125,
            "end_logit": -7.625,
            "text": "S100A4 interacts with p53",
            "probability": 0.0
        },
        {
            "start_logit": -7.89453125,
            "end_logit": -7.59765625,
            "text": "4 interacts with",
            "probability": 0.0
        },
        {
            "start_logit": -7.89453125,
            "end_logit": -7.625,
            "text": "4 interacts with p53",
            "probability": 0.0
        },
        {
            "start_logit": -7.9375,
            "end_logit": -7.59765625,
            "text": "interacts with",
            "probability": 0.0
        },
        {
            "start_logit": -7.9375,
            "end_logit": -7.625,
            "text": "interacts with p53",
            "probability": 0.0
        },
        {
            "start_logit": -7.9765625,
            "end_logit": -7.625,
            "text": "p53",
            "probability": 0.0
        }
    ],
    "54e8c7220fc566b149000002_2": [
        {
            "start_logit": 5.3515625,
            "end_logit": 7.19140625,
            "text": "nucleus",
            "probability": 1.0
        },
        {
            "start_logit": -3.87890625,
            "end_logit": 7.19140625,
            "text": "proximity ligation assay, we show that the interaction takes place in the cell nucleus",
            "probability": 9.763240814208984e-05
        },
        {
            "start_logit": -5.19921875,
            "end_logit": 7.19140625,
            "text": "cell nucleus",
            "probability": 2.6047229766845703e-05
        },
        {
            "start_logit": -6.62890625,
            "end_logit": 7.19140625,
            "text": "using proximity ligation assay, we show that the interaction takes place in the cell nucleus",
            "probability": 6.258487701416016e-06
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 7.19140625,
            "text": ", we show that the interaction takes place in the cell nucleus",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": -6.86328125,
            "end_logit": 7.19140625,
            "text": "the interaction takes place in the cell nucleus",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -6.9375,
            "end_logit": 7.19140625,
            "text": "the cell nucleus",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -7.03125,
            "end_logit": 7.19140625,
            "text": "that the interaction takes place in the cell nucleus",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 7.19140625,
            "text": "we show that the interaction takes place in the cell nucleus",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -7.1953125,
            "end_logit": 7.19140625,
            "text": "show that the interaction takes place in the cell nucleus",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 7.19140625,
            "text": "interaction takes place in the cell nucleus",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -7.703125,
            "end_logit": 7.19140625,
            "text": "ligation assay, we show that the interaction takes place in the cell nucleus",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 7.19140625,
            "text": "in the cell nucleus",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -7.859375,
            "end_logit": 7.19140625,
            "text": "place in the cell nucleus",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 7.19140625,
            "text": "takes place in the cell nucleus",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 5.3515625,
            "end_logit": -6.3203125,
            "text": "nucleus.",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -3.87890625,
            "end_logit": -6.3203125,
            "text": "proximity ligation assay, we show that the interaction takes place in the cell nucleus.",
            "probability": 0.0
        },
        {
            "start_logit": -3.87890625,
            "end_logit": -6.7109375,
            "text": "proximity ligation assay",
            "probability": 0.0
        },
        {
            "start_logit": -3.87890625,
            "end_logit": -6.90234375,
            "text": "proximity ligation assay, we show",
            "probability": 0.0
        },
        {
            "start_logit": -3.87890625,
            "end_logit": -7.5625,
            "text": "proximity ligation assay, we show that the interaction takes",
            "probability": 0.0
        }
    ],
    "58f0b0c070f9fc6f0f000006_1": [
        {
            "start_logit": 8.171875,
            "end_logit": 8.09375,
            "text": "tardive dyskinesia",
            "probability": 1.0
        },
        {
            "start_logit": 8.171875,
            "end_logit": -1.4814453125,
            "text": "tard",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": -1.427734375,
            "end_logit": 8.09375,
            "text": "dyskinesia",
            "probability": 6.765127182006836e-05
        },
        {
            "start_logit": -6.1875,
            "end_logit": 8.09375,
            "text": "ive dyskinesia",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.16796875,
            "text": "tardive",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.2734375,
            "text": "tardive dyskinesia.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 8.09375,
            "text": "treating tardive dyskinesia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 8.09375,
            "text": "Valbenazine granted breakthrough drug status for treating tardive dyskinesia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 8.09375,
            "text": "breakthrough drug status for treating tardive dyskinesia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 8.09375,
            "text": "benazine granted breakthrough drug status for treating tardive dyskinesia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 8.09375,
            "text": "status for treating tardive dyskinesia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 8.09375,
            "text": "nazine granted breakthrough drug status for treating tardive dyskinesia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 8.09375,
            "text": "drug status for treating tardive dyskinesia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 8.09375,
            "text": "granted breakthrough drug status for treating tardive dyskinesia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 8.09375,
            "text": "zine granted breakthrough drug status for treating tardive dyskinesia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 8.09375,
            "text": "for treating tardive dyskinesia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 8.09375,
            "text": "ine granted breakthrough drug status for treating tardive dyskinesia",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.427734375,
            "end_logit": -7.2734375,
            "text": "dyskinesia.",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -1.4814453125,
            "text": "treating tard",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -1.4814453125,
            "text": "Valbenazine granted breakthrough drug status for treating tard",
            "probability": 0.0
        }
    ],
    "5aae6499fcf456587200000c_1": [
        {
            "start_logit": 6.28515625,
            "end_logit": 7.81640625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 1.0
        },
        {
            "start_logit": -2.197265625,
            "end_logit": 7.81640625,
            "text": "aureus",
            "probability": 0.0002067089080810547
        },
        {
            "start_logit": -4.6328125,
            "end_logit": 7.81640625,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -4.38671875,
            "text": "Borderline",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -5.953125,
            "end_logit": 7.81640625,
            "text": "cillin-resistant Staphylococcus aureus",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -6.4921875,
            "end_logit": 7.81640625,
            "text": "lin-resistant Staphylococcus aureus",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 7.81640625,
            "text": "-resistant Staphylococcus aureus",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -5.2734375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -6.84375,
            "end_logit": 7.81640625,
            "text": "Staphylococcus aureus",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -6.859375,
            "end_logit": 7.81640625,
            "text": "resistant Staphylococcus aureus",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -7.06640625,
            "text": "Borderline oxacillin-resistant",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -7.49609375,
            "text": "Borderline oxacillin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -7.60546875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -7.66015625,
            "text": "Borderline oxacillin-resistant Staphylococcus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.197265625,
            "end_logit": -5.2734375,
            "text": "aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -2.197265625,
            "end_logit": -7.60546875,
            "text": "aureus (BORSA)",
            "probability": 0.0
        },
        {
            "start_logit": -4.6328125,
            "end_logit": -5.2734375,
            "text": "oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -5.953125,
            "end_logit": -5.2734375,
            "text": "cillin-resistant Staphylococcus aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -4.6328125,
            "end_logit": -7.06640625,
            "text": "oxacillin-resistant",
            "probability": 0.0
        },
        {
            "start_logit": -6.4921875,
            "end_logit": -5.2734375,
            "text": "lin-resistant Staphylococcus aureus (",
            "probability": 0.0
        }
    ],
    "5aae6499fcf456587200000c_2": [
        {
            "start_logit": 6.4140625,
            "end_logit": 6.61328125,
            "text": "MRSA",
            "probability": 1.0
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -5.73828125,
            "text": "MRSA) in the clinical laboratory.",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -6.1171875,
            "end_logit": 6.61328125,
            "text": "oxacillin-resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -6.16796875,
            "end_logit": 6.61328125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 3.3974647521972656e-06
        },
        {
            "start_logit": -6.984375,
            "end_logit": 6.61328125,
            "text": "misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.1015625,
            "end_logit": 6.61328125,
            "text": "cillin-resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 6.61328125,
            "text": "identified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.19140625,
            "text": "MRSA) in",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 6.61328125,
            "text": "(MRSA",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 6.61328125,
            "text": "methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 6.61328125,
            "text": "BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 6.61328125,
            "text": "intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.484375,
            "text": "MRSA)",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 6.61328125,
            "text": "lin-resistant Staphylococcus aureus (BORSA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 6.61328125,
            "text": "ified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 6.61328125,
            "text": "SA) may be misidentified as intrinsically methicillin-resistant Staphylococcus aureus (MRSA",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.5859375,
            "text": "MRSA) in the clinical laboratory",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.1171875,
            "end_logit": -5.33203125,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": -6.16796875,
            "end_logit": -5.33203125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.0
        },
        {
            "start_logit": -7.1015625,
            "end_logit": -5.33203125,
            "text": "cillin-resistant Staphylococcus aureus",
            "probability": 0.0
        }
    ],
    "5aae6499fcf456587200000c_3": [
        {
            "start_logit": 5.62890625,
            "end_logit": 7.33203125,
            "text": "borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.9921875
        },
        {
            "start_logit": 0.734375,
            "end_logit": 7.33203125,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 0.0074005126953125
        },
        {
            "start_logit": -2.912109375,
            "end_logit": 7.33203125,
            "text": "aureus",
            "probability": 0.00019407272338867188
        },
        {
            "start_logit": 5.62890625,
            "end_logit": -3.71484375,
            "text": "borderline",
            "probability": 1.5795230865478516e-05
        },
        {
            "start_logit": -6.13671875,
            "end_logit": 7.33203125,
            "text": "resistant Staphylococcus aureus",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": -6.18359375,
            "end_logit": 7.33203125,
            "text": "cillin-resistant Staphylococcus aureus",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": -6.3515625,
            "end_logit": 7.33203125,
            "text": "Staphylococcus aureus",
            "probability": 6.198883056640625e-06
        },
        {
            "start_logit": 5.62890625,
            "end_logit": -4.796875,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": -6.8359375,
            "end_logit": 7.33203125,
            "text": "lin-resistant Staphylococcus aureus",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 7.33203125,
            "text": "against borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -7.0703125,
            "end_logit": 7.33203125,
            "text": "-resistant Staphylococcus aureus",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -7.15625,
            "end_logit": 7.33203125,
            "text": "Since it is unknown whether \u03b2-lactam antimicrobial agents can be used effectively against borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.33203125,
            "text": "\u03b2-lactam antimicrobial agents can be used effectively against borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -7.421875,
            "end_logit": 7.33203125,
            "text": "it is unknown whether \u03b2-lactam antimicrobial agents can be used effectively against borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 5.62890625,
            "end_logit": -5.94921875,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 5.62890625,
            "end_logit": -6.3671875,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs \u22654",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 5.62890625,
            "end_logit": -7.015625,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs \u22654 mg/",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 5.62890625,
            "end_logit": -7.1796875,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacillin MICs \u2265",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 5.62890625,
            "end_logit": -7.2265625,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA) with oxacil",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 5.62890625,
            "end_logit": -7.265625,
            "text": "borderline oxacillin",
            "probability": 4.76837158203125e-07
        }
    ],
    "5aae6499fcf456587200000c_4": [
        {
            "start_logit": 8.203125,
            "end_logit": 6.69140625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.998046875
        },
        {
            "start_logit": 8.203125,
            "end_logit": 0.344482421875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin resistance.",
            "probability": 0.0017538070678710938
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.29296875,
            "text": "Borderline",
            "probability": 0.0003414154052734375
        },
        {
            "start_logit": 8.203125,
            "end_logit": -2.412109375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin resistance",
            "probability": 0.0001112818717956543
        },
        {
            "start_logit": 8.203125,
            "end_logit": -3.82421875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 2.7060508728027344e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -5.3125,
            "text": "Borderline oxacillin-resistant",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": -3.994140625,
            "end_logit": 6.69140625,
            "text": "aureus",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.296875,
            "text": "Borderline oxacillin",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.80859375,
            "text": "Borderline oxa",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.01171875,
            "text": "Borderline oxacil",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.31640625,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.33984375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.38671875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.43359375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.48046875,
            "text": "Borderline oxacillin-",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5078125,
            "text": "Borderline oxacillin-resistant Staphylococcus",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5078125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5703125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.58984375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 6.69140625,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 2.980232238769531e-07
        }
    ],
    "5aae6499fcf456587200000c_5": [
        {
            "start_logit": 6.4375,
            "end_logit": 6.65234375,
            "text": "mecA",
            "probability": 0.8017578125
        },
        {
            "start_logit": 6.4375,
            "end_logit": 5.23046875,
            "text": "mecA, which encodes the low-affinity penicillin-binding protein (PBP)2a.",
            "probability": 0.1934814453125
        },
        {
            "start_logit": 7.703125,
            "end_logit": -0.1864013671875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.0030307769775390625
        },
        {
            "start_logit": 7.703125,
            "end_logit": -1.2099609375,
            "text": "Borderline",
            "probability": 0.0010890960693359375
        },
        {
            "start_logit": 7.703125,
            "end_logit": -2.705078125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin",
            "probability": 0.0002448558807373047
        },
        {
            "start_logit": 7.703125,
            "end_logit": -2.94921875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.00019073486328125
        },
        {
            "start_logit": -2.40234375,
            "end_logit": 6.65234375,
            "text": "oxacillin MIC values of 1-8 microg ml(-1), but lack mecA",
            "probability": 0.0001156926155090332
        },
        {
            "start_logit": -1.732421875,
            "end_logit": 5.23046875,
            "text": ".",
            "probability": 5.46574592590332e-05
        },
        {
            "start_logit": 6.4375,
            "end_logit": -3.1171875,
            "text": "mec",
            "probability": 4.565715789794922e-05
        },
        {
            "start_logit": 7.703125,
            "end_logit": -4.8203125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of 1",
            "probability": 2.950429916381836e-05
        },
        {
            "start_logit": -3.94140625,
            "end_logit": 6.65234375,
            "text": "A",
            "probability": 2.47955322265625e-05
        },
        {
            "start_logit": 7.703125,
            "end_logit": -5.71875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit",
            "probability": 1.1980533599853516e-05
        },
        {
            "start_logit": 6.4375,
            "end_logit": -4.6484375,
            "text": "mecA, which encodes the low-affinity penicillin-binding protein (PBP)2a",
            "probability": 9.894371032714844e-06
        },
        {
            "start_logit": 7.703125,
            "end_logit": -5.94921875,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of 1-8 microg ml(-1),",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": 7.703125,
            "end_logit": -6.24609375,
            "text": "Borderline oxacillin",
            "probability": 7.092952728271484e-06
        },
        {
            "start_logit": 7.703125,
            "end_logit": -6.3125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of 1-8 microg ml(-1), but",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": 7.703125,
            "end_logit": -6.328125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": 7.703125,
            "end_logit": -6.39453125,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": 7.703125,
            "end_logit": -6.40234375,
            "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) exhibit oxacillin MIC values of",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": -3.94140625,
            "end_logit": 5.23046875,
            "text": "A, which encodes the low-affinity penicillin-binding protein (PBP)2a.",
            "probability": 5.9604644775390625e-06
        }
    ],
    "5aae6499fcf456587200000c_6": [
        {
            "start_logit": 5.375,
            "end_logit": 7.73828125,
            "text": "borderline oxacillin resistant Staphylococcus aureus",
            "probability": 0.9990234375
        },
        {
            "start_logit": -2.3671875,
            "end_logit": 7.73828125,
            "text": "aureus",
            "probability": 0.0004353523254394531
        },
        {
            "start_logit": -4.80078125,
            "end_logit": 7.73828125,
            "text": "oxacillin resistant Staphylococcus aureus",
            "probability": 3.814697265625e-05
        },
        {
            "start_logit": -5.84765625,
            "end_logit": 7.73828125,
            "text": "cillin resistant Staphylococcus aureus",
            "probability": 1.341104507446289e-05
        },
        {
            "start_logit": -6.37890625,
            "end_logit": 7.73828125,
            "text": "lin resistant Staphylococcus aureus",
            "probability": 7.867813110351562e-06
        },
        {
            "start_logit": -6.90625,
            "end_logit": 7.73828125,
            "text": "Staphylococcus aureus",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 7.73828125,
            "text": "resistant Staphylococcus aureus",
            "probability": 3.993511199951172e-06
        },
        {
            "start_logit": 5.375,
            "end_logit": -5.3671875,
            "text": "borderline",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 5.375,
            "end_logit": -5.76953125,
            "text": "borderline oxacillin resistant Staphylococcus aureus (",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 5.375,
            "end_logit": -6.6953125,
            "text": "borderline oxacillin resistant",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.375,
            "end_logit": -7.24609375,
            "text": "borderline oxacillin",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.375,
            "end_logit": -7.57421875,
            "text": "borderline oxacillin resistant Staphylococcus aureus (BORSA)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.375,
            "end_logit": -7.65625,
            "text": "borderline oxacillin resistant Staphylococcus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.3671875,
            "end_logit": -5.76953125,
            "text": "aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -2.3671875,
            "end_logit": -7.57421875,
            "text": "aureus (BORSA)",
            "probability": 0.0
        },
        {
            "start_logit": -4.80078125,
            "end_logit": -5.76953125,
            "text": "oxacillin resistant Staphylococcus aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -4.80078125,
            "end_logit": -6.6953125,
            "text": "oxacillin resistant",
            "probability": 0.0
        },
        {
            "start_logit": -5.84765625,
            "end_logit": -5.76953125,
            "text": "cillin resistant Staphylococcus aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -4.80078125,
            "end_logit": -7.24609375,
            "text": "oxacillin",
            "probability": 0.0
        },
        {
            "start_logit": -6.37890625,
            "end_logit": -5.76953125,
            "text": "lin resistant Staphylococcus aureus (",
            "probability": 0.0
        }
    ],
    "5aae6499fcf456587200000c_7": [
        {
            "start_logit": 6.28515625,
            "end_logit": 7.81640625,
            "text": "borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 1.0
        },
        {
            "start_logit": -2.197265625,
            "end_logit": 7.81640625,
            "text": "aureus",
            "probability": 0.0002067089080810547
        },
        {
            "start_logit": -4.6328125,
            "end_logit": 7.81640625,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 1.806020736694336e-05
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -4.38671875,
            "text": "borderline",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -5.953125,
            "end_logit": 7.81640625,
            "text": "cillin-resistant Staphylococcus aureus",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -6.4921875,
            "end_logit": 7.81640625,
            "text": "lin-resistant Staphylococcus aureus",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 7.81640625,
            "text": "-resistant Staphylococcus aureus",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -5.2734375,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -6.84375,
            "end_logit": 7.81640625,
            "text": "Staphylococcus aureus",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -6.859375,
            "end_logit": 7.81640625,
            "text": "resistant Staphylococcus aureus",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -7.06640625,
            "text": "borderline oxacillin-resistant",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -7.49609375,
            "text": "borderline oxacillin",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -7.60546875,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (BORSA)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -7.66015625,
            "text": "borderline oxacillin-resistant Staphylococcus",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.197265625,
            "end_logit": -5.2734375,
            "text": "aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -2.197265625,
            "end_logit": -7.60546875,
            "text": "aureus (BORSA)",
            "probability": 0.0
        },
        {
            "start_logit": -4.6328125,
            "end_logit": -5.2734375,
            "text": "oxacillin-resistant Staphylococcus aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -5.953125,
            "end_logit": -5.2734375,
            "text": "cillin-resistant Staphylococcus aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -4.6328125,
            "end_logit": -7.06640625,
            "text": "oxacillin-resistant",
            "probability": 0.0
        },
        {
            "start_logit": -6.4921875,
            "end_logit": -5.2734375,
            "text": "lin-resistant Staphylococcus aureus (",
            "probability": 0.0
        }
    ],
    "5aae6499fcf456587200000c_8": [
        {
            "start_logit": 4.375,
            "end_logit": 7.25,
            "text": "borderline oxacillin-resistant Staphylococcus aureus",
            "probability": 0.998046875
        },
        {
            "start_logit": -2.6640625,
            "end_logit": 7.25,
            "text": "oxacillin-resistant Staphylococcus aureus",
            "probability": 0.0008749961853027344
        },
        {
            "start_logit": -3.337890625,
            "end_logit": 7.25,
            "text": "aureus",
            "probability": 0.0004470348358154297
        },
        {
            "start_logit": 4.375,
            "end_logit": -2.337890625,
            "text": "borderline oxacillin-resistant Staphylococcus aureus (",
            "probability": 6.854534149169922e-05
        },
        {
            "start_logit": -5.37890625,
            "end_logit": 7.25,
            "text": "cillin-resistant Staphylococcus aureus",
            "probability": 5.817413330078125e-05
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 7.25,
            "text": "lin-resistant Staphylococcus aureus",
            "probability": 2.0384788513183594e-05
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 7.25,
            "text": "Staphylococcus aureus",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 7.25,
            "text": "-resistant Staphylococcus aureus",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": -6.98046875,
            "end_logit": 7.25,
            "text": "resistant Staphylococcus aureus",
            "probability": 1.1682510375976562e-05
        },
        {
            "start_logit": 4.375,
            "end_logit": -5.9921875,
            "text": "borderline",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 4.375,
            "end_logit": -6.80078125,
            "text": "borderline oxacillin-resistant",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 4.375,
            "end_logit": -7.484375,
            "text": "borderline oxacillin",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 4.375,
            "end_logit": -7.69921875,
            "text": "borderline oxacillin-resistant Staphylococcus",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -2.6640625,
            "end_logit": -2.337890625,
            "text": "oxacillin-resistant Staphylococcus aureus (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.337890625,
            "end_logit": -2.337890625,
            "text": "aureus (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.37890625,
            "end_logit": -2.337890625,
            "text": "cillin-resistant Staphylococcus aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -6.42578125,
            "end_logit": -2.337890625,
            "text": "lin-resistant Staphylococcus aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -6.79296875,
            "end_logit": -2.337890625,
            "text": "Staphylococcus aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -6.96484375,
            "end_logit": -2.337890625,
            "text": "-resistant Staphylococcus aureus (",
            "probability": 0.0
        },
        {
            "start_logit": -6.98046875,
            "end_logit": -2.337890625,
            "text": "resistant Staphylococcus aureus (",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_1": [
        {
            "start_logit": 8.25,
            "end_logit": 8.203125,
            "text": "Parkinson's Disease",
            "probability": 1.0
        },
        {
            "start_logit": -0.95068359375,
            "end_logit": 8.203125,
            "text": "Disease",
            "probability": 0.00010073184967041016
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.025390625,
            "text": "Parkinson",
            "probability": 9.840726852416992e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -4.296875,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -5.8046875,
            "end_logit": 8.203125,
            "text": "'s Disease",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -5.8984375,
            "end_logit": 8.203125,
            "text": "s Disease",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.6640625,
            "text": "Parkinson's Disease Rating",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.89453125,
            "end_logit": 8.203125,
            "text": "Unified Parkinson's Disease",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.25,
            "text": "Parkinson's",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.2890625,
            "text": "Parkinson's Disease Rating Scale",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 8.203125,
            "text": "the Unified Parkinson's Disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.35546875,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor Questionnaire (QUEST) were",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.3671875,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor Questionnaire (QUEST",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.42578125,
            "text": "Parkinson'",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.42578125,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.4296875,
            "text": "Parkinson's Disease Rating Scale,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.203125,
            "text": ", the Unified Parkinson's Disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 8.203125,
            "text": ", the Fahn-Tolosa-Marin (FTM) scale, the Unified Parkinson's Disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.51953125,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor Questionnaire (QUEST) were administered along with kinematic assessment of the treated limb",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.546875,
            "text": "Parkinson's Disease Rating Scale, and the Quality of Life for Essential Tremor Questionnaire (",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e46eb7a3f5415952900000d_2": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.140625,
            "text": "essential tremor",
            "probability": 1.0
        },
        {
            "start_logit": -1.13671875,
            "end_logit": 8.140625,
            "text": "tremor",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.251953125,
            "text": "essential",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": -2.291015625,
            "end_logit": 8.140625,
            "text": "Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 2.7298927307128906e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -3.265625,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -4.9140625,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor are probably too low for patients with severe tremor",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.6796875,
            "text": "essential tremor (ET",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3671875,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4 of upper limb",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.42578125,
            "text": "essential tremor (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4921875,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.515625,
            "text": "essential tremor (ET), but its anchors for ratings from 0 to 4",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.52734375,
            "text": "essential tremor (ET)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 8.140625,
            "text": "for Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 8.140625,
            "text": "Clinical Rating Scale for Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 8.140625,
            "text": ": The Fahn-Tolosa-Marin Clinical Rating Scale for Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 8.140625,
            "text": "Background: The Fahn-Tolosa-Marin Clinical Rating Scale for Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 8.140625,
            "text": "Fahn-Tolosa-Marin Clinical Rating Scale for Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.140625,
            "text": "The Fahn-Tolosa-Marin Clinical Rating Scale for Tremor (FTM) has been used in large trials for essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.291015625,
            "end_logit": -1.251953125,
            "text": "Tremor (FTM) has been used in large trials for essential",
            "probability": 0.0
        },
        {
            "start_logit": -1.13671875,
            "end_logit": -3.265625,
            "text": "tremor (ET), but its anchors for ratings from 0 to 4 of upper limb tremor",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_3": [
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2890625,
            "text": "Essential Tremor",
            "probability": 0.1663818359375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.2890625,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential Tremor",
            "probability": 0.1663818359375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.2890625,
            "text": "Essential Tremor",
            "probability": 0.1663818359375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.28125,
            "text": "Essential Tremor",
            "probability": 0.1636962890625
        },
        {
            "start_logit": 8.21875,
            "end_logit": 8.328125,
            "text": "Essential Tremor",
            "probability": 0.1636962890625
        },
        {
            "start_logit": 8.21875,
            "end_logit": 8.2890625,
            "text": "Essential Tremor Questionnaire), and one screening instrument (the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.15625
        },
        {
            "start_logit": 5.4921875,
            "end_logit": 8.28125,
            "text": "Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.01023101806640625
        },
        {
            "start_logit": 6.609375,
            "end_logit": 6.2578125,
            "text": "Tremor",
            "probability": 0.004131317138671875
        },
        {
            "start_logit": 3.18359375,
            "end_logit": 8.328125,
            "text": "Tremor ADL Scale), one quality-of-life scale (the Quality of Life in Essential Tremor",
            "probability": 0.0010690689086914062
        },
        {
            "start_logit": 6.609375,
            "end_logit": 3.794921875,
            "text": "Tremor Rating Scale, the Bain and Findley Clinical Tremor",
            "probability": 0.0003528594970703125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 1.9072265625,
            "text": "Essential Tremor Rating Assessment Scale), one ADL/disability scale (the Bain and Findley Tremor",
            "probability": 0.0002810955047607422
        },
        {
            "start_logit": 8.265625,
            "end_logit": 1.9072265625,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential Tremor Rating Assessment Scale), one ADL/disability scale (the Bain and Findley Tremor",
            "probability": 0.0002789497375488281
        },
        {
            "start_logit": 1.658203125,
            "end_logit": 8.2890625,
            "text": "Tremor Research Group Essential Tremor",
            "probability": 0.0002224445343017578
        },
        {
            "start_logit": 5.4921875,
            "end_logit": 3.794921875,
            "text": "Tremor",
            "probability": 0.00011539459228515625
        },
        {
            "start_logit": 0.04425048828125,
            "end_logit": 8.328125,
            "text": "Tremor",
            "probability": 4.6253204345703125e-05
        },
        {
            "start_logit": 0.04425048828125,
            "end_logit": 8.2890625,
            "text": "Tremor Questionnaire), and one screening instrument (the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 4.45246696472168e-05
        },
        {
            "start_logit": -0.064453125,
            "end_logit": 8.28125,
            "text": "Clinical Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 3.9577484130859375e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.0789794921875,
            "text": "Essential Tremor Rating Scale, and the Tremor",
            "probability": 3.832578659057617e-05
        },
        {
            "start_logit": 1.796875,
            "end_logit": 6.2578125,
            "text": "tremor severity scales (the Fahn-Tolosa-Marin Tremor",
            "probability": 3.361701965332031e-05
        },
        {
            "start_logit": -0.2471923828125,
            "end_logit": 8.2890625,
            "text": "Tremor",
            "probability": 3.30805778503418e-05
        }
    ],
    "5e46eb7a3f5415952900000d_4": [
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2890625,
            "text": "Essential Tremor",
            "probability": 0.1663818359375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.2890625,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential Tremor",
            "probability": 0.1663818359375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.2890625,
            "text": "Essential Tremor",
            "probability": 0.1663818359375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.28125,
            "text": "Essential Tremor",
            "probability": 0.1636962890625
        },
        {
            "start_logit": 8.21875,
            "end_logit": 8.328125,
            "text": "Essential Tremor",
            "probability": 0.1636962890625
        },
        {
            "start_logit": 8.21875,
            "end_logit": 8.2890625,
            "text": "Essential Tremor Questionnaire), and one screening instrument (the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.15625
        },
        {
            "start_logit": 5.4921875,
            "end_logit": 8.28125,
            "text": "Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.01023101806640625
        },
        {
            "start_logit": 6.609375,
            "end_logit": 6.2578125,
            "text": "Tremor",
            "probability": 0.004131317138671875
        },
        {
            "start_logit": 3.18359375,
            "end_logit": 8.328125,
            "text": "Tremor ADL Scale), one quality-of-life scale (the Quality of Life in Essential Tremor",
            "probability": 0.0010690689086914062
        },
        {
            "start_logit": 6.609375,
            "end_logit": 3.794921875,
            "text": "Tremor Rating Scale, the Bain and Findley Clinical Tremor",
            "probability": 0.0003528594970703125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 1.9072265625,
            "text": "Essential Tremor Rating Assessment Scale), one ADL/disability scale (the Bain and Findley Tremor",
            "probability": 0.0002810955047607422
        },
        {
            "start_logit": 8.265625,
            "end_logit": 1.9072265625,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential Tremor Rating Assessment Scale), one ADL/disability scale (the Bain and Findley Tremor",
            "probability": 0.0002789497375488281
        },
        {
            "start_logit": 1.658203125,
            "end_logit": 8.2890625,
            "text": "Tremor Research Group Essential Tremor",
            "probability": 0.0002224445343017578
        },
        {
            "start_logit": 5.4921875,
            "end_logit": 3.794921875,
            "text": "Tremor",
            "probability": 0.00011539459228515625
        },
        {
            "start_logit": 0.04425048828125,
            "end_logit": 8.328125,
            "text": "Tremor",
            "probability": 4.6253204345703125e-05
        },
        {
            "start_logit": 0.04425048828125,
            "end_logit": 8.2890625,
            "text": "Tremor Questionnaire), and one screening instrument (the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 4.45246696472168e-05
        },
        {
            "start_logit": -0.064453125,
            "end_logit": 8.28125,
            "text": "Clinical Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 3.9577484130859375e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.0789794921875,
            "text": "Essential Tremor Rating Scale, and the Tremor",
            "probability": 3.832578659057617e-05
        },
        {
            "start_logit": 1.796875,
            "end_logit": 6.2578125,
            "text": "tremor severity scales (the Fahn-Tolosa-Marin Tremor",
            "probability": 3.361701965332031e-05
        },
        {
            "start_logit": -0.2471923828125,
            "end_logit": 8.2890625,
            "text": "Tremor",
            "probability": 3.30805778503418e-05
        }
    ],
    "5e46eb7a3f5415952900000d_5": [
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2890625,
            "text": "Essential Tremor",
            "probability": 0.1663818359375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.2890625,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential Tremor",
            "probability": 0.1663818359375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.2890625,
            "text": "Essential Tremor",
            "probability": 0.1663818359375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.28125,
            "text": "Essential Tremor",
            "probability": 0.1636962890625
        },
        {
            "start_logit": 8.21875,
            "end_logit": 8.328125,
            "text": "Essential Tremor",
            "probability": 0.1636962890625
        },
        {
            "start_logit": 8.21875,
            "end_logit": 8.2890625,
            "text": "Essential Tremor Questionnaire), and one screening instrument (the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.15625
        },
        {
            "start_logit": 5.4921875,
            "end_logit": 8.28125,
            "text": "Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.01023101806640625
        },
        {
            "start_logit": 6.609375,
            "end_logit": 6.2578125,
            "text": "Tremor",
            "probability": 0.004131317138671875
        },
        {
            "start_logit": 3.18359375,
            "end_logit": 8.328125,
            "text": "Tremor ADL Scale), one quality-of-life scale (the Quality of Life in Essential Tremor",
            "probability": 0.0010690689086914062
        },
        {
            "start_logit": 6.609375,
            "end_logit": 3.794921875,
            "text": "Tremor Rating Scale, the Bain and Findley Clinical Tremor",
            "probability": 0.0003528594970703125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 1.9072265625,
            "text": "Essential Tremor Rating Assessment Scale), one ADL/disability scale (the Bain and Findley Tremor",
            "probability": 0.0002810955047607422
        },
        {
            "start_logit": 8.265625,
            "end_logit": 1.9072265625,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential Tremor Rating Assessment Scale), one ADL/disability scale (the Bain and Findley Tremor",
            "probability": 0.0002789497375488281
        },
        {
            "start_logit": 1.658203125,
            "end_logit": 8.2890625,
            "text": "Tremor Research Group Essential Tremor",
            "probability": 0.0002224445343017578
        },
        {
            "start_logit": 5.4921875,
            "end_logit": 3.794921875,
            "text": "Tremor",
            "probability": 0.00011539459228515625
        },
        {
            "start_logit": 0.04425048828125,
            "end_logit": 8.328125,
            "text": "Tremor",
            "probability": 4.6253204345703125e-05
        },
        {
            "start_logit": 0.04425048828125,
            "end_logit": 8.2890625,
            "text": "Tremor Questionnaire), and one screening instrument (the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 4.45246696472168e-05
        },
        {
            "start_logit": -0.064453125,
            "end_logit": 8.28125,
            "text": "Clinical Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 3.9577484130859375e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.0789794921875,
            "text": "Essential Tremor Rating Scale, and the Tremor",
            "probability": 3.832578659057617e-05
        },
        {
            "start_logit": 1.796875,
            "end_logit": 6.2578125,
            "text": "tremor severity scales (the Fahn-Tolosa-Marin Tremor",
            "probability": 3.361701965332031e-05
        },
        {
            "start_logit": -0.2471923828125,
            "end_logit": 8.2890625,
            "text": "Tremor",
            "probability": 3.30805778503418e-05
        }
    ],
    "5e46eb7a3f5415952900000d_6": [
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2890625,
            "text": "Essential Tremor",
            "probability": 0.1663818359375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.2890625,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential Tremor",
            "probability": 0.1663818359375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.2890625,
            "text": "Essential Tremor",
            "probability": 0.1663818359375
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.28125,
            "text": "Essential Tremor",
            "probability": 0.1636962890625
        },
        {
            "start_logit": 8.21875,
            "end_logit": 8.328125,
            "text": "Essential Tremor",
            "probability": 0.1636962890625
        },
        {
            "start_logit": 8.21875,
            "end_logit": 8.2890625,
            "text": "Essential Tremor Questionnaire), and one screening instrument (the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.15625
        },
        {
            "start_logit": 5.4921875,
            "end_logit": 8.28125,
            "text": "Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 0.01023101806640625
        },
        {
            "start_logit": 6.609375,
            "end_logit": 6.2578125,
            "text": "Tremor",
            "probability": 0.004131317138671875
        },
        {
            "start_logit": 3.18359375,
            "end_logit": 8.328125,
            "text": "Tremor ADL Scale), one quality-of-life scale (the Quality of Life in Essential Tremor",
            "probability": 0.0010690689086914062
        },
        {
            "start_logit": 6.609375,
            "end_logit": 3.794921875,
            "text": "Tremor Rating Scale, the Bain and Findley Clinical Tremor",
            "probability": 0.0003528594970703125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 1.9072265625,
            "text": "Essential Tremor Rating Assessment Scale), one ADL/disability scale (the Bain and Findley Tremor",
            "probability": 0.0002810955047607422
        },
        {
            "start_logit": 8.265625,
            "end_logit": 1.9072265625,
            "text": "Essential Tremor Rating Scale, and the Tremor Research Group Essential Tremor Rating Assessment Scale), one ADL/disability scale (the Bain and Findley Tremor",
            "probability": 0.0002789497375488281
        },
        {
            "start_logit": 1.658203125,
            "end_logit": 8.2890625,
            "text": "Tremor Research Group Essential Tremor",
            "probability": 0.0002224445343017578
        },
        {
            "start_logit": 5.4921875,
            "end_logit": 3.794921875,
            "text": "Tremor",
            "probability": 0.00011539459228515625
        },
        {
            "start_logit": 0.04425048828125,
            "end_logit": 8.328125,
            "text": "Tremor",
            "probability": 4.6253204345703125e-05
        },
        {
            "start_logit": 0.04425048828125,
            "end_logit": 8.2890625,
            "text": "Tremor Questionnaire), and one screening instrument (the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 4.45246696472168e-05
        },
        {
            "start_logit": -0.064453125,
            "end_logit": 8.28125,
            "text": "Clinical Tremor Rating Scale, the Bain and Findley Spirography Scale, the Washington Heights-Inwood Genetic Study of Essential Tremor",
            "probability": 3.9577484130859375e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.0789794921875,
            "text": "Essential Tremor Rating Scale, and the Tremor",
            "probability": 3.832578659057617e-05
        },
        {
            "start_logit": 1.796875,
            "end_logit": 6.2578125,
            "text": "tremor severity scales (the Fahn-Tolosa-Marin Tremor",
            "probability": 3.361701965332031e-05
        },
        {
            "start_logit": -0.2471923828125,
            "end_logit": 8.2890625,
            "text": "Tremor",
            "probability": 3.30805778503418e-05
        }
    ],
    "5e46eb7a3f5415952900000d_7": [
        {
            "start_logit": 8.140625,
            "end_logit": 8.171875,
            "text": "essential tremor",
            "probability": 0.85595703125
        },
        {
            "start_logit": 6.234375,
            "end_logit": 8.171875,
            "text": "Tremor Rating Scale (TRS) in essential tremor",
            "probability": 0.1273193359375
        },
        {
            "start_logit": 6.234375,
            "end_logit": 6.1328125,
            "text": "Tremor",
            "probability": 0.016571044921875
        },
        {
            "start_logit": -1.09375,
            "end_logit": 8.171875,
            "text": "tremor",
            "probability": 8.356571197509766e-05
        },
        {
            "start_logit": 8.140625,
            "end_logit": -1.4853515625,
            "text": "essential",
            "probability": 5.4836273193359375e-05
        },
        {
            "start_logit": 6.234375,
            "end_logit": -1.4853515625,
            "text": "Tremor Rating Scale (TRS) in essential",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": 8.140625,
            "end_logit": -6.75390625,
            "text": "essential tremor (ET",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -6.98828125,
            "text": "essential tremor (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.3515625,
            "text": "essential tremor (ET)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 8.171875,
            "text": "study was to evaluate interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 8.171875,
            "text": "was to evaluate interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 8.171875,
            "text": "evaluate interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 8.171875,
            "text": "to evaluate interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 8.171875,
            "text": "in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 8.171875,
            "text": "interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 8.171875,
            "text": "Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 8.171875,
            "text": "intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale (TRS) in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.234375,
            "end_logit": -6.75390625,
            "text": "Tremor Rating Scale (TRS) in essential tremor (ET",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.234375,
            "end_logit": -6.98828125,
            "text": "Tremor Rating Scale (TRS) in essential tremor (",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.234375,
            "end_logit": -7.0234375,
            "text": "Tremor Rating Scale (TRS",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e46eb7a3f5415952900000d_8": [
        {
            "start_logit": 8.1953125,
            "end_logit": 8.1171875,
            "text": "essential tremor",
            "probability": 0.84814453125
        },
        {
            "start_logit": 6.30078125,
            "end_logit": 8.1171875,
            "text": "Tremor Rating Scale in essential tremor",
            "probability": 0.1280517578125
        },
        {
            "start_logit": 6.30078125,
            "end_logit": 6.4375,
            "text": "Tremor",
            "probability": 0.0236968994140625
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -1.294921875,
            "text": "essential",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": -1.384765625,
            "end_logit": 8.1171875,
            "text": "tremor",
            "probability": 5.8710575103759766e-05
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -1.294921875,
            "text": "Tremor Rating Scale in essential",
            "probability": 1.049041748046875e-05
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 8.1171875,
            "text": "in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 8.1171875,
            "text": "Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 8.1171875,
            "text": "Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 8.1171875,
            "text": "n Tremor Rating Scale in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 8.1171875,
            "text": "Marin Tremor Rating Scale in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 8.1171875,
            "text": "interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 8.1171875,
            "text": "of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 8.1171875,
            "text": "and intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 8.1171875,
            "text": "rater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 8.1171875,
            "text": "intrarater reliability of the Fahn-Tolosa-Marin Tremor Rating Scale in essential tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -7.28125,
            "text": "Tremor Rating",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -7.40234375,
            "text": "Tremor Rating Scale",
            "probability": 0.0
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 6.4375,
            "text": "Assessment of interrater and intrarater reliability of the Fahn-Tolosa-Marin Tremor",
            "probability": 0.0
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -7.66796875,
            "text": "Tremor Rating Scale in",
            "probability": 0.0
        }
    ],
    "5e46eb7a3f5415952900000d_9": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.15625,
            "text": "Essential Tremor",
            "probability": 1.0
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.1953125,
            "text": "Essential",
            "probability": 8.684396743774414e-05
        },
        {
            "start_logit": -1.185546875,
            "end_logit": 8.15625,
            "text": "Tremor",
            "probability": 8.094310760498047e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4140625,
            "text": "Essential Tremor Rating Assessment Scale",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4375,
            "text": "Essential Tremor Rating Assessment",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4765625,
            "text": "Essential Tremor Rating",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 8.15625,
            "text": "Comparison of the Fahn-Tolosa-Marin Clinical Rating Scale and the Essential Tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 8.15625,
            "text": "the Essential Tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 8.15625,
            "text": "and the Essential Tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 8.15625,
            "text": "Clinical Rating Scale and the Essential Tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 8.15625,
            "text": "Rating Scale and the Essential Tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 8.15625,
            "text": "Fahn-Tolosa-Marin Clinical Rating Scale and the Essential Tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 8.15625,
            "text": "Marin Clinical Rating Scale and the Essential Tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 8.15625,
            "text": "of the Fahn-Tolosa-Marin Clinical Rating Scale and the Essential Tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 8.15625,
            "text": "the Fahn-Tolosa-Marin Clinical Rating Scale and the Essential Tremor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.185546875,
            "end_logit": -7.4140625,
            "text": "Tremor Rating Assessment Scale",
            "probability": 0.0
        },
        {
            "start_logit": -1.185546875,
            "end_logit": -7.4375,
            "text": "Tremor Rating Assessment",
            "probability": 0.0
        },
        {
            "start_logit": -1.185546875,
            "end_logit": -7.4765625,
            "text": "Tremor Rating",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -1.1953125,
            "text": "Comparison of the Fahn-Tolosa-Marin Clinical Rating Scale and the Essential",
            "probability": 0.0
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -1.1953125,
            "text": "the Essential",
            "probability": 0.0
        }
    ],
    "58f4b1a170f9fc6f0f000010_1": [
        {
            "start_logit": -3.01953125,
            "end_logit": 4.203125,
            "text": "Amanita phalloides",
            "probability": 0.85595703125
        },
        {
            "start_logit": -5.11328125,
            "end_logit": 4.203125,
            "text": "in Amanita phalloides",
            "probability": 0.10552978515625
        },
        {
            "start_logit": -6.6484375,
            "end_logit": 4.203125,
            "text": "ides",
            "probability": 0.022735595703125
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 4.203125,
            "text": "anita phalloides",
            "probability": 0.0096588134765625
        },
        {
            "start_logit": -8.0625,
            "end_logit": 4.203125,
            "text": "liver transplantation improves patients' short-term post liver transplantation survival in Amanita phalloides",
            "probability": 0.005527496337890625
        },
        {
            "start_logit": -3.01953125,
            "end_logit": -4.8828125,
            "text": "Amanita phalloides poisoning",
            "probability": 9.697675704956055e-05
        },
        {
            "start_logit": -3.01953125,
            "end_logit": -5.89453125,
            "text": "Amanita phal",
            "probability": 3.540515899658203e-05
        },
        {
            "start_logit": -3.01953125,
            "end_logit": -6.32421875,
            "text": "Amanita phallo",
            "probability": 2.288818359375e-05
        },
        {
            "start_logit": -3.01953125,
            "end_logit": -6.3671875,
            "text": "Amanita",
            "probability": 2.181529998779297e-05
        },
        {
            "start_logit": -3.01953125,
            "end_logit": -6.9765625,
            "text": "Amani",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": -5.11328125,
            "end_logit": -4.8828125,
            "text": "in Amanita phalloides poisoning",
            "probability": 1.1861324310302734e-05
        },
        {
            "start_logit": -5.11328125,
            "end_logit": -5.89453125,
            "text": "in Amanita phal",
            "probability": 4.351139068603516e-06
        },
        {
            "start_logit": -5.11328125,
            "end_logit": -6.32421875,
            "text": "in Amanita phallo",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -5.11328125,
            "end_logit": -6.3671875,
            "text": "in Amanita",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -6.6484375,
            "end_logit": -4.8828125,
            "text": "ides poisoning",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -5.11328125,
            "end_logit": -6.9765625,
            "text": "in Amani",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.50390625,
            "end_logit": -4.8828125,
            "text": "anita phalloides poisoning",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -8.0625,
            "end_logit": -4.8828125,
            "text": "liver transplantation improves patients' short-term post liver transplantation survival in Amanita phalloides poisoning",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": -5.89453125,
            "text": "anita phal",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": -6.32421875,
            "text": "anita phallo",
            "probability": 2.384185791015625e-07
        }
    ],
    "58aa0c6f396a458e50000008_1": [
        {
            "start_logit": 6.4140625,
            "end_logit": 6.6796875,
            "text": "oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.22265625,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation of pro-social behaviors, including social recognition, pair bonding",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 6.6796875,
            "text": "neurohypophysial hormone oxytocin",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 6.6796875,
            "text": "ypophysial hormone oxytocin",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 6.6796875,
            "text": "ophysial hormone oxytocin",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 6.6796875,
            "text": "The neurohypophysial hormone oxytocin",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.60546875,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation of",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.61328125,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation of pro-",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.62890625,
            "text": "oxytocin (OXT",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.6953125,
            "text": "oxytocin (OXT) and its receptor (",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.69921875,
            "text": "oxytocin (OXT) and its",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.70703125,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.7109375,
            "text": "oxytocin (OXT)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.71875,
            "text": "oxytocin (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.72265625,
            "text": "oxytocin (OXT) and its receptor (OXTR",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.7265625,
            "text": "oxytocin (OXT) and its receptor (OXTR)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.73046875,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation of pro-social behaviors",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.734375,
            "text": "oxytocin (OXT) and its receptor (OXTR) have",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.75,
            "text": "oxytocin (OXT) and its receptor (OXTR) have critical roles in the regulation of pro-social behaviors, including social recognition",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": -7.22265625,
            "text": "pair bonding",
            "probability": 0.0
        }
    ],
    "58aa0c6f396a458e50000008_2": [
        {
            "start_logit": 6.4375,
            "end_logit": 6.68359375,
            "text": "oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.07421875,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to good physical, mental and social health.",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 6.68359375,
            "text": "Neuropeptide hormone oxytocin",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.62109375,
            "text": "oxytocin has roles in",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.6640625,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.6875,
            "text": "oxytocin has",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.69140625,
            "text": "oxytocin has roles",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.71875,
            "text": "oxytocin has roles in social bonding",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.734375,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.734375,
            "text": "oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -7.07421875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -7.07421875,
            "text": "social bonding, energy metabolism, and wound healing contributing to good physical, mental and social health.",
            "probability": 0.0
        },
        {
            "start_logit": -7.78515625,
            "end_logit": -7.07421875,
            "text": ", mental and social health.",
            "probability": 0.0
        },
        {
            "start_logit": -7.7890625,
            "end_logit": -7.07421875,
            "text": "Neuropeptide hormone oxytocin has roles in social bonding, energy metabolism, and wound healing contributing to good physical, mental and social health.",
            "probability": 0.0
        },
        {
            "start_logit": -7.7890625,
            "end_logit": -7.07421875,
            "text": "wound healing contributing to good physical, mental and social health.",
            "probability": 0.0
        },
        {
            "start_logit": -7.8125,
            "end_logit": -7.07421875,
            "text": "health.",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.07421875,
            "text": "and wound healing contributing to good physical, mental and social health.",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -7.07421875,
            "text": "energy metabolism, and wound healing contributing to good physical, mental and social health.",
            "probability": 0.0
        },
        {
            "start_logit": -7.8203125,
            "end_logit": -7.07421875,
            "text": "metabolism, and wound healing contributing to good physical, mental and social health.",
            "probability": 0.0
        },
        {
            "start_logit": -7.828125,
            "end_logit": -7.07421875,
            "text": "and social health.",
            "probability": 0.0
        }
    ],
    "58aa0c6f396a458e50000008_3": [
        {
            "start_logit": 6.4375,
            "end_logit": 6.67578125,
            "text": "Oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": 6.4375,
            "end_logit": -6.109375,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and pair bonding.",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.3828125,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.39453125,
            "text": "Oxytocin is known as the 'love hormone",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.54296875,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.546875,
            "text": "Oxytocin is known as the 'love hormone' due its role in",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.55078125,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.56640625,
            "text": "Oxytocin is known as the 'love hormone'",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.5703125,
            "text": "Oxytocin is known as",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.59375,
            "text": "Oxytocin is known as the 'love hormone' due its",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.609375,
            "text": "Oxytocin is known",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.62109375,
            "text": "Oxytocin is known as the 'love hormone' due",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.6328125,
            "text": "Oxytocin is known as the 'love",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.65234375,
            "text": "Oxytocin is known as the",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.7109375,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and pair bonding",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.7265625,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.73828125,
            "text": "Oxytocin is known as the 'love hormone' due its role in promoting mother-child and pair",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.76171875,
            "text": "Oxytocin is known as the 'lov",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": -6.109375,
            "text": "is known as the 'love hormone' due its role in promoting mother-child and pair bonding.",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -6.109375,
            "text": "mother-child and pair bonding.",
            "probability": 0.0
        }
    ],
    "58aa0c6f396a458e50000008_4": [
        {
            "start_logit": 6.4765625,
            "end_logit": 6.46875,
            "text": "oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.125,
            "text": "oxytocin (",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.1328125,
            "text": "oxytocin (OT",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.39453125,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.5,
            "text": "oxytocin (OT) hormone",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.53125,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.546875,
            "text": "oxytocin (OT)",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.5546875,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OXTR) has been implicated in pair bonding",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 6.46875,
            "text": "The oxytocin",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.64453125,
            "text": "oxytocin (OT) hormone pathway is involved in",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.68359375,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.703125,
            "text": "oxytocin (OT) hormone pathway",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.734375,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.73828125,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.74609375,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.76171875,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes,",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.7734375,
            "text": "oxytocin (OT) hormone pathway is involved in numerous physiological processes, and one of its receptor genes (OXTR) has been implicated in",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.7734375,
            "text": "oxytocin (OT) hormone pathway is",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.95703125,
            "end_logit": -6.15234375,
            "text": "pair bonding behavior in mammalian lineages.",
            "probability": 0.0
        },
        {
            "start_logit": -7.04296875,
            "end_logit": -6.15234375,
            "text": ".",
            "probability": 0.0
        }
    ],
    "58aa0c6f396a458e50000008_5": [
        {
            "start_logit": 6.515625,
            "end_logit": 6.60546875,
            "text": "oxytocin",
            "probability": 1.0
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.09765625,
            "text": "oxytocin, a hormone involved in parent-offspring",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.3984375,
            "text": "oxytocin, a hormone involved in parent-offspring bonding",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.515625,
            "end_logit": -7.5078125,
            "text": "oxytocin, a hormone involved in parent-",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -7.09765625,
            "text": "parent-offspring",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -7.3984375,
            "text": "parent-offspring bonding",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -7.09765625,
            "text": ", a hormone involved in parent-offspring",
            "probability": 0.0
        },
        {
            "start_logit": -7.2734375,
            "end_logit": -7.5078125,
            "text": "parent-",
            "probability": 0.0
        },
        {
            "start_logit": -7.7734375,
            "end_logit": -7.09765625,
            "text": "involved in parent-offspring",
            "probability": 0.0
        },
        {
            "start_logit": -7.80078125,
            "end_logit": -7.09765625,
            "text": "in parent-offspring",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.09765625,
            "text": "a hormone involved in parent-offspring",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -7.3984375,
            "text": ", a hormone involved in parent-offspring bonding",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -7.5078125,
            "text": ", a hormone involved in parent-",
            "probability": 0.0
        },
        {
            "start_logit": -7.7734375,
            "end_logit": -7.3984375,
            "text": "involved in parent-offspring bonding",
            "probability": 0.0
        },
        {
            "start_logit": -7.80078125,
            "end_logit": -7.3984375,
            "text": "in parent-offspring bonding",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.3984375,
            "text": "a hormone involved in parent-offspring bonding",
            "probability": 0.0
        },
        {
            "start_logit": -7.7734375,
            "end_logit": -7.5078125,
            "text": "involved in parent-",
            "probability": 0.0
        },
        {
            "start_logit": -7.80078125,
            "end_logit": -7.5078125,
            "text": "in parent-",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.5078125,
            "text": "a hormone involved in parent-",
            "probability": 0.0
        }
    ],
    "58a5b1fe60087bc10a000024_1": [
        {
            "start_logit": -0.72021484375,
            "end_logit": 3.35546875,
            "text": "SUMO-conjugating enzyme (Ubc9) is an important conjunction enzyme in the SUMO pathway.",
            "probability": 0.35693359375
        },
        {
            "start_logit": -1.23828125,
            "end_logit": 3.35546875,
            "text": ". SUMO-conjugating enzyme (Ubc9) is an important conjunction enzyme in the SUMO pathway.",
            "probability": 0.212890625
        },
        {
            "start_logit": -1.23828125,
            "end_logit": 3.35546875,
            "text": ".",
            "probability": 0.212890625
        },
        {
            "start_logit": -1.23828125,
            "end_logit": 3.353515625,
            "text": ".",
            "probability": 0.21240234375
        },
        {
            "start_logit": -7.12890625,
            "end_logit": 3.35546875,
            "text": "conjugating enzyme (Ubc9) is an important conjunction enzyme in the SUMO pathway.",
            "probability": 0.0005893707275390625
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 3.353515625,
            "text": "ubiquitin-like modifier (SUMO) pathway in eukaryotes is an essential post-translational modification required for a variety of cellular processes, development and organelle biogenesis.",
            "probability": 0.0005388259887695312
        },
        {
            "start_logit": -7.3125,
            "end_logit": 3.35546875,
            "text": "Ubc9) is an important conjunction enzyme in the SUMO pathway.",
            "probability": 0.0004887580871582031
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 3.35546875,
            "text": "the SUMO pathway.",
            "probability": 0.00045228004455566406
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 3.35546875,
            "text": "an important conjunction enzyme in the SUMO pathway.",
            "probability": 0.00041484832763671875
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 3.35546875,
            "text": "in the SUMO pathway.",
            "probability": 0.00040221214294433594
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 3.35546875,
            "text": "conjunction enzyme in the SUMO pathway.",
            "probability": 0.0003719329833984375
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 3.353515625,
            "text": "SUMO) pathway in eukaryotes is an essential post-translational modification required for a variety of cellular processes, development and organelle biogenesis.",
            "probability": 0.00036597251892089844
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 3.353515625,
            "text": "-like modifier (SUMO) pathway in eukaryotes is an essential post-translational modification required for a variety of cellular processes, development and organelle biogenesis.",
            "probability": 0.00036025047302246094
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 3.353515625,
            "text": "like modifier (SUMO) pathway in eukaryotes is an essential post-translational modification required for a variety of cellular processes, development and organelle biogenesis.",
            "probability": 0.00036025047302246094
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 3.35546875,
            "text": "-conjugating enzyme (Ubc9) is an important conjunction enzyme in the SUMO pathway.",
            "probability": 0.0003521442413330078
        },
        {
            "start_logit": -0.72021484375,
            "end_logit": -6.0,
            "text": "SUMO-conjugating enzyme (Ubc9) is an important conjunction enzyme in the SUMO pathway",
            "probability": 3.0994415283203125e-05
        },
        {
            "start_logit": -0.72021484375,
            "end_logit": -6.3203125,
            "text": "SUMO-conjugating enzyme",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": -1.23828125,
            "end_logit": -6.0,
            "text": ". SUMO-conjugating enzyme (Ubc9) is an important conjunction enzyme in the SUMO pathway",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": -0.72021484375,
            "end_logit": -6.73828125,
            "text": "SUMO-conjugating enzyme (Ubc9) is an important",
            "probability": 1.4781951904296875e-05
        },
        {
            "start_logit": -0.72021484375,
            "end_logit": -6.76953125,
            "text": "SUMO-conjugating",
            "probability": 1.430511474609375e-05
        }
    ],
    "58a5b1fe60087bc10a000024_2": [
        {
            "start_logit": 0.217529296875,
            "end_logit": 5.16015625,
            "text": "RAP80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 0.80712890625
        },
        {
            "start_logit": -1.474609375,
            "end_logit": 5.16015625,
            "text": ".",
            "probability": 0.1484375
        },
        {
            "start_logit": -2.90625,
            "end_logit": 5.16015625,
            "text": "SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 0.03546142578125
        },
        {
            "start_logit": -5.453125,
            "end_logit": 5.16015625,
            "text": "UBC9 and is a novel target for sumoylation.",
            "probability": 0.002777099609375
        },
        {
            "start_logit": -6.30859375,
            "end_logit": 5.16015625,
            "text": "sumoylation.",
            "probability": 0.0011806488037109375
        },
        {
            "start_logit": -6.734375,
            "end_logit": 5.16015625,
            "text": "9 and is a novel target for sumoylation.",
            "probability": 0.0007710456848144531
        },
        {
            "start_logit": -6.82421875,
            "end_logit": 5.16015625,
            "text": "C9 and is a novel target for sumoylation.",
            "probability": 0.0007047653198242188
        },
        {
            "start_logit": -7.140625,
            "end_logit": 5.16015625,
            "text": "conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 0.0005135536193847656
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 5.16015625,
            "text": "target for sumoylation.",
            "probability": 0.00042748451232910156
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 5.16015625,
            "text": "novel target for sumoylation.",
            "probability": 0.0003955364227294922
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 5.16015625,
            "text": "the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 0.0003921985626220703
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 5.16015625,
            "text": "-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 0.00032258033752441406
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 5.16015625,
            "text": "80 interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 0.0003154277801513672
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 5.16015625,
            "text": "ylation.",
            "probability": 0.0003139972686767578
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 5.16015625,
            "text": "for sumoylation.",
            "probability": 0.00031280517578125
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 5.16015625,
            "text": "interacts with the SUMO-conjugating enzyme UBC9 and is a novel target for sumoylation.",
            "probability": 0.00030541419982910156
        },
        {
            "start_logit": 0.217529296875,
            "end_logit": -3.6875,
            "text": "RAP80 interacts with the SUMO-conjugating enzyme UBC9 and",
            "probability": 0.00011551380157470703
        },
        {
            "start_logit": 0.217529296875,
            "end_logit": -5.50390625,
            "text": "RAP80",
            "probability": 1.8835067749023438e-05
        },
        {
            "start_logit": 0.217529296875,
            "end_logit": -5.640625,
            "text": "RAP80 interacts with the SUMO-conjugating enzyme",
            "probability": 1.6510486602783203e-05
        },
        {
            "start_logit": 0.217529296875,
            "end_logit": -6.328125,
            "text": "RAP80 interacts with the SUMO-conjugating",
            "probability": 8.344650268554688e-06
        }
    ],
    "58a5b1fe60087bc10a000024_3": [
        {
            "start_logit": -1.3671875,
            "end_logit": -4.8984375,
            "text": "E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy",
            "probability": 0.165771484375
        },
        {
            "start_logit": -1.3671875,
            "end_logit": -4.9921875,
            "text": "E2 SUMO-conjugating enzyme",
            "probability": 0.1510009765625
        },
        {
            "start_logit": -2.1953125,
            "end_logit": -4.8984375,
            "text": "demonstrated that the E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy",
            "probability": 0.0723876953125
        },
        {
            "start_logit": -2.236328125,
            "end_logit": -4.890625,
            "text": "PIASy, can enhance Ets-1 sumoylation, while a SUMO protease, SENP1, can desumoylate Ets-1",
            "probability": 0.0701904296875
        },
        {
            "start_logit": -2.236328125,
            "end_logit": -4.8984375,
            "text": "PIASy",
            "probability": 0.06964111328125
        },
        {
            "start_logit": -2.1953125,
            "end_logit": -4.9921875,
            "text": "demonstrated that the E2 SUMO-conjugating enzyme",
            "probability": 0.06591796875
        },
        {
            "start_logit": -1.3671875,
            "end_logit": -6.01953125,
            "text": "E2 SUMO-conjugating",
            "probability": 0.054046630859375
        },
        {
            "start_logit": -1.3671875,
            "end_logit": -6.01953125,
            "text": "E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance Ets-1",
            "probability": 0.054046630859375
        },
        {
            "start_logit": -1.3671875,
            "end_logit": -6.13671875,
            "text": "E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance Ets-1 sumoylation",
            "probability": 0.04803466796875
        },
        {
            "start_logit": -1.3671875,
            "end_logit": -6.58984375,
            "text": "E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase",
            "probability": 0.030548095703125
        },
        {
            "start_logit": -1.3671875,
            "end_logit": -6.703125,
            "text": "E2 SUMO-conjug",
            "probability": 0.02728271484375
        },
        {
            "start_logit": -1.3671875,
            "end_logit": -6.796875,
            "text": "E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance Ets-",
            "probability": 0.02484130859375
        },
        {
            "start_logit": -2.1953125,
            "end_logit": -6.01953125,
            "text": "demonstrated that the E2 SUMO-conjugating",
            "probability": 0.0235137939453125
        },
        {
            "start_logit": -2.1953125,
            "end_logit": -6.01953125,
            "text": "demonstrated that the E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance Ets-1",
            "probability": 0.0235137939453125
        },
        {
            "start_logit": -2.236328125,
            "end_logit": -6.01953125,
            "text": "PIASy, can enhance Ets-1",
            "probability": 0.022613525390625
        },
        {
            "start_logit": -2.1953125,
            "end_logit": -6.13671875,
            "text": "demonstrated that the E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance Ets-1 sumoylation",
            "probability": 0.0210723876953125
        },
        {
            "start_logit": -2.236328125,
            "end_logit": -6.13671875,
            "text": "PIASy, can enhance Ets-1 sumoylation",
            "probability": 0.020111083984375
        },
        {
            "start_logit": -1.3671875,
            "end_logit": -7.06640625,
            "text": "E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PIASy, can enhance Ets-1 sumoylation, while a SUMO protease",
            "probability": 0.018890380859375
        },
        {
            "start_logit": -1.3671875,
            "end_logit": -7.078125,
            "text": "E2 SUMO-conjugating enzyme Ubc9 and a E3 SUMO ligase, PI",
            "probability": 0.0187530517578125
        },
        {
            "start_logit": -2.1953125,
            "end_logit": -6.32421875,
            "text": "demonstrated",
            "probability": 0.0174713134765625
        }
    ],
    "58a5b1fe60087bc10a000024_4": [
        {
            "start_logit": -5.3359375,
            "end_logit": -3.466796875,
            "text": "E2 SUMO-conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p100 processing and ultimate activation of the alternative NF-kappaB",
            "probability": 0.179443359375
        },
        {
            "start_logit": -6.02734375,
            "end_logit": -3.466796875,
            "text": "NF-kappaB",
            "probability": 0.0902099609375
        },
        {
            "start_logit": -5.3359375,
            "end_logit": -4.1796875,
            "text": "E2 SUMO-conjugating enzyme",
            "probability": 0.088134765625
        },
        {
            "start_logit": -5.3359375,
            "end_logit": -4.19140625,
            "text": "E2 SUMO-conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p100 processing and ultimate activation of the alternative NF-kappaB pathway",
            "probability": 0.0867919921875
        },
        {
            "start_logit": -6.21484375,
            "end_logit": -3.466796875,
            "text": "of E2 SUMO-conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p100 processing and ultimate activation of the alternative NF-kappaB",
            "probability": 0.07476806640625
        },
        {
            "start_logit": -6.70703125,
            "end_logit": -3.466796875,
            "text": "SUMO-conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p100 processing and ultimate activation of the alternative NF-kappaB",
            "probability": 0.04571533203125
        },
        {
            "start_logit": -4.796875,
            "end_logit": -5.390625,
            "text": "SUMO modification is required for stimuli-induced p100 phosphorylation and",
            "probability": 0.045013427734375
        },
        {
            "start_logit": -6.02734375,
            "end_logit": -4.19140625,
            "text": "NF-kappaB pathway",
            "probability": 0.043609619140625
        },
        {
            "start_logit": -6.7578125,
            "end_logit": -3.466796875,
            "text": "diminution of E2 SUMO-conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p100 processing and ultimate activation of the alternative NF-kappaB",
            "probability": 0.04327392578125
        },
        {
            "start_logit": -6.21484375,
            "end_logit": -4.1796875,
            "text": "of E2 SUMO-conjugating enzyme",
            "probability": 0.036712646484375
        },
        {
            "start_logit": -6.21484375,
            "end_logit": -4.19140625,
            "text": "of E2 SUMO-conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p100 processing and ultimate activation of the alternative NF-kappaB pathway",
            "probability": 0.036163330078125
        },
        {
            "start_logit": -6.23828125,
            "end_logit": -4.1796875,
            "text": "blocking SUMOylation of p100, either by site-directed mutation or by short interfering RNA-targeted diminution of E2 SUMO-conjugating enzyme",
            "probability": 0.035614013671875
        },
        {
            "start_logit": -7.0234375,
            "end_logit": -3.466796875,
            "text": "alternative NF-kappaB",
            "probability": 0.033172607421875
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -3.466796875,
            "text": "the alternative NF-kappaB",
            "probability": 0.0268707275390625
        },
        {
            "start_logit": -5.44921875,
            "end_logit": -5.390625,
            "text": "The results show that basal SUMO modification is required for stimuli-induced p100 phosphorylation and",
            "probability": 0.023345947265625
        },
        {
            "start_logit": -7.38671875,
            "end_logit": -3.466796875,
            "text": "activation of the alternative NF-kappaB",
            "probability": 0.023162841796875
        },
        {
            "start_logit": -6.6953125,
            "end_logit": -4.1796875,
            "text": "SUMOylation of p100, either by site-directed mutation or by short interfering RNA-targeted diminution of E2 SUMO-conjugating enzyme",
            "probability": 0.0226287841796875
        },
        {
            "start_logit": -6.70703125,
            "end_logit": -4.1796875,
            "text": "SUMO-conjugating enzyme",
            "probability": 0.02227783203125
        },
        {
            "start_logit": -6.70703125,
            "end_logit": -4.19140625,
            "text": "SUMO-conjugating enzyme Ubc9, inhibits various physiological stimuli-induced p100 processing and ultimate activation of the alternative NF-kappaB pathway",
            "probability": 0.0221099853515625
        },
        {
            "start_logit": -6.7578125,
            "end_logit": -4.1796875,
            "text": "diminution of E2 SUMO-conjugating enzyme",
            "probability": 0.021270751953125
        }
    ],
    "58a5b1fe60087bc10a000024_5": [
        {
            "start_logit": 5.7578125,
            "end_logit": 5.45703125,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 0.9990234375
        },
        {
            "start_logit": -1.54296875,
            "end_logit": 5.45703125,
            "text": ".",
            "probability": 0.0006718635559082031
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -3.927734375,
            "text": "SUMO",
            "probability": 8.344650268554688e-05
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -5.44140625,
            "text": "SUMO-conjugating enzyme E2",
            "probability": 1.8358230590820312e-05
        },
        {
            "start_logit": -5.8046875,
            "end_logit": 5.45703125,
            "text": "crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 9.5367431640625e-06
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -6.734375,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -6.5,
            "end_logit": 5.45703125,
            "text": "viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -6.83203125,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -6.62109375,
            "end_logit": 5.45703125,
            "text": "UBC9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -6.98828125,
            "text": "SUMO-conjugating enzyme",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -7.0,
            "text": "SUMO-conjugating",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -7.20703125,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -7.2421875,
            "text": "SUMO-conjug",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -6.9453125,
            "end_logit": 5.45703125,
            "text": "of white spot syndrome virus.",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 5.45703125,
            "text": "SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 5.45703125,
            "text": "mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus.",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -7.359375,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in crayfish to facilitate reproduction of white spot syndrome virus",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -7.38671875,
            "text": "SUMO-",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -7.140625,
            "end_logit": 5.45703125,
            "text": "to facilitate reproduction of white spot syndrome virus.",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 5.7578125,
            "end_logit": -7.44921875,
            "text": "SUMO-conjugating enzyme E2 UBC9 mediates viral immediate-early protein SUMOylation in crayfish",
            "probability": 2.5033950805664062e-06
        }
    ],
    "58a5b1fe60087bc10a000024_6": [
        {
            "start_logit": -1.248046875,
            "end_logit": 1.2548828125,
            "text": "E2 SUMO-conjugating enzyme.",
            "probability": 0.83935546875
        },
        {
            "start_logit": -3.42578125,
            "end_logit": 1.2548828125,
            "text": ".",
            "probability": 0.09490966796875
        },
        {
            "start_logit": -5.33203125,
            "end_logit": 1.2548828125,
            "text": "SUMO-conjugating enzyme.",
            "probability": 0.01409912109375
        },
        {
            "start_logit": -5.3984375,
            "end_logit": 1.2548828125,
            "text": "Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.01320648193359375
        },
        {
            "start_logit": -5.96484375,
            "end_logit": 1.2548828125,
            "text": "the role of Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.0074920654296875
        },
        {
            "start_logit": -6.328125,
            "end_logit": 1.2548828125,
            "text": "revisited the role of Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.00521087646484375
        },
        {
            "start_logit": -6.5703125,
            "end_logit": 1.2548828125,
            "text": "Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.00408935546875
        },
        {
            "start_logit": -6.70703125,
            "end_logit": 1.2548828125,
            "text": "unique E2 SUMO-conjugating enzyme.",
            "probability": 0.003566741943359375
        },
        {
            "start_logit": -6.828125,
            "end_logit": 1.2548828125,
            "text": "ited the role of Tax SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.0031604766845703125
        },
        {
            "start_logit": -6.94921875,
            "end_logit": 1.2548828125,
            "text": "SUMOylation using a strategy based on the targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.00279998779296875
        },
        {
            "start_logit": -6.96484375,
            "end_logit": 1.2548828125,
            "text": "targeting of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.0027561187744140625
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 1.2548828125,
            "text": "of Ubc9, the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.0025691986083984375
        },
        {
            "start_logit": -7.1328125,
            "end_logit": 1.2548828125,
            "text": "the unique E2 SUMO-conjugating enzyme.",
            "probability": 0.0023288726806640625
        },
        {
            "start_logit": -7.171875,
            "end_logit": 1.2548828125,
            "text": "conjugating enzyme.",
            "probability": 0.0022411346435546875
        },
        {
            "start_logit": -1.248046875,
            "end_logit": -4.84375,
            "text": "E2 SUMO-conjugating enzyme",
            "probability": 0.0018796920776367188
        },
        {
            "start_logit": -1.248046875,
            "end_logit": -6.97265625,
            "text": "E2 SUMO-conjugating",
            "probability": 0.0002244710922241211
        },
        {
            "start_logit": -1.248046875,
            "end_logit": -7.38671875,
            "text": "E2 SUMO-conjug",
            "probability": 0.00014841556549072266
        },
        {
            "start_logit": -1.248046875,
            "end_logit": -7.72265625,
            "text": "E2 SUMO-",
            "probability": 0.00010603666305541992
        },
        {
            "start_logit": -5.33203125,
            "end_logit": -4.84375,
            "text": "SUMO-conjugating enzyme",
            "probability": 3.1828880310058594e-05
        },
        {
            "start_logit": -5.3984375,
            "end_logit": -4.84375,
            "text": "Ubc9, the unique E2 SUMO-conjugating enzyme",
            "probability": 2.968311309814453e-05
        }
    ],
    "5c011057133db5eb78000025_1": [
        {
            "start_logit": 8.0859375,
            "end_logit": 8.203125,
            "text": "phase II",
            "probability": 1.0
        },
        {
            "start_logit": -0.6865234375,
            "end_logit": 8.203125,
            "text": "II",
            "probability": 0.00015604496002197266
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -1.515625,
            "text": "phase",
            "probability": 6.0617923736572266e-05
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.3046875,
            "text": "phase II clinical trials",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.30859375,
            "text": "phase II clinical trials.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 8.203125,
            "text": ") have been evaluated in phase II",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.56640625,
            "text": "phase II clinical",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 8.203125,
            "text": "sutezolid) have been evaluated in phase II",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 8.203125,
            "text": "have been evaluated in phase II",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 8.203125,
            "text": "and sutezolid) have been evaluated in phase II",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.6865234375,
            "end_logit": -7.3046875,
            "text": "II clinical trials",
            "probability": 0.0
        },
        {
            "start_logit": -0.6865234375,
            "end_logit": -7.30859375,
            "text": "II clinical trials.",
            "probability": 0.0
        },
        {
            "start_logit": -0.6865234375,
            "end_logit": -7.56640625,
            "text": "II clinical",
            "probability": 0.0
        },
        {
            "start_logit": -7.27734375,
            "end_logit": -1.515625,
            "text": "tuberculosis, while several other novel compounds (AZD5847, PA-824, SQ109 and sutezolid) have been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": -1.515625,
            "text": ") have been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -1.515625,
            "text": "sutezolid) have been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -7.75,
            "end_logit": -1.515625,
            "text": "have been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -7.7734375,
            "end_logit": -1.515625,
            "text": "and sutezolid) have been evaluated in phase",
            "probability": 0.0
        },
        {
            "start_logit": -7.27734375,
            "end_logit": -6.23046875,
            "text": "tuberculosis",
            "probability": 0.0
        },
        {
            "start_logit": -7.46484375,
            "end_logit": -6.23046875,
            "text": "antituberculosis medications, bedaquiline and delamanid have been conditionally approved for the treatment of drug-resistant tuberculosis",
            "probability": 0.0
        }
    ],
    "601bfa531cb411341a000008_1": [
        {
            "start_logit": 8.1875,
            "end_logit": 8.1015625,
            "text": "primary microcephaly",
            "probability": 1.0
        },
        {
            "start_logit": 8.1875,
            "end_logit": -1.314453125,
            "text": "primary",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": -1.3671875,
            "end_logit": 8.1015625,
            "text": "y",
            "probability": 7.140636444091797e-05
        },
        {
            "start_logit": 8.1875,
            "end_logit": -5.0625,
            "text": "primary microcephaly and define a novel laminopathy.",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 8.1875,
            "end_logit": -5.234375,
            "text": "primary microcephaly and",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -5.92578125,
            "end_logit": 8.1015625,
            "text": "microcephaly",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.58203125,
            "end_logit": 8.1015625,
            "text": "ephaly",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -6.7578125,
            "text": "primary microcephal",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -6.953125,
            "text": "primary microcephaly and define a novel lamin",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.03515625,
            "text": "primary microcephaly and define a novel laminopathy",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.4296875,
            "text": "primary microcephaly and define",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 8.1015625,
            "text": "Heterozygous lamin B1 and lamin B2 variants cause primary microcephaly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.5390625,
            "text": "primary microcephaly and define a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.61328125,
            "text": "primary microc",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 8.1015625,
            "text": "lamin B1 and lamin B2 variants cause primary microcephaly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 8.1015625,
            "text": "lamin B2 variants cause primary microcephaly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 8.1015625,
            "text": "cause primary microcephaly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 8.1015625,
            "text": "B2 variants cause primary microcephaly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 8.1015625,
            "text": "variants cause primary microcephaly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 8.1015625,
            "text": "B1 and lamin B2 variants cause primary microcephaly",
            "probability": 1.1920928955078125e-07
        }
    ],
    "601bfa531cb411341a000008_2": [
        {
            "start_logit": 8.1796875,
            "end_logit": 8.15625,
            "text": "primary microcephaly",
            "probability": 0.307861328125
        },
        {
            "start_logit": 8.1640625,
            "end_logit": 8.1171875,
            "text": "primary microcephaly",
            "probability": 0.289306640625
        },
        {
            "start_logit": 7.8828125,
            "end_logit": 8.0234375,
            "text": "extreme microcephaly",
            "probability": 0.19873046875
        },
        {
            "start_logit": 7.1015625,
            "end_logit": 8.0234375,
            "text": "novel microcephaly genes.RESULTS: Starting from a cohort of patients with extreme microcephaly",
            "probability": 0.09100341796875
        },
        {
            "start_logit": 6.953125,
            "end_logit": 8.0234375,
            "text": "microcephaly",
            "probability": 0.0784912109375
        },
        {
            "start_logit": 7.1015625,
            "end_logit": 6.9921875,
            "text": "novel microcephaly",
            "probability": 0.032440185546875
        },
        {
            "start_logit": 2.93359375,
            "end_logit": 8.0234375,
            "text": "microcephaly genes.RESULTS: Starting from a cohort of patients with extreme microcephaly",
            "probability": 0.00140380859375
        },
        {
            "start_logit": 2.93359375,
            "end_logit": 6.9921875,
            "text": "microcephaly",
            "probability": 0.0005006790161132812
        },
        {
            "start_logit": 1.033203125,
            "end_logit": 8.15625,
            "text": "LMNB1 and LMNB2 as a genetic cause of primary microcephaly",
            "probability": 0.00024020671844482422
        },
        {
            "start_logit": -0.5146484375,
            "end_logit": 8.1171875,
            "text": "y",
            "probability": 4.9173831939697266e-05
        },
        {
            "start_logit": -0.587890625,
            "end_logit": 8.15625,
            "text": "y",
            "probability": 4.762411117553711e-05
        },
        {
            "start_logit": -0.498291015625,
            "end_logit": 8.0234375,
            "text": "y",
            "probability": 4.547834396362305e-05
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -0.953125,
            "text": "primary",
            "probability": 3.3795833587646484e-05
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -0.98388671875,
            "text": "primary",
            "probability": 3.224611282348633e-05
        },
        {
            "start_logit": 7.8828125,
            "end_logit": -1.4951171875,
            "text": "extreme",
            "probability": 1.4662742614746094e-05
        },
        {
            "start_logit": -2.17578125,
            "end_logit": 8.0234375,
            "text": "y genes.RESULTS: Starting from a cohort of patients with extreme microcephaly",
            "probability": 8.463859558105469e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -1.4951171875,
            "text": "novel microcephaly genes.RESULTS: Starting from a cohort of patients with extreme",
            "probability": 6.67572021484375e-06
        },
        {
            "start_logit": -2.970703125,
            "end_logit": 8.0234375,
            "text": "ephaly genes.RESULTS: Starting from a cohort of patients with extreme microcephaly",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -2.17578125,
            "end_logit": 6.9921875,
            "text": "y",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 7.8828125,
            "end_logit": -3.263671875,
            "text": "extreme microc",
            "probability": 2.5033950805664062e-06
        }
    ],
    "601bfa531cb411341a000008_3": [
        {
            "start_logit": 8.1796875,
            "end_logit": 8.15625,
            "text": "primary microcephaly",
            "probability": 0.307861328125
        },
        {
            "start_logit": 8.1640625,
            "end_logit": 8.1171875,
            "text": "primary microcephaly",
            "probability": 0.289306640625
        },
        {
            "start_logit": 7.8828125,
            "end_logit": 8.0234375,
            "text": "extreme microcephaly",
            "probability": 0.19873046875
        },
        {
            "start_logit": 7.1015625,
            "end_logit": 8.0234375,
            "text": "novel microcephaly genes.RESULTS: Starting from a cohort of patients with extreme microcephaly",
            "probability": 0.09100341796875
        },
        {
            "start_logit": 6.953125,
            "end_logit": 8.0234375,
            "text": "microcephaly",
            "probability": 0.0784912109375
        },
        {
            "start_logit": 7.1015625,
            "end_logit": 6.9921875,
            "text": "novel microcephaly",
            "probability": 0.032440185546875
        },
        {
            "start_logit": 2.93359375,
            "end_logit": 8.0234375,
            "text": "microcephaly genes.RESULTS: Starting from a cohort of patients with extreme microcephaly",
            "probability": 0.00140380859375
        },
        {
            "start_logit": 2.93359375,
            "end_logit": 6.9921875,
            "text": "microcephaly",
            "probability": 0.0005006790161132812
        },
        {
            "start_logit": 1.033203125,
            "end_logit": 8.15625,
            "text": "LMNB1 and LMNB2 as a genetic cause of primary microcephaly",
            "probability": 0.00024020671844482422
        },
        {
            "start_logit": -0.5146484375,
            "end_logit": 8.1171875,
            "text": "y",
            "probability": 4.9173831939697266e-05
        },
        {
            "start_logit": -0.587890625,
            "end_logit": 8.15625,
            "text": "y",
            "probability": 4.762411117553711e-05
        },
        {
            "start_logit": -0.498291015625,
            "end_logit": 8.0234375,
            "text": "y",
            "probability": 4.547834396362305e-05
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -0.953125,
            "text": "primary",
            "probability": 3.3795833587646484e-05
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -0.98388671875,
            "text": "primary",
            "probability": 3.224611282348633e-05
        },
        {
            "start_logit": 7.8828125,
            "end_logit": -1.4951171875,
            "text": "extreme",
            "probability": 1.4662742614746094e-05
        },
        {
            "start_logit": -2.17578125,
            "end_logit": 8.0234375,
            "text": "y genes.RESULTS: Starting from a cohort of patients with extreme microcephaly",
            "probability": 8.463859558105469e-06
        },
        {
            "start_logit": 7.1015625,
            "end_logit": -1.4951171875,
            "text": "novel microcephaly genes.RESULTS: Starting from a cohort of patients with extreme",
            "probability": 6.67572021484375e-06
        },
        {
            "start_logit": -2.970703125,
            "end_logit": 8.0234375,
            "text": "ephaly genes.RESULTS: Starting from a cohort of patients with extreme microcephaly",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -2.17578125,
            "end_logit": 6.9921875,
            "text": "y",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 7.8828125,
            "end_logit": -3.263671875,
            "text": "extreme microc",
            "probability": 2.5033950805664062e-06
        }
    ],
    "601bfa531cb411341a000008_4": [
        {
            "start_logit": 8.1640625,
            "end_logit": 8.0703125,
            "text": "primary microcephaly",
            "probability": 1.0
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -1.423828125,
            "text": "primary",
            "probability": 7.545948028564453e-05
        },
        {
            "start_logit": -1.466796875,
            "end_logit": 8.0703125,
            "text": "y",
            "probability": 6.556510925292969e-05
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -5.75390625,
            "text": "primary microcephaly and",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -5.97265625,
            "end_logit": 8.0703125,
            "text": "microcephaly",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -6.76171875,
            "text": "primary microcephal",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.734375,
            "end_logit": 8.0703125,
            "text": "ephaly",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.0234375,
            "text": "primary microcephaly and define a novel lamin",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.39453125,
            "text": "primary microcephaly and define a novel laminopathy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.41796875,
            "text": "primary microcephaly and define",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 8.0703125,
            "text": "Heterozygous lamin B1 and lamin B2 variants cause primary microcephaly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.625,
            "text": "primary microcephaly and define a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.6640625,
            "text": "primary microc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 8.0703125,
            "text": "lamin B1 and lamin B2 variants cause primary microcephaly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 8.0703125,
            "text": "cause primary microcephaly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 8.0703125,
            "text": "lamin B2 variants cause primary microcephaly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 8.0703125,
            "text": "variants cause primary microcephaly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 8.0703125,
            "text": "B2 variants cause primary microcephaly",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.466796875,
            "end_logit": -5.75390625,
            "text": "y and",
            "probability": 0.0
        },
        {
            "start_logit": -1.466796875,
            "end_logit": -7.0234375,
            "text": "y and define a novel lamin",
            "probability": 0.0
        }
    ],
    "601bfa531cb411341a000008_5": [
        {
            "start_logit": 8.1875,
            "end_logit": 8.1171875,
            "text": "primary microcephaly",
            "probability": 1.0
        },
        {
            "start_logit": 8.1875,
            "end_logit": -1.2236328125,
            "text": "primary",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": -1.171875,
            "end_logit": 8.1171875,
            "text": "y",
            "probability": 8.547306060791016e-05
        },
        {
            "start_logit": 8.1875,
            "end_logit": -4.90234375,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -5.25,
            "end_logit": 8.1171875,
            "text": "LMNB1 and LMNB2 as a genetic cause of primary microcephaly",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -5.81640625,
            "end_logit": 8.1171875,
            "text": "microcephaly",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -6.0234375,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and defining a new form of laminopathy.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.203125,
            "end_logit": 8.1171875,
            "text": "ephaly",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.1015625,
            "text": "primary microcephal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.1015625,
            "text": "primary microcephaly,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 8.1171875,
            "text": "identify dominant pathogenic variants in LMNB1 and LMNB2 as a genetic cause of primary microcephaly",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.34375,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.35546875,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its etiology and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 8.1171875,
            "text": "of primary microcephaly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 8.1171875,
            "text": "dominant pathogenic variants in LMNB1 and LMNB2 as a genetic cause of primary microcephaly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.546875,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 8.1171875,
            "text": "LMNB2 as a genetic cause of primary microcephaly",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.6328125,
            "text": "primary microc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.6640625,
            "text": "primary microcephaly, implicating a major structural component of the nuclear envelope in its",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.70703125,
            "text": "primary microcephaly, implicating a major structural component of",
            "probability": 1.1920928955078125e-07
        }
    ],
    "61f7d745882a024a10000038_1": [
        {
            "start_logit": 6.41015625,
            "end_logit": 6.66796875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -6.56640625,
            "end_logit": 6.66796875,
            "text": "100% protection against controlled human malaria",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -6.3984375,
            "text": "malaria infection (CHMI) using homologous parasites (same P. falciparum",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 6.66796875,
            "text": "protection against controlled human malaria",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 6.66796875,
            "text": "sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.26953125,
            "text": "malaria infection (CHMI) using homologous parasites (same P.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 6.66796875,
            "text": "controlled human malaria",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.3125,
            "text": "malaria infection",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 6.66796875,
            "text": "falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.66796875,
            "text": "SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 6.66796875,
            "text": "Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.39453125,
            "text": "malaria infection (CHMI) using homologous parasites (same P. falciparum strain as",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.41015625,
            "text": "malaria infection (CHMI) using homologous parasites (same P. falciparum strain as in the vaccine).",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 6.66796875,
            "text": "attenuated Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 6.66796875,
            "text": "A live-attenuated Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 6.66796875,
            "text": "live-attenuated Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.51171875,
            "text": "malaria infection (CHMI) using homologous parasites (same P",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.5546875,
            "text": "malaria infection (",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.62109375,
            "text": "malaria infection (CHMI) using homologous parasites (same P. falciparum strain as in",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.625,
            "text": "malaria infection (CHMI",
            "probability": 5.960464477539062e-07
        }
    ],
    "61f7d745882a024a10000038_2": [
        {
            "start_logit": 6.4609375,
            "end_logit": 6.58984375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -5.49609375,
            "text": "malaria infection",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": -6.50390625,
            "end_logit": 6.58984375,
            "text": "100% against homologous controlled human malaria",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.2890625,
            "text": "malaria infection (",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 6.58984375,
            "text": "human malaria",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": 6.58984375,
            "text": "controlled human malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.44921875,
            "text": "malaria infection (CHMI) in",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.47265625,
            "text": "malaria infection (CHMI",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 6.58984375,
            "text": ") have shown vaccine efficacies (VEs) of 100% against homologous controlled human malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.58984375,
            "text": "chloroquine chemoprophylaxis) have shown vaccine efficacies (VEs) of 100% against homologous controlled human malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 6.58984375,
            "text": "against homologous controlled human malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.58984375,
            "text": "chemoprophylaxis) have shown vaccine efficacies (VEs) of 100% against homologous controlled human malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.50390625,
            "end_logit": -5.49609375,
            "text": "100% against homologous controlled human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.0546875,
            "end_logit": -5.49609375,
            "text": "infection",
            "probability": 0.0
        },
        {
            "start_logit": -6.50390625,
            "end_logit": -6.24609375,
            "text": "100",
            "probability": 0.0
        },
        {
            "start_logit": -7.44140625,
            "end_logit": -5.49609375,
            "text": "human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -5.49609375,
            "text": "controlled human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -6.50390625,
            "end_logit": -6.65625,
            "text": "100%",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -5.49609375,
            "text": ") have shown vaccine efficacies (VEs) of 100% against homologous controlled human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -5.49609375,
            "text": "chloroquine chemoprophylaxis) have shown vaccine efficacies (VEs) of 100% against homologous controlled human malaria infection",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_3": [
        {
            "start_logit": 6.37109375,
            "end_logit": 6.671875,
            "text": "malaria",
            "probability": 0.5
        },
        {
            "start_logit": 6.37109375,
            "end_logit": 6.6796875,
            "text": "malaria",
            "probability": 0.5
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.59765625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": 6.671875,
            "text": "100%) against homologous Pf (same strain as in the vaccine) controlled human malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 6.6796875,
            "text": "sporozoite (SPZ) malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 6.671875,
            "text": "controlled human malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.2421875,
            "text": "malaria infection",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 6.671875,
            "text": "human malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 6.6796875,
            "text": ") malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 6.6796875,
            "text": "SPZ) malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 6.6796875,
            "text": "Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 6.6796875,
            "text": "radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 6.6796875,
            "text": "attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.6796875,
            "text": "Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 6.6796875,
            "text": "(Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 6.6796875,
            "text": "ozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.42578125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.55859375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.5859375,
            "text": "malaria infection (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.63671875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf",
            "probability": 2.980232238769531e-07
        }
    ],
    "61f7d745882a024a10000038_4": [
        {
            "start_logit": 6.37109375,
            "end_logit": 6.671875,
            "text": "malaria",
            "probability": 0.5
        },
        {
            "start_logit": 6.37109375,
            "end_logit": 6.6796875,
            "text": "malaria",
            "probability": 0.5
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -6.59765625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.0625,
            "end_logit": 6.671875,
            "text": "100%) against homologous Pf (same strain as in the vaccine) controlled human malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 6.6796875,
            "text": "sporozoite (SPZ) malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 6.671875,
            "text": "controlled human malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.2421875,
            "text": "malaria infection",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 6.671875,
            "text": "human malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 6.6796875,
            "text": ") malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 6.6796875,
            "text": "SPZ) malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 6.6796875,
            "text": "Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 6.6796875,
            "text": "radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6875,
            "end_logit": 6.6796875,
            "text": "attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.6796875,
            "text": "Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 6.6796875,
            "text": "(Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 6.6796875,
            "text": "ozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.42578125,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.55859375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.5859375,
            "text": "malaria infection (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.37109375,
            "end_logit": -7.63671875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf",
            "probability": 2.980232238769531e-07
        }
    ],
    "61f7d745882a024a10000038_5": [
        {
            "start_logit": 6.39453125,
            "end_logit": 6.68359375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -6.03515625,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 6.68359375,
            "text": "this limited review, we focus on four approaches to malaria",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 6.68359375,
            "text": "In this limited review, we focus on four approaches to malaria",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 6.68359375,
            "text": "review, we focus on four approaches to malaria",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.32421875,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-erythrocytic",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.4140625,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.4375,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.5390625,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.54296875,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.5703125,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.61328125,
            "end_logit": -6.30859375,
            "text": "Plasmodium vivax",
            "probability": 0.0
        },
        {
            "start_logit": -6.66015625,
            "end_logit": -6.30859375,
            "text": "vivax",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -6.03515625,
            "text": "this limited review, we focus on four approaches to malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -6.03515625,
            "text": "In this limited review, we focus on four approaches to malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.44140625,
            "end_logit": -6.03515625,
            "text": "review, we focus on four approaches to malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -6.30859375,
            "text": ") recombinant protein with adjuvant vaccines aimed at Pf and Plasmodium vivax",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": -6.30859375,
            "text": ", but also asexual erythrocytic stages, and (4) recombinant protein with adjuvant vaccines aimed at Pf and Plasmodium vivax",
            "probability": 0.0
        },
        {
            "start_logit": -6.61328125,
            "end_logit": -7.19140625,
            "text": "Plasmodium",
            "probability": 0.0
        },
        {
            "start_logit": -6.61328125,
            "end_logit": -7.37890625,
            "text": "Plasmodium vivax sexual erythrocytic",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_6": [
        {
            "start_logit": 6.39453125,
            "end_logit": 6.68359375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -6.03515625,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -7.36328125,
            "end_logit": 6.68359375,
            "text": "this limited review, we focus on four approaches to malaria",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 6.68359375,
            "text": "In this limited review, we focus on four approaches to malaria",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 6.68359375,
            "text": "review, we focus on four approaches to malaria",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.32421875,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-erythrocytic",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.4140625,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.4375,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.5390625,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre-",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.54296875,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (Pf) pre",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.39453125,
            "end_logit": -7.5703125,
            "text": "malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum (",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.61328125,
            "end_logit": -6.30859375,
            "text": "Plasmodium vivax",
            "probability": 0.0
        },
        {
            "start_logit": -6.66015625,
            "end_logit": -6.30859375,
            "text": "vivax",
            "probability": 0.0
        },
        {
            "start_logit": -7.36328125,
            "end_logit": -6.03515625,
            "text": "this limited review, we focus on four approaches to malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.42578125,
            "end_logit": -6.03515625,
            "text": "In this limited review, we focus on four approaches to malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.44140625,
            "end_logit": -6.03515625,
            "text": "review, we focus on four approaches to malaria vaccines, (1) a recombinant protein with adjuvant vaccine aimed at Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -6.30859375,
            "text": ") recombinant protein with adjuvant vaccines aimed at Pf and Plasmodium vivax",
            "probability": 0.0
        },
        {
            "start_logit": -7.453125,
            "end_logit": -6.30859375,
            "text": ", but also asexual erythrocytic stages, and (4) recombinant protein with adjuvant vaccines aimed at Pf and Plasmodium vivax",
            "probability": 0.0
        },
        {
            "start_logit": -6.61328125,
            "end_logit": -7.19140625,
            "text": "Plasmodium",
            "probability": 0.0
        },
        {
            "start_logit": -6.61328125,
            "end_logit": -7.37890625,
            "text": "Plasmodium vivax sexual erythrocytic",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_7": [
        {
            "start_logit": 6.44140625,
            "end_logit": 6.6015625,
            "text": "malaria",
            "probability": 0.203125
        },
        {
            "start_logit": 6.44140625,
            "end_logit": 6.59375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination. No injectable malaria",
            "probability": 0.199951171875
        },
        {
            "start_logit": 6.43359375,
            "end_logit": 6.59375,
            "text": "malaria",
            "probability": 0.199951171875
        },
        {
            "start_logit": 6.41796875,
            "end_logit": 6.6171875,
            "text": "malaria",
            "probability": 0.199951171875
        },
        {
            "start_logit": 6.41796875,
            "end_logit": 6.6015625,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 0.1968994140625
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 6.59375,
            "text": ". No injectable malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -6.89453125,
            "text": "malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.41796875,
            "end_logit": -6.89453125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -7.0703125,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -7.16015625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -7.19921875,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -7.3125,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -7.34765625,
            "text": "malaria vaccine has demonstrated long",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 6.6015625,
            "text": "controlled human malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -7.38671875,
            "text": "malaria infection (CHMI) with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 6.6015625,
            "text": "protection against controlled human malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -7.40234375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.41796875,
            "end_logit": -7.38671875,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CHMI) with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.41796875,
            "end_logit": -7.41015625,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 6.6015625,
            "text": "Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 1.7881393432617188e-07
        }
    ],
    "61f7d745882a024a10000038_8": [
        {
            "start_logit": 6.44140625,
            "end_logit": 6.6015625,
            "text": "malaria",
            "probability": 0.203125
        },
        {
            "start_logit": 6.44140625,
            "end_logit": 6.59375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination. No injectable malaria",
            "probability": 0.199951171875
        },
        {
            "start_logit": 6.43359375,
            "end_logit": 6.59375,
            "text": "malaria",
            "probability": 0.199951171875
        },
        {
            "start_logit": 6.41796875,
            "end_logit": 6.6171875,
            "text": "malaria",
            "probability": 0.199951171875
        },
        {
            "start_logit": 6.41796875,
            "end_logit": 6.6015625,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 0.1968994140625
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 6.59375,
            "text": ". No injectable malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -6.89453125,
            "text": "malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.41796875,
            "end_logit": -6.89453125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -7.0703125,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -7.16015625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -7.19921875,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -7.3125,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -7.34765625,
            "text": "malaria vaccine has demonstrated long",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 6.6015625,
            "text": "controlled human malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -7.38671875,
            "text": "malaria infection (CHMI) with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 6.6015625,
            "text": "protection against controlled human malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -7.40234375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.41796875,
            "end_logit": -7.38671875,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CHMI) with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.41796875,
            "end_logit": -7.41015625,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 6.6015625,
            "text": "Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 1.7881393432617188e-07
        }
    ],
    "61f7d745882a024a10000038_9": [
        {
            "start_logit": 6.44140625,
            "end_logit": 6.6015625,
            "text": "malaria",
            "probability": 0.203125
        },
        {
            "start_logit": 6.44140625,
            "end_logit": 6.59375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination. No injectable malaria",
            "probability": 0.199951171875
        },
        {
            "start_logit": 6.43359375,
            "end_logit": 6.59375,
            "text": "malaria",
            "probability": 0.199951171875
        },
        {
            "start_logit": 6.41796875,
            "end_logit": 6.6171875,
            "text": "malaria",
            "probability": 0.199951171875
        },
        {
            "start_logit": 6.41796875,
            "end_logit": 6.6015625,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 0.1968994140625
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 6.59375,
            "text": ". No injectable malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -6.89453125,
            "text": "malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.41796875,
            "end_logit": -6.89453125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -7.0703125,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -7.16015625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -7.19921875,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -7.3125,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -7.34765625,
            "text": "malaria vaccine has demonstrated long",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 6.6015625,
            "text": "controlled human malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -7.38671875,
            "text": "malaria infection (CHMI) with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 6.6015625,
            "text": "protection against controlled human malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.44140625,
            "end_logit": -7.40234375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.41796875,
            "end_logit": -7.38671875,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CHMI) with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.41796875,
            "end_logit": -7.41015625,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 6.6015625,
            "text": "Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 1.7881393432617188e-07
        }
    ],
    "61f7d745882a024a10000038_10": [
        {
            "start_logit": 6.4375,
            "end_logit": 6.66015625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.3984375,
            "text": "malaria, but the features of the antibody response induced",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 6.66015625,
            "text": "Immunization with attenuated Plasmodium falciparum sporozoites (PfSPZs) has been shown to be protective against malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.50390625,
            "text": "malaria, but the features of the antibody response",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 6.66015625,
            "text": "sporozoites (PfSPZs) has been shown to be protective against malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 6.66015625,
            "text": "protective against malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.578125,
            "text": "malaria, but the features of the antibody response induced by",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 6.66015625,
            "text": "PfSPZs) has been shown to be protective against malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 6.66015625,
            "text": "shown to be protective against malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 6.66015625,
            "text": "against malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.6171875,
            "text": "malaria, but the features of the antibody response induced by this treatment",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.6328125,
            "text": "malaria, but the features of the antibody",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.6328125,
            "text": "malaria, but the features of the antibody response induced by this",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.640625,
            "text": "malaria, but the features of",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.66015625,
            "text": "Plasmodium falciparum sporozoites (PfSPZs) has been shown to be protective against malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.66015625,
            "text": "ozoites (PfSPZs) has been shown to be protective against malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 6.66015625,
            "text": "PZs) has been shown to be protective against malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 6.66015625,
            "text": "Zs) has been shown to be protective against malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 6.66015625,
            "text": "falciparum sporozoites (PfSPZs) has been shown to be protective against malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 6.66015625,
            "text": "attenuated Plasmodium falciparum sporozoites (PfSPZs) has been shown to be protective against malaria",
            "probability": 5.364418029785156e-07
        }
    ],
    "61f7d745882a024a10000038_11": [
        {
            "start_logit": 6.40625,
            "end_logit": 6.68359375,
            "text": "malaria",
            "probability": 0.20556640625
        },
        {
            "start_logit": 6.375,
            "end_logit": 6.69140625,
            "text": "malaria",
            "probability": 0.1993408203125
        },
        {
            "start_logit": 6.375,
            "end_logit": 6.68359375,
            "text": "malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 0.1993408203125
        },
        {
            "start_logit": 6.375,
            "end_logit": 6.6796875,
            "text": "malaria vaccines, which is based on human malaria",
            "probability": 0.19775390625
        },
        {
            "start_logit": 6.375,
            "end_logit": 6.6796875,
            "text": "malaria",
            "probability": 0.19775390625
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 6.68359375,
            "text": "shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.265625,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.265625,
            "text": "malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 6.68359375,
            "text": "sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.68359375,
            "text": ", has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 6.68359375,
            "text": "based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 6.6796875,
            "text": "based on human malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.68359375,
            "text": "getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.68359375,
            "text": "ozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 6.68359375,
            "text": "human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 6.6796875,
            "text": "human malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.68359375,
            "text": "PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.40625,
            "end_logit": -7.44921875,
            "text": "malaria.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.68359375,
            "text": "which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.6796875,
            "text": "which is based on human malaria",
            "probability": 1.1920928955078125e-07
        }
    ],
    "61f7d745882a024a10000038_12": [
        {
            "start_logit": 6.40625,
            "end_logit": 6.68359375,
            "text": "malaria",
            "probability": 0.20556640625
        },
        {
            "start_logit": 6.375,
            "end_logit": 6.69140625,
            "text": "malaria",
            "probability": 0.1993408203125
        },
        {
            "start_logit": 6.375,
            "end_logit": 6.68359375,
            "text": "malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 0.1993408203125
        },
        {
            "start_logit": 6.375,
            "end_logit": 6.6796875,
            "text": "malaria vaccines, which is based on human malaria",
            "probability": 0.19775390625
        },
        {
            "start_logit": 6.375,
            "end_logit": 6.6796875,
            "text": "malaria",
            "probability": 0.19775390625
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 6.68359375,
            "text": "shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.265625,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.265625,
            "text": "malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 6.68359375,
            "text": "sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.68359375,
            "text": ", has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 6.68359375,
            "text": "based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 6.6796875,
            "text": "based on human malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.68359375,
            "text": "getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.68359375,
            "text": "ozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 6.68359375,
            "text": "human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 6.6796875,
            "text": "human malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.68359375,
            "text": "PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.40625,
            "end_logit": -7.44921875,
            "text": "malaria.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.68359375,
            "text": "which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.6796875,
            "text": "which is based on human malaria",
            "probability": 1.1920928955078125e-07
        }
    ],
    "61f7d745882a024a10000038_13": [
        {
            "start_logit": 6.40625,
            "end_logit": 6.68359375,
            "text": "malaria",
            "probability": 0.20556640625
        },
        {
            "start_logit": 6.375,
            "end_logit": 6.69140625,
            "text": "malaria",
            "probability": 0.1993408203125
        },
        {
            "start_logit": 6.375,
            "end_logit": 6.68359375,
            "text": "malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 0.1993408203125
        },
        {
            "start_logit": 6.375,
            "end_logit": 6.6796875,
            "text": "malaria vaccines, which is based on human malaria",
            "probability": 0.19775390625
        },
        {
            "start_logit": 6.375,
            "end_logit": 6.6796875,
            "text": "malaria",
            "probability": 0.19775390625
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 6.68359375,
            "text": "shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.265625,
            "text": "malaria vaccines, which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.265625,
            "text": "malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 6.68359375,
            "text": "sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.68359375,
            "text": ", has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 6.68359375,
            "text": "based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 6.6796875,
            "text": "based on human malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.68359375,
            "text": "getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.68359375,
            "text": "ozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 6.68359375,
            "text": "human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 6.6796875,
            "text": "human malaria",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.68359375,
            "text": "PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.40625,
            "end_logit": -7.44921875,
            "text": "malaria.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.68359375,
            "text": "which is based on human malaria sporozoites and called PfSPZ Vaccine, has been shown to protect a significant proportion of vaccine recipients from getting malaria",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.6796875,
            "text": "which is based on human malaria",
            "probability": 1.1920928955078125e-07
        }
    ],
    "61f7d745882a024a10000038_14": [
        {
            "start_logit": 6.4140625,
            "end_logit": 6.671875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -6.875,
            "end_logit": 6.671875,
            "text": "100% protection against controlled human malaria",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.671875,
            "text": "protection against controlled human malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 6.671875,
            "text": "sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.39453125,
            "text": "malaria infection",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 6.671875,
            "text": "SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.671875,
            "text": "controlled human malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.671875,
            "text": "Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.53125,
            "text": "malaria infection (",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 6.671875,
            "text": "live-attenuated Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 6.671875,
            "text": "attenuated Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 6.671875,
            "text": "A live-attenuated Plasmodium falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 6.671875,
            "text": "falciparum sporozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 6.671875,
            "text": "ozoite (SPZ) vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 6.671875,
            "text": "PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.609375,
            "text": "malaria infection (CHMI",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.640625,
            "text": "malaria infection (CH",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.6484375,
            "text": "malaria infection (CHMI)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 6.671875,
            "text": "vaccine (PfSPZ Vaccine) has shown up to 100% protection against controlled human malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.67578125,
            "text": "malaria infection (CHMI) using homologous parasites (",
            "probability": 5.960464477539062e-07
        }
    ],
    "61f7d745882a024a10000038_15": [
        {
            "start_logit": 6.453125,
            "end_logit": 6.609375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.453125,
            "end_logit": -7.36328125,
            "text": "malaria infection",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.453125,
            "end_logit": -7.36328125,
            "text": "malaria infection (",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.453125,
            "end_logit": -7.37890625,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 6.609375,
            "text": "sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 6.609375,
            "text": "SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.609375,
            "text": "controlled human malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.453125,
            "end_logit": -7.515625,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.453125,
            "end_logit": -7.5546875,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.453125,
            "end_logit": -7.56640625,
            "text": "malaria infection (CHMI",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 6.609375,
            "text": "human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 6.609375,
            "text": "Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.453125,
            "end_logit": -7.6171875,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 6.609375,
            "text": "attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 6.609375,
            "text": "An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 6.609375,
            "text": "protective against controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": -7.515625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -7.36328125,
            "text": "sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -7.36328125,
            "text": "sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria infection (",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -7.36328125,
            "text": "SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria infection",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_16": [
        {
            "start_logit": 6.36328125,
            "end_logit": 6.71875,
            "text": "malaria",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.359375,
            "end_logit": 6.71875,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.359375,
            "end_logit": 6.7109375,
            "text": "malaria",
            "probability": 0.33154296875
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -5.56640625,
            "text": "malaria infection in malaria-naive",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.359375,
            "end_logit": -5.56640625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-naive",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -5.6171875,
            "text": "malaria infection in malaria",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.359375,
            "end_logit": -5.6171875,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.0390625,
            "text": "malaria infection in malaria-naive ind",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.0390625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-naive ind",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.203125,
            "text": "malaria infection in malaria-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.203125,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.21875,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 6.71875,
            "text": "whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 6.7109375,
            "text": "whole malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.71875,
            "text": ", whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.7109375,
            "text": ", whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 6.7109375,
            "text": "Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.7109375,
            "text": "BACKGROUND: Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 6.71875,
            "text": "human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.4140625,
            "text": "malaria infection",
            "probability": 2.384185791015625e-07
        }
    ],
    "61f7d745882a024a10000038_17": [
        {
            "start_logit": 6.36328125,
            "end_logit": 6.71875,
            "text": "malaria",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.359375,
            "end_logit": 6.71875,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.359375,
            "end_logit": 6.7109375,
            "text": "malaria",
            "probability": 0.33154296875
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -5.56640625,
            "text": "malaria infection in malaria-naive",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.359375,
            "end_logit": -5.56640625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-naive",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -5.6171875,
            "text": "malaria infection in malaria",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.359375,
            "end_logit": -5.6171875,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.0390625,
            "text": "malaria infection in malaria-naive ind",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.0390625,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-naive ind",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.203125,
            "text": "malaria infection in malaria-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.203125,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.21875,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 6.71875,
            "text": "whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 6.7109375,
            "text": "whole malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.71875,
            "text": ", whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.7109375,
            "text": ", whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 6.7109375,
            "text": "Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.7109375,
            "text": "BACKGROUND: Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 6.71875,
            "text": "human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.4140625,
            "text": "malaria infection",
            "probability": 2.384185791015625e-07
        }
    ],
    "61f7d745882a024a10000038_18": [
        {
            "start_logit": 6.4140625,
            "end_logit": 6.72265625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -6.99609375,
            "text": "malaria by",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.72265625,
            "text": "Sterile protection against human malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 6.72265625,
            "text": "protection against human malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.546875,
            "text": "malaria by chemoattenuated",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.5546875,
            "text": "malaria by chemoattenuated PfSPZ vaccine",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.57421875,
            "text": "malaria by chemoattenuated PfSPZ",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.5859375,
            "text": "malaria by chemoatten",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.65625,
            "text": "malaria by chemoattenuated PfSP",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.6640625,
            "text": "malaria by chemoat",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.6796875,
            "text": "malaria by chemoattenuated PfS",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -6.99609375,
            "text": "Sterile protection against human malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": -6.99609375,
            "text": "protection against human malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -7.546875,
            "text": "Sterile protection against human malaria by chemoattenuated",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -7.5546875,
            "text": "Sterile protection against human malaria by chemoattenuated PfSPZ vaccine",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -7.57421875,
            "text": "Sterile protection against human malaria by chemoattenuated PfSPZ",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -7.5859375,
            "text": "Sterile protection against human malaria by chemoatten",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -7.59765625,
            "text": "Sterile protection against human",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": -7.546875,
            "text": "protection against human malaria by chemoattenuated",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -7.640625,
            "text": "Sterile protection against",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_19": [
        {
            "start_logit": 6.40625,
            "end_logit": 6.65625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 6.65625,
            "text": "falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 6.65625,
            "text": "sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 6.65625,
            "text": "against malaria",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 6.65625,
            "text": "aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 6.65625,
            "text": ", aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 6.65625,
            "text": "cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.65625,
            "text": "attenuated, aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 6.65625,
            "text": "radiation-attenuated, aseptic, purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 6.65625,
            "text": "Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 6.65625,
            "text": ", is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.40625,
            "end_logit": -7.40625,
            "text": "malaria.",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 6.65625,
            "text": "ozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 6.65625,
            "text": ", purified, cryopreserved Plasmodium falciparum sporozoites, is administered by direct venous inoculation (DVI) for maximal efficacy against malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 6.65625,
            "text": "maximal efficacy against malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.65625,
            "text": "inoculation (DVI) for maximal efficacy against malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": -6.4140625,
            "text": "falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.5703125,
            "end_logit": -6.4140625,
            "text": "aseptic, purified, cryopreserved Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -6.4140625,
            "text": ", aseptic, purified, cryopreserved Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.5859375,
            "end_logit": -6.4140625,
            "text": "cryopreserved Plasmodium falciparum",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_20": [
        {
            "start_logit": 6.4140625,
            "end_logit": 6.67578125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": 6.67578125,
            "text": "nfections. The radiation attenuated sporozoite (PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 6.67578125,
            "text": "sporozoite (PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.51171875,
            "text": "malaria vaccines because",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.53125,
            "text": "malaria vaccines because of",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 6.67578125,
            "text": "considered the gold standard for malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.609375,
            "text": "malaria vaccines because of its unparalleled",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.67578125,
            "text": "gold standard for malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 6.67578125,
            "text": "radiation attenuated sporozoite (PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 6.67578125,
            "text": "(PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 6.67578125,
            "text": "PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 6.67578125,
            "text": "The radiation attenuated sporozoite (PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 6.67578125,
            "text": "been considered the gold standard for malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.6796875,
            "text": "malaria vaccines because of its",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.68359375,
            "text": "malaria vaccines",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 6.67578125,
            "text": "for malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 6.67578125,
            "text": "attenuated sporozoite (PfSPZ) vaccine has been considered the gold standard for malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": -7.453125,
            "text": "nfections. The radiation attenuated sporozoite (PfSPZ) vaccine has been considered the gold standard",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -7.51171875,
            "text": "nfections. The radiation attenuated sporozoite (PfSPZ) vaccine has been considered the gold standard for malaria vaccines because",
            "probability": 0.0
        },
        {
            "start_logit": -7.59375,
            "end_logit": -7.53125,
            "text": "nfections. The radiation attenuated sporozoite (PfSPZ) vaccine has been considered the gold standard for malaria vaccines because of",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_21": [
        {
            "start_logit": 6.37890625,
            "end_logit": 6.67578125,
            "text": "malaria",
            "probability": 0.5
        },
        {
            "start_logit": 6.375,
            "end_logit": 6.6796875,
            "text": "malaria",
            "probability": 0.5
        },
        {
            "start_logit": 6.375,
            "end_logit": -6.7890625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.1875,
            "end_logit": 6.67578125,
            "text": "100%) against homologous Pf (same strain as in the vaccine) controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 6.6796875,
            "text": "sporozoite (SPZ) malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 6.67578125,
            "text": "controlled human malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 6.6796875,
            "text": "attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.67578125,
            "text": "human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 6.6796875,
            "text": "radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 6.6796875,
            "text": "SPZ) malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 6.6796875,
            "text": "Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 6.6796875,
            "text": "ozoite (SPZ) malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.3515625,
            "text": "malaria infection",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 6.6796875,
            "text": "falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 6.6796875,
            "text": "A radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.6796875,
            "text": "(Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.48046875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.53515625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.55078125,
            "text": "malaria infection (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.56640625,
            "text": "malaria vaccine,",
            "probability": 3.5762786865234375e-07
        }
    ],
    "61f7d745882a024a10000038_22": [
        {
            "start_logit": 6.37890625,
            "end_logit": 6.67578125,
            "text": "malaria",
            "probability": 0.5
        },
        {
            "start_logit": 6.375,
            "end_logit": 6.6796875,
            "text": "malaria",
            "probability": 0.5
        },
        {
            "start_logit": 6.375,
            "end_logit": -6.7890625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.1875,
            "end_logit": 6.67578125,
            "text": "100%) against homologous Pf (same strain as in the vaccine) controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 6.6796875,
            "text": "sporozoite (SPZ) malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 6.67578125,
            "text": "controlled human malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 6.6796875,
            "text": "attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.67578125,
            "text": "human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 6.6796875,
            "text": "radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 6.6796875,
            "text": "SPZ) malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 6.6796875,
            "text": "Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 6.6796875,
            "text": "ozoite (SPZ) malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.3515625,
            "text": "malaria infection",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6640625,
            "end_logit": 6.6796875,
            "text": "falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 6.6796875,
            "text": "A radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.6796875,
            "text": "(Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.48046875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.53515625,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.37890625,
            "end_logit": -7.55078125,
            "text": "malaria infection (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.56640625,
            "text": "malaria vaccine,",
            "probability": 3.5762786865234375e-07
        }
    ],
    "61f7d745882a024a10000038_23": [
        {
            "start_logit": 6.45703125,
            "end_logit": 6.57421875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.1953125,
            "text": "malaria chemoprop",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.28515625,
            "text": "malaria chemo",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.3359375,
            "text": "malaria chemoprophylax",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.3671875,
            "text": "malaria chemoprophylaxis",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 6.57421875,
            "text": "on malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.46484375,
            "text": "malaria chemoprophy",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.46875,
            "text": "malaria chemoprophylaxis.",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.4921875,
            "text": "malaria chemoprophyla",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.57421875,
            "text": "inoculation of radiation-attenuated PfSPZ or in those who were exposed to live PfSPZ while on malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.57421875,
            "text": "while on malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 6.57421875,
            "text": "volunteers after intravenous (IV) inoculation of radiation-attenuated PfSPZ or in those who were exposed to live PfSPZ while on malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 6.57421875,
            "text": "live PfSPZ while on malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.63671875,
            "text": "malaria chemoprophylaxis. These advance",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 6.57421875,
            "text": "(IV) inoculation of radiation-attenuated PfSPZ or in those who were exposed to live PfSPZ while on malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 6.57421875,
            "text": "who were exposed to live PfSPZ while on malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 6.57421875,
            "text": "PfSPZ or in those who were exposed to live PfSPZ while on malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 6.57421875,
            "text": "PfSPZ while on malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 6.57421875,
            "text": "radiation-attenuated PfSPZ or in those who were exposed to live PfSPZ while on malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.1015625,
            "end_logit": -7.46875,
            "text": ".",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_24": [
        {
            "start_logit": 6.44921875,
            "end_logit": 6.59765625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 6.59765625,
            "text": "to malaria",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 6.59765625,
            "text": "); or individuals exposed to malaria",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 6.59765625,
            "text": "); an irradiated whole sporozoite vaccine PfSPZ (mAbs CIS43 and MGG4); or individuals exposed to malaria",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 6.59765625,
            "text": "sporozoite vaccine PfSPZ (mAbs CIS43 and MGG4); or individuals exposed to malaria",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.59765625,
            "text": "whole sporozoite vaccine PfSPZ (mAbs CIS43 and MGG4); or individuals exposed to malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 6.59765625,
            "text": "exposed to malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -7.2109375,
            "text": "pared in vitro and in vivo activities of six CSP-specific mAbs derived from human recipients of a recombinant CSP vaccine RTS,S/AS",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -7.2265625,
            "text": "pared in vitro and in vivo activities of six CSP-specific mAbs derived from human recipients of a recombinant CSP vaccine RTS,S/AS01",
            "probability": 0.0
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -7.35546875,
            "text": "); an irradiated whole sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -7.2109375,
            "text": "/AS",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -7.2265625,
            "text": "/AS01",
            "probability": 0.0
        },
        {
            "start_logit": -7.6328125,
            "end_logit": -7.2109375,
            "text": "AS",
            "probability": 0.0
        },
        {
            "start_logit": -7.6328125,
            "end_logit": -7.2265625,
            "text": "AS01",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.35546875,
            "text": "sporozoite",
            "probability": 0.0
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -7.2109375,
            "text": "RTS,S/AS",
            "probability": 0.0
        },
        {
            "start_logit": -7.5078125,
            "end_logit": -7.3984375,
            "text": "pared in vitro and in vivo activities of six CSP-specific mAbs derived from human recipients of a recombinant CSP",
            "probability": 0.0
        },
        {
            "start_logit": -7.68359375,
            "end_logit": -7.2265625,
            "text": "RTS,S/AS01",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.2109375,
            "text": "in vitro and in vivo activities of six CSP-specific mAbs derived from human recipients of a recombinant CSP vaccine RTS,S/AS",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.2265625,
            "text": "in vitro and in vivo activities of six CSP-specific mAbs derived from human recipients of a recombinant CSP vaccine RTS,S/AS01",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_25": [
        {
            "start_logit": 6.49609375,
            "end_logit": 6.58203125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.109375,
            "text": "malaria by",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.3671875,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine regimen in",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 6.58203125,
            "text": "Heterologous protection against malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.45703125,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine regimen",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.48046875,
            "text": "malaria by a simple chemoattenuated",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.484375,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial.",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.5078125,
            "text": "malaria by a",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.58203125,
            "text": "protection against malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.55078125,
            "text": "malaria by a simple chemoattenuated PfSPZ",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.55859375,
            "text": "malaria by a simple chemoattenuated PfSPZ vaccine",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.60546875,
            "text": "malaria by a simple chemoatten",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.69921875,
            "text": "malaria by a simple chemoattenuated PfS",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.7109375,
            "text": "malaria by a simple chemoattenuated PfSP",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.49609375,
            "end_logit": -7.7265625,
            "text": "malaria by a simple chemoat",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 6.58203125,
            "text": "against malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.109375,
            "text": "Heterologous protection against malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -7.109375,
            "text": "protection against malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -7.484375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.3671875,
            "text": "Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_26": [
        {
            "start_logit": 6.4296875,
            "end_logit": 6.66015625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.66015625,
            "text": "Protection against malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.51953125,
            "text": "malaria at",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.5390625,
            "text": "malaria at 1 year",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.578125,
            "text": "malaria at 1 year and",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.640625,
            "text": "malaria at 1 year and immune correlates following PfSPZ vaccination.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.66796875,
            "text": "malaria at 1 year and immune correlates following PfSPZ",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.6875,
            "text": "malaria at 1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.6953125,
            "text": "malaria at 1 year and immune correlates following",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.7109375,
            "text": "malaria at 1 year and immune correlates following PfSPZ vaccination",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.72265625,
            "text": "malaria at 1 year and immune correlates",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -7.640625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -7.51953125,
            "text": "Protection against malaria at",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -7.53125,
            "text": "Protection against",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -7.5390625,
            "text": "Protection against malaria at 1 year",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -7.578125,
            "text": "Protection against malaria at 1 year and",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -7.640625,
            "text": "Protection against malaria at 1 year and immune correlates following PfSPZ vaccination.",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -7.66796875,
            "text": "Protection against malaria at 1 year and immune correlates following PfSPZ",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -7.6875,
            "text": "Protection against malaria at 1",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -7.6953125,
            "text": "Protection against malaria at 1 year and immune correlates following",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_27": [
        {
            "start_logit": 6.52734375,
            "end_logit": 6.48828125,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -2.67578125,
            "text": "malaria infection",
            "probability": 0.00010472536087036133
        },
        {
            "start_logit": 6.52734375,
            "end_logit": -7.29296875,
            "text": "malaria infection.",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 6.48828125,
            "text": "human malaria",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 6.48828125,
            "text": "controlled human malaria",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 6.48828125,
            "text": "heterologous controlled human malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 6.48828125,
            "text": "protection against heterologous controlled human malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 6.48828125,
            "text": "Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 6.48828125,
            "text": "T cells and durable protection against heterologous controlled human malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 6.48828125,
            "text": "durable protection against heterologous controlled human malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 6.48828125,
            "text": "against heterologous controlled human malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 6.48828125,
            "text": "PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 6.48828125,
            "text": "strain-transcending T cells and durable protection against heterologous controlled human malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 6.48828125,
            "text": "induces strain-transcending T cells and durable protection against heterologous controlled human malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.48828125,
            "text": "PZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 6.48828125,
            "text": "ending T cells and durable protection against heterologous controlled human malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.8203125,
            "end_logit": -2.67578125,
            "text": "infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.26171875,
            "end_logit": -2.67578125,
            "text": "human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -2.67578125,
            "text": "controlled human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.51953125,
            "end_logit": -2.67578125,
            "text": "heterologous controlled human malaria infection",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_28": [
        {
            "start_logit": 6.27734375,
            "end_logit": 6.88671875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -5.6796875,
            "end_logit": 6.88671875,
            "text": "Plasmodium falciparum malaria",
            "probability": 6.4373016357421875e-06
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 6.88671875,
            "text": "Protection against Plasmodium falciparum malaria",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -6.94140625,
            "text": "malaria by",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.765625,
            "end_logit": 6.88671875,
            "text": "falciparum malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 6.88671875,
            "text": "against Plasmodium falciparum malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.59375,
            "text": "malaria by PfSPZ Vaccine.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.62890625,
            "text": "malaria by PfSPZ Vaccine",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.67578125,
            "text": "malaria by PfS",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.72265625,
            "text": "malaria by PfSPZ",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.74609375,
            "text": "malaria by PfSP",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.6796875,
            "end_logit": -6.484375,
            "text": "Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -5.6796875,
            "end_logit": -6.94140625,
            "text": "Plasmodium falciparum malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -5.6796875,
            "end_logit": -7.59375,
            "text": "Plasmodium falciparum malaria by PfSPZ Vaccine.",
            "probability": 0.0
        },
        {
            "start_logit": -5.6796875,
            "end_logit": -7.62890625,
            "text": "Plasmodium falciparum malaria by PfSPZ Vaccine",
            "probability": 0.0
        },
        {
            "start_logit": -5.6796875,
            "end_logit": -7.67578125,
            "text": "Plasmodium falciparum malaria by PfS",
            "probability": 0.0
        },
        {
            "start_logit": -5.6796875,
            "end_logit": -7.72265625,
            "text": "Plasmodium falciparum malaria by PfSPZ",
            "probability": 0.0
        },
        {
            "start_logit": -5.6796875,
            "end_logit": -7.74609375,
            "text": "Plasmodium falciparum malaria by PfSP",
            "probability": 0.0
        },
        {
            "start_logit": -7.4453125,
            "end_logit": -6.484375,
            "text": "Protection against Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.765625,
            "end_logit": -6.484375,
            "text": "falciparum",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_29": [
        {
            "start_logit": 6.45703125,
            "end_logit": 6.65625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -6.59765625,
            "text": "malaria by",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 6.65625,
            "text": "Sterile protection against human malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.65625,
            "text": "protection against human malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.45703125,
            "text": "malaria by chemoattenuated",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.46484375,
            "text": "malaria by chemoattenuated PfSPZ vaccine",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.52734375,
            "text": "malaria by chemoattenuated PfSPZ",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.53125,
            "text": "malaria by chemoatten",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.58984375,
            "text": "malaria by chemoat",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.59765625,
            "text": "malaria by chemoattenuated PfSPZ vaccine.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.62109375,
            "text": "malaria by chemoattenuated PfS",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.68359375,
            "text": "malaria by chemoattenuated PfSP",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -6.59765625,
            "text": "Sterile protection against human malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -6.59765625,
            "text": "protection against human malaria by",
            "probability": 0.0
        },
        {
            "start_logit": -7.0703125,
            "end_logit": -7.59765625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.45703125,
            "text": "Sterile protection against human malaria by chemoattenuated",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.46484375,
            "text": "Sterile protection against human malaria by chemoattenuated PfSPZ vaccine",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.52734375,
            "text": "Sterile protection against human malaria by chemoattenuated PfSPZ",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -7.53125,
            "text": "Sterile protection against human malaria by chemoatten",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -7.45703125,
            "text": "protection against human malaria by chemoattenuated",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_30": [
        {
            "start_logit": 6.41015625,
            "end_logit": 6.66796875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 6.66796875,
            "text": "against malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.4921875,
            "text": "malaria in",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.66796875,
            "text": "PfSPZ Vaccine against malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.640625,
            "text": "malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.64453125,
            "text": "malaria in infants in",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.671875,
            "text": "malaria in infants in western Kenya: a double-blind, randomized, placebo",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.69140625,
            "text": "malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.7109375,
            "text": "malaria in infants in western Kenya: a double-blind",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.7109375,
            "text": "malaria in infants in western",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.71484375,
            "text": "malaria in infants in western Kenya:",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.41015625,
            "end_logit": -7.734375,
            "text": "malaria in infants in western Kenya",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.046875,
            "end_logit": -7.640625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": -7.4921875,
            "text": "against malaria in",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": -7.640625,
            "text": "a double-blind, randomized, placebo-controlled phase 2 trial.",
            "probability": 0.0
        },
        {
            "start_logit": -7.58984375,
            "end_logit": -7.640625,
            "text": "phase 2 trial.",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": -7.671875,
            "text": "a double-blind, randomized, placebo",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": -7.69140625,
            "text": "a double-blind, randomized, placebo-controlled phase 2",
            "probability": 0.0
        },
        {
            "start_logit": -7.6328125,
            "end_logit": -7.640625,
            "text": "trial.",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": -7.7109375,
            "text": "a double-blind",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_31": [
        {
            "start_logit": 6.359375,
            "end_logit": 6.73046875,
            "text": "malaria",
            "probability": 0.50390625
        },
        {
            "start_logit": 6.34765625,
            "end_logit": 6.7265625,
            "text": "malaria",
            "probability": 0.49609375
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.03125,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 6.73046875,
            "text": "sporozoites (SPZ) (PfSPZ Challenge) to try to reduce time and costs of developing PfSPZ Vaccine to prevent malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.10546875,
            "text": "malaria in Africa",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 6.73046875,
            "text": "ozoites (SPZ) (PfSPZ Challenge) to try to reduce time and costs of developing PfSPZ Vaccine to prevent malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.7265625,
            "text": "controlled human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.7265625,
            "text": "human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 6.73046875,
            "text": "try to reduce time and costs of developing PfSPZ Vaccine to prevent malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 6.7265625,
            "text": "We are using controlled human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.5625,
            "text": "malaria in",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.57421875,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.59375,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (SPZ",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.6484375,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.6796875,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.68359375,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (SP",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.6953125,
            "text": "malaria infection (CHMI) by direct venous inoculation (DV",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -7.10546875,
            "text": "sporozoites (SPZ) (PfSPZ Challenge) to try to reduce time and costs of developing PfSPZ Vaccine to prevent malaria in Africa",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": -7.03125,
            "text": "inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -7.03125,
            "text": "controlled human malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_32": [
        {
            "start_logit": 6.359375,
            "end_logit": 6.73046875,
            "text": "malaria",
            "probability": 0.50390625
        },
        {
            "start_logit": 6.34765625,
            "end_logit": 6.7265625,
            "text": "malaria",
            "probability": 0.49609375
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.03125,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 6.73046875,
            "text": "sporozoites (SPZ) (PfSPZ Challenge) to try to reduce time and costs of developing PfSPZ Vaccine to prevent malaria",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.10546875,
            "text": "malaria in Africa",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 6.73046875,
            "text": "ozoites (SPZ) (PfSPZ Challenge) to try to reduce time and costs of developing PfSPZ Vaccine to prevent malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.7265625,
            "text": "controlled human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.7265625,
            "text": "human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 6.73046875,
            "text": "try to reduce time and costs of developing PfSPZ Vaccine to prevent malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 6.7265625,
            "text": "We are using controlled human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.359375,
            "end_logit": -7.5625,
            "text": "malaria in",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.57421875,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.59375,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (SPZ",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.6484375,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.6796875,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.68359375,
            "text": "malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum (Pf) sporozoites (SP",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.34765625,
            "end_logit": -7.6953125,
            "text": "malaria infection (CHMI) by direct venous inoculation (DV",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -7.10546875,
            "text": "sporozoites (SPZ) (PfSPZ Challenge) to try to reduce time and costs of developing PfSPZ Vaccine to prevent malaria in Africa",
            "probability": 0.0
        },
        {
            "start_logit": -7.57421875,
            "end_logit": -7.03125,
            "text": "inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -7.03125,
            "text": "controlled human malaria infection (CHMI) by direct venous inoculation (DVI) of cryopreserved, infectious Plasmodium falciparum",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_33": [
        {
            "start_logit": 6.46875,
            "end_logit": 6.58984375,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.46875,
            "end_logit": -7.3203125,
            "text": "malaria infection (",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.46875,
            "end_logit": -7.34375,
            "text": "malaria infection",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 6.58984375,
            "text": "sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.46875,
            "end_logit": -7.41015625,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection is unknown.",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 6.58984375,
            "text": "SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 6.58984375,
            "text": "controlled human malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.46875,
            "end_logit": -7.46484375,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of protection",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.46875,
            "end_logit": -7.5078125,
            "text": "malaria infection (CHMI) 3 weeks after immunization, but the durability of",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.46875,
            "end_logit": -7.54296875,
            "text": "malaria infection (CHMI",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.58984375,
            "text": "human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 6.58984375,
            "text": "protective against controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 6.58984375,
            "text": "Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 6.58984375,
            "text": "attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 6.58984375,
            "text": "An attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.46875,
            "end_logit": -7.66796875,
            "text": "malaria infection (CHMI) 3 weeks after",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.08984375,
            "end_logit": -7.41015625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -7.3203125,
            "text": "sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria infection (",
            "probability": 0.0
        },
        {
            "start_logit": -7.54296875,
            "end_logit": -7.3203125,
            "text": "SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria infection (",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -7.34375,
            "text": "sporozoite (SPZ) vaccine, PfSPZ Vaccine, is highly protective against controlled human malaria infection",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_34": [
        {
            "start_logit": 6.421875,
            "end_logit": 6.66796875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.21484375,
            "text": "malaria through long-lived tissue-resident T cells and",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 6.66796875,
            "text": "protection to malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.39453125,
            "text": "malaria through long-lived tissue-resident T cells and that administration of higher doses may further enhance protection.",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.453125,
            "text": "malaria through long-lived tissue-resident T cells and that administration of higher doses may further enhance protection",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 6.66796875,
            "text": "Our findings suggest that PfSPZ Vaccine conferred durable protection to malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 6.66796875,
            "text": "durable protection to malaria",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.49609375,
            "text": "malaria through",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.52734375,
            "text": "malaria through long-lived tissue-resident T cells and that administration of higher doses may",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 6.66796875,
            "text": "suggest that PfSPZ Vaccine conferred durable protection to malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 6.66796875,
            "text": "findings suggest that PfSPZ Vaccine conferred durable protection to malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.66796875,
            "text": "that PfSPZ Vaccine conferred durable protection to malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.64453125,
            "text": "malaria through long-lived",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.64453125,
            "text": "malaria through long-lived tissue",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.6484375,
            "text": "malaria through long-lived tissue-resident T cells",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.66015625,
            "text": "malaria through long-lived tissue-resident",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.66796875,
            "text": "malaria through long",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.421875,
            "end_logit": -7.67578125,
            "text": "malaria through long-lived tissue-resident T cells and that administration of higher doses may further enhance",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 6.66796875,
            "text": "PfSPZ Vaccine conferred durable protection to malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.16796875,
            "end_logit": -7.39453125,
            "text": ".",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_35": [
        {
            "start_logit": 6.4765625,
            "end_logit": 6.56640625,
            "text": "malaria",
            "probability": 0.3359375
        },
        {
            "start_logit": 6.45703125,
            "end_logit": 6.5859375,
            "text": "malaria",
            "probability": 0.3359375
        },
        {
            "start_logit": 6.45703125,
            "end_logit": 6.56640625,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 0.328369140625
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -6.74609375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -6.74609375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.04296875,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.09765625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.30078125,
            "text": "malaria infection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.30078125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 6.56640625,
            "text": "controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.359375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.375,
            "text": "malaria vaccine, Plasmodium falciparum",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.41015625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.421875,
            "text": "malaria infection (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 6.56640625,
            "text": "Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.44140625,
            "text": "malaria infection (CHMI) with",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.421875,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.44140625,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CHMI) with",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 6.56640625,
            "text": "sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.44921875,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite",
            "probability": 2.384185791015625e-07
        }
    ],
    "61f7d745882a024a10000038_36": [
        {
            "start_logit": 6.4765625,
            "end_logit": 6.56640625,
            "text": "malaria",
            "probability": 0.3359375
        },
        {
            "start_logit": 6.45703125,
            "end_logit": 6.5859375,
            "text": "malaria",
            "probability": 0.3359375
        },
        {
            "start_logit": 6.45703125,
            "end_logit": 6.56640625,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 0.328369140625
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -6.74609375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -6.74609375,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CHMI) with Plasmodium falciparum",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.04296875,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo after final vaccination.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.09765625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.30078125,
            "text": "malaria infection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.30078125,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 6.56640625,
            "text": "controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.359375,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf) parasites homologous to the vaccine strain up to 14 mo",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.375,
            "text": "malaria vaccine, Plasmodium falciparum",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.41015625,
            "text": "malaria infection (CHMI) with Plasmodium falciparum (Pf",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.421875,
            "text": "malaria infection (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 6.56640625,
            "text": "Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -7.44140625,
            "text": "malaria infection (CHMI) with",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.421875,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.44140625,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria infection (CHMI) with",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 6.56640625,
            "text": "sporozoite vaccine (PfSPZ Vaccine), confers sterile protection against controlled human malaria",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.44921875,
            "text": "malaria vaccine, Plasmodium falciparum sporozoite",
            "probability": 2.384185791015625e-07
        }
    ],
    "61f7d745882a024a10000038_37": [
        {
            "start_logit": 6.484375,
            "end_logit": 6.5625,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.484375,
            "end_logit": -7.12109375,
            "text": "malaria season.",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 6.5625,
            "text": ". PfSPZ Vaccine showed significant protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.484375,
            "end_logit": -7.1953125,
            "text": "malaria season",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 6.5625,
            "text": "P falciparum infection throughout an entire malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.5625,
            "text": "falciparum infection throughout an entire malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 6.5625,
            "text": "protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 6.5625,
            "text": "PfSPZ Vaccine was well tolerated and safe. PfSPZ Vaccine showed significant protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 6.5625,
            "text": "entire malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 6.5625,
            "text": "safe. PfSPZ Vaccine showed significant protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 6.5625,
            "text": "well tolerated and safe. PfSPZ Vaccine showed significant protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 6.5625,
            "text": "infection throughout an entire malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 6.5625,
            "text": "PfSPZ Vaccine showed significant protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 6.5625,
            "text": ": PfSPZ Vaccine was well tolerated and safe. PfSPZ Vaccine showed significant protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 6.5625,
            "text": "was well tolerated and safe. PfSPZ Vaccine showed significant protection in African adults against P falciparum infection throughout an entire malaria",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -5.60546875,
            "text": ". PfSPZ Vaccine showed significant protection in African adults against P falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -5.60546875,
            "text": "P falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -5.60546875,
            "text": "falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.62890625,
            "end_logit": -5.60546875,
            "text": "protection in African adults against P falciparum",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -5.60546875,
            "text": "PfSPZ Vaccine was well tolerated and safe. PfSPZ Vaccine showed significant protection in African adults against P falciparum",
            "probability": 0.0
        }
    ],
    "61f7d745882a024a10000038_38": [
        {
            "start_logit": 6.38671875,
            "end_logit": 6.65625,
            "text": "malaria",
            "probability": 0.501953125
        },
        {
            "start_logit": 6.390625,
            "end_logit": 6.6484375,
            "text": "malaria",
            "probability": 0.498046875
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -6.41796875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 6.6484375,
            "text": "100%) against homologous Pf (same strain as in the vaccine) controlled human malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.390625,
            "end_logit": -6.90234375,
            "text": "malaria infection",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 6.65625,
            "text": "sporozoite (SPZ) malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 6.6484375,
            "text": "controlled human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 6.6484375,
            "text": "human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -7.3671875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 6.65625,
            "text": "SPZ) malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 6.65625,
            "text": ") malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.65625,
            "text": "Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.65625,
            "text": "attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 6.65625,
            "text": "radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 6.65625,
            "text": "Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 6.65625,
            "text": "ozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 6.65625,
            "text": "(Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.6484375,
            "text": ") against homologous Pf (same strain as in the vaccine) controlled human malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.390625,
            "end_logit": -7.48828125,
            "text": "malaria infection (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -7.484375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as",
            "probability": 3.5762786865234375e-07
        }
    ],
    "61f7d745882a024a10000038_39": [
        {
            "start_logit": 6.38671875,
            "end_logit": 6.65625,
            "text": "malaria",
            "probability": 0.501953125
        },
        {
            "start_logit": 6.390625,
            "end_logit": 6.6484375,
            "text": "malaria",
            "probability": 0.498046875
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -6.41796875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -6.9921875,
            "end_logit": 6.6484375,
            "text": "100%) against homologous Pf (same strain as in the vaccine) controlled human malaria",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.390625,
            "end_logit": -6.90234375,
            "text": "malaria infection",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 6.65625,
            "text": "sporozoite (SPZ) malaria",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 6.6484375,
            "text": "controlled human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 6.6484375,
            "text": "human malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -7.3671875,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 6.65625,
            "text": "SPZ) malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 6.65625,
            "text": ") malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.65625,
            "text": "Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.65625,
            "text": "attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 6.65625,
            "text": "radiation-attenuated Plasmodium falciparum (Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 6.65625,
            "text": "Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 6.65625,
            "text": "ozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 6.65625,
            "text": "(Pf) sporozoite (SPZ) malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.6484375,
            "text": ") against homologous Pf (same strain as in the vaccine) controlled human malaria",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.390625,
            "end_logit": -7.48828125,
            "text": "malaria infection (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -7.484375,
            "text": "malaria vaccine, PfSPZ Vaccine, protected 6 of 6 subjects (100%) against homologous Pf (same strain as",
            "probability": 3.5762786865234375e-07
        }
    ],
    "61f7d745882a024a10000038_40": [
        {
            "start_logit": 6.375,
            "end_logit": 6.71484375,
            "text": "malaria",
            "probability": 0.3369140625
        },
        {
            "start_logit": 6.3671875,
            "end_logit": 6.71484375,
            "text": "malaria",
            "probability": 0.33154296875
        },
        {
            "start_logit": 6.3671875,
            "end_logit": 6.71484375,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 0.33154296875
        },
        {
            "start_logit": 6.375,
            "end_logit": -5.71875,
            "text": "malaria infection in malaria",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -5.71875,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.375,
            "end_logit": -6.79296875,
            "text": "malaria infection in malaria-naive",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -6.79296875,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-naive",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.26171875,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.28125,
            "text": "malaria infection in malaria-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.28125,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 6.71484375,
            "text": "whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 6.71484375,
            "text": "whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.71484375,
            "text": "Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.71484375,
            "text": ", whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.71484375,
            "text": ", whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 6.71484375,
            "text": "controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.71484375,
            "text": "human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 6.71484375,
            "text": "BACKGROUND: Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.4375,
            "text": "malaria infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.4375,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection",
            "probability": 2.384185791015625e-07
        }
    ],
    "61f7d745882a024a10000038_41": [
        {
            "start_logit": 6.375,
            "end_logit": 6.71484375,
            "text": "malaria",
            "probability": 0.3369140625
        },
        {
            "start_logit": 6.3671875,
            "end_logit": 6.71484375,
            "text": "malaria",
            "probability": 0.33154296875
        },
        {
            "start_logit": 6.3671875,
            "end_logit": 6.71484375,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 0.33154296875
        },
        {
            "start_logit": 6.375,
            "end_logit": -5.71875,
            "text": "malaria infection in malaria",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -5.71875,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.375,
            "end_logit": -6.79296875,
            "text": "malaria infection in malaria-naive",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -6.79296875,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-naive",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.26171875,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.28125,
            "text": "malaria infection in malaria-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.28125,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection in malaria-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 6.71484375,
            "text": "whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 6.71484375,
            "text": "whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.71484375,
            "text": "Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.71484375,
            "text": ", whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.71484375,
            "text": ", whole malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 6.71484375,
            "text": "controlled human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.71484375,
            "text": "human malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 6.71484375,
            "text": "BACKGROUND: Plasmodium falciparum sporozite (PfSPZ) Vaccine is a metabolically active, non-replicating, whole malaria",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.4375,
            "text": "malaria infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.3671875,
            "end_logit": -7.4375,
            "text": "malaria sporozoite vaccine that has been reported to be safe and protective against P falciparum controlled human malaria infection",
            "probability": 2.384185791015625e-07
        }
    ],
    "61f7d745882a024a10000038_42": [
        {
            "start_logit": 6.3515625,
            "end_logit": 6.71875,
            "text": "malaria",
            "probability": 1.0
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -4.96875,
            "text": "malaria infection",
            "probability": 8.404254913330078e-06
        },
        {
            "start_logit": -5.91796875,
            "end_logit": 6.71875,
            "text": "human malaria",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 6.71875,
            "text": "controlled human malaria",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 6.71875,
            "text": "infection in 9 out of 9 (100%) volunteers who underwent controlled human malaria",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 6.71875,
            "text": "Challenge at 28-day intervals were well tolerated and safe, and prevented infection in 9 out of 9 (100%) volunteers who underwent controlled human malaria",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 6.71875,
            "text": "underwent controlled human malaria",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 6.71875,
            "text": ", and prevented infection in 9 out of 9 (100%) volunteers who underwent controlled human malaria",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.24609375,
            "text": "malaria infection ten",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 6.71875,
            "text": "safe, and prevented infection in 9 out of 9 (100%) volunteers who underwent controlled human malaria",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.3671875,
            "text": "malaria infection ten weeks after the last dose (group III",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.515625,
            "text": "malaria infection ten weeks after the last dose (group III).",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.6015625,
            "text": "malaria infection ten weeks after the last",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.91796875,
            "end_logit": -4.96875,
            "text": "human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -6.0390625,
            "end_logit": -4.96875,
            "text": "infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.18359375,
            "end_logit": -4.96875,
            "text": "controlled human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.3046875,
            "end_logit": -4.96875,
            "text": "infection in 9 out of 9 (100%) volunteers who underwent controlled human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -4.96875,
            "text": "underwent controlled human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -4.96875,
            "text": ", and prevented infection in 9 out of 9 (100%) volunteers who underwent controlled human malaria infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -4.96875,
            "text": "safe, and prevented infection in 9 out of 9 (100%) volunteers who underwent controlled human malaria infection",
            "probability": 0.0
        }
    ],
    "622d1ed13a8413c6530000a3_1": [
        {
            "start_logit": 7.86328125,
            "end_logit": -1.2119140625,
            "text": "The",
            "probability": 0.68798828125
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -2.517578125,
            "text": "The daughterless (da) gene in Drosophila",
            "probability": 0.18603515625
        },
        {
            "start_logit": -1.65234375,
            "end_logit": 6.01953125,
            "text": ".",
            "probability": 0.07000732421875
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -5.75,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator",
            "probability": 0.007350921630859375
        },
        {
            "start_logit": -3.916015625,
            "end_logit": 6.01953125,
            "text": "daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex determination and neurogenesis have been extensively examined.",
            "probability": 0.007293701171875
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -6.23828125,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed",
            "probability": 0.004512786865234375
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -6.2734375,
            "text": "The daughterless (da) gene in Drosophila encodes a",
            "probability": 0.00435638427734375
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -6.421875,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly",
            "probability": 0.003753662109375
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -6.44140625,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose",
            "probability": 0.0036830902099609375
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -6.64453125,
            "text": "The daughterless (da) gene in",
            "probability": 0.0030059814453125
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -6.65234375,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional",
            "probability": 0.00298309326171875
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -6.76171875,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex determination",
            "probability": 0.002674102783203125
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -6.8671875,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex",
            "probability": 0.0024051666259765625
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -6.9921875,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific",
            "probability": 0.0021228790283203125
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.00390625,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of",
            "probability": 0.00209808349609375
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.0390625,
            "text": "The daughterless (da",
            "probability": 0.002025604248046875
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.109375,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the",
            "probability": 0.0018892288208007812
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.109375,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex determination and",
            "probability": 0.0018892288208007812
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.1328125,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in",
            "probability": 0.0018444061279296875
        },
        {
            "start_logit": 7.86328125,
            "end_logit": -7.1328125,
            "text": "The daughterless (da) gene in Drosophila encodes a broadly expressed transcriptional regulator whose specific functions in the control of sex determination and neurogenesis have been",
            "probability": 0.0018444061279296875
        }
    ],
    "56bc9268ac7ad1001900001b_1": [
        {
            "start_logit": 8.15625,
            "end_logit": 8.140625,
            "text": "interleukin-17",
            "probability": 1.0
        },
        {
            "start_logit": -1.14453125,
            "end_logit": 8.140625,
            "text": "17",
            "probability": 9.173154830932617e-05
        },
        {
            "start_logit": 8.15625,
            "end_logit": -1.5654296875,
            "text": "interleukin",
            "probability": 6.109476089477539e-05
        },
        {
            "start_logit": 8.15625,
            "end_logit": -6.10546875,
            "text": "interleukin-17 receptor",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -6.26171875,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has efficacy in the treatment of psoriasis",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -6.91796875,
            "text": "interleukin-17 receptor A",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -6.98046875,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has efficacy in the treatment of psoriasis.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 8.140625,
            "text": "-17",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.04296875,
            "text": "interleukin-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.4375,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.54296875,
            "text": "interleukin-17 receptor A monoclonal antibody",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.546875,
            "text": "interleukin-17 receptor A monoclonal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.62109375,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has efficacy in the treatment of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.640625,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.6640625,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has efficacy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 8.140625,
            "text": "Early clinical studies suggested that the anti-interleukin-17",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.70703125,
            "text": "interleukin-17 receptor A monoclonal antibody brodalumab has efficacy in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 8.140625,
            "text": "BACKGROUND: Early clinical studies suggested that the anti-interleukin-17",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 8.140625,
            "text": "clinical studies suggested that the anti-interleukin-17",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 8.140625,
            "text": "anti-interleukin-17",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56bc9268ac7ad1001900001b_2": [
        {
            "start_logit": 7.05078125,
            "end_logit": 6.83984375,
            "text": "interleukin-17",
            "probability": 1.0
        },
        {
            "start_logit": 7.05078125,
            "end_logit": -3.533203125,
            "text": "interleukin",
            "probability": 3.11732292175293e-05
        },
        {
            "start_logit": -3.75,
            "end_logit": 6.83984375,
            "text": "17",
            "probability": 2.0444393157958984e-05
        },
        {
            "start_logit": 7.05078125,
            "end_logit": -5.02734375,
            "text": "interleukin-17-receptor",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": 7.05078125,
            "end_logit": -5.0703125,
            "text": "interleukin-17-receptor antibody for psoriasis.",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": 7.05078125,
            "end_logit": -5.8359375,
            "text": "interleukin-17-receptor antibody for psoriasis",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 7.05078125,
            "end_logit": -6.58984375,
            "text": "interleukin-17-",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 7.05078125,
            "end_logit": -6.8125,
            "text": "interleukin-",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.05078125,
            "end_logit": -7.40234375,
            "text": "interleukin-17-receptor antibody",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 6.83984375,
            "text": "anti-interleukin-17",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 6.83984375,
            "text": "-17",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 6.83984375,
            "text": ", an anti-interleukin-17",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 6.83984375,
            "text": "an anti-interleukin-17",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 6.83984375,
            "text": "Brodalumab, an anti-interleukin-17",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 6.83984375,
            "text": "lumab, an anti-interleukin-17",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 6.83984375,
            "text": "dalumab, an anti-interleukin-17",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -3.75,
            "end_logit": -5.02734375,
            "text": "17-receptor",
            "probability": 0.0
        },
        {
            "start_logit": -3.75,
            "end_logit": -5.0703125,
            "text": "17-receptor antibody for psoriasis.",
            "probability": 0.0
        },
        {
            "start_logit": -3.75,
            "end_logit": -5.8359375,
            "text": "17-receptor antibody for psoriasis",
            "probability": 0.0
        },
        {
            "start_logit": -3.75,
            "end_logit": -6.58984375,
            "text": "17-",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_1": [
        {
            "start_logit": 6.12890625,
            "end_logit": 6.90234375,
            "text": "hypertension",
            "probability": 1.0
        },
        {
            "start_logit": -3.390625,
            "end_logit": 6.90234375,
            "text": "essential hypertension",
            "probability": 7.367134094238281e-05
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.90234375,
            "text": ") administered for 3 years to patients with essential hypertension",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.671875,
            "end_logit": 6.90234375,
            "text": "with essential hypertension",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 6.90234375,
            "text": "to patients with essential hypertension",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.90234375,
            "text": "patients with essential hypertension",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.12890625,
            "end_logit": -7.26953125,
            "text": "hypertension (WHO",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -2.96875,
            "text": "antihypertensive",
            "probability": 0.0
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -7.078125,
            "text": "antihypertensive treatment",
            "probability": 0.0
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -7.26171875,
            "text": "antihypertensive treatment with isradipine as",
            "probability": 0.0
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -7.2734375,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/- 0.56 mg twice daily",
            "probability": 0.0
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -7.3046875,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/",
            "probability": 0.0
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -7.3359375,
            "text": "antihypertensive treatment with",
            "probability": 0.0
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -7.3671875,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/-",
            "probability": 0.0
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -7.41796875,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/- 0.56 mg twice daily; n = 11",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -2.96875,
            "text": "preliminary data of an open multicenter trial of antihypertensive",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": -2.96875,
            "text": "multicenter trial of antihypertensive",
            "probability": 0.0
        },
        {
            "start_logit": -7.6484375,
            "end_logit": -2.96875,
            "text": "the preliminary data of an open multicenter trial of antihypertensive",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -2.96875,
            "text": "are the preliminary data of an open multicenter trial of antihypertensive",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -2.96875,
            "text": "data of an open multicenter trial of antihypertensive",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_2": [
        {
            "start_logit": 5.99609375,
            "end_logit": 7.03125,
            "text": "hypertension",
            "probability": 1.0
        },
        {
            "start_logit": -2.96875,
            "end_logit": 7.03125,
            "text": "antihypertensive drug in blacks with essential hypertension",
            "probability": 0.00012731552124023438
        },
        {
            "start_logit": -6.08203125,
            "end_logit": 7.03125,
            "text": "essential hypertension",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 7.03125,
            "text": "Isradipine monotherapy was an effective antihypertensive drug in blacks with essential hypertension",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 7.03125,
            "text": "blacks with essential hypertension",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 7.03125,
            "text": "pine monotherapy was an effective antihypertensive drug in blacks with essential hypertension",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 7.03125,
            "text": "effective antihypertensive drug in blacks with essential hypertension",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 7.03125,
            "text": "dipine monotherapy was an effective antihypertensive drug in blacks with essential hypertension",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 5.99609375,
            "end_logit": -7.3203125,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100 g left ventricular mass.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 5.99609375,
            "end_logit": -7.3515625,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100 g left ventricular",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.99609375,
            "end_logit": -7.38671875,
            "text": "hypertension,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.99609375,
            "end_logit": -7.54296875,
            "text": "hypertension, resulting in",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 5.99609375,
            "end_logit": -7.57421875,
            "text": "hypertension, resulting",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 5.99609375,
            "end_logit": -7.59375,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.99609375,
            "end_logit": -7.609375,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.99609375,
            "end_logit": -7.6171875,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of fractional shortening per 100",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.99609375,
            "end_logit": -7.625,
            "text": "hypertension, resulting in regression of left ventricular",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.99609375,
            "end_logit": -7.6328125,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.99609375,
            "end_logit": -7.6875,
            "text": "hypertension, resulting in regression of left ventricular wall thickness and mass and augmentation of",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -2.96875,
            "end_logit": -4.234375,
            "text": "antihypertensive",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_3": [
        {
            "start_logit": 6.12890625,
            "end_logit": 6.90234375,
            "text": "hypertension",
            "probability": 1.0
        },
        {
            "start_logit": -3.390625,
            "end_logit": 6.90234375,
            "text": "essential hypertension",
            "probability": 7.367134094238281e-05
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.90234375,
            "text": ") administered for 3 years to patients with essential hypertension",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.671875,
            "end_logit": 6.90234375,
            "text": "with essential hypertension",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 6.90234375,
            "text": "to patients with essential hypertension",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.90234375,
            "text": "patients with essential hypertension",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.12890625,
            "end_logit": -7.26953125,
            "text": "hypertension (WHO",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -2.96875,
            "text": "antihypertensive",
            "probability": 0.0
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -7.078125,
            "text": "antihypertensive treatment",
            "probability": 0.0
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -7.26171875,
            "text": "antihypertensive treatment with isradipine as",
            "probability": 0.0
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -7.2734375,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/- 0.56 mg twice daily",
            "probability": 0.0
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -7.3046875,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/",
            "probability": 0.0
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -7.3359375,
            "text": "antihypertensive treatment with",
            "probability": 0.0
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -7.3671875,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/-",
            "probability": 0.0
        },
        {
            "start_logit": -2.69140625,
            "end_logit": -7.41796875,
            "text": "antihypertensive treatment with isradipine as monotherapy (dose, 4.55 +/- 0.56 mg twice daily; n = 11",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -2.96875,
            "text": "preliminary data of an open multicenter trial of antihypertensive",
            "probability": 0.0
        },
        {
            "start_logit": -7.64453125,
            "end_logit": -2.96875,
            "text": "multicenter trial of antihypertensive",
            "probability": 0.0
        },
        {
            "start_logit": -7.6484375,
            "end_logit": -2.96875,
            "text": "the preliminary data of an open multicenter trial of antihypertensive",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -2.96875,
            "text": "are the preliminary data of an open multicenter trial of antihypertensive",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -2.96875,
            "text": "data of an open multicenter trial of antihypertensive",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_4": [
        {
            "start_logit": 6.34375,
            "end_logit": 6.6171875,
            "text": "hypertension",
            "probability": 1.0
        },
        {
            "start_logit": 6.34375,
            "end_logit": -3.916015625,
            "text": "hypertension (mean age 59 years) using casual and ambulatory 24-h blood pressure",
            "probability": 2.6702880859375e-05
        },
        {
            "start_logit": -5.375,
            "end_logit": 6.6171875,
            "text": "antihypertensive effect of isradipine was studied in 45 patients with mild-to-moderate hypertension",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.078125,
            "text": "hypertension (mean age 59 years) using casual and ambulatory 24-h blood pressure measurement.",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 6.6171875,
            "text": "The antihypertensive effect of isradipine was studied in 45 patients with mild-to-moderate hypertension",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 6.6171875,
            "text": "mild-to-moderate hypertension",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 6.6171875,
            "text": "studied in 45 patients with mild-to-moderate hypertension",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 6.6171875,
            "text": "45 patients with mild-to-moderate hypertension",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 6.6171875,
            "text": "isradipine was studied in 45 patients with mild-to-moderate hypertension",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 6.6171875,
            "text": "patients with mild-to-moderate hypertension",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.5,
            "text": "hypertension (",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.53125,
            "text": "hypertension (mean age 59 years)",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.62109375,
            "text": "hypertension (mean age 59",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.98046875,
            "end_logit": -3.916015625,
            "text": "blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": -5.375,
            "end_logit": -4.74609375,
            "text": "antihypertensive",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": -3.916015625,
            "text": "pressure",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -3.916015625,
            "text": ") using casual and ambulatory 24-h blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": -7.61328125,
            "end_logit": -3.916015625,
            "text": "mean age 59 years) using casual and ambulatory 24-h blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": -7.66015625,
            "end_logit": -3.916015625,
            "text": "mild-to-moderate hypertension (mean age 59 years) using casual and ambulatory 24-h blood pressure",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -3.916015625,
            "text": "h blood pressure",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_5": [
        {
            "start_logit": 0.3984375,
            "end_logit": 6.8671875,
            "text": "hypertension",
            "probability": 0.98291015625
        },
        {
            "start_logit": -4.796875,
            "end_logit": 6.8671875,
            "text": "antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0054473876953125
        },
        {
            "start_logit": -5.23046875,
            "end_logit": 6.8671875,
            "text": "Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0035305023193359375
        },
        {
            "start_logit": -5.37109375,
            "end_logit": 6.8671875,
            "text": "coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0030670166015625
        },
        {
            "start_logit": -5.38671875,
            "end_logit": 6.8671875,
            "text": "arterial hypertension",
            "probability": 0.0030193328857421875
        },
        {
            "start_logit": -6.99609375,
            "end_logit": 6.8671875,
            "text": "[Long-term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0006041526794433594
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 6.8671875,
            "text": "Long-term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.00045752525329589844
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 6.8671875,
            "text": "with arterial hypertension",
            "probability": 0.00037932395935058594
        },
        {
            "start_logit": -7.625,
            "end_logit": 6.8671875,
            "text": "isradipine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0003218650817871094
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 6.8671875,
            "text": "pine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0002911090850830078
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.8671875,
            "text": "term antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0002911090850830078
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 6.8671875,
            "text": "dipine. Improvement of coronary flow reserve in patients with arterial hypertension",
            "probability": 0.0002732276916503906
        },
        {
            "start_logit": 0.3984375,
            "end_logit": -4.1796875,
            "text": "hypertension and microvascular angina].",
            "probability": 1.5616416931152344e-05
        },
        {
            "start_logit": 0.3984375,
            "end_logit": -5.95703125,
            "text": "hypertension and microvascular angina]",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 0.3984375,
            "end_logit": -6.1484375,
            "text": "hypertension and",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 0.3984375,
            "end_logit": -6.70703125,
            "text": "hypertension and microvascular angina",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -4.796875,
            "end_logit": -4.1796875,
            "text": "antihypertensive therapy with isradipine. Improvement of coronary flow reserve in patients with arterial hypertension and microvascular angina].",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.796875,
            "end_logit": -4.48046875,
            "text": "antihypertensive",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.23046875,
            "end_logit": -4.1796875,
            "text": "Improvement of coronary flow reserve in patients with arterial hypertension and microvascular angina].",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.37109375,
            "end_logit": -4.1796875,
            "text": "coronary flow reserve in patients with arterial hypertension and microvascular angina].",
            "probability": 5.960464477539063e-08
        }
    ],
    "56c3184050c68dd416000003_6": [
        {
            "start_logit": 4.48828125,
            "end_logit": 7.78515625,
            "text": "arterial hypertension",
            "probability": 0.998046875
        },
        {
            "start_logit": -2.03125,
            "end_logit": 7.78515625,
            "text": "hypertension",
            "probability": 0.0014715194702148438
        },
        {
            "start_logit": -7.17578125,
            "end_logit": 7.78515625,
            "text": "Isradipine in arterial hypertension",
            "probability": 8.58306884765625e-06
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 7.78515625,
            "text": "[Isradipine in arterial hypertension",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 7.78515625,
            "text": "dipine in arterial hypertension",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 4.48828125,
            "end_logit": -6.1015625,
            "text": "arterial",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 4.48828125,
            "end_logit": -6.9609375,
            "text": "arterial hypertension in motor vehicle drivers]",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 4.48828125,
            "end_logit": -7.4609375,
            "text": "arterial hypertension in motor vehicle drivers].",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.48828125,
            "end_logit": -7.484375,
            "text": "arterial hypertension in motor vehicle drivers",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.48828125,
            "end_logit": -7.74609375,
            "text": "arterial hypertension in motor vehicle",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.48828125,
            "end_logit": -7.765625,
            "text": "arterial hypertension in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.03125,
            "end_logit": -6.9609375,
            "text": "hypertension in motor vehicle drivers]",
            "probability": 0.0
        },
        {
            "start_logit": -2.03125,
            "end_logit": -7.4609375,
            "text": "hypertension in motor vehicle drivers].",
            "probability": 0.0
        },
        {
            "start_logit": -2.03125,
            "end_logit": -7.484375,
            "text": "hypertension in motor vehicle drivers",
            "probability": 0.0
        },
        {
            "start_logit": -2.03125,
            "end_logit": -7.74609375,
            "text": "hypertension in motor vehicle",
            "probability": 0.0
        },
        {
            "start_logit": -2.03125,
            "end_logit": -7.765625,
            "text": "hypertension in",
            "probability": 0.0
        },
        {
            "start_logit": -7.17578125,
            "end_logit": -6.1015625,
            "text": "Isradipine in arterial",
            "probability": 0.0
        },
        {
            "start_logit": -7.18359375,
            "end_logit": -6.1015625,
            "text": "[Isradipine in arterial",
            "probability": 0.0
        },
        {
            "start_logit": -7.8203125,
            "end_logit": -6.1015625,
            "text": "dipine in arterial",
            "probability": 0.0
        },
        {
            "start_logit": -7.0859375,
            "end_logit": -6.9609375,
            "text": "motor vehicle drivers]",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_7": [
        {
            "start_logit": 5.91796875,
            "end_logit": 7.1015625,
            "text": "hypertension",
            "probability": 1.0
        },
        {
            "start_logit": -4.59375,
            "end_logit": 7.1015625,
            "text": "essential hypertension",
            "probability": 2.7298927307128906e-05
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 7.1015625,
            "text": "Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 7.1015625,
            "text": "elderly patients with essential hypertension",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.671875,
            "end_logit": 7.1015625,
            "text": "isradipine in elderly patients with essential hypertension",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 7.1015625,
            "text": "of the safety and efficacy of isradipine in elderly patients with essential hypertension",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 7.1015625,
            "text": "safety and efficacy of isradipine in elderly patients with essential hypertension",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 7.1015625,
            "text": "patients with essential hypertension",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.859375,
            "end_logit": 7.1015625,
            "text": "with essential hypertension",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 7.1015625,
            "text": "pine in elderly patients with essential hypertension",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -7.5703125,
            "text": "hypertension.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -4.59375,
            "end_logit": -7.5703125,
            "text": "essential hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -7.23828125,
            "end_logit": -7.5703125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": -7.484375,
            "text": "Evaluation of the safety and efficacy of isradipine in elderly patients",
            "probability": 0.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": -7.53125,
            "text": "Evaluation of the safety and",
            "probability": 0.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": -7.5703125,
            "text": "Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension.",
            "probability": 0.0
        },
        {
            "start_logit": -7.62109375,
            "end_logit": -7.484375,
            "text": "elderly patients",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -7.484375,
            "text": "isradipine in elderly patients",
            "probability": 0.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": -7.75390625,
            "text": "Evaluation of the safety and efficacy of isradipine in elderly patients with",
            "probability": 0.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": -7.765625,
            "text": "Evaluation of the safety and efficacy",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_8": [
        {
            "start_logit": 6.21875,
            "end_logit": 6.84765625,
            "text": "hypertension",
            "probability": 1.0
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 6.84765625,
            "text": "treatment of hypertension",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -7.421875,
            "end_logit": 6.84765625,
            "text": "A multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 6.84765625,
            "text": "evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 6.84765625,
            "text": "multicenter evaluation of the safety and efficacy of isradipine and atenolol in the treatment of hypertension",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 6.84765625,
            "text": "the treatment of hypertension",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 6.84765625,
            "text": "isradipine and atenolol in the treatment of hypertension",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 6.84765625,
            "text": "atenolol in the treatment of hypertension",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 6.84765625,
            "text": "and atenolol in the treatment of hypertension",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 6.84765625,
            "text": "dipine and atenolol in the treatment of hypertension",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 6.84765625,
            "text": "safety and efficacy of isradipine and atenolol in the treatment of hypertension",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 6.84765625,
            "text": "pine and atenolol in the treatment of hypertension",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 6.84765625,
            "text": "efficacy of isradipine and atenolol in the treatment of hypertension",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 6.84765625,
            "text": "in the treatment of hypertension",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 6.84765625,
            "text": "the safety and efficacy of isradipine and atenolol in the treatment of hypertension",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 6.84765625,
            "text": "of isradipine and atenolol in the treatment of hypertension",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.21875,
            "end_logit": -7.6171875,
            "text": "hypertension.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.78515625,
            "end_logit": -7.37109375,
            "text": "treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -6.78515625,
            "end_logit": -7.3984375,
            "text": "treatment",
            "probability": 0.0
        },
        {
            "start_logit": -6.78515625,
            "end_logit": -7.6171875,
            "text": "treatment of hypertension.",
            "probability": 0.0
        }
    ],
    "56c3184050c68dd416000003_9": [
        {
            "start_logit": 6.3203125,
            "end_logit": 6.75,
            "text": "hypertension",
            "probability": 1.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": 6.75,
            "text": "it is advisable to be very careful in the use of isradipine as a therapy for hypertension",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.75,
            "text": "use of isradipine as a therapy for hypertension",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 6.75,
            "text": "very careful in the use of isradipine as a therapy for hypertension",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 6.75,
            "text": "careful in the use of isradipine as a therapy for hypertension",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 6.75,
            "text": "the use of isradipine as a therapy for hypertension",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 6.75,
            "text": "isradipine as a therapy for hypertension",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 6.75,
            "text": "therapy for hypertension",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 6.75,
            "text": "for hypertension",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.5234375,
            "text": "hypertension and other",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.53515625,
            "text": "hypertension and other indications.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.73828125,
            "text": "hypertension and",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.29296875,
            "end_logit": -7.53515625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -7.5234375,
            "text": "it is advisable to be very careful in the use of isradipine as a therapy for hypertension and other",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -7.53515625,
            "text": "it is advisable to be very careful in the use of isradipine as",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -7.53515625,
            "text": "it is advisable to be very careful in the use of isradipine as a therapy for hypertension and other indications.",
            "probability": 0.0
        },
        {
            "start_logit": -7.546875,
            "end_logit": -7.625,
            "text": "it is advisable to",
            "probability": 0.0
        },
        {
            "start_logit": -7.6953125,
            "end_logit": -7.5234375,
            "text": "and other",
            "probability": 0.0
        },
        {
            "start_logit": -7.6953125,
            "end_logit": -7.53515625,
            "text": "and other indications.",
            "probability": 0.0
        },
        {
            "start_logit": -7.7109375,
            "end_logit": -7.5234375,
            "text": "other",
            "probability": 0.0
        }
    ],
    "56ffd08bcf1c325851000009_1": [
        {
            "start_logit": -0.1136474609375,
            "end_logit": 5.84375,
            "text": "the 7SL RNA gene.",
            "probability": 0.7470703125
        },
        {
            "start_logit": -1.548828125,
            "end_logit": 5.84375,
            "text": ".",
            "probability": 0.1781005859375
        },
        {
            "start_logit": 5.27734375,
            "end_logit": -2.615234375,
            "text": "Alu",
            "probability": 0.03472900390625
        },
        {
            "start_logit": -4.359375,
            "end_logit": 5.84375,
            "text": "300 bp, and originate from the 7SL RNA gene.",
            "probability": 0.0106964111328125
        },
        {
            "start_logit": 5.27734375,
            "end_logit": -4.01171875,
            "text": "Alu elements are each a dimer of similar, but not identical, fragments of total size about 300 bp, and originate from the 7SL RNA gene",
            "probability": 0.0085906982421875
        },
        {
            "start_logit": 5.27734375,
            "end_logit": -4.23828125,
            "text": "Alu elements are each a dimer of similar, but not identical, fragments of total size about 300 bp, and",
            "probability": 0.0068511962890625
        },
        {
            "start_logit": -5.73828125,
            "end_logit": 5.84375,
            "text": "7SL RNA gene.",
            "probability": 0.00269317626953125
        },
        {
            "start_logit": -6.09375,
            "end_logit": 5.84375,
            "text": "from the 7SL RNA gene.",
            "probability": 0.0018873214721679688
        },
        {
            "start_logit": 5.27734375,
            "end_logit": -5.77734375,
            "text": "Alu elements are each a dimer of similar, but not identical, fragments of total size about 300 bp",
            "probability": 0.0014705657958984375
        },
        {
            "start_logit": 5.27734375,
            "end_logit": -5.90234375,
            "text": "Alu elements are each a dimer of similar, but not identical, fragments of total size about 300 bp,",
            "probability": 0.0012979507446289062
        },
        {
            "start_logit": 5.27734375,
            "end_logit": -6.25,
            "text": "Alu elements are each a dimer of similar, but not identical, fragments of total size about 300 bp, and originate",
            "probability": 0.0009169578552246094
        },
        {
            "start_logit": -6.84375,
            "end_logit": 5.84375,
            "text": ", and originate from the 7SL RNA gene.",
            "probability": 0.0008916854858398438
        },
        {
            "start_logit": -7.046875,
            "end_logit": 5.84375,
            "text": "SL RNA gene.",
            "probability": 0.0007281303405761719
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 5.84375,
            "text": "L RNA gene.",
            "probability": 0.0006861686706542969
        },
        {
            "start_logit": 5.27734375,
            "end_logit": -6.59375,
            "text": "Alu elements are",
            "probability": 0.0006499290466308594
        },
        {
            "start_logit": 5.27734375,
            "end_logit": -6.69921875,
            "text": "Alu elements are each a dimer of similar, but not identical, fragments of",
            "probability": 0.0005846023559570312
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 5.84375,
            "text": "about 300 bp, and originate from the 7SL RNA gene.",
            "probability": 0.0005712509155273438
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 5.84375,
            "text": "each a dimer of similar, but not identical, fragments of total size about 300 bp, and originate from the 7SL RNA gene.",
            "probability": 0.0005536079406738281
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 5.84375,
            "text": "of similar, but not identical, fragments of total size about 300 bp, and originate from the 7SL RNA gene.",
            "probability": 0.0005102157592773438
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 5.84375,
            "text": "dimer of similar, but not identical, fragments of total size about 300 bp, and originate from the 7SL RNA gene.",
            "probability": 0.0004963874816894531
        }
    ],
    "58cf5c5a8acda34529000003_1": [
        {
            "start_logit": 4.7578125,
            "end_logit": 1.1220703125,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats (99%) and in regions where transcription starts and stops.",
            "probability": 0.8251953125
        },
        {
            "start_logit": 4.7578125,
            "end_logit": -0.54345703125,
            "text": "1% of T",
            "probability": 0.15625
        },
        {
            "start_logit": 4.7578125,
            "end_logit": -3.654296875,
            "text": "1%",
            "probability": 0.006977081298828125
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": 1.1220703125,
            "text": "T in the Leishmania genome and is only found in telomeric repeats (99%) and in regions where transcription starts and stops.",
            "probability": 0.0031070709228515625
        },
        {
            "start_logit": 4.7578125,
            "end_logit": -4.5390625,
            "text": "1",
            "probability": 0.0028743743896484375
        },
        {
            "start_logit": 4.7578125,
            "end_logit": -5.59765625,
            "text": "1% of T in the Leishmania genome and",
            "probability": 0.0009965896606445312
        },
        {
            "start_logit": 4.7578125,
            "end_logit": -5.92578125,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.0007181167602539062
        },
        {
            "start_logit": 4.7578125,
            "end_logit": -6.07421875,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats (99%",
            "probability": 0.0006189346313476562
        },
        {
            "start_logit": -0.82373046875,
            "end_logit": -0.54345703125,
            "text": "T",
            "probability": 0.0005884170532226562
        },
        {
            "start_logit": 4.7578125,
            "end_logit": -6.3828125,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats (99",
            "probability": 0.0004544258117675781
        },
        {
            "start_logit": 4.7578125,
            "end_logit": -6.55859375,
            "text": "1% of T in",
            "probability": 0.00038123130798339844
        },
        {
            "start_logit": 4.7578125,
            "end_logit": -7.06640625,
            "text": "1% of T in the Leishmania genome and is only found in telomeric",
            "probability": 0.00022935867309570312
        },
        {
            "start_logit": 4.7578125,
            "end_logit": -7.07421875,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats (99%) and in regions where transcription starts",
            "probability": 0.0002275705337524414
        },
        {
            "start_logit": 4.7578125,
            "end_logit": -7.16796875,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats (99%) and",
            "probability": 0.0002073049545288086
        },
        {
            "start_logit": 4.7578125,
            "end_logit": -7.21875,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats (99%) and in regions where transcription starts and stop",
            "probability": 0.00019621849060058594
        },
        {
            "start_logit": 4.7578125,
            "end_logit": -7.22265625,
            "text": "1% of T in the Leishmania genome",
            "probability": 0.00019621849060058594
        },
        {
            "start_logit": 4.7578125,
            "end_logit": -7.26171875,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats (99%) and in regions where transcription starts and",
            "probability": 0.00018870830535888672
        },
        {
            "start_logit": 4.7578125,
            "end_logit": -7.3046875,
            "text": "1% of T in the Leishmania genome and is",
            "probability": 0.00018155574798583984
        },
        {
            "start_logit": -4.4140625,
            "end_logit": 1.1220703125,
            "text": ".",
            "probability": 8.577108383178711e-05
        },
        {
            "start_logit": -5.72265625,
            "end_logit": 1.1220703125,
            "text": "99%) and in regions where transcription starts and stops.",
            "probability": 2.3066997528076172e-05
        }
    ],
    "58cf5c5a8acda34529000003_2": [
        {
            "start_logit": 6.11328125,
            "end_logit": 1.5166015625,
            "text": "1% of T",
            "probability": 0.984375
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -3.419921875,
            "text": "1%",
            "probability": 0.007061004638671875
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -3.814453125,
            "text": "1",
            "probability": 0.0047760009765625
        },
        {
            "start_logit": -0.875,
            "end_logit": 1.5166015625,
            "text": "T",
            "probability": 0.0009083747863769531
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -5.9375,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats",
            "probability": 0.0005707740783691406
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -6.19140625,
            "text": "1% of T in the Leishmania genome and",
            "probability": 0.00044274330139160156
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -6.24609375,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats (99%",
            "probability": 0.00041937828063964844
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -6.7109375,
            "text": "1% of T in",
            "probability": 0.00026345252990722656
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -6.7421875,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats (99",
            "probability": 0.0002551078796386719
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -7.0078125,
            "text": "1% of T in the Leishmania genome and is only found in telomeric",
            "probability": 0.00019562244415283203
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -7.21484375,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats (99%) and in regions where transcription starts",
            "probability": 0.00015842914581298828
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -7.28125,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats (99%) and in regions where transcription starts and stop",
            "probability": 0.000148773193359375
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -7.30859375,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats (99%) and in regions where transcription starts and",
            "probability": 0.0001442432403564453
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -7.31640625,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats (99%) and",
            "probability": 0.0001442432403564453
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -7.3359375,
            "text": "1% of T in the Leishmania genome",
            "probability": 0.00014102458953857422
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -7.36328125,
            "text": "1% of T in the Leishmania genome and is only found in telomeric repeats (99%) and in regions where transcription",
            "probability": 0.00013768672943115234
        },
        {
            "start_logit": -5.56640625,
            "end_logit": 1.5166015625,
            "text": "glucosyl-hydroxymethyluracil) replaces 1% of T",
            "probability": 8.344650268554688e-06
        },
        {
            "start_logit": -5.9140625,
            "end_logit": 1.5166015625,
            "text": "\u03b2-D-glucosyl-hydroxymethyluracil) replaces 1% of T",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": -6.8515625,
            "end_logit": 1.5166015625,
            "text": "D-glucosyl-hydroxymethyluracil) replaces 1% of T",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -6.95703125,
            "end_logit": 1.5166015625,
            "text": "hydroxymethyluracil) replaces 1% of T",
            "probability": 2.0265579223632812e-06
        }
    ],
    "61f86c03882a024a10000044_1": [
        {
            "start_logit": 8.03125,
            "end_logit": 7.96875,
            "text": "recessive hereditary motor neuropathy",
            "probability": 1.0
        },
        {
            "start_logit": 8.03125,
            "end_logit": -1.759765625,
            "text": "recessive",
            "probability": 5.9664249420166016e-05
        },
        {
            "start_logit": -1.69921875,
            "end_logit": 7.96875,
            "text": "neuropathy",
            "probability": 5.918741226196289e-05
        },
        {
            "start_logit": 8.03125,
            "end_logit": -2.669921875,
            "text": "recessive hereditary motor neuropathy.",
            "probability": 2.390146255493164e-05
        },
        {
            "start_logit": -4.1640625,
            "end_logit": 7.96875,
            "text": "hereditary motor neuropathy",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -5.8515625,
            "end_logit": 7.96875,
            "text": "motor neuropathy",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.5546875,
            "end_logit": 7.96875,
            "text": "An ancestral 10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 7.96875,
            "text": "VWA1 causes recessive hereditary motor neuropathy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 7.96875,
            "text": "10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.453125,
            "end_logit": 7.96875,
            "text": "A1 causes recessive hereditary motor neuropathy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 7.96875,
            "text": "causes recessive hereditary motor neuropathy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.54296875,
            "text": "recessive hereditary motor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 7.96875,
            "text": "ancestral 10-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 7.96875,
            "text": "expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 7.96875,
            "text": "-bp repeat expansion in VWA1 causes recessive hereditary motor neuropathy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.69921875,
            "end_logit": -2.669921875,
            "text": "neuropathy.",
            "probability": 0.0
        },
        {
            "start_logit": -4.1640625,
            "end_logit": -2.669921875,
            "text": "hereditary motor neuropathy.",
            "probability": 0.0
        },
        {
            "start_logit": -6.5546875,
            "end_logit": -1.759765625,
            "text": "An ancestral 10-bp repeat expansion in VWA1 causes recessive",
            "probability": 0.0
        },
        {
            "start_logit": -5.8515625,
            "end_logit": -2.669921875,
            "text": "motor neuropathy.",
            "probability": 0.0
        },
        {
            "start_logit": -7.421875,
            "end_logit": -1.759765625,
            "text": "VWA1 causes recessive",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_1": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.1640625,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.169921875,
            "end_logit": 8.1640625,
            "text": "fibrosis",
            "probability": 8.416175842285156e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.28125,
            "text": "cystic",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.6640625,
            "text": "cystic fibrosis (CF",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.90625,
            "text": "cystic fibrosis (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.39453125,
            "text": "cystic fibrosis (CF) involves",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4140625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.41796875,
            "text": "cystic fibrosis (CF)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.44921875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.48828125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.6015625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.640625,
            "text": "cystic fibrosis (CF) involves sweat induction,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.65234375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.69140625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 8.1640625,
            "text": "BACKGROUND: Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 8.1640625,
            "text": ": Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 8.1640625,
            "text": "diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.169921875,
            "end_logit": -6.6640625,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -1.169921875,
            "end_logit": -6.90625,
            "text": "fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": -1.169921875,
            "end_logit": -7.39453125,
            "text": "fibrosis (CF) involves",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_2": [
        {
            "start_logit": 5.78515625,
            "end_logit": 0.422607421875,
            "text": "cystic fibrosis",
            "probability": 0.9697265625
        },
        {
            "start_logit": 5.78515625,
            "end_logit": -3.58203125,
            "text": "cystic fibrosis transmembrane conductance regulator",
            "probability": 0.0177001953125
        },
        {
            "start_logit": 5.78515625,
            "end_logit": -4.6015625,
            "text": "cystic",
            "probability": 0.006381988525390625
        },
        {
            "start_logit": 5.78515625,
            "end_logit": -6.29296875,
            "text": "cystic fibrosis transmembrane conductance",
            "probability": 0.0011758804321289062
        },
        {
            "start_logit": 5.78515625,
            "end_logit": -7.27734375,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to",
            "probability": 0.0004394054412841797
        },
        {
            "start_logit": 5.78515625,
            "end_logit": -7.30078125,
            "text": "cystic fibrosis transmembrane conductance regulator)",
            "probability": 0.00042939186096191406
        },
        {
            "start_logit": 5.78515625,
            "end_logit": -7.3125,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST",
            "probability": 0.0004241466522216797
        },
        {
            "start_logit": 5.78515625,
            "end_logit": -7.33984375,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as correlating sweat sodium and sweat chloride concentrations in subjects.",
            "probability": 0.00041294097900390625
        },
        {
            "start_logit": 5.78515625,
            "end_logit": -7.4609375,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the",
            "probability": 0.0003657341003417969
        },
        {
            "start_logit": 5.78515625,
            "end_logit": -7.484375,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as",
            "probability": 0.0003571510314941406
        },
        {
            "start_logit": 5.78515625,
            "end_logit": -7.5859375,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as correlating sweat sodium and sweat chloride",
            "probability": 0.0003228187561035156
        },
        {
            "start_logit": 5.78515625,
            "end_logit": -7.58984375,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and",
            "probability": 0.00032019615173339844
        },
        {
            "start_logit": 5.78515625,
            "end_logit": -7.6015625,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations",
            "probability": 0.00031757354736328125
        },
        {
            "start_logit": 5.78515625,
            "end_logit": -7.61328125,
            "text": "cystic fibrosis transmembrane",
            "probability": 0.0003154277801513672
        },
        {
            "start_logit": 5.78515625,
            "end_logit": -7.6171875,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as correlating sweat sodium",
            "probability": 0.00031280517578125
        },
        {
            "start_logit": 5.78515625,
            "end_logit": -7.625,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as correlating sweat sodium and sweat chloride concentrations",
            "probability": 0.0003104209899902344
        },
        {
            "start_logit": 5.78515625,
            "end_logit": -7.640625,
            "text": "cystic fibrosis transmembrane conductance regulator) mutations and reasons to indicate the ST, as well as correlating sweat sodium and sweat chloride concentrations in subjects",
            "probability": 0.0003056526184082031
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 0.422607421875,
            "text": "(cystic fibrosis",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 0.422607421875,
            "text": "To conduct a descriptive analysis of the sweat test (ST), associating ST results with epidemiological data, CFTR (cystic fibrosis",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 0.422607421875,
            "text": "a descriptive analysis of the sweat test (ST), associating ST results with epidemiological data, CFTR (cystic fibrosis",
            "probability": 1.7881393432617188e-06
        }
    ],
    "5c6e16eb7c78d6947100004e_3": [
        {
            "start_logit": 8.265625,
            "end_logit": 8.2109375,
            "text": "Cystic Fibrosis",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.2109375,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.2578125,
            "end_logit": 8.2109375,
            "text": "cystic fibrosis",
            "probability": 0.333251953125
        },
        {
            "start_logit": -0.79931640625,
            "end_logit": 8.2109375,
            "text": "Fibrosis",
            "probability": 3.8623809814453125e-05
        },
        {
            "start_logit": -0.79931640625,
            "end_logit": 8.2109375,
            "text": "Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 3.8623809814453125e-05
        },
        {
            "start_logit": -0.8173828125,
            "end_logit": 8.2109375,
            "text": "fibrosis",
            "probability": 3.802776336669922e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -1.029296875,
            "text": "Cystic",
            "probability": 3.254413604736328e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -1.068359375,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic",
            "probability": 3.129243850708008e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -1.068359375,
            "text": "cystic",
            "probability": 3.1054019927978516e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -6.3125,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis (CF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -6.3125,
            "text": "cystic fibrosis (CF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.7265625,
            "end_logit": 8.2109375,
            "text": ".The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -6.82421875,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -6.82421875,
            "text": "cystic fibrosis (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.1953125,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis (CF) in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.1953125,
            "text": "cystic fibrosis (CF) in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.20703125,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.25,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.359375,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.47265625,
            "text": "cystic fibrosis (CF) in support of universal newborn screening",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c6e16eb7c78d6947100004e_4": [
        {
            "start_logit": 8.265625,
            "end_logit": 8.2109375,
            "text": "Cystic Fibrosis",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.2109375,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.2578125,
            "end_logit": 8.2109375,
            "text": "cystic fibrosis",
            "probability": 0.333251953125
        },
        {
            "start_logit": -0.79931640625,
            "end_logit": 8.2109375,
            "text": "Fibrosis",
            "probability": 3.8623809814453125e-05
        },
        {
            "start_logit": -0.79931640625,
            "end_logit": 8.2109375,
            "text": "Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 3.8623809814453125e-05
        },
        {
            "start_logit": -0.8173828125,
            "end_logit": 8.2109375,
            "text": "fibrosis",
            "probability": 3.802776336669922e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -1.029296875,
            "text": "Cystic",
            "probability": 3.254413604736328e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -1.068359375,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic",
            "probability": 3.129243850708008e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -1.068359375,
            "text": "cystic",
            "probability": 3.1054019927978516e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -6.3125,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis (CF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -6.3125,
            "text": "cystic fibrosis (CF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.7265625,
            "end_logit": 8.2109375,
            "text": ".The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -6.82421875,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -6.82421875,
            "text": "cystic fibrosis (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.1953125,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis (CF) in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.1953125,
            "text": "cystic fibrosis (CF) in",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.20703125,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.25,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.359375,
            "text": "Cystic Fibrosis Infants: Revealing Mechanisms beyond Impaired Chloride Transport.The sweat chloride test remains the gold standard for confirmatory diagnosis of",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.47265625,
            "text": "cystic fibrosis (CF) in support of universal newborn screening",
            "probability": 5.960464477539063e-08
        }
    ],
    "5c6e16eb7c78d6947100004e_5": [
        {
            "start_logit": 8.25,
            "end_logit": 8.1640625,
            "text": "Cystic Fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.146484375,
            "text": "Cystic",
            "probability": 9.101629257202148e-05
        },
        {
            "start_logit": -1.08984375,
            "end_logit": 8.1640625,
            "text": "Fibrosis",
            "probability": 8.887052536010742e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.40234375,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.125,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.24609375,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.265625,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients at the time of diagnosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.28515625,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients at the time of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.30078125,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients at",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.3046875,
            "text": "Cystic Fibrosis Patients.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.3046875,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients at the time of diagnosis.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.3046875,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.32421875,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.3359375,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.3671875,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.4140625,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.4375,
            "text": "Cystic Fibrosis Patients",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.4921875,
            "text": "Cystic Fibrosis Patients.The diagnosis is often delayed and the disease is advanced in most patients at the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.49609375,
            "text": "Cystic Fibrosis Patients.The diagnosis is often",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.50390625,
            "text": "Cystic Fibrosis Patients.The diagnosis is",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5c6e16eb7c78d6947100004e_6": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.140625,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.236328125,
            "end_logit": 8.140625,
            "text": "fibrosis",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.3359375,
            "text": "cystic",
            "probability": 7.665157318115234e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -4.3671875,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing systemic drugs designed to activate mutant CFTR.",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.25,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing systemic drugs designed to activate mutant CFTR",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.5625,
            "text": "cystic fibrosis (CF",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.859375,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.9765625,
            "text": "cystic fibrosis (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.9140625,
            "end_logit": 8.140625,
            "text": "In cystic fibrosis",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.08984375,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.24609375,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.25,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.27734375,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.39453125,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.52734375,
            "text": "cystic fibrosis (CF), sweat chloride concentration has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.53125,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing systemic drugs",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.54296875,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing systemic drugs designed to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5625,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5625,
            "text": "cystic fibrosis (CF), sweat chloride concentration has been proposed as an index of CFTR function for testing systemic drugs designed",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.63671875,
            "text": "cystic fibrosis (CF), sweat chloride",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5c6e16eb7c78d6947100004e_7": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.171875,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.12890625,
            "end_logit": 8.171875,
            "text": "fibrosis",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.26953125,
            "text": "cystic",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.671875,
            "text": "cystic fibrosis (CF",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.96875,
            "text": "cystic fibrosis (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.3515625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.37890625,
            "text": "cystic fibrosis (CF) involves",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.40625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.453125,
            "text": "cystic fibrosis (CF)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.49609375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.61328125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.66015625,
            "text": "cystic fibrosis (CF) involves sweat induction,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.66796875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.67578125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.69921875,
            "text": "cystic fibrosis (CF) involves sweat",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 8.171875,
            "text": "BACKGROUND Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 8.171875,
            "text": "diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.12890625,
            "end_logit": -6.671875,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -1.12890625,
            "end_logit": -6.96875,
            "text": "fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": -1.12890625,
            "end_logit": -7.3515625,
            "text": "fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_8": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.1640625,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": 8.1640625,
            "text": "fibrosis",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.2783203125,
            "text": "cystic",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.8671875,
            "text": "cystic fibrosis (CF",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3203125,
            "text": "cystic fibrosis (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.62109375,
            "text": "cystic fibrosis (CF)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.72265625,
            "text": "cystic fibrosis (CF).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 8.1640625,
            "text": "OBJECTIVES Sweat chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 8.1640625,
            "text": "diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 8.1640625,
            "text": "Sweat chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 8.1640625,
            "text": "gold standard for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 8.1640625,
            "text": "chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 8.1640625,
            "text": "testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 8.1640625,
            "text": "for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 8.1640625,
            "text": "of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -6.8671875,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -7.3203125,
            "text": "fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -7.62109375,
            "text": "fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -7.72265625,
            "text": "fibrosis (CF).",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -1.2783203125,
            "text": "OBJECTIVES Sweat chloride testing is the gold standard for diagnosis of cystic",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_9": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1875,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.037109375,
            "end_logit": 8.1875,
            "text": "fibrosis",
            "probability": 9.5367431640625e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.2509765625,
            "text": "cystic",
            "probability": 8.028745651245117e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.7734375,
            "text": "cystic fibrosis (CF",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.95703125,
            "text": "cystic fibrosis (CF) in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.20703125,
            "text": "cystic fibrosis (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.47265625,
            "text": "cystic fibrosis (CF) in support of universal newborn",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.4921875,
            "text": "cystic fibrosis (CF) in support of universal newborn screening programs.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.59375,
            "text": "cystic fibrosis (CF) in support of universal newborn screening",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.59375,
            "text": "cystic fibrosis (CF)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.60546875,
            "text": "cystic fibrosis (CF) in support of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.625,
            "text": "cystic fibrosis (CF) in support of universal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.62890625,
            "text": "cystic fibrosis (CF) in support",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6484375,
            "text": "cystic fibrosis (CF) in support of universal newborn screening programs",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 8.1875,
            "text": "diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 8.1875,
            "text": "confirmatory diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.1875,
            "text": "The sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 8.1875,
            "text": "gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 8.1875,
            "text": "remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 8.1875,
            "text": "sweat chloride test remains the gold standard for confirmatory diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5c6e16eb7c78d6947100004e_10": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.1875,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.1171875,
            "end_logit": 8.1875,
            "text": "fibrosis",
            "probability": 8.821487426757812e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.328125,
            "text": "cystic",
            "probability": 7.367134094238281e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.68359375,
            "text": "cystic fibrosis, electrolyte metabolism disorders, electrolyte balance, and electrolyte loss during exercise.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.73828125,
            "text": "cystic fibrosis,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.7578125,
            "text": "cystic fibrosis, electrolyte metabolism disorders, electrolyte balance, and electrolyte loss during",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.76953125,
            "text": "cystic fibrosis, electrolyte metabolism disorders",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 8.1875,
            "text": "for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.1875,
            "text": "Sweat chloride is of interest as a biomarker for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 8.1875,
            "text": "biomarker for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.1171875,
            "end_logit": -7.68359375,
            "text": "fibrosis, electrolyte metabolism disorders, electrolyte balance, and electrolyte loss during exercise.",
            "probability": 0.0
        },
        {
            "start_logit": -1.1171875,
            "end_logit": -7.73828125,
            "text": "fibrosis,",
            "probability": 0.0
        },
        {
            "start_logit": -1.1171875,
            "end_logit": -7.7578125,
            "text": "fibrosis, electrolyte metabolism disorders, electrolyte balance, and electrolyte loss during",
            "probability": 0.0
        },
        {
            "start_logit": -1.1171875,
            "end_logit": -7.76953125,
            "text": "fibrosis, electrolyte metabolism disorders",
            "probability": 0.0
        },
        {
            "start_logit": -7.796875,
            "end_logit": -1.328125,
            "text": "for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.859375,
            "end_logit": -1.328125,
            "text": "Sweat chloride is of interest as a biomarker for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -1.328125,
            "text": "biomarker for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.08203125,
            "end_logit": -7.68359375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -7.68359375,
            "text": ", and electrolyte loss during exercise.",
            "probability": 0.0
        },
        {
            "start_logit": -7.55078125,
            "end_logit": -7.7578125,
            "text": ", and electrolyte loss during",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_11": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.1640625,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": 8.1640625,
            "text": "fibrosis",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.2783203125,
            "text": "cystic",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.8671875,
            "text": "cystic fibrosis (CF",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.3203125,
            "text": "cystic fibrosis (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.62109375,
            "text": "cystic fibrosis (CF)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.72265625,
            "text": "cystic fibrosis (CF).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 8.1640625,
            "text": "OBJECTIVES Sweat chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 8.1640625,
            "text": "diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 8.1640625,
            "text": "Sweat chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 8.1640625,
            "text": "gold standard for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 8.1640625,
            "text": "chloride testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 8.1640625,
            "text": "testing is the gold standard for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 8.1640625,
            "text": "for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 8.1640625,
            "text": "of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -6.8671875,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -7.3203125,
            "text": "fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -7.62109375,
            "text": "fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -7.72265625,
            "text": "fibrosis (CF).",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -1.2783203125,
            "text": "OBJECTIVES Sweat chloride testing is the gold standard for diagnosis of cystic",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_12": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.171875,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.12890625,
            "end_logit": 8.171875,
            "text": "fibrosis",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.26953125,
            "text": "cystic",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.671875,
            "text": "cystic fibrosis (CF",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.96875,
            "text": "cystic fibrosis (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.3515625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.37890625,
            "text": "cystic fibrosis (CF) involves",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.40625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.453125,
            "text": "cystic fibrosis (CF)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.49609375,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.61328125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.66015625,
            "text": "cystic fibrosis (CF) involves sweat induction,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.66796875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.67578125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.69921875,
            "text": "cystic fibrosis (CF) involves sweat",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 8.171875,
            "text": "BACKGROUND Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 8.171875,
            "text": "diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.12890625,
            "end_logit": -6.671875,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -1.12890625,
            "end_logit": -6.96875,
            "text": "fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": -1.12890625,
            "end_logit": -7.3515625,
            "text": "fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_13": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.171875,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.16796875,
            "end_logit": 8.171875,
            "text": "fibrosis",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.27734375,
            "text": "cystic",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.4375,
            "text": "cystic fibrosis (CF",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.01953125,
            "text": "cystic fibrosis (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.453125,
            "text": "cystic fibrosis (CF)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.4921875,
            "text": "cystic fibrosis (CF) diagnosis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6796875,
            "text": "cystic fibrosis (CF) diagnosis.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 8.171875,
            "text": "BACKGROUND Sweat chloride test is the gold standard test for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 8.171875,
            "text": "gold standard test for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 8.171875,
            "text": "Sweat chloride test is the gold standard test for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 8.171875,
            "text": "for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 8.171875,
            "text": "the gold standard test for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 8.171875,
            "text": "test is the gold standard test for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 8.171875,
            "text": "is the gold standard test for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 8.171875,
            "text": "chloride test is the gold standard test for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.16796875,
            "end_logit": -6.4375,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -1.16796875,
            "end_logit": -7.01953125,
            "text": "fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": -1.16796875,
            "end_logit": -7.453125,
            "text": "fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": -1.16796875,
            "end_logit": -7.4921875,
            "text": "fibrosis (CF) diagnosis",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_14": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.1796875,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.03515625,
            "end_logit": 8.1796875,
            "text": "fibrosis",
            "probability": 9.459257125854492e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.2197265625,
            "text": "cystic",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.34375,
            "text": "cystic fibrosis due to the fact that electrolyte levels in sweat are elevated in patients.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4140625,
            "text": "cystic fibrosis due to the fact that",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.42578125,
            "text": "cystic fibrosis due to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4296875,
            "text": "cystic fibrosis due",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.43359375,
            "text": "cystic fibrosis due to the fact that electrolyte levels in sweat are",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.5390625,
            "text": "cystic fibrosis due to the fact",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.56640625,
            "text": "cystic fibrosis due to the fact that electrolyte levels",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.578125,
            "text": "cystic fibrosis due to the fact that electrolyte levels in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.609375,
            "text": "cystic fibrosis due to the fact that electrolyte levels in sweat are elevated in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.62109375,
            "text": "cystic fibrosis due to the fact that electrolyte levels in sweat are elevated",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.62109375,
            "text": "cystic fibrosis due to the fact that electrolyte",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.640625,
            "text": "cystic fibrosis due to the fact that electrolyte levels in sweat are elevated in patients",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 8.1796875,
            "text": "the cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 8.1796875,
            "text": "screening test for the cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 8.1796875,
            "text": "for the cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 8.1796875,
            "text": "Sweat chloride test is known to be a screening test for the cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 8.1796875,
            "text": "known to be a screening test for the cystic fibrosis",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5c6e16eb7c78d6947100004e_15": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.1640625,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.1796875,
            "end_logit": 8.1640625,
            "text": "fibrosis",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.3173828125,
            "text": "cystic",
            "probability": 7.605552673339844e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.72265625,
            "text": "cystic fibrosis (CF",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.85546875,
            "text": "cystic fibrosis (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.51171875,
            "text": "cystic fibrosis (CF)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.703125,
            "text": "cystic fibrosis (CF).",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 8.1640625,
            "text": "OBJECTIVE Sweat chloride measurement is considered a standard diagnostic tool for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 8.1640625,
            "text": "considered a standard diagnostic tool for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 8.1640625,
            "text": "for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 8.1640625,
            "text": "Sweat chloride measurement is considered a standard diagnostic tool for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 8.1640625,
            "text": "standard diagnostic tool for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 8.1640625,
            "text": "diagnostic tool for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 8.1640625,
            "text": "measurement is considered a standard diagnostic tool for cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.1796875,
            "end_logit": -6.72265625,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -1.1796875,
            "end_logit": -6.85546875,
            "text": "fibrosis (",
            "probability": 0.0
        },
        {
            "start_logit": -1.1796875,
            "end_logit": -7.51171875,
            "text": "fibrosis (CF)",
            "probability": 0.0
        },
        {
            "start_logit": -1.1796875,
            "end_logit": -7.703125,
            "text": "fibrosis (CF).",
            "probability": 0.0
        },
        {
            "start_logit": -7.73828125,
            "end_logit": -1.3173828125,
            "text": "OBJECTIVE Sweat chloride measurement is considered a standard diagnostic tool for cystic",
            "probability": 0.0
        },
        {
            "start_logit": -7.8515625,
            "end_logit": -1.3173828125,
            "text": "considered a standard diagnostic tool for cystic",
            "probability": 0.0
        }
    ],
    "5c6e16eb7c78d6947100004e_16": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.1640625,
            "text": "cystic fibrosis",
            "probability": 1.0
        },
        {
            "start_logit": -1.142578125,
            "end_logit": 8.1640625,
            "text": "fibrosis",
            "probability": 8.684396743774414e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.27734375,
            "text": "cystic",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.7578125,
            "text": "cystic fibrosis (CF",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.9453125,
            "text": "cystic fibrosis (",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.16796875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.26953125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an analytical lab",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4453125,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.4453125,
            "text": "cystic fibrosis (CF) involves",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.5,
            "text": "cystic fibrosis (CF)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.53515625,
            "text": "cystic fibrosis (CF) involves sweat induction,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.6015625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and measurement in an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.63671875,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.63671875,
            "text": "cystic fibrosis (CF) involves sweat",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.6640625,
            "text": "cystic fibrosis (CF) involves sweat induction, collection and handling,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.66796875,
            "text": "cystic fibrosis (CF) involves sweat induction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 8.1640625,
            "text": "diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 8.1640625,
            "text": "Sweat chloride testing for diagnosis of cystic fibrosis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.142578125,
            "end_logit": -6.7578125,
            "text": "fibrosis (CF",
            "probability": 0.0
        },
        {
            "start_logit": -1.142578125,
            "end_logit": -6.9453125,
            "text": "fibrosis (",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_1": [
        {
            "start_logit": 8.046875,
            "end_logit": 8.2734375,
            "text": "bladder cancer",
            "probability": 1.0
        },
        {
            "start_logit": -0.86669921875,
            "end_logit": 8.2734375,
            "text": "cancer",
            "probability": 0.00013554096221923828
        },
        {
            "start_logit": 8.046875,
            "end_logit": -1.654296875,
            "text": "bladder",
            "probability": 4.9114227294921875e-05
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 8.2734375,
            "text": "Bacillus Calmette-Gu\u00e9rin immunotherapy for bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 8.2734375,
            "text": "Calmette-Gu\u00e9rin immunotherapy for bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -7.59375,
            "text": "bladder cancer: a review of immunological aspects, clinical effects and BCG",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 8.2734375,
            "text": "for bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -7.71484375,
            "text": "bladder cancer: a review of immunological aspects",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -7.74609375,
            "text": "bladder cancer: a review of immunological",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -7.77734375,
            "text": "bladder cancer: a review of immunological aspects, clinical effects and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.86669921875,
            "end_logit": -7.59375,
            "text": "cancer: a review of immunological aspects, clinical effects and BCG",
            "probability": 0.0
        },
        {
            "start_logit": -0.86669921875,
            "end_logit": -7.71484375,
            "text": "cancer: a review of immunological aspects",
            "probability": 0.0
        },
        {
            "start_logit": -0.86669921875,
            "end_logit": -7.74609375,
            "text": "cancer: a review of immunological",
            "probability": 0.0
        },
        {
            "start_logit": -0.86669921875,
            "end_logit": -7.77734375,
            "text": "cancer: a review of immunological aspects, clinical effects and",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -1.654296875,
            "text": "Bacillus Calmette-Gu\u00e9rin immunotherapy for bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.76171875,
            "end_logit": -1.654296875,
            "text": "Calmette-Gu\u00e9rin immunotherapy for bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -1.654296875,
            "text": "for bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": -7.59375,
            "text": "a review of immunological aspects, clinical effects and BCG",
            "probability": 0.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": -7.71484375,
            "text": "a review of immunological aspects",
            "probability": 0.0
        },
        {
            "start_logit": -7.52734375,
            "end_logit": -7.59375,
            "text": "review of immunological aspects, clinical effects and BCG",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_2": [
        {
            "start_logit": 4.85546875,
            "end_logit": 7.734375,
            "text": "cancer",
            "probability": 0.89892578125
        },
        {
            "start_logit": 2.673828125,
            "end_logit": 7.734375,
            "text": "bladder cancer",
            "probability": 0.100830078125
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.734375,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy for bladder cancer",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": -7.546875,
            "end_logit": 7.734375,
            "text": "Calmette-Gu\u00e9rin (BCG) immunotherapy for bladder cancer",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 7.734375,
            "text": "for bladder cancer",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 4.85546875,
            "end_logit": -7.28515625,
            "text": "cancer has",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.85546875,
            "end_logit": -7.359375,
            "text": "cancer has been used since 1976 when the first evidence of its ability to lower recurrence and progression rates was published.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.85546875,
            "end_logit": -7.4609375,
            "text": "cancer has been used since",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.85546875,
            "end_logit": -7.51953125,
            "text": "cancer has been used since 1976 when the first evidence of its ability to lower recurrence and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.85546875,
            "end_logit": -7.51953125,
            "text": "cancer has been",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.85546875,
            "end_logit": -7.52734375,
            "text": "cancer has been used since 1976 when the first evidence of its ability to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.85546875,
            "end_logit": -7.56640625,
            "text": "cancer has been used",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.85546875,
            "end_logit": -7.6484375,
            "text": "cancer has been used since 1976 when the first evidence of its ability to lower recurrence and progression rates",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.85546875,
            "end_logit": -7.6640625,
            "text": "cancer has been used since 1976 when the first evidence of its ability",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.85546875,
            "end_logit": -7.66796875,
            "text": "cancer has been used since 1976 when the first evidence of its ability to lower recurrence and progression rates was",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.85546875,
            "end_logit": -7.69140625,
            "text": "cancer has been used since 1976 when the first evidence of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 2.673828125,
            "end_logit": -6.046875,
            "text": "bladder",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.673828125,
            "end_logit": -7.28515625,
            "text": "bladder cancer has",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.673828125,
            "end_logit": -7.359375,
            "text": "bladder cancer has been used since 1976 when the first evidence of its ability to lower recurrence and progression rates was published.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.673828125,
            "end_logit": -7.4609375,
            "text": "bladder cancer has been used since",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_3": [
        {
            "start_logit": 6.4375,
            "end_logit": 6.67578125,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -5.23828125,
            "end_logit": 6.67578125,
            "text": "bladder cancer",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 6.67578125,
            "text": "non-muscle invasive bladder cancer",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 6.67578125,
            "text": "muscle invasive bladder cancer",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 6.67578125,
            "text": "invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 6.67578125,
            "text": "BCG immunotherapy is the choice of care for high-grade non-muscle invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 6.67578125,
            "text": "high-grade non-muscle invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 6.67578125,
            "text": "grade non-muscle invasive bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.52734375,
            "text": "cancer (NMIBC",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 6.67578125,
            "text": "for high-grade non-muscle invasive bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.6171875,
            "text": "cancer (NMIBC) after transurethral resection.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.70703125,
            "text": "cancer (NMIB",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.7109375,
            "text": "cancer (NMIBC) after transurethral resection",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.71875,
            "text": "cancer (NMIBC) after",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.73828125,
            "text": "cancer (",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.4375,
            "end_logit": -7.80078125,
            "text": "cancer (NMIBC)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.23828125,
            "end_logit": -6.578125,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": -5.23828125,
            "end_logit": -7.52734375,
            "text": "bladder cancer (NMIBC",
            "probability": 0.0
        },
        {
            "start_logit": -5.23828125,
            "end_logit": -7.6171875,
            "text": "bladder cancer (NMIBC) after transurethral resection.",
            "probability": 0.0
        },
        {
            "start_logit": -5.23828125,
            "end_logit": -7.70703125,
            "text": "bladder cancer (NMIB",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_4": [
        {
            "start_logit": 6.27734375,
            "end_logit": 7.9921875,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder Cancer",
            "probability": 0.72119140625
        },
        {
            "start_logit": 6.27734375,
            "end_logit": 6.4453125,
            "text": "Tuberculosis",
            "probability": 0.153564453125
        },
        {
            "start_logit": 3.884765625,
            "end_logit": 7.9921875,
            "text": "Cancer",
            "probability": 0.0660400390625
        },
        {
            "start_logit": 3.783203125,
            "end_logit": 7.9921875,
            "text": "Bladder Cancer",
            "probability": 0.05963134765625
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 7.9921875,
            "text": "Renal Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder Cancer",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 7.9921875,
            "text": "Treatment of Bladder Cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 7.9921875,
            "text": "of Bladder Cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 7.9921875,
            "text": "the Treatment of Bladder Cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 7.9921875,
            "text": "Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder Cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 7.9921875,
            "text": "Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder Cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -6.32421875,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 6.4453125,
            "text": "Renal Tuberculosis",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.1484375,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of Bladder Cancer.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.2109375,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.36328125,
            "text": "Tuberculosis Following",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.4375,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.4609375,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.48828125,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for the Treatment",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.55078125,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.5859375,
            "text": "Tuberculosis Following Intravesical Bacillus Calmette-Gu\u00e9rin (BCG) Immunotherapy for",
            "probability": 1.1920928955078125e-07
        }
    ],
    "60292d191cb411341a00010e_5": [
        {
            "start_logit": 6.3359375,
            "end_logit": 6.8359375,
            "text": "cancer",
            "probability": 0.9990234375
        },
        {
            "start_logit": -0.62158203125,
            "end_logit": 6.8359375,
            "text": "bladder cancer",
            "probability": 0.0009508132934570312
        },
        {
            "start_logit": -6.8125,
            "end_logit": 6.8359375,
            "text": "superficial bladder cancer",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -7.609375,
            "end_logit": 6.8359375,
            "text": "Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 6.8359375,
            "text": "treat superficial bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 6.8359375,
            "text": "nearly 40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 6.8359375,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 6.8359375,
            "text": "40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.3359375,
            "end_logit": -7.359375,
            "text": "cancer.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 6.8359375,
            "text": "(BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 6.8359375,
            "text": "It is nearly 40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 6.8359375,
            "text": "BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 6.8359375,
            "text": "immunotherapy to treat superficial bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 6.8359375,
            "text": "ette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 6.8359375,
            "text": ") was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.0,
            "end_logit": 6.8359375,
            "text": "to treat superficial bladder cancer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -0.62158203125,
            "end_logit": -5.60546875,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": -0.62158203125,
            "end_logit": -7.359375,
            "text": "bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -6.8125,
            "end_logit": -5.60546875,
            "text": "superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.609375,
            "end_logit": -5.60546875,
            "text": "Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_6": [
        {
            "start_logit": 5.671875,
            "end_logit": 7.3359375,
            "text": "cancer",
            "probability": 0.8310546875
        },
        {
            "start_logit": 4.078125,
            "end_logit": 7.3359375,
            "text": "bladder cancer",
            "probability": 0.1688232421875
        },
        {
            "start_logit": -7.4921875,
            "end_logit": 7.3359375,
            "text": "with bladder cancer",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.65625,
            "end_logit": 7.3359375,
            "text": "Prostatic urethral mucosal involvement with bladder cancer",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 4.078125,
            "end_logit": -5.203125,
            "text": "bladder",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 5.671875,
            "end_logit": -6.890625,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.671875,
            "end_logit": -7.0234375,
            "text": "cancer can",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 5.671875,
            "end_logit": -7.35546875,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.671875,
            "end_logit": -7.5,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.671875,
            "end_logit": -7.50390625,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates, but has had no positive impact on disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.671875,
            "end_logit": -7.546875,
            "text": "cancer can be",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 5.671875,
            "end_logit": -7.6015625,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates, but has had no positive impact on disease progression or",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.671875,
            "end_logit": -7.640625,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.671875,
            "end_logit": -7.66796875,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates, but has had no positive impact on disease progression",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.671875,
            "end_logit": -7.6875,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates, but",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.671875,
            "end_logit": -7.734375,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.671875,
            "end_logit": -7.734375,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates, but has",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.671875,
            "end_logit": -7.765625,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.671875,
            "end_logit": -7.77734375,
            "text": "cancer can be effectively",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 5.671875,
            "end_logit": -7.7890625,
            "text": "cancer can be effectively treated with BCG intravesical immunotherapy-it has demonstrated a reduction in tumor recurrence rates, but has had no positive impact",
            "probability": 2.384185791015625e-07
        }
    ],
    "60292d191cb411341a00010e_7": [
        {
            "start_logit": 5.8515625,
            "end_logit": 7.16796875,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -2.6484375,
            "end_logit": 7.16796875,
            "text": "bladder cancer",
            "probability": 0.0002034902572631836
        },
        {
            "start_logit": -5.63671875,
            "end_logit": 7.16796875,
            "text": "nonmuscle invasive bladder cancer",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 7.16796875,
            "text": "invasive bladder cancer",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.16796875,
            "text": "in nonmuscle invasive bladder cancer",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 7.16796875,
            "text": "uscle invasive bladder cancer",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 7.16796875,
            "text": "immunotherapy in nonmuscle invasive bladder cancer",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.75,
            "end_logit": 7.16796875,
            "text": "Mycobacterium bovis BCG for immunotherapy in nonmuscle invasive bladder cancer",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.796875,
            "end_logit": 7.16796875,
            "text": "le invasive bladder cancer",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 7.16796875,
            "text": "Recombinant Mycobacterium bovis BCG for immunotherapy in nonmuscle invasive bladder cancer",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 7.16796875,
            "text": "BCG for immunotherapy in nonmuscle invasive bladder cancer",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 7.16796875,
            "text": "bovis BCG for immunotherapy in nonmuscle invasive bladder cancer",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 7.16796875,
            "text": "for immunotherapy in nonmuscle invasive bladder cancer",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 5.8515625,
            "end_logit": -7.69921875,
            "text": "cancer.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -2.6484375,
            "end_logit": -7.546875,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": -2.6484375,
            "end_logit": -7.69921875,
            "text": "bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -5.63671875,
            "end_logit": -7.5078125,
            "text": "nonmusc",
            "probability": 0.0
        },
        {
            "start_logit": -5.63671875,
            "end_logit": -7.546875,
            "text": "nonmuscle invasive bladder",
            "probability": 0.0
        },
        {
            "start_logit": -5.63671875,
            "end_logit": -7.56640625,
            "text": "nonmuscle invasive",
            "probability": 0.0
        },
        {
            "start_logit": -5.63671875,
            "end_logit": -7.6484375,
            "text": "nonmuscle",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_8": [
        {
            "start_logit": 8.0546875,
            "end_logit": 8.453125,
            "text": "bladder cancer",
            "probability": 0.9990234375
        },
        {
            "start_logit": 0.5029296875,
            "end_logit": 8.453125,
            "text": "cancer",
            "probability": 0.0005273818969726562
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -1.47265625,
            "text": "bladder",
            "probability": 4.9054622650146484e-05
        },
        {
            "start_logit": -7.125,
            "end_logit": 8.453125,
            "text": "superficial bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -6.7734375,
            "text": "bladder cancer has been most apparent in patients with carcinoma",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.05078125,
            "text": "bladder cancer has been most apparent in patients with carcinoma in situ",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.1953125,
            "text": "bladder cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 8.453125,
            "text": "The advantage of BCG immunotherapy over intravesical chemotherapy in superficial bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.28125,
            "text": "bladder cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to more",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.34375,
            "text": "bladder cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50%",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.35546875,
            "text": "bladder cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to more than",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.359375,
            "text": "bladder cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to more than 70",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.36328125,
            "text": "bladder cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.37890625,
            "text": "bladder cancer has been most apparent in patients with carcinoma in situ (CIS), where complete response is increased from 50% to more than 70%",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.41015625,
            "text": "bladder cancer has been most apparent in patients with carcinoma in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 8.453125,
            "text": "intravesical chemotherapy in superficial bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 8.453125,
            "text": "advantage of BCG immunotherapy over intravesical chemotherapy in superficial bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 8.453125,
            "text": "in superficial bladder cancer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 0.5029296875,
            "end_logit": -6.7734375,
            "text": "cancer has been most apparent in patients with carcinoma",
            "probability": 0.0
        },
        {
            "start_logit": 0.5029296875,
            "end_logit": -7.05078125,
            "text": "cancer has been most apparent in patients with carcinoma in situ",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_9": [
        {
            "start_logit": 6.4609375,
            "end_logit": 6.65234375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -3.66015625,
            "end_logit": 6.65234375,
            "text": "bladder cancer",
            "probability": 4.035234451293945e-05
        },
        {
            "start_logit": -7.2578125,
            "end_logit": 6.65234375,
            "text": "Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.375,
            "end_logit": 6.65234375,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 6.65234375,
            "text": "standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 6.65234375,
            "text": "dministration of Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 6.65234375,
            "text": "muscle invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.38671875,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of recurrence and progression. While most a",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 6.65234375,
            "text": "high-grade non-muscle invasive bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 6.65234375,
            "text": "non-muscle invasive bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 6.65234375,
            "text": "invasive bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 6.65234375,
            "text": "become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.52734375,
            "text": "cancer (NMIB",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.52734375,
            "text": "cancer (NMIBC",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.53515625,
            "text": "cancer (NMIBC) and carcinoma in-",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.5390625,
            "text": "cancer (NMIBC) and carcinoma in",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.65234375,
            "text": "grade non-muscle invasive bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 6.65234375,
            "text": "for high-grade non-muscle invasive bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.5625,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4609375,
            "end_logit": -7.63671875,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of recurrence and",
            "probability": 6.556510925292969e-07
        }
    ],
    "60292d191cb411341a00010e_10": [
        {
            "start_logit": 6.28515625,
            "end_logit": 8.265625,
            "text": "bladder cancer",
            "probability": 0.97314453125
        },
        {
            "start_logit": 2.68359375,
            "end_logit": 8.265625,
            "text": "cancer",
            "probability": 0.026763916015625
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -3.90234375,
            "text": "bladder",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 8.265625,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy is regarded as the current treatment of choice for stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 8.265625,
            "text": "current treatment of choice for stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.265625,
            "text": "Calmette-Gu\u00e9rin (BCG) immunotherapy is regarded as the current treatment of choice for stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 8.265625,
            "text": "stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 8.265625,
            "text": "regarded as the current treatment of choice for stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 8.265625,
            "text": ") bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 8.265625,
            "text": "treatment of choice for stage T1 grade 3 (T1G3) bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.265625,
            "text": "T1G3) bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -7.48046875,
            "text": "bladder cancer (BC",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -7.6171875,
            "text": "bladder cancer (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -7.62109375,
            "text": "bladder cancer (BC), though its efficacy is limited by high recurrence and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -7.66796875,
            "text": "bladder cancer (BC), though its efficacy is limited by high recurrence and progression",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -7.7109375,
            "text": "bladder cancer (BC)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.28515625,
            "end_logit": -7.73828125,
            "text": "bladder cancer (BC), though its efficacy is limited by high",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 2.68359375,
            "end_logit": -7.48046875,
            "text": "cancer (BC",
            "probability": 0.0
        },
        {
            "start_logit": 2.68359375,
            "end_logit": -7.6171875,
            "text": "cancer (",
            "probability": 0.0
        },
        {
            "start_logit": 2.68359375,
            "end_logit": -7.62109375,
            "text": "cancer (BC), though its efficacy is limited by high recurrence and",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_11": [
        {
            "start_logit": 6.4140625,
            "end_logit": 6.6953125,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 6.6953125,
            "text": "bladder cancer",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 6.6953125,
            "text": "non-muscle-invasive bladder cancer",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.1328125,
            "end_logit": 6.6953125,
            "text": "invasive bladder cancer",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 6.6953125,
            "text": "The standard of care for most patients with non-muscle-invasive bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 6.6953125,
            "text": "standard of care for most patients with non-muscle-invasive bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 6.6953125,
            "text": "muscle-invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.3125,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu\u00e9rin (BCG), which activates the immune system to recognize and destroy malignant",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.41015625,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu\u00e9rin (",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 6.6953125,
            "text": "most patients with non-muscle-invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.4765625,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu\u00e9rin",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.53125,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.55078125,
            "text": "cancer (NMIBC) is",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.5625,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu\u00e9rin (BCG),",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.578125,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.578125,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu\u00e9rin (BCG), which activates the immune system to recognize and",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.59765625,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu\u00e9rin (BCG), which activates the immune system to",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.62890625,
            "text": "cancer (NMIBC) is immunotherapy with intravesical Bacillus Calmette-Gu\u00e9rin (BCG), which activates the immune system",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.4140625,
            "end_logit": -7.6484375,
            "text": "cancer (NMIBC)",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.69921875,
            "end_logit": -6.73828125,
            "text": "bladder",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_12": [
        {
            "start_logit": 6.35546875,
            "end_logit": 6.80859375,
            "text": "cancer",
            "probability": 0.9990234375
        },
        {
            "start_logit": -0.59033203125,
            "end_logit": 6.80859375,
            "text": "bladder cancer",
            "probability": 0.0009622573852539062
        },
        {
            "start_logit": -6.7578125,
            "end_logit": 6.80859375,
            "text": "superficial bladder cancer",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -7.59375,
            "end_logit": 6.80859375,
            "text": "treat superficial bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 6.80859375,
            "text": "Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 6.80859375,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 6.80859375,
            "text": "nearly 40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 6.80859375,
            "text": "40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 6.80859375,
            "text": "(BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.80859375,
            "text": "immunotherapy to treat superficial bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 6.80859375,
            "text": "BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 6.80859375,
            "text": "It is nearly 40 years since Bacillus Calmette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.46875,
            "text": "cancer.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 6.80859375,
            "text": "first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 6.80859375,
            "text": "to treat superficial bladder cancer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 6.80859375,
            "text": ") was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 6.80859375,
            "text": "ette-Gu\u00e9rin (BCG) was first used as an immunotherapy to treat superficial bladder cancer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -0.59033203125,
            "end_logit": -5.37109375,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": -0.59033203125,
            "end_logit": -7.46875,
            "text": "bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -6.7578125,
            "end_logit": -5.37109375,
            "text": "superficial bladder",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_13": [
        {
            "start_logit": 6.5,
            "end_logit": 6.59765625,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -7.08203125,
            "end_logit": 6.59765625,
            "text": "bladder cancer",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.22265625,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from NMIB",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.2265625,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from NMIBC",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 6.59765625,
            "text": "non-muscle-invasive bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 6.59765625,
            "text": "invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.390625,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from NM",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 6.59765625,
            "text": "Calmette-Gu\u00e9rin (BCG) vaccine is the main treatment for non-muscle-invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.4609375,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from NMIBC.",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.4609375,
            "text": "cancer (NMIBC",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.51171875,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence, progression, and",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 6.59765625,
            "text": "Intravesical immunotherapy with bacille Calmette-Gu\u00e9rin (BCG) vaccine is the main treatment for non-muscle-invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.53515625,
            "text": "cancer (NM",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.55078125,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence,",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.5546875,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence, progression, and death from",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.578125,
            "text": "cancer (NMIBC), with proven effects on reducing recurrence, progression, and death",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.5859375,
            "text": "cancer (NMIB",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.59765625,
            "text": "bacille Calmette-Gu\u00e9rin (BCG) vaccine is the main treatment for non-muscle-invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.59375,
            "text": "cancer (NMIBC), with proven effects on",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.640625,
            "text": "cancer (",
            "probability": 6.556510925292969e-07
        }
    ],
    "60292d191cb411341a00010e_14": [
        {
            "start_logit": 4.96875,
            "end_logit": 7.83203125,
            "text": "bladder cancer",
            "probability": 0.5888671875
        },
        {
            "start_logit": 4.60546875,
            "end_logit": 7.83203125,
            "text": "cancer",
            "probability": 0.4111328125
        },
        {
            "start_logit": 4.96875,
            "end_logit": -4.10546875,
            "text": "bladder",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.83203125,
            "text": "muscle invasive bladder cancer",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 7.83203125,
            "text": "first line therapy for intermediate to high-risk non-muscle invasive bladder cancer",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 7.83203125,
            "text": "risk non-muscle invasive bladder cancer",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.83203125,
            "text": "intermediate to high-risk non-muscle invasive bladder cancer",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.83203125,
            "text": "non-muscle invasive bladder cancer",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 7.83203125,
            "text": "invasive bladder cancer",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 7.83203125,
            "text": "many decades ago as a first line therapy for intermediate to high-risk non-muscle invasive bladder cancer",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -7.6875,
            "end_logit": 7.83203125,
            "text": "for intermediate to high-risk non-muscle invasive bladder cancer",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 4.96875,
            "end_logit": -7.37890625,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of up to 30-40",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.96875,
            "end_logit": -7.43359375,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of up to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.96875,
            "end_logit": -7.4375,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of up to 30-40%",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.96875,
            "end_logit": -7.484375,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of up to 30-40% of patients will develop recurrence or",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.96875,
            "end_logit": -7.51171875,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of up to 30",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.96875,
            "end_logit": -7.5625,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of up to 30-40% of patients will",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.96875,
            "end_logit": -7.5703125,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of up to 30-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.96875,
            "end_logit": -7.640625,
            "text": "bladder cancer, its long-term efficacy is still arguable",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 4.96875,
            "end_logit": -7.6484375,
            "text": "bladder cancer, its long-term efficacy is still arguable as a proportion of",
            "probability": 1.1920928955078125e-07
        }
    ],
    "60292d191cb411341a00010e_15": [
        {
            "start_logit": 6.50390625,
            "end_logit": 6.59375,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -5.296875,
            "end_logit": 6.59375,
            "text": "bladder cancer",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": -7.328125,
            "end_logit": 6.59375,
            "text": "Calmette-Gu\u00e9rin (BCG) intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 6.59375,
            "text": "treat high-risk non-muscle-invasive bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 6.59375,
            "text": "intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 6.59375,
            "text": "reduce recurrences, bacillus Calmette-Gu\u00e9rin (BCG) intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 6.59375,
            "text": "high-risk non-muscle-invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 6.59375,
            "text": "bacillus Calmette-Gu\u00e9rin (BCG) intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 6.59375,
            "text": ", bacillus Calmette-Gu\u00e9rin (BCG) intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.4453125,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 6.59375,
            "text": "invasive bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.59375,
            "text": "to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.515625,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 6.59375,
            "text": "recurrences, bacillus Calmette-Gu\u00e9rin (BCG) intravesical immunotherapy to treat high-risk non-muscle-invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.609375,
            "text": "cancer and urothelial CIS and platin",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.62109375,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.62890625,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific survival are examples of therapy",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.6640625,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.50390625,
            "end_logit": -7.7265625,
            "text": "cancer and urothelial CIS and platin-based systemic chemotherapy to improve postcystectomy disease-specific survival",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.296875,
            "end_logit": -6.453125,
            "text": "bladder",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_16": [
        {
            "start_logit": 6.5,
            "end_logit": 6.59765625,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -6.0546875,
            "end_logit": 6.59765625,
            "text": "bladder cancer",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -7.01953125,
            "end_logit": 6.59765625,
            "text": "muscle invasive bladder cancer",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 6.59765625,
            "text": "high risk non-muscle invasive bladder cancer",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 6.59765625,
            "text": "intravesical immunotherapy to treat high risk non-muscle invasive bladder cancer",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 6.59765625,
            "text": "to treat high risk non-muscle invasive bladder cancer",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 6.59765625,
            "text": "treat high risk non-muscle invasive bladder cancer",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.34375,
            "end_logit": 6.59765625,
            "text": "invasive bladder cancer",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 6.59765625,
            "text": ", BCG intravesical immunotherapy to treat high risk non-muscle invasive bladder cancer",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 6.59765625,
            "text": "reduce recurrences, BCG intravesical immunotherapy to treat high risk non-muscle invasive bladder cancer",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 6.59765625,
            "text": "non-muscle invasive bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 6.59765625,
            "text": "transurethral resection of bladder tumor to reduce recurrences, BCG intravesical immunotherapy to treat high risk non-muscle invasive bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 6.59765625,
            "text": "resection of bladder tumor to reduce recurrences, BCG intravesical immunotherapy to treat high risk non-muscle invasive bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.37109375,
            "text": "cancer and urothelial",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.5859375,
            "text": "cancer and urothelial carcinoma in situ, and platinum-based systemic chemotherapy to improve post-cystectomy",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.609375,
            "text": "cancer and urothelial carcinoma in situ, and platinum-based systemic chemotherapy to improve post-cystectomy disease-",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.65625,
            "text": "cancer and urothelial carcinoma in situ, and platinum-based systemic chemotherapy to improve post-cystectomy disease-specific",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.66015625,
            "text": "cancer and urothelial carcinoma in situ, and platinum-based systemic chemotherapy to improve post-cystectomy disease",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.703125,
            "text": "cancer and urothelial carcinoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.5,
            "end_logit": -7.73828125,
            "text": "cancer and urothelial carcinoma in situ, and platinum-based systemic chemotherapy to improve post-cystectomy disease-specific survival some of the causes of therapy related",
            "probability": 5.960464477539062e-07
        }
    ],
    "60292d191cb411341a00010e_17": [
        {
            "start_logit": 7.12890625,
            "end_logit": 8.3984375,
            "text": "bladder cancer",
            "probability": 0.99609375
        },
        {
            "start_logit": 1.630859375,
            "end_logit": 8.3984375,
            "text": "cancer",
            "probability": 0.004070281982421875
        },
        {
            "start_logit": 7.12890625,
            "end_logit": -3.1796875,
            "text": "bladder",
            "probability": 9.298324584960938e-06
        },
        {
            "start_logit": -7.15625,
            "end_logit": 8.3984375,
            "text": "This comprehensive review highlights recent developments in intravesical therapy of bladder cancer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.3984375,
            "text": "comprehensive review highlights recent developments in intravesical therapy of bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 8.3984375,
            "text": "of bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 8.3984375,
            "text": "review highlights recent developments in intravesical therapy of bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 8.3984375,
            "text": "intravesical therapy of bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.12890625,
            "end_logit": -6.52734375,
            "text": "bladder cancer and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.12890625,
            "end_logit": -6.69921875,
            "text": "bladder cancer and summarizes the mechanisms of action of BCG, and the important",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.12890625,
            "end_logit": -7.23046875,
            "text": "bladder cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and other immunotherapeutic agents in the therapy and prophylaxis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.12890625,
            "end_logit": -7.26953125,
            "text": "bladder cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and other immunotherapeutic agents in the therapy and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.12890625,
            "end_logit": -7.35546875,
            "text": "bladder cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and other immunotherapeutic agents",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.12890625,
            "end_logit": -7.37890625,
            "text": "bladder cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.12890625,
            "end_logit": -7.44140625,
            "text": "bladder cancer and summarizes the mechanisms of action of BCG, and the important role of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.12890625,
            "end_logit": -7.4453125,
            "text": "bladder cancer and summarizes the mechanisms of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.12890625,
            "end_logit": -7.4609375,
            "text": "bladder cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and other immunotherapeutic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.12890625,
            "end_logit": -7.5234375,
            "text": "bladder cancer and summarizes the mechanisms of action of BCG, and the important role",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.12890625,
            "end_logit": -7.5390625,
            "text": "bladder cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and other immunotherapeutic agents in the therapy",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.12890625,
            "end_logit": -7.54296875,
            "text": "bladder cancer and summarizes the mechanisms of action of BCG, and the important role of intravesical BCG immunotherapy and other",
            "probability": 1.1920928955078125e-07
        }
    ],
    "60292d191cb411341a00010e_18": [
        {
            "start_logit": 6.36328125,
            "end_logit": 6.765625,
            "text": "cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer",
            "probability": 0.3369140625
        },
        {
            "start_logit": 6.3515625,
            "end_logit": 6.765625,
            "text": "cancer",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.36328125,
            "end_logit": 6.73828125,
            "text": "cancer",
            "probability": 0.3291015625
        },
        {
            "start_logit": -3.787109375,
            "end_logit": 6.765625,
            "text": "bladder cancer",
            "probability": 1.3172626495361328e-05
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -6.79296875,
            "text": "cancer, discusses promising new therapies closely related to BCG, and briefly explores the possibility that BCG or related treatments may have an application in other urological malignancies",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 6.765625,
            "text": "This review summarises the history and development of BCG as a modern cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.3046875,
            "end_logit": 6.73828125,
            "text": "This review summarises the history and development of BCG as a modern cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -6.9453125,
            "text": "cancer treatment, appraises current optimal application of BCG immunotherapy in bladder",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 6.765625,
            "text": "summarises the history and development of BCG as a modern cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 6.73828125,
            "text": "summarises the history and development of BCG as a modern cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 6.765625,
            "text": "appraises current optimal application of BCG immunotherapy in bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 6.765625,
            "text": "modern cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 6.73828125,
            "text": "modern cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 6.765625,
            "text": ", appraises current optimal application of BCG immunotherapy in bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 6.765625,
            "text": "review summarises the history and development of BCG as a modern cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 6.73828125,
            "text": "review summarises the history and development of BCG as a modern cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 6.765625,
            "text": "ises current optimal application of BCG immunotherapy in bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.33203125,
            "text": "cancer, discusses promising new therapies closely related to BCG, and briefly explores the possibility that BCG or related treatments may have an application in other urological",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.44921875,
            "text": "cancer treatment",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.36328125,
            "end_logit": -7.5078125,
            "text": "cancer treatment, appraises current optimal application of BCG immunotherapy in bladder cancer,",
            "probability": 2.384185791015625e-07
        }
    ],
    "60292d191cb411341a00010e_19": [
        {
            "start_logit": 6.35546875,
            "end_logit": 6.80078125,
            "text": "cancer",
            "probability": 0.9990234375
        },
        {
            "start_logit": -1.18359375,
            "end_logit": 6.80078125,
            "text": "bladder cancer",
            "probability": 0.0005311965942382812
        },
        {
            "start_logit": -6.9296875,
            "end_logit": 6.80078125,
            "text": "prevent the recurrence of superficial bladder cancer",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 6.80078125,
            "text": "recurrence of superficial bladder cancer",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.375,
            "end_logit": 6.80078125,
            "text": "superficial bladder cancer",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 6.80078125,
            "text": "Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 6.80078125,
            "text": "and prevent the recurrence of superficial bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 6.80078125,
            "text": "treat and prevent the recurrence of superficial bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 6.80078125,
            "text": "Immunotherapy by intravesicular delivery of Bacillus Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 6.80078125,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 6.80078125,
            "text": "ette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 6.80078125,
            "text": "intravesicular delivery of Bacillus Calmette-Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.35546875,
            "end_logit": -7.453125,
            "text": "cancer.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 6.80078125,
            "text": "BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 6.80078125,
            "text": "Gu\u00e9rin (BCG) is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 6.80078125,
            "text": ") is used to treat and prevent the recurrence of superficial bladder cancer",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -1.18359375,
            "end_logit": -6.359375,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": -1.18359375,
            "end_logit": -7.453125,
            "text": "bladder cancer.",
            "probability": 0.0
        },
        {
            "start_logit": -6.9296875,
            "end_logit": -6.359375,
            "text": "prevent the recurrence of superficial bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.3203125,
            "end_logit": -6.359375,
            "text": "recurrence of superficial bladder",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_20": [
        {
            "start_logit": 6.43359375,
            "end_logit": 6.671875,
            "text": "cancer",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.4296875,
            "end_logit": 6.6796875,
            "text": "cancer",
            "probability": 0.334228515625
        },
        {
            "start_logit": 6.4296875,
            "end_logit": 6.671875,
            "text": "cancer and one of the most successful applications of immunotherapy to the treatment of cancer",
            "probability": 0.33154296875
        },
        {
            "start_logit": -6.5625,
            "end_logit": 6.6796875,
            "text": "bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.5625,
            "end_logit": 6.671875,
            "text": "bladder cancer and one of the most successful applications of immunotherapy to the treatment of cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.0078125,
            "text": "cancer and one of the most successful applications of immunotherapy to the treatment of",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.33984375,
            "text": "cancer and one of the most successful applications of immunotherapy to the treatment",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.35546875,
            "text": "cancer and one of the most successful applications of immunotherapy to",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.6796875,
            "text": "Calmette-Gu\u00e9rin (BCG) immunotherapy is currently the most effective treatment of non-muscle invasive bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 6.6796875,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy is currently the most effective treatment of non-muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 6.6796875,
            "text": "muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 6.671875,
            "text": "muscle invasive bladder cancer and one of the most successful applications of immunotherapy to the treatment of cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.43359375,
            "end_logit": -7.46484375,
            "text": "cancer.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.46484375,
            "text": "cancer and one of the most successful applications of immunotherapy to the treatment of cancer.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 6.6796875,
            "text": "invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 6.671875,
            "text": "invasive bladder cancer and one of the most successful applications of immunotherapy to the treatment of cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.4296875,
            "end_logit": -7.48828125,
            "text": "cancer and",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.671875,
            "text": "treatment of cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 6.6796875,
            "text": "non-muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 6.6796875,
            "text": "most effective treatment of non-muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        }
    ],
    "60292d191cb411341a00010e_21": [
        {
            "start_logit": 6.47265625,
            "end_logit": 6.62890625,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -4.65234375,
            "end_logit": 6.62890625,
            "text": "bladder cancer",
            "probability": 1.4722347259521484e-05
        },
        {
            "start_logit": -7.3515625,
            "end_logit": 6.62890625,
            "text": "Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.453125,
            "end_logit": 6.62890625,
            "text": "muscle invasive bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 6.62890625,
            "text": "Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 6.62890625,
            "text": "standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 6.62890625,
            "text": "non-muscle invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 6.62890625,
            "text": "high-grade non-muscle invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 6.62890625,
            "text": "invasive bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 6.62890625,
            "text": ": The administration of Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -7.484375,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of recurrence and",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -7.5078125,
            "text": "cancer (NMIBC) and carcinoma in-",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -7.5234375,
            "text": "cancer (NMIBC) and carcinoma in",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 6.62890625,
            "text": "become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.62890625,
            "text": "grade non-muscle invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -7.55859375,
            "text": "cancer (NMIBC",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.62890625,
            "text": "The administration of Bacillus Calmette-Gu\u00e9rin (BCG) immunotherapy has become the standard of care for high-grade non-muscle invasive bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -7.60546875,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -7.65234375,
            "text": "cancer (NMIBC) and carcinoma in-situ",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.47265625,
            "end_logit": -7.66796875,
            "text": "cancer (NMIBC) and carcinoma in-situ (CIS) in terms of prevention of",
            "probability": 5.960464477539062e-07
        }
    ],
    "60292d191cb411341a00010e_22": [
        {
            "start_logit": 6.1875,
            "end_logit": 6.9453125,
            "text": "cancer",
            "probability": 0.98828125
        },
        {
            "start_logit": 1.736328125,
            "end_logit": 6.9453125,
            "text": "bladder cancer",
            "probability": 0.011505126953125
        },
        {
            "start_logit": -7.078125,
            "end_logit": 6.9453125,
            "text": "invasive bladder cancer",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 6.9453125,
            "text": "SUMMARY: When T1 high-grade non-muscle-invasive bladder cancer",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 6.9453125,
            "text": "muscle-invasive bladder cancer",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 6.9453125,
            "text": ": When T1 high-grade non-muscle-invasive bladder cancer",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 6.9453125,
            "text": "When T1 high-grade non-muscle-invasive bladder cancer",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 6.9453125,
            "text": "grade non-muscle-invasive bladder cancer",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.1875,
            "end_logit": -7.046875,
            "text": "cancer is persistent or recurs shortly after a full course of bacille Calmette-Gu\u00e9rin (",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.1875,
            "end_logit": -7.0625,
            "text": "cancer is",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.1875,
            "end_logit": -7.28515625,
            "text": "cancer is persistent or",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.1875,
            "end_logit": -7.3125,
            "text": "cancer is persistent or recurs shortly after a full course of bacille Calmette-Gu",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.1875,
            "end_logit": -7.32421875,
            "text": "cancer is persistent or recurs shortly after a full course of bacille Calmette-Gu\u00e9rin",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.1875,
            "end_logit": -7.32421875,
            "text": "cancer is persistent or recurs shortly after a full course of bacille Calmette-Gu\u00e9rin (BCG",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.1875,
            "end_logit": -7.4765625,
            "text": "cancer is persistent or recurs shortly after a full course of bacille Calmette-",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.1875,
            "end_logit": -7.4921875,
            "text": "cancer is persistent or recurs shortly after a full course of bacille Calmette-Gu\u00e9rin (BCG) plus",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.1875,
            "end_logit": -7.4921875,
            "text": "cancer is persistent or recurs shortly after a full course of bacille Calmette-Gu\u00e9rin (BCG) plus maintenance, further BCG is not likely to",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 1.736328125,
            "end_logit": -5.7109375,
            "text": "bladder",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 1.736328125,
            "end_logit": -7.046875,
            "text": "bladder cancer is persistent or recurs shortly after a full course of bacille Calmette-Gu\u00e9rin (",
            "probability": 0.0
        },
        {
            "start_logit": 1.736328125,
            "end_logit": -7.0625,
            "text": "bladder cancer is",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_23": [
        {
            "start_logit": 6.2734375,
            "end_logit": 6.85546875,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -2.4296875,
            "end_logit": 6.85546875,
            "text": "bladder cancer",
            "probability": 0.00016605854034423828
        },
        {
            "start_logit": -7.140625,
            "end_logit": 6.85546875,
            "text": "invasive bladder cancer",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 6.85546875,
            "text": "muscle-invasive bladder cancer",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.40625,
            "end_logit": 6.85546875,
            "text": "non-muscle-invasive bladder cancer",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 6.85546875,
            "text": "PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.578125,
            "end_logit": 6.85546875,
            "text": "grade non-muscle-invasive bladder cancer",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.85546875,
            "text": "patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 6.85546875,
            "text": "high-grade non-muscle-invasive bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 6.85546875,
            "text": "pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 6.85546875,
            "text": "Prognostic significance of pre- and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 6.85546875,
            "text": "in patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 6.85546875,
            "text": "and post-treatment PD-L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 6.85546875,
            "text": "L1 expression in patients with primary high-grade non-muscle-invasive bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.2734375,
            "end_logit": -7.45703125,
            "text": "cancer treated with BCG immunotherapy.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.2734375,
            "end_logit": -7.5859375,
            "text": "cancer treated",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -2.4296875,
            "end_logit": -6.375,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": -2.4296875,
            "end_logit": -7.45703125,
            "text": "bladder cancer treated with BCG immunotherapy.",
            "probability": 0.0
        },
        {
            "start_logit": -2.4296875,
            "end_logit": -7.5859375,
            "text": "bladder cancer treated",
            "probability": 0.0
        },
        {
            "start_logit": -7.140625,
            "end_logit": -6.375,
            "text": "invasive bladder",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_24": [
        {
            "start_logit": 6.31640625,
            "end_logit": 6.8203125,
            "text": "cancer",
            "probability": 0.353271484375
        },
        {
            "start_logit": 6.41796875,
            "end_logit": 6.68359375,
            "text": "cancer",
            "probability": 0.33984375
        },
        {
            "start_logit": 6.31640625,
            "end_logit": 6.68359375,
            "text": "cancer and it still remains at the forefront of immunotherapy for cancer",
            "probability": 0.306884765625
        },
        {
            "start_logit": -2.857421875,
            "end_logit": 6.8203125,
            "text": "bladder cancer",
            "probability": 3.641843795776367e-05
        },
        {
            "start_logit": -2.857421875,
            "end_logit": 6.68359375,
            "text": "bladder cancer and it still remains at the forefront of immunotherapy for cancer",
            "probability": 3.1888484954833984e-05
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 6.8203125,
            "text": "In the past three decades, intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 6.8203125,
            "text": "the past three decades, intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 6.8203125,
            "text": "past three decades, intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.41796875,
            "end_logit": -7.02734375,
            "text": "cancer patients",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -6.99609375,
            "text": "cancer and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.31640625,
            "end_logit": -7.02734375,
            "text": "cancer and it still remains at the forefront of immunotherapy for cancer patients",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 6.8203125,
            "text": "Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 6.8203125,
            "text": ", intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 6.68359375,
            "text": "Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer and it still remains at the forefront of immunotherapy for cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 6.8203125,
            "text": "treating bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.8203125,
            "text": "intravesical instillation of Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 6.8203125,
            "text": "Mycobacterium bovis bacille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 6.8203125,
            "text": "BCG) has been used for treating bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 6.8203125,
            "text": "(BCG) has been used for treating bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 6.8203125,
            "text": "ille Calmette-Gu\u00e9rin (BCG) has been used for treating bladder cancer",
            "probability": 2.384185791015625e-07
        }
    ],
    "60292d191cb411341a00010e_25": [
        {
            "start_logit": 8.03125,
            "end_logit": 8.4765625,
            "text": "bladder cancer",
            "probability": 0.998046875
        },
        {
            "start_logit": 1.47265625,
            "end_logit": 8.4765625,
            "text": "cancer",
            "probability": 0.0014314651489257812
        },
        {
            "start_logit": 8.03125,
            "end_logit": -1.5576171875,
            "text": "bladder",
            "probability": 4.392862319946289e-05
        },
        {
            "start_logit": -6.37109375,
            "end_logit": 8.4765625,
            "text": "tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 8.4765625,
            "text": "muscle invasive bladder cancer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.4765625,
            "text": "invasive bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.4765625,
            "text": "intravesical therapy for this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 8.4765625,
            "text": "the most effective intravesical therapy for this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 8.4765625,
            "text": "effective intravesical therapy for this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 8.4765625,
            "text": "of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.4765625,
            "text": "this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.4765625,
            "text": "BCG-based therapy is the most effective intravesical therapy for this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.4765625,
            "text": "most effective intravesical therapy for this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.4765625,
            "text": "Although BCG-based therapy is the most effective intravesical therapy for this kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.4765625,
            "text": "reduce progression into muscle invasive bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.4765625,
            "text": "kind of tumor and represents the only agent known to reduce progression into muscle invasive bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 8.4765625,
            "text": "progression into muscle invasive bladder cancer",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.43359375,
            "text": "bladder cancer, BCG is ineffective in approximately 30-40 % of cases and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.4375,
            "text": "bladder cancer, BCG is ineffective in approximately 30-40 % of cases and disease recurs in up to 50 %",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.03125,
            "end_logit": -7.4609375,
            "text": "bladder cancer, BCG is ineffective in approximately 30-40",
            "probability": 1.1920928955078125e-07
        }
    ],
    "60292d191cb411341a00010e_26": [
        {
            "start_logit": 6.45703125,
            "end_logit": 6.6796875,
            "text": "cancer",
            "probability": 1.0
        },
        {
            "start_logit": -6.7109375,
            "end_logit": 6.6796875,
            "text": "bladder cancer",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 6.6796875,
            "text": "less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 6.6796875,
            "text": "search for less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.37109375,
            "text": "cancer immunotherapy.",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.6796875,
            "text": ", the genetic manipulation of these mycobacteria has been appealing in the search for less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 6.6796875,
            "text": "the search for less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 6.6796875,
            "text": "the genetic manipulation of these mycobacteria has been appealing in the search for less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 6.6796875,
            "text": "manipulation of these mycobacteria has been appealing in the search for less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 6.6796875,
            "text": "more potent therapeutic agents for bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 6.6796875,
            "text": "genetic manipulation of these mycobacteria has been appealing in the search for less toxic and more potent therapeutic agents for bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 6.6796875,
            "text": "therapeutic agents for bladder cancer",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.7109375,
            "end_logit": -7.203125,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": -6.7109375,
            "end_logit": -7.37109375,
            "text": "bladder cancer immunotherapy.",
            "probability": 0.0
        },
        {
            "start_logit": -7.19921875,
            "end_logit": -7.37109375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -7.203125,
            "text": "less toxic and more potent therapeutic agents for bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.37109375,
            "end_logit": -7.37109375,
            "text": "less toxic and more potent therapeutic agents for bladder cancer immunotherapy.",
            "probability": 0.0
        },
        {
            "start_logit": -7.55859375,
            "end_logit": -7.203125,
            "text": "search for less toxic and more potent therapeutic agents for bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -7.203125,
            "text": ", the genetic manipulation of these mycobacteria has been appealing in the search for less toxic and more potent therapeutic agents for bladder",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": -7.203125,
            "text": "the search for less toxic and more potent therapeutic agents for bladder",
            "probability": 0.0
        }
    ],
    "60292d191cb411341a00010e_27": [
        {
            "start_logit": 6.14453125,
            "end_logit": 7.0,
            "text": "cancer",
            "probability": 0.9990234375
        },
        {
            "start_logit": -1.462890625,
            "end_logit": 7.0,
            "text": "bladder cancer",
            "probability": 0.0004992485046386719
        },
        {
            "start_logit": -7.2421875,
            "end_logit": 7.0,
            "text": "BCG immunotherapy of bladder cancer",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.765625,
            "end_logit": 7.0,
            "text": "immunotherapy of bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 7.0,
            "text": "of bladder cancer",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.14453125,
            "end_logit": -7.17578125,
            "text": "cancer: inhibition of tumor",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.14453125,
            "end_logit": -7.40625,
            "text": "cancer: inhibition of tumor recurrence",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.14453125,
            "end_logit": -7.40625,
            "text": "cancer: inhibition of tumor recurrence and associated immune responses.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.14453125,
            "end_logit": -7.59375,
            "text": "cancer: inhibition of tumor recurrence and associated immune responses",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.14453125,
            "end_logit": -7.6796875,
            "text": "cancer: inhibition of tumor recurrence and",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.14453125,
            "end_logit": -7.7578125,
            "text": "cancer: inhibition of tumor recurrence and associated",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -1.462890625,
            "end_logit": -7.00390625,
            "text": "bladder",
            "probability": 0.0
        },
        {
            "start_logit": -1.462890625,
            "end_logit": -7.17578125,
            "text": "bladder cancer: inhibition of tumor",
            "probability": 0.0
        },
        {
            "start_logit": -1.462890625,
            "end_logit": -7.40625,
            "text": "bladder cancer: inhibition of tumor recurrence",
            "probability": 0.0
        },
        {
            "start_logit": -1.462890625,
            "end_logit": -7.40625,
            "text": "bladder cancer: inhibition of tumor recurrence and associated immune responses.",
            "probability": 0.0
        },
        {
            "start_logit": -1.462890625,
            "end_logit": -7.59375,
            "text": "bladder cancer: inhibition of tumor recurrence and associated immune responses",
            "probability": 0.0
        },
        {
            "start_logit": -1.462890625,
            "end_logit": -7.6796875,
            "text": "bladder cancer: inhibition of tumor recurrence and",
            "probability": 0.0
        },
        {
            "start_logit": -1.462890625,
            "end_logit": -7.7578125,
            "text": "bladder cancer: inhibition of tumor recurrence and associated",
            "probability": 0.0
        },
        {
            "start_logit": -6.8359375,
            "end_logit": -7.17578125,
            "text": "tumor",
            "probability": 0.0
        },
        {
            "start_logit": -6.8359375,
            "end_logit": -7.40625,
            "text": ".",
            "probability": 0.0
        }
    ],
    "5e776db8835f4e4777000011_1": [
        {
            "start_logit": 8.0859375,
            "end_logit": 8.140625,
            "text": "MannKind Corporation",
            "probability": 1.0
        },
        {
            "start_logit": -1.076171875,
            "end_logit": 8.140625,
            "text": "tion",
            "probability": 0.0001055598258972168
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -1.736328125,
            "text": "Mann",
            "probability": 5.1856040954589844e-05
        },
        {
            "start_logit": -5.73046875,
            "end_logit": 8.140625,
            "text": "Kind Corporation",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.2109375,
            "text": "MannKind Corporation started developing its ultra-rapid-acting insulin",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.38671875,
            "text": "MannKind Corporation started",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.4765625,
            "end_logit": 8.140625,
            "text": "d Corporation",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.46875,
            "text": "MannKind Corpora",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.73046875,
            "end_logit": 8.140625,
            "text": "Corporation",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 0.46337890625,
            "end_logit": 0.475830078125,
            "text": "Sanofi",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 8.140625,
            "text": ", MannKind Corporation",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.26171875,
            "text": "MannKind",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 8.140625,
            "text": "contrary, MannKind Corporation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 0.46337890625,
            "end_logit": -4.7421875,
            "text": "Sanofi after",
            "probability": 0.0
        },
        {
            "start_logit": 0.46337890625,
            "end_logit": -5.4453125,
            "text": "Sanof",
            "probability": 0.0
        },
        {
            "start_logit": 0.46337890625,
            "end_logit": -5.62890625,
            "text": "Sanofi after getting FDA approval in June 2014",
            "probability": 0.0
        },
        {
            "start_logit": 0.46337890625,
            "end_logit": -5.7421875,
            "text": "Sanofi after getting FDA",
            "probability": 0.0
        },
        {
            "start_logit": 0.46337890625,
            "end_logit": -6.07421875,
            "text": "San",
            "probability": 0.0
        },
        {
            "start_logit": -6.63671875,
            "end_logit": 0.475830078125,
            "text": ". Afrezza has been marketed since February, 2015 by Sanofi",
            "probability": 0.0
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 0.475830078125,
            "text": "by Sanofi",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_1": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.0625,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 8.21875,
            "end_logit": -0.56103515625,
            "text": "Nox1 oxidase",
            "probability": 0.00017952919006347656
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.150390625,
            "text": "Nox",
            "probability": 9.995698928833008e-05
        },
        {
            "start_logit": -1.369140625,
            "end_logit": 8.0625,
            "text": "1",
            "probability": 6.866455078125e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -3.6640625,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p47(phox",
            "probability": 8.046627044677734e-06
        },
        {
            "start_logit": 8.21875,
            "end_logit": -4.26171875,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p47",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 8.21875,
            "end_logit": -4.47265625,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1)",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": 8.21875,
            "end_logit": -4.875,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.0546875,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.19140625,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.8515625,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (Nox",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.88671875,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.92578125,
            "text": "Nox1 oxidase,",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.9765625,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p47(phox)",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.0,
            "end_logit": 8.0625,
            "text": ", Nox1",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.4921875,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or p4",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.55859375,
            "end_logit": 8.0625,
            "text": "A unique member of this family, Nox1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.73046875,
            "text": "Nox1 oxidase, functions as either a canonical or hybrid system using Nox organizing subunit 1 (NoxO1) or",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.83203125,
            "end_logit": 8.0625,
            "text": "family, Nox1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -1.369140625,
            "end_logit": -0.56103515625,
            "text": "1 oxidase",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_2": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.0703125,
            "text": "Nox1",
            "probability": 0.43212890625
        },
        {
            "start_logit": 7.98828125,
            "end_logit": 8.0703125,
            "text": "Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 0.33642578125
        },
        {
            "start_logit": 7.98828125,
            "end_logit": 7.6953125,
            "text": "Noxa1",
            "probability": 0.231201171875
        },
        {
            "start_logit": 8.234375,
            "end_logit": -0.765625,
            "text": "Nox",
            "probability": 6.23464584350586e-05
        },
        {
            "start_logit": 7.98828125,
            "end_logit": -0.765625,
            "text": "Noxa1 and the superoxide-producing activity of Nox",
            "probability": 4.851818084716797e-05
        },
        {
            "start_logit": 7.98828125,
            "end_logit": -1.0302734375,
            "text": "Nox",
            "probability": 3.719329833984375e-05
        },
        {
            "start_logit": -1.3125,
            "end_logit": 8.0703125,
            "text": "1",
            "probability": 3.063678741455078e-05
        },
        {
            "start_logit": -1.951171875,
            "end_logit": 8.0703125,
            "text": "a1 and the superoxide-producing activity of Nox1",
            "probability": 1.615285873413086e-05
        },
        {
            "start_logit": -1.951171875,
            "end_logit": 7.6953125,
            "text": "a1",
            "probability": 1.1086463928222656e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -3.908203125,
            "text": "Nox1.",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 7.98828125,
            "end_logit": -3.908203125,
            "text": "Noxa1 and the superoxide-producing activity of Nox1.",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": -5.1484375,
            "end_logit": 8.0703125,
            "text": "of Nox1",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.37890625,
            "end_logit": 8.0703125,
            "text": "Noxo1 at threonine 341 regulates its interaction with Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.37890625,
            "end_logit": 7.6953125,
            "text": "Noxo1 at threonine 341 regulates its interaction with Noxa1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 8.0703125,
            "text": "superoxide-producing activity of Nox1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.98828125,
            "end_logit": -6.66015625,
            "text": "Noxa1 and the superoxide-producing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 8.0703125,
            "text": "with Noxa1 and the superoxide-producing activity of Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.0390625,
            "end_logit": 8.0703125,
            "text": "the superoxide-producing activity of Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 7.6953125,
            "text": "with Noxa1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 7.98828125,
            "end_logit": -7.1015625,
            "text": "Noxa1 and the superoxide-producing activity",
            "probability": 5.960464477539063e-08
        }
    ],
    "58a5a51060087bc10a000021_3": [
        {
            "start_logit": 5.1171875,
            "end_logit": 3.95703125,
            "text": "Nox1",
            "probability": 0.89990234375
        },
        {
            "start_logit": 3.90625,
            "end_logit": 2.943359375,
            "text": "Noxa1",
            "probability": 0.09710693359375
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -2.244140625,
            "text": "Nox",
            "probability": 0.0018205642700195312
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -4.43359375,
            "text": "Nox1, a member of the Nox",
            "probability": 0.00020420551300048828
        },
        {
            "start_logit": 3.90625,
            "end_logit": -3.498046875,
            "text": "Nox",
            "probability": 0.00015413761138916016
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -4.890625,
            "text": "Nox1, a member of the Nox family",
            "probability": 0.00012886524200439453
        },
        {
            "start_logit": -3.01953125,
            "end_logit": 2.943359375,
            "text": "Noxo1 (Nox organizer 1) and Noxa1",
            "probability": 9.500980377197266e-05
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -5.328125,
            "text": "Nox1, a member of the Nox family NAPDH oxidase",
            "probability": 8.320808410644531e-05
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -5.3828125,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1)",
            "probability": 7.873773574829102e-05
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -5.46875,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1",
            "probability": 7.224082946777344e-05
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -5.59375,
            "text": "Nox1, a member of the Nox family NAPDH oxidases,",
            "probability": 6.377696990966797e-05
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -5.890625,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox",
            "probability": 4.738569259643555e-05
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -6.09375,
            "text": "Nox1, a member of the Nox family NAPDH oxidases",
            "probability": 3.8683414459228516e-05
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -6.203125,
            "text": "Nox1,",
            "probability": 3.463029861450195e-05
        },
        {
            "start_logit": -5.13671875,
            "end_logit": 3.95703125,
            "text": "Superoxide production by Nox1",
            "probability": 3.159046173095703e-05
        },
        {
            "start_logit": 3.90625,
            "end_logit": -5.10546875,
            "text": "Noxa1 (Nox",
            "probability": 3.081560134887695e-05
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -6.390625,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1",
            "probability": 2.872943878173828e-05
        },
        {
            "start_logit": -5.6015625,
            "end_logit": 3.95703125,
            "text": "1",
            "probability": 1.990795135498047e-05
        },
        {
            "start_logit": 3.90625,
            "end_logit": -5.80859375,
            "text": "Noxa1 (Nox activator 1",
            "probability": 1.52587890625e-05
        },
        {
            "start_logit": -5.75,
            "end_logit": 2.943359375,
            "text": ") and Noxa1",
            "probability": 6.198883056640625e-06
        }
    ],
    "58a5a51060087bc10a000021_4": [
        {
            "start_logit": 8.140625,
            "end_logit": 8.0859375,
            "text": "Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox1",
            "probability": 0.154541015625
        },
        {
            "start_logit": 8.140625,
            "end_logit": 8.0859375,
            "text": "Nox1",
            "probability": 0.154541015625
        },
        {
            "start_logit": 8.125,
            "end_logit": 8.0859375,
            "text": "Nox1",
            "probability": 0.154541015625
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 8.03125,
            "text": "Nox1",
            "probability": 0.1407470703125
        },
        {
            "start_logit": 8.0546875,
            "end_logit": 8.078125,
            "text": "Nox1",
            "probability": 0.1407470703125
        },
        {
            "start_logit": 8.0546875,
            "end_logit": 8.03125,
            "text": "Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 0.1363525390625
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 8.078125,
            "text": "Noxa1, an interaction that participates in Nox1",
            "probability": 0.08013916015625
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 7.31640625,
            "text": "Noxa1",
            "probability": 0.037567138671875
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 2.560546875,
            "text": "Nox1, providing a molecular link between PKC-mediated signal transduction and Nox1",
            "probability": 0.0005979537963867188
        },
        {
            "start_logit": 8.140625,
            "end_logit": 0.009765625,
            "text": "Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox",
            "probability": 4.8279762268066406e-05
        },
        {
            "start_logit": 8.125,
            "end_logit": 0.009765625,
            "text": "Nox",
            "probability": 4.756450653076172e-05
        },
        {
            "start_logit": 8.140625,
            "end_logit": -0.087158203125,
            "text": "Nox",
            "probability": 4.398822784423828e-05
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -0.148193359375,
            "text": "Nox",
            "probability": 3.790855407714844e-05
        },
        {
            "start_logit": -0.301513671875,
            "end_logit": 8.0859375,
            "text": ". Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox1",
            "probability": 3.343820571899414e-05
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -0.357421875,
            "text": "Nox",
            "probability": 3.218650817871094e-05
        },
        {
            "start_logit": -0.30126953125,
            "end_logit": 8.03125,
            "text": ". Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -0.357421875,
            "text": "Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": -0.65576171875,
            "end_logit": 8.078125,
            "text": "1",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": -0.65576171875,
            "end_logit": 8.03125,
            "text": "1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": -0.716796875,
            "end_logit": 8.0859375,
            "text": "1",
            "probability": 2.2113323211669922e-05
        }
    ],
    "58a5a51060087bc10a000021_5": [
        {
            "start_logit": 8.140625,
            "end_logit": 8.0859375,
            "text": "Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox1",
            "probability": 0.154541015625
        },
        {
            "start_logit": 8.140625,
            "end_logit": 8.0859375,
            "text": "Nox1",
            "probability": 0.154541015625
        },
        {
            "start_logit": 8.125,
            "end_logit": 8.0859375,
            "text": "Nox1",
            "probability": 0.154541015625
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 8.03125,
            "text": "Nox1",
            "probability": 0.1407470703125
        },
        {
            "start_logit": 8.0546875,
            "end_logit": 8.078125,
            "text": "Nox1",
            "probability": 0.1407470703125
        },
        {
            "start_logit": 8.0546875,
            "end_logit": 8.03125,
            "text": "Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 0.1363525390625
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 8.078125,
            "text": "Noxa1, an interaction that participates in Nox1",
            "probability": 0.08013916015625
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 7.31640625,
            "text": "Noxa1",
            "probability": 0.037567138671875
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 2.560546875,
            "text": "Nox1, providing a molecular link between PKC-mediated signal transduction and Nox1",
            "probability": 0.0005979537963867188
        },
        {
            "start_logit": 8.140625,
            "end_logit": 0.009765625,
            "text": "Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox",
            "probability": 4.8279762268066406e-05
        },
        {
            "start_logit": 8.125,
            "end_logit": 0.009765625,
            "text": "Nox",
            "probability": 4.756450653076172e-05
        },
        {
            "start_logit": 8.140625,
            "end_logit": -0.087158203125,
            "text": "Nox",
            "probability": 4.398822784423828e-05
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -0.148193359375,
            "text": "Nox",
            "probability": 3.790855407714844e-05
        },
        {
            "start_logit": -0.301513671875,
            "end_logit": 8.0859375,
            "text": ". Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox1",
            "probability": 3.343820571899414e-05
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -0.357421875,
            "text": "Nox",
            "probability": 3.218650817871094e-05
        },
        {
            "start_logit": -0.30126953125,
            "end_logit": 8.03125,
            "text": ". Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -0.357421875,
            "text": "Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": -0.65576171875,
            "end_logit": 8.078125,
            "text": "1",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": -0.65576171875,
            "end_logit": 8.03125,
            "text": "1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": -0.716796875,
            "end_logit": 8.0859375,
            "text": "1",
            "probability": 2.2113323211669922e-05
        }
    ],
    "58a5a51060087bc10a000021_6": [
        {
            "start_logit": 8.140625,
            "end_logit": 8.0859375,
            "text": "Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox1",
            "probability": 0.154541015625
        },
        {
            "start_logit": 8.140625,
            "end_logit": 8.0859375,
            "text": "Nox1",
            "probability": 0.154541015625
        },
        {
            "start_logit": 8.125,
            "end_logit": 8.0859375,
            "text": "Nox1",
            "probability": 0.154541015625
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 8.03125,
            "text": "Nox1",
            "probability": 0.1407470703125
        },
        {
            "start_logit": 8.0546875,
            "end_logit": 8.078125,
            "text": "Nox1",
            "probability": 0.1407470703125
        },
        {
            "start_logit": 8.0546875,
            "end_logit": 8.03125,
            "text": "Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 0.1363525390625
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 8.078125,
            "text": "Noxa1, an interaction that participates in Nox1",
            "probability": 0.08013916015625
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 7.31640625,
            "text": "Noxa1",
            "probability": 0.037567138671875
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 2.560546875,
            "text": "Nox1, providing a molecular link between PKC-mediated signal transduction and Nox1",
            "probability": 0.0005979537963867188
        },
        {
            "start_logit": 8.140625,
            "end_logit": 0.009765625,
            "text": "Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox",
            "probability": 4.8279762268066406e-05
        },
        {
            "start_logit": 8.125,
            "end_logit": 0.009765625,
            "text": "Nox",
            "probability": 4.756450653076172e-05
        },
        {
            "start_logit": 8.140625,
            "end_logit": -0.087158203125,
            "text": "Nox",
            "probability": 4.398822784423828e-05
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -0.148193359375,
            "text": "Nox",
            "probability": 3.790855407714844e-05
        },
        {
            "start_logit": -0.301513671875,
            "end_logit": 8.0859375,
            "text": ". Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox1",
            "probability": 3.343820571899414e-05
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -0.357421875,
            "text": "Nox",
            "probability": 3.218650817871094e-05
        },
        {
            "start_logit": -0.30126953125,
            "end_logit": 8.03125,
            "text": ". Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -0.357421875,
            "text": "Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": -0.65576171875,
            "end_logit": 8.078125,
            "text": "1",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": -0.65576171875,
            "end_logit": 8.03125,
            "text": "1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": -0.716796875,
            "end_logit": 8.0859375,
            "text": "1",
            "probability": 2.2113323211669922e-05
        }
    ],
    "58a5a51060087bc10a000021_7": [
        {
            "start_logit": 8.140625,
            "end_logit": 8.0859375,
            "text": "Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox1",
            "probability": 0.154541015625
        },
        {
            "start_logit": 8.140625,
            "end_logit": 8.0859375,
            "text": "Nox1",
            "probability": 0.154541015625
        },
        {
            "start_logit": 8.125,
            "end_logit": 8.0859375,
            "text": "Nox1",
            "probability": 0.154541015625
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 8.03125,
            "text": "Nox1",
            "probability": 0.1407470703125
        },
        {
            "start_logit": 8.0546875,
            "end_logit": 8.078125,
            "text": "Nox1",
            "probability": 0.1407470703125
        },
        {
            "start_logit": 8.0546875,
            "end_logit": 8.03125,
            "text": "Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 0.1363525390625
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 8.078125,
            "text": "Noxa1, an interaction that participates in Nox1",
            "probability": 0.08013916015625
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 7.31640625,
            "text": "Noxa1",
            "probability": 0.037567138671875
        },
        {
            "start_logit": 8.1015625,
            "end_logit": 2.560546875,
            "text": "Nox1, providing a molecular link between PKC-mediated signal transduction and Nox1",
            "probability": 0.0005979537963867188
        },
        {
            "start_logit": 8.140625,
            "end_logit": 0.009765625,
            "text": "Nox1. Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox",
            "probability": 4.8279762268066406e-05
        },
        {
            "start_logit": 8.125,
            "end_logit": 0.009765625,
            "text": "Nox",
            "probability": 4.756450653076172e-05
        },
        {
            "start_logit": 8.140625,
            "end_logit": -0.087158203125,
            "text": "Nox",
            "probability": 4.398822784423828e-05
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -0.148193359375,
            "text": "Nox",
            "probability": 3.790855407714844e-05
        },
        {
            "start_logit": -0.301513671875,
            "end_logit": 8.0859375,
            "text": ". Ser154 may also be involved in protein kinase A (PKA) mediated regulation of Nox1",
            "probability": 3.343820571899414e-05
        },
        {
            "start_logit": 8.1015625,
            "end_logit": -0.357421875,
            "text": "Nox",
            "probability": 3.218650817871094e-05
        },
        {
            "start_logit": -0.30126953125,
            "end_logit": 8.03125,
            "text": ". Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -0.357421875,
            "text": "Nox1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": -0.65576171875,
            "end_logit": 8.078125,
            "text": "1",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": -0.65576171875,
            "end_logit": 8.03125,
            "text": "1 activation. Thus phosphorylation of Noxo1 at Thr341 appears to play a crucial role in PMA-elicited activation of Nox1",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": -0.716796875,
            "end_logit": 8.0859375,
            "text": "1",
            "probability": 2.2113323211669922e-05
        }
    ],
    "58a5a51060087bc10a000021_8": [
        {
            "start_logit": 8.3515625,
            "end_logit": 8.1484375,
            "text": "Nox1",
            "probability": 1.0
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -0.336181640625,
            "text": "Nox",
            "probability": 0.0002067089080810547
        },
        {
            "start_logit": -1.05859375,
            "end_logit": 8.1484375,
            "text": "1",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": -4.98046875,
            "end_logit": 8.1484375,
            "text": "Noxo1 at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -5.77734375,
            "text": "Nox1 activity in different manners.",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.69140625,
            "end_logit": 8.1484375,
            "text": "341 and at Ser154 appears to regulate Nox1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.88671875,
            "end_logit": 8.1484375,
            "text": "Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.9375,
            "end_logit": 8.1484375,
            "text": "Thus phosphorylation of Noxo1 at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.9375,
            "end_logit": 8.1484375,
            "text": "regulate Nox1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.2109375,
            "text": "Nox1 activity",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.0234375,
            "end_logit": 8.1484375,
            "text": "of Noxo1 at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.02734375,
            "end_logit": 8.1484375,
            "text": "154 appears to regulate Nox1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.36328125,
            "text": "Nox1 activity in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.171875,
            "end_logit": 8.1484375,
            "text": "Ser154 appears to regulate Nox1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 8.1484375,
            "text": "phosphorylation of Noxo1 at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.3515625,
            "end_logit": -7.4375,
            "text": "Nox1 activity in different",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 8.1484375,
            "text": "o1 at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 8.1484375,
            "text": "appears to regulate Nox1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 8.1484375,
            "text": "1 and at Ser154 appears to regulate Nox1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 8.1484375,
            "text": "at Thr341 and at Ser154 appears to regulate Nox1",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58a5a51060087bc10a000021_9": [
        {
            "start_logit": 5.81640625,
            "end_logit": 4.140625,
            "text": "Nox1",
            "probability": 0.67724609375
        },
        {
            "start_logit": 4.609375,
            "end_logit": 4.140625,
            "text": "gp91(phox)/Nox2 and Nox1",
            "probability": 0.203369140625
        },
        {
            "start_logit": 4.609375,
            "end_logit": 3.482421875,
            "text": "gp91(phox)",
            "probability": 0.10546875
        },
        {
            "start_logit": 5.81640625,
            "end_logit": -1.166015625,
            "text": "Nox",
            "probability": 0.00336456298828125
        },
        {
            "start_logit": 5.81640625,
            "end_logit": -1.330078125,
            "text": "Nox1 is known to absolutely require both an organizer protein (p47(phox)",
            "probability": 0.0028553009033203125
        },
        {
            "start_logit": 0.06005859375,
            "end_logit": 4.140625,
            "text": "Nox2 and Nox1",
            "probability": 0.002147674560546875
        },
        {
            "start_logit": 2.8515625,
            "end_logit": 0.7646484375,
            "text": "Noxa1",
            "probability": 0.0011997222900390625
        },
        {
            "start_logit": 4.609375,
            "end_logit": -1.166015625,
            "text": "gp91(phox)/Nox2 and Nox",
            "probability": 0.0010099411010742188
        },
        {
            "start_logit": 4.609375,
            "end_logit": -1.330078125,
            "text": "gp91(phox)/Nox2 and Nox1 is known to absolutely require both an organizer protein (p47(phox)",
            "probability": 0.0008578300476074219
        },
        {
            "start_logit": 4.609375,
            "end_logit": -1.5615234375,
            "text": "gp91(phox)/Nox2",
            "probability": 0.0006780624389648438
        },
        {
            "start_logit": 5.81640625,
            "end_logit": -3.357421875,
            "text": "Nox1 is known to absolutely require both an organizer protein (p47(phox",
            "probability": 0.00037741661071777344
        },
        {
            "start_logit": 2.8515625,
            "end_logit": -0.449462890625,
            "text": "Noxa1); for the p47(phox",
            "probability": 0.0003559589385986328
        },
        {
            "start_logit": 5.81640625,
            "end_logit": -3.44140625,
            "text": "Nox1 is known to absolutely require both an organizer protein (p47(phox) or Noxo1",
            "probability": 0.0003464221954345703
        },
        {
            "start_logit": 4.609375,
            "end_logit": -2.412109375,
            "text": "gp91(phox)/Nox",
            "probability": 0.0002894401550292969
        },
        {
            "start_logit": 5.81640625,
            "end_logit": -4.17578125,
            "text": "Nox1 is known to absolutely require both an organizer protein (p47",
            "probability": 0.00016617774963378906
        },
        {
            "start_logit": 4.609375,
            "end_logit": -3.357421875,
            "text": "gp91(phox)/Nox2 and Nox1 is known to absolutely require both an organizer protein (p47(phox",
            "probability": 0.00011247396469116211
        },
        {
            "start_logit": 4.609375,
            "end_logit": -3.44140625,
            "text": "gp91(phox)/Nox2 and Nox1 is known to absolutely require both an organizer protein (p47(phox) or Noxo1",
            "probability": 0.00010401010513305664
        },
        {
            "start_logit": 0.1278076171875,
            "end_logit": 0.7646484375,
            "text": "Noxo1) andanactivatorprotein (p67(phox) or Noxa1",
            "probability": 7.849931716918945e-05
        },
        {
            "start_logit": 4.609375,
            "end_logit": -4.0625,
            "text": "gp91(phox",
            "probability": 5.5670738220214844e-05
        },
        {
            "start_logit": 4.609375,
            "end_logit": -4.17578125,
            "text": "gp91(phox)/Nox2 and Nox1 is known to absolutely require both an organizer protein (p47",
            "probability": 4.988908767700195e-05
        }
    ],
    "58a5a51060087bc10a000021_10": [
        {
            "start_logit": 8.2578125,
            "end_logit": 8.140625,
            "text": "NOX1",
            "probability": 0.2088623046875
        },
        {
            "start_logit": 8.2578125,
            "end_logit": 8.125,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1",
            "probability": 0.202392578125
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 8.140625,
            "text": "NOXA1",
            "probability": 0.1961669921875
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 8.140625,
            "text": "NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1",
            "probability": 0.1961669921875
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 8.125,
            "text": "NOXA1",
            "probability": 0.1961669921875
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -0.7666015625,
            "text": "NOX",
            "probability": 2.8073787689208984e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -0.87646484375,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOX",
            "probability": 2.5153160095214844e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -0.8466796875,
            "text": "NOX",
            "probability": 2.4616718292236328e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -0.8466796875,
            "text": "NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOX",
            "probability": 2.4616718292236328e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -0.87646484375,
            "text": "NOX",
            "probability": 2.4020671844482422e-05
        },
        {
            "start_logit": -0.96630859375,
            "end_logit": 8.140625,
            "text": "1",
            "probability": 2.0384788513183594e-05
        },
        {
            "start_logit": -0.96630859375,
            "end_logit": 8.125,
            "text": "1 was absolutely required for activation with NOXO1 and NOXA1",
            "probability": 2.008676528930664e-05
        },
        {
            "start_logit": -0.984375,
            "end_logit": 8.140625,
            "text": "A1",
            "probability": 2.008676528930664e-05
        },
        {
            "start_logit": -1.08203125,
            "end_logit": 8.140625,
            "text": "A1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1",
            "probability": 1.8298625946044922e-05
        },
        {
            "start_logit": -1.08203125,
            "end_logit": 8.125,
            "text": "A1",
            "probability": 1.800060272216797e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -2.693359375,
            "text": "NOXA1.",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -2.693359375,
            "text": "NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1.",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -3.486328125,
            "end_logit": 8.140625,
            "text": "NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -3.486328125,
            "end_logit": 8.125,
            "text": "NOXO1 and NOXA1",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -4.55078125,
            "end_logit": 8.140625,
            "text": "and NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1",
            "probability": 5.960464477539062e-07
        }
    ],
    "58a5a51060087bc10a000021_11": [
        {
            "start_logit": 7.9296875,
            "end_logit": 7.92578125,
            "text": "Nox1",
            "probability": 0.998046875
        },
        {
            "start_logit": 7.9296875,
            "end_logit": 1.6240234375,
            "text": "Nox1.",
            "probability": 0.0018243789672851562
        },
        {
            "start_logit": 7.9296875,
            "end_logit": -0.18408203125,
            "text": "Nox",
            "probability": 0.0003001689910888672
        },
        {
            "start_logit": -0.6474609375,
            "end_logit": 7.92578125,
            "text": "NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox1",
            "probability": 0.00018787384033203125
        },
        {
            "start_logit": -1.546875,
            "end_logit": 7.92578125,
            "text": "1",
            "probability": 7.593631744384766e-05
        },
        {
            "start_logit": -3.091796875,
            "end_logit": 7.92578125,
            "text": "NoxO1) is shown to interact with the NADPH-binding region of Nox1",
            "probability": 1.627206802368164e-05
        },
        {
            "start_logit": -3.841796875,
            "end_logit": 7.92578125,
            "text": "(NoxO1) is shown to interact with the NADPH-binding region of Nox1",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": -4.8125,
            "end_logit": 7.92578125,
            "text": "of Nox1",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -5.29296875,
            "end_logit": 7.92578125,
            "text": ", NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox1",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -6.94140625,
            "end_logit": 7.92578125,
            "text": "Additionally, NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -0.6474609375,
            "end_logit": 1.6240234375,
            "text": "NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox1.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 7.92578125,
            "text": "shown to interact with the NADPH-binding region of Nox1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.12109375,
            "end_logit": 7.92578125,
            "text": ") is shown to interact with the NADPH-binding region of Nox1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 7.92578125,
            "text": "Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.515625,
            "end_logit": 7.92578125,
            "text": "oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.92578125,
            "text": "O1) is shown to interact with the NADPH-binding region of Nox1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.546875,
            "end_logit": 1.6240234375,
            "text": "1.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -2.232421875,
            "end_logit": 1.6240234375,
            "text": ".",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -0.6474609375,
            "end_logit": -0.18408203125,
            "text": "NADPH oxidase Organizer 1 (NoxO1) is shown to interact with the NADPH-binding region of Nox",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.091796875,
            "end_logit": 1.6240234375,
            "text": "NoxO1) is shown to interact with the NADPH-binding region of Nox1.",
            "probability": 5.960464477539063e-08
        }
    ],
    "58a5a51060087bc10a000021_12": [
        {
            "start_logit": 5.91796875,
            "end_logit": 5.05078125,
            "text": "Nox1",
            "probability": 0.49560546875
        },
        {
            "start_logit": 5.91796875,
            "end_logit": 4.4140625,
            "text": "Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1",
            "probability": 0.26123046875
        },
        {
            "start_logit": 5.71484375,
            "end_logit": 4.4140625,
            "text": "Noxa1",
            "probability": 0.2132568359375
        },
        {
            "start_logit": 5.91796875,
            "end_logit": 1.6015625,
            "text": "Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1.",
            "probability": 0.0157470703125
        },
        {
            "start_logit": 5.71484375,
            "end_logit": 1.6015625,
            "text": "Noxa1.",
            "probability": 0.012847900390625
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -2.1796875,
            "text": "Nox",
            "probability": 0.0003590583801269531
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -2.81640625,
            "text": "Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Nox",
            "probability": 0.00018990039825439453
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -3.017578125,
            "text": "Nox1,",
            "probability": 0.00015497207641601562
        },
        {
            "start_logit": 5.71484375,
            "end_logit": -2.81640625,
            "text": "Nox",
            "probability": 0.00015497207641601562
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -4.09375,
            "text": "Nox1, complexed with p22(phox",
            "probability": 5.316734313964844e-05
        },
        {
            "start_logit": 0.010162353515625,
            "end_logit": 1.6015625,
            "text": ".",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": -3.072265625,
            "end_logit": 4.4140625,
            "text": "p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1",
            "probability": 3.272294998168945e-05
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -4.66015625,
            "text": "Nox1, complexed with p22(phox)",
            "probability": 3.0040740966796875e-05
        },
        {
            "start_logit": -4.15625,
            "end_logit": 4.4140625,
            "text": "Noxo1 and Noxa1",
            "probability": 1.1026859283447266e-05
        },
        {
            "start_logit": -5.02734375,
            "end_logit": 5.05078125,
            "text": "1",
            "probability": 8.761882781982422e-06
        },
        {
            "start_logit": -5.02734375,
            "end_logit": 4.4140625,
            "text": "1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -5.19921875,
            "end_logit": 4.4140625,
            "text": "and Noxa1",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -6.7265625,
            "text": "Nox1, complexed with p22(phox) at the membrane, requires",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 5.91796875,
            "end_logit": -6.859375,
            "text": "Nox1, complexed with p22(phox) at",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -5.4765625,
            "end_logit": 4.4140625,
            "text": "a1",
            "probability": 2.9802322387695312e-06
        }
    ],
    "58a5a51060087bc10a000021_13": [
        {
            "start_logit": 5.58203125,
            "end_logit": 3.748046875,
            "text": "NADPH oxidase 1 assembly and activation.",
            "probability": 0.56640625
        },
        {
            "start_logit": 5.58203125,
            "end_logit": 3.359375,
            "text": "NADPH oxidase 1",
            "probability": 0.38330078125
        },
        {
            "start_logit": 2.61328125,
            "end_logit": 3.748046875,
            "text": "NOXO1 phosphorylation on serine 154 is critical for optimal NADPH oxidase 1 assembly and activation.",
            "probability": 0.029083251953125
        },
        {
            "start_logit": 2.61328125,
            "end_logit": 3.359375,
            "text": "NOXO1 phosphorylation on serine 154 is critical for optimal NADPH oxidase 1",
            "probability": 0.0197601318359375
        },
        {
            "start_logit": -0.80322265625,
            "end_logit": 3.748046875,
            "text": ".",
            "probability": 0.0009570121765136719
        },
        {
            "start_logit": 5.58203125,
            "end_logit": -3.9140625,
            "text": "NADPH oxidase",
            "probability": 0.00026679039001464844
        },
        {
            "start_logit": 5.58203125,
            "end_logit": -4.50390625,
            "text": "NADPH",
            "probability": 0.00014793872833251953
        },
        {
            "start_logit": 5.58203125,
            "end_logit": -6.28125,
            "text": "NADPH oxidase 1 assembly and",
            "probability": 2.491474151611328e-05
        },
        {
            "start_logit": 5.58203125,
            "end_logit": -6.3828125,
            "text": "NADPH oxidase 1 assembly and activation",
            "probability": 2.2709369659423828e-05
        },
        {
            "start_logit": 2.61328125,
            "end_logit": -3.9140625,
            "text": "NOXO1 phosphorylation on serine 154 is critical for optimal NADPH oxidase",
            "probability": 1.3768672943115234e-05
        },
        {
            "start_logit": 5.58203125,
            "end_logit": -7.3671875,
            "text": "NADPH oxidase 1 assembly",
            "probability": 8.463859558105469e-06
        },
        {
            "start_logit": 2.61328125,
            "end_logit": -4.50390625,
            "text": "NOXO1 phosphorylation on serine 154 is critical for optimal NADPH",
            "probability": 7.569789886474609e-06
        },
        {
            "start_logit": -6.07421875,
            "end_logit": 3.748046875,
            "text": "optimal NADPH oxidase 1 assembly and activation.",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -6.16015625,
            "end_logit": 3.748046875,
            "text": "1 assembly and activation.",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -6.07421875,
            "end_logit": 3.359375,
            "text": "optimal NADPH oxidase 1",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -6.16015625,
            "end_logit": 3.359375,
            "text": "1",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 2.61328125,
            "end_logit": -5.82421875,
            "text": "NOX",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 3.748046875,
            "text": "phosphorylation on serine 154 is critical for optimal NADPH oxidase 1 assembly and activation.",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 3.748046875,
            "text": "serine 154 is critical for optimal NADPH oxidase 1 assembly and activation.",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 2.61328125,
            "end_logit": -6.28125,
            "text": "NOXO1 phosphorylation on serine 154 is critical for optimal NADPH oxidase 1 assembly and",
            "probability": 1.3113021850585938e-06
        }
    ],
    "58a5a51060087bc10a000021_14": [
        {
            "start_logit": 8.171875,
            "end_logit": 8.0625,
            "text": "Nox1",
            "probability": 0.90283203125
        },
        {
            "start_logit": 8.171875,
            "end_logit": 5.7421875,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator protein Noxa1",
            "probability": 0.0887451171875
        },
        {
            "start_logit": 5.69921875,
            "end_logit": 5.7421875,
            "text": "Noxa1",
            "probability": 0.00745391845703125
        },
        {
            "start_logit": 8.171875,
            "end_logit": -0.2391357421875,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator protein Noxa1.",
            "probability": 0.00022518634796142578
        },
        {
            "start_logit": 8.171875,
            "end_logit": -0.99267578125,
            "text": "Nox",
            "probability": 0.0001055002212524414
        },
        {
            "start_logit": -1.4921875,
            "end_logit": 8.0625,
            "text": "1",
            "probability": 5.739927291870117e-05
        },
        {
            "start_logit": 8.171875,
            "end_logit": -1.9716796875,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator protein Nox",
            "probability": 3.9696693420410156e-05
        },
        {
            "start_logit": 5.69921875,
            "end_logit": -0.2391357421875,
            "text": "Noxa1.",
            "probability": 1.8894672393798828e-05
        },
        {
            "start_logit": -1.4921875,
            "end_logit": 5.7421875,
            "text": "1 requires both the organizer protein Noxo1 and the activator protein Noxa1",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": 5.69921875,
            "end_logit": -1.9716796875,
            "text": "Nox",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -3.939453125,
            "end_logit": 5.7421875,
            "text": "a1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -6.46484375,
            "text": "Nox1 requires",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 8.0625,
            "text": "NADPH oxidase Nox1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -4.15625,
            "end_logit": 5.7421875,
            "text": "Noxo1 and the activator protein Noxa1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -6.609375,
            "text": "Nox1 requires both",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 8.0625,
            "text": "Activation of the superoxide-producing NADPH oxidase Nox1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -6.94921875,
            "text": "Nox1 requires both the organizer protein Nox",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -6.953125,
            "text": "Nox1 requires both the organizer protein Noxo1 and",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.1796875,
            "text": "Nox1 requires both the organizer protein Noxo1 and the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.171875,
            "end_logit": -7.21875,
            "text": "Nox1 requires both the organizer protein Noxo1",
            "probability": 2.384185791015625e-07
        }
    ],
    "58a5a51060087bc10a000021_15": [
        {
            "start_logit": 7.26171875,
            "end_logit": 7.39453125,
            "text": "NOX1",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -0.418701171875,
            "text": "NOX",
            "probability": 0.00040411949157714844
        },
        {
            "start_logit": 3.412109375,
            "end_logit": 2.8671875,
            "text": "NOXA1",
            "probability": 0.00023031234741210938
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -1.728515625,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1)",
            "probability": 0.00010877847671508789
        },
        {
            "start_logit": -2.423828125,
            "end_logit": 7.39453125,
            "text": "1",
            "probability": 6.198883056640625e-05
        },
        {
            "start_logit": 3.412109375,
            "end_logit": 0.431396484375,
            "text": "NOXA1 (NOX activating protein 1), as well as the flavocytochrome component p22(phox) for maximal activity.",
            "probability": 2.014636993408203e-05
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -4.0078125,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1",
            "probability": 1.1146068572998047e-05
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -5.24609375,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -5.49609375,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -5.6796875,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 7.26171875,
            "end_logit": -5.92578125,
            "text": "NOX1, an NADPH oxidase",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": 3.412109375,
            "end_logit": -2.447265625,
            "text": "NOXA1 (NOX activating protein",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -1.919921875,
            "end_logit": 2.8671875,
            "text": "NOXO1 (NOX organizing protein 1) and NOXA1",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 3.412109375,
            "end_logit": -3.146484375,
            "text": "NOXA1 (NOX activating protein 1",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -2.65234375,
            "end_logit": 2.8671875,
            "text": "NOX organizing protein 1) and NOXA1",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 3.412109375,
            "end_logit": -3.2890625,
            "text": "NOX",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -0.9736328125,
            "end_logit": 0.431396484375,
            "text": "(NOX activating protein 1), as well as the flavocytochrome component p22(phox) for maximal activity.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -1.244140625,
            "end_logit": 0.431396484375,
            "text": ".",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.828125,
            "end_logit": 2.8671875,
            "text": "(NOX organizing protein 1) and NOXA1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 3.412109375,
            "end_logit": -4.96875,
            "text": "NOXA1 (NOX activating",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58a5a51060087bc10a000021_16": [
        {
            "start_logit": 6.3515625,
            "end_logit": 6.859375,
            "text": "Nox1",
            "probability": 0.54736328125
        },
        {
            "start_logit": 6.328125,
            "end_logit": 6.68359375,
            "text": "Noxa1",
            "probability": 0.450439453125
        },
        {
            "start_logit": 6.328125,
            "end_logit": 0.99462890625,
            "text": "Noxa1, respectively.",
            "probability": 0.0015192031860351562
        },
        {
            "start_logit": -2.419921875,
            "end_logit": 6.68359375,
            "text": "Noxo1 and Noxa1",
            "probability": 7.134675979614258e-05
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -2.455078125,
            "text": "Nox",
            "probability": 4.947185516357422e-05
        },
        {
            "start_logit": 6.328125,
            "end_logit": -2.568359375,
            "text": "Nox",
            "probability": 4.297494888305664e-05
        },
        {
            "start_logit": -3.291015625,
            "end_logit": 6.859375,
            "text": "1",
            "probability": 3.55839729309082e-05
        },
        {
            "start_logit": -3.724609375,
            "end_logit": 6.68359375,
            "text": "a1",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": -3.97265625,
            "end_logit": 6.68359375,
            "text": "designated Noxo1 and Noxa1",
            "probability": 1.5079975128173828e-05
        },
        {
            "start_logit": -4.03515625,
            "end_logit": 6.68359375,
            "text": "p47phox and p67phox, designated Noxo1 and Noxa1",
            "probability": 1.4185905456542969e-05
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -4.1015625,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon, requires novel proteins homologous to p47phox",
            "probability": 9.47713851928711e-06
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -4.80859375,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon, requires novel proteins homologous to p47phox and p67phox",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -5.57421875,
            "end_logit": 6.859375,
            "text": "Activation of Nox1",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -5.66796875,
            "end_logit": 6.68359375,
            "text": "and Noxa1",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -5.87109375,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon, requires novel proteins homologous to p47phox and p67",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -6.23046875,
            "text": "Nox1, an oxidase that is likely involved in host defence at the colon, requires novel proteins homologous to p4",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -6.3125,
            "text": "Nox1, an oxidase that",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.328125,
            "end_logit": -6.3828125,
            "text": "Noxa1,",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -6.4609375,
            "text": "Nox1, an oxidase",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -6.4921875,
            "text": "Nox1, an oxidase that is likely involved in host defence",
            "probability": 8.940696716308594e-07
        }
    ],
    "58a5a51060087bc10a000021_17": [
        {
            "start_logit": 0.0006103515625,
            "end_logit": 2.630859375,
            "text": "Nox Organizer 1.",
            "probability": 0.72802734375
        },
        {
            "start_logit": -1.267578125,
            "end_logit": 2.630859375,
            "text": ".",
            "probability": 0.204833984375
        },
        {
            "start_logit": -2.529296875,
            "end_logit": 2.630859375,
            "text": "NADPH oxidase 1 with betaPix and Nox Organizer 1.",
            "probability": 0.058013916015625
        },
        {
            "start_logit": 0.0006103515625,
            "end_logit": -2.869140625,
            "text": "Nox Organizer 1",
            "probability": 0.0029735565185546875
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 2.630859375,
            "text": "and Nox Organizer 1.",
            "probability": 0.0013780593872070312
        },
        {
            "start_logit": -6.82421875,
            "end_logit": 2.630859375,
            "text": "Pix and Nox Organizer 1.",
            "probability": 0.0007877349853515625
        },
        {
            "start_logit": -6.84375,
            "end_logit": 2.630859375,
            "text": "Molecular interaction of NADPH oxidase 1 with betaPix and Nox Organizer 1.",
            "probability": 0.0007758140563964844
        },
        {
            "start_logit": -6.85546875,
            "end_logit": 2.630859375,
            "text": "x and Nox Organizer 1.",
            "probability": 0.0007643699645996094
        },
        {
            "start_logit": -7.03125,
            "end_logit": 2.630859375,
            "text": "betaPix and Nox Organizer 1.",
            "probability": 0.0006432533264160156
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 2.630859375,
            "text": "1 with betaPix and Nox Organizer 1.",
            "probability": 0.000438690185546875
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 2.630859375,
            "text": "Organizer 1.",
            "probability": 0.0003635883331298828
        },
        {
            "start_logit": -7.6875,
            "end_logit": 2.630859375,
            "text": "interaction of NADPH oxidase 1 with betaPix and Nox Organizer 1.",
            "probability": 0.0003337860107421875
        },
        {
            "start_logit": 0.0006103515625,
            "end_logit": -5.31640625,
            "text": "Nox",
            "probability": 0.00025773048400878906
        },
        {
            "start_logit": -2.529296875,
            "end_logit": -2.869140625,
            "text": "NADPH oxidase 1 with betaPix and Nox Organizer 1",
            "probability": 0.00023663043975830078
        },
        {
            "start_logit": 0.0006103515625,
            "end_logit": -6.5625,
            "text": "Nox Organizer",
            "probability": 7.385015487670898e-05
        },
        {
            "start_logit": 0.0006103515625,
            "end_logit": -7.05078125,
            "text": "Nox Organize",
            "probability": 4.547834396362305e-05
        },
        {
            "start_logit": -2.529296875,
            "end_logit": -5.31640625,
            "text": "NADPH oxidase 1 with betaPix and Nox",
            "probability": 2.0503997802734375e-05
        },
        {
            "start_logit": -2.529296875,
            "end_logit": -6.140625,
            "text": "NADPH oxidase 1",
            "probability": 9.000301361083984e-06
        },
        {
            "start_logit": -2.529296875,
            "end_logit": -6.4921875,
            "text": "NADPH oxidase 1 with betaPix",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": -2.529296875,
            "end_logit": -6.5625,
            "text": "NADPH oxidase 1 with betaPix and Nox Organizer",
            "probability": 5.841255187988281e-06
        }
    ],
    "58a5a51060087bc10a000021_18": [
        {
            "start_logit": 4.11328125,
            "end_logit": 3.03125,
            "text": "NOX1)",
            "probability": 0.55322265625
        },
        {
            "start_logit": 4.11328125,
            "end_logit": 2.72265625,
            "text": "NOX1",
            "probability": 0.40625
        },
        {
            "start_logit": 4.11328125,
            "end_logit": 0.346923828125,
            "text": "NOX",
            "probability": 0.03778076171875
        },
        {
            "start_logit": 4.11328125,
            "end_logit": -3.12109375,
            "text": "NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX",
            "probability": 0.0011777877807617188
        },
        {
            "start_logit": 1.310546875,
            "end_logit": -1.4013671875,
            "text": "p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX activator 1 (NOXA1",
            "probability": 0.0003991127014160156
        },
        {
            "start_logit": 1.310546875,
            "end_logit": -1.6064453125,
            "text": "p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX activator 1 (NOXA1), and Rac1",
            "probability": 0.00032448768615722656
        },
        {
            "start_logit": -3.607421875,
            "end_logit": 3.03125,
            "text": "NADPH oxidase 1 (NOX1)",
            "probability": 0.00024580955505371094
        },
        {
            "start_logit": -3.607421875,
            "end_logit": 2.72265625,
            "text": "NADPH oxidase 1 (NOX1",
            "probability": 0.0001798868179321289
        },
        {
            "start_logit": 4.11328125,
            "end_logit": -5.6484375,
            "text": "NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX)",
            "probability": 9.40561294555664e-05
        },
        {
            "start_logit": 4.11328125,
            "end_logit": -5.91015625,
            "text": "NOX1),",
            "probability": 7.265806198120117e-05
        },
        {
            "start_logit": 1.310546875,
            "end_logit": -3.12109375,
            "text": "p22(PHOX",
            "probability": 7.152557373046875e-05
        },
        {
            "start_logit": 4.11328125,
            "end_logit": -6.078125,
            "text": "NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound",
            "probability": 6.121397018432617e-05
        },
        {
            "start_logit": -5.2890625,
            "end_logit": 3.03125,
            "text": "1)",
            "probability": 4.547834396362305e-05
        },
        {
            "start_logit": -5.2890625,
            "end_logit": 2.72265625,
            "text": "1",
            "probability": 3.355741500854492e-05
        },
        {
            "start_logit": -5.828125,
            "end_logit": 3.03125,
            "text": "(NOX1)",
            "probability": 2.676248550415039e-05
        },
        {
            "start_logit": -5.875,
            "end_logit": 3.03125,
            "text": ")",
            "probability": 2.5510787963867188e-05
        },
        {
            "start_logit": -5.828125,
            "end_logit": 2.72265625,
            "text": "(NOX1",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": -1.75390625,
            "end_logit": -1.4013671875,
            "text": "NOXA1",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": -3.607421875,
            "end_logit": 0.346923828125,
            "text": "NADPH oxidase 1 (NOX",
            "probability": 1.6689300537109375e-05
        },
        {
            "start_logit": -1.75390625,
            "end_logit": -1.6064453125,
            "text": "NOXA1), and Rac1",
            "probability": 1.52587890625e-05
        }
    ],
    "58a5a51060087bc10a000021_19": [
        {
            "start_logit": 7.14453125,
            "end_logit": 7.40625,
            "text": "NOX1",
            "probability": 0.9990234375
        },
        {
            "start_logit": 7.14453125,
            "end_logit": -0.66259765625,
            "text": "NOX",
            "probability": 0.00031495094299316406
        },
        {
            "start_logit": 2.873046875,
            "end_logit": 2.24609375,
            "text": "NOXA1",
            "probability": 8.022785186767578e-05
        },
        {
            "start_logit": -2.419921875,
            "end_logit": 7.40625,
            "text": "1",
            "probability": 7.027387619018555e-05
        },
        {
            "start_logit": 7.14453125,
            "end_logit": -2.615234375,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1)",
            "probability": 4.464387893676758e-05
        },
        {
            "start_logit": 7.14453125,
            "end_logit": -4.52734375,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein 1",
            "probability": 6.616115570068359e-06
        },
        {
            "start_logit": 7.14453125,
            "end_logit": -5.5703125,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX organizing protein",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 7.14453125,
            "end_logit": -5.7578125,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1 (NOX",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 7.14453125,
            "end_logit": -6.00390625,
            "text": "NOX1, an NADPH oxidase",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 7.14453125,
            "end_logit": -6.2265625,
            "text": "NOX1, an NADPH oxidase homologue that",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.14453125,
            "end_logit": -6.3203125,
            "text": "NOX1, an NADPH oxidase homologue that is most abundantly expressed in colon epithelial cells, requires the regulatory subunits NOXO1",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 2.873046875,
            "end_logit": -2.912109375,
            "text": "NOXA1 (NOX activating protein",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 2.873046875,
            "end_logit": -3.49609375,
            "text": "NOXA1 (NOX activating protein 1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 2.873046875,
            "end_logit": -3.666015625,
            "text": "NOX",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.099609375,
            "end_logit": 2.24609375,
            "text": "NOX organizing protein 1) and NOXA1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 2.873046875,
            "end_logit": -4.7578125,
            "text": "NOXA1 (NOX activating protein 1)",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.26171875,
            "end_logit": 2.24609375,
            "text": "(NOX organizing protein 1) and NOXA1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.421875,
            "end_logit": 2.24609375,
            "text": "NOXO1 (NOX organizing protein 1) and NOXA1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.873046875,
            "end_logit": -5.1875,
            "text": "NOXA1 (NOX activating protein 1), as well as the flavocytochrome component p22(phox",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.873046875,
            "end_logit": -5.453125,
            "text": "NOXA1 (NOX activating",
            "probability": 5.960464477539063e-08
        }
    ],
    "58a5a51060087bc10a000021_20": [
        {
            "start_logit": 8.0859375,
            "end_logit": 8.0,
            "text": "Nox1",
            "probability": 0.99609375
        },
        {
            "start_logit": 8.0859375,
            "end_logit": 2.34375,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator protein Noxa1",
            "probability": 0.0034542083740234375
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -1.1064453125,
            "text": "Nox",
            "probability": 0.00011020898818969727
        },
        {
            "start_logit": -1.70703125,
            "end_logit": 8.0,
            "text": "1",
            "probability": 5.537271499633789e-05
        },
        {
            "start_logit": 3.88671875,
            "end_logit": 2.34375,
            "text": "Noxa1",
            "probability": 5.2094459533691406e-05
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -2.966796875,
            "text": "Nox1 requires both the organizer protein Noxo1 and the activator protein Nox",
            "probability": 1.704692840576172e-05
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.45703125,
            "text": "Nox1 requires",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.7265625,
            "text": "Nox1 requires both",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.73828125,
            "text": "Nox1 requires both the organizer protein Noxo1 and the",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -6.8125,
            "text": "Nox1 requires both the organizer protein Noxo1 and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.7421875,
            "end_logit": 8.0,
            "text": "NADPH oxidase Nox1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.00390625,
            "end_logit": 8.0,
            "text": "Activation of the superoxide-producing NADPH oxidase Nox1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 3.88671875,
            "end_logit": -2.966796875,
            "text": "Nox",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.328125,
            "text": "Nox1 requires both the organizer",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0859375,
            "end_logit": -7.40625,
            "text": "Nox1 requires both the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.70703125,
            "end_logit": 2.34375,
            "text": "1 requires both the organizer protein Noxo1 and the activator protein Noxa1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.62109375,
            "end_logit": 8.0,
            "text": "of the superoxide-producing NADPH oxidase Nox1",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 8.0,
            "text": "superoxide-producing NADPH oxidase Nox1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.6328125,
            "end_logit": 2.34375,
            "text": "Noxo1 and the activator protein Noxa1",
            "probability": 0.0
        },
        {
            "start_logit": -6.453125,
            "end_logit": 2.34375,
            "text": "a1",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_21": [
        {
            "start_logit": 6.58203125,
            "end_logit": 6.1953125,
            "text": "Nox1",
            "probability": 0.9970703125
        },
        {
            "start_logit": 6.58203125,
            "end_logit": 0.246826171875,
            "text": "Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1",
            "probability": 0.002590179443359375
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -1.9599609375,
            "text": "Nox",
            "probability": 0.00028586387634277344
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -2.728515625,
            "text": "Nox1, complexed with p22(phox",
            "probability": 0.00013208389282226562
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -3.283203125,
            "text": "Nox1,",
            "probability": 7.581710815429688e-05
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -3.619140625,
            "text": "Nox1, complexed with p22(phox)",
            "probability": 5.418062210083008e-05
        },
        {
            "start_logit": -4.26953125,
            "end_logit": 6.1953125,
            "text": "1",
            "probability": 1.919269561767578e-05
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -5.78515625,
            "text": "Nox1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Nox",
            "probability": 6.258487701416016e-06
        },
        {
            "start_logit": -0.3359375,
            "end_logit": 0.246826171875,
            "text": "Noxa1",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -6.73828125,
            "text": "Nox1, complexed with p22(phox) at",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -6.80078125,
            "text": "Nox1, complexed with p22(phox) at the membrane, requires",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": -6.43359375,
            "end_logit": 6.1953125,
            "text": "NADPH oxidase Nox1",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.046875,
            "text": "Nox1, complexed with p22(phox) at the membrane,",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.58203125,
            "end_logit": -7.09375,
            "text": "Nox1, complexed with p22",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -6.75,
            "end_logit": 6.1953125,
            "text": "Activation of the non-phagocytic superoxide-producing NADPH oxidase Nox1",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 6.1953125,
            "text": "of the non-phagocytic superoxide-producing NADPH oxidase Nox1",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 6.1953125,
            "text": "phagocytic superoxide-producing NADPH oxidase Nox1",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -2.80859375,
            "end_logit": 0.246826171875,
            "text": "p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.26953125,
            "end_logit": 0.246826171875,
            "text": "1, complexed with p22(phox) at the membrane, requires its regulatory soluble proteins Noxo1 and Noxa1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.5,
            "end_logit": 0.246826171875,
            "text": "Noxo1 and Noxa1",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_22": [
        {
            "start_logit": 5.2890625,
            "end_logit": 5.25,
            "text": "Nox1",
            "probability": 0.83251953125
        },
        {
            "start_logit": 3.375,
            "end_logit": 5.25,
            "text": "NADPH oxidase 1 (Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox1",
            "probability": 0.12274169921875
        },
        {
            "start_logit": 1.69921875,
            "end_logit": 5.25,
            "text": "Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox1",
            "probability": 0.022979736328125
        },
        {
            "start_logit": 3.375,
            "end_logit": 3.15234375,
            "text": "NADPH oxidase 1 (Nox1",
            "probability": 0.01506805419921875
        },
        {
            "start_logit": 1.69921875,
            "end_logit": 3.15234375,
            "text": "Nox1",
            "probability": 0.0028209686279296875
        },
        {
            "start_logit": 5.2890625,
            "end_logit": -0.92724609375,
            "text": "Nox1 activator 1, and Rac1",
            "probability": 0.0017309188842773438
        },
        {
            "start_logit": 5.2890625,
            "end_logit": -1.1044921875,
            "text": "Nox",
            "probability": 0.0014467239379882812
        },
        {
            "start_logit": 3.375,
            "end_logit": -1.1044921875,
            "text": "NADPH oxidase 1 (Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox",
            "probability": 0.0002142190933227539
        },
        {
            "start_logit": -3.755859375,
            "end_logit": 5.25,
            "text": "NOXO1), Nox1",
            "probability": 9.804964065551758e-05
        },
        {
            "start_logit": -3.974609375,
            "end_logit": 5.25,
            "text": "p22(phox), Nox organizer 1 (NOXO1), Nox1",
            "probability": 7.873773574829102e-05
        },
        {
            "start_logit": 3.375,
            "end_logit": -2.33984375,
            "text": "NADPH oxidase 1 (Nox",
            "probability": 6.23464584350586e-05
        },
        {
            "start_logit": -4.265625,
            "end_logit": 5.25,
            "text": "(NOXO1), Nox1",
            "probability": 5.900859832763672e-05
        },
        {
            "start_logit": -4.53515625,
            "end_logit": 5.25,
            "text": "1",
            "probability": 4.488229751586914e-05
        },
        {
            "start_logit": 1.69921875,
            "end_logit": -1.1044921875,
            "text": "Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox",
            "probability": 3.987550735473633e-05
        },
        {
            "start_logit": -4.80078125,
            "end_logit": 5.25,
            "text": ", Nox1",
            "probability": 3.445148468017578e-05
        },
        {
            "start_logit": 1.69921875,
            "end_logit": -2.33984375,
            "text": "Nox",
            "probability": 1.1622905731201172e-05
        },
        {
            "start_logit": 3.375,
            "end_logit": -4.3203125,
            "text": "NADPH oxidase 1 (Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1",
            "probability": 8.58306884765625e-06
        },
        {
            "start_logit": -6.3125,
            "end_logit": 5.25,
            "text": "), Nox1",
            "probability": 7.62939453125e-06
        },
        {
            "start_logit": -6.40234375,
            "end_logit": 5.25,
            "text": "1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox1",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": -6.43359375,
            "end_logit": 5.25,
            "text": ", Nox organizer 1 (NOXO1), Nox1",
            "probability": 6.794929504394531e-06
        }
    ],
    "58a5a51060087bc10a000021_23": [
        {
            "start_logit": 5.2890625,
            "end_logit": 5.25,
            "text": "Nox1",
            "probability": 0.83251953125
        },
        {
            "start_logit": 3.375,
            "end_logit": 5.25,
            "text": "NADPH oxidase 1 (Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox1",
            "probability": 0.12274169921875
        },
        {
            "start_logit": 1.69921875,
            "end_logit": 5.25,
            "text": "Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox1",
            "probability": 0.022979736328125
        },
        {
            "start_logit": 3.375,
            "end_logit": 3.15234375,
            "text": "NADPH oxidase 1 (Nox1",
            "probability": 0.01506805419921875
        },
        {
            "start_logit": 1.69921875,
            "end_logit": 3.15234375,
            "text": "Nox1",
            "probability": 0.0028209686279296875
        },
        {
            "start_logit": 5.2890625,
            "end_logit": -0.92724609375,
            "text": "Nox1 activator 1, and Rac1",
            "probability": 0.0017309188842773438
        },
        {
            "start_logit": 5.2890625,
            "end_logit": -1.1044921875,
            "text": "Nox",
            "probability": 0.0014467239379882812
        },
        {
            "start_logit": 3.375,
            "end_logit": -1.1044921875,
            "text": "NADPH oxidase 1 (Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox",
            "probability": 0.0002142190933227539
        },
        {
            "start_logit": -3.755859375,
            "end_logit": 5.25,
            "text": "NOXO1), Nox1",
            "probability": 9.804964065551758e-05
        },
        {
            "start_logit": -3.974609375,
            "end_logit": 5.25,
            "text": "p22(phox), Nox organizer 1 (NOXO1), Nox1",
            "probability": 7.873773574829102e-05
        },
        {
            "start_logit": 3.375,
            "end_logit": -2.33984375,
            "text": "NADPH oxidase 1 (Nox",
            "probability": 6.23464584350586e-05
        },
        {
            "start_logit": -4.265625,
            "end_logit": 5.25,
            "text": "(NOXO1), Nox1",
            "probability": 5.900859832763672e-05
        },
        {
            "start_logit": -4.53515625,
            "end_logit": 5.25,
            "text": "1",
            "probability": 4.488229751586914e-05
        },
        {
            "start_logit": 1.69921875,
            "end_logit": -1.1044921875,
            "text": "Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox",
            "probability": 3.987550735473633e-05
        },
        {
            "start_logit": -4.80078125,
            "end_logit": 5.25,
            "text": ", Nox1",
            "probability": 3.445148468017578e-05
        },
        {
            "start_logit": 1.69921875,
            "end_logit": -2.33984375,
            "text": "Nox",
            "probability": 1.1622905731201172e-05
        },
        {
            "start_logit": 3.375,
            "end_logit": -4.3203125,
            "text": "NADPH oxidase 1 (Nox1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1",
            "probability": 8.58306884765625e-06
        },
        {
            "start_logit": -6.3125,
            "end_logit": 5.25,
            "text": "), Nox1",
            "probability": 7.62939453125e-06
        },
        {
            "start_logit": -6.40234375,
            "end_logit": 5.25,
            "text": "1) is a multicomponent enzyme consisting of p22(phox), Nox organizer 1 (NOXO1), Nox1",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": -6.43359375,
            "end_logit": 5.25,
            "text": ", Nox organizer 1 (NOXO1), Nox1",
            "probability": 6.794929504394531e-06
        }
    ],
    "58a5a51060087bc10a000021_24": [
        {
            "start_logit": 6.8046875,
            "end_logit": 6.66015625,
            "text": "Nox1",
            "probability": 0.9990234375
        },
        {
            "start_logit": 3.298828125,
            "end_logit": 3.130859375,
            "text": "Noxa1",
            "probability": 0.0008759498596191406
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -1.49609375,
            "text": "Nox",
            "probability": 0.0002865791320800781
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -3.71484375,
            "text": "Nox1, a member of the Nox",
            "probability": 3.1113624572753906e-05
        },
        {
            "start_logit": -3.59375,
            "end_logit": 6.66015625,
            "text": "1",
            "probability": 3.0219554901123047e-05
        },
        {
            "start_logit": -3.666015625,
            "end_logit": 6.66015625,
            "text": "Superoxide production by Nox1",
            "probability": 2.8192996978759766e-05
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -4.859375,
            "text": "Nox1, a member of the Nox family",
            "probability": 9.894371032714844e-06
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -5.578125,
            "text": "Nox1, a member of the Nox family NAPDH oxidases,",
            "probability": 4.827976226806641e-06
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -5.78125,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -5.78515625,
            "text": "Nox1, a member of the Nox family NAPDH oxidase",
            "probability": 3.933906555175781e-06
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -5.80078125,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -5.81640625,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1)",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -6.0625,
            "text": "Nox1,",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -2.611328125,
            "end_logit": 3.130859375,
            "text": "Noxo1 (Nox organizer 1) and Noxa1",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 6.8046875,
            "end_logit": -6.35546875,
            "text": "Nox1, a",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 3.298828125,
            "end_logit": -3.791015625,
            "text": "Nox",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 3.298828125,
            "end_logit": -5.19140625,
            "text": "Noxa1 (Nox",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 3.298828125,
            "end_logit": -5.69921875,
            "text": "Noxa1 (Nox activator 1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.76171875,
            "end_logit": 3.130859375,
            "text": "(Nox organizer 1) and Noxa1",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.91015625,
            "end_logit": 3.130859375,
            "text": "a1",
            "probability": 5.960464477539063e-08
        }
    ],
    "58a5a51060087bc10a000021_25": [
        {
            "start_logit": 5.8984375,
            "end_logit": 6.765625,
            "text": "NOX1",
            "probability": 0.9970703125
        },
        {
            "start_logit": 5.8984375,
            "end_logit": 0.316650390625,
            "text": "NOX",
            "probability": 0.0015773773193359375
        },
        {
            "start_logit": -2.060546875,
            "end_logit": 6.765625,
            "text": "1",
            "probability": 0.0003478527069091797
        },
        {
            "start_logit": -2.322265625,
            "end_logit": 6.765625,
            "text": "NADPH oxidase 1 (NOX1",
            "probability": 0.0002689361572265625
        },
        {
            "start_logit": -2.83984375,
            "end_logit": 6.765625,
            "text": "of NADPH oxidase 1 (NOX1",
            "probability": 0.00016045570373535156
        },
        {
            "start_logit": -4.23046875,
            "end_logit": 6.765625,
            "text": "p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1",
            "probability": 3.993511199951172e-05
        },
        {
            "start_logit": 5.8984375,
            "end_logit": -3.833984375,
            "text": "NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling and endothelial dysfunction in a streptozotocin-induced murine model of diabetes.",
            "probability": 2.47955322265625e-05
        },
        {
            "start_logit": -5.15625,
            "end_logit": 6.765625,
            "text": "(NOX1",
            "probability": 1.5735626220703125e-05
        },
        {
            "start_logit": -6.1015625,
            "end_logit": 6.765625,
            "text": "1 (NOX1",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": -6.109375,
            "end_logit": 6.765625,
            "text": "and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": -6.3671875,
            "end_logit": 6.765625,
            "text": "(NOXO1)-dependent activation of NADPH oxidase 1 (NOX1",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": -6.40234375,
            "end_logit": 6.765625,
            "text": "activation of NADPH oxidase 1 (NOX1",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": -6.49609375,
            "end_logit": 6.765625,
            "text": "NOXO1)-dependent activation of NADPH oxidase 1 (NOX1",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -6.58203125,
            "end_logit": 6.765625,
            "text": "NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1",
            "probability": 3.814697265625e-06
        },
        {
            "start_logit": -6.72265625,
            "end_logit": 6.765625,
            "text": "The p47phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1",
            "probability": 3.2782554626464844e-06
        },
        {
            "start_logit": 5.8984375,
            "end_logit": -6.375,
            "text": "NOX1)",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 6.765625,
            "text": "phox- and NADPH oxidase organiser 1 (NOXO1)-dependent activation of NADPH oxidase 1 (NOX1",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 5.8984375,
            "end_logit": -6.65234375,
            "text": "NOX1) mediates endothelial nitric oxide synthase (eNOS",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 5.8984375,
            "end_logit": -6.94140625,
            "text": "NOX1) mediates endothelial nitric oxide synthase (eNOS) uncoupling",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 5.8984375,
            "end_logit": -7.07421875,
            "text": "NOX1) mediates endothelial nitric oxide synthase",
            "probability": 9.5367431640625e-07
        }
    ],
    "58a5a51060087bc10a000021_26": [
        {
            "start_logit": 8.2578125,
            "end_logit": 8.140625,
            "text": "NOX1",
            "probability": 0.2088623046875
        },
        {
            "start_logit": 8.2578125,
            "end_logit": 8.125,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOXA1",
            "probability": 0.202392578125
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 8.140625,
            "text": "NOXA1",
            "probability": 0.1961669921875
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 8.140625,
            "text": "NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1",
            "probability": 0.1961669921875
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 8.125,
            "text": "NOXA1",
            "probability": 0.1961669921875
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -0.7666015625,
            "text": "NOX",
            "probability": 2.8073787689208984e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -0.87646484375,
            "text": "NOX1 was absolutely required for activation with NOXO1 and NOX",
            "probability": 2.5153160095214844e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -0.8466796875,
            "text": "NOX",
            "probability": 2.4616718292236328e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -0.8466796875,
            "text": "NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOX",
            "probability": 2.4616718292236328e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -0.87646484375,
            "text": "NOX",
            "probability": 2.4020671844482422e-05
        },
        {
            "start_logit": -0.96630859375,
            "end_logit": 8.140625,
            "text": "1",
            "probability": 2.0384788513183594e-05
        },
        {
            "start_logit": -0.96630859375,
            "end_logit": 8.125,
            "text": "1 was absolutely required for activation with NOXO1 and NOXA1",
            "probability": 2.008676528930664e-05
        },
        {
            "start_logit": -0.984375,
            "end_logit": 8.140625,
            "text": "A1",
            "probability": 2.008676528930664e-05
        },
        {
            "start_logit": -1.08203125,
            "end_logit": 8.140625,
            "text": "A1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1",
            "probability": 1.8298625946044922e-05
        },
        {
            "start_logit": -1.08203125,
            "end_logit": 8.125,
            "text": "A1",
            "probability": 1.800060272216797e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -2.693359375,
            "text": "NOXA1.",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -2.693359375,
            "text": "NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1.",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": -3.486328125,
            "end_logit": 8.140625,
            "text": "NOXO1 and NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -3.486328125,
            "end_logit": 8.125,
            "text": "NOXO1 and NOXA1",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -4.55078125,
            "end_logit": 8.140625,
            "text": "and NOXA1 and that this activity required interaction of the putative NADPH-binding region of this domain with NOXA1",
            "probability": 5.960464477539062e-07
        }
    ],
    "58a5a51060087bc10a000021_27": [
        {
            "start_logit": 8.0546875,
            "end_logit": 7.765625,
            "text": "Nox1",
            "probability": 0.9892578125
        },
        {
            "start_logit": 8.0546875,
            "end_logit": 3.1796875,
            "text": "Nox1.",
            "probability": 0.0100860595703125
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -0.5068359375,
            "text": "Nox",
            "probability": 0.0002524852752685547
        },
        {
            "start_logit": -2.09375,
            "end_logit": 7.765625,
            "text": "1",
            "probability": 3.8743019104003906e-05
        },
        {
            "start_logit": -4.58203125,
            "end_logit": 7.765625,
            "text": "NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -4.6015625,
            "end_logit": 7.765625,
            "text": "(NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -0.96923828125,
            "end_logit": 3.1796875,
            "text": ".",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -5.7734375,
            "end_logit": 7.765625,
            "text": "with Nox organizer 1 (NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -6.15234375,
            "end_logit": 7.765625,
            "text": "regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.16796875,
            "end_logit": 7.765625,
            "text": "conjunction with Nox organizer 1 (NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.25390625,
            "end_logit": 7.765625,
            "text": "the NADPH oxidase Nox1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.5078125,
            "end_logit": 7.765625,
            "text": ") to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -2.09375,
            "end_logit": 3.1796875,
            "text": "1.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.7109375,
            "end_logit": 7.765625,
            "text": "NADPH oxidase Nox1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.875,
            "end_logit": 7.765625,
            "text": "acts in conjunction with Nox organizer 1 (NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -4.58203125,
            "end_logit": 3.1796875,
            "text": "NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -4.6015625,
            "end_logit": 3.1796875,
            "text": "(NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -5.7734375,
            "end_logit": 3.1796875,
            "text": "with Nox organizer 1 (NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1.",
            "probability": 0.0
        },
        {
            "start_logit": -6.15234375,
            "end_logit": 3.1796875,
            "text": "regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1.",
            "probability": 0.0
        },
        {
            "start_logit": -6.16796875,
            "end_logit": 3.1796875,
            "text": "conjunction with Nox organizer 1 (NoxO1) to regulate reactive oxygen species (ROS) production by the NADPH oxidase Nox1.",
            "probability": 0.0
        }
    ],
    "58a5a51060087bc10a000021_28": [
        {
            "start_logit": 7.5234375,
            "end_logit": 7.81640625,
            "text": "NoxA1",
            "probability": 0.76416015625
        },
        {
            "start_logit": 6.30078125,
            "end_logit": 7.81640625,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator subunit NoxA1",
            "probability": 0.22412109375
        },
        {
            "start_logit": 6.30078125,
            "end_logit": 4.859375,
            "text": "Nox1",
            "probability": 0.01160430908203125
        },
        {
            "start_logit": 7.5234375,
            "end_logit": -0.8857421875,
            "text": "NoxA1, as well as the binding of Rac1 GTPase, for its activity.",
            "probability": 0.00012695789337158203
        },
        {
            "start_logit": 7.5234375,
            "end_logit": -1.5439453125,
            "text": "Nox",
            "probability": 6.580352783203125e-05
        },
        {
            "start_logit": -1.916015625,
            "end_logit": 7.81640625,
            "text": "A1",
            "probability": 6.03795051574707e-05
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -1.5439453125,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator subunit Nox",
            "probability": 1.9311904907226562e-05
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -1.837890625,
            "text": "Nox",
            "probability": 1.436471939086914e-05
        },
        {
            "start_logit": -3.78125,
            "end_logit": 7.81640625,
            "text": "NoxO1 and the activator subunit NoxA1",
            "probability": 9.357929229736328e-06
        },
        {
            "start_logit": -5.4375,
            "end_logit": 7.81640625,
            "text": "1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator subunit NoxA1",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 7.5234375,
            "end_logit": -5.7890625,
            "text": "NoxA1, as well as the binding of Rac1",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.30078125,
            "end_logit": 7.81640625,
            "text": "subunit NoxA1",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.55078125,
            "end_logit": 7.81640625,
            "text": "subunit NoxO1 and the activator subunit NoxA1",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.5234375,
            "end_logit": -6.7265625,
            "text": "NoxA1, as well as the binding of Rac1 GTPase",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 7.81640625,
            "text": "organizer subunit NoxO1 and the activator subunit NoxA1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 7.81640625,
            "text": "colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and the activator subunit NoxA1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -6.41015625,
            "text": "Nox1 is highly expressed in the colon, and requires two cytosolic regulators, the organizer subunit NoxO1 and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -6.421875,
            "text": "Nox1 is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -6.421875,
            "text": "Nox1 is highly expressed in the colon, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -6.5234375,
            "text": "Nox1 is highly expressed in the colon,",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58a5a51060087bc10a000021_29": [
        {
            "start_logit": 7.734375,
            "end_logit": 7.91015625,
            "text": "NoxA1",
            "probability": 0.8798828125
        },
        {
            "start_logit": 5.73046875,
            "end_logit": 7.91015625,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1",
            "probability": 0.11907958984375
        },
        {
            "start_logit": 7.734375,
            "end_logit": 0.59912109375,
            "text": "NoxA1, as well as the binding of Rac1 GTPase, for its activity.",
            "probability": 0.000591278076171875
        },
        {
            "start_logit": 5.73046875,
            "end_logit": 2.19921875,
            "text": "Nox1",
            "probability": 0.0003941059112548828
        },
        {
            "start_logit": 7.734375,
            "end_logit": -1.2421875,
            "text": "Nox",
            "probability": 9.357929229736328e-05
        },
        {
            "start_logit": -1.73828125,
            "end_logit": 7.91015625,
            "text": "A1",
            "probability": 6.794929504394531e-05
        },
        {
            "start_logit": -2.7890625,
            "end_logit": 7.91015625,
            "text": "NoxO1 and NoxA1",
            "probability": 2.384185791015625e-05
        },
        {
            "start_logit": 5.73046875,
            "end_logit": -1.2421875,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and Nox",
            "probability": 1.2576580047607422e-05
        },
        {
            "start_logit": 5.73046875,
            "end_logit": -2.248046875,
            "text": "Nox",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": 7.734375,
            "end_logit": -4.953125,
            "text": "NoxA1, as well as the binding of Rac1",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -5.7265625,
            "end_logit": 7.91015625,
            "text": "and NoxA1",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.28515625,
            "end_logit": 7.91015625,
            "text": ", NoxO1 and NoxA1",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -6.4921875,
            "text": "NoxA1, as well as the binding of Rac1 GTPase",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 7.91015625,
            "text": "1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 5.73046875,
            "end_logit": -4.953125,
            "text": "Nox1 is highly expressed in the colon, and it requires two cytosolic regulators, NoxO1 and NoxA1, as well as the binding of Rac1",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -6.98828125,
            "text": "NoxA1, as well as the binding of Rac1 GTPase, for",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 7.91015625,
            "text": ", and it requires two cytosolic regulators, NoxO1 and NoxA1",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.06640625,
            "text": "NoxA1, as well as the binding of Rac1 GTPase,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.734375,
            "end_logit": -7.10546875,
            "text": "NoxA1, as well as the binding of Rac1 GTPase, for its",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 7.91015625,
            "text": "O1 and NoxA1",
            "probability": 2.384185791015625e-07
        }
    ],
    "58a5a51060087bc10a000021_30": [
        {
            "start_logit": 4.76953125,
            "end_logit": 3.5234375,
            "text": "NOX1)",
            "probability": 0.4951171875
        },
        {
            "start_logit": 4.76953125,
            "end_logit": 3.505859375,
            "text": "NOX1",
            "probability": 0.48388671875
        },
        {
            "start_logit": 4.76953125,
            "end_logit": -0.034881591796875,
            "text": "NOX",
            "probability": 0.01404571533203125
        },
        {
            "start_logit": -0.80859375,
            "end_logit": 3.5234375,
            "text": "NADPH oxidase 1 (NOX1)",
            "probability": 0.0018644332885742188
        },
        {
            "start_logit": -0.80859375,
            "end_logit": 3.505859375,
            "text": "NADPH oxidase 1 (NOX1",
            "probability": 0.0018281936645507812
        },
        {
            "start_logit": 0.447998046875,
            "end_logit": 2.005859375,
            "text": "p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX activator 1 (NOXA1), and Rac1.",
            "probability": 0.001434326171875
        },
        {
            "start_logit": -0.11572265625,
            "end_logit": 2.005859375,
            "text": ".",
            "probability": 0.0008172988891601562
        },
        {
            "start_logit": -1.123046875,
            "end_logit": 2.005859375,
            "text": "NOXA1), and Rac1.",
            "probability": 0.00029850006103515625
        },
        {
            "start_logit": 4.76953125,
            "end_logit": -4.0234375,
            "text": "NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX",
            "probability": 0.0002601146697998047
        },
        {
            "start_logit": 0.447998046875,
            "end_logit": -0.332763671875,
            "text": "p22(PHOX) and the cytosolic partners NOX organizer 1 (NOXO1), NOX activator 1 (NOXA1",
            "probability": 0.00013887882232666016
        },
        {
            "start_logit": -0.80859375,
            "end_logit": -0.034881591796875,
            "text": "NADPH oxidase 1 (NOX",
            "probability": 5.310773849487305e-05
        },
        {
            "start_logit": 4.76953125,
            "end_logit": -5.73046875,
            "text": "NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound component p22(PHOX)",
            "probability": 4.7206878662109375e-05
        },
        {
            "start_logit": -4.5859375,
            "end_logit": 3.5234375,
            "text": "1)",
            "probability": 4.267692565917969e-05
        },
        {
            "start_logit": -4.5859375,
            "end_logit": 3.505859375,
            "text": "1",
            "probability": 4.202127456665039e-05
        },
        {
            "start_logit": 4.76953125,
            "end_logit": -5.8671875,
            "text": "NOX1),",
            "probability": 4.1365623474121094e-05
        },
        {
            "start_logit": 4.76953125,
            "end_logit": -6.19140625,
            "text": "NOX1), which is mainly expressed in colon epithelial cells, requires the membrane-bound",
            "probability": 2.9802322387695312e-05
        },
        {
            "start_logit": -1.123046875,
            "end_logit": -0.332763671875,
            "text": "NOXA1",
            "probability": 2.8848648071289062e-05
        },
        {
            "start_logit": -3.78515625,
            "end_logit": 2.005859375,
            "text": ", NOX activator 1 (NOXA1), and Rac1.",
            "probability": 2.0802021026611328e-05
        },
        {
            "start_logit": -5.3203125,
            "end_logit": 3.5234375,
            "text": ")",
            "probability": 2.0503997802734375e-05
        },
        {
            "start_logit": -5.38671875,
            "end_logit": 3.5234375,
            "text": "(NOX1)",
            "probability": 1.9252300262451172e-05
        }
    ],
    "58a5a51060087bc10a000021_31": [
        {
            "start_logit": 5.1171875,
            "end_logit": 3.95703125,
            "text": "Nox1",
            "probability": 0.89990234375
        },
        {
            "start_logit": 3.90625,
            "end_logit": 2.943359375,
            "text": "Noxa1",
            "probability": 0.09710693359375
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -2.244140625,
            "text": "Nox",
            "probability": 0.0018205642700195312
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -4.43359375,
            "text": "Nox1, a member of the Nox",
            "probability": 0.00020420551300048828
        },
        {
            "start_logit": 3.90625,
            "end_logit": -3.498046875,
            "text": "Nox",
            "probability": 0.00015413761138916016
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -4.890625,
            "text": "Nox1, a member of the Nox family",
            "probability": 0.00012886524200439453
        },
        {
            "start_logit": -3.01953125,
            "end_logit": 2.943359375,
            "text": "Noxo1 (Nox organizer 1) and Noxa1",
            "probability": 9.500980377197266e-05
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -5.328125,
            "text": "Nox1, a member of the Nox family NAPDH oxidase",
            "probability": 8.320808410644531e-05
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -5.3828125,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1)",
            "probability": 7.873773574829102e-05
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -5.46875,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1",
            "probability": 7.224082946777344e-05
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -5.59375,
            "text": "Nox1, a member of the Nox family NAPDH oxidases,",
            "probability": 6.377696990966797e-05
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -5.890625,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox",
            "probability": 4.738569259643555e-05
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -6.09375,
            "text": "Nox1, a member of the Nox family NAPDH oxidases",
            "probability": 3.8683414459228516e-05
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -6.203125,
            "text": "Nox1,",
            "probability": 3.463029861450195e-05
        },
        {
            "start_logit": -5.13671875,
            "end_logit": 3.95703125,
            "text": "Superoxide production by Nox1",
            "probability": 3.159046173095703e-05
        },
        {
            "start_logit": 3.90625,
            "end_logit": -5.10546875,
            "text": "Noxa1 (Nox",
            "probability": 3.081560134887695e-05
        },
        {
            "start_logit": 5.1171875,
            "end_logit": -6.390625,
            "text": "Nox1, a member of the Nox family NAPDH oxidases, requires expression of its regulatory soluble proteins Noxo1 (Nox organizer 1",
            "probability": 2.872943878173828e-05
        },
        {
            "start_logit": -5.6015625,
            "end_logit": 3.95703125,
            "text": "1",
            "probability": 1.990795135498047e-05
        },
        {
            "start_logit": 3.90625,
            "end_logit": -5.80859375,
            "text": "Noxa1 (Nox activator 1",
            "probability": 1.52587890625e-05
        },
        {
            "start_logit": -5.75,
            "end_logit": 2.943359375,
            "text": ") and Noxa1",
            "probability": 6.198883056640625e-06
        }
    ],
    "58e7902b3e8b6dc87c000007_1": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.140625,
            "text": "IFN signature",
            "probability": 1.0
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.283203125,
            "text": "IFN",
            "probability": 8.094310760498047e-05
        },
        {
            "start_logit": -1.2265625,
            "end_logit": 8.140625,
            "text": "signature",
            "probability": 8.028745651245117e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.6484375,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.109375,
            "end_logit": 8.140625,
            "text": "five gene type I IFN signature",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.2109375,
            "end_logit": 8.140625,
            "text": "type I IFN signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5078125,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.515625,
            "text": "IFN signature was",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.515625,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 8.140625,
            "text": "A five gene type I IFN signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.140625,
            "text": "gene type I IFN signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.59375,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.6328125,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in the peripheral blood and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.63671875,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in the peripheral blood and disease",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.66015625,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in the peripheral blood",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.6796875,
            "text": "IFN signature was assessed in these subjects to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.6953125,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN pathway in the peripheral blood and disease-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.703125,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.70703125,
            "text": "IFN signature was assessed in these subjects to identify subpopulations showing both activation and concordance of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.2265625,
            "end_logit": -6.6484375,
            "text": "signature was assessed in these subjects to identify subpopulations showing both activation and concordance of the type I IFN",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_2": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.171875,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": -1.130859375,
            "end_logit": 8.171875,
            "text": "signature",
            "probability": 8.821487426757812e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.2333984375,
            "text": "interferon",
            "probability": 8.285045623779297e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.44921875,
            "text": "interferon signature similar to but less intense than that",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.47265625,
            "text": "interferon signature similar",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.5,
            "text": "interferon signature similar to but less intense than that seen in patients with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.50390625,
            "text": "interferon signature similar to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.51171875,
            "text": "interferon signature similar to but",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.58203125,
            "text": "interferon signature similar to but less intense than",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.58984375,
            "text": "interferon signature similar to but less intense than that seen",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.609375,
            "text": "interferon signature similar to but less intense than that seen in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.609375,
            "text": "interferon signature similar to but less intense than that seen in patients with lupus.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.62109375,
            "text": "interferon signature similar to but less intense than that seen in patients with lupus",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 8.171875,
            "text": "demonstrate an interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 8.171875,
            "text": "peripheral blood cells from patients with rheumatoid arthritis and multiple sclerosis demonstrate an interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 8.171875,
            "text": "Gene expression analysis of peripheral blood cells from patients with rheumatoid arthritis and multiple sclerosis demonstrate an interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 8.171875,
            "text": "sclerosis demonstrate an interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 8.171875,
            "text": "cells from patients with rheumatoid arthritis and multiple sclerosis demonstrate an interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 8.171875,
            "text": "blood cells from patients with rheumatoid arthritis and multiple sclerosis demonstrate an interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 8.171875,
            "text": "analysis of peripheral blood cells from patients with rheumatoid arthritis and multiple sclerosis demonstrate an interferon signature",
            "probability": 1.1920928955078125e-07
        }
    ],
    "58e7902b3e8b6dc87c000007_3": [
        {
            "start_logit": 8.1875,
            "end_logit": 8.125,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": 8.1875,
            "end_logit": -1.3115234375,
            "text": "interferon",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": -1.314453125,
            "end_logit": 8.125,
            "text": "signature",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 8.125,
            "text": "interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.39453125,
            "end_logit": 8.125,
            "text": "termed the interferon signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 8.125,
            "text": "the interferon signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 8.125,
            "text": ", and a fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 8.125,
            "text": ", psoriasis, and a fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 8.125,
            "text": "fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 8.125,
            "text": "specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 8.125,
            "text": "omyositis, psoriasis, and a fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.32421875,
            "end_logit": -1.3115234375,
            "text": "interferon-dependent genes in their leukocytes, termed the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.39453125,
            "end_logit": -1.3115234375,
            "text": "termed the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -1.3115234375,
            "text": "the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.7265625,
            "end_logit": -1.3115234375,
            "text": ", and a fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.83984375,
            "end_logit": -1.3115234375,
            "text": ", psoriasis, and a fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.86328125,
            "end_logit": -1.3115234375,
            "text": "fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -1.3115234375,
            "text": "specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -1.3115234375,
            "text": "dermatomyositis, psoriasis, and a fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.9375,
            "end_logit": -1.3115234375,
            "text": "omyositis, psoriasis, and a fraction of patients with rheumatoid arthritis display a specific expression pattern of interferon-dependent genes in their leukocytes, termed the interferon",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_4": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.1171875,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.2216796875,
            "text": "interferon",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": -1.3203125,
            "end_logit": 8.1171875,
            "text": "signature",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": -7.11328125,
            "end_logit": 8.1171875,
            "text": "have led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon signature",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 8.1171875,
            "text": "led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.1171875,
            "text": ". interferon signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.546875,
            "text": "interferon signature in lupus).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.45703125,
            "end_logit": 8.1171875,
            "text": ", have led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon signature",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.578125,
            "text": "interferon signature in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.6953125,
            "text": "interferon signature in lupus)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 8.1171875,
            "text": "with autoimmune disorders, have led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.11328125,
            "end_logit": -1.2216796875,
            "text": "have led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -1.2216796875,
            "text": "led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.43359375,
            "end_logit": -1.2216796875,
            "text": ". interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.45703125,
            "end_logit": -1.2216796875,
            "text": ", have led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon",
            "probability": 0.0
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.546875,
            "text": "signature in lupus).",
            "probability": 0.0
        },
        {
            "start_logit": -7.65625,
            "end_logit": -1.2216796875,
            "text": "with autoimmune disorders, have led to the identification of gene signatures associated with the activation of specific pathways in these diseases (e.g. interferon",
            "probability": 0.0
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.578125,
            "text": "signature in",
            "probability": 0.0
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.6953125,
            "text": "signature in lupus)",
            "probability": 0.0
        },
        {
            "start_logit": -6.296875,
            "end_logit": -7.546875,
            "text": ".",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_5": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.15625,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.1728515625,
            "text": "interferon",
            "probability": 8.958578109741211e-05
        },
        {
            "start_logit": -1.220703125,
            "end_logit": 8.15625,
            "text": "signature",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": -5.6015625,
            "end_logit": 8.15625,
            "text": "type I interferon signature",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.62109375,
            "text": "interferon signature and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.703125,
            "text": "interferon signature and the response to rituximab in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.72265625,
            "text": "interferon signature and the response to rituximab",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.7421875,
            "text": "interferon signature and the response to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 8.15625,
            "text": "Relationship between the type I interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.15625,
            "text": "the type I interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 8.15625,
            "text": "between the type I interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.6015625,
            "end_logit": -1.1728515625,
            "text": "type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -1.220703125,
            "end_logit": -7.62109375,
            "text": "signature and",
            "probability": 0.0
        },
        {
            "start_logit": -1.220703125,
            "end_logit": -7.703125,
            "text": "signature and the response to rituximab in",
            "probability": 0.0
        },
        {
            "start_logit": -7.75,
            "end_logit": -1.1728515625,
            "text": "Relationship between the type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -1.220703125,
            "end_logit": -7.72265625,
            "text": "signature and the response to rituximab",
            "probability": 0.0
        },
        {
            "start_logit": -1.220703125,
            "end_logit": -7.7421875,
            "text": "signature and the response to",
            "probability": 0.0
        },
        {
            "start_logit": -7.859375,
            "end_logit": -1.1728515625,
            "text": "the type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.94921875,
            "end_logit": -1.1728515625,
            "text": "between the type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -5.6015625,
            "end_logit": -6.4765625,
            "text": "type I",
            "probability": 0.0
        }
    ],
    "58e7902b3e8b6dc87c000007_6": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.125,
            "text": "interferon signature",
            "probability": 1.0
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.15625,
            "text": "interferon",
            "probability": 9.387731552124023e-05
        },
        {
            "start_logit": -1.306640625,
            "end_logit": 8.125,
            "text": "signature",
            "probability": 7.31348991394043e-05
        },
        {
            "start_logit": -6.5546875,
            "end_logit": 8.125,
            "text": "type I interferon signature",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.609375,
            "text": "interferon signature in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 8.125,
            "text": "the type I interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 8.125,
            "text": "application to the type I interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 8.125,
            "text": "to the type I interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 8.125,
            "text": "Importance of correlation between gene expression levels: application to the type I interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 8.125,
            "text": ": application to the type I interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 8.125,
            "text": "gene expression levels: application to the type I interferon signature",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.5546875,
            "end_logit": -1.15625,
            "text": "type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.5859375,
            "end_logit": -1.15625,
            "text": "the type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -1.15625,
            "text": "application to the type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -1.306640625,
            "end_logit": -7.609375,
            "text": "signature in",
            "probability": 0.0
        },
        {
            "start_logit": -7.80078125,
            "end_logit": -1.15625,
            "text": "to the type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.86328125,
            "end_logit": -1.15625,
            "text": "Importance of correlation between gene expression levels: application to the type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.89453125,
            "end_logit": -1.15625,
            "text": ": application to the type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": -1.15625,
            "text": "gene expression levels: application to the type I interferon",
            "probability": 0.0
        },
        {
            "start_logit": -6.5546875,
            "end_logit": -7.09375,
            "text": "type I",
            "probability": 0.0
        }
    ],
    "517170c48ed59a060a00000d_1": [
        {
            "start_logit": 6.55078125,
            "end_logit": 6.4765625,
            "text": "25",
            "probability": 1.0
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -6.68359375,
            "text": "25 selenoproteins",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -6.78125,
            "end_logit": 6.4765625,
            "text": "The human selenoproteome consists of 25",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.234375,
            "end_logit": 6.4765625,
            "text": "selenoproteome consists of 25",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.5546875,
            "text": "25 selenoproteins.",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.55078125,
            "end_logit": -7.72265625,
            "text": "25 selen",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 6.4765625,
            "text": "consists of 25",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 6.4765625,
            "text": "human selenoproteome consists of 25",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.4765625,
            "text": "oproteome consists of 25",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 6.4765625,
            "text": "of 25",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.71875,
            "end_logit": -6.68359375,
            "text": "selenoproteins",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -6.68359375,
            "text": "The human selenoproteome consists of 25 selenoproteins",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -6.98828125,
            "text": "The human selenoproteome consists of",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -6.68359375,
            "text": "selenoproteome consists of 25 selenoproteins",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -7.3203125,
            "text": "The human selenoproteome",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -7.43359375,
            "text": "The human selenoproteome consists",
            "probability": 0.0
        },
        {
            "start_logit": -7.234375,
            "end_logit": -6.98828125,
            "text": "selenoproteome consists of",
            "probability": 0.0
        },
        {
            "start_logit": -6.71875,
            "end_logit": -7.5546875,
            "text": "selenoproteins.",
            "probability": 0.0
        },
        {
            "start_logit": -6.78125,
            "end_logit": -7.5546875,
            "text": "The human selenoproteome consists of 25 selenoproteins.",
            "probability": 0.0
        },
        {
            "start_logit": -7.66796875,
            "end_logit": -6.68359375,
            "text": "consists of 25 selenoproteins",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_1": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.1640625,
            "text": "XXY",
            "probability": 1.0
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.224609375,
            "text": "XX",
            "probability": 8.416175842285156e-05
        },
        {
            "start_logit": -1.173828125,
            "end_logit": 8.1640625,
            "text": "Y",
            "probability": 8.416175842285156e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.2265625,
            "text": "XXY)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 8.1640625,
            "text": "Klinefelter syndrome (XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 8.1640625,
            "text": "(XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 8.1640625,
            "text": "inefelter syndrome (XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 8.1640625,
            "text": "felter syndrome (XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 8.1640625,
            "text": "lter syndrome (XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 8.1640625,
            "text": "syndrome (XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.173828125,
            "end_logit": -7.2265625,
            "text": "Y)",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -1.224609375,
            "text": "Klinefelter syndrome (XX",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -1.224609375,
            "text": "(XX",
            "probability": 0.0
        },
        {
            "start_logit": -7.6953125,
            "end_logit": -1.224609375,
            "text": "inefelter syndrome (XX",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -1.224609375,
            "text": "felter syndrome (XX",
            "probability": 0.0
        },
        {
            "start_logit": -7.89453125,
            "end_logit": -1.224609375,
            "text": "lter syndrome (XX",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": -1.224609375,
            "text": "syndrome (XX",
            "probability": 0.0
        },
        {
            "start_logit": -7.58203125,
            "end_logit": -7.2265625,
            "text": "Klinefelter syndrome (XXY)",
            "probability": 0.0
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -7.2265625,
            "text": "(XXY)",
            "probability": 0.0
        },
        {
            "start_logit": -7.66796875,
            "end_logit": -7.2265625,
            "text": ")",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_2": [
        {
            "start_logit": 6.83984375,
            "end_logit": 8.0625,
            "text": "47,XXY",
            "probability": 0.63232421875
        },
        {
            "start_logit": 6.0234375,
            "end_logit": 8.0625,
            "text": "X chromosome (47,XXY or Klinefelter syndrome). 47,XXY",
            "probability": 0.2783203125
        },
        {
            "start_logit": 6.0234375,
            "end_logit": 6.890625,
            "text": "X",
            "probability": 0.086181640625
        },
        {
            "start_logit": 6.0234375,
            "end_logit": 3.3203125,
            "text": "X chromosome (47,XXY",
            "probability": 0.0024261474609375
        },
        {
            "start_logit": -0.5009765625,
            "end_logit": 8.0625,
            "text": "47,XXY or Klinefelter syndrome). 47,XXY",
            "probability": 0.0004086494445800781
        },
        {
            "start_logit": -0.7890625,
            "end_logit": 8.0625,
            "text": "Y",
            "probability": 0.00030612945556640625
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -3.1875,
            "text": "47",
            "probability": 8.225440979003906e-06
        },
        {
            "start_logit": 6.0234375,
            "end_logit": -3.1875,
            "text": "X chromosome (47,XXY or Klinefelter syndrome). 47",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -0.5009765625,
            "end_logit": 3.3203125,
            "text": "47,XXY",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -5.4375,
            "end_logit": 8.0625,
            "text": "XXY or Klinefelter syndrome). 47,XXY",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -4.29296875,
            "text": "47,XX",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -5.88671875,
            "end_logit": 8.0625,
            "text": "Y or Klinefelter syndrome). 47,XXY",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -6.05078125,
            "end_logit": 8.0625,
            "text": "extra X chromosome (47,XXY or Klinefelter syndrome). 47,XXY",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.21875,
            "end_logit": 8.0625,
            "text": "XXY",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.0234375,
            "end_logit": -4.29296875,
            "text": "X chromosome (47,XXY or Klinefelter syndrome). 47,XX",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -6.671875,
            "end_logit": 8.0625,
            "text": ",XXY or Klinefelter syndrome). 47,XXY",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.984375,
            "end_logit": 8.0625,
            "text": ". 47,XXY",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.05078125,
            "end_logit": 6.890625,
            "text": "extra X",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 8.0625,
            "text": ",XXY",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.0625,
            "text": "). 47,XXY",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5e669e0e1af46fc130000019_3": [
        {
            "start_logit": 6.83984375,
            "end_logit": 8.0625,
            "text": "47,XXY",
            "probability": 0.63232421875
        },
        {
            "start_logit": 6.0234375,
            "end_logit": 8.0625,
            "text": "X chromosome (47,XXY or Klinefelter syndrome). 47,XXY",
            "probability": 0.2783203125
        },
        {
            "start_logit": 6.0234375,
            "end_logit": 6.890625,
            "text": "X",
            "probability": 0.086181640625
        },
        {
            "start_logit": 6.0234375,
            "end_logit": 3.3203125,
            "text": "X chromosome (47,XXY",
            "probability": 0.0024261474609375
        },
        {
            "start_logit": -0.5009765625,
            "end_logit": 8.0625,
            "text": "47,XXY or Klinefelter syndrome). 47,XXY",
            "probability": 0.0004086494445800781
        },
        {
            "start_logit": -0.7890625,
            "end_logit": 8.0625,
            "text": "Y",
            "probability": 0.00030612945556640625
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -3.1875,
            "text": "47",
            "probability": 8.225440979003906e-06
        },
        {
            "start_logit": 6.0234375,
            "end_logit": -3.1875,
            "text": "X chromosome (47,XXY or Klinefelter syndrome). 47",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -0.5009765625,
            "end_logit": 3.3203125,
            "text": "47,XXY",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -5.4375,
            "end_logit": 8.0625,
            "text": "XXY or Klinefelter syndrome). 47,XXY",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 6.83984375,
            "end_logit": -4.29296875,
            "text": "47,XX",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -5.88671875,
            "end_logit": 8.0625,
            "text": "Y or Klinefelter syndrome). 47,XXY",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -6.05078125,
            "end_logit": 8.0625,
            "text": "extra X chromosome (47,XXY or Klinefelter syndrome). 47,XXY",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -6.21875,
            "end_logit": 8.0625,
            "text": "XXY",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.0234375,
            "end_logit": -4.29296875,
            "text": "X chromosome (47,XXY or Klinefelter syndrome). 47,XX",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -6.671875,
            "end_logit": 8.0625,
            "text": ",XXY or Klinefelter syndrome). 47,XXY",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.984375,
            "end_logit": 8.0625,
            "text": ". 47,XXY",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.05078125,
            "end_logit": 6.890625,
            "text": "extra X",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 8.0625,
            "text": ",XXY",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.0625,
            "text": "). 47,XXY",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5e669e0e1af46fc130000019_4": [
        {
            "start_logit": 6.34375,
            "end_logit": 6.6875,
            "text": "X",
            "probability": 1.0
        },
        {
            "start_logit": 6.34375,
            "end_logit": -1.615234375,
            "text": "X chromosome in males (47,XXY",
            "probability": 0.0002472400665283203
        },
        {
            "start_logit": 6.34375,
            "end_logit": -4.9296875,
            "text": "X chromosome in males (47,XX",
            "probability": 9.000301361083984e-06
        },
        {
            "start_logit": -5.7890625,
            "end_logit": 6.6875,
            "text": "additional X",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": 6.34375,
            "end_logit": -6.78515625,
            "text": "X chromosome",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.34375,
            "end_logit": -6.90625,
            "text": "X chromosome in",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 6.6875,
            "text": ", Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.09765625,
            "text": "X chromosome in males (47,XXY), and the characteristic clinical findings include tall stature, immaturity of external genitalia, testicular dysfunction.",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 6.6875,
            "text": "Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.10546875,
            "text": "X chromosome in males (47,XXY)",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.46875,
            "end_logit": 6.6875,
            "text": "well recognized chromosomal abnormality caused by an additional X",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 6.6875,
            "text": "On the other hand, Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 6.6875,
            "text": "hand, Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 6.6875,
            "text": "the other hand, Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.3671875,
            "text": "X chromosome in males (47,XXY),",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.38671875,
            "text": "X chromosome in males (47",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 6.6875,
            "text": "inefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 6.6875,
            "text": "is well recognized chromosomal abnormality caused by an additional X",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.625,
            "text": "X chromosome in males (47,XXY), and",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.75,
            "text": "X chromosome in males (47,XXY), and the characteristic clinical findings",
            "probability": 5.364418029785156e-07
        }
    ],
    "5e669e0e1af46fc130000019_5": [
        {
            "start_logit": 8.15625,
            "end_logit": 8.2109375,
            "text": "47, XXY",
            "probability": 1.0
        },
        {
            "start_logit": -1.0185546875,
            "end_logit": 8.2109375,
            "text": "Y",
            "probability": 0.00010228157043457031
        },
        {
            "start_logit": 8.15625,
            "end_logit": -1.521484375,
            "text": "47",
            "probability": 5.8770179748535156e-05
        },
        {
            "start_logit": -5.95703125,
            "end_logit": 8.2109375,
            "text": ", XXY",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.109375,
            "end_logit": 8.2109375,
            "text": "XXY",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -6.44140625,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondisjunction.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -6.98046875,
            "text": "47, XX",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.1953125,
            "text": "47, XXY; the extra sex chromosome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.4296875,
            "text": "47, XXY; the extra sex chromosome is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.48046875,
            "text": "47, XXY; the extra sex chromosome is due to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.54296875,
            "end_logit": 8.2109375,
            "text": "The formal cytogenetic designation for Klinefelter syndrome is 47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.2109375,
            "text": "Klinefelter syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.640625,
            "text": "47, XXY; the extra sex",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 8.2109375,
            "text": "syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 8.2109375,
            "text": "formal cytogenetic designation for Klinefelter syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 8.2109375,
            "text": "inefelter syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 8.2109375,
            "text": "designation for Klinefelter syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.71484375,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondisjunction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.0185546875,
            "end_logit": -6.44140625,
            "text": "Y; the extra sex chromosome is due to meiotic chromosomal nondisjunction.",
            "probability": 0.0
        },
        {
            "start_logit": -1.0185546875,
            "end_logit": -7.1953125,
            "text": "Y; the extra sex chromosome",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_6": [
        {
            "start_logit": 6.45703125,
            "end_logit": 6.55859375,
            "text": "X",
            "probability": 1.0
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -4.29296875,
            "text": "X chromosome in males leading to a karyotype of 47,XXY.",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -5.9453125,
            "text": "X chromosome in males leading to a karyotype of 47,XXY",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -6.11328125,
            "text": "X chromosome in males leading to a karyotype of 47,XX",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 6.55859375,
            "text": "additional X",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -7.16015625,
            "end_logit": 6.55859375,
            "text": "Klinefelter syndrome (KS) is characterized by an additional X",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.11328125,
            "text": "X chromosome in males leading to",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.140625,
            "text": "X chromosome in males leading to a karyotype",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.31640625,
            "text": "X chromosome in males leading to a",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.36328125,
            "text": "X chromosome in males leading to a karyotype of",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.3828125,
            "text": "X chromosome in",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.42578125,
            "text": "X chromosome",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.55078125,
            "text": "X chromosome in males leading to a karyotype of 47",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 6.55859375,
            "text": ") is characterized by an additional X",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 6.55859375,
            "text": "inefelter syndrome (KS) is characterized by an additional X",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 6.55859375,
            "text": "characterized by an additional X",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.45703125,
            "end_logit": -7.70703125,
            "text": "X chromosome in males leading",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 6.55859375,
            "text": "KS) is characterized by an additional X",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 6.55859375,
            "text": "is characterized by an additional X",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 6.55859375,
            "text": "lter syndrome (KS) is characterized by an additional X",
            "probability": 5.960464477539062e-07
        }
    ],
    "5e669e0e1af46fc130000019_7": [
        {
            "start_logit": 7.82421875,
            "end_logit": 8.234375,
            "text": "47,XXY",
            "probability": 1.0
        },
        {
            "start_logit": -0.86083984375,
            "end_logit": 8.234375,
            "text": "Y",
            "probability": 0.00016868114471435547
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -2.427734375,
            "text": "47",
            "probability": 2.3365020751953125e-05
        },
        {
            "start_logit": -6.140625,
            "end_logit": 8.234375,
            "text": ",XXY",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -6.65625,
            "end_logit": 8.234375,
            "text": "XXY",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.68359375,
            "end_logit": 8.234375,
            "text": "a 47,XXY",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -6.28125,
            "text": "47,XX",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.234375,
            "text": "Klinefelter syndrome (KS), a 47,XXY",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.546875,
            "end_logit": 8.234375,
            "text": ", a 47,XXY",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.234375,
            "text": "), a 47,XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 8.234375,
            "text": "KS), a 47,XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.34375,
            "text": "47,XXY chromosomal abnormality,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 8.234375,
            "text": "inefelter syndrome (KS), a 47,XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.37890625,
            "text": "47,XXY chromosomal abnormality, has been shown to be associated with a number of malignancies, but has not been linked to acute leukemias to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.3828125,
            "text": "47,XXY chromosomal abnormality",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 8.234375,
            "text": "lter syndrome (KS), a 47,XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.421875,
            "text": "47,XXY chromosomal abnormality, has been shown to be associated with a number of malignancies, but has not been linked to acute leukemias to date.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 8.234375,
            "text": "felter syndrome (KS), a 47,XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.49609375,
            "text": "47,XXY chromosomal abnormality, has been",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 7.82421875,
            "end_logit": -7.53125,
            "text": "47,XXY chromosomal abnormality, has been shown to",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e669e0e1af46fc130000019_8": [
        {
            "start_logit": 8.15625,
            "end_logit": 8.21875,
            "text": "47, XXY",
            "probability": 1.0
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": 8.21875,
            "text": "Y",
            "probability": 0.00010722875595092773
        },
        {
            "start_logit": 8.15625,
            "end_logit": -1.515625,
            "text": "47",
            "probability": 5.918741226196289e-05
        },
        {
            "start_logit": -6.11328125,
            "end_logit": 8.21875,
            "text": ", XXY",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.20703125,
            "end_logit": 8.21875,
            "text": "XXY",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -6.796875,
            "text": "47, XX",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.06640625,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondisjunction.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.1953125,
            "text": "47, XXY; the extra sex chromosome",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.21875,
            "text": "formal cytogenetic designation for Klinefelter syndrome is 47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.45703125,
            "text": "47, XXY; the extra sex chromosome is due to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.47265625,
            "text": "47, XXY; the extra sex chromosome is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.21875,
            "text": "Klinefelter syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 8.21875,
            "text": "inefelter syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 8.21875,
            "text": "felter syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 8.21875,
            "text": "syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 8.21875,
            "text": "designation for Klinefelter syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 8.21875,
            "text": "lter syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 8.21875,
            "text": "cytogenetic designation for Klinefelter syndrome is 47, XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.7265625,
            "text": "47, XXY; the extra sex chromosome is due to meiotic chromosomal nondisjunction",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": -7.06640625,
            "text": "Y; the extra sex chromosome is due to meiotic chromosomal nondisjunction.",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_9": [
        {
            "start_logit": 8.2578125,
            "end_logit": 8.234375,
            "text": "XXY",
            "probability": 1.0
        },
        {
            "start_logit": -0.8271484375,
            "end_logit": 8.234375,
            "text": "Y",
            "probability": 0.00011235475540161133
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -0.99853515625,
            "text": "XX",
            "probability": 9.685754776000977e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.02734375,
            "text": "XXY chromosomal abnormality may",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.265625,
            "end_logit": 8.234375,
            "text": "teratocarcinoma is reported suggesting that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.34375,
            "text": "XXY chromosomal abnormality",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.234375,
            "text": "mediastinal teratocarcinoma is reported suggesting that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 8.234375,
            "text": "development of a mediastinal teratocarcinoma is reported suggesting that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 8.234375,
            "text": "the development of a mediastinal teratocarcinoma is reported suggesting that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.234375,
            "text": "the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.234375,
            "text": "felter's syndrome with the development of a mediastinal teratocarcinoma is reported suggesting that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.59765625,
            "text": "XXY chromosomal abnormality may be more than",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.6015625,
            "text": "XXY chromosomal abnormality may be more than coincidental.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.234375,
            "text": "the XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 8.234375,
            "text": "ocarcinoma is reported suggesting that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 8.234375,
            "text": "a mediastinal teratocarcinoma is reported suggesting that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.234375,
            "text": "that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 8.234375,
            "text": "lter's syndrome with the development of a mediastinal teratocarcinoma is reported suggesting that the association of a gonadotropin-secreting tumor with the XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.6953125,
            "text": "XXY chromosomal abnormality may be",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.6953125,
            "text": "XXY chromosomal abnormality may be more",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e669e0e1af46fc130000019_10": [
        {
            "start_logit": 5.02734375,
            "end_logit": 7.55859375,
            "text": "47, XXY",
            "probability": 0.9990234375
        },
        {
            "start_logit": -2.30859375,
            "end_logit": 7.55859375,
            "text": "Y",
            "probability": 0.0006513595581054688
        },
        {
            "start_logit": 5.02734375,
            "end_logit": 0.107177734375,
            "text": "47, XXY karyotype",
            "probability": 0.0005793571472167969
        },
        {
            "start_logit": -4.125,
            "end_logit": 7.55859375,
            "text": "a 47, XXY",
            "probability": 0.00010544061660766602
        },
        {
            "start_logit": -6.03125,
            "end_logit": 7.55859375,
            "text": ", XXY",
            "probability": 1.5676021575927734e-05
        },
        {
            "start_logit": -6.21875,
            "end_logit": 7.55859375,
            "text": "XXY",
            "probability": 1.2993812561035156e-05
        },
        {
            "start_logit": -6.83203125,
            "end_logit": 7.55859375,
            "text": "Klinefelter syndrome (KS) is a chromosomal abnormality characterised by a 47, XXY",
            "probability": 7.092952728271484e-06
        },
        {
            "start_logit": -7.3671875,
            "end_logit": 7.55859375,
            "text": "characterised by a 47, XXY",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.55859375,
            "text": "by a 47, XXY",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": -7.71875,
            "end_logit": 7.55859375,
            "text": ") is a chromosomal abnormality characterised by a 47, XXY",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 7.55859375,
            "text": "inefelter syndrome (KS) is a chromosomal abnormality characterised by a 47, XXY",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 7.55859375,
            "text": "lter syndrome (KS) is a chromosomal abnormality characterised by a 47, XXY",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 7.55859375,
            "text": "felter syndrome (KS) is a chromosomal abnormality characterised by a 47, XXY",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 7.55859375,
            "text": "is a chromosomal abnormality characterised by a 47, XXY",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 5.02734375,
            "end_logit": -5.48828125,
            "text": "47, XXY karyotype associated with hypogonadism and infertility.",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 5.02734375,
            "end_logit": -5.78515625,
            "text": "47, XX",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 5.02734375,
            "end_logit": -5.87109375,
            "text": "47",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -2.30859375,
            "end_logit": 0.107177734375,
            "text": "Y karyotype",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 5.02734375,
            "end_logit": -7.64453125,
            "text": "47, XXY karyotype associated",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -4.125,
            "end_logit": 0.107177734375,
            "text": "a 47, XXY karyotype",
            "probability": 5.960464477539063e-08
        }
    ],
    "5e669e0e1af46fc130000019_11": [
        {
            "start_logit": 4.22265625,
            "end_logit": 7.875,
            "text": "47,XXY",
            "probability": 0.99609375
        },
        {
            "start_logit": -1.720703125,
            "end_logit": 7.875,
            "text": "Y",
            "probability": 0.002628326416015625
        },
        {
            "start_logit": 4.22265625,
            "end_logit": 0.353759765625,
            "text": "47,XXY) and Y",
            "probability": 0.0005426406860351562
        },
        {
            "start_logit": 2.81640625,
            "end_logit": 0.353759765625,
            "text": "Y",
            "probability": 0.0001329183578491211
        },
        {
            "start_logit": -5.18359375,
            "end_logit": 7.875,
            "text": "XXY",
            "probability": 8.189678192138672e-05
        },
        {
            "start_logit": -5.51953125,
            "end_logit": 7.875,
            "text": ",XXY",
            "probability": 5.894899368286133e-05
        },
        {
            "start_logit": -6.48828125,
            "end_logit": 7.875,
            "text": "(47,XXY",
            "probability": 2.2411346435546875e-05
        },
        {
            "start_logit": -7.15625,
            "end_logit": 7.875,
            "text": "including Klinefelter syndrome (47,XXY",
            "probability": 1.1444091796875e-05
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 7.875,
            "text": "nonobstructive azoospermia are numerical and structural chromosome abnormalities, including Klinefelter syndrome (47,XXY",
            "probability": 1.0251998901367188e-05
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 7.875,
            "text": "Klinefelter syndrome (47,XXY",
            "probability": 8.702278137207031e-06
        },
        {
            "start_logit": -7.4375,
            "end_logit": 7.875,
            "text": "numerical and structural chromosome abnormalities, including Klinefelter syndrome (47,XXY",
            "probability": 8.58306884765625e-06
        },
        {
            "start_logit": -7.46875,
            "end_logit": 7.875,
            "text": "tructive azoospermia are numerical and structural chromosome abnormalities, including Klinefelter syndrome (47,XXY",
            "probability": 8.344650268554688e-06
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 7.875,
            "text": "inefelter syndrome (47,XXY",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.875,
            "text": "ive azoospermia are numerical and structural chromosome abnormalities, including Klinefelter syndrome (47,XXY",
            "probability": 7.510185241699219e-06
        },
        {
            "start_logit": -1.720703125,
            "end_logit": 0.353759765625,
            "text": "Y) and Y",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 4.22265625,
            "end_logit": -5.6875,
            "text": "47,XXY) and Y chromosome microdeletions",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 4.22265625,
            "end_logit": -6.13671875,
            "text": "47,XXY) and Y chromosome microdelet",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 4.22265625,
            "end_logit": -6.24609375,
            "text": "47,XX",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 4.22265625,
            "end_logit": -6.4765625,
            "text": "47,XXY) and Y chromosome microdeletions.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 4.22265625,
            "end_logit": -6.484375,
            "text": "47",
            "probability": 5.960464477539062e-07
        }
    ],
    "5e669e0e1af46fc130000019_12": [
        {
            "start_logit": 6.30078125,
            "end_logit": 6.71875,
            "text": "X",
            "probability": 1.0
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -4.00390625,
            "text": "X chromosome in males (47,XXY",
            "probability": 2.2113323211669922e-05
        },
        {
            "start_logit": -4.59375,
            "end_logit": 6.71875,
            "text": "additional X",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -4.91015625,
            "text": "X chromosome in males (47,XX",
            "probability": 8.940696716308594e-06
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -6.49609375,
            "text": "X chromosome",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -6.7578125,
            "text": "X chromosome in",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 6.71875,
            "text": ", Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 6.71875,
            "text": "hand, Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 6.71875,
            "text": "Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -7.0078125,
            "text": "X chromosome in males (47,XXY), and the characteristic clinical findings include tall stature, immaturity of external genitalia, testicular dysfunction.",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 6.71875,
            "text": "well recognized chromosomal abnormality caused by an additional X",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.53125,
            "end_logit": 6.71875,
            "text": "other hand, Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 6.71875,
            "text": "the other hand, Klinefelter syndrome is well recognized chromosomal abnormality caused by an additional X",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.71875,
            "text": "is well recognized chromosomal abnormality caused by an additional X",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -7.28515625,
            "text": "X chromosome in males (47,XXY)",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -7.32421875,
            "text": "X chromosome in males (47,XXY),",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -7.5390625,
            "text": "X chromosome in males (47",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -7.6015625,
            "text": "X chromosome in males (47,XXY), and",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -7.7578125,
            "text": "X chromosome in males (47,XXY), and the characteristic clinical findings",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.30078125,
            "end_logit": -7.7578125,
            "text": "X chromosome in males (47,XXY), and the characteristic",
            "probability": 5.364418029785156e-07
        }
    ],
    "5e669e0e1af46fc130000019_13": [
        {
            "start_logit": 8.046875,
            "end_logit": 8.2578125,
            "text": "47, XXY",
            "probability": 1.0
        },
        {
            "start_logit": -0.74951171875,
            "end_logit": 8.2578125,
            "text": "Y",
            "probability": 0.0001500844955444336
        },
        {
            "start_logit": 8.046875,
            "end_logit": -1.84375,
            "text": "47",
            "probability": 4.07099723815918e-05
        },
        {
            "start_logit": -6.08984375,
            "end_logit": 8.2578125,
            "text": ", XXY",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -5.95703125,
            "text": "47, XX",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.48828125,
            "end_logit": 8.2578125,
            "text": "XXY",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.96875,
            "end_logit": 8.2578125,
            "text": "which Klinefelter's syndrome (47, XXY",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.984375,
            "end_logit": 8.2578125,
            "text": "(47, XXY",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -6.96875,
            "text": "47, XXY)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -7.15234375,
            "text": "47, XXY) was the most common chromosomal aberration",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 8.2578125,
            "text": "Klinefelter's syndrome (47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4375,
            "end_logit": 8.2578125,
            "text": "found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 8.2578125,
            "text": "have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -7.25390625,
            "text": "47, XXY) was the most common",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -7.26171875,
            "text": "47, XXY) was the most common chromosomal aberration.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.51953125,
            "end_logit": 8.2578125,
            "text": "patients, 39(10.9%) were found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 8.2578125,
            "text": "(10.9%) were found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55078125,
            "end_logit": 8.2578125,
            "text": "inefelter's syndrome (47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.55859375,
            "end_logit": 8.2578125,
            "text": ") were found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.2578125,
            "text": "39(10.9%) were found to have chromosomal abnormalities in which Klinefelter's syndrome (47, XXY",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5e669e0e1af46fc130000019_14": [
        {
            "start_logit": 5.91015625,
            "end_logit": 7.625,
            "text": "47, XXY",
            "probability": 1.0
        },
        {
            "start_logit": -2.294921875,
            "end_logit": 7.625,
            "text": "Y",
            "probability": 0.00027370452880859375
        },
        {
            "start_logit": -3.66796875,
            "end_logit": 7.625,
            "text": "a 47, XXY",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": -5.97265625,
            "end_logit": 7.625,
            "text": ", XXY",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": 5.91015625,
            "end_logit": -4.28125,
            "text": "47, XXY karyotype associated with hypogonadism and infertility.",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": -6.1484375,
            "end_logit": 7.625,
            "text": "XXY",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": -6.2265625,
            "end_logit": 7.625,
            "text": "Klinefelter syndrome (KS) is a chromosome abnormality characterized by a 47, XXY",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": 5.91015625,
            "end_logit": -4.5234375,
            "text": "47, XXY karyotype",
            "probability": 5.364418029785156e-06
        },
        {
            "start_logit": 5.91015625,
            "end_logit": -5.08203125,
            "text": "47",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -7.37890625,
            "end_logit": 7.625,
            "text": "by a 47, XXY",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": -7.421875,
            "end_logit": 7.625,
            "text": "characterized by a 47, XXY",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 5.91015625,
            "end_logit": -5.75,
            "text": "47, XX",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 7.625,
            "text": ") is a chromosome abnormality characterized by a 47, XXY",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 7.625,
            "text": "inefelter syndrome (KS) is a chromosome abnormality characterized by a 47, XXY",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 7.625,
            "text": "lter syndrome (KS) is a chromosome abnormality characterized by a 47, XXY",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 7.625,
            "text": "felter syndrome (KS) is a chromosome abnormality characterized by a 47, XXY",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 5.91015625,
            "end_logit": -7.71484375,
            "text": "47, XXY karyotype associated",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.294921875,
            "end_logit": -4.28125,
            "text": "Y karyotype associated with hypogonadism and infertility.",
            "probability": 0.0
        },
        {
            "start_logit": -2.294921875,
            "end_logit": -4.5234375,
            "text": "Y karyotype",
            "probability": 0.0
        },
        {
            "start_logit": -3.66796875,
            "end_logit": -4.28125,
            "text": "a 47, XXY karyotype associated with hypogonadism and infertility.",
            "probability": 0.0
        }
    ],
    "5e669e0e1af46fc130000019_15": [
        {
            "start_logit": 7.65234375,
            "end_logit": 4.64453125,
            "text": "XXY",
            "probability": 0.44091796875
        },
        {
            "start_logit": 7.65234375,
            "end_logit": 4.234375,
            "text": "XXY, XXYY, XXXY and XXXXY",
            "probability": 0.293701171875
        },
        {
            "start_logit": 7.65234375,
            "end_logit": 4.00390625,
            "text": "XXY, XXYY, XXXY and XXXXY.",
            "probability": 0.2322998046875
        },
        {
            "start_logit": 7.65234375,
            "end_logit": 0.724609375,
            "text": "XXY, XXYY, XXXY",
            "probability": 0.00873565673828125
        },
        {
            "start_logit": 3.68359375,
            "end_logit": 4.234375,
            "text": "XXXXY",
            "probability": 0.00553131103515625
        },
        {
            "start_logit": 3.603515625,
            "end_logit": 4.234375,
            "text": "XXXY and XXXXY",
            "probability": 0.005092620849609375
        },
        {
            "start_logit": 7.65234375,
            "end_logit": 0.071533203125,
            "text": "XX",
            "probability": 0.004547119140625
        },
        {
            "start_logit": 3.68359375,
            "end_logit": 4.00390625,
            "text": "XXXXY.",
            "probability": 0.004390716552734375
        },
        {
            "start_logit": 3.603515625,
            "end_logit": 4.00390625,
            "text": "XXXY and XXXXY.",
            "probability": 0.004062652587890625
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -3.298828125,
            "text": "XXY, XXYY, XX",
            "probability": 0.00015628337860107422
        },
        {
            "start_logit": 3.603515625,
            "end_logit": 0.724609375,
            "text": "XXXY",
            "probability": 0.00015270709991455078
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -4.171875,
            "text": "XXY, XXYY, XXXY and XX",
            "probability": 6.568431854248047e-05
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -5.04296875,
            "text": "XXY, XX",
            "probability": 2.7358531951904297e-05
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -5.3828125,
            "text": "XXY, XXYY",
            "probability": 1.9371509552001953e-05
        },
        {
            "start_logit": -2.408203125,
            "end_logit": 4.234375,
            "text": "XXYY, XXXY and XXXXY",
            "probability": 1.2516975402832031e-05
        },
        {
            "start_logit": -2.408203125,
            "end_logit": 4.00390625,
            "text": "XXYY, XXXY and XXXXY.",
            "probability": 9.894371032714844e-06
        },
        {
            "start_logit": 7.65234375,
            "end_logit": -6.50390625,
            "text": "XXY, XXYY, XXXY and XXX",
            "probability": 6.377696990966797e-06
        },
        {
            "start_logit": -3.75,
            "end_logit": 4.64453125,
            "text": "Klinefelter's syndrome may be associated with a variety of different sex chromosome anomalies including XXY",
            "probability": 4.887580871582031e-06
        },
        {
            "start_logit": -3.4296875,
            "end_logit": 4.234375,
            "text": "XY",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -3.41796875,
            "end_logit": 4.00390625,
            "text": ".",
            "probability": 3.635883331298828e-06
        }
    ],
    "5e669e0e1af46fc130000019_16": [
        {
            "start_logit": 8.0390625,
            "end_logit": 8.21875,
            "text": "47,XXY",
            "probability": 1.0
        },
        {
            "start_logit": -0.947265625,
            "end_logit": 8.21875,
            "text": "Y",
            "probability": 0.00012636184692382812
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -1.904296875,
            "text": "47",
            "probability": 4.035234451293945e-05
        },
        {
            "start_logit": -6.1328125,
            "end_logit": 8.21875,
            "text": "XXY",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.16796875,
            "end_logit": 8.21875,
            "text": ",XXY",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -6.45703125,
            "text": "47,XXY chromosomal pattern, has largely been associated with physical abnormalities.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -6.77734375,
            "text": "47,XX",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.05078125,
            "text": "47,XXY chromosomal pattern",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 8.21875,
            "text": "characterised by a 47,XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 8.21875,
            "text": "Klinefelter's syndrome, characterised by a 47,XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.328125,
            "text": "47,XXY chromosomal pattern,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.4765625,
            "text": "47,XXY chromosomal",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.51171875,
            "text": "47,XXY chromosomal pattern, has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 8.21875,
            "text": "inefelter's syndrome, characterised by a 47,XXY",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.53515625,
            "text": "47,XXY chromosomal pattern, has largely",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 8.21875,
            "text": "felter's syndrome, characterised by a 47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0390625,
            "end_logit": -7.60546875,
            "text": "47,XXY chromosomal pattern, has largely been",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 8.21875,
            "text": ", characterised by a 47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 8.21875,
            "text": "lter's syndrome, characterised by a 47,XXY",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 8.21875,
            "text": "syndrome, characterised by a 47,XXY",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5e669e0e1af46fc130000019_17": [
        {
            "start_logit": 7.6875,
            "end_logit": 7.8515625,
            "text": "46,XXY",
            "probability": 0.9931640625
        },
        {
            "start_logit": 7.6875,
            "end_logit": 2.658203125,
            "text": "46,XXY,t(13q;14q)",
            "probability": 0.005504608154296875
        },
        {
            "start_logit": 5.63671875,
            "end_logit": 2.658203125,
            "text": "t(13q;14q)",
            "probability": 0.0007109642028808594
        },
        {
            "start_logit": -1.970703125,
            "end_logit": 7.8515625,
            "text": "Y",
            "probability": 6.35981559753418e-05
        },
        {
            "start_logit": 7.6875,
            "end_logit": -2.62890625,
            "text": "46",
            "probability": 2.777576446533203e-05
        },
        {
            "start_logit": 7.6875,
            "end_logit": -3.7890625,
            "text": "46,XXY,t(13q;14q",
            "probability": 8.761882781982422e-06
        },
        {
            "start_logit": 7.6875,
            "end_logit": -3.8203125,
            "text": "46,XXY,t(13q;14q).",
            "probability": 8.463859558105469e-06
        },
        {
            "start_logit": 7.6875,
            "end_logit": -4.6484375,
            "text": "46,XXY,t",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 7.6875,
            "end_logit": -4.87109375,
            "text": "46,XXY,t(13q",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -5.7109375,
            "end_logit": 7.8515625,
            "text": "translocation abnormality 46,XXY",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 7.6875,
            "end_logit": -5.7578125,
            "text": "46,XXY,t(13q;14",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -5.953125,
            "end_logit": 7.8515625,
            "text": ",XXY",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 5.63671875,
            "end_logit": -3.7890625,
            "text": "t(13q;14q",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 5.63671875,
            "end_logit": -3.8203125,
            "text": "t(13q;14q).",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.6875,
            "end_logit": -6.109375,
            "text": "46,XXY,t(",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.3828125,
            "end_logit": 7.8515625,
            "text": "XXY",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.6875,
            "end_logit": -6.2578125,
            "text": "46,XXY,t(13q;",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 7.6875,
            "end_logit": -6.64453125,
            "text": "46,XXY,t(13",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 5.63671875,
            "end_logit": -4.6484375,
            "text": "t",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.6875,
            "end_logit": -6.875,
            "text": "46,XX",
            "probability": 4.172325134277344e-07
        }
    ],
    "56c8f4615795f9a73e00001a_1": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.1640625,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": 8.1640625,
            "text": "e",
            "probability": 0.00010228157043457031
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.248046875,
            "text": "GBs",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": -6.26953125,
            "end_logit": 8.1640625,
            "text": "hape",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.96875,
            "text": "GBshap",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.484375,
            "text": "GBshape: a genome browser",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.51171875,
            "text": "GBshape: a genome browser database",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.56640625,
            "text": "GBshape: a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.6328125,
            "text": "GBshape: a genome browser database for",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.640625,
            "text": "GBshape: a genome browse",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": -7.484375,
            "text": "e: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": -7.51171875,
            "text": "e: a genome browser database",
            "probability": 0.0
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": -7.56640625,
            "text": "e: a",
            "probability": 0.0
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": -7.6328125,
            "text": "e: a genome browser database for",
            "probability": 0.0
        },
        {
            "start_logit": -0.97900390625,
            "end_logit": -7.640625,
            "text": "e: a genome browse",
            "probability": 0.0
        },
        {
            "start_logit": -6.26953125,
            "end_logit": -6.96875,
            "text": "hap",
            "probability": 0.0
        },
        {
            "start_logit": -6.26953125,
            "end_logit": -7.484375,
            "text": "hape: a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -6.26953125,
            "end_logit": -7.51171875,
            "text": "hape: a genome browser database",
            "probability": 0.0
        },
        {
            "start_logit": -6.26953125,
            "end_logit": -7.56640625,
            "text": "hape: a",
            "probability": 0.0
        },
        {
            "start_logit": -6.26953125,
            "end_logit": -7.6328125,
            "text": "hape: a genome browser database for",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_2": [
        {
            "start_logit": 8.2734375,
            "end_logit": 8.21875,
            "text": "GBshape",
            "probability": 0.168701171875
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.21875,
            "text": "GBshape framework. GBshape",
            "probability": 0.168701171875
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2109375,
            "text": "GBshape",
            "probability": 0.1661376953125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2109375,
            "text": "GBshape",
            "probability": 0.1661376953125
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.21875,
            "text": "GBshape",
            "probability": 0.1661376953125
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.2109375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.16357421875
        },
        {
            "start_logit": -0.281982421875,
            "end_logit": 8.21875,
            "text": "e framework. GBshape",
            "probability": 3.224611282348633e-05
        },
        {
            "start_logit": -0.281982421875,
            "end_logit": 8.2109375,
            "text": "e",
            "probability": 3.2007694244384766e-05
        },
        {
            "start_logit": -0.297607421875,
            "end_logit": 8.21875,
            "text": "e",
            "probability": 3.17692756652832e-05
        },
        {
            "start_logit": -0.322998046875,
            "end_logit": 8.2109375,
            "text": "e",
            "probability": 3.075599670410156e-05
        },
        {
            "start_logit": -0.368408203125,
            "end_logit": 8.21875,
            "text": "e",
            "probability": 2.956390380859375e-05
        },
        {
            "start_logit": -0.368408203125,
            "end_logit": 8.2109375,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.9385089874267578e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.83837890625,
            "text": "GBs",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.83837890625,
            "text": "GBshape framework. GBs",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.84228515625,
            "text": "GBs",
            "probability": 1.9431114196777344e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.8486328125,
            "text": "GBs",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.8486328125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.8671875,
            "text": "GBs",
            "probability": 1.8835067749023438e-05
        },
        {
            "start_logit": -4.55859375,
            "end_logit": 8.2109375,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.06640625,
            "end_logit": 8.21875,
            "text": ". GBshape",
            "probability": 2.980232238769531e-07
        }
    ],
    "56c8f4615795f9a73e00001a_3": [
        {
            "start_logit": 8.2734375,
            "end_logit": 8.21875,
            "text": "GBshape",
            "probability": 0.168701171875
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.21875,
            "text": "GBshape framework. GBshape",
            "probability": 0.168701171875
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2109375,
            "text": "GBshape",
            "probability": 0.1661376953125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2109375,
            "text": "GBshape",
            "probability": 0.1661376953125
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.21875,
            "text": "GBshape",
            "probability": 0.1661376953125
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.2109375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.16357421875
        },
        {
            "start_logit": -0.281982421875,
            "end_logit": 8.21875,
            "text": "e framework. GBshape",
            "probability": 3.224611282348633e-05
        },
        {
            "start_logit": -0.281982421875,
            "end_logit": 8.2109375,
            "text": "e",
            "probability": 3.2007694244384766e-05
        },
        {
            "start_logit": -0.297607421875,
            "end_logit": 8.21875,
            "text": "e",
            "probability": 3.17692756652832e-05
        },
        {
            "start_logit": -0.322998046875,
            "end_logit": 8.2109375,
            "text": "e",
            "probability": 3.075599670410156e-05
        },
        {
            "start_logit": -0.368408203125,
            "end_logit": 8.21875,
            "text": "e",
            "probability": 2.956390380859375e-05
        },
        {
            "start_logit": -0.368408203125,
            "end_logit": 8.2109375,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.9385089874267578e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.83837890625,
            "text": "GBs",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.83837890625,
            "text": "GBshape framework. GBs",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.84228515625,
            "text": "GBs",
            "probability": 1.9431114196777344e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.8486328125,
            "text": "GBs",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.8486328125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.8671875,
            "text": "GBs",
            "probability": 1.8835067749023438e-05
        },
        {
            "start_logit": -4.55859375,
            "end_logit": 8.2109375,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.06640625,
            "end_logit": 8.21875,
            "text": ". GBshape",
            "probability": 2.980232238769531e-07
        }
    ],
    "56c8f4615795f9a73e00001a_4": [
        {
            "start_logit": 8.2734375,
            "end_logit": 8.21875,
            "text": "GBshape",
            "probability": 0.168701171875
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.21875,
            "text": "GBshape framework. GBshape",
            "probability": 0.168701171875
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2109375,
            "text": "GBshape",
            "probability": 0.1661376953125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2109375,
            "text": "GBshape",
            "probability": 0.1661376953125
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.21875,
            "text": "GBshape",
            "probability": 0.1661376953125
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.2109375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.16357421875
        },
        {
            "start_logit": -0.281982421875,
            "end_logit": 8.21875,
            "text": "e framework. GBshape",
            "probability": 3.224611282348633e-05
        },
        {
            "start_logit": -0.281982421875,
            "end_logit": 8.2109375,
            "text": "e",
            "probability": 3.2007694244384766e-05
        },
        {
            "start_logit": -0.297607421875,
            "end_logit": 8.21875,
            "text": "e",
            "probability": 3.17692756652832e-05
        },
        {
            "start_logit": -0.322998046875,
            "end_logit": 8.2109375,
            "text": "e",
            "probability": 3.075599670410156e-05
        },
        {
            "start_logit": -0.368408203125,
            "end_logit": 8.21875,
            "text": "e",
            "probability": 2.956390380859375e-05
        },
        {
            "start_logit": -0.368408203125,
            "end_logit": 8.2109375,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.9385089874267578e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.83837890625,
            "text": "GBs",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.83837890625,
            "text": "GBshape framework. GBs",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.84228515625,
            "text": "GBs",
            "probability": 1.9431114196777344e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.8486328125,
            "text": "GBs",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.8486328125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.8671875,
            "text": "GBs",
            "probability": 1.8835067749023438e-05
        },
        {
            "start_logit": -4.55859375,
            "end_logit": 8.2109375,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.06640625,
            "end_logit": 8.21875,
            "text": ". GBshape",
            "probability": 2.980232238769531e-07
        }
    ],
    "56c8f4615795f9a73e00001a_5": [
        {
            "start_logit": 8.2734375,
            "end_logit": 8.21875,
            "text": "GBshape",
            "probability": 0.168701171875
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.21875,
            "text": "GBshape framework. GBshape",
            "probability": 0.168701171875
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2109375,
            "text": "GBshape",
            "probability": 0.1661376953125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.2109375,
            "text": "GBshape",
            "probability": 0.1661376953125
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.21875,
            "text": "GBshape",
            "probability": 0.1661376953125
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.2109375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.16357421875
        },
        {
            "start_logit": -0.281982421875,
            "end_logit": 8.21875,
            "text": "e framework. GBshape",
            "probability": 3.224611282348633e-05
        },
        {
            "start_logit": -0.281982421875,
            "end_logit": 8.2109375,
            "text": "e",
            "probability": 3.2007694244384766e-05
        },
        {
            "start_logit": -0.297607421875,
            "end_logit": 8.21875,
            "text": "e",
            "probability": 3.17692756652832e-05
        },
        {
            "start_logit": -0.322998046875,
            "end_logit": 8.2109375,
            "text": "e",
            "probability": 3.075599670410156e-05
        },
        {
            "start_logit": -0.368408203125,
            "end_logit": 8.21875,
            "text": "e",
            "probability": 2.956390380859375e-05
        },
        {
            "start_logit": -0.368408203125,
            "end_logit": 8.2109375,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.9385089874267578e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.83837890625,
            "text": "GBs",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.83837890625,
            "text": "GBshape framework. GBs",
            "probability": 1.9550323486328125e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.84228515625,
            "text": "GBs",
            "probability": 1.9431114196777344e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.8486328125,
            "text": "GBs",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.8486328125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 1.9252300262451172e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.8671875,
            "text": "GBs",
            "probability": 1.8835067749023438e-05
        },
        {
            "start_logit": -4.55859375,
            "end_logit": 8.2109375,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.06640625,
            "end_logit": 8.21875,
            "text": ". GBshape",
            "probability": 2.980232238769531e-07
        }
    ],
    "56c8f4615795f9a73e00001a_6": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1796875,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -0.81787109375,
            "end_logit": 8.1796875,
            "text": "e",
            "probability": 0.00011777877807617188
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.2021484375,
            "text": "GBs",
            "probability": 8.416175842285156e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.54296875,
            "text": "GBshap",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 8.1796875,
            "text": "hape",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.19921875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.375,
            "text": "GBshape can",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.40234375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.4140625,
            "text": "GBshape can be",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.421875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.53125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.56640625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.57421875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.62109375,
            "text": "GBshape can be used to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6640625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.81787109375,
            "end_logit": -7.19921875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -0.81787109375,
            "end_logit": -7.375,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -0.81787109375,
            "end_logit": -7.40234375,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 0.0
        },
        {
            "start_logit": -0.81787109375,
            "end_logit": -7.4140625,
            "text": "e can be",
            "probability": 0.0
        },
        {
            "start_logit": -0.81787109375,
            "end_logit": -7.421875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_7": [
        {
            "start_logit": 8.25,
            "end_logit": 8.1875,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1875,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": -0.51220703125,
            "end_logit": 8.1875,
            "text": "e",
            "probability": 5.2034854888916016e-05
        },
        {
            "start_logit": -0.638671875,
            "end_logit": 8.1875,
            "text": "e",
            "probability": 4.589557647705078e-05
        },
        {
            "start_logit": -0.638671875,
            "end_logit": 8.1875,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 4.589557647705078e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.0068359375,
            "text": "GBs",
            "probability": 3.3855438232421875e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.0068359375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 3.355741500854492e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.05078125,
            "text": "GBs",
            "probability": 3.2007694244384766e-05
        },
        {
            "start_logit": -5.73046875,
            "end_logit": 8.1875,
            "text": "hape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.73046875,
            "end_logit": 8.1875,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -5.8984375,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -5.8984375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.00390625,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.0546875,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.05859375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.06640625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.06640625,
            "end_logit": 8.1875,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.06640625,
            "end_logit": 8.1875,
            "text": "hape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.33203125,
            "text": "GBshape/",
            "probability": 1.7881393432617188e-07
        }
    ],
    "56c8f4615795f9a73e00001a_8": [
        {
            "start_logit": 8.25,
            "end_logit": 8.1875,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1875,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": -0.51220703125,
            "end_logit": 8.1875,
            "text": "e",
            "probability": 5.2034854888916016e-05
        },
        {
            "start_logit": -0.638671875,
            "end_logit": 8.1875,
            "text": "e",
            "probability": 4.589557647705078e-05
        },
        {
            "start_logit": -0.638671875,
            "end_logit": 8.1875,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 4.589557647705078e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.0068359375,
            "text": "GBs",
            "probability": 3.3855438232421875e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.0068359375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 3.355741500854492e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.05078125,
            "text": "GBs",
            "probability": 3.2007694244384766e-05
        },
        {
            "start_logit": -5.73046875,
            "end_logit": 8.1875,
            "text": "hape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.73046875,
            "end_logit": 8.1875,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -5.8984375,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -5.8984375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.00390625,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.0546875,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.05859375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.06640625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.06640625,
            "end_logit": 8.1875,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.06640625,
            "end_logit": 8.1875,
            "text": "hape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.33203125,
            "text": "GBshape/",
            "probability": 1.7881393432617188e-07
        }
    ],
    "56c8f4615795f9a73e00001a_9": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1796875,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -0.81787109375,
            "end_logit": 8.1796875,
            "text": "e",
            "probability": 0.00011777877807617188
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.2021484375,
            "text": "GBs",
            "probability": 8.416175842285156e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.54296875,
            "text": "GBshap",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 8.1796875,
            "text": "hape",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.19921875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.375,
            "text": "GBshape can",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.40234375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.4140625,
            "text": "GBshape can be",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.421875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.53125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.56640625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.57421875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.62109375,
            "text": "GBshape can be used to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6640625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.81787109375,
            "end_logit": -7.19921875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -0.81787109375,
            "end_logit": -7.375,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -0.81787109375,
            "end_logit": -7.40234375,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 0.0
        },
        {
            "start_logit": -0.81787109375,
            "end_logit": -7.4140625,
            "text": "e can be",
            "probability": 0.0
        },
        {
            "start_logit": -0.81787109375,
            "end_logit": -7.421875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_10": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1953125,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -0.73681640625,
            "end_logit": 8.1953125,
            "text": "e",
            "probability": 0.00012731552124023438
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.19140625,
            "text": "GBs",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.33984375,
            "text": "GBshap",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.68359375,
            "end_logit": 8.1953125,
            "text": "hape",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.06640625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.41796875,
            "text": "GBshape can",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.5,
            "text": "GBshape can be",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.55078125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.55859375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.58203125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6328125,
            "text": "GBshape can be used to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.63671875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.73681640625,
            "end_logit": -7.06640625,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -0.73681640625,
            "end_logit": -7.41796875,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -0.73681640625,
            "end_logit": -7.5,
            "text": "e can be",
            "probability": 0.0
        },
        {
            "start_logit": -0.73681640625,
            "end_logit": -7.55078125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 0.0
        },
        {
            "start_logit": -0.73681640625,
            "end_logit": -7.55859375,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 0.0
        },
        {
            "start_logit": -0.73681640625,
            "end_logit": -7.58203125,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 0.0
        },
        {
            "start_logit": -0.73681640625,
            "end_logit": -7.6328125,
            "text": "e can be used to",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_11": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.171875,
            "text": "GBshape",
            "probability": 0.33837890625
        },
        {
            "start_logit": 8.21875,
            "end_logit": 8.171875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.3330078125
        },
        {
            "start_logit": 8.21875,
            "end_logit": 8.15625,
            "text": "GBshape",
            "probability": 0.327880859375
        },
        {
            "start_logit": -0.46875,
            "end_logit": 8.171875,
            "text": "e",
            "probability": 5.620718002319336e-05
        },
        {
            "start_logit": -0.63427734375,
            "end_logit": 8.171875,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 4.76837158203125e-05
        },
        {
            "start_logit": -0.63427734375,
            "end_logit": 8.15625,
            "text": "e",
            "probability": 4.696846008300781e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -0.94873046875,
            "text": "GBs",
            "probability": 3.743171691894531e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -0.94873046875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 3.629922866821289e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.1259765625,
            "text": "GBs",
            "probability": 3.057718276977539e-05
        },
        {
            "start_logit": -4.68359375,
            "end_logit": 8.15625,
            "text": ". Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -5.47265625,
            "text": "GBshap",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.47265625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshap",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.546875,
            "end_logit": 8.171875,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.546875,
            "end_logit": 8.15625,
            "text": "hape",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.62890625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.80078125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.87109375,
            "end_logit": 8.171875,
            "text": "hape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.87109375,
            "end_logit": 8.15625,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.00390625,
            "text": "GBshape/",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.99609375,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 2.384185791015625e-07
        }
    ],
    "56c8f4615795f9a73e00001a_12": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.171875,
            "text": "GBshape",
            "probability": 0.33837890625
        },
        {
            "start_logit": 8.21875,
            "end_logit": 8.171875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.3330078125
        },
        {
            "start_logit": 8.21875,
            "end_logit": 8.15625,
            "text": "GBshape",
            "probability": 0.327880859375
        },
        {
            "start_logit": -0.46875,
            "end_logit": 8.171875,
            "text": "e",
            "probability": 5.620718002319336e-05
        },
        {
            "start_logit": -0.63427734375,
            "end_logit": 8.171875,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 4.76837158203125e-05
        },
        {
            "start_logit": -0.63427734375,
            "end_logit": 8.15625,
            "text": "e",
            "probability": 4.696846008300781e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -0.94873046875,
            "text": "GBs",
            "probability": 3.743171691894531e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -0.94873046875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 3.629922866821289e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.1259765625,
            "text": "GBs",
            "probability": 3.057718276977539e-05
        },
        {
            "start_logit": -4.68359375,
            "end_logit": 8.15625,
            "text": ". Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -5.47265625,
            "text": "GBshap",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.47265625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshap",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -5.546875,
            "end_logit": 8.171875,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.546875,
            "end_logit": 8.15625,
            "text": "hape",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.62890625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.80078125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.87109375,
            "end_logit": 8.171875,
            "text": "hape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.87109375,
            "end_logit": 8.15625,
            "text": "Our Genome Browser for DNA shape annotations (GBshape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.00390625,
            "text": "GBshape/",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -5.99609375,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 2.384185791015625e-07
        }
    ],
    "56c8f4615795f9a73e00001a_13": [
        {
            "start_logit": 8.25,
            "end_logit": 8.1953125,
            "text": "GBshape framework. GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.1953125,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1953125,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": -0.623046875,
            "end_logit": 8.1953125,
            "text": "e framework. GBshape",
            "probability": 4.696846008300781e-05
        },
        {
            "start_logit": -0.623046875,
            "end_logit": 8.1953125,
            "text": "e",
            "probability": 4.696846008300781e-05
        },
        {
            "start_logit": -0.63427734375,
            "end_logit": 8.1953125,
            "text": "e",
            "probability": 4.661083221435547e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.0537109375,
            "text": "GBs",
            "probability": 3.230571746826172e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.0712890625,
            "text": "GBshape framework. GBs",
            "probability": 3.17692756652832e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.0712890625,
            "text": "GBs",
            "probability": 3.153085708618164e-05
        },
        {
            "start_logit": -5.796875,
            "end_logit": 8.1953125,
            "text": "hape framework. GBshape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.796875,
            "end_logit": 8.1953125,
            "text": "hape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.2109375,
            "end_logit": 8.1953125,
            "text": "hape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.5703125,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.6015625,
            "text": "GBshape framework. GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.6015625,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.59375,
            "end_logit": 8.1953125,
            "text": ". GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.8828125,
            "text": "GBshape framework. GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.8828125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.21484375,
            "text": "GBshape framework. GBshape can",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.21484375,
            "text": "GBshape can",
            "probability": 5.960464477539063e-08
        }
    ],
    "56c8f4615795f9a73e00001a_14": [
        {
            "start_logit": 8.25,
            "end_logit": 8.1953125,
            "text": "GBshape framework. GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.1953125,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1953125,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": -0.623046875,
            "end_logit": 8.1953125,
            "text": "e framework. GBshape",
            "probability": 4.696846008300781e-05
        },
        {
            "start_logit": -0.623046875,
            "end_logit": 8.1953125,
            "text": "e",
            "probability": 4.696846008300781e-05
        },
        {
            "start_logit": -0.63427734375,
            "end_logit": 8.1953125,
            "text": "e",
            "probability": 4.661083221435547e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.0537109375,
            "text": "GBs",
            "probability": 3.230571746826172e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.0712890625,
            "text": "GBshape framework. GBs",
            "probability": 3.17692756652832e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.0712890625,
            "text": "GBs",
            "probability": 3.153085708618164e-05
        },
        {
            "start_logit": -5.796875,
            "end_logit": 8.1953125,
            "text": "hape framework. GBshape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.796875,
            "end_logit": 8.1953125,
            "text": "hape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.2109375,
            "end_logit": 8.1953125,
            "text": "hape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.5703125,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.6015625,
            "text": "GBshape framework. GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.6015625,
            "text": "GBshap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.59375,
            "end_logit": 8.1953125,
            "text": ". GBshape",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.8828125,
            "text": "GBshape framework. GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.8828125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.21484375,
            "text": "GBshape framework. GBshape can",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.21484375,
            "text": "GBshape can",
            "probability": 5.960464477539063e-08
        }
    ],
    "56c8f4615795f9a73e00001a_15": [
        {
            "start_logit": 8.2578125,
            "end_logit": 8.203125,
            "text": "GBshape",
            "probability": 0.25
        },
        {
            "start_logit": 8.2578125,
            "end_logit": 8.203125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.25
        },
        {
            "start_logit": 8.2578125,
            "end_logit": 8.203125,
            "text": "GBshape",
            "probability": 0.25
        },
        {
            "start_logit": 8.2578125,
            "end_logit": 8.203125,
            "text": "GBshape",
            "probability": 0.25
        },
        {
            "start_logit": -0.372314453125,
            "end_logit": 8.203125,
            "text": "e",
            "probability": 4.4226646423339844e-05
        },
        {
            "start_logit": -0.399169921875,
            "end_logit": 8.203125,
            "text": "e",
            "probability": 4.315376281738281e-05
        },
        {
            "start_logit": -0.5078125,
            "end_logit": 8.203125,
            "text": "e",
            "probability": 3.8683414459228516e-05
        },
        {
            "start_logit": -0.5078125,
            "end_logit": 8.203125,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.8683414459228516e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -0.9287109375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 2.682209014892578e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -0.9287109375,
            "text": "GBs",
            "probability": 2.682209014892578e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -0.94140625,
            "text": "GBs",
            "probability": 2.6404857635498047e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -0.9580078125,
            "text": "GBs",
            "probability": 2.5987625122070312e-05
        },
        {
            "start_logit": -5.42578125,
            "end_logit": 8.203125,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -5.515625,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.46484375,
            "end_logit": 8.203125,
            "text": "hape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.46484375,
            "end_logit": 8.203125,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.5,
            "end_logit": 8.203125,
            "text": ". Additional genomes can easily be added using the GBshape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -5.64453125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -5.67578125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -5.67578125,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 2.384185791015625e-07
        }
    ],
    "56c8f4615795f9a73e00001a_16": [
        {
            "start_logit": 8.2578125,
            "end_logit": 8.203125,
            "text": "GBshape",
            "probability": 0.25
        },
        {
            "start_logit": 8.2578125,
            "end_logit": 8.203125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.25
        },
        {
            "start_logit": 8.2578125,
            "end_logit": 8.203125,
            "text": "GBshape",
            "probability": 0.25
        },
        {
            "start_logit": 8.2578125,
            "end_logit": 8.203125,
            "text": "GBshape",
            "probability": 0.25
        },
        {
            "start_logit": -0.372314453125,
            "end_logit": 8.203125,
            "text": "e",
            "probability": 4.4226646423339844e-05
        },
        {
            "start_logit": -0.399169921875,
            "end_logit": 8.203125,
            "text": "e",
            "probability": 4.315376281738281e-05
        },
        {
            "start_logit": -0.5078125,
            "end_logit": 8.203125,
            "text": "e",
            "probability": 3.8683414459228516e-05
        },
        {
            "start_logit": -0.5078125,
            "end_logit": 8.203125,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.8683414459228516e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -0.9287109375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 2.682209014892578e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -0.9287109375,
            "text": "GBs",
            "probability": 2.682209014892578e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -0.94140625,
            "text": "GBs",
            "probability": 2.6404857635498047e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -0.9580078125,
            "text": "GBs",
            "probability": 2.5987625122070312e-05
        },
        {
            "start_logit": -5.42578125,
            "end_logit": 8.203125,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -5.515625,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.46484375,
            "end_logit": 8.203125,
            "text": "hape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.46484375,
            "end_logit": 8.203125,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.5,
            "end_logit": 8.203125,
            "text": ". Additional genomes can easily be added using the GBshape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -5.64453125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -5.67578125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -5.67578125,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 2.384185791015625e-07
        }
    ],
    "56c8f4615795f9a73e00001a_17": [
        {
            "start_logit": 8.2578125,
            "end_logit": 8.203125,
            "text": "GBshape",
            "probability": 0.25
        },
        {
            "start_logit": 8.2578125,
            "end_logit": 8.203125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.25
        },
        {
            "start_logit": 8.2578125,
            "end_logit": 8.203125,
            "text": "GBshape",
            "probability": 0.25
        },
        {
            "start_logit": 8.2578125,
            "end_logit": 8.203125,
            "text": "GBshape",
            "probability": 0.25
        },
        {
            "start_logit": -0.372314453125,
            "end_logit": 8.203125,
            "text": "e",
            "probability": 4.4226646423339844e-05
        },
        {
            "start_logit": -0.399169921875,
            "end_logit": 8.203125,
            "text": "e",
            "probability": 4.315376281738281e-05
        },
        {
            "start_logit": -0.5078125,
            "end_logit": 8.203125,
            "text": "e",
            "probability": 3.8683414459228516e-05
        },
        {
            "start_logit": -0.5078125,
            "end_logit": 8.203125,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 3.8683414459228516e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -0.9287109375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 2.682209014892578e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -0.9287109375,
            "text": "GBs",
            "probability": 2.682209014892578e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -0.94140625,
            "text": "GBs",
            "probability": 2.6404857635498047e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -0.9580078125,
            "text": "GBs",
            "probability": 2.5987625122070312e-05
        },
        {
            "start_logit": -5.42578125,
            "end_logit": 8.203125,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -5.515625,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.46484375,
            "end_logit": 8.203125,
            "text": "hape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.46484375,
            "end_logit": 8.203125,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.5,
            "end_logit": 8.203125,
            "text": ". Additional genomes can easily be added using the GBshape",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -5.64453125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -5.67578125,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -5.67578125,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 2.384185791015625e-07
        }
    ],
    "56c8f4615795f9a73e00001a_18": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1796875,
            "text": "GBshape",
            "probability": 1.0
        },
        {
            "start_logit": -0.81787109375,
            "end_logit": 8.1796875,
            "text": "e",
            "probability": 0.00011777877807617188
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.2021484375,
            "text": "GBs",
            "probability": 8.416175842285156e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.54296875,
            "text": "GBshap",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.65234375,
            "end_logit": 8.1796875,
            "text": "hape",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.19921875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.375,
            "text": "GBshape can",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.40234375,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.4140625,
            "text": "GBshape can be",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.421875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.53125,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.56640625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.57421875,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.62109375,
            "text": "GBshape can be used to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.6640625,
            "text": "GBshape can be used to visualize DNA shape annotations qualitatively in a genome browser track",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.81787109375,
            "end_logit": -7.19921875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format",
            "probability": 0.0
        },
        {
            "start_logit": -0.81787109375,
            "end_logit": -7.375,
            "text": "e can",
            "probability": 0.0
        },
        {
            "start_logit": -0.81787109375,
            "end_logit": -7.40234375,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format,",
            "probability": 0.0
        },
        {
            "start_logit": -0.81787109375,
            "end_logit": -7.4140625,
            "text": "e can be",
            "probability": 0.0
        },
        {
            "start_logit": -0.81787109375,
            "end_logit": -7.421875,
            "text": "e can be used to visualize DNA shape annotations qualitatively in a genome browser track format, and",
            "probability": 0.0
        }
    ],
    "56c8f4615795f9a73e00001a_19": [
        {
            "start_logit": 8.25,
            "end_logit": 8.1875,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1875,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": -0.51220703125,
            "end_logit": 8.1875,
            "text": "e",
            "probability": 5.2034854888916016e-05
        },
        {
            "start_logit": -0.638671875,
            "end_logit": 8.1875,
            "text": "e",
            "probability": 4.589557647705078e-05
        },
        {
            "start_logit": -0.638671875,
            "end_logit": 8.1875,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 4.589557647705078e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.0068359375,
            "text": "GBs",
            "probability": 3.3855438232421875e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.0068359375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 3.355741500854492e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.05078125,
            "text": "GBs",
            "probability": 3.2007694244384766e-05
        },
        {
            "start_logit": -5.73046875,
            "end_logit": 8.1875,
            "text": "hape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.73046875,
            "end_logit": 8.1875,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -5.8984375,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -5.8984375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.00390625,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.0546875,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.05859375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.06640625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.06640625,
            "end_logit": 8.1875,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.06640625,
            "end_logit": 8.1875,
            "text": "hape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.33203125,
            "text": "GBshape/",
            "probability": 1.7881393432617188e-07
        }
    ],
    "56c8f4615795f9a73e00001a_20": [
        {
            "start_logit": 8.25,
            "end_logit": 8.1875,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1875,
            "text": "GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1875,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 0.333251953125
        },
        {
            "start_logit": -0.51220703125,
            "end_logit": 8.1875,
            "text": "e",
            "probability": 5.2034854888916016e-05
        },
        {
            "start_logit": -0.638671875,
            "end_logit": 8.1875,
            "text": "e",
            "probability": 4.589557647705078e-05
        },
        {
            "start_logit": -0.638671875,
            "end_logit": 8.1875,
            "text": "e; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 4.589557647705078e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.0068359375,
            "text": "GBs",
            "probability": 3.3855438232421875e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.0068359375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBs",
            "probability": 3.355741500854492e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.05078125,
            "text": "GBs",
            "probability": 3.2007694244384766e-05
        },
        {
            "start_logit": -5.73046875,
            "end_logit": 8.1875,
            "text": "hape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.73046875,
            "end_logit": 8.1875,
            "text": "hape; freely available at http://rohslab.cmb.usc.edu/GBshape",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -5.8984375,
            "text": "GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -5.8984375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu/GBshap",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.00390625,
            "text": "GBshape; freely available at http://rohslab.cmb.us",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.0546875,
            "text": "GBshape; freely available at http://rohslab",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.05859375,
            "text": "GBshape; freely available at http://rohslab.cmb.usc.edu",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.06640625,
            "text": "GBshape; freely available at http://rohslab.cmb.usc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.06640625,
            "end_logit": 8.1875,
            "text": "http://rohslab.cmb.usc.edu/GBshape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.06640625,
            "end_logit": 8.1875,
            "text": "hape",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.33203125,
            "text": "GBshape/",
            "probability": 1.7881393432617188e-07
        }
    ],
    "5e36cf8eb5b409ea53000007_1": [
        {
            "start_logit": 6.4765625,
            "end_logit": 6.2421875,
            "text": "melanocytes",
            "probability": 0.265380859375
        },
        {
            "start_logit": 6.484375,
            "end_logit": 6.19140625,
            "text": "melanocytes",
            "probability": 0.253173828125
        },
        {
            "start_logit": 6.453125,
            "end_logit": 6.21484375,
            "text": "melanocytes",
            "probability": 0.253173828125
        },
        {
            "start_logit": 5.58203125,
            "end_logit": 6.2421875,
            "text": "melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes",
            "probability": 0.10888671875
        },
        {
            "start_logit": 6.453125,
            "end_logit": 5.15234375,
            "text": "melanocytes above the haematopoietic niche protect HSPCs from ultraviolet-light-induced DNA damage in aquatic vertebrates and",
            "probability": 0.0875244140625
        },
        {
            "start_logit": 5.58203125,
            "end_logit": 4.41015625,
            "text": "melanocytes",
            "probability": 0.017364501953125
        },
        {
            "start_logit": 4.77734375,
            "end_logit": 4.41015625,
            "text": "melanocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish. Because mutants that lack melanocytes",
            "probability": 0.007762908935546875
        },
        {
            "start_logit": 6.453125,
            "end_logit": 2.248046875,
            "text": "melanocytes above the haematopoietic niche",
            "probability": 0.00478363037109375
        },
        {
            "start_logit": 4.77734375,
            "end_logit": 3.1171875,
            "text": "melanocyte",
            "probability": 0.0021305084228515625
        },
        {
            "start_logit": 0.40478515625,
            "end_logit": 5.15234375,
            "text": "and",
            "probability": 0.00020611286163330078
        },
        {
            "start_logit": 6.484375,
            "end_logit": -3.662109375,
            "text": "melanocytes associated with the haematopoietic niche",
            "probability": 1.33514404296875e-05
        },
        {
            "start_logit": 4.77734375,
            "end_logit": -2.5625,
            "text": "melan",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -4.45703125,
            "text": "melanocytes above the stem cell niche",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": -4.34375,
            "end_logit": 6.2421875,
            "text": ". Because mutants that lack melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -4.34375,
            "end_logit": 6.21484375,
            "text": ". Our studies reveal that melanocytes",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -4.34375,
            "end_logit": 6.19140625,
            "text": ". The umbrella of melanocytes",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -5.078125,
            "end_logit": 6.21484375,
            "text": "reveal that melanocytes",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 5.58203125,
            "end_logit": -4.45703125,
            "text": "melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes above the stem cell niche",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -4.34375,
            "end_logit": 5.15234375,
            "text": ". Our studies reveal that melanocytes above the haematopoietic niche protect HSPCs from ultraviolet-light-induced DNA damage in aquatic vertebrates and",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.453125,
            "end_logit": -6.0859375,
            "text": "melanocytes above the haematopoietic",
            "probability": 1.1324882507324219e-06
        }
    ],
    "5e36cf8eb5b409ea53000007_2": [
        {
            "start_logit": 6.4765625,
            "end_logit": 6.2421875,
            "text": "melanocytes",
            "probability": 0.265380859375
        },
        {
            "start_logit": 6.484375,
            "end_logit": 6.19140625,
            "text": "melanocytes",
            "probability": 0.253173828125
        },
        {
            "start_logit": 6.453125,
            "end_logit": 6.21484375,
            "text": "melanocytes",
            "probability": 0.253173828125
        },
        {
            "start_logit": 5.58203125,
            "end_logit": 6.2421875,
            "text": "melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes",
            "probability": 0.10888671875
        },
        {
            "start_logit": 6.453125,
            "end_logit": 5.15234375,
            "text": "melanocytes above the haematopoietic niche protect HSPCs from ultraviolet-light-induced DNA damage in aquatic vertebrates and",
            "probability": 0.0875244140625
        },
        {
            "start_logit": 5.58203125,
            "end_logit": 4.41015625,
            "text": "melanocytes",
            "probability": 0.017364501953125
        },
        {
            "start_logit": 4.77734375,
            "end_logit": 4.41015625,
            "text": "melanocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish. Because mutants that lack melanocytes",
            "probability": 0.007762908935546875
        },
        {
            "start_logit": 6.453125,
            "end_logit": 2.248046875,
            "text": "melanocytes above the haematopoietic niche",
            "probability": 0.00478363037109375
        },
        {
            "start_logit": 4.77734375,
            "end_logit": 3.1171875,
            "text": "melanocyte",
            "probability": 0.0021305084228515625
        },
        {
            "start_logit": 0.40478515625,
            "end_logit": 5.15234375,
            "text": "and",
            "probability": 0.00020611286163330078
        },
        {
            "start_logit": 6.484375,
            "end_logit": -3.662109375,
            "text": "melanocytes associated with the haematopoietic niche",
            "probability": 1.33514404296875e-05
        },
        {
            "start_logit": 4.77734375,
            "end_logit": -2.5625,
            "text": "melan",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -4.45703125,
            "text": "melanocytes above the stem cell niche",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": -4.34375,
            "end_logit": 6.2421875,
            "text": ". Because mutants that lack melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -4.34375,
            "end_logit": 6.21484375,
            "text": ". Our studies reveal that melanocytes",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -4.34375,
            "end_logit": 6.19140625,
            "text": ". The umbrella of melanocytes",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -5.078125,
            "end_logit": 6.21484375,
            "text": "reveal that melanocytes",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 5.58203125,
            "end_logit": -4.45703125,
            "text": "melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes above the stem cell niche",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -4.34375,
            "end_logit": 5.15234375,
            "text": ". Our studies reveal that melanocytes above the haematopoietic niche protect HSPCs from ultraviolet-light-induced DNA damage in aquatic vertebrates and",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.453125,
            "end_logit": -6.0859375,
            "text": "melanocytes above the haematopoietic",
            "probability": 1.1324882507324219e-06
        }
    ],
    "5e36cf8eb5b409ea53000007_3": [
        {
            "start_logit": 6.4765625,
            "end_logit": 6.2421875,
            "text": "melanocytes",
            "probability": 0.265380859375
        },
        {
            "start_logit": 6.484375,
            "end_logit": 6.19140625,
            "text": "melanocytes",
            "probability": 0.253173828125
        },
        {
            "start_logit": 6.453125,
            "end_logit": 6.21484375,
            "text": "melanocytes",
            "probability": 0.253173828125
        },
        {
            "start_logit": 5.58203125,
            "end_logit": 6.2421875,
            "text": "melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes",
            "probability": 0.10888671875
        },
        {
            "start_logit": 6.453125,
            "end_logit": 5.15234375,
            "text": "melanocytes above the haematopoietic niche protect HSPCs from ultraviolet-light-induced DNA damage in aquatic vertebrates and",
            "probability": 0.0875244140625
        },
        {
            "start_logit": 5.58203125,
            "end_logit": 4.41015625,
            "text": "melanocytes",
            "probability": 0.017364501953125
        },
        {
            "start_logit": 4.77734375,
            "end_logit": 4.41015625,
            "text": "melanocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish. Because mutants that lack melanocytes",
            "probability": 0.007762908935546875
        },
        {
            "start_logit": 6.453125,
            "end_logit": 2.248046875,
            "text": "melanocytes above the haematopoietic niche",
            "probability": 0.00478363037109375
        },
        {
            "start_logit": 4.77734375,
            "end_logit": 3.1171875,
            "text": "melanocyte",
            "probability": 0.0021305084228515625
        },
        {
            "start_logit": 0.40478515625,
            "end_logit": 5.15234375,
            "text": "and",
            "probability": 0.00020611286163330078
        },
        {
            "start_logit": 6.484375,
            "end_logit": -3.662109375,
            "text": "melanocytes associated with the haematopoietic niche",
            "probability": 1.33514404296875e-05
        },
        {
            "start_logit": 4.77734375,
            "end_logit": -2.5625,
            "text": "melan",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -4.45703125,
            "text": "melanocytes above the stem cell niche",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": -4.34375,
            "end_logit": 6.2421875,
            "text": ". Because mutants that lack melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -4.34375,
            "end_logit": 6.21484375,
            "text": ". Our studies reveal that melanocytes",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -4.34375,
            "end_logit": 6.19140625,
            "text": ". The umbrella of melanocytes",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -5.078125,
            "end_logit": 6.21484375,
            "text": "reveal that melanocytes",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 5.58203125,
            "end_logit": -4.45703125,
            "text": "melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes above the stem cell niche",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -4.34375,
            "end_logit": 5.15234375,
            "text": ". Our studies reveal that melanocytes above the haematopoietic niche protect HSPCs from ultraviolet-light-induced DNA damage in aquatic vertebrates and",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.453125,
            "end_logit": -6.0859375,
            "text": "melanocytes above the haematopoietic",
            "probability": 1.1324882507324219e-06
        }
    ],
    "5e36cf8eb5b409ea53000007_4": [
        {
            "start_logit": 6.4765625,
            "end_logit": 6.2421875,
            "text": "melanocytes",
            "probability": 0.265380859375
        },
        {
            "start_logit": 6.484375,
            "end_logit": 6.19140625,
            "text": "melanocytes",
            "probability": 0.253173828125
        },
        {
            "start_logit": 6.453125,
            "end_logit": 6.21484375,
            "text": "melanocytes",
            "probability": 0.253173828125
        },
        {
            "start_logit": 5.58203125,
            "end_logit": 6.2421875,
            "text": "melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes",
            "probability": 0.10888671875
        },
        {
            "start_logit": 6.453125,
            "end_logit": 5.15234375,
            "text": "melanocytes above the haematopoietic niche protect HSPCs from ultraviolet-light-induced DNA damage in aquatic vertebrates and",
            "probability": 0.0875244140625
        },
        {
            "start_logit": 5.58203125,
            "end_logit": 4.41015625,
            "text": "melanocytes",
            "probability": 0.017364501953125
        },
        {
            "start_logit": 4.77734375,
            "end_logit": 4.41015625,
            "text": "melanocyte umbrella above the kidney marrow protects HSPCs against ultraviolet light in zebrafish. Because mutants that lack melanocytes",
            "probability": 0.007762908935546875
        },
        {
            "start_logit": 6.453125,
            "end_logit": 2.248046875,
            "text": "melanocytes above the haematopoietic niche",
            "probability": 0.00478363037109375
        },
        {
            "start_logit": 4.77734375,
            "end_logit": 3.1171875,
            "text": "melanocyte",
            "probability": 0.0021305084228515625
        },
        {
            "start_logit": 0.40478515625,
            "end_logit": 5.15234375,
            "text": "and",
            "probability": 0.00020611286163330078
        },
        {
            "start_logit": 6.484375,
            "end_logit": -3.662109375,
            "text": "melanocytes associated with the haematopoietic niche",
            "probability": 1.33514404296875e-05
        },
        {
            "start_logit": 4.77734375,
            "end_logit": -2.5625,
            "text": "melan",
            "probability": 7.331371307373047e-06
        },
        {
            "start_logit": 6.4765625,
            "end_logit": -4.45703125,
            "text": "melanocytes above the stem cell niche",
            "probability": 5.9604644775390625e-06
        },
        {
            "start_logit": -4.34375,
            "end_logit": 6.2421875,
            "text": ". Because mutants that lack melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": -4.34375,
            "end_logit": 6.21484375,
            "text": ". Our studies reveal that melanocytes",
            "probability": 5.185604095458984e-06
        },
        {
            "start_logit": -4.34375,
            "end_logit": 6.19140625,
            "text": ". The umbrella of melanocytes",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": -5.078125,
            "end_logit": 6.21484375,
            "text": "reveal that melanocytes",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 5.58203125,
            "end_logit": -4.45703125,
            "text": "melanocytes have normal steady-state haematopoiesis under standard laboratory conditions, we hypothesized that melanocytes above the stem cell niche",
            "probability": 2.4437904357910156e-06
        },
        {
            "start_logit": -4.34375,
            "end_logit": 5.15234375,
            "text": ". Our studies reveal that melanocytes above the haematopoietic niche protect HSPCs from ultraviolet-light-induced DNA damage in aquatic vertebrates and",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 6.453125,
            "end_logit": -6.0859375,
            "text": "melanocytes above the haematopoietic",
            "probability": 1.1324882507324219e-06
        }
    ],
    "54ff45966ad7dcbc12000010_1": [
        {
            "start_logit": 7.3984375,
            "end_logit": 2.529296875,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor LEKTI",
            "probability": 0.57763671875
        },
        {
            "start_logit": 7.3984375,
            "end_logit": 2.171875,
            "text": "SPINK5",
            "probability": 0.4033203125
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -1.17578125,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5)",
            "probability": 0.01418304443359375
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -2.861328125,
            "text": "SPIN",
            "probability": 0.00263214111328125
        },
        {
            "start_logit": 1.357421875,
            "end_logit": 2.529296875,
            "text": "LEKTI",
            "probability": 0.0013713836669921875
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.62109375,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor",
            "probability": 0.00016570091247558594
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -5.94921875,
            "text": "SPINK",
            "probability": 0.00011938810348510742
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -6.03125,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease",
            "probability": 0.00011038780212402344
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -6.078125,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor LEKT",
            "probability": 0.00010532140731811523
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -6.984375,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor LEKTI (lymphoepithelial Kazal",
            "probability": 4.2557716369628906e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -7.015625,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor LEKTI (lymphoepithelial Kazal type",
            "probability": 4.124641418457031e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -7.0859375,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5",
            "probability": 3.844499588012695e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -7.125,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes for",
            "probability": 3.695487976074219e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -7.2734375,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which",
            "probability": 3.1888484954833984e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -7.3046875,
            "text": "SPINK5 (serine protease inhibitor Kazal type 5) which encodes",
            "probability": 3.0875205993652344e-05
        },
        {
            "start_logit": 7.3984375,
            "end_logit": -7.34375,
            "text": "SPINK5 (serine protease",
            "probability": 2.968311309814453e-05
        },
        {
            "start_logit": 1.357421875,
            "end_logit": -1.7568359375,
            "text": "LEKTI (lymphoepithelial Kazal type-related inhibitor",
            "probability": 1.8894672393798828e-05
        },
        {
            "start_logit": -5.67578125,
            "end_logit": 2.529296875,
            "text": "(serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor LEKTI",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 1.357421875,
            "end_logit": -5.35546875,
            "text": "LEKTI (lymphoepithelial Kazal type-related inhibitor)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.55078125,
            "end_logit": 2.529296875,
            "text": "mutations in the gene SPINK5 (serine protease inhibitor Kazal type 5) which encodes for a serine protease inhibitor LEKTI",
            "probability": 5.364418029785156e-07
        }
    ],
    "54ff45966ad7dcbc12000010_2": [
        {
            "start_logit": 4.8203125,
            "end_logit": 5.13671875,
            "text": "LEKTI) deficiency cause NS.",
            "probability": 0.71337890625
        },
        {
            "start_logit": 4.8203125,
            "end_logit": 4.171875,
            "text": "LEKTI",
            "probability": 0.27294921875
        },
        {
            "start_logit": 0.03167724609375,
            "end_logit": 5.13671875,
            "text": "SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI) deficiency cause NS.",
            "probability": 0.005962371826171875
        },
        {
            "start_logit": 4.8203125,
            "end_logit": -0.34814453125,
            "text": "LEKTI)",
            "probability": 0.002971649169921875
        },
        {
            "start_logit": 0.03167724609375,
            "end_logit": 4.171875,
            "text": "SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 0.0022716522216796875
        },
        {
            "start_logit": 4.8203125,
            "end_logit": -1.943359375,
            "text": "LEKTI) deficiency",
            "probability": 0.0006017684936523438
        },
        {
            "start_logit": -2.287109375,
            "end_logit": 5.13671875,
            "text": ".",
            "probability": 0.0005879402160644531
        },
        {
            "start_logit": -2.712890625,
            "end_logit": 5.13671875,
            "text": "lymphoepithelial Kazal-type-related inhibitor (LEKTI) deficiency cause NS.",
            "probability": 0.00038242340087890625
        },
        {
            "start_logit": -3.259765625,
            "end_logit": 5.13671875,
            "text": ") deficiency cause NS.",
            "probability": 0.00022137165069580078
        },
        {
            "start_logit": -2.712890625,
            "end_logit": 4.171875,
            "text": "lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 0.0001462697982788086
        },
        {
            "start_logit": -4.609375,
            "end_logit": 5.13671875,
            "text": "(LEKTI) deficiency cause NS.",
            "probability": 5.7756900787353516e-05
        },
        {
            "start_logit": -4.62890625,
            "end_logit": 5.13671875,
            "text": "(SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI) deficiency cause NS.",
            "probability": 5.638599395751953e-05
        },
        {
            "start_logit": -4.6328125,
            "end_logit": 5.13671875,
            "text": "to lymphoepithelial Kazal-type-related inhibitor (LEKTI) deficiency cause NS.",
            "probability": 5.59687614440918e-05
        },
        {
            "start_logit": -4.72265625,
            "end_logit": 5.13671875,
            "text": "I) deficiency cause NS.",
            "probability": 5.137920379638672e-05
        },
        {
            "start_logit": 1.49609375,
            "end_logit": -1.6796875,
            "text": "Mutations in the serine protease inhibitor Kazal type 5 (SPINK5)",
            "probability": 2.8133392333984375e-05
        },
        {
            "start_logit": 0.03167724609375,
            "end_logit": -0.34814453125,
            "text": "SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI)",
            "probability": 2.485513687133789e-05
        },
        {
            "start_logit": 4.8203125,
            "end_logit": -5.20703125,
            "text": "LE",
            "probability": 2.294778823852539e-05
        },
        {
            "start_logit": -4.609375,
            "end_logit": 4.171875,
            "text": "(LEKTI",
            "probability": 2.187490463256836e-05
        },
        {
            "start_logit": -4.62890625,
            "end_logit": 4.171875,
            "text": "(SPINK5) gene leading to lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 2.1576881408691406e-05
        },
        {
            "start_logit": -4.6328125,
            "end_logit": 4.171875,
            "text": "to lymphoepithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 2.1398067474365234e-05
        }
    ],
    "54ff45966ad7dcbc12000010_3": [
        {
            "start_logit": 8.1796875,
            "end_logit": 8.0859375,
            "text": "LEKTI",
            "probability": 0.97607421875
        },
        {
            "start_logit": 4.4453125,
            "end_logit": 8.0859375,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI",
            "probability": 0.0233306884765625
        },
        {
            "start_logit": -1.208984375,
            "end_logit": 8.0859375,
            "text": "I",
            "probability": 8.153915405273438e-05
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -1.47265625,
            "text": "LE",
            "probability": 6.866455078125e-05
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -3.787109375,
            "text": "LEKTI in the skin and all stratified epithelial tissues.",
            "probability": 6.794929504394531e-06
        },
        {
            "start_logit": 4.4453125,
            "end_logit": -1.13671875,
            "text": "SPINK5",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 4.4453125,
            "end_logit": -1.47265625,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LE",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -6.015625,
            "text": "LEKTI in",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.13671875,
            "end_logit": 8.0859375,
            "text": "K5 gene and to the consequent lack of expression of its encoded protein LEKTI",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.1640625,
            "end_logit": 8.0859375,
            "text": "KTI",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -6.8828125,
            "text": "LEKT",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.1328125,
            "end_logit": 8.0859375,
            "text": "protein LEKTI",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.33984375,
            "text": "LEKTI in the skin and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.41015625,
            "text": "LEKTI in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1796875,
            "end_logit": -7.42578125,
            "text": "LEKTI in the skin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.0859375,
            "text": "the SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.0859375,
            "text": "loss-of-function mutations in the SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 8.0859375,
            "text": "due to loss-of-function mutations in the SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.41796875,
            "end_logit": 8.0859375,
            "text": "NS is due to loss-of-function mutations in the SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.4453125,
            "end_logit": -3.787109375,
            "text": "SPINK5 gene and to the consequent lack of expression of its encoded protein LEKTI in the skin and all stratified epithelial tissues.",
            "probability": 1.7881393432617188e-07
        }
    ],
    "54ff45966ad7dcbc12000010_4": [
        {
            "start_logit": 6.65234375,
            "end_logit": 7.7890625,
            "text": "LEKTI",
            "probability": 1.0
        },
        {
            "start_logit": -1.5,
            "end_logit": 7.7890625,
            "text": "Lympho-epithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 0.0002892017364501953
        },
        {
            "start_logit": -2.11328125,
            "end_logit": 7.7890625,
            "text": "I",
            "probability": 0.00015604496002197266
        },
        {
            "start_logit": -4.97265625,
            "end_logit": 7.7890625,
            "text": "(LEKTI",
            "probability": 8.940696716308594e-06
        },
        {
            "start_logit": 6.65234375,
            "end_logit": -4.11328125,
            "text": "LE",
            "probability": 6.794929504394531e-06
        },
        {
            "start_logit": 6.65234375,
            "end_logit": -4.51953125,
            "text": "LEKTI)",
            "probability": 4.5299530029296875e-06
        },
        {
            "start_logit": 6.65234375,
            "end_logit": -4.734375,
            "text": "LEKTI) is the defective protein of the ichthyosiform condition Netherton syndrome (NS).",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": -6.328125,
            "end_logit": 7.7890625,
            "text": "KTI",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -7.140625,
            "end_logit": 7.7890625,
            "text": "Kazal-type-related inhibitor (LEKTI",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 7.7890625,
            "text": "zal-type-related inhibitor (LEKTI",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 7.7890625,
            "text": "epithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.52734375,
            "end_logit": 7.7890625,
            "text": "related inhibitor (LEKTI",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 7.7890625,
            "text": "-epithelial Kazal-type-related inhibitor (LEKTI",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.65234375,
            "end_logit": -6.59765625,
            "text": "LEKT",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.65234375,
            "end_logit": -7.375,
            "text": "LEKTI) is",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.65234375,
            "end_logit": -7.38671875,
            "text": "LEKTI) is the defective protein of the ichthyosiform",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.65234375,
            "end_logit": -7.40234375,
            "text": "LEKTI) is the defective protein of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.65234375,
            "end_logit": -7.41015625,
            "text": "LEKTI) is the defective protein of the ichthyosi",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.65234375,
            "end_logit": -7.47265625,
            "text": "LEKTI) is the defective protein",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.65234375,
            "end_logit": -7.546875,
            "text": "LEKTI) is the defective protein of the ichthy",
            "probability": 2.384185791015625e-07
        }
    ],
    "54ff45966ad7dcbc12000010_5": [
        {
            "start_logit": 8.046875,
            "end_logit": 7.92578125,
            "text": "LEKTI",
            "probability": 1.0
        },
        {
            "start_logit": 8.046875,
            "end_logit": -1.8701171875,
            "text": "LE",
            "probability": 5.561113357543945e-05
        },
        {
            "start_logit": -1.923828125,
            "end_logit": 7.92578125,
            "text": "I",
            "probability": 4.684925079345703e-05
        },
        {
            "start_logit": -4.2890625,
            "end_logit": 7.92578125,
            "text": "Deficiency in the serine protease inhibitor LEKTI",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 8.046875,
            "end_logit": -4.44140625,
            "text": "LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum and chronic inflammation.",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -6.234375,
            "end_logit": 7.92578125,
            "text": "KTI",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -6.8046875,
            "text": "LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -7.15625,
            "text": "LEKT",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -7.4296875,
            "text": "LEKTI is the etiological origin of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -7.4609375,
            "text": "LEKTI is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 7.92578125,
            "text": "serine protease inhibitor LEKTI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -7.47265625,
            "text": "LEKTI is the etiological origin",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -7.61328125,
            "text": "LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -7.63671875,
            "text": "LEKTI is the etiological origin of Netherton",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -7.63671875,
            "text": "LEKTI is the etiological origin of Netherton syndrome, which causes detachment of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -7.63671875,
            "text": "LEKTI is the etiological origin of Netherton syndrome, which causes detachment of the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.046875,
            "end_logit": -7.640625,
            "text": "LEKTI is the etiological origin of Netherton syndrome, which",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.2890625,
            "end_logit": -1.8701171875,
            "text": "Deficiency in the serine protease inhibitor LE",
            "probability": 0.0
        },
        {
            "start_logit": -1.923828125,
            "end_logit": -4.44140625,
            "text": "I is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum and chronic inflammation.",
            "probability": 0.0
        },
        {
            "start_logit": -1.923828125,
            "end_logit": -6.8046875,
            "text": "I is the etiological origin of Netherton syndrome, which causes detachment of the stratum corneum",
            "probability": 0.0
        }
    ],
    "53175e9fb166e2b80600000a_1": [
        {
            "start_logit": 5.203125,
            "end_logit": 4.83984375,
            "text": "Wnt-signaling pathway",
            "probability": 0.82568359375
        },
        {
            "start_logit": 3.6484375,
            "end_logit": 4.83984375,
            "text": "Recent functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 0.173095703125
        },
        {
            "start_logit": 5.203125,
            "end_logit": -2.140625,
            "text": "Wnt-signaling pathway and",
            "probability": 0.0007648468017578125
        },
        {
            "start_logit": 3.6484375,
            "end_logit": -2.140625,
            "text": "Recent functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway and",
            "probability": 0.0001615285873413086
        },
        {
            "start_logit": -3.505859375,
            "end_logit": 4.83984375,
            "text": "controlling the Wnt-signaling pathway",
            "probability": 0.0001360177993774414
        },
        {
            "start_logit": -2.32421875,
            "end_logit": 3.5546875,
            "text": ".",
            "probability": 0.00012290477752685547
        },
        {
            "start_logit": -4.83203125,
            "end_logit": 4.83984375,
            "text": "LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 3.606081008911133e-05
        },
        {
            "start_logit": 5.203125,
            "end_logit": -5.26171875,
            "text": "Wnt",
            "probability": 3.361701965332031e-05
        },
        {
            "start_logit": 3.6484375,
            "end_logit": -3.845703125,
            "text": "Recent",
            "probability": 2.944469451904297e-05
        },
        {
            "start_logit": -5.4453125,
            "end_logit": 4.83984375,
            "text": "pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 1.9431114196777344e-05
        },
        {
            "start_logit": -5.6171875,
            "end_logit": 4.83984375,
            "text": "pathway",
            "probability": 1.6391277313232422e-05
        },
        {
            "start_logit": 5.203125,
            "end_logit": -6.65234375,
            "text": "Wnt-signaling pathway and activation",
            "probability": 8.344650268554688e-06
        },
        {
            "start_logit": -6.37890625,
            "end_logit": 4.83984375,
            "text": "the Wnt-signaling pathway",
            "probability": 7.68899917602539e-06
        },
        {
            "start_logit": 5.203125,
            "end_logit": -6.79296875,
            "text": "Wnt-signaling pathway and activation of the pathway as a consequence of LKB1 haploinsufficiency might",
            "probability": 7.271766662597656e-06
        },
        {
            "start_logit": 3.6484375,
            "end_logit": -5.26171875,
            "text": "Recent functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt",
            "probability": 7.152557373046875e-06
        },
        {
            "start_logit": -6.50390625,
            "end_logit": 4.83984375,
            "text": "have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 6.794929504394531e-06
        },
        {
            "start_logit": -6.515625,
            "end_logit": 4.83984375,
            "text": "functional genetic studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": 5.203125,
            "end_logit": -7.01171875,
            "text": "Wnt-signaling",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 4.83984375,
            "text": "studies have pointed out that LKB1 plays a physiological role in controlling the Wnt-signaling pathway",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": 5.203125,
            "end_logit": -7.15625,
            "text": "Wnt-signaling pathway and activation of the pathway as a consequence of LKB1 haploinsufficiency might be",
            "probability": 5.066394805908203e-06
        }
    ],
    "5a9d31711d1251d03b00001c_1": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.1640625,
            "text": "100 nm",
            "probability": 1.0
        },
        {
            "start_logit": -1.109375,
            "end_logit": 8.1640625,
            "text": "nm",
            "probability": 8.958578109741211e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.1875,
            "text": "100",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": -6.1953125,
            "end_logit": 8.1640625,
            "text": "diamtere of 100 nm",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.92578125,
            "end_logit": 8.1640625,
            "text": "tere of 100 nm",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.09765625,
            "end_logit": 8.1640625,
            "text": "attained their maximum diamtere of 100 nm",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.265625,
            "text": "100 nm.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.23828125,
            "end_logit": 8.1640625,
            "text": "maximum diamtere of 100 nm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 8.1640625,
            "text": "they attained their maximum diamtere of 100 nm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 8.1640625,
            "text": "the vesicles increased until they attained their maximum diamtere of 100 nm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 8.1640625,
            "text": "the size of the vesicles increased until they attained their maximum diamtere of 100 nm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.40234375,
            "end_logit": 8.1640625,
            "text": "of 100 nm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 8.1640625,
            "text": "relatively constant while the size of the vesicles increased until they attained their maximum diamtere of 100 nm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 8.1640625,
            "text": "until they attained their maximum diamtere of 100 nm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46484375,
            "end_logit": 8.1640625,
            "text": "their maximum diamtere of 100 nm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 8.1640625,
            "text": "vesicles increased until they attained their maximum diamtere of 100 nm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 8.1640625,
            "text": "number remained relatively constant while the size of the vesicles increased until they attained their maximum diamtere of 100 nm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.1640625,
            "text": "constant while the size of the vesicles increased until they attained their maximum diamtere of 100 nm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.1640625,
            "text": "while the size of the vesicles increased until they attained their maximum diamtere of 100 nm",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.1953125,
            "end_logit": -1.1875,
            "text": "diamtere of 100",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_1": [
        {
            "start_logit": 7.96484375,
            "end_logit": 8.0390625,
            "text": "intravenous drug abuse",
            "probability": 1.0
        },
        {
            "start_logit": -1.642578125,
            "end_logit": 8.0390625,
            "text": "abuse",
            "probability": 6.765127182006836e-05
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -2.064453125,
            "text": "intravenous",
            "probability": 4.100799560546875e-05
        },
        {
            "start_logit": -3.85546875,
            "end_logit": 8.0390625,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -4.20703125,
            "text": "intravenous drug abuse.",
            "probability": 4.827976226806641e-06
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 8.0390625,
            "text": "drug abuse",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.56640625,
            "end_logit": 8.0390625,
            "text": "complication of intravenous drug abuse",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.328125,
            "end_logit": 8.0390625,
            "text": "y hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.265625,
            "text": "intravenous drug",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 8.0390625,
            "text": "unrecognized complication of intravenous drug abuse",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.0390625,
            "text": "an unrecognized complication of intravenous drug abuse",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 8.0390625,
            "text": "syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 8.0390625,
            "text": "of intravenous drug abuse",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 8.0390625,
            "text": "hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.642578125,
            "end_logit": -4.20703125,
            "text": "abuse.",
            "probability": 0.0
        },
        {
            "start_logit": -3.85546875,
            "end_logit": -2.064453125,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous",
            "probability": 0.0
        },
        {
            "start_logit": -3.85546875,
            "end_logit": -4.20703125,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug abuse.",
            "probability": 0.0
        },
        {
            "start_logit": -6.56640625,
            "end_logit": -2.064453125,
            "text": "complication of intravenous",
            "probability": 0.0
        },
        {
            "start_logit": -7.328125,
            "end_logit": -2.064453125,
            "text": "y hand syndrome is an unrecognized complication of intravenous",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -2.064453125,
            "text": "unrecognized complication of intravenous",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_2": [
        {
            "start_logit": 6.3203125,
            "end_logit": 8.0703125,
            "text": "intravenous drug abuse",
            "probability": 1.0
        },
        {
            "start_logit": -1.515625,
            "end_logit": 8.0703125,
            "text": "abuse",
            "probability": 0.0003952980041503906
        },
        {
            "start_logit": -6.05859375,
            "end_logit": 8.0703125,
            "text": "drug abuse",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -6.19140625,
            "end_logit": 8.0703125,
            "text": "complication of intravenous drug abuse",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -4.7265625,
            "text": "intravenous",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -5.39453125,
            "text": "intravenous drug abuse, which has no current available treatment.",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.27734375,
            "end_logit": 8.0703125,
            "text": "Puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 8.0703125,
            "text": ": Puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 8.0703125,
            "text": "BACKGROUND: Puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 8.0703125,
            "text": "of intravenous drug abuse",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 8.0703125,
            "text": "y hand syndrome is a complication of intravenous drug abuse",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.36328125,
            "text": "intravenous drug abuse,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.56640625,
            "text": "intravenous drug abuse, which has no",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.58203125,
            "text": "intravenous drug abuse, which has no current available",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.64453125,
            "text": "intravenous drug abuse, which has no current",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.6953125,
            "text": "intravenous drug",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.77734375,
            "text": "intravenous drug abuse, which has",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.80078125,
            "text": "intravenous drug abuse, which",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 6.3203125,
            "end_logit": -7.828125,
            "text": "intravenous drug abuse, which has no current available treatment",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.515625,
            "end_logit": -5.39453125,
            "text": "abuse, which has no current available treatment.",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_3": [
        {
            "start_logit": 6.91796875,
            "end_logit": 8.0234375,
            "text": "intravenous drug abuse",
            "probability": 0.9990234375
        },
        {
            "start_logit": -1.0263671875,
            "end_logit": 8.0234375,
            "text": "Puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 0.0003554821014404297
        },
        {
            "start_logit": -1.6796875,
            "end_logit": 8.0234375,
            "text": "abuse",
            "probability": 0.0001850128173828125
        },
        {
            "start_logit": 6.91796875,
            "end_logit": -3.740234375,
            "text": "intravenous drug abuse, which has no current available treatment.",
            "probability": 7.808208465576172e-06
        },
        {
            "start_logit": 6.91796875,
            "end_logit": -4.00390625,
            "text": "intravenous",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": -6.44921875,
            "end_logit": 8.0234375,
            "text": "drug abuse",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -6.65625,
            "end_logit": 8.0234375,
            "text": "complication of intravenous drug abuse",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.53125,
            "end_logit": 8.0234375,
            "text": "y hand syndrome is a complication of intravenous drug abuse",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.91796875,
            "end_logit": -6.53515625,
            "text": "intravenous drug abuse,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 8.0234375,
            "text": "of intravenous drug abuse",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 8.0234375,
            "text": "syndrome is a complication of intravenous drug abuse",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.91796875,
            "end_logit": -7.3515625,
            "text": "intravenous drug abuse, which has no",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 6.91796875,
            "end_logit": -7.38671875,
            "text": "intravenous drug abuse, which has no current available",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.91796875,
            "end_logit": -7.48046875,
            "text": "intravenous drug abuse, which has no current",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.91796875,
            "end_logit": -7.484375,
            "text": "intravenous drug",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.91796875,
            "end_logit": -7.5234375,
            "text": "intravenous drug abuse, which",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.91796875,
            "end_logit": -7.5625,
            "text": "intravenous drug abuse, which has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 6.91796875,
            "end_logit": -7.6796875,
            "text": "intravenous drug abuse, which has no current available treatment",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.0263671875,
            "end_logit": -3.740234375,
            "text": "Puffy hand syndrome is a complication of intravenous drug abuse, which has no current available treatment.",
            "probability": 0.0
        },
        {
            "start_logit": -1.0263671875,
            "end_logit": -4.00390625,
            "text": "Puffy hand syndrome is a complication of intravenous",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_4": [
        {
            "start_logit": 7.96484375,
            "end_logit": 8.0390625,
            "text": "intravenous drug abuse",
            "probability": 1.0
        },
        {
            "start_logit": -1.642578125,
            "end_logit": 8.0390625,
            "text": "abuse",
            "probability": 6.765127182006836e-05
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -2.064453125,
            "text": "intravenous",
            "probability": 4.100799560546875e-05
        },
        {
            "start_logit": -3.85546875,
            "end_logit": 8.0390625,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 7.3909759521484375e-06
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -4.20703125,
            "text": "intravenous drug abuse.",
            "probability": 4.827976226806641e-06
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 8.0390625,
            "text": "drug abuse",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.56640625,
            "end_logit": 8.0390625,
            "text": "complication of intravenous drug abuse",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.328125,
            "end_logit": 8.0390625,
            "text": "y hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.96484375,
            "end_logit": -7.265625,
            "text": "intravenous drug",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 8.0390625,
            "text": "unrecognized complication of intravenous drug abuse",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 8.0390625,
            "text": "an unrecognized complication of intravenous drug abuse",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.66015625,
            "end_logit": 8.0390625,
            "text": "syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 8.0390625,
            "text": "of intravenous drug abuse",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 8.0390625,
            "text": "hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.642578125,
            "end_logit": -4.20703125,
            "text": "abuse.",
            "probability": 0.0
        },
        {
            "start_logit": -3.85546875,
            "end_logit": -2.064453125,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous",
            "probability": 0.0
        },
        {
            "start_logit": -3.85546875,
            "end_logit": -4.20703125,
            "text": "Puffy hand syndrome is an unrecognized complication of intravenous drug abuse.",
            "probability": 0.0
        },
        {
            "start_logit": -6.56640625,
            "end_logit": -2.064453125,
            "text": "complication of intravenous",
            "probability": 0.0
        },
        {
            "start_logit": -7.328125,
            "end_logit": -2.064453125,
            "text": "y hand syndrome is an unrecognized complication of intravenous",
            "probability": 0.0
        },
        {
            "start_logit": -7.51171875,
            "end_logit": -2.064453125,
            "text": "unrecognized complication of intravenous",
            "probability": 0.0
        }
    ],
    "5a7346662dc08e987e00001a_5": [
        {
            "start_logit": -0.6484375,
            "end_logit": 7.921875,
            "text": "puffy hand syndrome is an unrecognized complication of intravenous drug abuse",
            "probability": 0.720703125
        },
        {
            "start_logit": -1.630859375,
            "end_logit": 7.921875,
            "text": "abuse",
            "probability": 0.269287109375
        },
        {
            "start_logit": -5.875,
            "end_logit": 7.921875,
            "text": "intravenous drug abuse",
            "probability": 0.0038700103759765625
        },
        {
            "start_logit": -6.33984375,
            "end_logit": 7.921875,
            "text": "complication of intravenous drug abuse",
            "probability": 0.0024318695068359375
        },
        {
            "start_logit": -6.6328125,
            "end_logit": 7.921875,
            "text": "drug abuse",
            "probability": 0.0018138885498046875
        },
        {
            "start_logit": -7.171875,
            "end_logit": 7.921875,
            "text": "of intravenous drug abuse",
            "probability": 0.0010585784912109375
        },
        {
            "start_logit": -7.3125,
            "end_logit": 7.921875,
            "text": "an unrecognized complication of intravenous drug abuse",
            "probability": 0.000919342041015625
        },
        {
            "start_logit": -0.6484375,
            "end_logit": -6.30078125,
            "text": "puffy hand syndrome is an unrecognized complication of intravenous drug abuse this painless syndrome appears during or after a long period of drug addiction",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -0.6484375,
            "end_logit": -6.9609375,
            "text": "puffy hand syndrome is an unrecognized complication of intravenous drug abuse this painless syndrome appears during or after a long period of drug",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -1.630859375,
            "end_logit": -6.30078125,
            "text": "abuse this painless syndrome appears during or after a long period of drug addiction",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.6484375,
            "end_logit": -7.29296875,
            "text": "puffy hand syndrome is an unrecognized complication of intravenous drug abuse this",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.6484375,
            "end_logit": -7.33984375,
            "text": "puffy hand syndrome is an unrecognized complication of intravenous drug abuse this painless syndrome appears during or after a long period of drug addiction it involves the hands",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -0.6484375,
            "end_logit": -7.4609375,
            "text": "puffy hand syndrome is an unrecognized complication of intravenous drug abuse this painless syndrome appears during or after a long period of drug addiction it involves the hands and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.6484375,
            "end_logit": -7.48828125,
            "text": "puffy hand syndrome is an unrecognized complication of intravenous drug abuse this painless",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.630859375,
            "end_logit": -6.9609375,
            "text": "abuse this painless syndrome appears during or after a long period of drug",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.630859375,
            "end_logit": -7.0546875,
            "text": "abuse this painless syndrome appears during or after a long period of drug addiction it involves the hands and sometimes the forearms and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.630859375,
            "end_logit": -7.29296875,
            "text": "abuse this",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.630859375,
            "end_logit": -7.33984375,
            "text": "abuse this painless syndrome appears during or after a long period of drug addiction it involves the hands",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.630859375,
            "end_logit": -7.4609375,
            "text": "abuse this painless syndrome appears during or after a long period of drug addiction it involves the hands and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.630859375,
            "end_logit": -7.48828125,
            "text": "abuse this painless",
            "probability": 5.960464477539063e-08
        }
    ],
    "5a7346662dc08e987e00001a_6": [
        {
            "start_logit": -2.0390625,
            "end_logit": 7.63671875,
            "text": "abuse",
            "probability": 0.49267578125
        },
        {
            "start_logit": -2.431640625,
            "end_logit": 7.63671875,
            "text": "intravenous drug abuse",
            "probability": 0.33203125
        },
        {
            "start_logit": -3.119140625,
            "end_logit": 7.63671875,
            "text": "puffy hand syndrome is a complication of intravenous drug abuse",
            "probability": 0.1669921875
        },
        {
            "start_logit": -6.13671875,
            "end_logit": 7.63671875,
            "text": "complication of intravenous drug abuse",
            "probability": 0.00818634033203125
        },
        {
            "start_logit": -4.21875,
            "end_logit": -2.1484375,
            "text": "intravenous drug users",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": -3.21484375,
            "end_logit": -3.68359375,
            "text": "multilayer bandaging",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -5.11328125,
            "end_logit": -2.1484375,
            "text": "both intravenous drug users",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -4.21875,
            "end_logit": -3.68359375,
            "text": "intravenous drug users with puffy hand syndrome were hospitalized for 11 days treatment included daily multilayer bandaging",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -2.0390625,
            "end_logit": -6.1640625,
            "text": "abuse which has no current available treatment arm and forearm edema",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -3.21484375,
            "end_logit": -5.05859375,
            "text": "multilayer bandaging lymphedema",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -4.89453125,
            "end_logit": -3.6640625,
            "text": "lymphedema",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -2.431640625,
            "end_logit": -6.1640625,
            "text": "intravenous drug abuse which has no current available treatment arm and forearm edema",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -5.11328125,
            "end_logit": -3.68359375,
            "text": "both intravenous drug users with puffy hand syndrome were hospitalized for 11 days treatment included daily multilayer bandaging",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -3.119140625,
            "end_logit": -6.1640625,
            "text": "puffy hand syndrome is a complication of intravenous drug abuse which has no current available treatment arm and forearm edema",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -4.21875,
            "end_logit": -5.05859375,
            "text": "intravenous drug users with puffy hand syndrome were hospitalized for 11 days treatment included daily multilayer bandaging lymphedema",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.21484375,
            "end_logit": -6.30859375,
            "text": "multilayer band",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.30859375,
            "end_logit": -4.23828125,
            "text": "multifactorial venous lymphatic insufficiency",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -3.21484375,
            "end_logit": -6.38671875,
            "text": "multilayer",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.94140625,
            "end_logit": -3.6640625,
            "text": "self bandaging techniques during their hospital stays elastic gloves were fitted at the end of treatment reduction of lymphedema",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.08984375,
            "end_logit": -3.6640625,
            "text": "bandaging techniques during their hospital stays elastic gloves were fitted at the end of treatment reduction of lymphedema",
            "probability": 1.1920928955078125e-07
        }
    ],
    "56cf236f3975bb303a000002_1": [
        {
            "start_logit": 8.2109375,
            "end_logit": 7.46875,
            "text": "T-type calcium channels",
            "probability": 0.36181640625
        },
        {
            "start_logit": 8.2109375,
            "end_logit": 7.40625,
            "text": "T-type calcium channels, we examined if more selective T-type",
            "probability": 0.33984375
        },
        {
            "start_logit": 8.078125,
            "end_logit": 7.40625,
            "text": "T-type",
            "probability": 0.297607421875
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.3408203125,
            "text": "T",
            "probability": 5.3882598876953125e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.67578125,
            "text": "T-type calcium channels, we examined if more selective T",
            "probability": 3.88026237487793e-05
        },
        {
            "start_logit": 8.078125,
            "end_logit": -1.67578125,
            "text": "T",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -2.2890625,
            "text": "T-type",
            "probability": 2.092123031616211e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -2.990234375,
            "text": "T-type calcium channels, we examined if more selective T-type calcium",
            "probability": 1.0371208190917969e-05
        },
        {
            "start_logit": 8.078125,
            "end_logit": -2.990234375,
            "text": "T-type calcium",
            "probability": 9.059906005859375e-06
        },
        {
            "start_logit": -2.578125,
            "end_logit": 7.46875,
            "text": "channels",
            "probability": 7.450580596923828e-06
        },
        {
            "start_logit": -2.578125,
            "end_logit": 7.40625,
            "text": "channels, we examined if more selective T-type",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": -2.638671875,
            "end_logit": 7.40625,
            "text": "type",
            "probability": 6.556510925292969e-06
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -3.865234375,
            "text": "T-type calcium channels, we examined if more selective T-type calcium channel",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": 8.078125,
            "end_logit": -3.865234375,
            "text": "T-type calcium channel",
            "probability": 3.7550926208496094e-06
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -5.22265625,
            "text": "T-type calcium channels, we examined if more selective T-",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.078125,
            "end_logit": -5.22265625,
            "text": "T-",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -5.68359375,
            "text": "T-type calcium",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -6.203125,
            "text": "T-",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.0546875,
            "end_logit": 7.46875,
            "text": "block T-type calcium channels",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.0546875,
            "end_logit": 7.40625,
            "text": "block T-type calcium channels, we examined if more selective T-type",
            "probability": 2.384185791015625e-07
        }
    ],
    "6026ed981cb411341a0000d2_1": [
        {
            "start_logit": -0.138427734375,
            "end_logit": 4.234375,
            "text": "calcitonin gene-related peptide",
            "probability": 0.994140625
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 4.234375,
            "text": "peptide",
            "probability": 0.00174713134765625
        },
        {
            "start_logit": -6.62890625,
            "end_logit": 4.234375,
            "text": "gene-related peptide",
            "probability": 0.001506805419921875
        },
        {
            "start_logit": -7.28125,
            "end_logit": 4.234375,
            "text": "the calcitonin gene-related peptide",
            "probability": 0.0007843971252441406
        },
        {
            "start_logit": -7.34375,
            "end_logit": 4.234375,
            "text": "related peptide",
            "probability": 0.0007371902465820312
        },
        {
            "start_logit": -7.359375,
            "end_logit": 4.234375,
            "text": "prevention of episodic and chronic migraine demonstrating the efficacy and safety of four mAbs targeting the calcitonin gene-related peptide",
            "probability": 0.0007257461547851562
        },
        {
            "start_logit": -0.138427734375,
            "end_logit": -5.44140625,
            "text": "calcitonin gene-related peptide (CGRP) pathway [ALD403 (eptinezumab), AMG334 (erenumab",
            "probability": 6.264448165893555e-05
        },
        {
            "start_logit": -0.138427734375,
            "end_logit": -5.86328125,
            "text": "calcitonin gene-related peptide (CGRP) pathway [ALD403 (eptinezumab), AMG334 (erenumab)",
            "probability": 4.112720489501953e-05
        },
        {
            "start_logit": -0.138427734375,
            "end_logit": -6.3203125,
            "text": "calcitonin gene-related peptide (CGRP) pathway [ALD403 (eptinezumab)",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": -0.138427734375,
            "end_logit": -6.69921875,
            "text": "calcitonin gene-related peptide (CGRP) pathway [ALD403 (eptinezumab",
            "probability": 1.7642974853515625e-05
        },
        {
            "start_logit": -0.138427734375,
            "end_logit": -6.9296875,
            "text": "calcitonin gene-related peptide (CGRP) pathway [ALD403 (eptinezumab), AMG334 (eren",
            "probability": 1.4126300811767578e-05
        },
        {
            "start_logit": -0.138427734375,
            "end_logit": -6.9609375,
            "text": "calcitonin gene-related peptide (CGRP) pathway [ALD403",
            "probability": 1.3649463653564453e-05
        },
        {
            "start_logit": -0.138427734375,
            "end_logit": -6.99609375,
            "text": "calcitonin gene-related peptide (",
            "probability": 1.3172626495361328e-05
        },
        {
            "start_logit": -0.138427734375,
            "end_logit": -7.109375,
            "text": "calcitonin gene-related peptide (CGRP) pathway",
            "probability": 1.1801719665527344e-05
        },
        {
            "start_logit": -0.138427734375,
            "end_logit": -7.13671875,
            "text": "calcitonin gene-related peptide (CGRP) pathway [ALD403 (eptinezumab), AMG334 (er",
            "probability": 1.1444091796875e-05
        },
        {
            "start_logit": -0.138427734375,
            "end_logit": -7.16015625,
            "text": "calcitonin gene-related peptide (CGRP",
            "probability": 1.1265277862548828e-05
        },
        {
            "start_logit": -5.21875,
            "end_logit": -5.765625,
            "text": ".",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.59375,
            "end_logit": -5.203125,
            "text": "LY2951742 (galcanezumab) and TEV48125",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.48046875,
            "end_logit": -5.44140625,
            "text": "peptide (CGRP) pathway [ALD403 (eptinezumab), AMG334 (erenumab",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.75390625,
            "end_logit": -5.203125,
            "text": "TEV48125",
            "probability": 1.1920928955078125e-07
        }
    ],
    "587e0116ae05ffb474000002_1": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.140625,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": -0.99853515625,
            "end_logit": 8.140625,
            "text": "per",
            "probability": 9.763240814208984e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.2080078125,
            "text": "Cis",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": -6.54296875,
            "end_logit": 8.140625,
            "text": "Mapper",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.76171875,
            "text": "CisMap",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4921875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.49609375,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.51171875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.51953125,
            "text": "CisMapper: predicting regulatory interactions from transcription factor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.5703125,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.578125,
            "text": "CisMapper: predicting regulatory interactions from",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.61328125,
            "text": "CisMapper: predicting regulatory interactions from transcription",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6484375,
            "text": "CisMapper: predicting regulatory interactions",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6640625,
            "text": "CisMapper: predicting regulatory",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.71875,
            "text": "CisMapper: predicting",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.99853515625,
            "end_logit": -7.4921875,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 0.0
        },
        {
            "start_logit": -0.99853515625,
            "end_logit": -7.49609375,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 0.0
        },
        {
            "start_logit": -0.99853515625,
            "end_logit": -7.51171875,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 0.0
        },
        {
            "start_logit": -0.99853515625,
            "end_logit": -7.51953125,
            "text": "per: predicting regulatory interactions from transcription factor",
            "probability": 0.0
        },
        {
            "start_logit": -0.99853515625,
            "end_logit": -7.5703125,
            "text": "per: predicting regulatory interactions from transcription factor ChIP",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_2": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.1640625,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": -0.85986328125,
            "end_logit": 8.1640625,
            "text": "per",
            "probability": 0.00011152029037475586
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.1767578125,
            "text": "Cis",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": -6.53515625,
            "end_logit": 8.1640625,
            "text": "Mapper",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.8046875,
            "text": "CisMap",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.9453125,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.21484375,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF'",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.25,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF's",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.3125,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.3828125,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF's bound sites and the expression of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.41015625,
            "text": "CisMapper, which predicts the regulatory targets of a TF using",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.41015625,
            "text": "CisMapper, which predicts the regulatory targets of a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.41015625,
            "text": "CisMapper, which predicts the regulatory targets of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.41796875,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.42578125,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at the TF's bound sites and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.43359375,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.453125,
            "text": "CisMapper,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4609375,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.46875,
            "text": "CisMapper, which predicts the regulatory targets of a TF using the correlation between a histone mark at",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.74609375,
            "end_logit": 8.1640625,
            "text": "present CisMapper",
            "probability": 1.1920928955078125e-07
        }
    ],
    "587e0116ae05ffb474000002_3": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1484375,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": -0.94775390625,
            "end_logit": 8.1484375,
            "text": "per",
            "probability": 0.00010395050048828125
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.23046875,
            "text": "Cis",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.71484375,
            "text": "CisMap",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.640625,
            "end_logit": 8.1484375,
            "text": "Mapper",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.22265625,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.4453125,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.484375,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.5078125,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.51171875,
            "text": "CisMapper is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.53125,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.54296875,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.55078125,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.5546875,
            "text": "CisMapper is more accurate at",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.5703125,
            "text": "CisMapper is more accurate at predicting the target genes of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 8.1484375,
            "text": "Using both chromatin conformation capture and differential expression data, we show that CisMapper",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.58203125,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.1484375,
            "text": "both chromatin conformation capture and differential expression data, we show that CisMapper",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.1484375,
            "text": "show that CisMapper",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 8.1484375,
            "text": ", we show that CisMapper",
            "probability": 1.1920928955078125e-07
        }
    ],
    "587e0116ae05ffb474000002_4": [
        {
            "start_logit": 8.25,
            "end_logit": 8.1640625,
            "text": "CisMapper",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.1640625,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, CisMapper",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.1640625,
            "text": "CisMapper",
            "probability": 0.333251953125
        },
        {
            "start_logit": -0.73974609375,
            "end_logit": 8.1640625,
            "text": "per",
            "probability": 4.178285598754883e-05
        },
        {
            "start_logit": -0.73974609375,
            "end_logit": 8.1640625,
            "text": "per also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, CisMapper",
            "probability": 4.178285598754883e-05
        },
        {
            "start_logit": -0.74267578125,
            "end_logit": 8.1640625,
            "text": "per",
            "probability": 4.178285598754883e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.060546875,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, Cis",
            "probability": 3.30805778503418e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.060546875,
            "text": "Cis",
            "probability": 3.30805778503418e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.0693359375,
            "text": "Cis",
            "probability": 3.2782554626464844e-05
        },
        {
            "start_logit": -6.08203125,
            "end_logit": 8.1640625,
            "text": ". Unlike distance-based methods, CisMapper",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.40234375,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, CisMap",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.40234375,
            "text": "CisMap",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.34375,
            "end_logit": 8.1640625,
            "text": "Mapper",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.34375,
            "end_logit": 8.1640625,
            "text": "Mapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, CisMapper",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 8.1640625,
            "text": "Mapper",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.61328125,
            "text": "CisMap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.6484375,
            "text": "CisMapper can predict which transcription start site of a gene is regulated by a particular binding site of the TF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.96484375,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.1484375,
            "text": "CisMapper also predicts which TF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.37890625,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene",
            "probability": 5.960464477539063e-08
        }
    ],
    "587e0116ae05ffb474000002_5": [
        {
            "start_logit": 8.25,
            "end_logit": 8.1640625,
            "text": "CisMapper",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.1640625,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, CisMapper",
            "probability": 0.333251953125
        },
        {
            "start_logit": 8.25,
            "end_logit": 8.1640625,
            "text": "CisMapper",
            "probability": 0.333251953125
        },
        {
            "start_logit": -0.73974609375,
            "end_logit": 8.1640625,
            "text": "per",
            "probability": 4.178285598754883e-05
        },
        {
            "start_logit": -0.73974609375,
            "end_logit": 8.1640625,
            "text": "per also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, CisMapper",
            "probability": 4.178285598754883e-05
        },
        {
            "start_logit": -0.74267578125,
            "end_logit": 8.1640625,
            "text": "per",
            "probability": 4.178285598754883e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.060546875,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, Cis",
            "probability": 3.30805778503418e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.060546875,
            "text": "Cis",
            "probability": 3.30805778503418e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.0693359375,
            "text": "Cis",
            "probability": 3.2782554626464844e-05
        },
        {
            "start_logit": -6.08203125,
            "end_logit": 8.1640625,
            "text": ". Unlike distance-based methods, CisMapper",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.40234375,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, CisMap",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.40234375,
            "text": "CisMap",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.34375,
            "end_logit": 8.1640625,
            "text": "Mapper",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.34375,
            "end_logit": 8.1640625,
            "text": "Mapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods, CisMapper",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 8.1640625,
            "text": "Mapper",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.61328125,
            "text": "CisMap",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.6484375,
            "text": "CisMapper can predict which transcription start site of a gene is regulated by a particular binding site of the TF",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.96484375,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene more accurately than using genomic distance. Unlike distance-based methods,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.1484375,
            "text": "CisMapper also predicts which TF",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.37890625,
            "text": "CisMapper also predicts which TF binding sites regulate a given gene",
            "probability": 5.960464477539063e-08
        }
    ],
    "587e0116ae05ffb474000002_6": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.15625,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": -0.95654296875,
            "end_logit": 8.15625,
            "text": "per",
            "probability": 0.00010228157043457031
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.1865234375,
            "text": "Cis",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 8.15625,
            "text": "Mapper",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.85546875,
            "text": "CisMap",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.45703125,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.46875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.48046875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.5,
            "text": "CisMapper: predicting regulatory interactions from transcription factor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.55859375,
            "text": "CisMapper: predicting regulatory interactions from transcription",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.55859375,
            "text": "CisMapper: predicting regulatory interactions from",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.5625,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6328125,
            "text": "CisMapper: predicting regulatory interactions",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.66796875,
            "text": "CisMapper: predicting regulatory",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6875,
            "text": "CisMapper:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.7109375,
            "text": "CisMapper: predicting",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.95654296875,
            "end_logit": -7.45703125,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 0.0
        },
        {
            "start_logit": -0.95654296875,
            "end_logit": -7.46875,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 0.0
        },
        {
            "start_logit": -0.95654296875,
            "end_logit": -7.48046875,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 0.0
        },
        {
            "start_logit": -0.95654296875,
            "end_logit": -7.5,
            "text": "per: predicting regulatory interactions from transcription factor",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_7": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.15625,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": -0.95654296875,
            "end_logit": 8.15625,
            "text": "per",
            "probability": 0.00010228157043457031
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.1865234375,
            "text": "Cis",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": -6.4296875,
            "end_logit": 8.15625,
            "text": "Mapper",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.85546875,
            "text": "CisMap",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.45703125,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.46875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.48046875,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.5,
            "text": "CisMapper: predicting regulatory interactions from transcription factor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.55859375,
            "text": "CisMapper: predicting regulatory interactions from transcription",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.55859375,
            "text": "CisMapper: predicting regulatory interactions from",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.5625,
            "text": "CisMapper: predicting regulatory interactions from transcription factor ChIP",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6328125,
            "text": "CisMapper: predicting regulatory interactions",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.66796875,
            "text": "CisMapper: predicting regulatory",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6875,
            "text": "CisMapper:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.7109375,
            "text": "CisMapper: predicting",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.95654296875,
            "end_logit": -7.45703125,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-",
            "probability": 0.0
        },
        {
            "start_logit": -0.95654296875,
            "end_logit": -7.46875,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq data",
            "probability": 0.0
        },
        {
            "start_logit": -0.95654296875,
            "end_logit": -7.48046875,
            "text": "per: predicting regulatory interactions from transcription factor ChIP-seq",
            "probability": 0.0
        },
        {
            "start_logit": -0.95654296875,
            "end_logit": -7.5,
            "text": "per: predicting regulatory interactions from transcription factor",
            "probability": 0.0
        }
    ],
    "587e0116ae05ffb474000002_8": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1640625,
            "text": "CisMapper",
            "probability": 1.0
        },
        {
            "start_logit": -0.87646484375,
            "end_logit": 8.1640625,
            "text": "per",
            "probability": 0.00011152029037475586
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.185546875,
            "text": "Cis",
            "probability": 8.684396743774414e-05
        },
        {
            "start_logit": -6.48046875,
            "end_logit": 8.1640625,
            "text": "Mapper",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.8125,
            "text": "CisMap",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.9453125,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.2890625,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.3046875,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.3515625,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used, and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.375,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.38671875,
            "text": "CisMapper is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.44140625,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.4609375,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.46875,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.48046875,
            "text": "CisMapper is more accurate at predicting the target genes of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.48046875,
            "text": "CisMapper is more accurate at",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.515625,
            "text": "CisMapper is more accurate at predicting the target genes of a TF than the distance-based approaches currently used,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.1640625,
            "text": "Using both chromatin conformation capture and differential expression data, we show that CisMapper",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 8.1640625,
            "text": "both chromatin conformation capture and differential expression data, we show that CisMapper",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.1640625,
            "text": "show that CisMapper",
            "probability": 1.1920928955078125e-07
        }
    ],
    "60314c361cb411341a00012e_1": [
        {
            "start_logit": 4.6875,
            "end_logit": 5.30078125,
            "text": "inflammation of the aorta",
            "probability": 0.57080078125
        },
        {
            "start_logit": 3.73046875,
            "end_logit": 5.30078125,
            "text": "Aortitis is the inflammation of the aorta",
            "probability": 0.2200927734375
        },
        {
            "start_logit": 4.6875,
            "end_logit": 3.966796875,
            "text": "inflammation of the aorta due to various causes.",
            "probability": 0.1512451171875
        },
        {
            "start_logit": 3.73046875,
            "end_logit": 3.966796875,
            "text": "Aortitis is the inflammation of the aorta due to various causes.",
            "probability": 0.057861328125
        },
        {
            "start_logit": -4.9921875,
            "end_logit": 5.30078125,
            "text": "aorta",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": -4.6328125,
            "end_logit": 3.966796875,
            "text": ".",
            "probability": 1.3530254364013672e-05
        },
        {
            "start_logit": 4.6875,
            "end_logit": -5.59375,
            "text": "inflammation",
            "probability": 1.0669231414794922e-05
        },
        {
            "start_logit": -4.9921875,
            "end_logit": 3.966796875,
            "text": "aorta due to various causes.",
            "probability": 9.47713851928711e-06
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 5.30078125,
            "text": "the inflammation of the aorta",
            "probability": 6.079673767089844e-06
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 5.30078125,
            "text": "of the aorta",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 3.73046875,
            "end_logit": -5.59375,
            "text": "Aortitis is the inflammation",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": 3.73046875,
            "end_logit": -5.71484375,
            "text": "Aort",
            "probability": 3.635883331298828e-06
        },
        {
            "start_logit": -6.11328125,
            "end_logit": 3.966796875,
            "text": "due to various causes.",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -7.53125,
            "end_logit": 5.30078125,
            "text": "the aorta",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 5.30078125,
            "text": "itis is the inflammation of the aorta",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": 4.6875,
            "end_logit": -7.20703125,
            "text": "inflammation of the",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 4.6875,
            "end_logit": -7.28125,
            "text": "inflammation of the aorta due to various",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 3.966796875,
            "text": "the inflammation of the aorta due to various causes.",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 4.6875,
            "end_logit": -7.53125,
            "text": "inflammation of the aorta due to various causes",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 3.73046875,
            "end_logit": -6.64453125,
            "text": "Aortitis is",
            "probability": 1.430511474609375e-06
        }
    ],
    "60314c361cb411341a00012e_2": [
        {
            "start_logit": 3.197265625,
            "end_logit": 7.109375,
            "text": "inflammation of the aorta",
            "probability": 0.998046875
        },
        {
            "start_logit": -3.443359375,
            "end_logit": 7.109375,
            "text": "aorta",
            "probability": 0.0013036727905273438
        },
        {
            "start_logit": -6.10546875,
            "end_logit": 7.109375,
            "text": "Aortitis is the inflammation of the aorta",
            "probability": 9.1552734375e-05
        },
        {
            "start_logit": -6.578125,
            "end_logit": 7.109375,
            "text": "of the aorta",
            "probability": 5.6803226470947266e-05
        },
        {
            "start_logit": -6.69921875,
            "end_logit": 7.109375,
            "text": "the aorta",
            "probability": 5.054473876953125e-05
        },
        {
            "start_logit": -7.0546875,
            "end_logit": 7.109375,
            "text": "the inflammation of the aorta",
            "probability": 3.528594970703125e-05
        },
        {
            "start_logit": -7.25,
            "end_logit": 7.109375,
            "text": ": Aortitis is the inflammation of the aorta",
            "probability": 2.9027462005615234e-05
        },
        {
            "start_logit": -7.59375,
            "end_logit": 7.109375,
            "text": "PURPOSE OF REVIEW: Aortitis is the inflammation of the aorta",
            "probability": 2.0563602447509766e-05
        },
        {
            "start_logit": -7.765625,
            "end_logit": 7.109375,
            "text": "REVIEW: Aortitis is the inflammation of the aorta",
            "probability": 1.728534698486328e-05
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 7.109375,
            "text": "itis is the inflammation of the aorta",
            "probability": 1.6927719116210938e-05
        },
        {
            "start_logit": 3.197265625,
            "end_logit": -6.8828125,
            "text": "inflammation",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 3.197265625,
            "end_logit": -7.31640625,
            "text": "inflammation of the aorta due",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -3.443359375,
            "end_logit": -7.31640625,
            "text": "aorta due",
            "probability": 0.0
        },
        {
            "start_logit": -6.10546875,
            "end_logit": -6.8828125,
            "text": "Aortitis is the inflammation",
            "probability": 0.0
        },
        {
            "start_logit": -6.10546875,
            "end_logit": -7.31640625,
            "text": "Aortitis is the inflammation of the aorta due",
            "probability": 0.0
        },
        {
            "start_logit": -6.10546875,
            "end_logit": -7.48046875,
            "text": "Aortitis is",
            "probability": 0.0
        },
        {
            "start_logit": -6.578125,
            "end_logit": -7.31640625,
            "text": "of the aorta due",
            "probability": 0.0
        },
        {
            "start_logit": -7.0546875,
            "end_logit": -6.8828125,
            "text": "the inflammation",
            "probability": 0.0
        },
        {
            "start_logit": -6.69921875,
            "end_logit": -7.31640625,
            "text": "the aorta due",
            "probability": 0.0
        },
        {
            "start_logit": -7.25,
            "end_logit": -6.8828125,
            "text": ": Aortitis is the inflammation",
            "probability": 0.0
        }
    ],
    "60314c361cb411341a00012e_3": [
        {
            "start_logit": 7.48828125,
            "end_logit": 5.48828125,
            "text": "Aortitis is the all-encompassing pathological term ascribed to inflammation of the aorta.",
            "probability": 0.517578125
        },
        {
            "start_logit": 7.48828125,
            "end_logit": 5.41796875,
            "text": "Aortitis is the all-encompassing pathological term ascribed to inflammation of the aorta",
            "probability": 0.482421875
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -2.267578125,
            "text": "Aort",
            "probability": 0.00022125244140625
        },
        {
            "start_logit": -2.833984375,
            "end_logit": 5.48828125,
            "text": ".",
            "probability": 1.704692840576172e-05
        },
        {
            "start_logit": -3.892578125,
            "end_logit": 5.48828125,
            "text": "inflammation of the aorta.",
            "probability": 5.900859832763672e-06
        },
        {
            "start_logit": -3.892578125,
            "end_logit": 5.41796875,
            "text": "inflammation of the aorta",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -6.859375,
            "text": "Aortitis is the all-encompassing pathological term ascribed to inflammation of the",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -6.9296875,
            "text": "Aortitis is",
            "probability": 2.086162567138672e-06
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.3828125,
            "text": "Aortitis is the all-encompassing pathological term ascribed to inflammation",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -5.40625,
            "end_logit": 5.48828125,
            "text": "aorta.",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -5.40625,
            "end_logit": 5.41796875,
            "text": "aorta",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.78125,
            "text": "Aortitis is the all-encompassing pathological term ascribed to inflammation of",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -5.83203125,
            "end_logit": 5.48828125,
            "text": "the all-encompassing pathological term ascribed to inflammation of the aorta.",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.48828125,
            "end_logit": -7.90234375,
            "text": "Aortitis is the all-",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -5.83203125,
            "end_logit": 5.41796875,
            "text": "the all-encompassing pathological term ascribed to inflammation of the aorta",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.0625,
            "end_logit": 5.48828125,
            "text": "ascribed to inflammation of the aorta.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.0625,
            "end_logit": 5.41796875,
            "text": "ascribed to inflammation of the aorta",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.4453125,
            "end_logit": 5.48828125,
            "text": "to inflammation of the aorta.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.4453125,
            "end_logit": 5.41796875,
            "text": "to inflammation of the aorta",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.578125,
            "end_logit": 5.48828125,
            "text": "all-encompassing pathological term ascribed to inflammation of the aorta.",
            "probability": 4.172325134277344e-07
        }
    ],
    "5891c90949702f2e01000001_1": [
        {
            "start_logit": 8.1875,
            "end_logit": 8.109375,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 8.1875,
            "end_logit": -1.3359375,
            "text": "INC",
            "probability": 7.903575897216797e-05
        },
        {
            "start_logit": -1.400390625,
            "end_logit": 8.109375,
            "text": "A",
            "probability": 6.866455078125e-05
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.57421875,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.5859375,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.60546875,
            "text": "INCA: synonymous codon usage",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.69921875,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.400390625,
            "end_logit": -7.57421875,
            "text": "A: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -1.400390625,
            "end_logit": -7.5859375,
            "text": "A: synonymous codon usage analysis and clustering by means of self-",
            "probability": 0.0
        },
        {
            "start_logit": -1.400390625,
            "end_logit": -7.60546875,
            "text": "A: synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": -1.400390625,
            "end_logit": -7.69921875,
            "text": "A: synonymous codon usage analysis and clustering by means of self-organizing",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -7.57421875,
            "text": "means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -7.5859375,
            "text": "means of self-",
            "probability": 0.0
        },
        {
            "start_logit": -7.72265625,
            "end_logit": -7.57421875,
            "text": "of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -7.72265625,
            "end_logit": -7.57421875,
            "text": "clustering by means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -7.72265625,
            "end_logit": -7.5859375,
            "text": "of self-",
            "probability": 0.0
        },
        {
            "start_logit": -7.72265625,
            "end_logit": -7.5859375,
            "text": "clustering by means of self-",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -7.57421875,
            "text": ": synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -7.69921875,
            "text": "means of self-organizing",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -7.5859375,
            "text": ": synonymous codon usage analysis and clustering by means of self-",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_2": [
        {
            "start_logit": 8.296875,
            "end_logit": 8.1328125,
            "text": "INCA",
            "probability": 0.2529296875
        },
        {
            "start_logit": 8.296875,
            "end_logit": 8.1328125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.2529296875
        },
        {
            "start_logit": 8.296875,
            "end_logit": 8.125,
            "text": "INCA",
            "probability": 0.2489013671875
        },
        {
            "start_logit": 8.28125,
            "end_logit": 8.125,
            "text": "INCA",
            "probability": 0.2451171875
        },
        {
            "start_logit": 8.296875,
            "end_logit": -0.76123046875,
            "text": "INC",
            "probability": 3.427267074584961e-05
        },
        {
            "start_logit": 8.296875,
            "end_logit": -0.76123046875,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 3.427267074584961e-05
        },
        {
            "start_logit": 8.296875,
            "end_logit": -0.7802734375,
            "text": "INC",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": 8.28125,
            "end_logit": -0.86083984375,
            "text": "INC",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": -1.005859375,
            "end_logit": 8.1328125,
            "text": "A",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": -1.0234375,
            "end_logit": 8.1328125,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": -1.0234375,
            "end_logit": 8.125,
            "text": "A",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": -1.080078125,
            "end_logit": 8.125,
            "text": "A",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": -4.70703125,
            "end_logit": 8.1328125,
            "text": ". Finally, INCA",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.75390625,
            "end_logit": 8.125,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.9765625,
            "end_logit": 8.1328125,
            "text": ", INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -6.52734375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 8.1328125,
            "text": "of INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 8.125,
            "text": "of INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.953125,
            "end_logit": 8.1328125,
            "text": "interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 8.1328125,
            "text": "display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 5.960464477539063e-08
        }
    ],
    "5891c90949702f2e01000001_3": [
        {
            "start_logit": 8.296875,
            "end_logit": 8.1328125,
            "text": "INCA",
            "probability": 0.2529296875
        },
        {
            "start_logit": 8.296875,
            "end_logit": 8.1328125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.2529296875
        },
        {
            "start_logit": 8.296875,
            "end_logit": 8.125,
            "text": "INCA",
            "probability": 0.2489013671875
        },
        {
            "start_logit": 8.28125,
            "end_logit": 8.125,
            "text": "INCA",
            "probability": 0.2451171875
        },
        {
            "start_logit": 8.296875,
            "end_logit": -0.76123046875,
            "text": "INC",
            "probability": 3.427267074584961e-05
        },
        {
            "start_logit": 8.296875,
            "end_logit": -0.76123046875,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 3.427267074584961e-05
        },
        {
            "start_logit": 8.296875,
            "end_logit": -0.7802734375,
            "text": "INC",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": 8.28125,
            "end_logit": -0.86083984375,
            "text": "INC",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": -1.005859375,
            "end_logit": 8.1328125,
            "text": "A",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": -1.0234375,
            "end_logit": 8.1328125,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": -1.0234375,
            "end_logit": 8.125,
            "text": "A",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": -1.080078125,
            "end_logit": 8.125,
            "text": "A",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": -4.70703125,
            "end_logit": 8.1328125,
            "text": ". Finally, INCA",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.75390625,
            "end_logit": 8.125,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.9765625,
            "end_logit": 8.1328125,
            "text": ", INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -6.52734375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 8.1328125,
            "text": "of INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 8.125,
            "text": "of INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.953125,
            "end_logit": 8.1328125,
            "text": "interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 8.1328125,
            "text": "display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 5.960464477539063e-08
        }
    ],
    "5891c90949702f2e01000001_4": [
        {
            "start_logit": 8.296875,
            "end_logit": 8.1328125,
            "text": "INCA",
            "probability": 0.2529296875
        },
        {
            "start_logit": 8.296875,
            "end_logit": 8.1328125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.2529296875
        },
        {
            "start_logit": 8.296875,
            "end_logit": 8.125,
            "text": "INCA",
            "probability": 0.2489013671875
        },
        {
            "start_logit": 8.28125,
            "end_logit": 8.125,
            "text": "INCA",
            "probability": 0.2451171875
        },
        {
            "start_logit": 8.296875,
            "end_logit": -0.76123046875,
            "text": "INC",
            "probability": 3.427267074584961e-05
        },
        {
            "start_logit": 8.296875,
            "end_logit": -0.76123046875,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 3.427267074584961e-05
        },
        {
            "start_logit": 8.296875,
            "end_logit": -0.7802734375,
            "text": "INC",
            "probability": 3.3736228942871094e-05
        },
        {
            "start_logit": 8.28125,
            "end_logit": -0.86083984375,
            "text": "INC",
            "probability": 3.069639205932617e-05
        },
        {
            "start_logit": -1.005859375,
            "end_logit": 8.1328125,
            "text": "A",
            "probability": 2.282857894897461e-05
        },
        {
            "start_logit": -1.0234375,
            "end_logit": 8.1328125,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": -1.0234375,
            "end_logit": 8.125,
            "text": "A",
            "probability": 2.2292137145996094e-05
        },
        {
            "start_logit": -1.080078125,
            "end_logit": 8.125,
            "text": "A",
            "probability": 2.110004425048828e-05
        },
        {
            "start_logit": -4.70703125,
            "end_logit": 8.1328125,
            "text": ". Finally, INCA",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.75390625,
            "end_logit": 8.125,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -5.9765625,
            "end_logit": 8.1328125,
            "text": ", INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.296875,
            "end_logit": -6.52734375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 8.1328125,
            "text": "of INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 8.125,
            "text": "of INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.953125,
            "end_logit": 8.1328125,
            "text": "interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.97265625,
            "end_logit": 8.1328125,
            "text": "display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 5.960464477539063e-08
        }
    ],
    "5891c90949702f2e01000001_5": [
        {
            "start_logit": 8.109375,
            "end_logit": 8.0703125,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": -1.4140625,
            "end_logit": 8.0703125,
            "text": "A",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": 8.109375,
            "end_logit": -1.478515625,
            "text": "INC",
            "probability": 7.086992263793945e-05
        },
        {
            "start_logit": -4.5234375,
            "end_logit": 8.0703125,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 8.109375,
            "end_logit": -6.671875,
            "text": "INCA)",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.3125,
            "text": "INCA) provides",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.40234375,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.4609375,
            "text": "INCA) provides an",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.43359375,
            "end_logit": 8.0703125,
            "text": ": INteractive Codon usage Analysis (INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.515625,
            "text": "INCA) provides an array of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.515625,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5546875,
            "end_logit": 8.0703125,
            "text": "UNLABELLED: INteractive Codon usage Analysis (INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.61328125,
            "text": "INCA) provides an array of features useful",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59375,
            "end_logit": 8.0703125,
            "text": "Codon usage Analysis (INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.6640625,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.109375,
            "end_logit": -7.6796875,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -4.5234375,
            "end_logit": -1.478515625,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": -1.4140625,
            "end_logit": -6.671875,
            "text": "A)",
            "probability": 0.0
        },
        {
            "start_logit": -1.4140625,
            "end_logit": -7.3125,
            "text": "A) provides",
            "probability": 0.0
        },
        {
            "start_logit": -1.4140625,
            "end_logit": -7.40234375,
            "text": "A) provides an array of features useful in analysis of synonymous codon usage in",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_6": [
        {
            "start_logit": 8.1953125,
            "end_logit": 8.109375,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -1.3173828125,
            "text": "INC",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": -1.38671875,
            "end_logit": 8.109375,
            "text": "A",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.5625,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.6015625,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.61328125,
            "text": "INCA: synonymous codon usage",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.66796875,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.38671875,
            "end_logit": -7.5625,
            "text": "A: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -1.38671875,
            "end_logit": -7.6015625,
            "text": "A: synonymous codon usage analysis and clustering by means of self-",
            "probability": 0.0
        },
        {
            "start_logit": -1.38671875,
            "end_logit": -7.61328125,
            "text": "A: synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": -1.38671875,
            "end_logit": -7.66796875,
            "text": "A: synonymous codon usage analysis and clustering by means of self-organizing",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -7.5625,
            "text": "means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -7.6015625,
            "text": "means of self-",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -7.5625,
            "text": "clustering by means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -7.671875,
            "end_logit": -7.66796875,
            "text": "means of self-organizing",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -7.6015625,
            "text": "clustering by means of self-",
            "probability": 0.0
        },
        {
            "start_logit": -7.80078125,
            "end_logit": -7.5625,
            "text": ": synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -7.7421875,
            "end_logit": -7.66796875,
            "text": "clustering by means of self-organizing",
            "probability": 0.0
        },
        {
            "start_logit": -7.80078125,
            "end_logit": -7.6015625,
            "text": ": synonymous codon usage analysis and clustering by means of self-",
            "probability": 0.0
        },
        {
            "start_logit": -7.83984375,
            "end_logit": -7.5625,
            "text": "of self-organizing map",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_7": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.1171875,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.265625,
            "text": "INC",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": -1.29296875,
            "end_logit": 8.1171875,
            "text": "A",
            "probability": 7.605552673339844e-05
        },
        {
            "start_logit": -7.1640625,
            "end_logit": 8.1171875,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.4375,
            "text": "INCA)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.53515625,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.57421875,
            "text": "INCA) provides",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.58984375,
            "text": "INCA) provides an array of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.609375,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.65234375,
            "text": "INCA) provides an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.69140625,
            "text": "INCA) provides an array of features useful",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.703125,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.1171875,
            "text": "Codon usage Analysis (INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 8.1171875,
            "text": "(INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.1640625,
            "end_logit": -1.265625,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": -1.29296875,
            "end_logit": -7.4375,
            "text": "A)",
            "probability": 0.0
        },
        {
            "start_logit": -1.29296875,
            "end_logit": -7.53515625,
            "text": "A) provides an array of features useful in analysis of synonymous codon usage in",
            "probability": 0.0
        },
        {
            "start_logit": -1.29296875,
            "end_logit": -7.57421875,
            "text": "A) provides",
            "probability": 0.0
        },
        {
            "start_logit": -1.29296875,
            "end_logit": -7.58984375,
            "text": "A) provides an array of",
            "probability": 0.0
        },
        {
            "start_logit": -1.29296875,
            "end_logit": -7.609375,
            "text": "A) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_8": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.1171875,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.2373046875,
            "text": "INC",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": -1.3203125,
            "end_logit": 8.1171875,
            "text": "A",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": -6.8359375,
            "end_logit": 8.1171875,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.3828125,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.41796875,
            "text": "INCA) provides",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.42578125,
            "text": "INCA)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.49609375,
            "text": "INCA) provides an array of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.5234375,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.5390625,
            "text": "INCA) provides an",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.6328125,
            "text": "INCA) provides an array of features useful",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.671875,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 8.1171875,
            "text": "Codon usage Analysis (INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 8.1171875,
            "text": "(INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8359375,
            "end_logit": -1.2373046875,
            "text": "INteractive Codon usage Analysis (INC",
            "probability": 0.0
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.3828125,
            "text": "A) provides an array of features useful in analysis of synonymous codon usage in",
            "probability": 0.0
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.41796875,
            "text": "A) provides",
            "probability": 0.0
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.42578125,
            "text": "A)",
            "probability": 0.0
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.49609375,
            "text": "A) provides an array of",
            "probability": 0.0
        },
        {
            "start_logit": -1.3203125,
            "end_logit": -7.5234375,
            "text": "A) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 0.0
        }
    ],
    "5891c90949702f2e01000001_9": [
        {
            "start_logit": 8.3046875,
            "end_logit": 8.125,
            "text": "INCA",
            "probability": 0.20361328125
        },
        {
            "start_logit": 8.3046875,
            "end_logit": 8.125,
            "text": "INCA",
            "probability": 0.20361328125
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 8.109375,
            "text": "INCA",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 8.125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 8.1171875,
            "text": "INCA",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -0.64453125,
            "text": "INC",
            "probability": 3.129243850708008e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.64453125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 3.075599670410156e-05
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -0.6708984375,
            "text": "INC",
            "probability": 3.057718276977539e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.73583984375,
            "text": "INC",
            "probability": 2.8252601623535156e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.73974609375,
            "text": "INC",
            "probability": 2.8014183044433594e-05
        },
        {
            "start_logit": -0.986328125,
            "end_logit": 8.125,
            "text": "A",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": -0.99560546875,
            "end_logit": 8.125,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 1.8417835235595703e-05
        },
        {
            "start_logit": -0.99560546875,
            "end_logit": 8.1171875,
            "text": "A",
            "probability": 1.8417835235595703e-05
        },
        {
            "start_logit": -1.0078125,
            "end_logit": 8.125,
            "text": "A",
            "probability": 1.823902130126953e-05
        },
        {
            "start_logit": -1.07421875,
            "end_logit": 8.109375,
            "text": "A",
            "probability": 1.6748905181884766e-05
        },
        {
            "start_logit": -4.19140625,
            "end_logit": 8.125,
            "text": ". Finally, INCA",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -4.19140625,
            "end_logit": 8.125,
            "text": ".AVAILABILITY: INCA",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -5.2421875,
            "end_logit": 8.109375,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.64453125,
            "end_logit": 8.125,
            "text": ", INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.2890625,
            "text": "INCA)",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5891c90949702f2e01000001_10": [
        {
            "start_logit": 8.3046875,
            "end_logit": 8.125,
            "text": "INCA",
            "probability": 0.20361328125
        },
        {
            "start_logit": 8.3046875,
            "end_logit": 8.125,
            "text": "INCA",
            "probability": 0.20361328125
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 8.109375,
            "text": "INCA",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 8.125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 8.1171875,
            "text": "INCA",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -0.64453125,
            "text": "INC",
            "probability": 3.129243850708008e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.64453125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 3.075599670410156e-05
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -0.6708984375,
            "text": "INC",
            "probability": 3.057718276977539e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.73583984375,
            "text": "INC",
            "probability": 2.8252601623535156e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.73974609375,
            "text": "INC",
            "probability": 2.8014183044433594e-05
        },
        {
            "start_logit": -0.986328125,
            "end_logit": 8.125,
            "text": "A",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": -0.99560546875,
            "end_logit": 8.125,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 1.8417835235595703e-05
        },
        {
            "start_logit": -0.99560546875,
            "end_logit": 8.1171875,
            "text": "A",
            "probability": 1.8417835235595703e-05
        },
        {
            "start_logit": -1.0078125,
            "end_logit": 8.125,
            "text": "A",
            "probability": 1.823902130126953e-05
        },
        {
            "start_logit": -1.07421875,
            "end_logit": 8.109375,
            "text": "A",
            "probability": 1.6748905181884766e-05
        },
        {
            "start_logit": -4.19140625,
            "end_logit": 8.125,
            "text": ". Finally, INCA",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -4.19140625,
            "end_logit": 8.125,
            "text": ".AVAILABILITY: INCA",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -5.2421875,
            "end_logit": 8.109375,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.64453125,
            "end_logit": 8.125,
            "text": ", INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.2890625,
            "text": "INCA)",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5891c90949702f2e01000001_11": [
        {
            "start_logit": 8.3046875,
            "end_logit": 8.125,
            "text": "INCA",
            "probability": 0.20361328125
        },
        {
            "start_logit": 8.3046875,
            "end_logit": 8.125,
            "text": "INCA",
            "probability": 0.20361328125
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 8.109375,
            "text": "INCA",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 8.125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 8.1171875,
            "text": "INCA",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -0.64453125,
            "text": "INC",
            "probability": 3.129243850708008e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.64453125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 3.075599670410156e-05
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -0.6708984375,
            "text": "INC",
            "probability": 3.057718276977539e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.73583984375,
            "text": "INC",
            "probability": 2.8252601623535156e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.73974609375,
            "text": "INC",
            "probability": 2.8014183044433594e-05
        },
        {
            "start_logit": -0.986328125,
            "end_logit": 8.125,
            "text": "A",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": -0.99560546875,
            "end_logit": 8.125,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 1.8417835235595703e-05
        },
        {
            "start_logit": -0.99560546875,
            "end_logit": 8.1171875,
            "text": "A",
            "probability": 1.8417835235595703e-05
        },
        {
            "start_logit": -1.0078125,
            "end_logit": 8.125,
            "text": "A",
            "probability": 1.823902130126953e-05
        },
        {
            "start_logit": -1.07421875,
            "end_logit": 8.109375,
            "text": "A",
            "probability": 1.6748905181884766e-05
        },
        {
            "start_logit": -4.19140625,
            "end_logit": 8.125,
            "text": ". Finally, INCA",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -4.19140625,
            "end_logit": 8.125,
            "text": ".AVAILABILITY: INCA",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -5.2421875,
            "end_logit": 8.109375,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.64453125,
            "end_logit": 8.125,
            "text": ", INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.2890625,
            "text": "INCA)",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5891c90949702f2e01000001_12": [
        {
            "start_logit": 8.3046875,
            "end_logit": 8.125,
            "text": "INCA",
            "probability": 0.20361328125
        },
        {
            "start_logit": 8.3046875,
            "end_logit": 8.125,
            "text": "INCA",
            "probability": 0.20361328125
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 8.109375,
            "text": "INCA",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 8.125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 8.1171875,
            "text": "INCA",
            "probability": 0.1973876953125
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -0.64453125,
            "text": "INC",
            "probability": 3.129243850708008e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.64453125,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 3.075599670410156e-05
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -0.6708984375,
            "text": "INC",
            "probability": 3.057718276977539e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.73583984375,
            "text": "INC",
            "probability": 2.8252601623535156e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.73974609375,
            "text": "INC",
            "probability": 2.8014183044433594e-05
        },
        {
            "start_logit": -0.986328125,
            "end_logit": 8.125,
            "text": "A",
            "probability": 1.8656253814697266e-05
        },
        {
            "start_logit": -0.99560546875,
            "end_logit": 8.125,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 1.8417835235595703e-05
        },
        {
            "start_logit": -0.99560546875,
            "end_logit": 8.1171875,
            "text": "A",
            "probability": 1.8417835235595703e-05
        },
        {
            "start_logit": -1.0078125,
            "end_logit": 8.125,
            "text": "A",
            "probability": 1.823902130126953e-05
        },
        {
            "start_logit": -1.07421875,
            "end_logit": 8.109375,
            "text": "A",
            "probability": 1.6748905181884766e-05
        },
        {
            "start_logit": -4.19140625,
            "end_logit": 8.125,
            "text": ". Finally, INCA",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -4.19140625,
            "end_logit": 8.125,
            "text": ".AVAILABILITY: INCA",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -5.2421875,
            "end_logit": 8.109375,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.64453125,
            "end_logit": 8.125,
            "text": ", INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.2890625,
            "text": "INCA)",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5891c90949702f2e01000001_13": [
        {
            "start_logit": 8.28125,
            "end_logit": 8.1171875,
            "text": "INCA",
            "probability": 0.5078125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.109375,
            "text": "INCA",
            "probability": 0.4921875
        },
        {
            "start_logit": 8.28125,
            "end_logit": -0.83056640625,
            "text": "INC",
            "probability": 6.568431854248047e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.8525390625,
            "text": "INC",
            "probability": 6.365776062011719e-05
        },
        {
            "start_logit": -1.072265625,
            "end_logit": 8.1171875,
            "text": "A",
            "probability": 4.374980926513672e-05
        },
        {
            "start_logit": -1.150390625,
            "end_logit": 8.109375,
            "text": "A",
            "probability": 4.011392593383789e-05
        },
        {
            "start_logit": -5.24609375,
            "end_logit": 8.109375,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -6.421875,
            "text": "INCA)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.55859375,
            "end_logit": 8.1171875,
            "text": "of INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -6.9296875,
            "text": "INCA has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -7.25390625,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.25390625,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -7.37109375,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 8.1171875,
            "text": "computing codon frequencies and several usage indices, such as 'codon bias', effective Nc and CAI, the primary strength of INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 8.1171875,
            "text": "CAI, the primary strength of INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.1171875,
            "text": "Nc and CAI, the primary strength of INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -7.6015625,
            "text": "INCA has numerous",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.59375,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes. In addition to computing codon frequencies and several usage",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 8.1171875,
            "text": "codon bias', effective Nc and CAI, the primary strength of INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.6015625,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 5.960464477539063e-08
        }
    ],
    "5891c90949702f2e01000001_14": [
        {
            "start_logit": 8.28125,
            "end_logit": 8.1171875,
            "text": "INCA",
            "probability": 0.5078125
        },
        {
            "start_logit": 8.2734375,
            "end_logit": 8.109375,
            "text": "INCA",
            "probability": 0.4921875
        },
        {
            "start_logit": 8.28125,
            "end_logit": -0.83056640625,
            "text": "INC",
            "probability": 6.568431854248047e-05
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.8525390625,
            "text": "INC",
            "probability": 6.365776062011719e-05
        },
        {
            "start_logit": -1.072265625,
            "end_logit": 8.1171875,
            "text": "A",
            "probability": 4.374980926513672e-05
        },
        {
            "start_logit": -1.150390625,
            "end_logit": 8.109375,
            "text": "A",
            "probability": 4.011392593383789e-05
        },
        {
            "start_logit": -5.24609375,
            "end_logit": 8.109375,
            "text": "INteractive Codon usage Analysis (INCA",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -6.421875,
            "text": "INCA)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -6.55859375,
            "end_logit": 8.1171875,
            "text": "of INCA",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -6.9296875,
            "text": "INCA has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -7.25390625,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.25390625,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -7.37109375,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 8.1171875,
            "text": "computing codon frequencies and several usage indices, such as 'codon bias', effective Nc and CAI, the primary strength of INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 8.1171875,
            "text": "CAI, the primary strength of INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.1171875,
            "text": "Nc and CAI, the primary strength of INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -7.6015625,
            "text": "INCA has numerous",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.59375,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage in whole genomes. In addition to computing codon frequencies and several usage",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.44140625,
            "end_logit": 8.1171875,
            "text": "codon bias', effective Nc and CAI, the primary strength of INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.6015625,
            "text": "INCA) provides an array of features useful in analysis of synonymous codon usage",
            "probability": 5.960464477539063e-08
        }
    ],
    "5891c90949702f2e01000001_15": [
        {
            "start_logit": 8.2734375,
            "end_logit": 8.140625,
            "text": "INCA",
            "probability": 0.25
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.1328125,
            "text": "INCA",
            "probability": 0.25
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.140625,
            "text": "INCA",
            "probability": 0.25
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.140625,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.25
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.94775390625,
            "text": "INC",
            "probability": 2.855062484741211e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.94775390625,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 2.8073787689208984e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.96728515625,
            "text": "INC",
            "probability": 2.765655517578125e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.97119140625,
            "text": "INC",
            "probability": 2.765655517578125e-05
        },
        {
            "start_logit": -1.01953125,
            "end_logit": 8.140625,
            "text": "A",
            "probability": 2.3305416107177734e-05
        },
        {
            "start_logit": -1.029296875,
            "end_logit": 8.1328125,
            "text": "A",
            "probability": 2.276897430419922e-05
        },
        {
            "start_logit": -1.0390625,
            "end_logit": 8.140625,
            "text": "A",
            "probability": 2.276897430419922e-05
        },
        {
            "start_logit": -1.0390625,
            "end_logit": 8.140625,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 2.276897430419922e-05
        },
        {
            "start_logit": -5.69140625,
            "end_logit": 8.140625,
            "text": ". Finally, INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.69140625,
            "end_logit": 8.1328125,
            "text": ".AVAILABILITY: INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -6.83203125,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.890625,
            "end_logit": 8.140625,
            "text": ", INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.05078125,
            "text": "INCA includes a specific unsupervised neural network",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.234375,
            "text": "INCA includes a specific unsupervised neural",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.29296875,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 8.140625,
            "text": "computing codon frequencies and several usage indices, such as 'codon bias', effective Nc and CAI, the primary strength of INCA",
            "probability": 5.960464477539063e-08
        }
    ],
    "5891c90949702f2e01000001_16": [
        {
            "start_logit": 8.2734375,
            "end_logit": 8.140625,
            "text": "INCA",
            "probability": 0.25
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.1328125,
            "text": "INCA",
            "probability": 0.25
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.140625,
            "text": "INCA",
            "probability": 0.25
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.140625,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.25
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.94775390625,
            "text": "INC",
            "probability": 2.855062484741211e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.94775390625,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 2.8073787689208984e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.96728515625,
            "text": "INC",
            "probability": 2.765655517578125e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.97119140625,
            "text": "INC",
            "probability": 2.765655517578125e-05
        },
        {
            "start_logit": -1.01953125,
            "end_logit": 8.140625,
            "text": "A",
            "probability": 2.3305416107177734e-05
        },
        {
            "start_logit": -1.029296875,
            "end_logit": 8.1328125,
            "text": "A",
            "probability": 2.276897430419922e-05
        },
        {
            "start_logit": -1.0390625,
            "end_logit": 8.140625,
            "text": "A",
            "probability": 2.276897430419922e-05
        },
        {
            "start_logit": -1.0390625,
            "end_logit": 8.140625,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 2.276897430419922e-05
        },
        {
            "start_logit": -5.69140625,
            "end_logit": 8.140625,
            "text": ". Finally, INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.69140625,
            "end_logit": 8.1328125,
            "text": ".AVAILABILITY: INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -6.83203125,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.890625,
            "end_logit": 8.140625,
            "text": ", INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.05078125,
            "text": "INCA includes a specific unsupervised neural network",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.234375,
            "text": "INCA includes a specific unsupervised neural",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.29296875,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 8.140625,
            "text": "computing codon frequencies and several usage indices, such as 'codon bias', effective Nc and CAI, the primary strength of INCA",
            "probability": 5.960464477539063e-08
        }
    ],
    "5891c90949702f2e01000001_17": [
        {
            "start_logit": 8.2734375,
            "end_logit": 8.140625,
            "text": "INCA",
            "probability": 0.25
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.1328125,
            "text": "INCA",
            "probability": 0.25
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.140625,
            "text": "INCA",
            "probability": 0.25
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.140625,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 0.25
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -0.94775390625,
            "text": "INC",
            "probability": 2.855062484741211e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.94775390625,
            "text": "INCA has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INC",
            "probability": 2.8073787689208984e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.96728515625,
            "text": "INC",
            "probability": 2.765655517578125e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -0.97119140625,
            "text": "INC",
            "probability": 2.765655517578125e-05
        },
        {
            "start_logit": -1.01953125,
            "end_logit": 8.140625,
            "text": "A",
            "probability": 2.3305416107177734e-05
        },
        {
            "start_logit": -1.029296875,
            "end_logit": 8.1328125,
            "text": "A",
            "probability": 2.276897430419922e-05
        },
        {
            "start_logit": -1.0390625,
            "end_logit": 8.140625,
            "text": "A",
            "probability": 2.276897430419922e-05
        },
        {
            "start_logit": -1.0390625,
            "end_logit": 8.140625,
            "text": "A has numerous options for the interactive graphical display of calculated values, thus allowing visual detection of various trends in codon usage. Finally, INCA",
            "probability": 2.276897430419922e-05
        },
        {
            "start_logit": -5.69140625,
            "end_logit": 8.140625,
            "text": ". Finally, INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.69140625,
            "end_logit": 8.1328125,
            "text": ".AVAILABILITY: INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -6.83203125,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -6.890625,
            "end_logit": 8.140625,
            "text": ", INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.05078125,
            "text": "INCA includes a specific unsupervised neural network",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.234375,
            "text": "INCA includes a specific unsupervised neural",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.2734375,
            "end_logit": -7.29296875,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.1796875,
            "end_logit": 8.140625,
            "text": "computing codon frequencies and several usage indices, such as 'codon bias', effective Nc and CAI, the primary strength of INCA",
            "probability": 5.960464477539063e-08
        }
    ],
    "5891c90949702f2e01000001_18": [
        {
            "start_logit": 8.265625,
            "end_logit": 8.1328125,
            "text": "INCA",
            "probability": 0.5
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.140625,
            "text": "INCA",
            "probability": 0.5
        },
        {
            "start_logit": 8.265625,
            "end_logit": -1.0009765625,
            "text": "INC",
            "probability": 5.364418029785156e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -1.001953125,
            "text": "INC",
            "probability": 5.364418029785156e-05
        },
        {
            "start_logit": -1.08203125,
            "end_logit": 8.140625,
            "text": "A",
            "probability": 4.374980926513672e-05
        },
        {
            "start_logit": -1.091796875,
            "end_logit": 8.1328125,
            "text": "A",
            "probability": 4.273653030395508e-05
        },
        {
            "start_logit": -6.40625,
            "end_logit": 8.1328125,
            "text": ".AVAILABILITY: INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.0546875,
            "text": "INCA is available for the Win32",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.17578125,
            "text": "INCA is available for the Win32 platform",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.41796875,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.42578125,
            "text": "INCA is available",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.4765625,
            "text": "INCA is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 8.1328125,
            "text": "neural network algorithm, the self-organizing map, used for gene clustering according to the preferred utilization of codons.AVAILABILITY: INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.4921875,
            "text": "INCA includes a specific unsupervised neural network",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.5234375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.5703125,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.59375,
            "text": "INCA is available for the Win32 platform and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.59765625,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.140625,
            "text": ", INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.625,
            "text": "INCA includes",
            "probability": 5.960464477539063e-08
        }
    ],
    "5891c90949702f2e01000001_19": [
        {
            "start_logit": 8.265625,
            "end_logit": 8.1328125,
            "text": "INCA",
            "probability": 0.5
        },
        {
            "start_logit": 8.265625,
            "end_logit": 8.140625,
            "text": "INCA",
            "probability": 0.5
        },
        {
            "start_logit": 8.265625,
            "end_logit": -1.0009765625,
            "text": "INC",
            "probability": 5.364418029785156e-05
        },
        {
            "start_logit": 8.265625,
            "end_logit": -1.001953125,
            "text": "INC",
            "probability": 5.364418029785156e-05
        },
        {
            "start_logit": -1.08203125,
            "end_logit": 8.140625,
            "text": "A",
            "probability": 4.374980926513672e-05
        },
        {
            "start_logit": -1.091796875,
            "end_logit": 8.1328125,
            "text": "A",
            "probability": 4.273653030395508e-05
        },
        {
            "start_logit": -6.40625,
            "end_logit": 8.1328125,
            "text": ".AVAILABILITY: INCA",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.0546875,
            "text": "INCA is available for the Win32",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.17578125,
            "text": "INCA is available for the Win32 platform",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.41796875,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.42578125,
            "text": "INCA is available",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.4765625,
            "text": "INCA is",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.35546875,
            "end_logit": 8.1328125,
            "text": "neural network algorithm, the self-organizing map, used for gene clustering according to the preferred utilization of codons.AVAILABILITY: INCA",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.4921875,
            "text": "INCA includes a specific unsupervised neural network",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.5234375,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing map,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.5703125,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.59375,
            "text": "INCA is available for the Win32 platform and",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.59765625,
            "text": "INCA includes a specific unsupervised neural network algorithm, the self-organizing",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 8.140625,
            "text": ", INCA",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 8.265625,
            "end_logit": -7.625,
            "text": "INCA includes",
            "probability": 5.960464477539063e-08
        }
    ],
    "5891c90949702f2e01000001_20": [
        {
            "start_logit": 8.1875,
            "end_logit": 8.109375,
            "text": "INCA",
            "probability": 1.0
        },
        {
            "start_logit": 8.1875,
            "end_logit": -1.3359375,
            "text": "INC",
            "probability": 7.903575897216797e-05
        },
        {
            "start_logit": -1.400390625,
            "end_logit": 8.109375,
            "text": "A",
            "probability": 6.866455078125e-05
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.57421875,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.5859375,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.60546875,
            "text": "INCA: synonymous codon usage",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.69921875,
            "text": "INCA: synonymous codon usage analysis and clustering by means of self-organizing",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.400390625,
            "end_logit": -7.57421875,
            "text": "A: synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -1.400390625,
            "end_logit": -7.5859375,
            "text": "A: synonymous codon usage analysis and clustering by means of self-",
            "probability": 0.0
        },
        {
            "start_logit": -1.400390625,
            "end_logit": -7.60546875,
            "text": "A: synonymous codon usage",
            "probability": 0.0
        },
        {
            "start_logit": -1.400390625,
            "end_logit": -7.69921875,
            "text": "A: synonymous codon usage analysis and clustering by means of self-organizing",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -7.57421875,
            "text": "means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -7.5859375,
            "text": "means of self-",
            "probability": 0.0
        },
        {
            "start_logit": -7.72265625,
            "end_logit": -7.57421875,
            "text": "of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -7.72265625,
            "end_logit": -7.57421875,
            "text": "clustering by means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -7.72265625,
            "end_logit": -7.5859375,
            "text": "of self-",
            "probability": 0.0
        },
        {
            "start_logit": -7.72265625,
            "end_logit": -7.5859375,
            "text": "clustering by means of self-",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -7.57421875,
            "text": ": synonymous codon usage analysis and clustering by means of self-organizing map",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -7.69921875,
            "text": "means of self-organizing",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -7.5859375,
            "text": ": synonymous codon usage analysis and clustering by means of self-",
            "probability": 0.0
        }
    ],
    "6277e4ee56bf9aee6f000008_1": [
        {
            "start_logit": 6.203125,
            "end_logit": 6.078125,
            "text": "NSAIDs",
            "probability": 0.72607421875
        },
        {
            "start_logit": 6.0859375,
            "end_logit": 5.21875,
            "text": "NSAIDs",
            "probability": 0.273681640625
        },
        {
            "start_logit": -2.025390625,
            "end_logit": 6.078125,
            "text": "acetaminophen for controlling fever and inflammation and be cautious about using NSAIDs",
            "probability": 0.00019431114196777344
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -6.4375,
            "text": "NSAIDs have been effective in treating respiratory infections caused by influenza",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -6.625,
            "end_logit": 6.078125,
            "text": "using NSAIDs",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -6.7421875,
            "text": "NSAIDs have",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -6.9296875,
            "text": "NSAIDs have been effective in treating respiratory infections caused by influenza and",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -6.98828125,
            "text": "NSAIDs have been effective in treating respiratory infections",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 6.203125,
            "end_logit": -7.19921875,
            "text": "NSAIDs in management of COVID-19 patients until there are enough evidence.",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -7.11328125,
            "text": "NSAIDs have been effective in treating respiratory infections caused by influenza and rhin",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.203125,
            "end_logit": -7.3125,
            "text": "NSAIDs in management of COVID-19",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -7.2578125,
            "text": "NSAIDs have been",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.0859375,
            "end_logit": -7.265625,
            "text": "NSAIDs have been effective in",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.296875,
            "end_logit": 6.078125,
            "text": "as acetaminophen for controlling fever and inflammation and be cautious about using NSAIDs",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.390625,
            "end_logit": 6.078125,
            "text": "controlling fever and inflammation and be cautious about using NSAIDs",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.40625,
            "end_logit": 6.078125,
            "text": "about using NSAIDs",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -6.71484375,
            "end_logit": 5.21875,
            "text": ", NSAIDs",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -6.95703125,
            "end_logit": 5.21875,
            "text": "based on existing evidence, NSAIDs",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.19140625,
            "end_logit": 5.21875,
            "text": "existing evidence, NSAIDs",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 5.21875,
            "text": "on existing evidence, NSAIDs",
            "probability": 3.5762786865234375e-07
        }
    ],
    "6277e4ee56bf9aee6f000008_2": [
        {
            "start_logit": 3.353515625,
            "end_logit": 2.658203125,
            "text": "pain",
            "probability": 0.998046875
        },
        {
            "start_logit": 3.353515625,
            "end_logit": -5.03125,
            "text": "pain management in children with COVID-19.",
            "probability": 0.00045752525329589844
        },
        {
            "start_logit": -4.9375,
            "end_logit": 2.658203125,
            "text": "acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.00025081634521484375
        },
        {
            "start_logit": -4.9921875,
            "end_logit": 2.658203125,
            "text": ". As per the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.00023734569549560547
        },
        {
            "start_logit": 3.353515625,
            "end_logit": -5.75,
            "text": "pain management in children",
            "probability": 0.00022304058074951172
        },
        {
            "start_logit": 3.353515625,
            "end_logit": -5.8203125,
            "text": "pain management",
            "probability": 0.0002079010009765625
        },
        {
            "start_logit": -5.30859375,
            "end_logit": 2.658203125,
            "text": "ibuprofen can be safely administered for pain",
            "probability": 0.0001723766326904297
        },
        {
            "start_logit": -5.5859375,
            "end_logit": 2.658203125,
            "text": ", acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.00013113021850585938
        },
        {
            "start_logit": 3.353515625,
            "end_logit": -6.87109375,
            "text": "pain management in",
            "probability": 7.241964340209961e-05
        },
        {
            "start_logit": 3.353515625,
            "end_logit": -7.421875,
            "text": "pain management in children with COVID-19",
            "probability": 4.190206527709961e-05
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 2.658203125,
            "text": "non-pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 3.93986701965332e-05
        },
        {
            "start_logit": -6.89453125,
            "end_logit": 2.658203125,
            "text": "current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 3.528594970703125e-05
        },
        {
            "start_logit": -6.953125,
            "end_logit": 2.658203125,
            "text": "if non-pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 3.314018249511719e-05
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 2.658203125,
            "text": ". can be used if non-pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 2.7477741241455078e-05
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 2.658203125,
            "text": "the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 2.4259090423583984e-05
        },
        {
            "start_logit": -4.9375,
            "end_logit": -1.0654296875,
            "text": "acetaminophen and ibuprofen",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": -4.9921875,
            "end_logit": -1.0654296875,
            "text": ". As per the current strength of evidence, acetaminophen and ibuprofen",
            "probability": 5.7220458984375e-06
        },
        {
            "start_logit": -5.30859375,
            "end_logit": -1.0654296875,
            "text": "ibuprofen",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -5.5859375,
            "end_logit": -1.0654296875,
            "text": ", acetaminophen and ibuprofen",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -5.95703125,
            "end_logit": -1.0654296875,
            "text": "spasmolytics etc. can be used if non-pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen",
            "probability": 2.205371856689453e-06
        }
    ],
    "6277e4ee56bf9aee6f000008_3": [
        {
            "start_logit": 3.353515625,
            "end_logit": 2.658203125,
            "text": "pain",
            "probability": 0.998046875
        },
        {
            "start_logit": 3.353515625,
            "end_logit": -5.03125,
            "text": "pain management in children with COVID-19.",
            "probability": 0.00045752525329589844
        },
        {
            "start_logit": -4.9375,
            "end_logit": 2.658203125,
            "text": "acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.00025081634521484375
        },
        {
            "start_logit": -4.9921875,
            "end_logit": 2.658203125,
            "text": ". As per the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.00023734569549560547
        },
        {
            "start_logit": 3.353515625,
            "end_logit": -5.75,
            "text": "pain management in children",
            "probability": 0.00022304058074951172
        },
        {
            "start_logit": 3.353515625,
            "end_logit": -5.8203125,
            "text": "pain management",
            "probability": 0.0002079010009765625
        },
        {
            "start_logit": -5.30859375,
            "end_logit": 2.658203125,
            "text": "ibuprofen can be safely administered for pain",
            "probability": 0.0001723766326904297
        },
        {
            "start_logit": -5.5859375,
            "end_logit": 2.658203125,
            "text": ", acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 0.00013113021850585938
        },
        {
            "start_logit": 3.353515625,
            "end_logit": -6.87109375,
            "text": "pain management in",
            "probability": 7.241964340209961e-05
        },
        {
            "start_logit": 3.353515625,
            "end_logit": -7.421875,
            "text": "pain management in children with COVID-19",
            "probability": 4.190206527709961e-05
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 2.658203125,
            "text": "non-pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 3.93986701965332e-05
        },
        {
            "start_logit": -6.89453125,
            "end_logit": 2.658203125,
            "text": "current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 3.528594970703125e-05
        },
        {
            "start_logit": -6.953125,
            "end_logit": 2.658203125,
            "text": "if non-pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 3.314018249511719e-05
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 2.658203125,
            "text": ". can be used if non-pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 2.7477741241455078e-05
        },
        {
            "start_logit": -7.26953125,
            "end_logit": 2.658203125,
            "text": "the current strength of evidence, acetaminophen and ibuprofen can be safely administered for pain",
            "probability": 2.4259090423583984e-05
        },
        {
            "start_logit": -4.9375,
            "end_logit": -1.0654296875,
            "text": "acetaminophen and ibuprofen",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": -4.9921875,
            "end_logit": -1.0654296875,
            "text": ". As per the current strength of evidence, acetaminophen and ibuprofen",
            "probability": 5.7220458984375e-06
        },
        {
            "start_logit": -5.30859375,
            "end_logit": -1.0654296875,
            "text": "ibuprofen",
            "probability": 4.172325134277344e-06
        },
        {
            "start_logit": -5.5859375,
            "end_logit": -1.0654296875,
            "text": ", acetaminophen and ibuprofen",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -5.95703125,
            "end_logit": -1.0654296875,
            "text": "spasmolytics etc. can be used if non-pharmacological therapy is inadequate. As per the current strength of evidence, acetaminophen and ibuprofen",
            "probability": 2.205371856689453e-06
        }
    ],
    "6277e4ee56bf9aee6f000008_4": [
        {
            "start_logit": 5.66015625,
            "end_logit": 5.40625,
            "text": "NSAIDs",
            "probability": 0.50732421875
        },
        {
            "start_logit": 5.19921875,
            "end_logit": 5.40625,
            "text": "NSAIDs should not be used, but there is no strong evidence that NSAIDs",
            "probability": 0.322509765625
        },
        {
            "start_logit": 5.19921875,
            "end_logit": 4.59375,
            "text": "NSAIDs",
            "probability": 0.14306640625
        },
        {
            "start_logit": 3.416015625,
            "end_logit": 4.59375,
            "text": "NSAIDs but there are issues with liver toxicity at high doses. There are clearly COVID-19 cases where NSAIDs",
            "probability": 0.0239105224609375
        },
        {
            "start_logit": 3.416015625,
            "end_logit": 2.6796875,
            "text": "NSAIDs",
            "probability": 0.0035247802734375
        },
        {
            "start_logit": -1.40625,
            "end_logit": 2.6796875,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": -5.45703125,
            "end_logit": 5.40625,
            "text": ". There are clearly COVID-19 cases where NSAIDs should not be used, but there is no strong evidence that NSAIDs",
            "probability": 7.569789886474609e-06
        },
        {
            "start_logit": -5.53125,
            "end_logit": 5.40625,
            "text": "where NSAIDs should not be used, but there is no strong evidence that NSAIDs",
            "probability": 7.033348083496094e-06
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -5.83203125,
            "text": "NSAIDs must be avoided in all patients with COVID-19; clinicians must weigh these choices on an individual basis.",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -6.375,
            "text": "NSAIDs must",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -6.47265625,
            "text": "NSAIDs must be avoided",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": -5.45703125,
            "end_logit": 4.59375,
            "text": ". There are clearly COVID-19 cases where NSAIDs",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -5.53125,
            "end_logit": 4.59375,
            "text": "where NSAIDs",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 5.19921875,
            "end_logit": -6.375,
            "text": "NSAIDs should not be used, but there is no strong evidence that NSAIDs must",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 5.19921875,
            "end_logit": -6.40625,
            "text": "NSAIDs should not",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 5.19921875,
            "end_logit": -6.47265625,
            "text": "NSAIDs should not be used, but there is no strong evidence that NSAIDs must be avoided",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -7.19140625,
            "text": "NSAIDs must be avoided in",
            "probability": 1.7285346984863281e-06
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -7.26171875,
            "text": "NSAIDs must be avoided in all patients",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -7.2890625,
            "text": "NSAIDs must be avoided in all patients with COVID-",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 5.19921875,
            "end_logit": -6.86328125,
            "text": "NSAIDs should",
            "probability": 1.4901161193847656e-06
        }
    ],
    "6277e4ee56bf9aee6f000008_5": [
        {
            "start_logit": 6.3515625,
            "end_logit": 6.51171875,
            "text": "paracetamol",
            "probability": 0.9951171875
        },
        {
            "start_logit": 6.3515625,
            "end_logit": 1.138671875,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used for pain",
            "probability": 0.004642486572265625
        },
        {
            "start_logit": 2.478515625,
            "end_logit": 1.138671875,
            "text": "pain",
            "probability": 9.638071060180664e-05
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -5.62109375,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used for pain management",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -6.359375,
            "text": "paracetamol can",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -6.58984375,
            "end_logit": 6.51171875,
            "text": "analgesia, paracetamol",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -6.87109375,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -6.8828125,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used for pain management in",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.125,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.25390625,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used for pain management in patients",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.3671875,
            "text": "paracetamol can be",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.53125,
            "end_logit": 6.51171875,
            "text": ", paracetamol",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.375,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used for pain management in patients with COVID-",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.5390625,
            "end_logit": 6.51171875,
            "text": "provide analgesia, paracetamol",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.44140625,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used for pain management in patients with",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.44140625,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.4921875,
            "text": "paracetamol can be listed as the first option",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.49609375,
            "text": "paracetamol can be listed as the first option in these patients, and then NSAIDs can also be reliably used for pain management in patients with COVID-19",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 6.51171875,
            "text": "To provide analgesia, paracetamol",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 2.478515625,
            "end_logit": -5.62109375,
            "text": "pain management",
            "probability": 1.1920928955078125e-07
        }
    ],
    "6277e4ee56bf9aee6f000008_6": [
        {
            "start_logit": 6.27734375,
            "end_logit": 6.6796875,
            "text": "Paracetamol",
            "probability": 1.0
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -6.86328125,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -6.96484375,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.15625,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver toxicity",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.19140625,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.40625,
            "text": "Paracetamol (acetaminophen) has been proposed as",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.45703125,
            "text": "Paracetamol (acetaminophen) has been proposed as an",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.46875,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.48828125,
            "text": "Paracetamol (acetaminophen) has",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.546875,
            "text": "Paracetamol (acetaminophen",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.5625,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver toxicity at high",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.56640625,
            "text": "Paracetamol (acetaminophen)",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.60546875,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver toxicity at high doses",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.62890625,
            "text": "Paracetamol (",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.65234375,
            "text": "Paracetamol (acetaminophen) has been",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.66015625,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.27734375,
            "end_logit": -7.71875,
            "text": "Paracetamol (acetaminophen) has been proposed as an alternative to NSAIDs but there are issues with liver toxicity at",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -6.86328125,
            "text": "proposed as an alternative to NSAIDs but there are issues with liver",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -6.86328125,
            "text": "there are issues with liver",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -6.96484375,
            "text": "proposed as an alternative to NSAIDs",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_1": [
        {
            "start_logit": 6.1953125,
            "end_logit": 6.81640625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": 6.81640625,
            "text": "risk neuroblastoma",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 6.81640625,
            "text": "high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 6.81640625,
            "text": "ch14.18), a monoclonal antibody against disialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 6.81640625,
            "text": "disialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 6.81640625,
            "text": ", improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 6.81640625,
            "text": "improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 6.81640625,
            "text": "ialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 6.81640625,
            "text": ", a monoclonal antibody against disialoganglioside, improved survival as part of post-consolidation therapy for high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.578125,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody against disialoganglioside",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.5859375,
            "text": "Unituxin\u2122",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.640625,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody against disialoganglioside, improved survival as part of post-",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.640625,
            "text": "Unituxin\u2122; ch14.",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.6796875,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody against disialoganglioside, improved survival as",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.68359375,
            "text": "Unituxin\u2122; ch14.18",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.6875,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody against disialoganglioside, improved survival as part of post-consolidation therapy",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.69921875,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody against disialoganglioside, improved survival as part of post-consolidation",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.70703125,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody against disialoganglioside, improved survival as part of",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.7265625,
            "text": "Unituxin\u2122; ch14",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -7.73046875,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody against disialogangli",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_2": [
        {
            "start_logit": 6.15625,
            "end_logit": 6.8671875,
            "text": "Neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.8671875,
            "text": "Review in High-Risk Neuroblastoma",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.8671875,
            "text": "A Review in High-Risk Neuroblastoma",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 6.8671875,
            "text": "in High-Risk Neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 6.8671875,
            "text": "High-Risk Neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 6.8671875,
            "text": "Risk Neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 6.8671875,
            "text": "Dinutuximab: A Review in High-Risk Neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 6.8671875,
            "text": "-Risk Neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 6.8671875,
            "text": "utuximab: A Review in High-Risk Neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 6.8671875,
            "text": ": A Review in High-Risk Neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 6.8671875,
            "text": "uximab: A Review in High-Risk Neuroblastoma",
            "probability": 7.152557373046875e-07
        }
    ],
    "589a247078275d0c4a000035_3": [
        {
            "start_logit": 6.078125,
            "end_logit": 6.828125,
            "text": "neuroblastoma",
            "probability": 0.51171875
        },
        {
            "start_logit": 6.0625,
            "end_logit": 6.80078125,
            "text": "neuroblastoma",
            "probability": 0.48828125
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 6.828125,
            "text": "risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 6.828125,
            "text": "high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 6.828125,
            "text": "patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 6.828125,
            "text": "isotretinoin for the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.0625,
            "end_logit": -7.1171875,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 6.80078125,
            "text": "of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 6.828125,
            "text": "of patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 6.828125,
            "text": "the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 6.828125,
            "text": ", interleukin (IL)-2 and isotretinoin for the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 6.80078125,
            "text": "ialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.078125,
            "end_logit": -7.27734375,
            "text": "neuroblastoma.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.0625,
            "end_logit": -7.27734375,
            "text": "neuroblastoma cells.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.0625,
            "end_logit": -7.3203125,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU and USA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.0625,
            "end_logit": -7.3203125,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.0625,
            "end_logit": -7.3203125,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU and USA as",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.0625,
            "end_logit": -7.35546875,
            "text": "neuroblastoma cells. This intravenous drug is approved in",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -7.1171875,
            "text": ". This intravenous drug is approved in the EU",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -7.27734375,
            "text": ".",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_4": [
        {
            "start_logit": 6.078125,
            "end_logit": 6.828125,
            "text": "neuroblastoma",
            "probability": 0.51171875
        },
        {
            "start_logit": 6.0625,
            "end_logit": 6.80078125,
            "text": "neuroblastoma",
            "probability": 0.48828125
        },
        {
            "start_logit": -7.25390625,
            "end_logit": 6.828125,
            "text": "risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 6.828125,
            "text": "high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 6.828125,
            "text": "patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 6.828125,
            "text": "isotretinoin for the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.0625,
            "end_logit": -7.1171875,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 6.80078125,
            "text": "of neuroblastoma",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 6.828125,
            "text": "of patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 6.828125,
            "text": "the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 6.828125,
            "text": ", interleukin (IL)-2 and isotretinoin for the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 6.80078125,
            "text": "ialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.078125,
            "end_logit": -7.27734375,
            "text": "neuroblastoma.",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 6.0625,
            "end_logit": -7.27734375,
            "text": "neuroblastoma cells.",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.0625,
            "end_logit": -7.3203125,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU and USA",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.0625,
            "end_logit": -7.3203125,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.0625,
            "end_logit": -7.3203125,
            "text": "neuroblastoma cells. This intravenous drug is approved in the EU and USA as",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.0625,
            "end_logit": -7.35546875,
            "text": "neuroblastoma cells. This intravenous drug is approved in",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -7.1171875,
            "text": ". This intravenous drug is approved in the EU",
            "probability": 0.0
        },
        {
            "start_logit": -6.16015625,
            "end_logit": -7.27734375,
            "text": ".",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_5": [
        {
            "start_logit": 6.125,
            "end_logit": 6.83203125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.83203125,
            "text": ", IL-2 and isotretinoin represents an important advance in the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.83203125,
            "text": "GM-CSF, IL-2 and isotretinoin represents an important advance in the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 6.83203125,
            "text": "postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 6.83203125,
            "text": "isotretinoin represents an important advance in the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 6.83203125,
            "text": "advance in the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 6.83203125,
            "text": "the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 6.83203125,
            "text": "IL-2 and isotretinoin represents an important advance in the postconsolidation treatment of patients with high-risk neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.125,
            "end_logit": -7.6328125,
            "text": "neuroblastoma, with its benefits outweighing its risks in a patient population",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.125,
            "end_logit": -7.65234375,
            "text": "neuroblastoma, with its benefits outweighing",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.125,
            "end_logit": -7.66796875,
            "text": "neuroblastoma, with its benefits outweigh",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -7.45703125,
            "text": ", IL-2 and isotretinoin represents an important advance in the postconsolidation treatment of patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.71875,
            "end_logit": -7.45703125,
            "text": "GM-CSF, IL-2 and isotretinoin represents an important advance in the postconsolidation treatment of patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -7.5234375,
            "text": ", IL-2 and isotretinoin represents an important advance in the postconsolidation treatment of patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -7.45703125,
            "text": "postconsolidation treatment of patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.77734375,
            "end_logit": -7.45703125,
            "text": "isotretinoin represents an important advance in the postconsolidation treatment of patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.71875,
            "end_logit": -7.5234375,
            "text": "GM-CSF, IL-2 and isotretinoin represents an important advance in the postconsolidation treatment of patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.78515625,
            "end_logit": -7.45703125,
            "text": "advance in the postconsolidation treatment of patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -7.546875,
            "text": ", IL-2 and isotretinoin represents an important advance in the postconsolidation treatment of patients with",
            "probability": 0.0
        },
        {
            "start_logit": -7.70703125,
            "end_logit": -7.5625,
            "text": ", IL-2 and isotretinoin represents an important advance in the postconsolidation treatment of patients with high-risk",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_6": [
        {
            "start_logit": 6.2109375,
            "end_logit": 6.8125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 6.8125,
            "text": "Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 6.8125,
            "text": "high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 6.8125,
            "text": "treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 6.8125,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 6.8125,
            "text": "patients with high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.0,
            "end_logit": 6.8125,
            "text": "risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 6.8125,
            "text": "utuximab for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 6.8125,
            "text": "the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 6.8125,
            "text": "uximab for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.37890625,
            "text": "Dinutuximab for the treatment of pediatric patients with high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.37890625,
            "text": "Dinutuximab for the treatment of pediatric patients",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": -7.37890625,
            "text": "high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": -7.37890625,
            "text": "treatment of pediatric patients with high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": -7.37890625,
            "text": "treatment of pediatric patients",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.453125,
            "text": "Dinutuximab for the treatment of pediatric patients with",
            "probability": 0.0
        },
        {
            "start_logit": -7.9375,
            "end_logit": -7.37890625,
            "text": "pediatric patients with high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.9375,
            "end_logit": -7.37890625,
            "text": "pediatric patients",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.46875,
            "text": "Dinutuximab for the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": -7.453125,
            "text": "treatment of pediatric patients with",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_7": [
        {
            "start_logit": 6.05078125,
            "end_logit": 6.84375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": 6.84375,
            "text": "risk neuroblastoma",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": 6.05078125,
            "end_logit": -6.90234375,
            "text": "neuroblastoma who",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.05078125,
            "end_logit": -7.3203125,
            "text": "neuroblastoma who achieve at least",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.05078125,
            "end_logit": -7.359375,
            "text": "neuroblastoma who achieve at",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.05078125,
            "end_logit": -7.3671875,
            "text": "neuroblastoma who achieve",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.05078125,
            "end_logit": -7.4375,
            "text": "neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -5.84765625,
            "end_logit": -7.2421875,
            "text": ".<br><b>CONCLUSIONS</b>: Dinutuximab is the first anti-GD2",
            "probability": 0.0
        },
        {
            "start_logit": -5.84765625,
            "end_logit": -7.31640625,
            "text": ".<br><b>CONCLUSIONS</b>: Dinutuximab is the first anti-GD2 monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -5.84765625,
            "end_logit": -7.3359375,
            "text": ".<br><b>CONCLUSIONS</b>: Dinutuximab is the first anti-GD2 monoclonal antibody approved",
            "probability": 0.0
        },
        {
            "start_logit": -5.84765625,
            "end_logit": -7.3984375,
            "text": ".<br><b>CONCLUSIONS</b",
            "probability": 0.0
        },
        {
            "start_logit": -5.84765625,
            "end_logit": -7.3984375,
            "text": ".<br><b>CONCLUSIONS</b>",
            "probability": 0.0
        },
        {
            "start_logit": -5.84765625,
            "end_logit": -7.40234375,
            "text": ".<br><b>CONCLUSIONS</b>: Dinutuximab is the first anti-GD2 monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": -5.84765625,
            "end_logit": -7.42578125,
            "text": ".<br><b>CONCLUSIONS</b>: Dinutuximab is the first anti-GD",
            "probability": 0.0
        },
        {
            "start_logit": -5.84765625,
            "end_logit": -7.4375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.578125,
            "end_logit": -6.90234375,
            "text": "risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.28125,
            "end_logit": -7.2421875,
            "text": "<br><b>CONCLUSIONS</b>: Dinutuximab is the first anti-GD2",
            "probability": 0.0
        },
        {
            "start_logit": -7.28125,
            "end_logit": -7.31640625,
            "text": "<br><b>CONCLUSIONS</b>: Dinutuximab is the first anti-GD2 monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -7.34765625,
            "end_logit": -7.2421875,
            "text": ": Dinutuximab is the first anti-GD2",
            "probability": 0.0
        },
        {
            "start_logit": -7.28125,
            "end_logit": -7.3359375,
            "text": "<br><b>CONCLUSIONS</b>: Dinutuximab is the first anti-GD2 monoclonal antibody approved",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_8": [
        {
            "start_logit": 6.11328125,
            "end_logit": 6.81640625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 6.81640625,
            "text": "), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.5625,
            "end_logit": 6.81640625,
            "text": ", and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.81640625,
            "text": "[RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 6.81640625,
            "text": "isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 6.81640625,
            "text": ") for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -7.171875,
            "text": "neuroblastoma who",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -7.47265625,
            "text": "neuroblastoma who achieve",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -7.4921875,
            "text": "neuroblastoma who achieve at",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -7.515625,
            "text": "neuroblastoma who achieve at least",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -7.5859375,
            "text": "neuroblastoma who achieve at least a partial response to first-line",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -7.171875,
            "text": "), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -7.171875,
            "text": ", and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -7.33203125,
            "text": "), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -7.33984375,
            "text": "), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.6953125,
            "end_logit": -7.171875,
            "text": "[RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -7.390625,
            "text": "), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -7.33203125,
            "text": ", and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -7.33984375,
            "text": ", and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.75390625,
            "end_logit": -7.171875,
            "text": "isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_9": [
        {
            "start_logit": 6.0,
            "end_logit": 6.90234375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 6.90234375,
            "text": ": Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 6.90234375,
            "text": "CONCLUSION</b>: Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 6.90234375,
            "text": "risk neuroblastoma",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.828125,
            "end_logit": 6.90234375,
            "text": "in pediatric patients with high-risk neuroblastoma",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 6.90234375,
            "text": "Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.90234375,
            "text": "high-risk neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -7.44921875,
            "text": "5 mg",
            "probability": 0.0
        },
        {
            "start_logit": -7.12109375,
            "end_logit": -7.44921875,
            "text": "The recommended dosage of dinutuximab is 17.5 mg",
            "probability": 0.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -7.51171875,
            "text": "5 mg/",
            "probability": 0.0
        },
        {
            "start_logit": -7.12109375,
            "end_logit": -7.47265625,
            "text": "The recommended dosage of dinutuximab is 17",
            "probability": 0.0
        },
        {
            "start_logit": -7.12109375,
            "end_logit": -7.5,
            "text": "The recommended dosage of dinutuximab is",
            "probability": 0.0
        },
        {
            "start_logit": -7.12109375,
            "end_logit": -7.51171875,
            "text": "The recommended dosage of dinutuximab is 17.5 mg/",
            "probability": 0.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -7.59765625,
            "text": "5 mg/m<br><b>CONCLUSION</b>: Dinutuximab is a novel monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -7.62109375,
            "text": "5 mg/m",
            "probability": 0.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -7.6328125,
            "text": "5 mg/m<br><b>CONCLUSION</b>: Dinutuximab is a novel monoclonal",
            "probability": 0.0
        },
        {
            "start_logit": -7.12109375,
            "end_logit": -7.58984375,
            "text": "The recommended dosage of dinutuximab",
            "probability": 0.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -7.64453125,
            "text": "5 mg/m<br><b>CONCLUSION</b>: Dinutuximab is a novel monoclonal antibody that is efficacious as part of",
            "probability": 0.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -7.6484375,
            "text": "5 mg/m<br><b>CONCLUSION</b>: Dinutuximab",
            "probability": 0.0
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -7.65234375,
            "text": "5 mg/m<br><b>CONCLUSION</b",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_10": [
        {
            "start_logit": 6.125,
            "end_logit": 6.8359375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": 6.125,
            "end_logit": -6.85546875,
            "text": "neuroblastoma and",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.8359375,
            "text": ", represents an important therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 6.8359375,
            "text": ", or dinutuximab, represents an important therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.8359375,
            "text": "the treatment of pediatric high-risk neuroblastoma",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 6.8359375,
            "text": "ch14.18, or dinutuximab, represents an important therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 6.8359375,
            "text": "risk neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 6.8359375,
            "text": "advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 6.8359375,
            "text": "treatment of pediatric high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 6.8359375,
            "text": "GD2 monoclonal antibody ch14.18, or dinutuximab, represents an important therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.8359375,
            "text": "14.18, or dinutuximab, represents an important therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 6.8359375,
            "text": "therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 6.8359375,
            "text": "anti-GD2 monoclonal antibody ch14.18, or dinutuximab, represents an important therapeutic advance in the treatment of pediatric high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.125,
            "end_logit": -7.4296875,
            "text": "neuroblastoma and is now considered part of standard of care in this patient population",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.125,
            "end_logit": -7.55078125,
            "text": "neuroblastoma and is now considered part of standard of care in this patient",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.125,
            "end_logit": -7.61328125,
            "text": "neuroblastoma and is now considered part",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.125,
            "end_logit": -7.625,
            "text": "neuroblastoma and is",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.125,
            "end_logit": -7.6640625,
            "text": "neuroblastoma and is now considered part of standard of",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.125,
            "end_logit": -7.6640625,
            "text": "neuroblastoma and is now considered part of",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.125,
            "end_logit": -7.69921875,
            "text": "neuroblastoma and is now considered part of standard of care",
            "probability": 4.76837158203125e-07
        }
    ],
    "589a247078275d0c4a000035_11": [
        {
            "start_logit": 6.1015625,
            "end_logit": 6.859375,
            "text": "neuroblastoma",
            "probability": 0.50390625
        },
        {
            "start_logit": 6.1015625,
            "end_logit": 6.84375,
            "text": "neuroblastoma",
            "probability": 0.49609375
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 6.859375,
            "text": "risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 6.859375,
            "text": ", and isotretinoin for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 6.84375,
            "text": "The pharmacology, clinical efficacy, safety, dosage and administration, and role in therapy of dinutuximab for the treatment of high-risk pediatric neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.84375,
            "text": ": The pharmacology, clinical efficacy, safety, dosage and administration, and role in therapy of dinutuximab for the treatment of high-risk pediatric neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.84375,
            "text": "the treatment of high-risk pediatric neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 6.859375,
            "text": "high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -7.5703125,
            "text": "neuroblastoma are",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -7.59765625,
            "text": "neuroblastoma are reviewed.<br><b>SUMMARY</b>: Dinut",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.81640625,
            "end_logit": -7.54296875,
            "text": ".<br><b>SUMMARY</b>: Dinutuximab (Unituxin, United Therapeutics) is a novel monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -5.81640625,
            "end_logit": -7.59765625,
            "text": ".<br><b>SUMMARY</b>: Dinut",
            "probability": 0.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -7.0390625,
            "text": ", and isotretinoin for the treatment of pediatric patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": -7.16015625,
            "text": "risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -7.16015625,
            "text": ", and isotretinoin for the treatment of pediatric patients with high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -7.25,
            "text": "The pharmacology, clinical efficacy, safety, dosage and administration, and role in therapy of dinutuximab for the treatment of high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -7.26953125,
            "text": "The pharmacology, clinical efficacy, safety, dosage and administration, and role in therapy of dinutuximab for the treatment of high",
            "probability": 0.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -7.328125,
            "text": ", and isotretinoin for the treatment of pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -7.0390625,
            "text": "high",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -7.43359375,
            "text": "The pharmacology, clinical efficacy, safety, dosage and administration, and role in therapy of dinutuximab for the treatment of",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_12": [
        {
            "start_logit": 6.1015625,
            "end_logit": 6.859375,
            "text": "neuroblastoma",
            "probability": 0.50390625
        },
        {
            "start_logit": 6.1015625,
            "end_logit": 6.84375,
            "text": "neuroblastoma",
            "probability": 0.49609375
        },
        {
            "start_logit": -7.30859375,
            "end_logit": 6.859375,
            "text": "risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 6.859375,
            "text": ", and isotretinoin for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.3359375,
            "end_logit": 6.84375,
            "text": "The pharmacology, clinical efficacy, safety, dosage and administration, and role in therapy of dinutuximab for the treatment of high-risk pediatric neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.58984375,
            "end_logit": 6.84375,
            "text": ": The pharmacology, clinical efficacy, safety, dosage and administration, and role in therapy of dinutuximab for the treatment of high-risk pediatric neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.84375,
            "text": "the treatment of high-risk pediatric neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 6.859375,
            "text": "high-risk neuroblastoma",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -7.5703125,
            "text": "neuroblastoma are",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.1015625,
            "end_logit": -7.59765625,
            "text": "neuroblastoma are reviewed.<br><b>SUMMARY</b>: Dinut",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -5.81640625,
            "end_logit": -7.54296875,
            "text": ".<br><b>SUMMARY</b>: Dinutuximab (Unituxin, United Therapeutics) is a novel monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -5.81640625,
            "end_logit": -7.59765625,
            "text": ".<br><b>SUMMARY</b>: Dinut",
            "probability": 0.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -7.0390625,
            "text": ", and isotretinoin for the treatment of pediatric patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.30859375,
            "end_logit": -7.16015625,
            "text": "risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -7.16015625,
            "text": ", and isotretinoin for the treatment of pediatric patients with high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -7.25,
            "text": "The pharmacology, clinical efficacy, safety, dosage and administration, and role in therapy of dinutuximab for the treatment of high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -7.26953125,
            "text": "The pharmacology, clinical efficacy, safety, dosage and administration, and role in therapy of dinutuximab for the treatment of high",
            "probability": 0.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -7.328125,
            "text": ", and isotretinoin for the treatment of pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -7.0390625,
            "text": "high",
            "probability": 0.0
        },
        {
            "start_logit": -7.3359375,
            "end_logit": -7.43359375,
            "text": "The pharmacology, clinical efficacy, safety, dosage and administration, and role in therapy of dinutuximab for the treatment of",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_13": [
        {
            "start_logit": 6.07421875,
            "end_logit": 6.8671875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.8671875,
            "text": "risk neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 6.8671875,
            "text": ", interleukin-2 and 13-cis retinoic acid) in the treatment of paediatric patients with high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.07421875,
            "end_logit": -7.23828125,
            "text": "neuroblastoma who",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.07421875,
            "end_logit": -7.3671875,
            "text": "neuroblastoma who achieve at",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.07421875,
            "end_logit": -7.3984375,
            "text": "neuroblastoma who achieve at least",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.07421875,
            "end_logit": -7.4375,
            "text": "neuroblastoma who achieve",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -7.32421875,
            "text": "This article summarizes the milestones in the development of dinutuximab leading to this first approval for",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -7.3984375,
            "text": "This article summarizes the milestones in the development of",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -7.40234375,
            "text": "This article summarizes the milestones in the development of dinutuximab leading to",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -7.4140625,
            "text": "This article summarizes the milestones in the development",
            "probability": 0.0
        },
        {
            "start_logit": -7.3515625,
            "end_logit": -7.4609375,
            "text": "This article summarizes the milestones in",
            "probability": 0.0
        },
        {
            "start_logit": -7.6875,
            "end_logit": -7.32421875,
            "text": "summarizes the milestones in the development of dinutuximab leading to this first approval for",
            "probability": 0.0
        },
        {
            "start_logit": -7.6875,
            "end_logit": -7.3984375,
            "text": "summarizes the milestones in the development of",
            "probability": 0.0
        },
        {
            "start_logit": -7.6875,
            "end_logit": -7.40234375,
            "text": "summarizes the milestones in the development of dinutuximab leading to",
            "probability": 0.0
        },
        {
            "start_logit": -7.6875,
            "end_logit": -7.4140625,
            "text": "summarizes the milestones in the development",
            "probability": 0.0
        },
        {
            "start_logit": -7.79296875,
            "end_logit": -7.32421875,
            "text": "milestones in the development of dinutuximab leading to this first approval for",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -7.23828125,
            "text": "risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.6875,
            "end_logit": -7.4609375,
            "text": "summarizes the milestones in",
            "probability": 0.0
        },
        {
            "start_logit": -7.79296875,
            "end_logit": -7.3984375,
            "text": "milestones in the development of",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_14": [
        {
            "start_logit": 6.26171875,
            "end_logit": 6.74609375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": 6.74609375,
            "text": "The US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 6.74609375,
            "text": "recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.26171875,
            "end_logit": -7.37890625,
            "text": "neuroblastoma in paediatric patients",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 6.74609375,
            "text": "risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 6.74609375,
            "text": "treatment of high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.26171875,
            "end_logit": -7.45703125,
            "text": "neuroblastoma in",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 6.74609375,
            "text": "dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 6.74609375,
            "text": "the treatment of high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.26171875,
            "end_logit": -7.5078125,
            "text": "neuroblastoma in paediatric",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 6.74609375,
            "text": "high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 6.74609375,
            "text": "use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 6.74609375,
            "text": "US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 6.74609375,
            "text": "utuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.26171875,
            "end_logit": -7.59765625,
            "text": "neuroblastoma in paediatric patients.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": -7.59765625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.37890625,
            "text": "The US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma in paediatric patients",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.44140625,
            "text": "The US FDA has recently approved the use of dinutuximab combination therapy for the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.453125,
            "text": "The US FDA has recently approved the use of dinutuximab combination therapy",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.45703125,
            "text": "The US FDA",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_15": [
        {
            "start_logit": 6.09375,
            "end_logit": 6.76171875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 6.76171875,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 6.76171875,
            "text": "the treatment of neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 6.76171875,
            "text": ", for the treatment of neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 6.76171875,
            "text": "developing dinutuximab (Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 6.76171875,
            "text": "ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 6.76171875,
            "text": "dinutuximab (Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 6.76171875,
            "text": "treatment of neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 6.76171875,
            "text": "GD2, for the treatment of neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -4.44921875,
            "text": "Cancer",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -5.46875,
            "text": "Cancer Institute",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.109375,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.33984375,
            "text": "Cancer Institute are",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.34765625,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122;",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.38671875,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122; ch14",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.40234375,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122; ch14.",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.4296875,
            "text": "Cancer Institute are developing dinutuximab (Unituxin",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.453125,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122; ch14.18",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.484375,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.484375,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_16": [
        {
            "start_logit": 6.18359375,
            "end_logit": 6.80078125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.4765625,
            "end_logit": 6.80078125,
            "text": "risk neuroblastoma",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 6.80078125,
            "text": "high-risk neuroblastoma",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.80078125,
            "text": "PURPOSE: Immunotherapy of high-risk neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 6.80078125,
            "text": "Immunotherapy of high-risk neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 6.80078125,
            "text": ": Immunotherapy of high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.18359375,
            "end_logit": -7.5078125,
            "text": "neuroblastoma using the anti-GD2",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.18359375,
            "end_logit": -7.546875,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity (ADCC).",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.18359375,
            "end_logit": -7.59765625,
            "text": "neuroblastoma using the anti-GD2 antibody",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.18359375,
            "end_logit": -7.61328125,
            "text": "neuroblastoma using the anti-",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.18359375,
            "end_logit": -7.6328125,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.18359375,
            "end_logit": -7.66796875,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity (ADCC)",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.18359375,
            "end_logit": -7.6796875,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.18359375,
            "end_logit": -7.69140625,
            "text": "neuroblastoma using the anti-GD",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.18359375,
            "end_logit": -7.69140625,
            "text": "neuroblastoma using",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.18359375,
            "end_logit": -7.6953125,
            "text": "neuroblastoma using the",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.18359375,
            "end_logit": -7.69921875,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.18359375,
            "end_logit": -7.703125,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.18359375,
            "end_logit": -7.70703125,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.18359375,
            "end_logit": -7.70703125,
            "text": "neuroblastoma using the anti-GD2 antibody dinutuximab induces antibody-dependent cell-mediated cytotoxicity (ADCC",
            "probability": 4.76837158203125e-07
        }
    ],
    "589a247078275d0c4a000035_17": [
        {
            "start_logit": 6.11328125,
            "end_logit": 6.81640625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 6.81640625,
            "text": "), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -7.5625,
            "end_logit": 6.81640625,
            "text": ", and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.81640625,
            "text": "[RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 6.81640625,
            "text": "isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 6.81640625,
            "text": ") for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -7.171875,
            "text": "neuroblastoma who",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -7.47265625,
            "text": "neuroblastoma who achieve",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -7.4921875,
            "text": "neuroblastoma who achieve at",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -7.515625,
            "text": "neuroblastoma who achieve at least",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -7.5859375,
            "text": "neuroblastoma who achieve at least a partial response to first-line",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -7.171875,
            "text": "), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -7.171875,
            "text": ", and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -7.33203125,
            "text": "), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -7.33984375,
            "text": "), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.6953125,
            "end_logit": -7.171875,
            "text": "[RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.48828125,
            "end_logit": -7.390625,
            "text": "), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -7.33203125,
            "text": ", and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.5625,
            "end_logit": -7.33984375,
            "text": ", and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.75390625,
            "end_logit": -7.171875,
            "text": "isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_18": [
        {
            "start_logit": 6.16015625,
            "end_logit": 6.82421875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 6.82421875,
            "text": "GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 6.82421875,
            "text": "risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.828125,
            "end_logit": 6.82421875,
            "text": ", and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 6.82421875,
            "text": "GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -7.2578125,
            "text": "neuroblastoma who",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -7.59765625,
            "text": "neuroblastoma who achieve at",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -7.59765625,
            "text": "neuroblastoma who achieve",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.16015625,
            "end_logit": -7.6015625,
            "text": "neuroblastoma who achieve at least",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.63671875,
            "end_logit": -7.3203125,
            "text": "anti-GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": -7.3359375,
            "text": "anti-GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.7890625,
            "end_logit": -7.2578125,
            "text": "GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": -7.421875,
            "text": "anti-GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -7.2578125,
            "text": "risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.828125,
            "end_logit": -7.2578125,
            "text": ", and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.84375,
            "end_logit": -7.2578125,
            "text": "GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk neuroblastoma who",
            "probability": 0.0
        },
        {
            "start_logit": -7.7890625,
            "end_logit": -7.3203125,
            "text": "GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.7890625,
            "end_logit": -7.3359375,
            "text": "GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.63671875,
            "end_logit": -7.49609375,
            "text": "anti-GD2 monoclonal antibody approved in combination with GM-CSF, IL-2, and RA for maintenance treatment of pediatric patients with",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -7.546875,
            "text": "CONCLUSIONS Dinutuximab is the first anti-GD2 monoclonal antibody",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_19": [
        {
            "start_logit": 6.09375,
            "end_logit": 6.76171875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 6.76171875,
            "text": "Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 6.76171875,
            "text": "the treatment of neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 6.76171875,
            "text": ", for the treatment of neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 6.76171875,
            "text": "developing dinutuximab (Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 6.76171875,
            "text": "ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 6.76171875,
            "text": "dinutuximab (Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 6.76171875,
            "text": "treatment of neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 6.76171875,
            "text": "GD2, for the treatment of neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -4.44921875,
            "text": "Cancer",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -5.46875,
            "text": "Cancer Institute",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.109375,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.33984375,
            "text": "Cancer Institute are",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.34765625,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122;",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.38671875,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122; ch14",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.40234375,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122; ch14.",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.4296875,
            "text": "Cancer Institute are developing dinutuximab (Unituxin",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.453125,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122; ch14.18",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.484375,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2",
            "probability": 0.0
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.484375,
            "text": "Cancer Institute are developing dinutuximab (Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_20": [
        {
            "start_logit": 6.046875,
            "end_logit": 6.91796875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.75,
            "end_logit": 6.91796875,
            "text": "the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 6.91796875,
            "text": "treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 6.91796875,
            "text": "high-risk neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 6.91796875,
            "text": ", and isotretinoin for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 6.91796875,
            "text": "risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": -7.36328125,
            "text": "the treatment of pediatric patients with high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.75,
            "end_logit": -7.40234375,
            "text": "the treatment of pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.703125,
            "end_logit": -7.5234375,
            "text": "SUMMARY Dinutuximab (Unituxin, United Therapeutics) is a novel monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -7.86328125,
            "end_logit": -7.36328125,
            "text": "treatment of pediatric patients with high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.36328125,
            "text": "high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.71875,
            "end_logit": -7.5234375,
            "text": ", United Therapeutics) is a novel monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -7.75,
            "end_logit": -7.5,
            "text": "the treatment of pediatric patients with high",
            "probability": 0.0
        },
        {
            "start_logit": -7.703125,
            "end_logit": -7.5546875,
            "text": "SUMMARY Dinutuximab (Unituxin, United Therapeutics) is a novel monoclonal antibody recently approved for",
            "probability": 0.0
        },
        {
            "start_logit": -7.86328125,
            "end_logit": -7.40234375,
            "text": "treatment of pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.40234375,
            "text": "high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": -7.36328125,
            "text": ", and isotretinoin for the treatment of pediatric patients with high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.71875,
            "end_logit": -7.5546875,
            "text": ", United Therapeutics) is a novel monoclonal antibody recently approved for",
            "probability": 0.0
        },
        {
            "start_logit": -7.75,
            "end_logit": -7.5234375,
            "text": "the treatment of pediatric patients with",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -7.36328125,
            "text": "risk",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_21": [
        {
            "start_logit": 6.22265625,
            "end_logit": 6.76953125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.76953125,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 6.76953125,
            "text": "Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 6.76953125,
            "text": "in pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 6.76953125,
            "text": "high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.76953125,
            "text": "risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.76953125,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.91015625,
            "end_logit": 6.76953125,
            "text": "novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 6.76953125,
            "text": "immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 6.76953125,
            "text": "is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 6.76953125,
            "text": "patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 6.76953125,
            "text": "combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 6.76953125,
            "text": "that is efficacious as part of combination immunotherapy in pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": -7.5546875,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.71875,
            "end_logit": -7.578125,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -7.71875,
            "end_logit": -7.6484375,
            "text": "CONCLUSION Dinutuximab",
            "probability": 0.0
        },
        {
            "start_logit": -7.71875,
            "end_logit": -7.6484375,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with",
            "probability": 0.0
        },
        {
            "start_logit": -7.71875,
            "end_logit": -7.6484375,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious as part of",
            "probability": 0.0
        },
        {
            "start_logit": -7.71875,
            "end_logit": -7.6640625,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal antibody that is efficacious as part of combination immunotherapy in pediatric patients with high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.71875,
            "end_logit": -7.66796875,
            "text": "CONCLUSION Dinutuximab is a novel monoclonal",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_22": [
        {
            "start_logit": 6.18359375,
            "end_logit": 6.796875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 6.796875,
            "text": ", has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 6.796875,
            "text": "risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 6.796875,
            "text": ", a monoclonal antibody targeting the disialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 6.796875,
            "text": "ialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 6.796875,
            "text": "), a monoclonal antibody targeting the disialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 6.796875,
            "text": "improve survival rates in patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 6.796875,
            "text": "GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 6.796875,
            "text": "patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -8.0,
            "end_logit": 6.796875,
            "text": "in patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.18359375,
            "end_logit": -7.52734375,
            "text": "neuroblastoma.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.9921875,
            "end_logit": -7.52734375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -7.39453125,
            "text": "formerly called ch14.18), a monoclonal antibody targeting the disialoganglioside GD2, has been shown to significantly improve survival rates",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -7.40625,
            "text": "formerly called ch14.18), a monoclonal antibody targeting the disialoganglioside GD2, has been shown to",
            "probability": 0.0
        },
        {
            "start_logit": -7.8359375,
            "end_logit": -7.39453125,
            "text": ", has been shown to significantly improve survival rates",
            "probability": 0.0
        },
        {
            "start_logit": -7.8359375,
            "end_logit": -7.3984375,
            "text": ", has been shown to significantly improve survival rates in patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.8359375,
            "end_logit": -7.40625,
            "text": ", has been shown to",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -7.4453125,
            "text": "formerly called ch14.18), a monoclonal antibody targeting the disialoganglioside GD2",
            "probability": 0.0
        },
        {
            "start_logit": -7.859375,
            "end_logit": -7.40625,
            "text": "Dinutuximab (formerly called ch14.18), a monoclonal antibody targeting the disialoganglioside GD2, has been shown to",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.39453125,
            "text": "ch14.18), a monoclonal antibody targeting the disialoganglioside GD2, has been shown to significantly improve survival rates",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_23": [
        {
            "start_logit": 6.11328125,
            "end_logit": 6.6640625,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -6.72265625,
            "text": "neuroblastoma cells.",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 6.11328125,
            "end_logit": -7.2890625,
            "text": "neuroblastoma cells",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.6640625,
            "text": "of neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 6.6640625,
            "text": "disialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -8.0625,
            "end_logit": 6.6640625,
            "text": "ialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -8.125,
            "end_logit": 6.6640625,
            "text": "chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside, which is highly expressed on the surface of neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.1328125,
            "end_logit": 6.6640625,
            "text": "on the surface of neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.1484375,
            "end_logit": 6.6640625,
            "text": "the surface of neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.16796875,
            "end_logit": -6.72265625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -6.7734375,
            "text": "Unituxin\u2122",
            "probability": 0.0
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -7.0546875,
            "text": "Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to the glycolipid antigen disialoganglioside",
            "probability": 0.0
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -7.07421875,
            "text": "Unituxin\u2122)",
            "probability": 0.0
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -7.140625,
            "text": "Unituxin",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -6.7734375,
            "text": "Dinutuximab (ch14.18; Unituxin\u2122",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -6.7734375,
            "text": "; Unituxin\u2122",
            "probability": 0.0
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -7.23828125,
            "text": "Unituxin\u2122) is a chimeric human-mouse monoclonal antibody",
            "probability": 0.0
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -7.2890625,
            "text": "Unituxin\u2122) is a chimeric human-",
            "probability": 0.0
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -7.29296875,
            "text": "Unituxin\u2122) is a",
            "probability": 0.0
        },
        {
            "start_logit": -7.24609375,
            "end_logit": -7.32421875,
            "text": "Unituxin\u2122) is a chimeric human-mouse monoclonal antibody that binds to",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_24": [
        {
            "start_logit": 6.26171875,
            "end_logit": 6.74609375,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": 6.74609375,
            "text": "The US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 6.74609375,
            "text": "recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.26171875,
            "end_logit": -7.37890625,
            "text": "neuroblastoma in paediatric patients",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 6.74609375,
            "text": "risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 6.74609375,
            "text": "treatment of high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.26171875,
            "end_logit": -7.45703125,
            "text": "neuroblastoma in",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 6.74609375,
            "text": "dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 6.74609375,
            "text": "the treatment of high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.26171875,
            "end_logit": -7.5078125,
            "text": "neuroblastoma in paediatric",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 6.74609375,
            "text": "high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 6.74609375,
            "text": "use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 6.74609375,
            "text": "US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -8.0703125,
            "end_logit": 6.74609375,
            "text": "utuximab combination therapy for the treatment of high-risk neuroblastoma",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.26171875,
            "end_logit": -7.59765625,
            "text": "neuroblastoma in paediatric patients.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.87109375,
            "end_logit": -7.59765625,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.37890625,
            "text": "The US FDA has recently approved the use of dinutuximab combination therapy for the treatment of high-risk neuroblastoma in paediatric patients",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.44140625,
            "text": "The US FDA has recently approved the use of dinutuximab combination therapy for the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.453125,
            "text": "The US FDA has recently approved the use of dinutuximab combination therapy",
            "probability": 0.0
        },
        {
            "start_logit": -7.734375,
            "end_logit": -7.45703125,
            "text": "The US FDA",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_25": [
        {
            "start_logit": 6.2109375,
            "end_logit": 6.8125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 6.8125,
            "text": "Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 6.8125,
            "text": "high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 6.8125,
            "text": "treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 6.8125,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.9921875,
            "end_logit": 6.8125,
            "text": "patients with high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.0,
            "end_logit": 6.8125,
            "text": "risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 6.8125,
            "text": "utuximab for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.0234375,
            "end_logit": 6.8125,
            "text": "the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -8.046875,
            "end_logit": 6.8125,
            "text": "uximab for the treatment of pediatric patients with high-risk neuroblastoma",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.37890625,
            "text": "Dinutuximab for the treatment of pediatric patients with high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.37890625,
            "text": "Dinutuximab for the treatment of pediatric patients",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": -7.37890625,
            "text": "high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": -7.37890625,
            "text": "treatment of pediatric patients with high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": -7.37890625,
            "text": "treatment of pediatric patients",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.453125,
            "text": "Dinutuximab for the treatment of pediatric patients with",
            "probability": 0.0
        },
        {
            "start_logit": -7.9375,
            "end_logit": -7.37890625,
            "text": "pediatric patients with high-risk",
            "probability": 0.0
        },
        {
            "start_logit": -7.9375,
            "end_logit": -7.37890625,
            "text": "pediatric patients",
            "probability": 0.0
        },
        {
            "start_logit": -7.85546875,
            "end_logit": -7.46875,
            "text": "Dinutuximab for the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -7.875,
            "end_logit": -7.453125,
            "text": "treatment of pediatric patients with",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_26": [
        {
            "start_logit": 6.1796875,
            "end_logit": 6.82421875,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.82421875,
            "text": "Transverse myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 6.82421875,
            "text": "complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 6.82421875,
            "text": "myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 6.82421875,
            "text": "pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.98046875,
            "end_logit": 6.82421875,
            "text": "risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.984375,
            "end_logit": 6.82421875,
            "text": "dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.98828125,
            "end_logit": 6.82421875,
            "text": "treatment with dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.99609375,
            "end_logit": 6.82421875,
            "text": "in pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -8.0078125,
            "end_logit": 6.82421875,
            "text": "following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.1796875,
            "end_logit": -7.625,
            "text": "neuroblastoma: A case series",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": -7.625,
            "text": "A case series",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -7.56640625,
            "text": "Transverse myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": -7.56640625,
            "text": "complication following treatment with dinutuximab in pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -7.625,
            "text": "Transverse myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high-risk neuroblastoma: A case series",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -7.62890625,
            "text": "Transverse myelitis",
            "probability": 0.0
        },
        {
            "start_logit": -7.9609375,
            "end_logit": -7.56640625,
            "text": "myelitis as an unexpected complication following treatment with dinutuximab in pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.96484375,
            "end_logit": -7.56640625,
            "text": "pediatric patients with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -7.640625,
            "text": "Transverse myelitis as an unexpected complication following treatment with dinutuximab",
            "probability": 0.0
        },
        {
            "start_logit": -7.984375,
            "end_logit": -7.56640625,
            "text": "dinutuximab in pediatric patients with high-",
            "probability": 0.0
        }
    ],
    "589a247078275d0c4a000035_27": [
        {
            "start_logit": 6.23828125,
            "end_logit": 6.7578125,
            "text": "neuroblastoma",
            "probability": 1.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": 6.7578125,
            "text": "ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.7578125,
            "text": "study (ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.7578125,
            "text": "BL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.734375,
            "end_logit": 6.7578125,
            "text": "phase III study (ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.7578125,
            "text": "(ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 6.7578125,
            "text": "led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 6.7578125,
            "text": "0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 6.7578125,
            "text": "randomized phase III study (ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 6.7578125,
            "text": ") led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 6.7578125,
            "text": "the randomized phase III study (ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.7578125,
            "text": "risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 6.7578125,
            "text": "approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 6.7578125,
            "text": "III study (ANBL0032) led to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 6.7578125,
            "text": "to the approval of dinutuximab for the treatment of children with high-risk neuroblastoma",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.23828125,
            "end_logit": -7.65234375,
            "text": "neuroblastoma.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -6.99609375,
            "end_logit": -7.65234375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -7.36328125,
            "text": "ANBL0032) led to the approval of dinutuximab for the treatment of children with high-",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -7.45703125,
            "text": "ANBL0032) led to the approval of dinutuximab for the treatment of",
            "probability": 0.0
        },
        {
            "start_logit": -7.4296875,
            "end_logit": -7.46875,
            "text": "ANBL0032) led to the approval of dinutuximab for the treatment of children with",
            "probability": 0.0
        }
    ],
    "5c8cd26a0101eac870000003_1": [
        {
            "start_logit": 6.5546875,
            "end_logit": 4.51171875,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were regulated by VdSec22 or VdSso1.",
            "probability": 0.9990234375
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -2.787109375,
            "text": "secreted protein content",
            "probability": 0.0006771087646484375
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -3.552734375,
            "text": "secreted",
            "probability": 0.00031495094299316406
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -4.91015625,
            "text": "secreted protein",
            "probability": 8.088350296020508e-05
        },
        {
            "start_logit": -3.23828125,
            "end_logit": 4.51171875,
            "text": ".",
            "probability": 5.602836608886719e-05
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -5.98828125,
            "text": "secreted protein content (",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -6.32421875,
            "text": "secreted protein content (exoproteome) revealed",
            "probability": 1.9848346710205078e-05
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -6.75,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis",
            "probability": 1.2934207916259766e-05
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.08984375,
            "text": "secreted protein content (exoproteome) revealed that many enzymes",
            "probability": 9.238719940185547e-06
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.21484375,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": -5.171875,
            "end_logit": 4.51171875,
            "text": "exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were regulated by VdSec22 or VdSso1.",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.22265625,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were",
            "probability": 7.987022399902344e-06
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.28125,
            "text": "secreted protein content (exoproteome)",
            "probability": 7.569789886474609e-06
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.37109375,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved",
            "probability": 6.973743438720703e-06
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.40234375,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate",
            "probability": 6.735324859619141e-06
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.54296875,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were regulated by VdSec22 or",
            "probability": 5.841255187988281e-06
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.56640625,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were regulated by VdSec22",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.5703125,
            "text": "secreted protein content (exoproteome) revealed that many enzymes involved in carbohydrate hydrolysis were regulated by",
            "probability": 5.662441253662109e-06
        },
        {
            "start_logit": 6.5546875,
            "end_logit": -7.6875,
            "text": "secreted protein content (exoproteome) revealed that",
            "probability": 5.066394805908203e-06
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 4.51171875,
            "text": "many enzymes involved in carbohydrate hydrolysis were regulated by VdSec22 or VdSso1.",
            "probability": 1.3113021850585938e-06
        }
    ],
    "5cb0e4a6ecadf2e73f00005b_1": [
        {
            "start_logit": 7.53125,
            "end_logit": 7.62109375,
            "text": "surfaceome",
            "probability": 0.8427734375
        },
        {
            "start_logit": 5.37890625,
            "end_logit": 7.62109375,
            "text": "surfaceome, we developed the surfaceome",
            "probability": 0.09759521484375
        },
        {
            "start_logit": 5.37890625,
            "end_logit": 7.125,
            "text": "surfaceome",
            "probability": 0.05914306640625
        },
        {
            "start_logit": 7.53125,
            "end_logit": 0.1846923828125,
            "text": "surfaceome predictor SURFY, based on machine learning.",
            "probability": 0.0004944801330566406
        },
        {
            "start_logit": 7.53125,
            "end_logit": -1.2666015625,
            "text": "surfaceome predictor",
            "probability": 0.00011605024337768555
        },
        {
            "start_logit": 5.37890625,
            "end_logit": 0.1846923828125,
            "text": "surfaceome, we developed the surfaceome predictor SURFY, based on machine learning.",
            "probability": 5.739927291870117e-05
        },
        {
            "start_logit": -2.08203125,
            "end_logit": 7.62109375,
            "text": "ome",
            "probability": 5.608797073364258e-05
        },
        {
            "start_logit": -2.5,
            "end_logit": 7.62109375,
            "text": "ome, we developed the surfaceome",
            "probability": 3.707408905029297e-05
        },
        {
            "start_logit": 7.53125,
            "end_logit": -2.419921875,
            "text": "surface",
            "probability": 3.653764724731445e-05
        },
        {
            "start_logit": -2.5,
            "end_logit": 7.125,
            "text": "ome",
            "probability": 2.2530555725097656e-05
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -1.2666015625,
            "text": "surfaceome, we developed the surfaceome predictor",
            "probability": 1.341104507446289e-05
        },
        {
            "start_logit": 7.53125,
            "end_logit": -4.32421875,
            "text": "surfaceome predictor SURFY, based on machine learning",
            "probability": 5.424022674560547e-06
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -2.419921875,
            "text": "surfaceome, we developed the surface",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -4.32421875,
            "text": "surfaceome, we developed the surfaceome predictor SURFY, based on machine learning",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 5.37890625,
            "end_logit": -4.33984375,
            "text": "surface",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 7.62109375,
            "text": "o enable analysis of the human surfaceome, we developed the surfaceome",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.91015625,
            "end_logit": 7.62109375,
            "text": "analysis of the human surfaceome, we developed the surfaceome",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.53125,
            "end_logit": -6.87890625,
            "text": "surfaceome predictor SURFY,",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 7.62109375,
            "text": "enable analysis of the human surfaceome, we developed the surfaceome",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.24609375,
            "end_logit": 7.62109375,
            "text": "the human surfaceome, we developed the surfaceome",
            "probability": 2.980232238769531e-07
        }
    ],
    "550618f58e1671127b000007_1": [
        {
            "start_logit": 6.5234375,
            "end_logit": -2.896484375,
            "text": ", protein phosphatase inhibitor-1 (PPI-1)",
            "probability": 0.355224609375
        },
        {
            "start_logit": 6.5234375,
            "end_logit": -3.24609375,
            "text": ", protein phosphatase inhibitor-1 (PPI-1",
            "probability": 0.25048828125
        },
        {
            "start_logit": 6.5234375,
            "end_logit": -3.5703125,
            "text": ",",
            "probability": 0.18115234375
        },
        {
            "start_logit": 6.5234375,
            "end_logit": -4.0703125,
            "text": ", protein phosphatase inhibitor-1",
            "probability": 0.10980224609375
        },
        {
            "start_logit": 6.5234375,
            "end_logit": -5.06640625,
            "text": ", protein phosphatase inhibitor-1 (PPI",
            "probability": 0.04058837890625
        },
        {
            "start_logit": 6.5234375,
            "end_logit": -5.6484375,
            "text": ", protein phosphatase inhibitor-1 (",
            "probability": 0.0226593017578125
        },
        {
            "start_logit": 6.5234375,
            "end_logit": -5.84375,
            "text": ", protein phosphatase inhibitor-1 (PPI-",
            "probability": 0.018646240234375
        },
        {
            "start_logit": 6.5234375,
            "end_logit": -6.40234375,
            "text": ", protein phosphatase inhibitor",
            "probability": 0.0106658935546875
        },
        {
            "start_logit": 6.5234375,
            "end_logit": -6.83984375,
            "text": ", protein phosphatase inhibitor-",
            "probability": 0.006885528564453125
        },
        {
            "start_logit": 6.5234375,
            "end_logit": -7.4296875,
            "text": ", protein phosphatase",
            "probability": 0.0038242340087890625
        },
        {
            "start_logit": -2.923828125,
            "end_logit": -2.896484375,
            "text": ". Phosphatase-1 is restrained by its endogenous inhibitor, protein phosphatase inhibitor-1 (PPI-1)",
            "probability": 2.8073787689208984e-05
        },
        {
            "start_logit": -2.923828125,
            "end_logit": -3.24609375,
            "text": ". Phosphatase-1 is restrained by its endogenous inhibitor, protein phosphatase inhibitor-1 (PPI-1",
            "probability": 1.9788742065429688e-05
        },
        {
            "start_logit": -3.2734375,
            "end_logit": -2.896484375,
            "text": "protein phosphatase inhibitor-1 (PPI-1)",
            "probability": 1.9788742065429688e-05
        },
        {
            "start_logit": -2.923828125,
            "end_logit": -3.5703125,
            "text": ". Phosphatase-1 is restrained by its endogenous inhibitor,",
            "probability": 1.436471939086914e-05
        },
        {
            "start_logit": -3.2734375,
            "end_logit": -3.24609375,
            "text": "protein phosphatase inhibitor-1 (PPI-1",
            "probability": 1.3887882232666016e-05
        },
        {
            "start_logit": -2.923828125,
            "end_logit": -3.650390625,
            "text": ".",
            "probability": 1.3172626495361328e-05
        },
        {
            "start_logit": -3.943359375,
            "end_logit": -2.896484375,
            "text": ")",
            "probability": 1.0073184967041016e-05
        },
        {
            "start_logit": -2.923828125,
            "end_logit": -4.0703125,
            "text": ". Phosphatase-1 is restrained by its endogenous inhibitor, protein phosphatase inhibitor-1",
            "probability": 8.702278137207031e-06
        },
        {
            "start_logit": -3.2734375,
            "end_logit": -4.0703125,
            "text": "protein phosphatase inhibitor-1",
            "probability": 6.139278411865234e-06
        },
        {
            "start_logit": -4.46484375,
            "end_logit": -2.896484375,
            "text": "(PPI-1)",
            "probability": 6.020069122314453e-06
        }
    ],
    "550618f58e1671127b000007_2": [
        {
            "start_logit": 8.1640625,
            "end_logit": 1.923828125,
            "text": "Inhibitor 1 (I-1)",
            "probability": 0.87451171875
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -0.892578125,
            "text": "Inhibitor",
            "probability": 0.052520751953125
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -0.9296875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.",
            "probability": 0.05047607421875
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -2.25390625,
            "text": "Inhibitor 1 (I-1) is",
            "probability": 0.01343536376953125
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -2.830078125,
            "text": "Inhibitor 1",
            "probability": 0.007564544677734375
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -4.7109375,
            "text": "Inhibitor 1 (I-1",
            "probability": 0.0011510848999023438
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -6.6328125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1)",
            "probability": 0.0001684427261352539
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -6.63671875,
            "text": "Inhibitor 1 (I-1) is a",
            "probability": 0.0001671314239501953
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -6.68359375,
            "text": "Inhibitor 1 (",
            "probability": 0.0001595020294189453
        },
        {
            "start_logit": -1.783203125,
            "end_logit": 1.923828125,
            "text": "(I-1)",
            "probability": 4.190206527709961e-05
        },
        {
            "start_logit": -1.783203125,
            "end_logit": -0.9296875,
            "text": "(I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -3.013671875,
            "end_logit": -0.9287109375,
            "text": ".",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -3.015625,
            "end_logit": -0.9287109375,
            "text": ". Nonphosphorylated I-1 is inactive, whereas phosphorylated I-1 is a potent PP1 inhibitor.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -3.015625,
            "end_logit": -0.9296875,
            "text": ".",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -1.783203125,
            "end_logit": -2.25390625,
            "text": "(I-1) is",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -3.1640625,
            "end_logit": -0.9287109375,
            "text": "phosphorylated I-1 is a potent PP1 inhibitor.",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -6.79296875,
            "end_logit": 1.923828125,
            "text": "I-1)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.01171875,
            "end_logit": 1.923828125,
            "text": ")",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -3.015625,
            "end_logit": -3.3515625,
            "text": ". Nonphosphorylated I-1 is inactive, whereas phosphorylated I-1",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.783203125,
            "end_logit": -4.7109375,
            "text": "(I-1",
            "probability": 5.960464477539063e-08
        }
    ],
    "550618f58e1671127b000007_3": [
        {
            "start_logit": 5.32421875,
            "end_logit": 4.03515625,
            "text": "Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor.",
            "probability": 0.5009765625
        },
        {
            "start_logit": 5.32421875,
            "end_logit": 4.01171875,
            "text": "Ser67-phosphorylated inhibitor 1 is",
            "probability": 0.489501953125
        },
        {
            "start_logit": 5.32421875,
            "end_logit": 0.022613525390625,
            "text": "Ser67-phosphorylated inhibitor 1",
            "probability": 0.009063720703125
        },
        {
            "start_logit": -2.62890625,
            "end_logit": 4.03515625,
            "text": "inhibitor 1 is a potent protein phosphatase 1 inhibitor.",
            "probability": 0.0001761913299560547
        },
        {
            "start_logit": -2.62890625,
            "end_logit": 4.01171875,
            "text": "inhibitor 1 is",
            "probability": 0.00017201900482177734
        },
        {
            "start_logit": -2.9921875,
            "end_logit": 4.03515625,
            "text": ".",
            "probability": 0.00012290477752685547
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -5.1171875,
            "text": "Ser",
            "probability": 5.2869319915771484e-05
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -6.1796875,
            "text": "Ser67-phosphorylated inhibitor 1 is a",
            "probability": 1.8298625946044922e-05
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -6.8984375,
            "text": "Ser67",
            "probability": 8.881092071533203e-06
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -7.24609375,
            "text": "Ser67-phosphorylated inhibitor 1 is a potent",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -7.37109375,
            "text": "Ser67-",
            "probability": 5.602836608886719e-06
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -7.41796875,
            "text": "Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1",
            "probability": 5.304813385009766e-06
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -7.5,
            "text": "Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase",
            "probability": 4.947185516357422e-06
        },
        {
            "start_logit": -6.27734375,
            "end_logit": 4.03515625,
            "text": "is a potent protein phosphatase 1 inhibitor.",
            "probability": 4.589557647705078e-06
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -7.58984375,
            "text": "Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": -6.27734375,
            "end_logit": 4.01171875,
            "text": "is",
            "probability": 4.470348358154297e-06
        },
        {
            "start_logit": 5.32421875,
            "end_logit": -7.62890625,
            "text": "Ser67-phosphorylated",
            "probability": 4.291534423828125e-06
        },
        {
            "start_logit": -2.62890625,
            "end_logit": 0.022613525390625,
            "text": "inhibitor 1",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 4.03515625,
            "text": "phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor.",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 4.01171875,
            "text": "phosphorylated inhibitor 1 is",
            "probability": 2.7418136596679688e-06
        }
    ],
    "550618f58e1671127b000007_4": [
        {
            "start_logit": 8.296875,
            "end_logit": 1.646484375,
            "text": "Inhibitor 1 (I-1)",
            "probability": 0.7744140625
        },
        {
            "start_logit": 8.296875,
            "end_logit": 0.055023193359375,
            "text": "Inhibitor 1 (I-1) is",
            "probability": 0.1573486328125
        },
        {
            "start_logit": 8.296875,
            "end_logit": -0.85791015625,
            "text": "Inhibitor",
            "probability": 0.06304931640625
        },
        {
            "start_logit": 8.296875,
            "end_logit": -4.62109375,
            "text": "Inhibitor 1 (I-1",
            "probability": 0.0014667510986328125
        },
        {
            "start_logit": 8.296875,
            "end_logit": -4.63671875,
            "text": "Inhibitor 1",
            "probability": 0.0014438629150390625
        },
        {
            "start_logit": 8.296875,
            "end_logit": -6.2890625,
            "text": "Inhibitor 1 (I",
            "probability": 0.0002765655517578125
        },
        {
            "start_logit": 8.296875,
            "end_logit": -6.31640625,
            "text": "Inhibitor 1 (I-1) is a",
            "probability": 0.00026917457580566406
        },
        {
            "start_logit": 8.296875,
            "end_logit": -6.81640625,
            "text": "Inhibitor 1 (I-",
            "probability": 0.00016260147094726562
        },
        {
            "start_logit": 8.296875,
            "end_logit": -6.90234375,
            "text": "Inhibitor 1 (",
            "probability": 0.00015044212341308594
        },
        {
            "start_logit": 8.296875,
            "end_logit": -6.9140625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase",
            "probability": 0.0001480579376220703
        },
        {
            "start_logit": 8.296875,
            "end_logit": -6.98828125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr",
            "probability": 0.00013697147369384766
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.05078125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase in the heart",
            "probability": 0.00012862682342529297
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.0625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1)",
            "probability": 0.00012755393981933594
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.328125,
            "text": "Inhibitor 1 (I-1) is a protein",
            "probability": 9.78708267211914e-05
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.35546875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1),",
            "probability": 9.554624557495117e-05
        },
        {
            "start_logit": -0.70556640625,
            "end_logit": 1.646484375,
            "text": "(I-1)",
            "probability": 9.483098983764648e-05
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.41796875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor",
            "probability": 8.982419967651367e-05
        },
        {
            "start_logit": 8.296875,
            "end_logit": -7.46484375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of",
            "probability": 8.571147918701172e-05
        },
        {
            "start_logit": -0.70556640625,
            "end_logit": 0.055023193359375,
            "text": "(I-1) is",
            "probability": 1.9431114196777344e-05
        },
        {
            "start_logit": -0.70556640625,
            "end_logit": -3.978515625,
            "text": "(I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase in the heart.",
            "probability": 2.980232238769531e-07
        }
    ],
    "550618f58e1671127b000007_5": [
        {
            "start_logit": 8.2890625,
            "end_logit": 0.369873046875,
            "text": "Inhibitor 1 (I-1) is",
            "probability": 0.5166015625
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.338134765625,
            "text": "Inhibitor 1 (I-1)",
            "probability": 0.254638671875
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.8740234375,
            "text": "Inhibitor",
            "probability": 0.149169921875
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -1.638671875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase.",
            "probability": 0.0693359375
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -4.6640625,
            "text": "Inhibitor 1",
            "probability": 0.0033721923828125
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -4.8203125,
            "text": "Inhibitor 1 (I-1",
            "probability": 0.0028839111328125
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.18359375,
            "text": "Inhibitor 1 (I-1) is a",
            "probability": 0.0007376670837402344
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.2578125,
            "text": "Inhibitor 1 (I",
            "probability": 0.0006852149963378906
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.65625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1)",
            "probability": 0.00045990943908691406
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.94140625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr",
            "probability": 0.0003459453582763672
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.94921875,
            "text": "Inhibitor 1 (I-",
            "probability": 0.00034332275390625
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -6.984375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1),",
            "probability": 0.0003314018249511719
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -7.109375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a major eukaryotic Ser/Thr phosphatase",
            "probability": 0.0002923011779785156
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -7.1640625,
            "text": "Inhibitor 1 (",
            "probability": 0.00027680397033691406
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -7.23828125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), a",
            "probability": 0.0002570152282714844
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -7.29296875,
            "text": "Inhibitor 1 (I-1) is a protein",
            "probability": 0.00024330615997314453
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -7.39453125,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (",
            "probability": 0.0002199411392211914
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -7.4375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor",
            "probability": 0.00021064281463623047
        },
        {
            "start_logit": -1.546875,
            "end_logit": 0.369873046875,
            "text": "(I-1) is",
            "probability": 2.759695053100586e-05
        },
        {
            "start_logit": -1.546875,
            "end_logit": -0.338134765625,
            "text": "(I-1)",
            "probability": 1.3649463653564453e-05
        }
    ],
    "550618f58e1671127b000007_6": [
        {
            "start_logit": 8.2421875,
            "end_logit": 3.095703125,
            "text": "Inhibitor 1 (I-1)",
            "probability": 0.96875
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.03125,
            "text": "Inhibitor 1 (I-1) is",
            "probability": 0.015655517578125
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.13671875,
            "text": "Inhibitor",
            "probability": 0.01409149169921875
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -4.24609375,
            "text": "Inhibitor 1 (I-1",
            "probability": 0.0006289482116699219
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -4.50390625,
            "text": "Inhibitor 1",
            "probability": 0.0004858970642089844
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.31640625,
            "text": "Inhibitor 1 (I",
            "probability": 7.963180541992188e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.39453125,
            "text": "Inhibitor 1 (I-1) is a",
            "probability": 7.367134094238281e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.53515625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase in the heart",
            "probability": 6.395578384399414e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.6640625,
            "text": "Inhibitor 1 (I-",
            "probability": 5.602836608886719e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.85546875,
            "text": "Inhibitor 1 (",
            "probability": 4.607439041137695e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.921875,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr phosphatase",
            "probability": 4.3332576751708984e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.0,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating Ser/Thr",
            "probability": 4.00543212890625e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.15234375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1)",
            "probability": 3.421306610107422e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.33984375,
            "text": "Inhibitor 1 (I-1) is a protein",
            "probability": 2.8431415557861328e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.37890625,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1),",
            "probability": 2.753734588623047e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.43359375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor",
            "probability": 2.586841583251953e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.46484375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1",
            "probability": 2.5033950805664062e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.484375,
            "text": "Inhibitor 1 (I-1) is a protein inhibitor of protein phosphatase 1 (PP1), the predominating",
            "probability": 2.467632293701172e-05
        },
        {
            "start_logit": -2.4296875,
            "end_logit": 3.095703125,
            "text": "(I-1)",
            "probability": 2.2470951080322266e-05
        },
        {
            "start_logit": -2.4296875,
            "end_logit": -1.03125,
            "text": "(I-1) is",
            "probability": 3.5762786865234375e-07
        }
    ],
    "5881f9b65bf093691f000001_1": [
        {
            "start_logit": 7.66015625,
            "end_logit": 7.640625,
            "text": "Parasympathetic neurons",
            "probability": 1.0
        },
        {
            "start_logit": -2.51171875,
            "end_logit": 7.640625,
            "text": "neurons",
            "probability": 3.820657730102539e-05
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -2.58203125,
            "text": "Parasympathetic",
            "probability": 3.647804260253906e-05
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -5.8984375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -6.3671875,
            "text": "Parasympathetic neurons originate",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.41015625,
            "text": "Parasympathetic neurons originate from",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.41796875,
            "text": "Parasympathetic neurons originate from nerve-",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.59375,
            "text": "Parasympathetic neurons originate from nerve-associated",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.64453125,
            "text": "Parasympathetic neurons originate from nerve",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.65234375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.67578125,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.66015625,
            "end_logit": -7.734375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.51171875,
            "end_logit": -5.8984375,
            "text": "neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": -2.51171875,
            "end_logit": -6.3671875,
            "text": "neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": -2.51171875,
            "end_logit": -7.41015625,
            "text": "neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": -2.51171875,
            "end_logit": -7.41796875,
            "text": "neurons originate from nerve-",
            "probability": 0.0
        },
        {
            "start_logit": -2.51171875,
            "end_logit": -7.59375,
            "text": "neurons originate from nerve-associated",
            "probability": 0.0
        },
        {
            "start_logit": -2.51171875,
            "end_logit": -7.64453125,
            "text": "neurons originate from nerve",
            "probability": 0.0
        },
        {
            "start_logit": -2.51171875,
            "end_logit": -7.65234375,
            "text": "neurons originate from nerve-associated peripheral glial",
            "probability": 0.0
        },
        {
            "start_logit": -2.51171875,
            "end_logit": -7.67578125,
            "text": "neurons originate from nerve-associated peripheral",
            "probability": 0.0
        }
    ],
    "5881f9b65bf093691f000001_2": [
        {
            "start_logit": 6.83203125,
            "end_logit": 7.48828125,
            "text": "Parasympathetic neurons",
            "probability": 1.0
        },
        {
            "start_logit": -2.4921875,
            "end_logit": 7.48828125,
            "text": "neurons",
            "probability": 8.887052536010742e-05
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -3.744140625,
            "text": "Parasympathetic",
            "probability": 1.3232231140136719e-05
        },
        {
            "start_logit": -6.17578125,
            "end_logit": 7.48828125,
            "text": ". Parasympathetic neurons",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -6.234375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -6.38671875,
            "text": "Parasympathetic neurons originate",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.48828125,
            "text": "Neurodevelopment. Parasympathetic neurons",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.48828125,
            "text": "ment. Parasympathetic neurons",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -7.4140625,
            "text": "Parasympathetic neurons originate from nerve-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -7.51171875,
            "text": "Parasympathetic neurons originate from",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -7.55859375,
            "text": "Parasympathetic neurons originate from nerve-associated",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -7.609375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -7.63671875,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -7.63671875,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -7.64453125,
            "text": "Parasympathetic neurons originate from nerve",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.4921875,
            "end_logit": -6.234375,
            "text": "neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": -2.4921875,
            "end_logit": -6.38671875,
            "text": "neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": -2.4921875,
            "end_logit": -7.4140625,
            "text": "neurons originate from nerve-",
            "probability": 0.0
        },
        {
            "start_logit": -6.17578125,
            "end_logit": -3.744140625,
            "text": ". Parasympathetic",
            "probability": 0.0
        },
        {
            "start_logit": -2.4921875,
            "end_logit": -7.51171875,
            "text": "neurons originate from",
            "probability": 0.0
        }
    ],
    "5881f9b65bf093691f000001_3": [
        {
            "start_logit": 7.6171875,
            "end_logit": 7.87109375,
            "text": "Parasympathetic neurons",
            "probability": 1.0
        },
        {
            "start_logit": -2.099609375,
            "end_logit": 7.87109375,
            "text": "neurons",
            "probability": 6.0617923736572266e-05
        },
        {
            "start_logit": 7.6171875,
            "end_logit": -2.755859375,
            "text": "Parasympathetic",
            "probability": 2.4318695068359375e-05
        },
        {
            "start_logit": 7.6171875,
            "end_logit": -6.99609375,
            "text": "Parasympathetic neurons originate",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 7.6171875,
            "end_logit": -7.49609375,
            "text": "Parasympathetic neurons originate from",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.6171875,
            "end_logit": -7.5,
            "text": "Parasympathetic neurons originate from nerve-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.6171875,
            "end_logit": -7.578125,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.6171875,
            "end_logit": -7.61328125,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.6171875,
            "end_logit": -7.61328125,
            "text": "Parasympathetic neurons originate from nerve",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.6171875,
            "end_logit": -7.6328125,
            "text": "Parasympathetic neurons originate from nerve-associated",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.6171875,
            "end_logit": -7.64453125,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.099609375,
            "end_logit": -6.99609375,
            "text": "neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": -2.099609375,
            "end_logit": -7.49609375,
            "text": "neurons originate from",
            "probability": 0.0
        },
        {
            "start_logit": -2.099609375,
            "end_logit": -7.5,
            "text": "neurons originate from nerve-",
            "probability": 0.0
        },
        {
            "start_logit": -2.099609375,
            "end_logit": -7.578125,
            "text": "neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 0.0
        },
        {
            "start_logit": -2.099609375,
            "end_logit": -7.61328125,
            "text": "neurons originate from nerve-associated peripheral",
            "probability": 0.0
        },
        {
            "start_logit": -2.099609375,
            "end_logit": -7.61328125,
            "text": "neurons originate from nerve",
            "probability": 0.0
        },
        {
            "start_logit": -2.099609375,
            "end_logit": -7.6328125,
            "text": "neurons originate from nerve-associated",
            "probability": 0.0
        },
        {
            "start_logit": -2.099609375,
            "end_logit": -7.64453125,
            "text": "neurons originate from nerve-associated peripheral glial",
            "probability": 0.0
        }
    ],
    "5881f9b65bf093691f000001_4": [
        {
            "start_logit": 6.83203125,
            "end_logit": 7.48828125,
            "text": "Parasympathetic neurons",
            "probability": 1.0
        },
        {
            "start_logit": -2.4921875,
            "end_logit": 7.48828125,
            "text": "neurons",
            "probability": 8.887052536010742e-05
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -3.744140625,
            "text": "Parasympathetic",
            "probability": 1.3232231140136719e-05
        },
        {
            "start_logit": -6.17578125,
            "end_logit": 7.48828125,
            "text": ". Parasympathetic neurons",
            "probability": 2.2649765014648438e-06
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -6.234375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -6.38671875,
            "text": "Parasympathetic neurons originate",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 7.48828125,
            "text": "Neurodevelopment. Parasympathetic neurons",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.5625,
            "end_logit": 7.48828125,
            "text": "ment. Parasympathetic neurons",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -7.4140625,
            "text": "Parasympathetic neurons originate from nerve-",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -7.51171875,
            "text": "Parasympathetic neurons originate from",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -7.55859375,
            "text": "Parasympathetic neurons originate from nerve-associated",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -7.609375,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -7.63671875,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral glial progenitors",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -7.63671875,
            "text": "Parasympathetic neurons originate from nerve-associated peripheral",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.83203125,
            "end_logit": -7.64453125,
            "text": "Parasympathetic neurons originate from nerve",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -2.4921875,
            "end_logit": -6.234375,
            "text": "neurons originate from nerve-associated peripheral glial progenitors.",
            "probability": 0.0
        },
        {
            "start_logit": -2.4921875,
            "end_logit": -6.38671875,
            "text": "neurons originate",
            "probability": 0.0
        },
        {
            "start_logit": -2.4921875,
            "end_logit": -7.4140625,
            "text": "neurons originate from nerve-",
            "probability": 0.0
        },
        {
            "start_logit": -6.17578125,
            "end_logit": -3.744140625,
            "text": ". Parasympathetic",
            "probability": 0.0
        },
        {
            "start_logit": -2.4921875,
            "end_logit": -7.51171875,
            "text": "neurons originate from",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_1": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.1328125,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.2392578125,
            "text": "Clostridium",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": -1.173828125,
            "end_logit": 8.1328125,
            "text": "difficile",
            "probability": 8.153915405273438e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.515625,
            "text": "Clostridium difficile,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.546875,
            "text": "Clostridium difficile, a common hospital-acquired infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.59375,
            "text": "Clostridium difficile, a common hospital-acquired",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.66796875,
            "text": "Clostridium difficile, a common hospital-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6875,
            "text": "Clostridium difficile, a common hospital",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6484375,
            "end_logit": 8.1328125,
            "text": "Fecal microbiota transplantation is a highly effective intervention for patients suffering from recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 8.1328125,
            "text": "recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 8.1328125,
            "text": "microbiota transplantation is a highly effective intervention for patients suffering from recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 8.1328125,
            "text": "intervention for patients suffering from recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 8.1328125,
            "text": "patients suffering from recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.93359375,
            "end_logit": 8.1328125,
            "text": "highly effective intervention for patients suffering from recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 8.1328125,
            "text": "effective intervention for patients suffering from recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96484375,
            "end_logit": 8.1328125,
            "text": "for patients suffering from recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.173828125,
            "end_logit": -7.515625,
            "text": "difficile,",
            "probability": 0.0
        },
        {
            "start_logit": -1.173828125,
            "end_logit": -7.546875,
            "text": "difficile, a common hospital-acquired infection",
            "probability": 0.0
        },
        {
            "start_logit": -1.173828125,
            "end_logit": -7.59375,
            "text": "difficile, a common hospital-acquired",
            "probability": 0.0
        },
        {
            "start_logit": -1.173828125,
            "end_logit": -7.66796875,
            "text": "difficile, a common hospital-",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_2": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.1171875,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.330078125,
            "text": "Clostridium",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": -1.3125,
            "end_logit": 8.1171875,
            "text": "difficile",
            "probability": 7.200241088867188e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -4.73828125,
            "text": "Clostridium difficile Proctitis",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": 8.21875,
            "end_logit": -6.75,
            "text": "Clostridium difficile Proct",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.03125,
            "text": "Clostridium difficile Proctitis Following Total Colectomy.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.28125,
            "text": "Clostridium difficile Proctitis Following",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.296875,
            "text": "Clostridium difficile Proctitis Following Total Colectomy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.5234375,
            "text": "Clostridium difficile Proctitis Following Total",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 8.1171875,
            "text": "Fecal Microbiota Transplantation for Treatment of Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 8.1171875,
            "text": "Treatment of Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 8.1171875,
            "text": "Mini-Fecal Microbiota Transplantation for Treatment of Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -8.015625,
            "end_logit": 8.1171875,
            "text": "Microbiota Transplantation for Treatment of Clostridium difficile",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -1.3125,
            "end_logit": -4.73828125,
            "text": "difficile Proctitis",
            "probability": 0.0
        },
        {
            "start_logit": -1.3125,
            "end_logit": -6.75,
            "text": "difficile Proct",
            "probability": 0.0
        },
        {
            "start_logit": -1.3125,
            "end_logit": -7.03125,
            "text": "difficile Proctitis Following Total Colectomy.",
            "probability": 0.0
        },
        {
            "start_logit": -1.3125,
            "end_logit": -7.28125,
            "text": "difficile Proctitis Following",
            "probability": 0.0
        },
        {
            "start_logit": -1.3125,
            "end_logit": -7.296875,
            "text": "difficile Proctitis Following Total Colectomy",
            "probability": 0.0
        },
        {
            "start_logit": -1.3125,
            "end_logit": -7.5234375,
            "text": "difficile Proctitis Following Total",
            "probability": 0.0
        },
        {
            "start_logit": -7.81640625,
            "end_logit": -1.330078125,
            "text": "Fecal Microbiota Transplantation for Treatment of Clostridium",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_3": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1328125,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": 8.1328125,
            "text": "difficile",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.26171875,
            "text": "Clostridium",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.29296875,
            "text": "Clostridium difficile carriage",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.31640625,
            "text": "Clostridium difficile carriage rates following fecal microbiota",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.36328125,
            "text": "Clostridium difficile carriage rates following fecal microbiota transplantation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.4609375,
            "text": "Clostridium difficile carriage rates",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.54296875,
            "text": "Clostridium difficile carriage rates following",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 8.1328125,
            "text": "We aimed to assess the asymptomatic Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 8.1328125,
            "text": "aimed to assess the asymptomatic Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 8.1328125,
            "text": "assess the asymptomatic Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 8.1328125,
            "text": "asymptomatic Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -7.29296875,
            "text": "difficile carriage",
            "probability": 0.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -7.31640625,
            "text": "difficile carriage rates following fecal microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -7.36328125,
            "text": "difficile carriage rates following fecal microbiota transplantation",
            "probability": 0.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -7.4609375,
            "text": "difficile carriage rates",
            "probability": 0.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -7.54296875,
            "text": "difficile carriage rates following",
            "probability": 0.0
        },
        {
            "start_logit": -7.87109375,
            "end_logit": -1.26171875,
            "text": "We aimed to assess the asymptomatic Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -7.90625,
            "end_logit": -1.26171875,
            "text": "aimed to assess the asymptomatic Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -1.26171875,
            "text": "assess the asymptomatic Clostridium",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_4": [
        {
            "start_logit": 8.25,
            "end_logit": 8.171875,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": -0.966796875,
            "end_logit": 8.171875,
            "text": "difficile",
            "probability": 9.918212890625e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.15625,
            "text": "Clostridium",
            "probability": 8.887052536010742e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.12109375,
            "text": "Clostridium difficile infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.24609375,
            "text": "Clostridium difficile infection, and case reports document its use in the successful treatment of constipation, diarrhea, and abdominal pain.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.421875,
            "text": "Clostridium difficile infection, and case reports document its use in the successful treatment of constipation, diarrhea",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.48046875,
            "text": "Clostridium difficile infection, and case reports document its use in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.48046875,
            "text": "Clostridium difficile infection, and case reports",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.48046875,
            "text": "Clostridium difficile infection,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 8.171875,
            "text": "infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 8.171875,
            "text": "recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 8.171875,
            "text": "Fecal transplantation, the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.171875,
            "text": "treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 8.171875,
            "text": "donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 8.171875,
            "text": "feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 8.171875,
            "text": ", the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 8.171875,
            "text": "the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.966796875,
            "end_logit": -7.12109375,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -0.966796875,
            "end_logit": -7.24609375,
            "text": "difficile infection, and case reports document its use in the successful treatment of constipation, diarrhea, and abdominal pain.",
            "probability": 0.0
        },
        {
            "start_logit": -0.966796875,
            "end_logit": -7.421875,
            "text": "difficile infection, and case reports document its use in the successful treatment of constipation, diarrhea",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_5": [
        {
            "start_logit": 8.3125,
            "end_logit": 8.171875,
            "text": "Clostridium difficile",
            "probability": 0.5
        },
        {
            "start_logit": 8.3046875,
            "end_logit": 8.1796875,
            "text": "Clostridium difficile",
            "probability": 0.5
        },
        {
            "start_logit": 8.3125,
            "end_logit": -0.787109375,
            "text": "Clostridium",
            "probability": 6.413459777832031e-05
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -0.8720703125,
            "text": "Clostridium",
            "probability": 5.888938903808594e-05
        },
        {
            "start_logit": -0.8720703125,
            "end_logit": 8.171875,
            "text": "difficile",
            "probability": 5.1140785217285156e-05
        },
        {
            "start_logit": -0.8837890625,
            "end_logit": 8.1796875,
            "text": "difficile",
            "probability": 5.1140785217285156e-05
        },
        {
            "start_logit": 8.3125,
            "end_logit": -6.11328125,
            "text": "Clostridium difficile infection (CDI",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.3125,
            "end_logit": -6.31640625,
            "text": "Clostridium difficile infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -6.7109375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -6.71484375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.6484375,
            "end_logit": 8.171875,
            "text": ".Fecal microbiota transplant (FMT) has emerged as a highly efficacious treatment for difficult cases of refractory and/or recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -6.953125,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3125,
            "end_logit": -7.08203125,
            "text": "Clostridium difficile infection (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.1640625,
            "text": "Clostridium difficile Infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.234375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT) has emerged as a highly efficacious treatment",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3125,
            "end_logit": -7.24609375,
            "text": "Clostridium difficile infection (CDI)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.265625,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FM",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.28515625,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.328125,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.33984375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT) has emerged as",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5c71d6d27c78d6947100006a_6": [
        {
            "start_logit": 8.3125,
            "end_logit": 8.171875,
            "text": "Clostridium difficile",
            "probability": 0.5
        },
        {
            "start_logit": 8.3046875,
            "end_logit": 8.1796875,
            "text": "Clostridium difficile",
            "probability": 0.5
        },
        {
            "start_logit": 8.3125,
            "end_logit": -0.787109375,
            "text": "Clostridium",
            "probability": 6.413459777832031e-05
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -0.8720703125,
            "text": "Clostridium",
            "probability": 5.888938903808594e-05
        },
        {
            "start_logit": -0.8720703125,
            "end_logit": 8.171875,
            "text": "difficile",
            "probability": 5.1140785217285156e-05
        },
        {
            "start_logit": -0.8837890625,
            "end_logit": 8.1796875,
            "text": "difficile",
            "probability": 5.1140785217285156e-05
        },
        {
            "start_logit": 8.3125,
            "end_logit": -6.11328125,
            "text": "Clostridium difficile infection (CDI",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.3125,
            "end_logit": -6.31640625,
            "text": "Clostridium difficile infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -6.7109375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -6.71484375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -6.6484375,
            "end_logit": 8.171875,
            "text": ".Fecal microbiota transplant (FMT) has emerged as a highly efficacious treatment for difficult cases of refractory and/or recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -6.953125,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3125,
            "end_logit": -7.08203125,
            "text": "Clostridium difficile infection (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.1640625,
            "text": "Clostridium difficile Infection",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.234375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT) has emerged as a highly efficacious treatment",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3125,
            "end_logit": -7.24609375,
            "text": "Clostridium difficile infection (CDI)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.265625,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FM",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.28515625,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.328125,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT)",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.3046875,
            "end_logit": -7.33984375,
            "text": "Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT) has emerged as",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5c71d6d27c78d6947100006a_7": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.1484375,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": -1.130859375,
            "end_logit": 8.1484375,
            "text": "difficile",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.2314453125,
            "text": "Clostridium",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.7890625,
            "text": "Clostridium difficile Infection following Fecal Microbiota",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.26953125,
            "text": "Clostridium difficile Infection following",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.37109375,
            "text": "Clostridium difficile Infection following Fecal Microbiota Transplantation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.484375,
            "text": "Clostridium difficile Infection following Fecal Microbiota Transplantation.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.48828125,
            "text": "Clostridium difficile Infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 8.1484375,
            "text": "Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 8.1484375,
            "text": "Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 8.1484375,
            "text": "Recovery from Recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 8.1484375,
            "text": "Recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.97265625,
            "end_logit": 8.1484375,
            "text": "from Recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.130859375,
            "end_logit": -6.7890625,
            "text": "difficile Infection following Fecal Microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -1.130859375,
            "end_logit": -7.26953125,
            "text": "difficile Infection following",
            "probability": 0.0
        },
        {
            "start_logit": -1.130859375,
            "end_logit": -7.37109375,
            "text": "difficile Infection following Fecal Microbiota Transplantation",
            "probability": 0.0
        },
        {
            "start_logit": -1.130859375,
            "end_logit": -7.484375,
            "text": "difficile Infection following Fecal Microbiota Transplantation.",
            "probability": 0.0
        },
        {
            "start_logit": -1.130859375,
            "end_logit": -7.48828125,
            "text": "difficile Infection",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -1.2314453125,
            "text": "Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium",
            "probability": 0.0
        },
        {
            "start_logit": -7.76953125,
            "end_logit": -1.2314453125,
            "text": "Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_8": [
        {
            "start_logit": 8.25,
            "end_logit": 8.171875,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": -0.966796875,
            "end_logit": 8.171875,
            "text": "difficile",
            "probability": 9.918212890625e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.15625,
            "text": "Clostridium",
            "probability": 8.887052536010742e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.12109375,
            "text": "Clostridium difficile infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.24609375,
            "text": "Clostridium difficile infection, and case reports document its use in the successful treatment of constipation, diarrhea, and abdominal pain.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.421875,
            "text": "Clostridium difficile infection, and case reports document its use in the successful treatment of constipation, diarrhea",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.48046875,
            "text": "Clostridium difficile infection, and case reports document its use in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.48046875,
            "text": "Clostridium difficile infection, and case reports",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.48046875,
            "text": "Clostridium difficile infection,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 8.171875,
            "text": "infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 8.171875,
            "text": "recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 8.171875,
            "text": "Fecal transplantation, the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.171875,
            "text": "treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 8.171875,
            "text": "donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 8.171875,
            "text": "feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 8.171875,
            "text": ", the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 8.171875,
            "text": "the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.966796875,
            "end_logit": -7.12109375,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -0.966796875,
            "end_logit": -7.24609375,
            "text": "difficile infection, and case reports document its use in the successful treatment of constipation, diarrhea, and abdominal pain.",
            "probability": 0.0
        },
        {
            "start_logit": -0.966796875,
            "end_logit": -7.421875,
            "text": "difficile infection, and case reports document its use in the successful treatment of constipation, diarrhea",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_9": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.171875,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": -1.005859375,
            "end_logit": 8.171875,
            "text": "difficile",
            "probability": 9.685754776000977e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.21484375,
            "text": "Clostridium",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.15234375,
            "text": "Clostridium difficile infection, with near 90",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.23828125,
            "text": "Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.26171875,
            "text": "Clostridium difficile infection, with near 90%",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.50390625,
            "text": "Clostridium difficile infection,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.53515625,
            "text": "Clostridium difficile infection, with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.5390625,
            "text": "Clostridium difficile infection, with near 90% of success.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5703125,
            "end_logit": 8.171875,
            "text": "Fecal microbiota transplantation (FMT) has an incomparable efficacy to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 8.171875,
            "text": "microbiota transplantation (FMT) has an incomparable efficacy to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 8.171875,
            "text": "recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 8.171875,
            "text": "FMT) has an incomparable efficacy to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 8.171875,
            "text": "arable efficacy to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 8.171875,
            "text": "treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 8.171875,
            "text": "incomparable efficacy to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 8.171875,
            "text": "efficacy to treat recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.005859375,
            "end_logit": -7.15234375,
            "text": "difficile infection, with near 90",
            "probability": 0.0
        },
        {
            "start_logit": -1.005859375,
            "end_logit": -7.23828125,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -1.005859375,
            "end_logit": -7.26171875,
            "text": "difficile infection, with near 90%",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_10": [
        {
            "start_logit": 8.25,
            "end_logit": 8.1640625,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": -1.009765625,
            "end_logit": 8.1640625,
            "text": "difficile",
            "probability": 9.608268737792969e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.1806640625,
            "text": "Clostridium",
            "probability": 8.821487426757812e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -5.953125,
            "text": "Clostridium difficile infection, has emerged as a promising therapy for intestinal MDR bacterial decolonization",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.4765625,
            "text": "Clostridium difficile infection, has emerged as a promising therapy for intestinal MDR bacterial decolon",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.77734375,
            "text": "Clostridium difficile infection, has emerged as a promising therapy for intestinal MDR bacterial",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.05859375,
            "text": "Clostridium difficile infection, has emerged as a promising therapy for intestinal MDR bacterial decolonization.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.18359375,
            "text": "Clostridium difficile infection, has emerged as a promising therapy for intestinal",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.30078125,
            "text": "Clostridium difficile infection, has emerged as a promising therapy for intestinal MDR",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.3203125,
            "text": "Clostridium difficile infection,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.33984375,
            "text": "Clostridium difficile infection, has emerged as a promising therapy for intestinal MDR bacterial dec",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.3515625,
            "text": "Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.484375,
            "text": "Clostridium difficile infection, has emerged as a promising therapy",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.56640625,
            "end_logit": 8.1640625,
            "text": "Fecal microbiota transplantation (FMT), a highly effective treatment for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.1640625,
            "text": "recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 8.1640625,
            "text": "effective treatment for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 8.1640625,
            "text": "FMT), a highly effective treatment for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 8.1640625,
            "text": "highly effective treatment for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 8.1640625,
            "text": "microbiota transplantation (FMT), a highly effective treatment for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 8.1640625,
            "text": "a highly effective treatment for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5c71d6d27c78d6947100006a_11": [
        {
            "start_logit": 8.2578125,
            "end_logit": 8.1953125,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": -0.89794921875,
            "end_logit": 8.1953125,
            "text": "difficile",
            "probability": 0.0001055598258972168
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -1.16015625,
            "text": "Clostridium",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -6.42578125,
            "text": "Clostridium difficile infection (R-CDI) that cannot be cured with antibiotics",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -6.96484375,
            "text": "Clostridium difficile infection (R-CDI) that cannot be cured with antibiotics alone",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.1796875,
            "text": "Clostridium difficile infection (R-CDI) that cannot be cured with antibiotics alone.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.20703125,
            "text": "Clostridium difficile infection (R-CDI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.23046875,
            "text": "Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.390625,
            "text": "Clostridium difficile infection (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.42578125,
            "text": "Clostridium difficile infection (R-CDI) that cannot be",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.47265625,
            "text": "Clostridium difficile infection (R-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.4765625,
            "text": "Clostridium difficile infection (R",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.48046875,
            "text": "Clostridium difficile infection (R-CDI) that cannot be cured",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 8.1953125,
            "text": "Fecal microbiota transplantation (FMT) is increasingly being used for treatment of recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 8.1953125,
            "text": "recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 8.1953125,
            "text": "microbiota transplantation (FMT) is increasingly being used for treatment of recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 8.1953125,
            "text": "FMT) is increasingly being used for treatment of recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 8.1953125,
            "text": "OBJECTIVES Fecal microbiota transplantation (FMT) is increasingly being used for treatment of recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 8.1953125,
            "text": "treatment of recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.89794921875,
            "end_logit": -6.42578125,
            "text": "difficile infection (R-CDI) that cannot be cured with antibiotics",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_12": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.15625,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": -1.0703125,
            "end_logit": 8.15625,
            "text": "difficile",
            "probability": 8.958578109741211e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.2138671875,
            "text": "Clostridium",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.34375,
            "text": "Clostridium difficile infection (CDI",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.6875,
            "text": "Clostridium difficile infection",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.015625,
            "text": "Clostridium difficile infection (CDI).",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.03515625,
            "end_logit": 8.15625,
            "text": "microbiota transplantation (FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.1484375,
            "text": "Clostridium difficile infection (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.390625,
            "text": "Clostridium difficile infection (CDI)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 8.15625,
            "text": "Fecal microbiota transplantation (FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 8.15625,
            "text": "diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 8.15625,
            "text": "FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 8.15625,
            "text": "BACKGROUND Fecal microbiota transplantation (FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 8.15625,
            "text": "restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 8.15625,
            "text": "gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 8.15625,
            "text": "treat patients with Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 8.15625,
            "text": "profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.0703125,
            "end_logit": -6.34375,
            "text": "difficile infection (CDI",
            "probability": 0.0
        },
        {
            "start_logit": -1.0703125,
            "end_logit": -6.6875,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -1.0703125,
            "end_logit": -7.015625,
            "text": "difficile infection (CDI).",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_13": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1796875,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": -0.96044921875,
            "end_logit": 8.1796875,
            "text": "difficile",
            "probability": 0.00010228157043457031
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.306640625,
            "text": "Clostridium",
            "probability": 7.605552673339844e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.671875,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.0,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.03125,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.1328125,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.25,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor stool",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.265625,
            "text": "Clostridium difficile infection (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.296875,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor stool samples or autologous stool",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.36328125,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FM",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.3671875,
            "text": "Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.37109375,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor stool samples or autologous stool samples,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.40625,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.42578125,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.42578125,
            "text": "Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor stool samples or autologous stool samples, were",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.4921875,
            "text": "Clostridium difficile infection (rCDI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 8.1796875,
            "text": "recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.96044921875,
            "end_logit": -6.671875,
            "text": "difficile infection (rCDI) by fecal microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -0.96044921875,
            "end_logit": -7.0,
            "text": "difficile infection (rCDI) by fecal microbiota transplantation (FMT",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_14": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.15625,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": -1.08984375,
            "end_logit": 8.15625,
            "text": "difficile",
            "probability": 8.887052536010742e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.2314453125,
            "text": "Clostridium",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.37890625,
            "text": "Clostridium difficile infections, with potential applications against other diseases associated with changes in gut microbiota",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.921875,
            "text": "Clostridium difficile infections, with potential applications against other diseases associated with changes in gut",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.23046875,
            "text": "Clostridium difficile infections, with potential applications against other diseases associated with changes in gut microbiota.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.43359375,
            "text": "Clostridium difficile infections,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4375,
            "text": "Clostridium difficile infections",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.58203125,
            "text": "Clostridium difficile infections, with potential applications against other diseases associated with changes",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.60546875,
            "text": "Clostridium difficile infections, with potential applications against other diseases associated with",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.62890625,
            "text": "Clostridium difficile infections, with potential applications against other diseases associated with changes in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6328125,
            "text": "Clostridium difficile infections, with potential applications against other diseases",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.58203125,
            "end_logit": 8.15625,
            "text": "recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 8.15625,
            "text": "Fecal microbiota transplantation is a compelling treatment for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 8.15625,
            "text": "microbiota transplantation is a compelling treatment for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 8.15625,
            "text": "compelling treatment for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.08984375,
            "end_logit": -6.37890625,
            "text": "difficile infections, with potential applications against other diseases associated with changes in gut microbiota",
            "probability": 0.0
        },
        {
            "start_logit": -1.08984375,
            "end_logit": -6.921875,
            "text": "difficile infections, with potential applications against other diseases associated with changes in gut",
            "probability": 0.0
        },
        {
            "start_logit": -1.08984375,
            "end_logit": -7.23046875,
            "text": "difficile infections, with potential applications against other diseases associated with changes in gut microbiota.",
            "probability": 0.0
        },
        {
            "start_logit": -1.08984375,
            "end_logit": -7.43359375,
            "text": "difficile infections,",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_15": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1640625,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": -1.046875,
            "end_logit": 8.1640625,
            "text": "difficile",
            "probability": 9.244680404663086e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.2294921875,
            "text": "Clostridium",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.31640625,
            "text": "Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.59765625,
            "text": "Clostridium difficile infection,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.625,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled trials and Long-term follow-up registries are stilt required",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.6328125,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled trials and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.6328125,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled trials and Long-term follow-up",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.640625,
            "text": "Clostridium difficile infection, but well-designed, randomized-controlled trials and Long-term follow-up registries are",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 8.1640625,
            "text": "Fecal microbiota transplantation (FMT) holds considerable promise as a therapy for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 8.1640625,
            "text": "promise as a therapy for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 8.1640625,
            "text": "recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 8.1640625,
            "text": "FMT) holds considerable promise as a therapy for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 8.1640625,
            "text": "microbiota transplantation (FMT) holds considerable promise as a therapy for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 8.1640625,
            "text": "therapy for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.046875,
            "end_logit": -7.31640625,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -1.046875,
            "end_logit": -7.59765625,
            "text": "difficile infection,",
            "probability": 0.0
        },
        {
            "start_logit": -1.046875,
            "end_logit": -7.625,
            "text": "difficile infection, but well-designed, randomized-controlled trials and Long-term follow-up registries are stilt required",
            "probability": 0.0
        },
        {
            "start_logit": -1.046875,
            "end_logit": -7.6328125,
            "text": "difficile infection, but well-designed, randomized-controlled trials and",
            "probability": 0.0
        },
        {
            "start_logit": -1.046875,
            "end_logit": -7.6328125,
            "text": "difficile infection, but well-designed, randomized-controlled trials and Long-term follow-up",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_16": [
        {
            "start_logit": 8.25,
            "end_logit": 8.1484375,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": -1.06640625,
            "end_logit": 8.1484375,
            "text": "difficile",
            "probability": 8.887052536010742e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.1904296875,
            "text": "Clostridium",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.4609375,
            "text": "Clostridium difficile infection (CDI",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.09375,
            "text": "Clostridium difficile infection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.26171875,
            "text": "Clostridium difficile infection (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.33984375,
            "text": "Clostridium difficile infection (CDI) and is considered as a treatment for other gastrointestinal (GI) diseases.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.34375,
            "text": "Clostridium difficile infection (CDI) and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.37109375,
            "text": "Clostridium difficile infection (CDI) and is considered as a treatment for other gastrointestinal (GI",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.43359375,
            "text": "Clostridium difficile infection (CDI) and is considered as a treatment for other gastrointestinal (GI)",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.46875,
            "text": "Clostridium difficile infection (CDI) and is considered as a treatment for other gastrointestinal (GI) diseases",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 8.1484375,
            "text": "Fecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 8.1484375,
            "text": "microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 8.1484375,
            "text": "recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 8.1484375,
            "text": "FMT) is an effective treatment for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 8.1484375,
            "text": "effective treatment for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 8.1484375,
            "text": "treatment for recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.06640625,
            "end_logit": -6.4609375,
            "text": "difficile infection (CDI",
            "probability": 0.0
        },
        {
            "start_logit": -1.06640625,
            "end_logit": -7.09375,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -1.06640625,
            "end_logit": -7.26171875,
            "text": "difficile infection (",
            "probability": 0.0
        }
    ],
    "5c71d6d27c78d6947100006a_17": [
        {
            "start_logit": 8.25,
            "end_logit": 8.171875,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": -0.9765625,
            "end_logit": 8.171875,
            "text": "difficile",
            "probability": 9.840726852416992e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.1875,
            "text": "Clostridium",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": 8.25,
            "end_logit": -6.98828125,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.11328125,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic therapy",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.36328125,
            "text": "Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.44140625,
            "text": "Clostridium difficile infection with ulcerative pancolitis",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.515625,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic therapy failure",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.51953125,
            "text": "Clostridium difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic therapy failure.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.52734375,
            "text": "Clostridium difficile infection with ulcerative pancoli",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.53125,
            "text": "Clostridium difficile infection with",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.546875,
            "text": "Clostridium difficile infection with ulcerative",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.578125,
            "text": "Clostridium difficile infection with ulcerative panc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.625,
            "text": "Clostridium difficile infection with ulcerative pancolitis,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 8.171875,
            "text": "Fecal microbiota transplantation is relatively simple to perform, well-tolerated, safe and effective in recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 8.171875,
            "text": "recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 8.171875,
            "text": ", well-tolerated, safe and effective in recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 8.171875,
            "text": "well-tolerated, safe and effective in recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 8.171875,
            "text": ", safe and effective in recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.171875,
            "text": "microbiota transplantation is relatively simple to perform, well-tolerated, safe and effective in recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5c71d6d27c78d6947100006a_18": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.171875,
            "text": "Clostridium difficile",
            "probability": 1.0
        },
        {
            "start_logit": -1.04296875,
            "end_logit": 8.171875,
            "text": "difficile",
            "probability": 9.316205978393555e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.2412109375,
            "text": "Clostridium",
            "probability": 8.153915405273438e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.265625,
            "text": "Clostridium difficile infection",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.453125,
            "text": "Clostridium difficile infection and coexistent inflammatory bowel",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4609375,
            "text": "Clostridium difficile infection and coexistent inflammatory bowel disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.47265625,
            "text": "Clostridium difficile infection and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.55078125,
            "text": "Clostridium difficile infection and coexistent inflammatory bowel disease remains unclear.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.58203125,
            "text": "Clostridium difficile infection and coexistent inflammatory",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.58984375,
            "text": "Clostridium difficile infection and coexistent inflammatory bowel disease remains unclear",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.59765625,
            "text": "Clostridium difficile infection and coexist",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.61328125,
            "text": "Clostridium difficile infection and coexistent",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 8.171875,
            "text": "recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 8.171875,
            "text": "fecal microbiota transplantation in recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 8.171875,
            "text": "microbiota transplantation in recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 8.171875,
            "text": "The use of fecal microbiota transplantation in recurrent Clostridium difficile",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.04296875,
            "end_logit": -7.265625,
            "text": "difficile infection",
            "probability": 0.0
        },
        {
            "start_logit": -1.04296875,
            "end_logit": -7.453125,
            "text": "difficile infection and coexistent inflammatory bowel",
            "probability": 0.0
        },
        {
            "start_logit": -1.04296875,
            "end_logit": -7.4609375,
            "text": "difficile infection and coexistent inflammatory bowel disease",
            "probability": 0.0
        },
        {
            "start_logit": -1.04296875,
            "end_logit": -7.47265625,
            "text": "difficile infection and",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_1": [
        {
            "start_logit": 5.48046875,
            "end_logit": 6.8125,
            "text": "histone deacetylase",
            "probability": 1.0
        },
        {
            "start_logit": 5.48046875,
            "end_logit": -2.12109375,
            "text": "histone deacetylase (HDAC",
            "probability": 0.00013136863708496094
        },
        {
            "start_logit": -3.49609375,
            "end_logit": 6.8125,
            "text": "deacetylase",
            "probability": 0.00012540817260742188
        },
        {
            "start_logit": 5.48046875,
            "end_logit": -4.85546875,
            "text": "histone",
            "probability": 8.52346420288086e-06
        },
        {
            "start_logit": -6.66796875,
            "end_logit": 6.8125,
            "text": ", histone deacetylase",
            "probability": 5.245208740234375e-06
        },
        {
            "start_logit": -7.08984375,
            "end_logit": 6.8125,
            "text": "carfilzomib, and ixazomib), monoclonal antibodies (daratumumab and elotuzumab), histone deacetylase",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 6.8125,
            "text": "), histone deacetylase",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 6.8125,
            "text": "), monoclonal antibodies (daratumumab and elotuzumab), histone deacetylase",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 6.8125,
            "text": "daratumumab and elotuzumab), histone deacetylase",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": -7.5,
            "end_logit": 6.8125,
            "text": "filzomib, and ixazomib), monoclonal antibodies (daratumumab and elotuzumab), histone deacetylase",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 5.48046875,
            "end_logit": -6.43359375,
            "text": "histone deacetylase (HDAC)",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 5.48046875,
            "end_logit": -6.68359375,
            "text": "histone deacetylase (HDAC) inhibitors (Panobinostat).",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": 5.48046875,
            "end_logit": -7.03125,
            "text": "histone deacetylase (",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 5.48046875,
            "end_logit": -7.26171875,
            "text": "histone deacetylase (HDAC) inhibitors",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 5.48046875,
            "end_logit": -7.30078125,
            "text": "histone deacetylase (HDAC) inhibitors (Panobinostat",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -2.58203125,
            "end_logit": -2.12109375,
            "text": "HDAC",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -3.49609375,
            "end_logit": -2.12109375,
            "text": "deacetylase (HDAC",
            "probability": 0.0
        },
        {
            "start_logit": -6.66796875,
            "end_logit": -2.12109375,
            "text": ", histone deacetylase (HDAC",
            "probability": 0.0
        },
        {
            "start_logit": -2.58203125,
            "end_logit": -6.43359375,
            "text": "HDAC)",
            "probability": 0.0
        },
        {
            "start_logit": -7.08984375,
            "end_logit": -2.12109375,
            "text": "carfilzomib, and ixazomib), monoclonal antibodies (daratumumab and elotuzumab), histone deacetylase (HDAC",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_2": [
        {
            "start_logit": 6.30859375,
            "end_logit": 6.58984375,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.31640625,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of bortezomib,",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 6.58984375,
            "text": "generation proteasome",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.39453125,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of bortezomib",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.58984375,
            "text": ", the second-generation proteasome",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.4609375,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 6.58984375,
            "text": "08-MLN2238), the second-generation proteasome",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.4921875,
            "text": "proteasome inhibitor, selectivity and potency were similar to",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.5078125,
            "text": "proteasome inhibitor, selectivity and",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 6.58984375,
            "text": "N9708-MLN2238), the second-generation proteasome",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 6.58984375,
            "text": "MLN2238), the second-generation proteasome",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 6.58984375,
            "text": "the second-generation proteasome",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 6.58984375,
            "text": "Ixazomib (MLN9708-MLN2238), the second-generation proteasome",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 6.58984375,
            "text": "), the second-generation proteasome",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.5390625,
            "text": "proteasome inhibitor, selectivity and potency were similar to that",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 6.58984375,
            "text": "N2238), the second-generation proteasome",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.828125,
            "end_logit": 6.58984375,
            "text": "9708-MLN2238), the second-generation proteasome",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.66796875,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of bortezomib, is currently being investigated in phase I",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.68359375,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of bortezomib, is",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.30859375,
            "end_logit": -7.69921875,
            "text": "proteasome inhibitor, selectivity and potency were similar to that of bortezomib, is currently being",
            "probability": 5.960464477539062e-07
        }
    ],
    "589630f378275d0c4a000007_3": [
        {
            "start_logit": 5.12890625,
            "end_logit": 5.390625,
            "text": "CD38",
            "probability": 0.9892578125
        },
        {
            "start_logit": 0.54736328125,
            "end_logit": 5.390625,
            "text": "proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 0.01016998291015625
        },
        {
            "start_logit": 0.54736328125,
            "end_logit": 0.080810546875,
            "text": "proteasome",
            "probability": 5.0127506256103516e-05
        },
        {
            "start_logit": 5.12890625,
            "end_logit": -6.34765625,
            "text": "CD38 and SLAMF7, respectively.",
            "probability": 7.927417755126953e-06
        },
        {
            "start_logit": -6.76171875,
            "end_logit": 5.390625,
            "text": "target CD38",
            "probability": 6.794929504394531e-06
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 5.390625,
            "text": "multiple myeloma: ixazomib, the first oral proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": 5.12890625,
            "end_logit": -6.78125,
            "text": "CD38 and SLAMF7",
            "probability": 5.125999450683594e-06
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 5.390625,
            "text": "daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": -7.625,
            "end_logit": 5.390625,
            "text": "the first oral proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 2.86102294921875e-06
        },
        {
            "start_logit": -7.63671875,
            "end_logit": 5.390625,
            "text": ", the first oral proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 5.12890625,
            "end_logit": -7.3984375,
            "text": "CD38 and",
            "probability": 2.8014183044433594e-06
        },
        {
            "start_logit": 5.12890625,
            "end_logit": -7.4296875,
            "text": "CD38 and SLAMF7, respectively",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 5.390625,
            "text": "for multiple myeloma: ixazomib, the first oral proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38",
            "probability": 2.562999725341797e-06
        },
        {
            "start_logit": 5.12890625,
            "end_logit": -7.51171875,
            "text": "CD38 and SLAMF",
            "probability": 2.5033950805664062e-06
        },
        {
            "start_logit": 0.54736328125,
            "end_logit": -6.34765625,
            "text": "proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38 and SLAMF7, respectively.",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.54736328125,
            "end_logit": -6.78125,
            "text": "proteasome inhibitor; and daratumumab and elotuzumab, two monoclonal antibodies that target CD38 and SLAMF7",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.54736328125,
            "end_logit": -7.16015625,
            "text": "proteasome inhibitor",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.54736328125,
            "end_logit": -7.328125,
            "text": "proteasome inhibitor;",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.54736328125,
            "end_logit": -7.33203125,
            "text": "proteasome inhibitor; and daratumumab",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 0.54736328125,
            "end_logit": -7.36328125,
            "text": "proteasome inhibitor; and daratumumab and",
            "probability": 5.960464477539063e-08
        }
    ],
    "589630f378275d0c4a000007_4": [
        {
            "start_logit": 6.34375,
            "end_logit": 6.62890625,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.2890625,
            "text": "proteasome inhibitor to be",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.3046875,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as a single agent and particularly in combination with immunomodulatory drugs and",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.3828125,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.3828125,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.390625,
            "text": "proteasome inhibitor to",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.39453125,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as a single agent and",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.453125,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.45703125,
            "text": "proteasome inhibitor to be evaluated",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.48828125,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma,",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.4921875,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as a single agent and particularly",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.51171875,
            "text": "proteasome inhibitor",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.51171875,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 6.62890625,
            "text": "Ixazomib, the first oral proteasome",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 6.62890625,
            "text": "first oral proteasome",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 6.62890625,
            "text": "oral proteasome",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 6.62890625,
            "text": ", the first oral proteasome",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.60546875,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.61328125,
            "text": "proteasome inhibitor to be evaluated in multiple myeloma, exerts substantial anti-myeloma activity as a single",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.34375,
            "end_logit": -7.63671875,
            "text": "proteasome inhibitor to be evaluated in",
            "probability": 6.556510925292969e-07
        }
    ],
    "589630f378275d0c4a000007_5": [
        {
            "start_logit": 5.66015625,
            "end_logit": 5.43359375,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -6.171875,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib, ixazomib, and delanzomib.",
            "probability": 9.059906005859375e-06
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -6.83203125,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib",
            "probability": 4.708766937255859e-06
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -6.90234375,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib",
            "probability": 4.410743713378906e-06
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -7.02734375,
            "text": "proteasome inhibitors",
            "probability": 3.874301910400391e-06
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -7.1328125,
            "text": "proteasome inhibitors have also been",
            "probability": 3.516674041748047e-06
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -7.1484375,
            "text": "proteasome inhibitors have also",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -7.1484375,
            "text": "proteasome inhibitors have",
            "probability": 3.4570693969726562e-06
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -7.20703125,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib, ixazomib",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -7.2421875,
            "text": "proteasome inhibitors have also been used clinically, including",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -7.27734375,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib, oprozomib, ixazomib, and delanzomib",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -7.296875,
            "text": "proteasome inhibitors have also been used",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -7.31640625,
            "text": "proteasome inhibitors have also been used clinically",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 5.66015625,
            "end_logit": -7.390625,
            "text": "proteasome inhibitors have also been used clinically, including carfilzomib,",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -7.453125,
            "end_logit": 5.43359375,
            "text": "generation proteasome",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 5.43359375,
            "text": ", several next-generation proteasome",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 5.43359375,
            "text": "Since the introduction of bortezomib in 2003, several next-generation proteasome",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 5.43359375,
            "text": "2003, several next-generation proteasome",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 5.43359375,
            "text": "introduction of bortezomib in 2003, several next-generation proteasome",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -7.90625,
            "end_logit": 5.43359375,
            "text": "the introduction of bortezomib in 2003, several next-generation proteasome",
            "probability": 1.3113021850585938e-06
        }
    ],
    "589630f378275d0c4a000007_6": [
        {
            "start_logit": 6.33203125,
            "end_logit": 6.58984375,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 6.58984375,
            "text": "The aim of the present study was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 6.58984375,
            "text": "present study was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.34765625,
            "text": "proteasome inhibitor, ixazomib, in patients with solid tumours and moderate or severe hepatic",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.60546875,
            "end_logit": 6.58984375,
            "text": "AIM: The aim of the present study was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 6.58984375,
            "text": "characterize the pharmacokinetics of the oral proteasome",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 6.58984375,
            "text": "study was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.7109375,
            "end_logit": 6.58984375,
            "text": "aim of the present study was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 6.58984375,
            "text": ": The aim of the present study was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.7421875,
            "end_logit": 6.58984375,
            "text": "the present study was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.828125,
            "end_logit": 6.58984375,
            "text": "was to characterize the pharmacokinetics of the oral proteasome",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.58984375,
            "text": "proteasome inhibitor, ixazomib, in",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.66015625,
            "text": "proteasome inhibitor",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.67578125,
            "text": "proteasome inhibitor, ixazomib",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.71484375,
            "text": "proteasome inhibitor, ixazomi",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.7421875,
            "text": "proteasome inhibitor, ixazomib, in patients with solid tumours",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.76171875,
            "text": "proteasome inhibitor, ixazo",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.765625,
            "text": "proteasome inhibitor, ixazomib, in patients",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.80078125,
            "text": "proteasome inhibitor, ixazomib, in patients with solid tumours and moderate or severe hepatic impairment",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.8125,
            "text": "proteasome inhibitor, ixazomib, in patients with solid tumours and moderate or",
            "probability": 5.364418029785156e-07
        }
    ],
    "589630f378275d0c4a000007_7": [
        {
            "start_logit": 6.375,
            "end_logit": 6.5234375,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.19140625,
            "text": "proteasome inhibitor, in",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.28515625,
            "text": "proteasome inhibitor, in solid tumour patients with moderate or severe hepatic",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.609375,
            "text": "proteasome inhibitor, in solid tumour",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.61328125,
            "text": "proteasome inhibitor, in solid tumour patients",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.65625,
            "text": "proteasome inhibitor",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 6.5234375,
            "text": "oral proteasome",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.734375,
            "text": "proteasome inhibitor,",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.73828125,
            "text": "proteasome inhibitor, in solid",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 6.5234375,
            "text": "Pharmacokinetics of ixazomib, an oral proteasome",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.75390625,
            "text": "proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.76953125,
            "text": "proteasome inhibitor, in solid tumour patients with",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 6.375,
            "end_logit": -7.76953125,
            "text": "proteasome inhibitor, in solid tumour patients with moderate or",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.953125,
            "end_logit": 6.5234375,
            "text": "ixazomib, an oral proteasome",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.19140625,
            "text": "oral proteasome inhibitor, in",
            "probability": 0.0
        },
        {
            "start_logit": -7.890625,
            "end_logit": -7.19140625,
            "text": "Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in",
            "probability": 0.0
        },
        {
            "start_logit": -7.94140625,
            "end_logit": -7.19140625,
            "text": ", in",
            "probability": 0.0
        },
        {
            "start_logit": -7.953125,
            "end_logit": -7.19140625,
            "text": "ixazomib, an oral proteasome inhibitor, in",
            "probability": 0.0
        },
        {
            "start_logit": -7.8671875,
            "end_logit": -7.28515625,
            "text": "oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic",
            "probability": 0.0
        },
        {
            "start_logit": -7.890625,
            "end_logit": -7.28515625,
            "text": "Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_8": [
        {
            "start_logit": 1.388671875,
            "end_logit": 1.453125,
            "text": "proteasome",
            "probability": 0.998046875
        },
        {
            "start_logit": 1.388671875,
            "end_logit": -5.34765625,
            "text": "proteasome inhibitor to reach phase III trials.",
            "probability": 0.0011110305786132812
        },
        {
            "start_logit": 1.388671875,
            "end_logit": -6.640625,
            "text": "proteasome inhibitor to",
            "probability": 0.00030493736267089844
        },
        {
            "start_logit": -7.140625,
            "end_logit": 1.453125,
            "text": ", proteasome",
            "probability": 0.00019681453704833984
        },
        {
            "start_logit": 1.388671875,
            "end_logit": -7.28515625,
            "text": "proteasome inhibitor",
            "probability": 0.00015938282012939453
        },
        {
            "start_logit": 1.388671875,
            "end_logit": -7.40234375,
            "text": "proteasome inhibitor to reach phase III",
            "probability": 0.0001418590545654297
        },
        {
            "start_logit": -7.703125,
            "end_logit": 1.453125,
            "text": "Ixazomib is the first oral, proteasome",
            "probability": 0.00011211633682250977
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 1.453125,
            "text": "first oral, proteasome",
            "probability": 0.00011038780212402344
        },
        {
            "start_logit": 1.388671875,
            "end_logit": -7.72265625,
            "text": "proteasome inhibitor to reach phase",
            "probability": 0.00010293722152709961
        },
        {
            "start_logit": 1.388671875,
            "end_logit": -7.7578125,
            "text": "proteasome inhibitor to reach",
            "probability": 9.97781753540039e-05
        },
        {
            "start_logit": -6.546875,
            "end_logit": -5.34765625,
            "text": ".",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.140625,
            "end_logit": -5.34765625,
            "text": ", proteasome inhibitor to reach phase III trials.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": -5.34765625,
            "text": "Ixazomib is the first oral, proteasome inhibitor to reach phase III trials.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": -5.34765625,
            "text": "first oral, proteasome inhibitor to reach phase III trials.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": -5.34765625,
            "text": "reach phase III trials.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": -5.34765625,
            "text": "trials.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.140625,
            "end_logit": -6.640625,
            "text": ", proteasome inhibitor to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.703125,
            "end_logit": -6.640625,
            "text": "Ixazomib is the first oral, proteasome inhibitor to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.72265625,
            "end_logit": -6.640625,
            "text": "first oral, proteasome inhibitor to",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": -7.140625,
            "end_logit": -7.28515625,
            "text": ", proteasome inhibitor",
            "probability": 5.960464477539063e-08
        }
    ],
    "589630f378275d0c4a000007_9": [
        {
            "start_logit": 5.90234375,
            "end_logit": 5.8046875,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 5.90234375,
            "end_logit": -7.16015625,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic parameters compared to bortezomib",
            "probability": 2.3245811462402344e-06
        },
        {
            "start_logit": 5.90234375,
            "end_logit": -7.25,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic parameters compared to",
            "probability": 2.1457672119140625e-06
        },
        {
            "start_logit": 5.90234375,
            "end_logit": -7.37890625,
            "text": "proteasome inhibitor, has",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": 5.90234375,
            "end_logit": -7.38671875,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic parameters compared to bortezomib.",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": 5.90234375,
            "end_logit": -7.52734375,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic parameters compared",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": 5.90234375,
            "end_logit": -7.5703125,
            "text": "proteasome inhibitor",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 5.90234375,
            "end_logit": -7.59765625,
            "text": "proteasome inhibitor,",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 5.90234375,
            "end_logit": -7.625,
            "text": "proteasome inhibitor, has improved",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": 5.90234375,
            "end_logit": -7.62890625,
            "text": "proteasome inhibitor, has improved pharmacotherapeutic parameters",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 5.8046875,
            "text": "MLN2238 (ixazomib), an oral proteasome",
            "probability": 1.3113021850585938e-06
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 5.8046875,
            "text": "oral proteasome",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 5.8046875,
            "text": ", an oral proteasome",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.94921875,
            "end_logit": 5.8046875,
            "text": "ixazomib), an oral proteasome",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": -7.38671875,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.66796875,
            "end_logit": -7.16015625,
            "text": "MLN2238 (ixazomib), an oral proteasome inhibitor, has improved pharmacotherapeutic parameters compared to bortezomib",
            "probability": 0.0
        },
        {
            "start_logit": -7.66796875,
            "end_logit": -7.25,
            "text": "MLN2238 (ixazomib), an oral proteasome inhibitor, has improved pharmacotherapeutic parameters compared to",
            "probability": 0.0
        },
        {
            "start_logit": -7.66796875,
            "end_logit": -7.3203125,
            "text": "MLN2238",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -7.16015625,
            "text": ", has improved pharmacotherapeutic parameters compared to bortezomib",
            "probability": 0.0
        },
        {
            "start_logit": -7.84765625,
            "end_logit": -7.16015625,
            "text": "oral proteasome inhibitor, has improved pharmacotherapeutic parameters compared to bortezomib",
            "probability": 0.0
        }
    ],
    "589630f378275d0c4a000007_10": [
        {
            "start_logit": 6.3515625,
            "end_logit": 6.55859375,
            "text": "proteasome",
            "probability": 1.0
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.16015625,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 6.55859375,
            "text": "This population pharmacokinetic analysis of the investigational oral proteasome",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.39453125,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.40625,
            "text": "proteasome inhibitor",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.44140625,
            "text": "proteasome inhibitor ixazomib",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 6.55859375,
            "text": "population pharmacokinetic analysis of the investigational oral proteasome",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.453125,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)-",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.5,
            "text": "proteasome inhibitor ixazomi",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.51171875,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.55078125,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)-based",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.5703125,
            "text": "proteasome inhibitor ixazo",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.6015625,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)-based to fixed dosing",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.60546875,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)-based to fixed dosing,",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.609375,
            "text": "proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)-based to fixed",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 6.55859375,
            "text": "investigational oral proteasome",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 6.55859375,
            "text": "oral proteasome",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": -7.16015625,
            "text": "This population pharmacokinetic analysis of the investigational oral proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)",
            "probability": 0.0
        },
        {
            "start_logit": -7.65234375,
            "end_logit": -7.16015625,
            "text": "population pharmacokinetic analysis of the investigational oral proteasome inhibitor ixazomib assessed the feasibility of switching from body surface area (BSA)",
            "probability": 0.0
        },
        {
            "start_logit": -7.71484375,
            "end_logit": -7.16015625,
            "text": "assessed the feasibility of switching from body surface area (BSA)",
            "probability": 0.0
        }
    ],
    "55201a316b348bb82c000019_1": [
        {
            "start_logit": 8.1640625,
            "end_logit": 7.90234375,
            "text": "55 S",
            "probability": 1.0
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -0.91943359375,
            "text": "55",
            "probability": 0.00014889240264892578
        },
        {
            "start_logit": -1.5390625,
            "end_logit": 7.90234375,
            "text": "S",
            "probability": 6.109476089477539e-05
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -5.46875,
            "text": "55 S, consisting of 39 S large and 28 S small subunits.",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -6.75390625,
            "text": "55 S, consisting of 39 S large and 28 S",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -6.84765625,
            "end_logit": 7.90234375,
            "text": "The mammalian mitochondrial ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55 S",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.9765625,
            "end_logit": 7.90234375,
            "text": "mitochondrial ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55 S",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 7.90234375,
            "text": "small sedimentation coefficient of 55 S",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.37890625,
            "text": "55 S, consisting of 39 S",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.42578125,
            "text": "55 S,",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.48828125,
            "text": "55 S, consisting of 39 S large and 28 S small subunits",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.53125,
            "text": "55 S, consisting",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2734375,
            "end_logit": 7.90234375,
            "text": "sedimentation coefficient of 55 S",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.54296875,
            "text": "55 S, consisting of 39 S large and 28",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.625,
            "text": "55 S, consisting of 39 S large and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.3828125,
            "end_logit": 7.90234375,
            "text": "a small sedimentation coefficient of 55 S",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.90234375,
            "text": "mammalian mitochondrial ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55 S",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 7.90234375,
            "text": "ribosome (mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55 S",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 7.90234375,
            "text": "mitoribosome) has a highly protein-rich composition with a small sedimentation coefficient of 55 S",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 7.90234375,
            "text": "composition with a small sedimentation coefficient of 55 S",
            "probability": 1.1920928955078125e-07
        }
    ],
    "55201a316b348bb82c000019_2": [
        {
            "start_logit": 8.203125,
            "end_logit": 6.9921875,
            "text": "55 S",
            "probability": 0.9990234375
        },
        {
            "start_logit": 8.203125,
            "end_logit": 0.0885009765625,
            "text": "55",
            "probability": 0.0010004043579101562
        },
        {
            "start_logit": -3.283203125,
            "end_logit": 6.9921875,
            "text": "S",
            "probability": 1.0311603546142578e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.8125,
            "text": "55 S mammalian mitochondrial ribosome",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.18359375,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.1953125,
            "text": "55 S mammalian mitochondrial ribosome (referred to",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.29296875,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.38671875,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.38671875,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.46484375,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich, containing nearly twice as much protein as",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.47265625,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.50390625,
            "text": "55 S mammalian mitochondrial ribosome (",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.515625,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich,",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5625,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.58203125,
            "text": "55 S mammalian mitochondrial ribosome (referred to hereafter as \"mitoribosome\") is protein-rich, containing nearly twice",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 6.9921875,
            "text": "The 55 S",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 0.0885009765625,
            "text": "The 55",
            "probability": 0.0
        },
        {
            "start_logit": -3.283203125,
            "end_logit": -6.8125,
            "text": "S mammalian mitochondrial ribosome",
            "probability": 0.0
        },
        {
            "start_logit": -3.283203125,
            "end_logit": -7.18359375,
            "text": "S mammalian mitochondrial ribosome (referred to hereafter",
            "probability": 0.0
        },
        {
            "start_logit": -3.283203125,
            "end_logit": -7.1953125,
            "text": "S mammalian mitochondrial ribosome (referred to",
            "probability": 0.0
        }
    ],
    "55201a316b348bb82c000019_3": [
        {
            "start_logit": 8.140625,
            "end_logit": 7.90625,
            "text": "55 S",
            "probability": 1.0
        },
        {
            "start_logit": 8.140625,
            "end_logit": -1.3623046875,
            "text": "55",
            "probability": 9.459257125854492e-05
        },
        {
            "start_logit": -1.8046875,
            "end_logit": 7.90625,
            "text": "S",
            "probability": 4.792213439941406e-05
        },
        {
            "start_logit": -6.8671875,
            "end_logit": 7.90625,
            "text": "The sedimentation coefficient of the intact monosome was about 55 S",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.015625,
            "end_logit": 7.90625,
            "text": "about 55 S",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.1484375,
            "end_logit": 7.90625,
            "text": "intact monosome was about 55 S",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 7.90625,
            "text": "monosome was about 55 S",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.140625,
            "end_logit": -7.55078125,
            "text": "55 S.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.33203125,
            "end_logit": 7.90625,
            "text": "ome was about 55 S",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 7.90625,
            "text": "the intact monosome was about 55 S",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.4140625,
            "end_logit": 7.90625,
            "text": "sedimentation coefficient of the intact monosome was about 55 S",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.48828125,
            "end_logit": 7.90625,
            "text": "was about 55 S",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 7.90625,
            "text": "of the intact monosome was about 55 S",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 7.90625,
            "text": "coefficient of the intact monosome was about 55 S",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.8671875,
            "end_logit": -1.3623046875,
            "text": "The sedimentation coefficient of the intact monosome was about 55",
            "probability": 0.0
        },
        {
            "start_logit": -7.015625,
            "end_logit": -1.3623046875,
            "text": "about 55",
            "probability": 0.0
        },
        {
            "start_logit": -7.1484375,
            "end_logit": -1.3623046875,
            "text": "intact monosome was about 55",
            "probability": 0.0
        },
        {
            "start_logit": -7.21484375,
            "end_logit": -1.3623046875,
            "text": "monosome was about 55",
            "probability": 0.0
        },
        {
            "start_logit": -7.33203125,
            "end_logit": -1.3623046875,
            "text": "ome was about 55",
            "probability": 0.0
        },
        {
            "start_logit": -7.41015625,
            "end_logit": -1.3623046875,
            "text": "the intact monosome was about 55",
            "probability": 0.0
        }
    ],
    "5e2a1096aa19d7443100000e_1": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.140625,
            "text": "vascular endothelial growth factor A",
            "probability": 1.0
        },
        {
            "start_logit": -1.03515625,
            "end_logit": 8.140625,
            "text": "A",
            "probability": 9.459257125854492e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.291015625,
            "text": "vascular",
            "probability": 8.028745651245117e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -5.4921875,
            "text": "vascular endothelial growth factor",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -5.46875,
            "end_logit": 8.140625,
            "text": "endothelial growth factor A",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": 8.234375,
            "end_logit": -5.6953125,
            "text": "vascular endothelial growth factor A (VEGF-A",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": -5.83984375,
            "end_logit": 8.140625,
            "text": "growth factor A",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 8.140625,
            "text": "factor A",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.0703125,
            "text": "vascular endothelial growth factor A (VEGF-",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.125,
            "text": "vascular endothelial growth factor A (VEGF-A)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.24609375,
            "text": "vascular endothelial",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.359375,
            "text": "vascular endothelial growth factor A (VEGF",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.37890625,
            "text": "vascular endothelial growth",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4296875,
            "text": "vascular endothelial growth factor A (VEGF-A),",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.37109375,
            "end_logit": 8.140625,
            "text": "modified mRNA encoding vascular endothelial growth factor A",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.375,
            "end_logit": 8.140625,
            "text": "Here, we longitudinally and comprehensively characterize microvascular responses to AZD8601, a modified mRNA encoding vascular endothelial growth factor A",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.48046875,
            "text": "vascular endothelial growth factor A (",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4921875,
            "text": "vascular endothelial growth factor A (VEGF-A), in vivo.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.484375,
            "end_logit": 8.140625,
            "text": ", we longitudinally and comprehensively characterize microvascular responses to AZD8601, a modified mRNA encoding vascular endothelial growth factor A",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.62109375,
            "text": "vascular endothelial growth factor A (VEGF-A), in",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5caa0247ecadf2e73f000055_1": [
        {
            "start_logit": 5.54296875,
            "end_logit": 3.095703125,
            "text": "moesin (Moe)",
            "probability": 0.9150390625
        },
        {
            "start_logit": 5.54296875,
            "end_logit": 0.07763671875,
            "text": "moesin (Moe).",
            "probability": 0.044677734375
        },
        {
            "start_logit": 5.54296875,
            "end_logit": -0.050018310546875,
            "text": "moesin",
            "probability": 0.039276123046875
        },
        {
            "start_logit": 5.54296875,
            "end_logit": -4.8984375,
            "text": "moesin (Mo",
            "probability": 0.0003082752227783203
        },
        {
            "start_logit": 5.54296875,
            "end_logit": -5.234375,
            "text": "mo",
            "probability": 0.00022113323211669922
        },
        {
            "start_logit": 5.54296875,
            "end_logit": -5.60546875,
            "text": "moesin (Moe",
            "probability": 0.0001519918441772461
        },
        {
            "start_logit": -1.408203125,
            "end_logit": 0.07763671875,
            "text": ".",
            "probability": 4.285573959350586e-05
        },
        {
            "start_logit": 5.54296875,
            "end_logit": -7.1796875,
            "text": "moesin (",
            "probability": 3.135204315185547e-05
        },
        {
            "start_logit": -5.04296875,
            "end_logit": 3.095703125,
            "text": "(Moe)",
            "probability": 2.3126602172851562e-05
        },
        {
            "start_logit": -5.640625,
            "end_logit": 3.095703125,
            "text": "Crb recruitment of moesin (Moe)",
            "probability": 1.2636184692382812e-05
        },
        {
            "start_logit": -5.79296875,
            "end_logit": 3.095703125,
            "text": ")",
            "probability": 1.0907649993896484e-05
        },
        {
            "start_logit": -6.73828125,
            "end_logit": 3.095703125,
            "text": "by Crb recruitment of moesin (Moe)",
            "probability": 4.231929779052734e-06
        },
        {
            "start_logit": -6.765625,
            "end_logit": 3.095703125,
            "text": "propose is mediated by Crb recruitment of moesin (Moe)",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": -6.8984375,
            "end_logit": 3.095703125,
            "text": "actomyosin complex, which we propose is mediated by Crb recruitment of moesin (Moe)",
            "probability": 3.5762786865234375e-06
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 3.095703125,
            "text": "of moesin (Moe)",
            "probability": 3.337860107421875e-06
        },
        {
            "start_logit": -7.05859375,
            "end_logit": 3.095703125,
            "text": "b recruitment of moesin (Moe)",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": -5.04296875,
            "end_logit": 0.07763671875,
            "text": "(Moe).",
            "probability": 1.1324882507324219e-06
        },
        {
            "start_logit": -5.640625,
            "end_logit": 0.07763671875,
            "text": "Crb recruitment of moesin (Moe).",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -5.640625,
            "end_logit": -0.050018310546875,
            "text": "Crb recruitment of moesin",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": -5.79296875,
            "end_logit": 0.07763671875,
            "text": ").",
            "probability": 5.364418029785156e-07
        }
    ],
    "5e4604d83f54159529000003_1": [
        {
            "start_logit": 5.53515625,
            "end_logit": 8.078125,
            "text": "carotid and vertebral artery dissection",
            "probability": 0.9990234375
        },
        {
            "start_logit": -1.3046875,
            "end_logit": 8.078125,
            "text": "dissection",
            "probability": 0.0010738372802734375
        },
        {
            "start_logit": -6.01953125,
            "end_logit": 8.078125,
            "text": "artery dissection",
            "probability": 9.655952453613281e-06
        },
        {
            "start_logit": -6.43359375,
            "end_logit": 8.078125,
            "text": "vertebral artery dissection",
            "probability": 6.318092346191406e-06
        },
        {
            "start_logit": -6.74609375,
            "end_logit": 8.078125,
            "text": ") carotid and vertebral artery dissection",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -6.87890625,
            "end_logit": 8.078125,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 4.112720489501953e-06
        },
        {
            "start_logit": -7.21875,
            "end_logit": 8.078125,
            "text": "CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 2.9206275939941406e-06
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -4.7265625,
            "text": "carotid",
            "probability": 2.7418136596679688e-06
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.078125,
            "text": "in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 2.384185791015625e-06
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.078125,
            "text": "AIMS: CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 2.0265579223632812e-06
        },
        {
            "start_logit": -7.640625,
            "end_logit": 8.078125,
            "text": "randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -7.64453125,
            "end_logit": 8.078125,
            "text": ": CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 8.078125,
            "text": "prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -7.78125,
            "end_logit": 8.078125,
            "text": "multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.6689300537109375e-06
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 8.078125,
            "text": "days of onset) carotid and vertebral artery dissection",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 8.078125,
            "text": "a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -6.40625,
            "text": "carotid and vertebral artery dissection.",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 5.53515625,
            "end_logit": -7.5703125,
            "text": "carotid and",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -1.3046875,
            "end_logit": -6.40625,
            "text": "dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -6.74609375,
            "end_logit": -4.7265625,
            "text": ") carotid",
            "probability": 0.0
        }
    ],
    "5e4604d83f54159529000003_2": [
        {
            "start_logit": 6.38671875,
            "end_logit": 8.109375,
            "text": "carotid and vertebral artery dissection",
            "probability": 0.9990234375
        },
        {
            "start_logit": -1.28125,
            "end_logit": 8.109375,
            "text": "dissection",
            "probability": 0.00046515464782714844
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -3.994140625,
            "text": "carotid",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": -5.89453125,
            "end_logit": 8.109375,
            "text": "artery dissection",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 8.109375,
            "text": "vertebral artery dissection",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 8.109375,
            "text": ") carotid and vertebral artery dissection",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 8.109375,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 8.109375,
            "text": "CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.359375,
            "end_logit": 8.109375,
            "text": "AIMS  CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.40625,
            "end_logit": 8.109375,
            "text": "in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 8.109375,
            "text": "randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 8.109375,
            "text": "and vertebral artery dissection",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 8.109375,
            "text": "prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.109375,
            "text": "multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 8.109375,
            "text": "days of onset) carotid and vertebral artery dissection",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -6.41796875,
            "text": "carotid and vertebral artery dissection.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -7.73046875,
            "text": "carotid and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.28125,
            "end_logit": -6.41796875,
            "text": "dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -6.77734375,
            "end_logit": -3.994140625,
            "text": ") carotid",
            "probability": 0.0
        },
        {
            "start_logit": -6.98828125,
            "end_logit": -3.994140625,
            "text": "acute (within 7 days of onset) carotid",
            "probability": 0.0
        }
    ],
    "5e4604d83f54159529000003_3": [
        {
            "start_logit": 6.38671875,
            "end_logit": 8.109375,
            "text": "carotid and vertebral artery dissection",
            "probability": 0.9990234375
        },
        {
            "start_logit": -1.28125,
            "end_logit": 8.109375,
            "text": "dissection",
            "probability": 0.00046515464782714844
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -3.994140625,
            "text": "carotid",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": -5.89453125,
            "end_logit": 8.109375,
            "text": "artery dissection",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 8.109375,
            "text": "vertebral artery dissection",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 8.109375,
            "text": ") carotid and vertebral artery dissection",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 8.109375,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 8.109375,
            "text": "CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.359375,
            "end_logit": 8.109375,
            "text": "AIMS CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.40625,
            "end_logit": 8.109375,
            "text": "in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 8.109375,
            "text": "randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 8.109375,
            "text": "and vertebral artery dissection",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 8.109375,
            "text": "prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.109375,
            "text": "multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 8.109375,
            "text": "days of onset) carotid and vertebral artery dissection",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -6.41796875,
            "text": "carotid and vertebral artery dissection.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -7.73046875,
            "text": "carotid and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.28125,
            "end_logit": -6.41796875,
            "text": "dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -6.77734375,
            "end_logit": -3.994140625,
            "text": ") carotid",
            "probability": 0.0
        },
        {
            "start_logit": -6.98828125,
            "end_logit": -3.994140625,
            "text": "acute (within 7 days of onset) carotid",
            "probability": 0.0
        }
    ],
    "5e4604d83f54159529000003_4": [
        {
            "start_logit": 6.38671875,
            "end_logit": 8.109375,
            "text": "carotid and vertebral artery dissection",
            "probability": 0.9990234375
        },
        {
            "start_logit": -1.28125,
            "end_logit": 8.109375,
            "text": "dissection",
            "probability": 0.00046515464782714844
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -3.994140625,
            "text": "carotid",
            "probability": 5.4836273193359375e-06
        },
        {
            "start_logit": -5.89453125,
            "end_logit": 8.109375,
            "text": "artery dissection",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": -6.47265625,
            "end_logit": 8.109375,
            "text": "vertebral artery dissection",
            "probability": 2.6226043701171875e-06
        },
        {
            "start_logit": -6.77734375,
            "end_logit": 8.109375,
            "text": ") carotid and vertebral artery dissection",
            "probability": 1.9073486328125e-06
        },
        {
            "start_logit": -6.98828125,
            "end_logit": 8.109375,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.10546875,
            "end_logit": 8.109375,
            "text": "CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.3709068298339844e-06
        },
        {
            "start_logit": -7.359375,
            "end_logit": 8.109375,
            "text": "AIMS CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": -7.40625,
            "end_logit": 8.109375,
            "text": "in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": -7.7734375,
            "end_logit": 8.109375,
            "text": "randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 8.109375,
            "text": "and vertebral artery dissection",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 8.109375,
            "text": "prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.109375,
            "text": "multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 8.109375,
            "text": "days of onset) carotid and vertebral artery dissection",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -6.41796875,
            "text": "carotid and vertebral artery dissection.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 6.38671875,
            "end_logit": -7.73046875,
            "text": "carotid and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.28125,
            "end_logit": -6.41796875,
            "text": "dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -6.77734375,
            "end_logit": -3.994140625,
            "text": ") carotid",
            "probability": 0.0
        },
        {
            "start_logit": -6.98828125,
            "end_logit": -3.994140625,
            "text": "acute (within 7 days of onset) carotid",
            "probability": 0.0
        }
    ],
    "5e4604d83f54159529000003_5": [
        {
            "start_logit": 7.21484375,
            "end_logit": 8.1484375,
            "text": "carotid and vertebral artery dissection",
            "probability": 1.0
        },
        {
            "start_logit": -1.232421875,
            "end_logit": 8.1484375,
            "text": "dissection",
            "probability": 0.0002149343490600586
        },
        {
            "start_logit": 7.21484375,
            "end_logit": -3.158203125,
            "text": "carotid",
            "probability": 1.233816146850586e-05
        },
        {
            "start_logit": -5.9765625,
            "end_logit": 8.1484375,
            "text": "artery dissection",
            "probability": 1.8477439880371094e-06
        },
        {
            "start_logit": -6.37890625,
            "end_logit": 8.1484375,
            "text": "vertebral artery dissection",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": -6.84765625,
            "end_logit": 8.1484375,
            "text": ") carotid and vertebral artery dissection",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 8.1484375,
            "text": "CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.09375,
            "end_logit": 8.1484375,
            "text": "acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 7.21484375,
            "end_logit": -6.359375,
            "text": "carotid and vertebral artery dissection.",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 8.1484375,
            "text": "and vertebral artery dissection",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.4609375,
            "end_logit": 8.1484375,
            "text": "in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 8.1484375,
            "text": "randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 8.1484375,
            "text": "prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 8.1484375,
            "text": "a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 8.1484375,
            "text": "multicentre randomised-controlled trial in acute (within 7 days of onset) carotid and vertebral artery dissection",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -1.232421875,
            "end_logit": -6.359375,
            "text": "dissection.",
            "probability": 0.0
        },
        {
            "start_logit": -6.84765625,
            "end_logit": -3.158203125,
            "text": ") carotid",
            "probability": 0.0
        },
        {
            "start_logit": -7.06640625,
            "end_logit": -3.158203125,
            "text": "CADISS is a prospective multicentre randomised-controlled trial in acute (within 7 days of onset) carotid",
            "probability": 0.0
        },
        {
            "start_logit": -7.09375,
            "end_logit": -3.158203125,
            "text": "acute (within 7 days of onset) carotid",
            "probability": 0.0
        },
        {
            "start_logit": -7.4609375,
            "end_logit": -3.158203125,
            "text": "in acute (within 7 days of onset) carotid",
            "probability": 0.0
        }
    ],
    "56c073fcef6e394741000020_1": [
        {
            "start_logit": 5.94921875,
            "end_logit": 5.17578125,
            "text": "Spermidine protects against \u03b1-synuclein neurotoxicity.",
            "probability": 1.0
        },
        {
            "start_logit": 5.94921875,
            "end_logit": -3.544921875,
            "text": "Spermidine",
            "probability": 0.0001634359359741211
        },
        {
            "start_logit": -3.416015625,
            "end_logit": 5.17578125,
            "text": ".",
            "probability": 8.547306060791016e-05
        },
        {
            "start_logit": -5.65234375,
            "end_logit": 5.17578125,
            "text": "protects against \u03b1-synuclein neurotoxicity.",
            "probability": 9.179115295410156e-06
        },
        {
            "start_logit": 5.94921875,
            "end_logit": -6.8828125,
            "text": "Spermidine protects against",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": 5.94921875,
            "end_logit": -7.0234375,
            "text": "Spermidine protects",
            "probability": 5.0067901611328125e-06
        },
        {
            "start_logit": 5.94921875,
            "end_logit": -7.3359375,
            "text": "Spermidine protects against \u03b1-synuclein",
            "probability": 3.6954879760742188e-06
        },
        {
            "start_logit": 5.94921875,
            "end_logit": -7.515625,
            "text": "Spermidine protects against \u03b1-synuclein neurotoxicity",
            "probability": 3.0994415283203125e-06
        },
        {
            "start_logit": 5.94921875,
            "end_logit": -7.66015625,
            "text": "Spermidine protects against \u03b1-",
            "probability": 2.682209014892578e-06
        },
        {
            "start_logit": -7.06640625,
            "end_logit": 5.17578125,
            "text": "\u03b1-synuclein neurotoxicity.",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": -7.3984375,
            "end_logit": 5.17578125,
            "text": "synuclein neurotoxicity.",
            "probability": 1.6093254089355469e-06
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 5.17578125,
            "text": "neurotoxicity.",
            "probability": 1.4901161193847656e-06
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 5.17578125,
            "text": "-synuclein neurotoxicity.",
            "probability": 1.430511474609375e-06
        },
        {
            "start_logit": -5.65234375,
            "end_logit": -6.8828125,
            "text": "protects against",
            "probability": 0.0
        },
        {
            "start_logit": -5.65234375,
            "end_logit": -7.0234375,
            "text": "protects",
            "probability": 0.0
        },
        {
            "start_logit": -5.65234375,
            "end_logit": -7.3359375,
            "text": "protects against \u03b1-synuclein",
            "probability": 0.0
        },
        {
            "start_logit": -5.65234375,
            "end_logit": -7.515625,
            "text": "protects against \u03b1-synuclein neurotoxicity",
            "probability": 0.0
        },
        {
            "start_logit": -5.65234375,
            "end_logit": -7.66015625,
            "text": "protects against \u03b1-",
            "probability": 0.0
        },
        {
            "start_logit": -7.06640625,
            "end_logit": -7.3359375,
            "text": "\u03b1-synuclein",
            "probability": 0.0
        },
        {
            "start_logit": -7.06640625,
            "end_logit": -7.515625,
            "text": "\u03b1-synuclein neurotoxicity",
            "probability": 0.0
        }
    ],
    "56c073fcef6e394741000020_2": [
        {
            "start_logit": -3.966796875,
            "end_logit": -5.8984375,
            "text": "Spermidine protects against \u03b1-synuclein neurotoxicity",
            "probability": 0.447265625
        },
        {
            "start_logit": -3.966796875,
            "end_logit": -7.109375,
            "text": "Spermidine protects",
            "probability": 0.1331787109375
        },
        {
            "start_logit": -3.966796875,
            "end_logit": -7.37890625,
            "text": "Spermidine protects against \u03b1-synuclein",
            "probability": 0.10211181640625
        },
        {
            "start_logit": -3.966796875,
            "end_logit": -7.390625,
            "text": "Spermidine protects against",
            "probability": 0.10052490234375
        },
        {
            "start_logit": -3.966796875,
            "end_logit": -7.83203125,
            "text": "Spermidine protects against \u03b1-",
            "probability": 0.06488037109375
        },
        {
            "start_logit": -6.25,
            "end_logit": -5.8984375,
            "text": "protects against \u03b1-synuclein neurotoxicity",
            "probability": 0.045684814453125
        },
        {
            "start_logit": -7.19921875,
            "end_logit": -5.8984375,
            "text": "\u03b1-synuclein neurotoxicity",
            "probability": 0.01776123046875
        },
        {
            "start_logit": -6.25,
            "end_logit": -7.109375,
            "text": "protects",
            "probability": 0.01361083984375
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -5.8984375,
            "text": "-synuclein neurotoxicity",
            "probability": 0.0118255615234375
        },
        {
            "start_logit": -6.25,
            "end_logit": -7.37890625,
            "text": "protects against \u03b1-synuclein",
            "probability": 0.01042938232421875
        },
        {
            "start_logit": -6.25,
            "end_logit": -7.390625,
            "text": "protects against",
            "probability": 0.01027679443359375
        },
        {
            "start_logit": -7.76171875,
            "end_logit": -5.8984375,
            "text": "synuclein neurotoxicity",
            "probability": 0.01010894775390625
        },
        {
            "start_logit": -7.79296875,
            "end_logit": -5.8984375,
            "text": "against \u03b1-synuclein neurotoxicity",
            "probability": 0.00980377197265625
        },
        {
            "start_logit": -6.25,
            "end_logit": -7.83203125,
            "text": "protects against \u03b1-",
            "probability": 0.006633758544921875
        },
        {
            "start_logit": -7.19921875,
            "end_logit": -7.37890625,
            "text": "\u03b1-synuclein",
            "probability": 0.00402069091796875
        },
        {
            "start_logit": -7.60546875,
            "end_logit": -7.37890625,
            "text": "-synuclein",
            "probability": 0.0026798248291015625
        },
        {
            "start_logit": -7.19921875,
            "end_logit": -7.83203125,
            "text": "\u03b1-",
            "probability": 0.0025577545166015625
        },
        {
            "start_logit": -7.76171875,
            "end_logit": -7.37890625,
            "text": "synuclein",
            "probability": 0.002292633056640625
        },
        {
            "start_logit": -7.79296875,
            "end_logit": -7.37890625,
            "text": "against \u03b1-synuclein",
            "probability": 0.00222015380859375
        },
        {
            "start_logit": -7.79296875,
            "end_logit": -7.390625,
            "text": "against",
            "probability": 0.0021877288818359375
        }
    ],
    "606074ab94d57fd87900003e_1": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1875,
            "text": "Rtpca",
            "probability": 1.0
        },
        {
            "start_logit": -1.0,
            "end_logit": 8.1875,
            "text": "a",
            "probability": 9.918212890625e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.2158203125,
            "text": "Rt",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": -6.42578125,
            "end_logit": 8.1875,
            "text": "pca",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.80859375,
            "text": "Rtpc",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.2109375,
            "text": "Rtpca: an R package",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.2734375,
            "text": "Rtpca: an R",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.515625,
            "text": "Rtpca: an R package for differential thermal proximity coaggregation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.609375,
            "text": "Rtpca: an R package for differential thermal proximity coaggreg",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.62109375,
            "text": "Rtpca: an R package for differential thermal proximity coaggregation analysis",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.640625,
            "text": "Rtpca:",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.671875,
            "text": "Rtpca: an R package for differential thermal proximity coaggr",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.71875,
            "text": "Rtpca: an",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.0,
            "end_logit": -7.2109375,
            "text": "a: an R package",
            "probability": 0.0
        },
        {
            "start_logit": -1.0,
            "end_logit": -7.2734375,
            "text": "a: an R",
            "probability": 0.0
        },
        {
            "start_logit": -1.0,
            "end_logit": -7.515625,
            "text": "a: an R package for differential thermal proximity coaggregation",
            "probability": 0.0
        },
        {
            "start_logit": -1.0,
            "end_logit": -7.609375,
            "text": "a: an R package for differential thermal proximity coaggreg",
            "probability": 0.0
        },
        {
            "start_logit": -1.0,
            "end_logit": -7.62109375,
            "text": "a: an R package for differential thermal proximity coaggregation analysis",
            "probability": 0.0
        },
        {
            "start_logit": -1.0,
            "end_logit": -7.640625,
            "text": "a:",
            "probability": 0.0
        },
        {
            "start_logit": -1.0,
            "end_logit": -7.671875,
            "text": "a: an R package for differential thermal proximity coaggr",
            "probability": 0.0
        }
    ],
    "606074ab94d57fd87900003e_2": [
        {
            "start_logit": 8.2890625,
            "end_logit": 8.2109375,
            "text": "Rtpca",
            "probability": 0.25
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 8.203125,
            "text": "Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rtpca",
            "probability": 0.25
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 8.203125,
            "text": "Rtpca",
            "probability": 0.25
        },
        {
            "start_logit": 8.28125,
            "end_logit": 8.21875,
            "text": "Rtpca",
            "probability": 0.25
        },
        {
            "start_logit": -0.48974609375,
            "end_logit": 8.2109375,
            "text": "a",
            "probability": 3.838539123535156e-05
        },
        {
            "start_logit": -0.484375,
            "end_logit": 8.203125,
            "text": "a",
            "probability": 3.838539123535156e-05
        },
        {
            "start_logit": -0.48974609375,
            "end_logit": 8.203125,
            "text": "a is available from Bioconductor (https://bioconductor.org/packages/Rtpca",
            "probability": 3.838539123535156e-05
        },
        {
            "start_logit": -0.5078125,
            "end_logit": 8.21875,
            "text": "a",
            "probability": 3.808736801147461e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.818359375,
            "text": "Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rt",
            "probability": 2.9921531677246094e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.818359375,
            "text": "Rt",
            "probability": 2.9921531677246094e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.82763671875,
            "text": "Rt",
            "probability": 2.968311309814453e-05
        },
        {
            "start_logit": 8.28125,
            "end_logit": -0.8759765625,
            "text": "Rt",
            "probability": 2.8073787689208984e-05
        },
        {
            "start_logit": -5.47265625,
            "end_logit": 8.2109375,
            "text": ".AVAILABILITY: Rtpca",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.47265625,
            "end_logit": 8.203125,
            "text": ".AVAILABILITY: Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rtpca",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -5.80078125,
            "text": "Rtpc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -5.859375,
            "text": "Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rtpc",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -5.859375,
            "text": "Rtpc",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -5.8515625,
            "text": "Rtpca is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -6.140625,
            "text": "Rtpc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.2109375,
            "end_logit": 8.203125,
            "text": "pca",
            "probability": 1.1920928955078125e-07
        }
    ],
    "606074ab94d57fd87900003e_3": [
        {
            "start_logit": 8.2890625,
            "end_logit": 8.2109375,
            "text": "Rtpca",
            "probability": 0.25
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 8.203125,
            "text": "Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rtpca",
            "probability": 0.25
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 8.203125,
            "text": "Rtpca",
            "probability": 0.25
        },
        {
            "start_logit": 8.28125,
            "end_logit": 8.21875,
            "text": "Rtpca",
            "probability": 0.25
        },
        {
            "start_logit": -0.48974609375,
            "end_logit": 8.2109375,
            "text": "a",
            "probability": 3.838539123535156e-05
        },
        {
            "start_logit": -0.484375,
            "end_logit": 8.203125,
            "text": "a",
            "probability": 3.838539123535156e-05
        },
        {
            "start_logit": -0.48974609375,
            "end_logit": 8.203125,
            "text": "a is available from Bioconductor (https://bioconductor.org/packages/Rtpca",
            "probability": 3.838539123535156e-05
        },
        {
            "start_logit": -0.5078125,
            "end_logit": 8.21875,
            "text": "a",
            "probability": 3.808736801147461e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.818359375,
            "text": "Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rt",
            "probability": 2.9921531677246094e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.818359375,
            "text": "Rt",
            "probability": 2.9921531677246094e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.82763671875,
            "text": "Rt",
            "probability": 2.968311309814453e-05
        },
        {
            "start_logit": 8.28125,
            "end_logit": -0.8759765625,
            "text": "Rt",
            "probability": 2.8073787689208984e-05
        },
        {
            "start_logit": -5.47265625,
            "end_logit": 8.2109375,
            "text": ".AVAILABILITY: Rtpca",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.47265625,
            "end_logit": 8.203125,
            "text": ".AVAILABILITY: Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rtpca",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -5.80078125,
            "text": "Rtpc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -5.859375,
            "text": "Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rtpc",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -5.859375,
            "text": "Rtpc",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -5.8515625,
            "text": "Rtpca is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -6.140625,
            "text": "Rtpc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.2109375,
            "end_logit": 8.203125,
            "text": "pca",
            "probability": 1.1920928955078125e-07
        }
    ],
    "606074ab94d57fd87900003e_4": [
        {
            "start_logit": 8.2890625,
            "end_logit": 8.2109375,
            "text": "Rtpca",
            "probability": 0.25
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 8.203125,
            "text": "Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rtpca",
            "probability": 0.25
        },
        {
            "start_logit": 8.2890625,
            "end_logit": 8.203125,
            "text": "Rtpca",
            "probability": 0.25
        },
        {
            "start_logit": 8.28125,
            "end_logit": 8.21875,
            "text": "Rtpca",
            "probability": 0.25
        },
        {
            "start_logit": -0.48974609375,
            "end_logit": 8.2109375,
            "text": "a",
            "probability": 3.838539123535156e-05
        },
        {
            "start_logit": -0.484375,
            "end_logit": 8.203125,
            "text": "a",
            "probability": 3.838539123535156e-05
        },
        {
            "start_logit": -0.48974609375,
            "end_logit": 8.203125,
            "text": "a is available from Bioconductor (https://bioconductor.org/packages/Rtpca",
            "probability": 3.838539123535156e-05
        },
        {
            "start_logit": -0.5078125,
            "end_logit": 8.21875,
            "text": "a",
            "probability": 3.808736801147461e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.818359375,
            "text": "Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rt",
            "probability": 2.9921531677246094e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.818359375,
            "text": "Rt",
            "probability": 2.9921531677246094e-05
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -0.82763671875,
            "text": "Rt",
            "probability": 2.968311309814453e-05
        },
        {
            "start_logit": 8.28125,
            "end_logit": -0.8759765625,
            "text": "Rt",
            "probability": 2.8073787689208984e-05
        },
        {
            "start_logit": -5.47265625,
            "end_logit": 8.2109375,
            "text": ".AVAILABILITY: Rtpca",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -5.47265625,
            "end_logit": 8.203125,
            "text": ".AVAILABILITY: Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rtpca",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -5.80078125,
            "text": "Rtpc",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -5.859375,
            "text": "Rtpca is available from Bioconductor (https://bioconductor.org/packages/Rtpc",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2890625,
            "end_logit": -5.859375,
            "text": "Rtpc",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -5.8515625,
            "text": "Rtpca is",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.28125,
            "end_logit": -6.140625,
            "text": "Rtpc",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.2109375,
            "end_logit": 8.203125,
            "text": "pca",
            "probability": 1.1920928955078125e-07
        }
    ],
    "513ce494bee46bd34c000009_1": [
        {
            "start_logit": 7.80859375,
            "end_logit": 7.40625,
            "text": "autosomal recessive polycystic kidney disease",
            "probability": 1.0
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -2.353515625,
            "text": "autosomal",
            "probability": 5.739927291870117e-05
        },
        {
            "start_logit": -2.912109375,
            "end_logit": 7.40625,
            "text": "disease",
            "probability": 2.193450927734375e-05
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -4.3125,
            "text": "autosomal recessive polycystic kidney disease (",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": -4.46875,
            "end_logit": 7.40625,
            "text": "polycystic kidney disease",
            "probability": 4.649162292480469e-06
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -5.25390625,
            "text": "autosomal recessive polycystic kidney disease (PKD",
            "probability": 3.159046173095703e-06
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -6.35546875,
            "text": "autosomal recessive",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -6.453125,
            "text": "autosomal recessive polycystic kidney disease (PK",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -6.84375,
            "text": "autosomal recessive polycystic kidney disease (PKD)",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -7.171875,
            "text": "autosomal recessive polycystic kidney",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 7.80859375,
            "end_logit": -7.50390625,
            "text": "autosomal recessive polycystic",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 7.40625,
            "text": "of autosomal recessive polycystic kidney disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.28515625,
            "end_logit": 7.40625,
            "text": "kidney disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.3125,
            "end_logit": 7.40625,
            "text": "development of autosomal recessive polycystic kidney disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 7.40625,
            "text": "malformation of primary cilia, and in the collecting ducts of kidney tubules this is accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 7.40625,
            "text": "recessive polycystic kidney disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 7.40625,
            "text": "kidney tubules this is accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 7.40625,
            "text": "accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 7.40625,
            "text": "in the collecting ducts of kidney tubules this is accompanied by development of autosomal recessive polycystic kidney disease",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -2.912109375,
            "end_logit": -4.3125,
            "text": "disease (",
            "probability": 0.0
        }
    ],
    "5a885daa61bb38fb24000018_1": [
        {
            "start_logit": 4.984375,
            "end_logit": 1.8525390625,
            "text": "DEAD box proteins are putative RNA helicases that have been implicated in cellular processes involving alteration of RNA secondary structure, such as translation initiation and splicing.",
            "probability": 0.58935546875
        },
        {
            "start_logit": 4.984375,
            "end_logit": 0.72412109375,
            "text": "DEAD box proteins are putative RNA helicase",
            "probability": 0.1905517578125
        },
        {
            "start_logit": 1.189453125,
            "end_logit": 4.22265625,
            "text": "Asp(D)-Glu-(E)-Ala(A)-Asp(D)",
            "probability": 0.14208984375
        },
        {
            "start_logit": 0.285888671875,
            "end_logit": 4.22265625,
            "text": "eight conserved amino acid motifs, including Asp(D)-Glu-(E)-Ala(A)-Asp(D)",
            "probability": 0.05743408203125
        },
        {
            "start_logit": 1.189453125,
            "end_logit": 1.8525390625,
            "text": "Asp(D)-Glu-(E)-Ala(A)-Asp(D) which is part of a more extended motif.",
            "probability": 0.01326751708984375
        },
        {
            "start_logit": 0.285888671875,
            "end_logit": 1.3271484375,
            "text": "eight",
            "probability": 0.003177642822265625
        },
        {
            "start_logit": 4.984375,
            "end_logit": -4.79296875,
            "text": "DEAD",
            "probability": 0.0007662773132324219
        },
        {
            "start_logit": -4.1640625,
            "end_logit": 4.22265625,
            "text": "including Asp(D)-Glu-(E)-Ala(A)-Asp(D)",
            "probability": 0.00067138671875
        },
        {
            "start_logit": -2.109375,
            "end_logit": 1.8525390625,
            "text": ".",
            "probability": 0.0004892349243164062
        },
        {
            "start_logit": -2.111328125,
            "end_logit": 1.8525390625,
            "text": ".",
            "probability": 0.0004892349243164062
        },
        {
            "start_logit": 4.984375,
            "end_logit": -5.59375,
            "text": "DEAD box proteins are putative RNA helicases",
            "probability": 0.0003440380096435547
        },
        {
            "start_logit": -2.513671875,
            "end_logit": 1.8525390625,
            "text": "RNA helicases that have been implicated in cellular processes involving alteration of RNA secondary structure, such as translation initiation and splicing.",
            "probability": 0.00032711029052734375
        },
        {
            "start_logit": -4.921875,
            "end_logit": 4.22265625,
            "text": ")",
            "probability": 0.0003147125244140625
        },
        {
            "start_logit": -2.111328125,
            "end_logit": 1.3271484375,
            "text": ". These proteins share eight",
            "probability": 0.0002887248992919922
        },
        {
            "start_logit": -2.513671875,
            "end_logit": 1.3271484375,
            "text": "RNA helicases that have been implicated in cellular processes involving alteration of RNA secondary structure, such as translation initiation and splicing. These proteins share eight",
            "probability": 0.00019299983978271484
        },
        {
            "start_logit": -2.513671875,
            "end_logit": 0.72412109375,
            "text": "RNA helicase",
            "probability": 0.00010579824447631836
        },
        {
            "start_logit": 1.189453125,
            "end_logit": -3.30078125,
            "text": "Asp(D)-Glu-(E)-Ala(A)-Asp",
            "probability": 7.677078247070312e-05
        },
        {
            "start_logit": -6.5234375,
            "end_logit": 4.22265625,
            "text": "share eight conserved amino acid motifs, including Asp(D)-Glu-(E)-Ala(A)-Asp(D)",
            "probability": 6.318092346191406e-05
        },
        {
            "start_logit": -4.1640625,
            "end_logit": 1.8525390625,
            "text": "including Asp(D)-Glu-(E)-Ala(A)-Asp(D) which is part of a more extended motif.",
            "probability": 6.270408630371094e-05
        },
        {
            "start_logit": -7.125,
            "end_logit": 4.22265625,
            "text": ")-Asp(D)",
            "probability": 3.4868717193603516e-05
        }
    ],
    "52b2e409f828ad283c00000e_1": [
        {
            "start_logit": 6.42578125,
            "end_logit": 6.6171875,
            "text": "schizophrenia",
            "probability": 1.0
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -7.140625,
            "text": "schizophrenia in",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -7.2890625,
            "text": "schizophrenia in Canada",
            "probability": 8.940696716308594e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 6.6171875,
            "text": "To describe the frequency and trends in the use of antipsychotics for adults with schizophrenia",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -7.4140625,
            "text": "schizophrenia in Canada from 2005 to",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -7.42578125,
            "text": "schizophrenia in Canada from",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 6.6171875,
            "text": "describe the frequency and trends in the use of antipsychotics for adults with schizophrenia",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 6.42578125,
            "end_logit": -7.55859375,
            "text": "schizophrenia in Canada from 2005 to 2009.",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 6.6171875,
            "text": "antipsychotics for adults with schizophrenia",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 6.6171875,
            "text": "adults with schizophrenia",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.8984375,
            "end_logit": 6.6171875,
            "text": "with schizophrenia",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -7.140625,
            "text": "To describe the frequency and trends in the use of antipsychotics for adults with schizophrenia in",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -7.140625,
            "text": "To describe the frequency and trends in the use of antipsychotics for adults with",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -7.15234375,
            "text": "To describe the frequency and trends in the use of antipsychotics",
            "probability": 0.0
        },
        {
            "start_logit": -7.28125,
            "end_logit": -7.55859375,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -7.140625,
            "text": "describe the frequency and trends in the use of antipsychotics for adults with schizophrenia in",
            "probability": 0.0
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -7.140625,
            "text": "describe the frequency and trends in the use of antipsychotics for adults with",
            "probability": 0.0
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -7.15234375,
            "text": "describe the frequency and trends in the use of antipsychotics",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -7.2890625,
            "text": "To describe the frequency and trends in the use of antipsychotics for adults with schizophrenia in Canada",
            "probability": 0.0
        },
        {
            "start_logit": -7.7890625,
            "end_logit": -7.140625,
            "text": "antipsychotics for adults with schizophrenia in",
            "probability": 0.0
        }
    ],
    "52b2e409f828ad283c00000e_2": [
        {
            "start_logit": 6.3515625,
            "end_logit": 6.6796875,
            "text": "schizophrenia",
            "probability": 0.3359375
        },
        {
            "start_logit": 6.33203125,
            "end_logit": 6.69140625,
            "text": "schizophrenia",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.33203125,
            "end_logit": 6.6796875,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia",
            "probability": 0.330810546875
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -6.4453125,
            "text": "schizophrenia increased by 38",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -6.4453125,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.89453125,
            "end_logit": 6.6796875,
            "text": ". RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 6.69140625,
            "text": "which schizophrenia",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 6.6796875,
            "text": "which schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.0,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.05078125,
            "text": "schizophrenia increased",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.0546875,
            "text": "schizophrenia increased by 38%",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.05078125,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.0546875,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38%",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.08984375,
            "text": "schizophrenia increased by",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.1015625,
            "text": "schizophrenia increased by 38% between 2005 and 2009, from 329 380 to 454 960 recommendations. There were notable increases in recommendations for chlorpromazine",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.1015625,
            "text": "schizophrenia increased by 38% between 2005 and 2009, from 329 380 to",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.08984375,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.19921875,
            "text": "schizophrenia increased by 38% between 2005 and 2009, from 329 380",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.23046875,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.24609375,
            "text": "schizophrenia was",
            "probability": 2.980232238769531e-07
        }
    ],
    "52b2e409f828ad283c00000e_3": [
        {
            "start_logit": 6.3515625,
            "end_logit": 6.6796875,
            "text": "schizophrenia",
            "probability": 0.3359375
        },
        {
            "start_logit": 6.33203125,
            "end_logit": 6.69140625,
            "text": "schizophrenia",
            "probability": 0.333251953125
        },
        {
            "start_logit": 6.33203125,
            "end_logit": 6.6796875,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia",
            "probability": 0.330810546875
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -6.4453125,
            "text": "schizophrenia increased by 38",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -6.4453125,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.89453125,
            "end_logit": 6.6796875,
            "text": ". RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 6.69140625,
            "text": "which schizophrenia",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": -7.31640625,
            "end_logit": 6.6796875,
            "text": "which schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.0,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.05078125,
            "text": "schizophrenia increased",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.0546875,
            "text": "schizophrenia increased by 38%",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.05078125,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.0546875,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by 38%",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.08984375,
            "text": "schizophrenia increased by",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.1015625,
            "text": "schizophrenia increased by 38% between 2005 and 2009, from 329 380 to 454 960 recommendations. There were notable increases in recommendations for chlorpromazine",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.1015625,
            "text": "schizophrenia increased by 38% between 2005 and 2009, from 329 380 to",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.08984375,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA) recommendations for adults with schizophrenia increased by",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 6.3515625,
            "end_logit": -7.19921875,
            "text": "schizophrenia increased by 38% between 2005 and 2009, from 329 380",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.23046875,
            "text": "schizophrenia was listed as the indication. RESULTS: First-generation antipsychotic (FGA",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 6.33203125,
            "end_logit": -7.24609375,
            "text": "schizophrenia was",
            "probability": 2.980232238769531e-07
        }
    ],
    "52b2e409f828ad283c00000e_4": [
        {
            "start_logit": 6.328125,
            "end_logit": 6.71484375,
            "text": "schizophrenia",
            "probability": 1.0
        },
        {
            "start_logit": -6.89453125,
            "end_logit": 6.71484375,
            "text": "paranoid schizophrenia",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -7.05078125,
            "end_logit": 6.71484375,
            "text": ". Its best indication seems to be paranoid schizophrenia",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -7.296875,
            "end_logit": 6.71484375,
            "text": "oid schizophrenia",
            "probability": 1.1920928955078125e-06
        },
        {
            "start_logit": -7.640625,
            "end_logit": 6.71484375,
            "text": ", serotonin (5-HT2) and adrenergic (alpha 1)-blocking activities. Its best indication seems to be paranoid schizophrenia",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.671875,
            "end_logit": 6.71484375,
            "text": "(alpha 1)-blocking activities. Its best indication seems to be paranoid schizophrenia",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.68359375,
            "end_logit": 6.71484375,
            "text": "5-HT2) and adrenergic (alpha 1)-blocking activities. Its best indication seems to be paranoid schizophrenia",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 6.71484375,
            "text": "and adrenergic (alpha 1)-blocking activities. Its best indication seems to be paranoid schizophrenia",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.6953125,
            "end_logit": 6.71484375,
            "text": "alpha 1)-blocking activities. Its best indication seems to be paranoid schizophrenia",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": -7.70703125,
            "end_logit": 6.71484375,
            "text": "adrenergic (alpha 1)-blocking activities. Its best indication seems to be paranoid schizophrenia",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 6.328125,
            "end_logit": -7.48828125,
            "text": "schizophrenia, although some data suggest bipolar action.",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -6.89453125,
            "end_logit": -7.30078125,
            "text": "paranoid",
            "probability": 0.0
        },
        {
            "start_logit": -7.05078125,
            "end_logit": -7.21484375,
            "text": ". Its pharmacological profile is close to that of clozapine",
            "probability": 0.0
        },
        {
            "start_logit": -7.05078125,
            "end_logit": -7.30078125,
            "text": ". Its best indication seems to be paranoid",
            "probability": 0.0
        },
        {
            "start_logit": -6.89453125,
            "end_logit": -7.48828125,
            "text": "paranoid schizophrenia, although some data suggest bipolar action.",
            "probability": 0.0
        },
        {
            "start_logit": -6.89453125,
            "end_logit": -7.48828125,
            "text": "paran",
            "probability": 0.0
        },
        {
            "start_logit": -7.05078125,
            "end_logit": -7.390625,
            "text": ". Its pharmacological profile is close to that of",
            "probability": 0.0
        },
        {
            "start_logit": -7.05078125,
            "end_logit": -7.48828125,
            "text": ".",
            "probability": 0.0
        },
        {
            "start_logit": -7.05078125,
            "end_logit": -7.48828125,
            "text": ". Its best indication seems to be paranoid schizophrenia, although some data suggest bipolar action.",
            "probability": 0.0
        },
        {
            "start_logit": -7.05078125,
            "end_logit": -7.48828125,
            "text": ".",
            "probability": 0.0
        }
    ],
    "6252f496e764a53204000020_1": [
        {
            "start_logit": 8.1875,
            "end_logit": 6.9765625,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 1.0
        },
        {
            "start_logit": 8.1875,
            "end_logit": -1.05078125,
            "text": "ABC",
            "probability": 0.00032520294189453125
        },
        {
            "start_logit": -1.27734375,
            "end_logit": 6.9765625,
            "text": ".",
            "probability": 7.724761962890625e-05
        },
        {
            "start_logit": 8.1875,
            "end_logit": -5.08203125,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter",
            "probability": 5.781650543212891e-06
        },
        {
            "start_logit": -4.828125,
            "end_logit": 6.9765625,
            "text": "ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 2.205371856689453e-06
        },
        {
            "start_logit": 8.1875,
            "end_logit": -6.40234375,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that",
            "probability": 1.5497207641601562e-06
        },
        {
            "start_logit": -5.40234375,
            "end_logit": 6.9765625,
            "text": "an ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 8.1875,
            "end_logit": -6.8671875,
            "text": "ABCG1 is an ATP binding cassette",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.01171875,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes excess cholesterol from",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.15625,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes excess",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.1640625,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes excess cholesterol",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.1640625,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral tissues",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.2109375,
            "text": "ABCG1 is",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.2109375,
            "text": "ABCG1 is an ATP binding cassette (ABC",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.2109375,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral",
            "probability": 7.152557373046875e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.3203125,
            "text": "ABCG1 is an ATP binding cassette (",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.3671875,
            "text": "ABCG1 is an ATP binding cassette (ABC) transporter that removes",
            "probability": 5.960464477539062e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.5390625,
            "text": "ABCG1 is an ATP binding",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.1875,
            "end_logit": -7.625,
            "text": "ABCG1 is an ATP binding cassette (ABC)",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": -6.5390625,
            "end_logit": 6.9765625,
            "text": "G1 is an ATP binding cassette (ABC) transporter that removes excess cholesterol from peripheral tissues.",
            "probability": 4.172325134277344e-07
        }
    ],
    "601ee4c61cb411341a000066_1": [
        {
            "start_logit": 8.1953125,
            "end_logit": 8.1328125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.09765625,
            "end_logit": 8.1328125,
            "text": "7",
            "probability": 9.173154830932617e-05
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -1.2890625,
            "text": "196",
            "probability": 8.094310760498047e-05
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.515625,
            "text": "1967 was",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.578125,
            "text": "1967 was performed using a deceased donor heart,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.53515625,
            "end_logit": 8.1328125,
            "text": "in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.625,
            "text": "1967 was performed using a deceased donor heart",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.67578125,
            "text": "1967 was performed using a",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 8.1328125,
            "text": "the first human heart transplant in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -7.765625,
            "text": "1967 was performed using a deceased donor",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 8.1328125,
            "text": "first human heart transplant in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 8.1328125,
            "text": "human heart transplant in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 8.1328125,
            "text": "transplant in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 8.1328125,
            "text": "heart transplant in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.09765625,
            "end_logit": -7.515625,
            "text": "7 was",
            "probability": 0.0
        },
        {
            "start_logit": -1.09765625,
            "end_logit": -7.578125,
            "text": "7 was performed using a deceased donor heart,",
            "probability": 0.0
        },
        {
            "start_logit": -1.09765625,
            "end_logit": -7.625,
            "text": "7 was performed using a deceased donor heart",
            "probability": 0.0
        },
        {
            "start_logit": -1.09765625,
            "end_logit": -7.67578125,
            "text": "7 was performed using a",
            "probability": 0.0
        },
        {
            "start_logit": -7.53515625,
            "end_logit": -1.2890625,
            "text": "in 196",
            "probability": 0.0
        },
        {
            "start_logit": -1.09765625,
            "end_logit": -7.765625,
            "text": "7 was performed using a deceased donor",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_2": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.1171875,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.11328125,
            "text": "196",
            "probability": 9.918212890625e-05
        },
        {
            "start_logit": -1.23046875,
            "end_logit": 8.1171875,
            "text": "7",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": -6.171875,
            "end_logit": 8.1171875,
            "text": "In 1967",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -6.78125,
            "text": "1967, Christian Barnard",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.13671875,
            "text": "1967, Christian Barnard performed the first successful human-to-human heart",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.21875,
            "text": "1967, Christian Barnard performed the first successful human-to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.32421875,
            "text": "1967, Christian Barnard performed the first successful human-to-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.35546875,
            "text": "1967, Christian",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.43359375,
            "text": "1967, Christian Barnard performed the first successful human-to-human heart transplant.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.43359375,
            "text": "1967, Christian Barnard performed the first successful human-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.48046875,
            "text": "1967, Christian Barnard performed the first successful human-to-human heart transplant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4921875,
            "text": "1967, Christian Barnard performed the first successful human",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.5078125,
            "text": "1967, Christian Barnard performed the first successful human-to-human",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.5078125,
            "text": "1967, Christ",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.53515625,
            "text": "1967, Chr",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.5390625,
            "text": "1967, Christian Barnard performed the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6171875,
            "text": "1967, Christian Barnard performed the first",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.62890625,
            "text": "1967, Christian Barnar",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.171875,
            "end_logit": -1.11328125,
            "text": "In 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_3": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.140625,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.0498046875,
            "text": "196",
            "probability": 0.00010228157043457031
        },
        {
            "start_logit": -1.029296875,
            "end_logit": 8.140625,
            "text": "7",
            "probability": 9.459257125854492e-05
        },
        {
            "start_logit": -6.45703125,
            "end_logit": 8.140625,
            "text": "Christiaan Barnard in 1967",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -6.87109375,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.06640625,
            "text": "1967, there has been substantial progress in the field of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.1171875,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several decades",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 8.140625,
            "text": "Since the first successful human heart transplant performed by Christiaan Barnard in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.3359375,
            "text": "1967, there has been substantial progress in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.36328125,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several decades.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.40234375,
            "text": "1967, there has been substantial progress in the field of heart",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.4140625,
            "text": "1967, there has been substantial progress in the field of heart transplantation,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.4296875,
            "text": "1967, there has been substantial progress in the field of heart transplantation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 8.140625,
            "text": "in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.49609375,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.46875,
            "end_logit": 8.140625,
            "text": "Barnard in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 8.140625,
            "text": "by Christiaan Barnard in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 8.140625,
            "text": "istiaan Barnard in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 8.140625,
            "text": "nard in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 8.140625,
            "text": "successful human heart transplant performed by Christiaan Barnard in 1967",
            "probability": 1.1920928955078125e-07
        }
    ],
    "601ee4c61cb411341a000066_4": [
        {
            "start_logit": 7.7890625,
            "end_logit": 8.09375,
            "text": "1967",
            "probability": 0.998046875
        },
        {
            "start_logit": 1.58984375,
            "end_logit": 8.09375,
            "text": "December 3rd, 1967",
            "probability": 0.0020351409912109375
        },
        {
            "start_logit": -1.21875,
            "end_logit": 8.09375,
            "text": "7",
            "probability": 0.00012218952178955078
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -2.259765625,
            "text": "196",
            "probability": 3.1888484954833984e-05
        },
        {
            "start_logit": -6.19921875,
            "end_logit": 8.09375,
            "text": "Christiaan ('Chris') Barnard at Groote Schuur Hospital in Cape Town on December 3rd, 1967",
            "probability": 8.344650268554688e-07
        },
        {
            "start_logit": 7.7890625,
            "end_logit": -7.0625,
            "text": "1967.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.4453125,
            "end_logit": 8.09375,
            "text": ", 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.48046875,
            "end_logit": 8.09375,
            "text": "on December 3rd, 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 8.09375,
            "text": ", Christiaan ('Chris') Barnard at Groote Schuur Hospital in Cape Town on December 3rd, 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 1.58984375,
            "end_logit": -2.259765625,
            "text": "December 3rd, 196",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.630859375,
            "end_logit": -3.453125,
            "text": "50th",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.630859375,
            "end_logit": -3.58984375,
            "text": "50th anniversary",
            "probability": 5.960464477539063e-08
        },
        {
            "start_logit": 2.630859375,
            "end_logit": -6.40234375,
            "text": "50th annivers",
            "probability": 0.0
        },
        {
            "start_logit": 1.58984375,
            "end_logit": -5.36328125,
            "text": "December",
            "probability": 0.0
        },
        {
            "start_logit": 2.630859375,
            "end_logit": -6.70703125,
            "text": "50th anniversary of the first human heart transplant that",
            "probability": 0.0
        },
        {
            "start_logit": 2.630859375,
            "end_logit": -6.76953125,
            "text": "50",
            "probability": 0.0
        },
        {
            "start_logit": 2.630859375,
            "end_logit": -6.96875,
            "text": "50th anniversary of the first human heart transplant that had been carried out by the South African",
            "probability": 0.0
        },
        {
            "start_logit": 2.630859375,
            "end_logit": -7.0078125,
            "text": "50th anniversary of the first human heart transplant that had",
            "probability": 0.0
        },
        {
            "start_logit": 2.630859375,
            "end_logit": -7.04296875,
            "text": "50th anniversary of the first human heart transplant that had been",
            "probability": 0.0
        },
        {
            "start_logit": 1.58984375,
            "end_logit": -6.05859375,
            "text": "December 3rd",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_5": [
        {
            "start_logit": 7.9375,
            "end_logit": 8.0234375,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.466796875,
            "end_logit": 8.0234375,
            "text": "7",
            "probability": 8.219480514526367e-05
        },
        {
            "start_logit": 7.9375,
            "end_logit": -2.01171875,
            "text": "196",
            "probability": 4.398822784423828e-05
        },
        {
            "start_logit": -5.28125,
            "end_logit": 8.0234375,
            "text": "December 1967",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": -7.3125,
            "end_logit": 8.0234375,
            "text": "Christiaan Barnard in December 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.67578125,
            "end_logit": 8.0234375,
            "text": "the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 8.0234375,
            "text": "South Africa by Christiaan Barnard in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7265625,
            "end_logit": 8.0234375,
            "text": "40 years since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 8.0234375,
            "text": "first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 8.0234375,
            "text": "human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 8.0234375,
            "text": "by Christiaan Barnard in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 8.0234375,
            "text": "since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 8.0234375,
            "text": "Africa by Christiaan Barnard in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 8.0234375,
            "text": "in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 8.0234375,
            "text": "Barnard in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 8.0234375,
            "text": "years since the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.28125,
            "end_logit": -2.01171875,
            "text": "December 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.3125,
            "end_logit": -2.01171875,
            "text": "Christiaan Barnard in December 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.67578125,
            "end_logit": -2.01171875,
            "text": "the first human-to-human heart transplant performed in South Africa by Christiaan Barnard in December 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.71484375,
            "end_logit": -2.01171875,
            "text": "South Africa by Christiaan Barnard in December 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_6": [
        {
            "start_logit": 8.25,
            "end_logit": 8.125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 8.25,
            "end_logit": -0.97802734375,
            "text": "196",
            "probability": 0.00011152029037475586
        },
        {
            "start_logit": -1.0703125,
            "end_logit": 8.125,
            "text": "7",
            "probability": 8.958578109741211e-05
        },
        {
            "start_logit": -6.7734375,
            "end_logit": 8.125,
            "text": "Christiaan Barnard in 1967",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.0,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.02734375,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several decades",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.2265625,
            "text": "1967, there has been substantial progress in the field of",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.45703125,
            "text": "1967, there has been substantial progress in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.5078125,
            "text": "1967, there has been substantial progress in the field of heart transplantation,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.53125,
            "text": "1967, there has been substantial progress in the field of heart",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.41015625,
            "end_logit": 8.125,
            "text": "in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.56640625,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.56640625,
            "text": "1967, there has been substantial progress in the field of heart transplantation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.57421875,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the last several decades.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.59375,
            "text": "1967, there has been substantial progress in the field",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.60546875,
            "text": "1967, there has been substantial progress in the field of heart transplantation, especially over the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.125,
            "text": "the first successful human heart transplant performed by Christiaan Barnard in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.66796875,
            "end_logit": 8.125,
            "text": "Barnard in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.703125,
            "end_logit": 8.125,
            "text": "istiaan Barnard in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 8.125,
            "text": "by Christiaan Barnard in 1967",
            "probability": 1.1920928955078125e-07
        }
    ],
    "601ee4c61cb411341a000066_7": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.1640625,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.015625,
            "end_logit": 8.1640625,
            "text": "7",
            "probability": 9.5367431640625e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.1240234375,
            "text": "196",
            "probability": 9.173154830932617e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.25390625,
            "text": "1967, the field of heart transplantation has advanced to",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.33203125,
            "text": "1967, the field of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.2890625,
            "end_logit": 8.1640625,
            "text": "Since the first human heart transplantation was performed in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.390625,
            "text": "1967, the field of heart transplantation has advanced to the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4140625,
            "text": "1967, the field of heart",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4296875,
            "text": "1967, the field of heart transplantation",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4453125,
            "text": "1967, the field of heart transplantation has advanced",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4453125,
            "text": "1967, the field of heart transplantation has",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.48828125,
            "text": "1967,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.421875,
            "end_logit": 8.1640625,
            "text": "in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.5,
            "text": "1967, the field of heart transplantation has advanced to the point where survival and acceptable quality of life are",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.57421875,
            "text": "1967, the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.6015625,
            "text": "1967, the field",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.60546875,
            "text": "1967, the field of heart transplantation has advanced to the point where survival and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.61328125,
            "text": "1967, the field of heart transplantation has advanced to the point where survival and acceptable quality of life are commonplace",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 8.1640625,
            "text": "the first human heart transplantation was performed in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 8.1640625,
            "text": "human heart transplantation was performed in 1967",
            "probability": 1.1920928955078125e-07
        }
    ],
    "601ee4c61cb411341a000066_8": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.0390625,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.2470703125,
            "text": "196",
            "probability": 9.173154830932617e-05
        },
        {
            "start_logit": -1.43359375,
            "end_logit": 8.0390625,
            "text": "7",
            "probability": 6.502866744995117e-05
        },
        {
            "start_logit": -7.47265625,
            "end_logit": 8.0390625,
            "text": "50 years ago in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 8.0390625,
            "text": "The first human-to-human heart transplant was performed 50 years ago in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 8.0390625,
            "text": "first human-to-human heart transplant was performed 50 years ago in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 8.0390625,
            "text": "performed 50 years ago in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 8.0390625,
            "text": "human-to-human heart transplant was performed 50 years ago in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 8.0390625,
            "text": "in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 8.0390625,
            "text": "human heart transplant was performed 50 years ago in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 8.0390625,
            "text": "heart transplant was performed 50 years ago in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.94140625,
            "end_logit": 8.0390625,
            "text": "transplant was performed 50 years ago in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.47265625,
            "end_logit": -1.2470703125,
            "text": "50 years ago in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.640625,
            "end_logit": -1.2470703125,
            "text": "The first human-to-human heart transplant was performed 50 years ago in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.79296875,
            "end_logit": -1.2470703125,
            "text": "first human-to-human heart transplant was performed 50 years ago in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.82421875,
            "end_logit": -1.2470703125,
            "text": "performed 50 years ago in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.8359375,
            "end_logit": -1.2470703125,
            "text": "human-to-human heart transplant was performed 50 years ago in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.89453125,
            "end_logit": -1.2470703125,
            "text": "in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.9140625,
            "end_logit": -1.2470703125,
            "text": "human heart transplant was performed 50 years ago in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.9375,
            "end_logit": -1.2470703125,
            "text": "heart transplant was performed 50 years ago in 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_9": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1484375,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.0771484375,
            "text": "196",
            "probability": 9.840726852416992e-05
        },
        {
            "start_logit": -1.0078125,
            "end_logit": 8.1484375,
            "text": "7",
            "probability": 9.608268737792969e-05
        },
        {
            "start_logit": -7.21484375,
            "end_logit": 8.1484375,
            "text": "in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5,
            "end_logit": 8.1484375,
            "text": "Since the first human-to-human heart transplantation, performed in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.703125,
            "text": "1967, advances in organ donation, surgical techniques, organ preservation, perioperative care, immunologic risk assessment, immunosuppression agents, monitoring of graft",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.7109375,
            "text": "1967, advances in organ donation, surgical techniques, organ preservation, perioperative care, immunologic risk assessment, immunosuppression agents, monitoring of graft function and",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.7109375,
            "text": "1967, advances in organ donation, surgical techniques, organ preservation, perioperative care, immunologic risk assessment, immunosuppression agents",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.625,
            "end_logit": 8.1484375,
            "text": "performed in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 8.1484375,
            "text": "the first human-to-human heart transplantation, performed in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 8.1484375,
            "text": ", performed in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 8.1484375,
            "text": "human-to-human heart transplantation, performed in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8046875,
            "end_logit": 8.1484375,
            "text": "transplantation, performed in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 8.1484375,
            "text": "human heart transplantation, performed in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 8.1484375,
            "text": "heart transplantation, performed in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 8.1484375,
            "text": "first human-to-human heart transplantation, performed in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.21484375,
            "end_logit": -1.0771484375,
            "text": "in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.5,
            "end_logit": -1.0771484375,
            "text": "Since the first human-to-human heart transplantation, performed in 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.625,
            "end_logit": -1.0771484375,
            "text": "performed in 196",
            "probability": 0.0
        },
        {
            "start_logit": -1.0078125,
            "end_logit": -7.703125,
            "text": "7, advances in organ donation, surgical techniques, organ preservation, perioperative care, immunologic risk assessment, immunosuppression agents, monitoring of graft",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_10": [
        {
            "start_logit": 8.2265625,
            "end_logit": 8.1640625,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -0.91943359375,
            "end_logit": 8.1640625,
            "text": "7",
            "probability": 0.00010722875595092773
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -1.1201171875,
            "text": "196",
            "probability": 9.316205978393555e-05
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -6.9921875,
            "text": "1967 was performed using a deceased donor heart, the advent of brain death criteria and the ability to avoid long warm ischemic times led donation after cardiac death",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.25390625,
            "text": "1967 was",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.19921875,
            "end_logit": 8.1640625,
            "text": "in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.33984375,
            "text": "1967 was performed using a deceased donor heart, the advent of brain death criteria and the ability to avoid long warm ischemic times led donation after cardiac",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 8.1640625,
            "text": "the first human heart transplant in 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.64453125,
            "text": "1967 was performed using a deceased donor heart,",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.65234375,
            "text": "1967 was performed using a deceased donor heart, the advent of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.66015625,
            "text": "1967 was performed using a deceased donor heart, the advent of brain death criteria and the ability to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2265625,
            "end_logit": -7.68359375,
            "text": "1967 was performed using a deceased donor heart, the advent of brain death",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 8.1640625,
            "text": "first human heart transplant in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 8.1640625,
            "text": "human heart transplant in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -0.91943359375,
            "end_logit": -6.9921875,
            "text": "7 was performed using a deceased donor heart, the advent of brain death criteria and the ability to avoid long warm ischemic times led donation after cardiac death",
            "probability": 0.0
        },
        {
            "start_logit": -0.91943359375,
            "end_logit": -7.0625,
            "text": "7 was performed using a deceased donor heart, the advent of brain death criteria and the ability to avoid long warm ischemic times led donation after cardiac death (",
            "probability": 0.0
        },
        {
            "start_logit": -0.91943359375,
            "end_logit": -7.25390625,
            "text": "7 was",
            "probability": 0.0
        },
        {
            "start_logit": -0.91943359375,
            "end_logit": -7.33984375,
            "text": "7 was performed using a deceased donor heart, the advent of brain death criteria and the ability to avoid long warm ischemic times led donation after cardiac",
            "probability": 0.0
        },
        {
            "start_logit": -7.19921875,
            "end_logit": -1.1201171875,
            "text": "in 196",
            "probability": 0.0
        },
        {
            "start_logit": -0.91943359375,
            "end_logit": -7.64453125,
            "text": "7 was performed using a deceased donor heart,",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_11": [
        {
            "start_logit": 7.94921875,
            "end_logit": 8.0078125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.544921875,
            "end_logit": 8.0078125,
            "text": "7",
            "probability": 7.545948028564453e-05
        },
        {
            "start_logit": 7.94921875,
            "end_logit": -1.9501953125,
            "text": "196",
            "probability": 4.756450653076172e-05
        },
        {
            "start_logit": -5.203125,
            "end_logit": 8.0078125,
            "text": "December 1967",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -7.69921875,
            "end_logit": 8.0078125,
            "text": "the first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 8.0078125,
            "text": "1983 had its origin in the first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 8.0078125,
            "text": "Christiaan Barnard and his team in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 8.0078125,
            "text": "Professor Christiaan Barnard and his team in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 8.0078125,
            "text": "successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 8.0078125,
            "text": "first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 8.0078125,
            "text": "in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8828125,
            "end_logit": 8.0078125,
            "text": "team in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 8.0078125,
            "text": "heart transplant operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 8.0078125,
            "text": "operation performed by Professor Christiaan Barnard and his team in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 8.0078125,
            "text": "Barnard and his team in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 8.0078125,
            "text": "istiaan Barnard and his team in December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -5.203125,
            "end_logit": -1.9501953125,
            "text": "December 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.69921875,
            "end_logit": -1.9501953125,
            "text": "the first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.75390625,
            "end_logit": -1.9501953125,
            "text": "1983 had its origin in the first successful heart transplant operation performed by Professor Christiaan Barnard and his team in December 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.75390625,
            "end_logit": -1.9501953125,
            "text": "Christiaan Barnard and his team in December 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_12": [
        {
            "start_logit": 7.55078125,
            "end_logit": 8.1171875,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.16015625,
            "end_logit": 8.1171875,
            "text": "7",
            "probability": 0.0001634359359741211
        },
        {
            "start_logit": -2.6015625,
            "end_logit": 8.1171875,
            "text": "December 1967",
            "probability": 3.886222839355469e-05
        },
        {
            "start_logit": 7.55078125,
            "end_logit": -2.833984375,
            "text": "196",
            "probability": 1.7523765563964844e-05
        },
        {
            "start_logit": -5.578125,
            "end_logit": 8.1171875,
            "text": "Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 1.9669532775878906e-06
        },
        {
            "start_logit": -7.30078125,
            "end_logit": 8.1171875,
            "text": "Dr. Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -7.578125,
            "end_logit": 8.1171875,
            "text": "istiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.55078125,
            "end_logit": -7.0703125,
            "text": "1967 in South Africa",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 8.1171875,
            "text": "iaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.71484375,
            "end_logit": 8.1171875,
            "text": "Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 8.1171875,
            "text": "performed the first human-to-human heart transplant in December 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.77734375,
            "end_logit": 8.1171875,
            "text": "It has been 50 years since Dr. Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 8.1171875,
            "text": "since Dr. Christiaan Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 7.55078125,
            "end_logit": -7.2578125,
            "text": "1967 in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 8.1171875,
            "text": "the first human-to-human heart transplant in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 8.1171875,
            "text": "nard performed the first human-to-human heart transplant in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 8.1171875,
            "text": "in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.88671875,
            "end_logit": 8.1171875,
            "text": "n Barnard performed the first human-to-human heart transplant in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 8.1171875,
            "text": "first human-to-human heart transplant in December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 7.55078125,
            "end_logit": -7.49609375,
            "text": "1967 in South",
            "probability": 1.7881393432617188e-07
        }
    ],
    "601ee4c61cb411341a000066_13": [
        {
            "start_logit": 8.0546875,
            "end_logit": 8.125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.22265625,
            "end_logit": 8.125,
            "text": "7",
            "probability": 9.316205978393555e-05
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -1.7197265625,
            "text": "196",
            "probability": 5.269050598144531e-05
        },
        {
            "start_logit": -7.14453125,
            "end_logit": 8.125,
            "text": "3 December 1967",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.3828125,
            "text": "1967, by Christiaan Barnard in South Africa",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.4921875,
            "text": "1967, by Christiaan Barnard in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.53125,
            "text": "1967,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.609375,
            "end_logit": 8.125,
            "text": "The first successful human heart transplantation was reported on 3 December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.58984375,
            "text": "1967, by Christiaan Barnard in South Africa.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.609375,
            "text": "1967, by",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.65234375,
            "text": "1967, by Christiaan",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 8.125,
            "text": "December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.671875,
            "text": "1967, by Christiaan Barnard",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.703125,
            "text": "1967, by Christiaan Barnard in South",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.0546875,
            "end_logit": -7.7265625,
            "text": "1967, by Chr",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 8.125,
            "text": "successful human heart transplantation was reported on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 8.125,
            "text": "human heart transplantation was reported on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 8.125,
            "text": "first successful human heart transplantation was reported on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 8.125,
            "text": "reported on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.22265625,
            "end_logit": -7.3828125,
            "text": "7, by Christiaan Barnard in South Africa",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_14": [
        {
            "start_logit": 8.15625,
            "end_logit": 8.1328125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.197265625,
            "end_logit": 8.1328125,
            "text": "7",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": 8.15625,
            "end_logit": -1.4013671875,
            "text": "196",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 8.1328125,
            "text": "December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6328125,
            "end_logit": 8.1328125,
            "text": "The world's first human-to-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.15625,
            "end_logit": -7.66796875,
            "text": "1967.",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 8.1328125,
            "text": "on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78515625,
            "end_logit": 8.1328125,
            "text": "human-to-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 8.1328125,
            "text": "performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 8.1328125,
            "text": "Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 8.1328125,
            "text": "Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 8.1328125,
            "text": "world's first human-to-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84375,
            "end_logit": 8.1328125,
            "text": "first human-to-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 8.1328125,
            "text": "2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 8.1328125,
            "text": "Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 8.1328125,
            "text": "human heart transplant was performed at Groote Schuur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 8.1328125,
            "text": "uur Hospital on the 2nd December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": -1.4013671875,
            "text": "December 196",
            "probability": 0.0
        },
        {
            "start_logit": -1.197265625,
            "end_logit": -7.66796875,
            "text": "7.",
            "probability": 0.0
        },
        {
            "start_logit": -7.6328125,
            "end_logit": -1.4013671875,
            "text": "The world's first human-to-human heart transplant was performed at Groote Schuur Hospital on the 2nd December 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_15": [
        {
            "start_logit": 8.1953125,
            "end_logit": 8.171875,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -0.9599609375,
            "end_logit": 8.171875,
            "text": "7",
            "probability": 0.00010472536087036133
        },
        {
            "start_logit": 8.1953125,
            "end_logit": -1.1923828125,
            "text": "196",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": -6.07421875,
            "end_logit": 8.171875,
            "text": "50 years have passed since the first human to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 6.556510925292969e-07
        },
        {
            "start_logit": -7.18359375,
            "end_logit": 8.171875,
            "text": "Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 8.171875,
            "text": "December 3rd 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 8.171875,
            "text": "Cape Town December 3rd 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.71875,
            "end_logit": 8.171875,
            "text": "to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 8.171875,
            "text": "human to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.82421875,
            "end_logit": 8.171875,
            "text": "istiaan Barnard in Cape Town December 3rd 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.828125,
            "end_logit": 8.171875,
            "text": "performed by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 8.171875,
            "text": "Town December 3rd 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 8.171875,
            "text": "3rd 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 8.171875,
            "text": "human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.171875,
            "text": "iaan Barnard in Cape Town December 3rd 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 8.171875,
            "text": "by Christiaan Barnard in Cape Town December 3rd 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87109375,
            "end_logit": 8.171875,
            "text": "Barnard in Cape Town December 3rd 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.07421875,
            "end_logit": -1.1923828125,
            "text": "50 years have passed since the first human to human heart transplantation, performed by Christiaan Barnard in Cape Town December 3rd 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.18359375,
            "end_logit": -1.1923828125,
            "text": "Christiaan Barnard in Cape Town December 3rd 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.6015625,
            "end_logit": -1.1923828125,
            "text": "December 3rd 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_16": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.1171875,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.212890625,
            "text": "196",
            "probability": 8.958578109741211e-05
        },
        {
            "start_logit": -1.259765625,
            "end_logit": 8.1171875,
            "text": "7",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": -6.84765625,
            "end_logit": 8.1171875,
            "text": "In 1967",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.1171875,
            "text": "1967, he led the team that performed the world's first human-to-human heart",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.1640625,
            "text": "1967, he led the team that performed the world",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.21484375,
            "text": "1967, he led the team that performed the world's",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.26171875,
            "text": "1967, he led the team that performed the world's first human-to",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.34765625,
            "text": "1967, he led the team that performed the world's first human-to-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.4375,
            "text": "1967, he led the team that performed the world's first human-",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.4609375,
            "text": "1967, he led the team that performed the world'",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.48046875,
            "text": "1967, he led the team that performed the world's first human-to-human heart transplant.",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.515625,
            "text": "1967, he led the team that performed the world's first human-to-human heart transplant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5234375,
            "text": "1967, he led the team that performed the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5546875,
            "text": "1967, he led the team that",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5625,
            "text": "1967, he led the team that performed the world's first",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.5625,
            "text": "1967, he led the team that performed the world's first human-to-human",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.65625,
            "text": "1967, he led the team that performed the world's first human",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.84765625,
            "end_logit": -1.212890625,
            "text": "In 196",
            "probability": 0.0
        },
        {
            "start_logit": -1.259765625,
            "end_logit": -7.1171875,
            "text": "7, he led the team that performed the world's first human-to-human heart",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_17": [
        {
            "start_logit": 8.1640625,
            "end_logit": 8.1171875,
            "text": "1967",
            "probability": 0.5361328125
        },
        {
            "start_logit": 7.5625,
            "end_logit": 8.1171875,
            "text": "1953, followed by the first successful heart transplant in 1967",
            "probability": 0.293701171875
        },
        {
            "start_logit": 7.5625,
            "end_logit": 7.5703125,
            "text": "1953",
            "probability": 0.1700439453125
        },
        {
            "start_logit": -1.080078125,
            "end_logit": 8.1171875,
            "text": "7",
            "probability": 5.1915645599365234e-05
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -1.3818359375,
            "text": "196",
            "probability": 4.011392593383789e-05
        },
        {
            "start_logit": 7.5625,
            "end_logit": -1.3818359375,
            "text": "1953, followed by the first successful heart transplant in 196",
            "probability": 2.199411392211914e-05
        },
        {
            "start_logit": -2.37890625,
            "end_logit": 8.1171875,
            "text": "3, followed by the first successful heart transplant in 1967",
            "probability": 1.4066696166992188e-05
        },
        {
            "start_logit": -2.37890625,
            "end_logit": 7.5703125,
            "text": "3",
            "probability": 8.165836334228516e-06
        },
        {
            "start_logit": 7.5625,
            "end_logit": -2.681640625,
            "text": "195",
            "probability": 6.020069122314453e-06
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -6.3984375,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to the human myocardium in 2002",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.2734375,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to the human myocardium in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.3203125,
            "end_logit": 8.1171875,
            "text": "in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.421875,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to the human myocardium in 2002, significant progress has been made",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.45703125,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to the human myocardium in 2002, significant progress has been made in",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.46875,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to the human myocardium in 2002, significant progress has been made in h",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.484375,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to the human myocardium in 2002, significant progress has been",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.51171875,
            "text": "1967, and later to the first infusion of bone marrow-",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.56640625,
            "text": "1967, and later to the first infusion of bone marrow-derived cells to",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.57421875,
            "text": "1967, and later to the first infusion of bone marrow",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.1640625,
            "end_logit": -7.59765625,
            "text": "1967, and later to the first",
            "probability": 1.1920928955078125e-07
        }
    ],
    "601ee4c61cb411341a000066_18": [
        {
            "start_logit": 8.109375,
            "end_logit": 8.109375,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": -1.26171875,
            "end_logit": 8.109375,
            "text": "7",
            "probability": 8.481740951538086e-05
        },
        {
            "start_logit": 8.109375,
            "end_logit": -1.4912109375,
            "text": "196",
            "probability": 6.765127182006836e-05
        },
        {
            "start_logit": -7.34375,
            "end_logit": 8.109375,
            "text": "3 December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.59765625,
            "end_logit": 8.109375,
            "text": "December 1967",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.7578125,
            "end_logit": 8.109375,
            "text": "Article on the first heart transplant, performed at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 8.109375,
            "text": "performed at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8125,
            "end_logit": 8.109375,
            "text": "Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8203125,
            "end_logit": 8.109375,
            "text": "on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.83203125,
            "end_logit": 8.109375,
            "text": ", on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.85546875,
            "end_logit": 8.109375,
            "text": "first heart transplant, performed at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.109375,
            "text": "at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8671875,
            "end_logit": 8.109375,
            "text": "the first heart transplant, performed at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 8.109375,
            "text": "Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 8.109375,
            "text": "on the first heart transplant, performed at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90625,
            "end_logit": 8.109375,
            "text": "heart transplant, performed at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 8.109375,
            "text": "transplant, performed at Groote Schuur Hospital, Cape Town, on 3 December 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.34375,
            "end_logit": -1.4912109375,
            "text": "3 December 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.59765625,
            "end_logit": -1.4912109375,
            "text": "December 196",
            "probability": 0.0
        },
        {
            "start_logit": -7.7578125,
            "end_logit": -1.4912109375,
            "text": "Article on the first heart transplant, performed at Groote Schuur Hospital, Cape Town, on 3 December 196",
            "probability": 0.0
        }
    ],
    "601ee4c61cb411341a000066_19": [
        {
            "start_logit": 4.88671875,
            "end_logit": 7.94921875,
            "text": "1967",
            "probability": 0.998046875
        },
        {
            "start_logit": -1.546875,
            "end_logit": 7.94921875,
            "text": "7",
            "probability": 0.0016040802001953125
        },
        {
            "start_logit": -6.15234375,
            "end_logit": 7.94921875,
            "text": "December 3, 1967",
            "probability": 1.5974044799804688e-05
        },
        {
            "start_logit": -6.43359375,
            "end_logit": 7.94921875,
            "text": "On December 3, 1967",
            "probability": 1.2099742889404297e-05
        },
        {
            "start_logit": -7.8125,
            "end_logit": 7.94921875,
            "text": ", 1967",
            "probability": 3.039836883544922e-06
        },
        {
            "start_logit": 4.88671875,
            "end_logit": -5.6328125,
            "text": "196",
            "probability": 1.2516975402832031e-06
        },
        {
            "start_logit": 4.88671875,
            "end_logit": -5.9375,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with the first successful human heart transplant.",
            "probability": 9.5367431640625e-07
        },
        {
            "start_logit": 4.88671875,
            "end_logit": -6.77734375,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 4.88671875,
            "end_logit": -6.9609375,
            "text": "1967, in Cape Town, South Africa",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 4.88671875,
            "end_logit": -7.0859375,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 4.88671875,
            "end_logit": -7.11328125,
            "text": "1967, in Cape Town, South Africa, Dr.",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 4.88671875,
            "end_logit": -7.21484375,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with the first successful human heart",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.88671875,
            "end_logit": -7.2265625,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with the",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.88671875,
            "end_logit": -7.36328125,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with the first successful human heart transplant",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.88671875,
            "end_logit": -7.39453125,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.88671875,
            "end_logit": -7.3984375,
            "text": "1967, in Cape Town, South Africa, Dr. Christ",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.88671875,
            "end_logit": -7.4140625,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ transplantation with the first",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 4.88671875,
            "end_logit": -7.43359375,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolution",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.88671875,
            "end_logit": -7.45703125,
            "text": "1967, in Cape Town, South Africa, Dr. Christian Barnard revolutionized organ",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 4.88671875,
            "end_logit": -7.46875,
            "text": "1967, in Cape Town, South Africa, Dr. Christian",
            "probability": 1.7881393432617188e-07
        }
    ],
    "601ee4c61cb411341a000066_20": [
        {
            "start_logit": 8.203125,
            "end_logit": 8.125,
            "text": "1967",
            "probability": 1.0
        },
        {
            "start_logit": 8.203125,
            "end_logit": -1.2314453125,
            "text": "196",
            "probability": 8.612871170043945e-05
        },
        {
            "start_logit": -1.189453125,
            "end_logit": 8.125,
            "text": "7",
            "probability": 8.350610733032227e-05
        },
        {
            "start_logit": 8.203125,
            "end_logit": -3.76953125,
            "text": "1967 and followed this by introducing the technique of heterotopic heart transplantation in 1974",
            "probability": 6.854534149169922e-06
        },
        {
            "start_logit": 8.203125,
            "end_logit": -6.7890625,
            "text": "1967 and",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": -6.78515625,
            "end_logit": 8.125,
            "text": "Barnard performed the 1st human-to-human orthotopic heart transplantation in 1967",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.046875,
            "text": "1967 and followed this by introducing the technique of heterotopic heart",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.09765625,
            "text": "1967 and followed this by introducing the technique of heterotopic heart transplantation",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.1640625,
            "text": "1967 and followed this by introducing the technique of heterotopic heart transplantation in",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.19921875,
            "text": "1967 and followed this by introducing the technique of heterotopic heart transplantation in 1974.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.328125,
            "text": "1967 and followed this by",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.55859375,
            "text": "1967 and followed this by introducing the technique of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.203125,
            "end_logit": -7.6015625,
            "text": "1967 and followed this by introducing the technique of heterotopic",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 8.125,
            "text": "in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.61328125,
            "end_logit": 8.125,
            "text": "performed the 1st human-to-human orthotopic heart transplantation in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.69140625,
            "end_logit": 8.125,
            "text": "nard performed the 1st human-to-human orthotopic heart transplantation in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73828125,
            "end_logit": 8.125,
            "text": "orthotopic heart transplantation in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 8.125,
            "text": "1st human-to-human orthotopic heart transplantation in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80078125,
            "end_logit": 8.125,
            "text": "the 1st human-to-human orthotopic heart transplantation in 1967",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 8.125,
            "text": "human-to-human orthotopic heart transplantation in 1967",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5fdb2e23a43ad3127800000a_1": [
        {
            "start_logit": 2.904296875,
            "end_logit": 0.9189453125,
            "text": "cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.45556640625
        },
        {
            "start_logit": 2.904296875,
            "end_logit": 0.90771484375,
            "text": "cis-regulatory elements",
            "probability": 0.4501953125
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -0.73876953125,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements",
            "probability": 0.08673095703125
        },
        {
            "start_logit": -3.01953125,
            "end_logit": 0.91943359375,
            "text": ".",
            "probability": 0.001220703125
        },
        {
            "start_logit": -3.01953125,
            "end_logit": 0.91943359375,
            "text": ". Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.001220703125
        },
        {
            "start_logit": -3.01953125,
            "end_logit": 0.9189453125,
            "text": ".",
            "probability": 0.0012159347534179688
        },
        {
            "start_logit": -3.865234375,
            "end_logit": 0.9189453125,
            "text": "The identification of cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.0005230903625488281
        },
        {
            "start_logit": -3.865234375,
            "end_logit": 0.90771484375,
            "text": "The identification of cis-regulatory elements",
            "probability": 0.0005168914794921875
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -6.046875,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to",
            "probability": 0.0004284381866455078
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -6.140625,
            "text": "cis",
            "probability": 0.00039005279541015625
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -6.40625,
            "text": "cis-regulatory elements is central to understanding gene transcription",
            "probability": 0.0002989768981933594
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -6.4140625,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory",
            "probability": 0.0002968311309814453
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -6.53125,
            "text": "cis-regulatory",
            "probability": 0.00026416778564453125
        },
        {
            "start_logit": -3.01953125,
            "end_logit": -0.73876953125,
            "text": ". Hypersensitivity of cis-regulatory elements",
            "probability": 0.00023221969604492188
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -6.7109375,
            "text": "cis-regulatory elements is",
            "probability": 0.0002205371856689453
        },
        {
            "start_logit": -4.8203125,
            "end_logit": 0.91943359375,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.0002008676528930664
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -7.05859375,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to",
            "probability": 0.0001558065414428711
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -7.15625,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-",
            "probability": 0.00014126300811767578
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -7.1640625,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard",
            "probability": 0.00014126300811767578
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -7.16796875,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains",
            "probability": 0.00013911724090576172
        }
    ],
    "5fdb2e23a43ad3127800000a_2": [
        {
            "start_logit": 2.904296875,
            "end_logit": 0.9189453125,
            "text": "cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.45556640625
        },
        {
            "start_logit": 2.904296875,
            "end_logit": 0.90771484375,
            "text": "cis-regulatory elements",
            "probability": 0.4501953125
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -0.73876953125,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements",
            "probability": 0.08673095703125
        },
        {
            "start_logit": -3.01953125,
            "end_logit": 0.91943359375,
            "text": ".",
            "probability": 0.001220703125
        },
        {
            "start_logit": -3.01953125,
            "end_logit": 0.91943359375,
            "text": ". Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.001220703125
        },
        {
            "start_logit": -3.01953125,
            "end_logit": 0.9189453125,
            "text": ".",
            "probability": 0.0012159347534179688
        },
        {
            "start_logit": -3.865234375,
            "end_logit": 0.9189453125,
            "text": "The identification of cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.0005230903625488281
        },
        {
            "start_logit": -3.865234375,
            "end_logit": 0.90771484375,
            "text": "The identification of cis-regulatory elements",
            "probability": 0.0005168914794921875
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -6.046875,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to",
            "probability": 0.0004284381866455078
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -6.140625,
            "text": "cis",
            "probability": 0.00039005279541015625
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -6.40625,
            "text": "cis-regulatory elements is central to understanding gene transcription",
            "probability": 0.0002989768981933594
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -6.4140625,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory",
            "probability": 0.0002968311309814453
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -6.53125,
            "text": "cis-regulatory",
            "probability": 0.00026416778564453125
        },
        {
            "start_logit": -3.01953125,
            "end_logit": -0.73876953125,
            "text": ". Hypersensitivity of cis-regulatory elements",
            "probability": 0.00023221969604492188
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -6.7109375,
            "text": "cis-regulatory elements is",
            "probability": 0.0002205371856689453
        },
        {
            "start_logit": -4.8203125,
            "end_logit": 0.91943359375,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.0002008676528930664
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -7.05859375,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to",
            "probability": 0.0001558065414428711
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -7.15625,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-",
            "probability": 0.00014126300811767578
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -7.1640625,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard",
            "probability": 0.00014126300811767578
        },
        {
            "start_logit": 2.904296875,
            "end_logit": -7.16796875,
            "text": "cis-regulatory elements is central to understanding gene transcription. Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains",
            "probability": 0.00013911724090576172
        }
    ],
    "5fdb2e23a43ad3127800000a_3": [
        {
            "start_logit": -1.0625,
            "end_logit": 4.15234375,
            "text": "cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.77685546875
        },
        {
            "start_logit": -2.748046875,
            "end_logit": 4.15234375,
            "text": ".",
            "probability": 0.1439208984375
        },
        {
            "start_logit": -4.0,
            "end_logit": 4.15234375,
            "text": "Hypersensitivity of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.04119873046875
        },
        {
            "start_logit": -1.0625,
            "end_logit": 0.380859375,
            "text": "cis-regulatory elements",
            "probability": 0.01788330078125
        },
        {
            "start_logit": -6.84765625,
            "end_logit": 4.15234375,
            "text": "locating such elements.",
            "probability": 0.00238800048828125
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 4.15234375,
            "text": "of cis-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.0019626617431640625
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 4.15234375,
            "text": "the gold-standard approach to locating such elements.",
            "probability": 0.00164031982421875
        },
        {
            "start_logit": -7.2265625,
            "end_logit": 4.15234375,
            "text": "remains the gold-standard approach to locating such elements.",
            "probability": 0.0016345977783203125
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 4.15234375,
            "text": "regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.0015783309936523438
        },
        {
            "start_logit": -7.28125,
            "end_logit": 4.15234375,
            "text": "digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.0015468597412109375
        },
        {
            "start_logit": -7.38671875,
            "end_logit": 4.15234375,
            "text": "elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.001392364501953125
        },
        {
            "start_logit": -7.44921875,
            "end_logit": 4.15234375,
            "text": "elements.",
            "probability": 0.001308441162109375
        },
        {
            "start_logit": -7.50390625,
            "end_logit": 4.15234375,
            "text": "ating such elements.",
            "probability": 0.0012388229370117188
        },
        {
            "start_logit": -7.640625,
            "end_logit": 4.15234375,
            "text": "DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.0010805130004882812
        },
        {
            "start_logit": -7.6875,
            "end_logit": 4.15234375,
            "text": "-regulatory elements to digestion with DNaseI remains the gold-standard approach to locating such elements.",
            "probability": 0.0010309219360351562
        },
        {
            "start_logit": -7.76953125,
            "end_logit": 4.15234375,
            "text": "gold-standard approach to locating such elements.",
            "probability": 0.000949859619140625
        },
        {
            "start_logit": -4.0,
            "end_logit": 0.380859375,
            "text": "Hypersensitivity of cis-regulatory elements",
            "probability": 0.000946044921875
        },
        {
            "start_logit": -7.80859375,
            "end_logit": 4.15234375,
            "text": "I remains the gold-standard approach to locating such elements.",
            "probability": 0.0009136199951171875
        },
        {
            "start_logit": -7.04296875,
            "end_logit": 0.380859375,
            "text": "of cis-regulatory elements",
            "probability": 4.5299530029296875e-05
        },
        {
            "start_logit": -7.26171875,
            "end_logit": 0.380859375,
            "text": "regulatory elements",
            "probability": 3.641843795776367e-05
        }
    ],
    "5fdb2e23a43ad3127800000a_4": [
        {
            "start_logit": -1.435546875,
            "end_logit": 3.80078125,
            "text": "The identification of cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.60791015625
        },
        {
            "start_logit": -2.490234375,
            "end_logit": 3.80078125,
            "text": "cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.211669921875
        },
        {
            "start_logit": -2.908203125,
            "end_logit": 3.80078125,
            "text": ".",
            "probability": 0.139404296875
        },
        {
            "start_logit": -4.640625,
            "end_logit": 3.80078125,
            "text": "gene transcription.",
            "probability": 0.0246429443359375
        },
        {
            "start_logit": -6.1171875,
            "end_logit": 3.80078125,
            "text": "understanding gene transcription.",
            "probability": 0.005641937255859375
        },
        {
            "start_logit": -6.66015625,
            "end_logit": 3.80078125,
            "text": "central to understanding gene transcription.",
            "probability": 0.0032634735107421875
        },
        {
            "start_logit": -6.765625,
            "end_logit": 3.80078125,
            "text": "identification of cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.002948760986328125
        },
        {
            "start_logit": -7.22265625,
            "end_logit": 3.80078125,
            "text": "to understanding gene transcription.",
            "probability": 0.0018606185913085938
        },
        {
            "start_logit": -7.32421875,
            "end_logit": 3.80078125,
            "text": "of cis-regulatory elements is central to understanding gene transcription.",
            "probability": 0.0016803741455078125
        },
        {
            "start_logit": -7.81640625,
            "end_logit": 3.80078125,
            "text": "regulatory elements is central to understanding gene transcription.",
            "probability": 0.0010271072387695312
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -4.58984375,
            "text": "The identification of cis-regulatory elements",
            "probability": 0.0001379251480102539
        },
        {
            "start_logit": -2.490234375,
            "end_logit": -4.58984375,
            "text": "cis-regulatory elements",
            "probability": 4.8041343688964844e-05
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -5.70703125,
            "text": "The identification of cis-regulatory elements is",
            "probability": 4.51207160949707e-05
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -6.23828125,
            "text": "The identification of cis-regulatory elements is central to understanding gene transcription",
            "probability": 2.6524066925048828e-05
        },
        {
            "start_logit": -2.490234375,
            "end_logit": -5.70703125,
            "text": "cis-regulatory elements is",
            "probability": 1.5735626220703125e-05
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -6.9921875,
            "text": "The identification of cis-regulatory",
            "probability": 1.239776611328125e-05
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -7.265625,
            "text": "The identification of cis-",
            "probability": 9.47713851928711e-06
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -7.28125,
            "text": "The",
            "probability": 9.298324584960938e-06
        },
        {
            "start_logit": -2.490234375,
            "end_logit": -6.23828125,
            "text": "cis-regulatory elements is central to understanding gene transcription",
            "probability": 9.238719940185547e-06
        },
        {
            "start_logit": -1.435546875,
            "end_logit": -7.3203125,
            "text": "The identification of cis-regulatory elements is central",
            "probability": 8.940696716308594e-06
        }
    ],
    "53318685d6d3ac6a3400003d_1": [
        {
            "start_logit": 8.2109375,
            "end_logit": 8.171875,
            "text": "autosomal dominant",
            "probability": 1.0
        },
        {
            "start_logit": -1.1640625,
            "end_logit": 8.171875,
            "text": "dominant",
            "probability": 8.547306060791016e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -1.28515625,
            "text": "autosomal",
            "probability": 7.843971252441406e-05
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.046875,
            "text": "autosomal dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of the femoral head)",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.4140625,
            "text": "autosomal dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of the femoral head).",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.48828125,
            "text": "autosomal dominant mode of inheritance",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.5234375,
            "text": "autosomal dominant mode of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.5390625,
            "text": "autosomal dominant mode of inheritance,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.5625,
            "text": "autosomal dominant mode",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.63671875,
            "text": "autosomal dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of the",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.67578125,
            "text": "autosomal dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.69921875,
            "text": "autosomal dominant mode of inheritance, distinct facial and skeleton features (",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.70703125,
            "text": "autosomal dominant mode of inheritance, distinct facial and skeleton",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.71875,
            "text": "autosomal dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of the femoral",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.734375,
            "text": "autosomal dominant mode of inheritance, distinct",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2109375,
            "end_logit": -7.75,
            "text": "autosomal dominant mode of inheritance, distinct facial",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 8.171875,
            "text": "AD has an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 8.171875,
            "text": "has an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8515625,
            "end_logit": 8.171875,
            "text": "an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.1640625,
            "end_logit": -7.046875,
            "text": "dominant mode of inheritance, distinct facial and skeleton features (a hoarse voice and internal notch of the femoral head)",
            "probability": 0.0
        }
    ],
    "53318685d6d3ac6a3400003d_2": [
        {
            "start_logit": 8.2578125,
            "end_logit": 8.2109375,
            "text": "autosomal dominant",
            "probability": 0.3349609375
        },
        {
            "start_logit": 8.2578125,
            "end_logit": 8.2109375,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 0.3349609375
        },
        {
            "start_logit": 8.2578125,
            "end_logit": 8.1953125,
            "text": "autosomal dominant",
            "probability": 0.329833984375
        },
        {
            "start_logit": -0.88623046875,
            "end_logit": 8.2109375,
            "text": "dominant",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": -1.0,
            "end_logit": 8.2109375,
            "text": "dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -1.064453125,
            "text": "autosomal",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -1.064453125,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": -1.0,
            "end_logit": 8.1953125,
            "text": "dominant",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -1.0908203125,
            "text": "autosomal",
            "probability": 3.075599670410156e-05
        },
        {
            "start_logit": -3.36328125,
            "end_logit": 8.2109375,
            "text": "autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -3.87109375,
            "end_logit": 8.2109375,
            "text": "autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -4.45703125,
            "text": "autosomal dominant or an autosomal recessive",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -4.75,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -5.76171875,
            "text": "autosomal dominant mode of inheritance",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -5.76171875,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant mode of inheritance",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.52734375,
            "end_logit": 8.2109375,
            "text": "mode of inheritance and AD by an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -6.74609375,
            "text": "autosomal dominant or an autosomal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -6.8046875,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 8.2109375,
            "text": "mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.05078125,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance",
            "probability": 5.960464477539063e-08
        }
    ],
    "53318685d6d3ac6a3400003d_3": [
        {
            "start_logit": 8.2578125,
            "end_logit": 8.2109375,
            "text": "autosomal dominant",
            "probability": 0.3349609375
        },
        {
            "start_logit": 8.2578125,
            "end_logit": 8.2109375,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 0.3349609375
        },
        {
            "start_logit": 8.2578125,
            "end_logit": 8.1953125,
            "text": "autosomal dominant",
            "probability": 0.329833984375
        },
        {
            "start_logit": -0.88623046875,
            "end_logit": 8.2109375,
            "text": "dominant",
            "probability": 3.594160079956055e-05
        },
        {
            "start_logit": -1.0,
            "end_logit": 8.2109375,
            "text": "dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 3.1948089599609375e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -1.064453125,
            "text": "autosomal",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -1.064453125,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": -1.0,
            "end_logit": 8.1953125,
            "text": "dominant",
            "probability": 3.147125244140625e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -1.0908203125,
            "text": "autosomal",
            "probability": 3.075599670410156e-05
        },
        {
            "start_logit": -3.36328125,
            "end_logit": 8.2109375,
            "text": "autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 2.9802322387695312e-06
        },
        {
            "start_logit": -3.87109375,
            "end_logit": 8.2109375,
            "text": "autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 1.7881393432617188e-06
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -4.45703125,
            "text": "autosomal dominant or an autosomal recessive",
            "probability": 1.0728836059570312e-06
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -4.75,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive",
            "probability": 7.748603820800781e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -5.76171875,
            "text": "autosomal dominant mode of inheritance",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -5.76171875,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant mode of inheritance",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.52734375,
            "end_logit": 8.2109375,
            "text": "mode of inheritance and AD by an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -6.74609375,
            "text": "autosomal dominant or an autosomal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -6.8046875,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.7890625,
            "end_logit": 8.2109375,
            "text": "mode of inheritance, GD by an autosomal recessive mode of inheritance and AD by an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.05078125,
            "text": "autosomal dominant or an autosomal recessive (AR) mode of inheritance, GD by an autosomal recessive mode of inheritance",
            "probability": 5.960464477539063e-08
        }
    ],
    "53318685d6d3ac6a3400003d_4": [
        {
            "start_logit": 8.2421875,
            "end_logit": 8.1640625,
            "text": "autosomal dominant",
            "probability": 1.0
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -1.1796875,
            "text": "autosomal",
            "probability": 8.749961853027344e-05
        },
        {
            "start_logit": -1.169921875,
            "end_logit": 8.1640625,
            "text": "dominant",
            "probability": 8.153915405273438e-05
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.0625,
            "text": "autosomal dominant mode of inheritance.",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.140625,
            "text": "autosomal dominant mode of inheritance",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": -7.29296875,
            "end_logit": 8.1640625,
            "text": "families was consistent with an autosomal dominant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.33984375,
            "end_logit": 8.1640625,
            "text": "three families was consistent with an autosomal dominant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.34765625,
            "end_logit": 8.1640625,
            "text": "vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2421875,
            "end_logit": -7.48046875,
            "text": "autosomal dominant mode of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.42578125,
            "end_logit": 8.1640625,
            "text": "consistent with an autosomal dominant",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.49609375,
            "end_logit": 8.1640625,
            "text": "transmission in three families was consistent with an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.51171875,
            "end_logit": 8.1640625,
            "text": "observation of vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5234375,
            "end_logit": 8.1640625,
            "text": "was consistent with an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 8.1640625,
            "text": "The condition appeared to be sporadic in 16 cases but the observation of vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6015625,
            "end_logit": 8.1640625,
            "text": "condition appeared to be sporadic in 16 cases but the observation of vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6171875,
            "end_logit": 8.1640625,
            "text": "an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 8.1640625,
            "text": "cases but the observation of vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.62890625,
            "end_logit": 8.1640625,
            "text": "the observation of vertical transmission in three families was consistent with an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.640625,
            "end_logit": 8.1640625,
            "text": "in three families was consistent with an autosomal dominant",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.65234375,
            "end_logit": 8.1640625,
            "text": "with an autosomal dominant",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5c5312097e3cb0e231000011_1": [
        {
            "start_logit": 8.21875,
            "end_logit": 8.09375,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 8.21875,
            "end_logit": -1.2177734375,
            "text": "Oh",
            "probability": 9.03010368347168e-05
        },
        {
            "start_logit": -1.37890625,
            "end_logit": 8.09375,
            "text": "io",
            "probability": 6.812810897827148e-05
        },
        {
            "start_logit": 8.21875,
            "end_logit": -7.39453125,
            "text": "Ohio,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.79296875,
            "end_logit": 8.09375,
            "text": "in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.828125,
            "end_logit": 8.09375,
            "text": "Recent outbreaks in Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.859375,
            "end_logit": 8.09375,
            "text": "2014 measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.87890625,
            "end_logit": 8.09375,
            "text": "measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 8.09375,
            "text": "a 2014 measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 8.09375,
            "text": "Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.92578125,
            "end_logit": 8.09375,
            "text": "outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9375,
            "end_logit": 8.09375,
            "text": "outbreaks in Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -1.37890625,
            "end_logit": -7.39453125,
            "text": "io,",
            "probability": 0.0
        },
        {
            "start_logit": -7.79296875,
            "end_logit": -1.2177734375,
            "text": "in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.828125,
            "end_logit": -1.2177734375,
            "text": "Recent outbreaks in Amish communities include a 2014 measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.859375,
            "end_logit": -1.2177734375,
            "text": "2014 measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.87890625,
            "end_logit": -1.2177734375,
            "text": "measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -1.2177734375,
            "text": "a 2014 measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.921875,
            "end_logit": -1.2177734375,
            "text": "Amish communities include a 2014 measles outbreak in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.92578125,
            "end_logit": -1.2177734375,
            "text": "outbreak in Oh",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_2": [
        {
            "start_logit": 8.1171875,
            "end_logit": 8.0234375,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 8.1171875,
            "end_logit": -1.494140625,
            "text": "Oh",
            "probability": 7.367134094238281e-05
        },
        {
            "start_logit": -1.583984375,
            "end_logit": 8.0234375,
            "text": "io",
            "probability": 6.109476089477539e-05
        },
        {
            "start_logit": -7.390625,
            "end_logit": 8.0234375,
            "text": "in Ohio",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.83984375,
            "end_logit": 8.0234375,
            "text": "the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.86328125,
            "end_logit": 8.0234375,
            "text": "undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 8.0234375,
            "text": "vaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.91796875,
            "end_logit": 8.0234375,
            "text": "a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9296875,
            "end_logit": 8.0234375,
            "text": "2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.95703125,
            "end_logit": 8.0234375,
            "text": "United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96875,
            "end_logit": 8.0234375,
            "text": "in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9765625,
            "end_logit": 8.0234375,
            "text": "numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.390625,
            "end_logit": -1.494140625,
            "text": "in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.83984375,
            "end_logit": -1.494140625,
            "text": "the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.83984375,
            "end_logit": -1.494140625,
            "text": "Measles outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.86328125,
            "end_logit": -1.494140625,
            "text": "undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.90234375,
            "end_logit": -1.494140625,
            "text": "vaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.91796875,
            "end_logit": -1.494140625,
            "text": "a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.9296875,
            "end_logit": -1.494140625,
            "text": "2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.95703125,
            "end_logit": -1.494140625,
            "text": "United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_3": [
        {
            "start_logit": 8.2578125,
            "end_logit": 8.1015625,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -1.0126953125,
            "text": "Oh",
            "probability": 0.000110626220703125
        },
        {
            "start_logit": -1.240234375,
            "end_logit": 8.1015625,
            "text": "io",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.28515625,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.42578125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.48828125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish community who",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.51171875,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish community",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.52734375,
            "text": "Ohio were",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.52734375,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.5390625,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.5703125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.578125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.58203125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.60546875,
            "text": "Ohio were transmission primarily within households, the small proportion of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.63671875,
            "text": "Ohio were transmission primarily within households, the small proportion",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.640625,
            "text": "Ohio were transmission primarily within households, the small",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 8.1015625,
            "text": "in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 8.1015625,
            "text": "CONCLUSIONS The key epidemiologic features of a measles outbreak in the Amish community in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 8.1015625,
            "text": "key epidemiologic features of a measles outbreak in the Amish community in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 8.1015625,
            "text": "The key epidemiologic features of a measles outbreak in the Amish community in Ohio",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5c5312097e3cb0e231000011_4": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.1328125,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.1025390625,
            "text": "Oh",
            "probability": 9.685754776000977e-05
        },
        {
            "start_logit": -1.19921875,
            "end_logit": 8.1328125,
            "text": "io",
            "probability": 7.969141006469727e-05
        },
        {
            "start_logit": -7.07421875,
            "end_logit": 8.1328125,
            "text": "in Ohio",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.453125,
            "text": "Ohio push",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.5390625,
            "text": "Ohio pushing the annual cases to the highest national number reported in the last 20 years",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.546875,
            "text": "Ohio pushing the annual cases to the highest national number reported in the last 20",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.55078125,
            "text": "Ohio pushing the annual cases to the highest national",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.5546875,
            "text": "Ohio pushing the annual cases to the highest national number reported in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.55859375,
            "text": "Ohio pushing the annual cases to the highest national number reported",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.55859375,
            "text": "Ohio pushing the annual cases to the highest national number",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.5703125,
            "text": "Ohio pushing the annual cases to the highest national number reported in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 8.1328125,
            "text": "undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 8.1328125,
            "text": "2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.796875,
            "end_logit": 8.1328125,
            "text": "vaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.8359375,
            "end_logit": 8.1328125,
            "text": "the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.89453125,
            "end_logit": 8.1328125,
            "text": "a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.90234375,
            "end_logit": 8.1328125,
            "text": "numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9140625,
            "end_logit": 8.1328125,
            "text": "subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.07421875,
            "end_logit": -1.1025390625,
            "text": "in Oh",
            "probability": 0.0
        }
    ],
    "5c5312097e3cb0e231000011_5": [
        {
            "start_logit": 8.234375,
            "end_logit": 8.1171875,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 8.234375,
            "end_logit": -1.1259765625,
            "text": "Oh",
            "probability": 9.763240814208984e-05
        },
        {
            "start_logit": -1.26953125,
            "end_logit": 8.1171875,
            "text": "io",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.4296875,
            "text": "Ohio,",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.46875,
            "text": "Ohio, resulting in 368 cases reported",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.5078125,
            "text": "Ohio, resulting in 36",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.52734375,
            "text": "Ohio, resulting in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.578125,
            "text": "Ohio, resulting in 368",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.609375,
            "text": "Ohio, resulting in 368 cases",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.234375,
            "end_logit": -7.62890625,
            "text": "Ohio, resulting",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.57421875,
            "end_logit": 8.1171875,
            "text": "in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.72265625,
            "end_logit": 8.1171875,
            "text": "2014 measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.765625,
            "end_logit": 8.1171875,
            "text": "Recent outbreaks in Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.84765625,
            "end_logit": 8.1171875,
            "text": "measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.875,
            "end_logit": 8.1171875,
            "text": "a 2014 measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.890625,
            "end_logit": 8.1171875,
            "text": "Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.921875,
            "end_logit": 8.1171875,
            "text": "outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9453125,
            "end_logit": 8.1171875,
            "text": "outbreaks in Amish communities include a 2014 measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.9609375,
            "end_logit": 8.1171875,
            "text": "sh communities include a 2014 measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.96875,
            "end_logit": 8.1171875,
            "text": "include a 2014 measles outbreak in Ohio",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5c5312097e3cb0e231000011_6": [
        {
            "start_logit": 8.2578125,
            "end_logit": 8.1015625,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -1.0126953125,
            "text": "Oh",
            "probability": 0.000110626220703125
        },
        {
            "start_logit": -1.240234375,
            "end_logit": 8.1015625,
            "text": "io",
            "probability": 7.486343383789062e-05
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.28515625,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.42578125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.48828125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish community who",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.51171875,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish community",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.52734375,
            "text": "Ohio were",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.52734375,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.5390625,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.5703125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.578125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.58203125,
            "text": "Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.60546875,
            "text": "Ohio were transmission primarily within households, the small proportion of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.63671875,
            "text": "Ohio were transmission primarily within households, the small proportion",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": 8.2578125,
            "end_logit": -7.640625,
            "text": "Ohio were transmission primarily within households, the small",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.65625,
            "end_logit": 8.1015625,
            "text": "in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75,
            "end_logit": 8.1015625,
            "text": "CONCLUSIONS The key epidemiologic features of a measles outbreak in the Amish community in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.75390625,
            "end_logit": 8.1015625,
            "text": "key epidemiologic features of a measles outbreak in the Amish community in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.78125,
            "end_logit": 8.1015625,
            "text": "The key epidemiologic features of a measles outbreak in the Amish community in Ohio",
            "probability": 1.1920928955078125e-07
        }
    ],
    "5c5312097e3cb0e231000011_7": [
        {
            "start_logit": 8.25,
            "end_logit": 8.1171875,
            "text": "Ohio",
            "probability": 1.0
        },
        {
            "start_logit": 8.25,
            "end_logit": -1.02734375,
            "text": "Oh",
            "probability": 0.0001055598258972168
        },
        {
            "start_logit": -1.26953125,
            "end_logit": 8.1171875,
            "text": "io",
            "probability": 7.253885269165039e-05
        },
        {
            "start_logit": -6.80078125,
            "end_logit": 8.1171875,
            "text": "in Ohio",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.5234375,
            "text": "Ohio pushing the annual cases to the highest national",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.5625,
            "text": "Ohio push",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.25,
            "end_logit": -7.61328125,
            "text": "Ohio pushing the annual cases to the highest national number reported",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.6796875,
            "end_logit": 8.1171875,
            "text": "a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.73046875,
            "end_logit": 8.1171875,
            "text": "2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.76171875,
            "end_logit": 8.1171875,
            "text": "undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -7.7890625,
            "end_logit": 8.1171875,
            "text": "the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
            "probability": 1.1920928955078125e-07
        },
        {
            "start_logit": -6.80078125,
            "end_logit": -1.02734375,
            "text": "in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.6796875,
            "end_logit": -1.02734375,
            "text": "a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.73046875,
            "end_logit": -1.02734375,
            "text": "2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.76171875,
            "end_logit": -1.02734375,
            "text": "undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -1.26953125,
            "end_logit": -7.5234375,
            "text": "io pushing the annual cases to the highest national",
            "probability": 0.0
        },
        {
            "start_logit": -7.7890625,
            "end_logit": -1.02734375,
            "text": "the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -7.79296875,
            "end_logit": -1.02734375,
            "text": "Measles outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Oh",
            "probability": 0.0
        },
        {
            "start_logit": -1.26953125,
            "end_logit": -7.5625,
            "text": "io push",
            "probability": 0.0
        },
        {
            "start_logit": -1.26953125,
            "end_logit": -7.61328125,
            "text": "io pushing the annual cases to the highest national number reported",
            "probability": 0.0
        }
    ],
    "61f95f9f882a024a1000004e_1": [
        {
            "start_logit": 8.1328125,
            "end_logit": 8.078125,
            "text": "Oguchi disease",
            "probability": 1.0
        },
        {
            "start_logit": -1.435546875,
            "end_logit": 8.078125,
            "text": "disease",
            "probability": 6.920099258422852e-05
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -1.611328125,
            "text": "Og",
            "probability": 6.157159805297852e-05
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -4.55078125,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness",
            "probability": 3.2186508178710938e-06
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -5.6953125,
            "text": "Oguchi",
            "probability": 1.0132789611816406e-06
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -6.32421875,
            "text": "Oguchi disease,",
            "probability": 5.364418029785156e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -6.50390625,
            "text": "Oguchi disease, a",
            "probability": 4.76837158203125e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -6.640625,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness (CSNB",
            "probability": 4.172325134277344e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -6.7109375,
            "text": "Oguch",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -6.81640625,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness (",
            "probability": 3.5762786865234375e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -6.8515625,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness (CSNB).",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": -6.8203125,
            "end_logit": 8.078125,
            "text": "uchi disease",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -6.91796875,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness (CSNB)",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -6.93359375,
            "text": "Oguchi disease, a rare subtype of congenital stationary night blindness (CS",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.02734375,
            "text": "Oguchi disease, a rare subtype",
            "probability": 2.980232238769531e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.22265625,
            "text": "Oguchi disease, a rare",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.2421875,
            "text": "Oguchi disease, a rare subtype of congenital stationary night",
            "probability": 2.384185791015625e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.33203125,
            "text": "Oguchi disease, a rare subtype of",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": 8.1328125,
            "end_logit": -7.40234375,
            "text": "Oguchi disease, a rare subtype of congenital",
            "probability": 1.7881393432617188e-07
        },
        {
            "start_logit": -7.5859375,
            "end_logit": 8.078125,
            "text": "i disease",
            "probability": 1.1920928955078125e-07
        }
    ]
}
